[
  
  {
    "source_url": "https://medex.com.bd/brands/30398/allertin-20-mg-tablet",
    "name": "Allertin",
    "dosage_form": "Tablet",
    "generic": "Bilastine",
    "strength": "20 mg",
    "company": "Navana Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": "৳ 150.00",
      "pack_size_info": "(3 x 10: ৳ 450.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 15.00",
          "pack_size_info": "(3 x 10: ৳ 450.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 150.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "12.5 mg/5 ml (Solution)",
        "href": "https://medex.com.bd/brands/31418/allertin-125-mg-oral-solution?ref=1"
      },
      {
        "text": "10 mg (DT)",
        "href": "https://medex.com.bd/brands/33724/allertin-odt-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1457/bilastine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allertin is indicated for the symptomatic treatment of- Allertin is also used to relieve the symptoms of hay fever (sneezing, itchy, runny, blocked-nose and red and watery eyes).",
        "items": [
          "Allergic rhino conjunctivitis (seasonal and perennial) and",
          "Urticaria"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Bilastine is a potent, effective, non-sedating, long-acting histamine antagonist with selective & high affinity to H1 receptor (3 times higher than Cetirizine and 5 times higher than Fexofenadine). Even at a high concentration, Bilastine does not show affinity for the 30 other receptors including muscarinic, serotonergic, dopaminergic and noradrenergic receptors, for the other histamine receptor subtypes (H2, H3 and H4). It shows excellent safety profile and very favorable pharmacokinetic characteristics. Bilastine doesn’t undergo any metabolism to be active. Bilastine is excreted by feces (non -systemic) & urine (systemic) approximately 66.35% & 28.31% respectively.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concomitant use of Allertin with ketoconazole, erythromycin, cyclosporine or diltiazem increases the concentration of Allertin. But these changes do not appear to affect the safety profile of any of the drugs. Intake of alcohol and 20 mg Allertin shows same psychomotor performance similar to that of alcohol and placebo. Concomitant intake of Allertin 20 mg and lorazepam 3 mg for 8 days did not potentiate the depressant CNS effects of lorazepam.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most commonly reported side effects in clinical trial are headache, dizziness, somnolence and fatigue. These adverse events occurred with a comparable frequency in patients receiving placebo.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no or limited amount of data from the use of Bilastine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, parturition or postnatal development. As a precautionary measure, it is preferable to avoid the use of Bilastine during pregnancy. The excretion of Bilastine in milk has not been studied in humans. A decision must be made taking into account the benefit of breast-feeding for the child and the benefit of Bilastine therapy for the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Treatment with Allertin 20 mg does not affect the driving performance. However, patients should be informed that very rarely some people experience drowsiness, which may affect their ability to drive or use machines. In clinical trials elderly patients (≥65 years) showed no difference in effcacy or safety with respect to younger patients. The maximum plasma concentration of Allertin after administration of 20 mg in patients with severe renal impairment is below the safety threshold of most common adverse e?ects and cardiac or CNS safety. No dosage adjustment is necessary in patients with renal impairment. Allertin is not metabolized in human. Since renal elimination is the major excretion, biliary excretion is expected to be only marginally involved in the elimination of Allertin. Changes in liver function are not expected to have a clinically relevant influence.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Efficacy and safety of Allertin in children under 2 years of age have not been established and there is little clinical experience in children aged 2 to 5 years, therefore Allertin should not be used in these age groups.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "In clinical trials, after administration of Allertin at doses 10 to 11 times the therapeutic dose (220 mg as single dose; or 200 mg/day for 7 days) frequency of treatment-emergent adverse events was two times higher than with placebo. The adverse reactions most frequently reported were dizziness, headache and nausea. No serious adverse events and no significant prolongation in the QTc interval were reported.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, protected from light and moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C28H37N3O3",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-1457-bilastine-chemical-structure-PylLjWiPzmvT6LbGl8QG.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Adults & adolescents (12 years of age and over)",
        "information": ": 20 mg tablet once daily for symptomatic relief of allergic rhinitis, urticaria and allergic rhinoconjunctivitis. The maximum recommended daily dose is 20 mg Bilastine (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken. 20 mg Bilastine tablet (1 tablet) once daily should be swallowed with water on an empty stomach to achieve optimal exposure to Bilastine.",
        "instructions": []
      },
      {
        "medication_type": "Children between 6 to 11 years",
        "information": ": 10 mg mouth dissolving tablet for the symptomatic relief of allergic rhinitis, allergic rhinoconjunctivitis and urticaria. The Mouth dissolving tablet is for oral use only. It should be placed in the mouth. It will disperse rapidly in saliva and can be easily swallowed. Alternatively, the mouth dissolving tablet can be dispersed in a tea spoon of water before being swallowed by the children. The maximum recommended daily dose for children in between 6 to 11 years is 10 mg Bilastine mouth dissolving tablet (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken.",
        "instructions": []
      },
      {
        "medication_type": "Children between 2 to 11 years",
        "information": ": 4 ml once daily.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Allertin 20 mg Tablet?",
        "answer": [
          "Allertin 20 mg Tablet is H1 receptor antagnist. It is commonly used to treat Allergic rhino conjunctivitis (seasonal and perennial) and Urticaria."
        ]
      },
      {
        "question": "Are there any pregnancy warnings of Allertin 20 mg Tablet?",
        "answer": [
          "Limited information is available. Allertin 20 mg Tablet is recommended to be used only after consulting a doctor for pregnant women."
        ]
      },
      {
        "question": "Are there any breast-feeding warnings of Allertin 20 mg Tablet?",
        "answer": [
          "It is advised to consult your doctor before taking Allertin 20 mg Tablet if you are breast feeding a baby as relevant information is not available."
        ]
      },
      {
        "question": "Does Allertin 20 mg Tablet safe with alcohol?",
        "answer": [
          "Excessive intake of alcohol should be avoided during the course of medication as it can increase sleepiness."
        ]
      },
      {
        "question": "Does Allertin 20 mg Tablet affect kidney function?",
        "answer": [
          "It is important to consult a doctor to know the dose adjustment for patients suffering from kidney diseases."
        ]
      },
      {
        "question": "Does Allertin 20 mg Tablet affect liver function?",
        "answer": [
          "Relevant information is not available. Please consult to know if any dose adjustment is needed in patients with liver impairment."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Your doctor has prescribed Allertin 20 mg Tablet to help relieve allergy symptoms such as itching, swelling, and rashes.",
          "As compared to other similar medications, it is much less likely to make you feel sleepy.",
          "Be cautious while driving or doing anything that requires concentration as it can cause dizziness and sleepiness.",
          "Do not drink alcohol while taking this medication as it may cause increased sleepiness.",
          "Stop taking Allertin 20 mg Tablet at least three days before taking an allergy test as it can affect the test results."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:24:00.517Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e39",
    "original_record": {
      "input_index": 699,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e39"
        },
        "name": "Allertin",
        "strength": "20 mg",
        "generic": "Bilastine",
        "company": "Navana Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/30398/allertin-20-mg-tablet",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/17560/almasil-ms-400-mg-suspension",
    "name": "Almasil MS",
    "dosage_form": "Oral Suspension",
    "generic": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicone",
    "strength": "(400 mg+400 mg+30 mg)/5 ml",
    "company": "United Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 55.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "200 ml bottle",
          "price": "৳ 55.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "400 mg+400 mg+30 mg (Chew. Tablet)",
        "href": "https://medex.com.bd/brands/17550/almasil-ms-400-mg-chewable-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/20/aluminium-hydroxide-magnesium-hydroxide-simethicone/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This is indicated for symptomatic relief of hyperacidity associated with the peptic ulcer, gastritis, peptic oesophagitis, gastric hyperacidity, heartburn, sour stomach or hiatus hernia. It is effective in the prevention of stress ulceration and GI bleeding. It acts as an antiflatulent to alleviate the symptoms of gas including post operative gas pain. This rapidly relieves acid pain, disperses gastric foam and facilitates eructation of gas and air.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the mixture of non-systemic acid neutralizing substances and antiflatulent. This preparation offers reliability as well as long action. Aluminium Hydroxide and Magnesium Hydroxide induce the relief of ulcer by neutralizing gastric acid secreted from parietal cells of the stomach. The clinical use of simethicone is based on its antifoam properties. Simethicone spreads on the surface of aqueous liquids, forming a film of low surface tension and causing collapse of foam bubbles. Simethicone repeatedly allows mucous surrounded gas bubbles in the GI tract to coalesce and be expelled. This is used in the treatment of flatulence and meteorism for the elimination of gas, air or foam from the gastro-intestinal tract prior to radiography and for the relief of abdominal distension and dyspepsia. Simethicone is physiologically inert; it does not appeared to be absorbed from the GI tract to interfere with gastric secretion or absorption of nutrients. Following oral administration, the drug is excreted unchanged in the feces.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "All antacids may increase or decrease the rate and/or extent of absorption of concomitantly administered oral drugs. Antacids decrease the bioavailability of theophyline, tetracycline, quinolone antibiotics, isoniazide, ketoconazole, ethambutol, some antimuscarinic drugs, benzodiazepines, phenothiazines, ranitidine, indomethacine, nitrofurantoin, fluoride, phosphate, propanolol, atenolol, digoxins, vitamins etc. Antacids increase the bioavailability of some drugs; e.g. sulphonamides, levodopa, valproic acid, enteric coated aspirin etc.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This should not be administered in patients with renal failure or hypophosphataemia or in those who are severely debilitated. It is also contraindicated in alkalosis and hypermagnesaemia, where abdominal distention may be due to partial or complete intestinal obstruction.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects are uncommon. Occasionally, if excessive amount is consumed, diarrhea, constipation or regurgitation may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "It is advised to avoid antacid preparations in the first trimester of pregnancy.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "This should be used with caution in patients with kidney disease.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ": 1-2 tablets 1-3 hours after meal and at bed time or as directed by the physician.",
        "instructions": []
      },
      {
        "medication_type": "Suspension",
        "information": ": 1-2 teaspoonful 1-3 hours after meal and at bedtime or as directed by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:01.850Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e46",
    "original_record": {
      "input_index": 701,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e46"
        },
        "name": "Almasil MS",
        "strength": "(400 mg+400 mg+30 mg)/5 ml",
        "generic": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicone",
        "company": "United Pharmaceuticals Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/17560/almasil-ms-400-mg-suspension",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/13225/alneed-capsule",
    "name": "Alneed",
    "dosage_form": "Capsule",
    "generic": "Iron + Folic acid + Vitamin B complex + Vitamin C",
    "strength": null,
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 3.00",
      "strip_price": "৳ 30.00",
      "pack_size_info": "(10 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.00",
          "pack_size_info": "(10 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/628/iron-folic-acid-vitamin-b-complex-vitamin-c/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This is indicated for the treatment and prophylaxis of Iron, Folic acid, Vitamin B complex and Vitamin C deficiency, or to meet extra need of these vitamins and minerals especially in pregnancy or when planning for pregnancy.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": "Iron",
        "information": "is an essential mineral, with several important roles in the body. For example, it helps to make red blood cells, which carry oxygen around the body. A lack of iron can lead to iron deficiency anaemia. Liver is a good source of iron, don't eat it if you are pregnant. This is because it is also rich in vitamin A which, in large amounts, can harm your unborn baby.",
        "items": []
      },
      {
        "title": "Folic acid",
        "information": "is essential for the production of certain coenzymes in many metabolic systems such as purine and pyrimidine synthesis. It is also essential in the synthesis and maintenance of nucleoprotein in erythropoesis. It also promotes WBC and platelet production in folate-deficiency anaemia.",
        "items": []
      },
      {
        "title": "Vitamin C",
        "information": "is necessary for collagen formation and tissue repair; plays a role in oxidation/reduction reactions as well as other metabolic pathways including synthesis of catecholamines, carnitine, and steroids; also plays a role in conversion of folic acid to folinic acid.",
        "items": []
      },
      {
        "title": "Vitamin B complex:",
        "information": "The building blocks for good health come from a variety of foods, even if they are from the same family of nutrients. Such is the case with vitamin B, a key player in maintaining cell health and keeping you energized. Not all types of vitamin B do the same thing. Additionally, the different types of vitamin B all come from different types of foods. Vitamin B deficiencies can lead to health problems. Sometimes a doctor will prescribe a supplement when they think you’re not getting enough.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Care should be taken when given to patients with Iron storage or Iron absorption disease. Iron form chelates with antacids and Tetracycline and absorption of all these may be impaired if taken concurrently",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Iron therapy is contraindicated in haemachromatosis and haemosiderosis, and in patients receiving repeated blood transfusion or with anaemia not due to by iron deficiency. It should be given cautiously to patients taking Levodopa as one of the ingredients (Pyridoxine) reduces the effect of Levodopa.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally well tolerated. However, a few allergic reactions may be seen.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "It is recommended during pregnancy and lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Care should be taken in patients who may develop iron overload, such as those with hemochromatosis, haemolytic anaemia or red cell aplasia. Iron chelates with tetracycline and absorption may be impaired.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Accidental overdose of iron containing products is a leading cause of fatal poisoning in children fewer than 6. Avoid higher doses if you have liver disease or hemochromatosis; excess can cause bloody diarrhea, vomiting, acidosis, darkened stools, abdominal pain. Symptoms may clear in a few hours. Riboflavin is reported to be completely safe and no toxic symptoms have been reported so far. Higher doses of Nicotinamide may cause vomiting, diarrhea. Sensory neuropathy was observed in individuals consuming more than 200 mg Pyridoxine for very long periods. No cases of Folic acid overdosages have been reported. Acute ingestion of Ascorbic acid, even of massive doses, is unlikely to cause significant effects.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a dry place below 25° C. Protect from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Iron & Vitamin Combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Recommended adult dose is one capsule daily. In more severe deficiency states, 2 capsules a day may be required or as directed by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:02.904Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e51",
    "original_record": {
      "input_index": 702,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e51"
        },
        "name": "Alneed",
        "strength": null,
        "generic": "Iron + Folic acid + Vitamin B complex + Vitamin C",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/13225/alneed-capsule",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/13258/alneed-plus-capsule",
    "name": "Alneed Plus",
    "dosage_form": "Capsule",
    "generic": "Iron + Folic Acid + Vitamin B Complex + Vitamine C + Zinc Sulfate",
    "strength": null,
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 3.50",
      "strip_price": "৳ 35.00",
      "pack_size_info": "(10 x 10: ৳ 350.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.50",
          "pack_size_info": "(10 x 10: ৳ 350.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 35.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/629/iron-folic-acid-vitamin-b-complex-vitamine-c-zinc-sulfate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This is indicated for the treatment and prophylaxis of Zinc, Iron, Folic Acid, Vitamin B Complex and Vitamin-C deficiency especially during pregnancy and lactation.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": "Zinc sulfate",
        "information": "precipitates protein and this is responsible for the astringent and weak antiseptic activity of Zn sulfate. It also produces mild vasodilation. Zinc sulfate can also be used orally or systemically as a zinc supplement. 220 mg of zinc sulfate (heptahydrate) contains 50 mg of elemental zinc.",
        "items": []
      },
      {
        "title": "Iron",
        "information": "is an essential mineral, with several important roles in the body. For example, it helps to make red blood cells, which carry oxygen around the body. A lack of iron can lead to iron deficiency anaemia. Liver is a good source of iron, don't eat it if you are pregnant. This is because it is also rich in vitamin A which, in large amounts, can harm your unborn baby.",
        "items": []
      },
      {
        "title": "Folic acid",
        "information": "is essential for the production of certain coenzymes in many metabolic systems such as purine and pyrimidine synthesis. It is also essential in the synthesis and maintenance of nucleoprotein in erythropoesis. It also promotes WBC and platelet production in folate-deficiency anaemia.",
        "items": []
      },
      {
        "title": "Nicotinamide",
        "information": "is a vitamin B3 derivative. It is incorporated into coenzymes nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are involved in multiple cellular metabolic pathways.",
        "items": []
      },
      {
        "title": "Vitamin C",
        "information": "is necessary for collagen formation and tissue repair; plays a role in oxidation/reduction reactions as well as other metabolic pathways including synthesis of catecholamines, carnitine, and steroids; also plays a role in conversion of folic acid to folinic acid.",
        "items": []
      },
      {
        "title": "Vitamin B complex",
        "information": ": The building blocks for good health come from a variety of foods, even if they are from the same family of nutrients. Such is the case with vitamin B, a key player in maintaining cell health and keeping you energized. Not all types of vitamin B do the same thing. Additionally, the different types of vitamin B all come from different types of foods. Vitamin B deficiencies can lead to health problems. Sometimes a doctor will prescribe a supplement when they think you’re not getting enough.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally well tolerated. However, a few allergic reactions may be seen.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Recommended.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Care should be taken in patients who may develop iron overload, such as those with haemochromatosis, haemolytic anaemia or red cell aplasia. Iron chelates with tetracycline and absorption may be impaired.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": "Accidental overdose of iron containing products",
        "information": "is a leading cause of fatal poisoning in children below 6 years. Avoid higher doses if you have liver disease or haemochromatosis; excess can cause bloody diarrhea, vomiting, acidosis, darkened stools, abdominal pain. Symptoms may clear in a few hours.",
        "items": []
      },
      {
        "title": "Riboflavin",
        "information": "is reported to be completely safe and no toxic symptoms have been reported so far. Higher doses of Nicotinamide may cause vomiting, diarrhea. Sensory neuropathy was observed in individuals consuming more than 200 mg Pyridoxine for very long periods. No case of Folic acid overdodage has been reported.",
        "items": []
      },
      {
        "title": "Acute ingestion of Ascorbic acid",
        "information": ", even of massive doses, is unlikely to cause significant effects.",
        "items": []
      },
      {
        "title": "Zinc",
        "information": "toxicity has been seen in both acute and chronic forms. Ingestion of 150 to 450 mg of zinc per day have been associated with low copper status, altered iron function, reduced immune function, and reduced levels of high-density lipoproteins. So, Zinc at its RDA dosages dose not cause any significant effect.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a dry place below 25 °C. Protect from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Iron & Vitamin Combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "One capsule daily. In more severe cases, 2 capsules a day may be required or as directed by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:04.217Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e53",
    "original_record": {
      "input_index": 703,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e53"
        },
        "name": "Alneed Plus",
        "strength": null,
        "generic": "Iron + Folic Acid + Vitamin B Complex + Vitamine C + Zinc Sulfate",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/13258/alneed-plus-capsule",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/784/aloten-5-mg-tablet",
    "name": "Aloten",
    "dosage_form": "Tablet",
    "generic": "Amlodipine Besilate + Atenolol",
    "strength": "5 mg+25 mg",
    "company": "Kemiko Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.24",
      "strip_price": "৳ 42.40",
      "pack_size_info": "(5 x 10: ৳ 212.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.24",
          "pack_size_info": "(5 x 10: ৳ 212.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 42.40",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg+50 mg (Tablet)",
        "href": "https://medex.com.bd/brands/785/aloten-forte-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/63/amlodipine-besilate-atenolol/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This is indicated in-",
        "items": [
          "Patients with essential hypertension",
          "Patients with angina pectoris & hypertension as co-existing diseases",
          "ln post Ml patients",
          "ln patients with refractory angina pectoris where nitrate therapy has failed."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a fixed-dose combination of Amlodipine and Atenolol. Amlodipine is a dihydropyridine calcium antagonist that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle; it has a greater effect on vascular smooth muscle than on cardiac muscle. Amlodipine is a peripheral vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure. Amlodipine reduces tone, decreases coronary vasoreactivity and lowers cardiac demand by reducing afterload. Atenolol is a cardioselective beta-blocker. The cardio-selectivity is dose-related. Atenolol causes a reduction in blood pressure by lowering cardiac output, decreasing the plasma renin activity and sympathetic outflow from CNS. Atenolol also causes a reduction in myocardial oxygen demand by virtue of its negative inotropic and negative chronotropic effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Disopyramide",
        "information": ": Atenolol reduces the clearance of disopyramide by 20%. Additive negative inotropic effects on the heart may be produced.",
        "items": []
      },
      {
        "title": "Ampicillin",
        "information": ": at doses of 1 gm and above may reduce Atenolol levels.",
        "items": []
      },
      {
        "title": "Oral antidiabetics and insulin",
        "information": ": Beta-blockers may decrease tissue sensitivity to insulin and inhibit insulin secretion e.g. in response to oral antidiabetics. Atenolol has less potential for these actions.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to either component, sinus bradycardia, second and higher degrees of heart block, cardiogenic shock, hypotension, congestive heart failure, poor left ventricular function.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The combination of Amlodipine and Atenolol is well tolerated. Overall side-effects include fatigue, headache, edema, nausea, drowsiness, anxiety and depression.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The combination should be used during pregnancy only if the expected benefit outweighs the potential fetal risk. The combination should not be used by nursing mothers. If its use is considered necessary, breast-feeding should be stopped.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Bronchospasm",
        "information": ": The combination should be used with caution in patients with airway obstruction.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": The combination can be used in patients with renal impairment. However, caution may be necessary if the creatinine clearance is less than 30 ml/min because of possible reduction in the excretion of unchanged Atenolol.",
        "items": []
      },
      {
        "title": "Hepatic impairment",
        "information": ": Caution may be necessary in the use of the combination in patients with severe liver damage because of prolongation of the elimination half-life of Amlodipine.",
        "items": []
      },
      {
        "title": "Drug withdrawal",
        "information": ": Since coronary heart disease may exist without being recognized, patients should be warned against stopping the drug suddenly. Any discontinuation should be gradual and under observation.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Though not documented, hypotension and less frequently congestive cardiac failure may occur in cases of overdosage. Unabsorbed drugs may be removed by gastric lavage or administration of activated charcoal. Symptomatic treatment is suggested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Combined antihypertensive preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended dosage is Amlodipine and Atenolol 5/25 mg tablet once daily. If necessary, the dosage may be increased to 5/25 mg two tablets daily or as advised by the physicians. The dosage however should be individualized.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:05.219Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e5d",
    "original_record": {
      "input_index": 704,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e5d"
        },
        "name": "Aloten",
        "strength": "5 mg+25 mg",
        "generic": "Amlodipine Besilate + Atenolol",
        "company": "Kemiko Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/784/aloten-5-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31401/alphalok-2-mg-tablet",
    "name": "Alphalok",
    "dosage_form": "Tablet",
    "generic": "Prazosin Hydrochloride",
    "strength": "2 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 6.00",
      "strip_price": "৳ 84.00",
      "pack_size_info": "(3 x 14: ৳ 252.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 6.00",
          "pack_size_info": "(3 x 14: ৳ 252.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 84.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "1 mg (Tablet)",
        "href": "https://medex.com.bd/brands/31400/alphalok-1-mg-tablet?ref=1"
      },
      {
        "text": "2.5 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/31617/alphalok-xr-25-mg-tablet?ref=1"
      },
      {
        "text": "5 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/31618/alphalok-xr-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/913/prazosin-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Hypertension: Alphalok is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a ... Read moreHypertension: Alphalok is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a diuretic and/or other antihypertensive drugs as needed for proper patient response. Renal blood flow and glomerular filtration rate are not impaired by long-term oral administration and thus Alphalok can be used with safety in hypertensive patients with impaired renal function.Left Ventricular Failure: Alphalok is indicated in the treatment of left ventricular failure. Alphalok may be added to the therapeutic regimen in those patients who have not shown a satisfactory response or who have become refractory to conventional therapy with diuretics, with or without cardiac glycosides.Raynaud's Phenomenon And Raynaud's Disease: Alphalok indicated in the treatment of Raynaud's phenomenon and Raynaud's disease.Benign Prostatic Hyperplasia: Alphalok is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia. It is also of value in patients awaiting prostatic surgery.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Prazosin causes a decrease in total peripheral vascular resistance through selective inhibition of postsynaptic alpha-1-adrenoreceptors in vascular smooth muscle. In hypertensive patients, blood pressure is lowered in both the supine and standing positions; this effect is more pronounced on the diastolic blood pressure. Rebound elevation of blood pressure does not occur following abrupt cessation of Prazosin therapy. The therapeutic efficacy of Prazosin in patients with congestive heart failure is ascribed to a reduction in left ventricular filling pressure, reduction in cardiac impedance and an augmentation of cardiac output. The use of Prazosin in congestive heart failure does not provoke a reflex tachycardia and blood pressure reduction is minimal in normotensive patients. Prazosin reduce the severity of the signs, symptoms, frequency and duration of attacks, in patients with Raynaud's disease. In low dosage, antagonism of alpha-1-receptors on prostatic and urethral smooth muscle has been shown to improve the urinary pressure profile in men and to improve symptoms of benign prostatic hyperplasia. Clinical studies have shown that Prazosin therapy is not associated with adverse changes in the serum lipid profile.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alphalok XR has been administered without any adverse drug interaction in clinical experience to date with the following:",
        "items": [
          "Cardiac-glycosides-digitalis and digoxin;",
          "Hypoglycemic agents-insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide;",
          "tranquilizers and sedatives-chlordiazepoxide, diazepam and phenobarbital;",
          "antiarrhythmic agents-procainamide, propranolol and quinidine; and",
          "analgesic, antipyretic and anti-inflammatory agents-propxyphene, aspirin, indomethacin and phenylbutazone type."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Prazosin is contraindicated in patients with a known sensitivity to quinazolines.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common reactions associated with Alphalok therapy are dizziness, headache, drowsiness, lack of energy, weakness, palpitations and nausea. In most instances, side effects have disappeared with continued therapy or have been tolerated with no decrease in the dosage of the drug. In addition, the following reactions have been associated with Alphalok therapy; vomiting diarrhea, constipation, abdominal discomfort and/or pain, liver function abnormalities, pancreatitis, edema, orthostatic hypotension, dyspnea, faintness, tachycardia, nervousness, vertigo, hallucinations, depression, paresthesia, rash, pruritus alopecia, lichen planus, urinary frequency, impotence, incontinence, priapism, blurred vision, reddened solera, epistaxis, tinnitus, dry mouth, nasal congestion, diaphoresis, fever, positive ANA liter, and arthralgia. Some of these reactions have occurred rarely, and in many instances, the exact causal relationships have not been established. Literature reports exist associating Alphalok, therapy with a worsening of pre-existing narcolepsy. A causal relationship is uncertain in these cases. The following have been observed in parents being managed for left ventricular failure with Alphalok when used in conjunction with cardiac glycosides and diuretics; drowsiness, dizziness, postural hypotension, blurred vision, edema, dry mouth, palpitations, nausea, diarrhea, impotence, headache, and nasal congestion. In most instances, these occurrences have been mild to moderate in severity and have resolved with continued therapy or have been tolerated with no decrease in drug dosage. The most commonly although infrequently reported side effect in the treatment of Raynaud's Phenomenon/Disease was mild dizziness.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although no teratogenic effects were seen in animal testing; the safety of Prazosin use during. pregnancy has not yet been established. The use of prazosin and a beta-blocker for the control of sever hypertension of 44 pregnant women revealed no drug-related fetal adnormalities or adverse effects. Therapy with prazosin was continued for as long as 14 weeks. Prazosin has also been used alone or in combination with other hypotensive agents in severe hypertension or pregnancy. No fetal or neonatal abnormalities have been reported with the use of Prazosin. There are no adequate and well controlled studies that establish the safety of Prazosin in pregnant women. Prazosin should be used during pregnancy only if in the opinion of the physician the potential benefit justifies the potential risk to the mother and fetus. Prazosin has been shown to be excreted in small amounts in human milk. Caution shold be exercised when Prazosin is adminsitered to nursing mothers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Hypertension",
        "information": ": A very small percentage of patients have responded in an abrupt and exaggerated manner to the initial dose of Alphalok. Postural hypotension evidenced by dizziness and weakness, or rarely loss of consciousness, has been reported, particularly with the commencement of therapy, but this effect is readily avoided by initiating treatment with a low dose of Alphalok XR and with small increases in dosage during the first one to two weeks of therapy. The effect when observed is not related to the severity of hypertension is self-limiting and in most patients does not recur after the initial period of therapy or during subsequent dose titration steps. When instituting therapy with any effective antihypertensive agent, the patient should be advised how to avoid symptoms resulting from postural hypotension and what measures to take should they develop. The patient should be cautioned to avoid situations where injury could result should dizziness or weakness occur during the initiation of Alphalok therapy.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": When prazosin is initially administered to patients with left ventricular failure who have undergone vigorous diuretic or other vasodilator treatment, particularly in higher than the recommended starting dose, the resultant decrease in left ventricular filling pressure may be associated with a significant fall in cardiac output and systemic blood pressure. In such patients, observance of the recommended starting dose of prazosin followed by gradual titration is particularly important. (See dosage and administration). In occasional patients with left ventricular failure, the clinical efficacy of Alphalok has been reported to diminish after several months of treatment. In these patients, there is usually evidence of weight gain or peripheral edema indicating fluid retention. Since spontaneous deterioration may occur in such severely ill patients a causal relationship to prazosin therapy has not been established. Thus, as with all patients with left ventricular failure, careful adjustment of diuretic dosage according to the patient's clinical condition is required to prevent excessive fluid retention and consequent relief of symptoms. In those patients without evidence of fluid retention, when clinical improvement has diminished; an increase in the dosage, of Alphalok will usually restore clinical efficacy.",
        "items": []
      },
      {
        "title": "Raynaud's Phenomenon and Raynaud's Disease",
        "information": ": Because Alphalok decreases peripheral vascular resistance, careful monitoring of blood pressure during initial administration and titration of Alphalok is suggested. Close observation is especially recommended for patients already taking medication that are known the lower blood pressure.",
        "items": []
      },
      {
        "title": "Benign Prostatic Hyperplasia",
        "information": ": Alphalok decreases peripheral vasular resistance and since many patients with this disorder are elderly, careful monitoring of blood pressure during initial administration and during adjustment of the dose of Alphalok is suggested. Close observation is especially recommended for patients taking medications that are known to lower blood pressure.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children",
        "information": ": Alphalok is not recommended for the treatment of children under the age of 12 years since safe conditions for its use have not been established.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": Alphalok is not recommended in the treatment of left ventricular failure due to mechanical obstrcution such as aortic valve stenosis, mitral valve stenosis, pulmonary embolism and restrictive pericardial disease. Adequate data are not yet available to establish efficacy in patients with left ventricular failure due to a recent myocardial infarction.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Accidental ingestion of at least 50 mg of Alphalok in a two-year child resulted in profound drowsiness and depressed reflexes, No decrease in blood pressure was noted. Recovery was uneventful. Should overdosage lead to hypotension, support of the cardiovascular system is of first importance. Restoration of blood pressure and normalization of heart rate may be accomplished by keeping the patient in the supine position. If this measure is inadequate, shock should first be treated with volume expanders. If necessary, vasopressors should then be used. Renal function should be monitored and supported as needed. Laboratory data indicate Alphalok is not dialyzable because it is protein bound.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep away from light and moisture, store below 30°C. Keep away from reach out of the children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Alpha adrenoceptor blocking drugs",
    "dosage": [
      {
        "medication_type": "Prazosin Tablet",
        "information": ": There is evidence that toleration is best when therapy is initiated with a low starting dose. During the first week, the dosage of Prazosin should be adjusted according to the patient's individual toleration. Thereafter the daily dosage is to be adjusted on the basis of the patient's response. The response is usually seen within one to 14 days if it is to occur at any particular dose. When a response is seen, therapy should be continued at that dosage until the degree of response has reached optimum before the next dose increment is added.",
        "instructions": [
          "Hypertension: For maximum benefit, small increases should be continued until the desired effect is achieved or a total daily dosage of 20 mg is reached. A diuretic or adrenergic beta-blocking agent may be added to enhance efficacy. The maintenance dosage of Prazosin may be given as a twice or three times daily regimen.",
          "Patients Receiving No Antihypertensive Therapy. It is recommended that therapy be initiated with 0.5 mg given in the evening at bedtime then 0.5 mg b.i.d. or t.i.d for three to seven days. Unless poor toleration suggests the patient is unusually sensitive, this dosage should be increased to 1 mg given b.i.d. or t.i.d. for a further three to seven days. Thereafter, as determined by the patient's response to the blood pressure lowering effect, the dosage should be increased gradually to a total daily dosage of 20 mg given in divided doses.",
          "Patients Receiving Diuretic Therapy With inadequate Control of Blood Pressure. The diuretic should be reduced to a maintenance dosage level for the particular agent and Prazosin initiated with 0.5 mg h.s then proceeding to 0.5 mg b.i.d or t.i.d. After the initial period of observation, the dosage of Prazosin should be gradually increased as determined by the patient's response.",
          "Patients Receiving Other Antihypertensives But With Inadequate Control. Because some additive effect is anticipated, the other agent dosage level (e.g. beta-adrenergic blocking agents, methyldopa. reserpine, lsnidine etc.) should be reduced and Prazosin initiated at 0.5 mg h.s. then proceeding to 0.5 mg b.i.d, or t.i.d. Subsequent dosage increase should be made depending upon the patient's response. There is evidence that adding Prazosin to beta-adrenergic blocking agents, calcium antagonists or ACE inhibitors may bring about a substantial reduction in blood pressure. Thus, to low initial dosage regimen is strong, recommended.",
          "Patients With Moderate to Severe Grades of Renal Impairment Evidence to date shows that Prazosin does not further compromise renal function when used in patients with renal impairment. Because some patients in this category have responded to small doses of Prazosin , it is recommended that therapy be initiated at 0.5 mg daily and that dosage increases be instituted cautiously."
        ]
      },
      {
        "medication_type": "Left Ventricular Failure",
        "information": ": The recommended starting dose is 0.5 mg two, three or four times a day, Dosage should be titrated according to the patent's clinical response, based on careful monitoring of cardiopulmonary signs and symptoms, and when indicated, hemodynamic studies. Dosage titration steps may be performed as often as every two or three days in patients under close medical supervision. In severely ill, decompensated patients, rapid dosage titiration over one to two days may be indicated and is best done when hemodynamic- monitoring is available In dininai studies, the therapeutic dosages ranged from 4 mg to 20mg daily in divided doses. Adjustment of dosage may be required in the course of Prazosin therapy in some patients to maintain optimal clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5 mg b.i.d., t.i.d. or q.i.d. increasing to 4 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Use Daily Maintenance Dosage",
        "information": ": 4 mg once daily to 20 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Raynaud's Phenomenon And Raynaud's Disease",
        "information": ": The recommended starting dosage is 0.5 mg b.i.d. given for a period of three to seven days. Dosage should be adjusted according to the patient's clinical response.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5mg b.i.d.",
        "instructions": []
      },
      {
        "medication_type": "Usual Daily Maintenance Dosage",
        "information": ": 1mg or 2 mg b.i.d Doses up to 2 mg t.i.d. may be required for some patients.",
        "instructions": []
      },
      {
        "medication_type": "Benign Prostatic Hyperplasia",
        "information": ": The recommended starting dose is 0.5 mg twice daily given for a period of 3 to 7 days and should then be adjusted according to the patient's clinical responses. The usual maintenance dose is 2 mg twice daily. The safety and efficacy of a total daily dosage greater than 4 mg have not been established. Therefore, total daily dosages greater than 4mg should be used with caution.",
        "instructions": []
      },
      {
        "medication_type": "Prazosin XR Tablet",
        "information": ": Prazosin XR Extended-Release Tablets must be swallowed whole and should not be bitten or divided. Therapy for hypertension with Prazosin XR must be initiated at 2.5 mg once daily. The 5 mg dosage form of Prazosin XR is not for initial dosing. Dosage may be increased slowly, in general over a 7 to 14-day period, depending on the response to each dose level. Doses above 20 mg once daily have not been studied. Maintenance Dose: Dosage may be increased as clinically indicated to 20 mg given in once-daily doses. Hypertensive patients controlled on Prazosin Tablets alone or in combination with other antihypertensive medications may be switched to Prazosin XR Extended Release Tablets at the equivalent or nearest higher total daily dose, e.g. Prazosin Tablets 4 mg daily equivalent to Prazosin XR Extended Release Tablets 5 mg once daily. Blood pressure measurements should be taken at the end of the dosing interval to assure adequate blood pressure control is maintained throughout the 24-hour period. Further titration may be necessary in some patients. The addition of a diuretic or other antihypertensive agent to prazosin has been shown to cause an additive hypotensive effect.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:06.469Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e67",
    "original_record": {
      "input_index": 705,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e67"
        },
        "name": "Alphalok",
        "strength": "2 mg",
        "generic": "Prazosin Hydrochloride",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/31401/alphalok-2-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31617/alphalok-xr-25-mg-tablet",
    "name": "Alphalok XR",
    "dosage_form": "Tablet (Extended Release)",
    "generic": "Prazosin Hydrochloride",
    "strength": "2.5 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 10.00",
      "strip_price": "৳ 140.00",
      "pack_size_info": "(2 x 14: ৳ 280.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.00",
          "pack_size_info": "(2 x 14: ৳ 280.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 140.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "1 mg (Tablet)",
        "href": "https://medex.com.bd/brands/31400/alphalok-1-mg-tablet?ref=1"
      },
      {
        "text": "2 mg (Tablet)",
        "href": "https://medex.com.bd/brands/31401/alphalok-2-mg-tablet?ref=1"
      },
      {
        "text": "5 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/31618/alphalok-xr-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/913/prazosin-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Hypertension: Alphalok XR is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a ... Read moreHypertension: Alphalok XR is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a diuretic and/or other antihypertensive drugs as needed for proper patient response. Renal blood flow and glomerular filtration rate are not impaired by long-term oral administration and thus Alphalok XR can be used with safety in hypertensive patients with impaired renal function.Left Ventricular Failure: Alphalok XR is indicated in the treatment of left ventricular failure. Alphalok XR may be added to the therapeutic regimen in those patients who have not shown a satisfactory response or who have become refractory to conventional therapy with diuretics, with or without cardiac glycosides.Raynaud's Phenomenon And Raynaud's Disease: Alphalok XR indicated in the treatment of Raynaud's phenomenon and Raynaud's disease.Benign Prostatic Hyperplasia: Alphalok XR is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia. It is also of value in patients awaiting prostatic surgery.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Prazosin causes a decrease in total peripheral vascular resistance through selective inhibition of postsynaptic alpha-1-adrenoreceptors in vascular smooth muscle. In hypertensive patients, blood pressure is lowered in both the supine and standing positions; this effect is more pronounced on the diastolic blood pressure. Rebound elevation of blood pressure does not occur following abrupt cessation of Prazosin therapy. The therapeutic efficacy of Prazosin in patients with congestive heart failure is ascribed to a reduction in left ventricular filling pressure, reduction in cardiac impedance and an augmentation of cardiac output. The use of Prazosin in congestive heart failure does not provoke a reflex tachycardia and blood pressure reduction is minimal in normotensive patients. Prazosin reduce the severity of the signs, symptoms, frequency and duration of attacks, in patients with Raynaud's disease. In low dosage, antagonism of alpha-1-receptors on prostatic and urethral smooth muscle has been shown to improve the urinary pressure profile in men and to improve symptoms of benign prostatic hyperplasia. Clinical studies have shown that Prazosin therapy is not associated with adverse changes in the serum lipid profile.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alphalok XR XR has been administered without any adverse drug interaction in clinical experience to date with the following:",
        "items": [
          "Cardiac-glycosides-digitalis and digoxin;",
          "Hypoglycemic agents-insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide;",
          "tranquilizers and sedatives-chlordiazepoxide, diazepam and phenobarbital;",
          "antiarrhythmic agents-procainamide, propranolol and quinidine; and",
          "analgesic, antipyretic and anti-inflammatory agents-propxyphene, aspirin, indomethacin and phenylbutazone type."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Prazosin is contraindicated in patients with a known sensitivity to quinazolines.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common reactions associated with Alphalok XR therapy are dizziness, headache, drowsiness, lack of energy, weakness, palpitations and nausea. In most instances, side effects have disappeared with continued therapy or have been tolerated with no decrease in the dosage of the drug. In addition, the following reactions have been associated with Alphalok XR therapy; vomiting diarrhea, constipation, abdominal discomfort and/or pain, liver function abnormalities, pancreatitis, edema, orthostatic hypotension, dyspnea, faintness, tachycardia, nervousness, vertigo, hallucinations, depression, paresthesia, rash, pruritus alopecia, lichen planus, urinary frequency, impotence, incontinence, priapism, blurred vision, reddened solera, epistaxis, tinnitus, dry mouth, nasal congestion, diaphoresis, fever, positive ANA liter, and arthralgia. Some of these reactions have occurred rarely, and in many instances, the exact causal relationships have not been established. Literature reports exist associating Alphalok XR, therapy with a worsening of pre-existing narcolepsy. A causal relationship is uncertain in these cases. The following have been observed in parents being managed for left ventricular failure with Alphalok XR when used in conjunction with cardiac glycosides and diuretics; drowsiness, dizziness, postural hypotension, blurred vision, edema, dry mouth, palpitations, nausea, diarrhea, impotence, headache, and nasal congestion. In most instances, these occurrences have been mild to moderate in severity and have resolved with continued therapy or have been tolerated with no decrease in drug dosage. The most commonly although infrequently reported side effect in the treatment of Raynaud's Phenomenon/Disease was mild dizziness.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although no teratogenic effects were seen in animal testing; the safety of Prazosin use during. pregnancy has not yet been established. The use of prazosin and a beta-blocker for the control of sever hypertension of 44 pregnant women revealed no drug-related fetal adnormalities or adverse effects. Therapy with prazosin was continued for as long as 14 weeks. Prazosin has also been used alone or in combination with other hypotensive agents in severe hypertension or pregnancy. No fetal or neonatal abnormalities have been reported with the use of Prazosin. There are no adequate and well controlled studies that establish the safety of Prazosin in pregnant women. Prazosin should be used during pregnancy only if in the opinion of the physician the potential benefit justifies the potential risk to the mother and fetus. Prazosin has been shown to be excreted in small amounts in human milk. Caution shold be exercised when Prazosin is adminsitered to nursing mothers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Hypertension",
        "information": ": A very small percentage of patients have responded in an abrupt and exaggerated manner to the initial dose of Alphalok XR. Postural hypotension evidenced by dizziness and weakness, or rarely loss of consciousness, has been reported, particularly with the commencement of therapy, but this effect is readily avoided by initiating treatment with a low dose of Alphalok XR XR and with small increases in dosage during the first one to two weeks of therapy. The effect when observed is not related to the severity of hypertension is self-limiting and in most patients does not recur after the initial period of therapy or during subsequent dose titration steps. When instituting therapy with any effective antihypertensive agent, the patient should be advised how to avoid symptoms resulting from postural hypotension and what measures to take should they develop. The patient should be cautioned to avoid situations where injury could result should dizziness or weakness occur during the initiation of Alphalok XR therapy.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": When prazosin is initially administered to patients with left ventricular failure who have undergone vigorous diuretic or other vasodilator treatment, particularly in higher than the recommended starting dose, the resultant decrease in left ventricular filling pressure may be associated with a significant fall in cardiac output and systemic blood pressure. In such patients, observance of the recommended starting dose of prazosin followed by gradual titration is particularly important. (See dosage and administration). In occasional patients with left ventricular failure, the clinical efficacy of Alphalok XR has been reported to diminish after several months of treatment. In these patients, there is usually evidence of weight gain or peripheral edema indicating fluid retention. Since spontaneous deterioration may occur in such severely ill patients a causal relationship to prazosin therapy has not been established. Thus, as with all patients with left ventricular failure, careful adjustment of diuretic dosage according to the patient's clinical condition is required to prevent excessive fluid retention and consequent relief of symptoms. In those patients without evidence of fluid retention, when clinical improvement has diminished; an increase in the dosage, of Alphalok XR will usually restore clinical efficacy.",
        "items": []
      },
      {
        "title": "Raynaud's Phenomenon and Raynaud's Disease",
        "information": ": Because Alphalok XR decreases peripheral vascular resistance, careful monitoring of blood pressure during initial administration and titration of Alphalok XR is suggested. Close observation is especially recommended for patients already taking medication that are known the lower blood pressure.",
        "items": []
      },
      {
        "title": "Benign Prostatic Hyperplasia",
        "information": ": Alphalok XR decreases peripheral vasular resistance and since many patients with this disorder are elderly, careful monitoring of blood pressure during initial administration and during adjustment of the dose of Alphalok XR is suggested. Close observation is especially recommended for patients taking medications that are known to lower blood pressure.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children",
        "information": ": Alphalok XR is not recommended for the treatment of children under the age of 12 years since safe conditions for its use have not been established.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": Alphalok XR is not recommended in the treatment of left ventricular failure due to mechanical obstrcution such as aortic valve stenosis, mitral valve stenosis, pulmonary embolism and restrictive pericardial disease. Adequate data are not yet available to establish efficacy in patients with left ventricular failure due to a recent myocardial infarction.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Accidental ingestion of at least 50 mg of Alphalok XR in a two-year child resulted in profound drowsiness and depressed reflexes, No decrease in blood pressure was noted. Recovery was uneventful. Should overdosage lead to hypotension, support of the cardiovascular system is of first importance. Restoration of blood pressure and normalization of heart rate may be accomplished by keeping the patient in the supine position. If this measure is inadequate, shock should first be treated with volume expanders. If necessary, vasopressors should then be used. Renal function should be monitored and supported as needed. Laboratory data indicate Alphalok XR is not dialyzable because it is protein bound.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep away from light and moisture, store below 30°C. Keep away from reach out of the children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Alpha adrenoceptor blocking drugs",
    "dosage": [
      {
        "medication_type": "Prazosin Tablet",
        "information": ": There is evidence that toleration is best when therapy is initiated with a low starting dose. During the first week, the dosage of Prazosin should be adjusted according to the patient's individual toleration. Thereafter the daily dosage is to be adjusted on the basis of the patient's response. The response is usually seen within one to 14 days if it is to occur at any particular dose. When a response is seen, therapy should be continued at that dosage until the degree of response has reached optimum before the next dose increment is added.",
        "instructions": [
          "Hypertension: For maximum benefit, small increases should be continued until the desired effect is achieved or a total daily dosage of 20 mg is reached. A diuretic or adrenergic beta-blocking agent may be added to enhance efficacy. The maintenance dosage of Prazosin may be given as a twice or three times daily regimen.",
          "Patients Receiving No Antihypertensive Therapy. It is recommended that therapy be initiated with 0.5 mg given in the evening at bedtime then 0.5 mg b.i.d. or t.i.d for three to seven days. Unless poor toleration suggests the patient is unusually sensitive, this dosage should be increased to 1 mg given b.i.d. or t.i.d. for a further three to seven days. Thereafter, as determined by the patient's response to the blood pressure lowering effect, the dosage should be increased gradually to a total daily dosage of 20 mg given in divided doses.",
          "Patients Receiving Diuretic Therapy With inadequate Control of Blood Pressure. The diuretic should be reduced to a maintenance dosage level for the particular agent and Prazosin initiated with 0.5 mg h.s then proceeding to 0.5 mg b.i.d or t.i.d. After the initial period of observation, the dosage of Prazosin should be gradually increased as determined by the patient's response.",
          "Patients Receiving Other Antihypertensives But With Inadequate Control. Because some additive effect is anticipated, the other agent dosage level (e.g. beta-adrenergic blocking agents, methyldopa. reserpine, lsnidine etc.) should be reduced and Prazosin initiated at 0.5 mg h.s. then proceeding to 0.5 mg b.i.d, or t.i.d. Subsequent dosage increase should be made depending upon the patient's response. There is evidence that adding Prazosin to beta-adrenergic blocking agents, calcium antagonists or ACE inhibitors may bring about a substantial reduction in blood pressure. Thus, to low initial dosage regimen is strong, recommended.",
          "Patients With Moderate to Severe Grades of Renal Impairment Evidence to date shows that Prazosin does not further compromise renal function when used in patients with renal impairment. Because some patients in this category have responded to small doses of Prazosin , it is recommended that therapy be initiated at 0.5 mg daily and that dosage increases be instituted cautiously."
        ]
      },
      {
        "medication_type": "Left Ventricular Failure",
        "information": ": The recommended starting dose is 0.5 mg two, three or four times a day, Dosage should be titrated according to the patent's clinical response, based on careful monitoring of cardiopulmonary signs and symptoms, and when indicated, hemodynamic studies. Dosage titration steps may be performed as often as every two or three days in patients under close medical supervision. In severely ill, decompensated patients, rapid dosage titiration over one to two days may be indicated and is best done when hemodynamic- monitoring is available In dininai studies, the therapeutic dosages ranged from 4 mg to 20mg daily in divided doses. Adjustment of dosage may be required in the course of Prazosin therapy in some patients to maintain optimal clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5 mg b.i.d., t.i.d. or q.i.d. increasing to 4 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Use Daily Maintenance Dosage",
        "information": ": 4 mg once daily to 20 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Raynaud's Phenomenon And Raynaud's Disease",
        "information": ": The recommended starting dosage is 0.5 mg b.i.d. given for a period of three to seven days. Dosage should be adjusted according to the patient's clinical response.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5mg b.i.d.",
        "instructions": []
      },
      {
        "medication_type": "Usual Daily Maintenance Dosage",
        "information": ": 1mg or 2 mg b.i.d Doses up to 2 mg t.i.d. may be required for some patients.",
        "instructions": []
      },
      {
        "medication_type": "Benign Prostatic Hyperplasia",
        "information": ": The recommended starting dose is 0.5 mg twice daily given for a period of 3 to 7 days and should then be adjusted according to the patient's clinical responses. The usual maintenance dose is 2 mg twice daily. The safety and efficacy of a total daily dosage greater than 4 mg have not been established. Therefore, total daily dosages greater than 4mg should be used with caution.",
        "instructions": []
      },
      {
        "medication_type": "Prazosin XR Tablet",
        "information": ": Prazosin XR Extended-Release Tablets must be swallowed whole and should not be bitten or divided. Therapy for hypertension with Prazosin XR must be initiated at 2.5 mg once daily. The 5 mg dosage form of Prazosin XR is not for initial dosing. Dosage may be increased slowly, in general over a 7 to 14-day period, depending on the response to each dose level. Doses above 20 mg once daily have not been studied. Maintenance Dose: Dosage may be increased as clinically indicated to 20 mg given in once-daily doses. Hypertensive patients controlled on Prazosin Tablets alone or in combination with other antihypertensive medications may be switched to Prazosin XR Extended Release Tablets at the equivalent or nearest higher total daily dose, e.g. Prazosin Tablets 4 mg daily equivalent to Prazosin XR Extended Release Tablets 5 mg once daily. Blood pressure measurements should be taken at the end of the dosing interval to assure adequate blood pressure control is maintained throughout the 24-hour period. Further titration may be necessary in some patients. The addition of a diuretic or other antihypertensive agent to prazosin has been shown to cause an additive hypotensive effect.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:07.587Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e68",
    "original_record": {
      "input_index": 706,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e68"
        },
        "name": "Alphalok XR",
        "strength": "2.5 mg",
        "generic": "Prazosin Hydrochloride",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Tablet (Extended Release)",
        "source_url": "https://medex.com.bd/brands/31617/alphalok-xr-25-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31618/alphalok-xr-5-mg-tablet",
    "name": "Alphalok XR",
    "dosage_form": "Tablet (Extended Release)",
    "generic": "Prazosin Hydrochloride",
    "strength": "5 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": "৳ 210.00",
      "pack_size_info": "(2 x 14: ৳ 420.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 15.00",
          "pack_size_info": "(2 x 14: ৳ 420.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 210.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "1 mg (Tablet)",
        "href": "https://medex.com.bd/brands/31400/alphalok-1-mg-tablet?ref=1"
      },
      {
        "text": "2 mg (Tablet)",
        "href": "https://medex.com.bd/brands/31401/alphalok-2-mg-tablet?ref=1"
      },
      {
        "text": "2.5 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/31617/alphalok-xr-25-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/913/prazosin-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Hypertension: Alphalok XR is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a ... Read moreHypertension: Alphalok XR is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a diuretic and/or other antihypertensive drugs as needed for proper patient response. Renal blood flow and glomerular filtration rate are not impaired by long-term oral administration and thus Alphalok XR can be used with safety in hypertensive patients with impaired renal function.Left Ventricular Failure: Alphalok XR is indicated in the treatment of left ventricular failure. Alphalok XR may be added to the therapeutic regimen in those patients who have not shown a satisfactory response or who have become refractory to conventional therapy with diuretics, with or without cardiac glycosides.Raynaud's Phenomenon And Raynaud's Disease: Alphalok XR indicated in the treatment of Raynaud's phenomenon and Raynaud's disease.Benign Prostatic Hyperplasia: Alphalok XR is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia. It is also of value in patients awaiting prostatic surgery.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Prazosin causes a decrease in total peripheral vascular resistance through selective inhibition of postsynaptic alpha-1-adrenoreceptors in vascular smooth muscle. In hypertensive patients, blood pressure is lowered in both the supine and standing positions; this effect is more pronounced on the diastolic blood pressure. Rebound elevation of blood pressure does not occur following abrupt cessation of Prazosin therapy. The therapeutic efficacy of Prazosin in patients with congestive heart failure is ascribed to a reduction in left ventricular filling pressure, reduction in cardiac impedance and an augmentation of cardiac output. The use of Prazosin in congestive heart failure does not provoke a reflex tachycardia and blood pressure reduction is minimal in normotensive patients. Prazosin reduce the severity of the signs, symptoms, frequency and duration of attacks, in patients with Raynaud's disease. In low dosage, antagonism of alpha-1-receptors on prostatic and urethral smooth muscle has been shown to improve the urinary pressure profile in men and to improve symptoms of benign prostatic hyperplasia. Clinical studies have shown that Prazosin therapy is not associated with adverse changes in the serum lipid profile.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alphalok XR XR has been administered without any adverse drug interaction in clinical experience to date with the following:",
        "items": [
          "Cardiac-glycosides-digitalis and digoxin;",
          "Hypoglycemic agents-insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide;",
          "tranquilizers and sedatives-chlordiazepoxide, diazepam and phenobarbital;",
          "antiarrhythmic agents-procainamide, propranolol and quinidine; and",
          "analgesic, antipyretic and anti-inflammatory agents-propxyphene, aspirin, indomethacin and phenylbutazone type."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Prazosin is contraindicated in patients with a known sensitivity to quinazolines.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common reactions associated with Alphalok XR therapy are dizziness, headache, drowsiness, lack of energy, weakness, palpitations and nausea. In most instances, side effects have disappeared with continued therapy or have been tolerated with no decrease in the dosage of the drug. In addition, the following reactions have been associated with Alphalok XR therapy; vomiting diarrhea, constipation, abdominal discomfort and/or pain, liver function abnormalities, pancreatitis, edema, orthostatic hypotension, dyspnea, faintness, tachycardia, nervousness, vertigo, hallucinations, depression, paresthesia, rash, pruritus alopecia, lichen planus, urinary frequency, impotence, incontinence, priapism, blurred vision, reddened solera, epistaxis, tinnitus, dry mouth, nasal congestion, diaphoresis, fever, positive ANA liter, and arthralgia. Some of these reactions have occurred rarely, and in many instances, the exact causal relationships have not been established. Literature reports exist associating Alphalok XR, therapy with a worsening of pre-existing narcolepsy. A causal relationship is uncertain in these cases. The following have been observed in parents being managed for left ventricular failure with Alphalok XR when used in conjunction with cardiac glycosides and diuretics; drowsiness, dizziness, postural hypotension, blurred vision, edema, dry mouth, palpitations, nausea, diarrhea, impotence, headache, and nasal congestion. In most instances, these occurrences have been mild to moderate in severity and have resolved with continued therapy or have been tolerated with no decrease in drug dosage. The most commonly although infrequently reported side effect in the treatment of Raynaud's Phenomenon/Disease was mild dizziness.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although no teratogenic effects were seen in animal testing; the safety of Prazosin use during. pregnancy has not yet been established. The use of prazosin and a beta-blocker for the control of sever hypertension of 44 pregnant women revealed no drug-related fetal adnormalities or adverse effects. Therapy with prazosin was continued for as long as 14 weeks. Prazosin has also been used alone or in combination with other hypotensive agents in severe hypertension or pregnancy. No fetal or neonatal abnormalities have been reported with the use of Prazosin. There are no adequate and well controlled studies that establish the safety of Prazosin in pregnant women. Prazosin should be used during pregnancy only if in the opinion of the physician the potential benefit justifies the potential risk to the mother and fetus. Prazosin has been shown to be excreted in small amounts in human milk. Caution shold be exercised when Prazosin is adminsitered to nursing mothers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Hypertension",
        "information": ": A very small percentage of patients have responded in an abrupt and exaggerated manner to the initial dose of Alphalok XR. Postural hypotension evidenced by dizziness and weakness, or rarely loss of consciousness, has been reported, particularly with the commencement of therapy, but this effect is readily avoided by initiating treatment with a low dose of Alphalok XR XR and with small increases in dosage during the first one to two weeks of therapy. The effect when observed is not related to the severity of hypertension is self-limiting and in most patients does not recur after the initial period of therapy or during subsequent dose titration steps. When instituting therapy with any effective antihypertensive agent, the patient should be advised how to avoid symptoms resulting from postural hypotension and what measures to take should they develop. The patient should be cautioned to avoid situations where injury could result should dizziness or weakness occur during the initiation of Alphalok XR therapy.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": When prazosin is initially administered to patients with left ventricular failure who have undergone vigorous diuretic or other vasodilator treatment, particularly in higher than the recommended starting dose, the resultant decrease in left ventricular filling pressure may be associated with a significant fall in cardiac output and systemic blood pressure. In such patients, observance of the recommended starting dose of prazosin followed by gradual titration is particularly important. (See dosage and administration). In occasional patients with left ventricular failure, the clinical efficacy of Alphalok XR has been reported to diminish after several months of treatment. In these patients, there is usually evidence of weight gain or peripheral edema indicating fluid retention. Since spontaneous deterioration may occur in such severely ill patients a causal relationship to prazosin therapy has not been established. Thus, as with all patients with left ventricular failure, careful adjustment of diuretic dosage according to the patient's clinical condition is required to prevent excessive fluid retention and consequent relief of symptoms. In those patients without evidence of fluid retention, when clinical improvement has diminished; an increase in the dosage, of Alphalok XR will usually restore clinical efficacy.",
        "items": []
      },
      {
        "title": "Raynaud's Phenomenon and Raynaud's Disease",
        "information": ": Because Alphalok XR decreases peripheral vascular resistance, careful monitoring of blood pressure during initial administration and titration of Alphalok XR is suggested. Close observation is especially recommended for patients already taking medication that are known the lower blood pressure.",
        "items": []
      },
      {
        "title": "Benign Prostatic Hyperplasia",
        "information": ": Alphalok XR decreases peripheral vasular resistance and since many patients with this disorder are elderly, careful monitoring of blood pressure during initial administration and during adjustment of the dose of Alphalok XR is suggested. Close observation is especially recommended for patients taking medications that are known to lower blood pressure.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children",
        "information": ": Alphalok XR is not recommended for the treatment of children under the age of 12 years since safe conditions for its use have not been established.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": Alphalok XR is not recommended in the treatment of left ventricular failure due to mechanical obstrcution such as aortic valve stenosis, mitral valve stenosis, pulmonary embolism and restrictive pericardial disease. Adequate data are not yet available to establish efficacy in patients with left ventricular failure due to a recent myocardial infarction.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Accidental ingestion of at least 50 mg of Alphalok XR in a two-year child resulted in profound drowsiness and depressed reflexes, No decrease in blood pressure was noted. Recovery was uneventful. Should overdosage lead to hypotension, support of the cardiovascular system is of first importance. Restoration of blood pressure and normalization of heart rate may be accomplished by keeping the patient in the supine position. If this measure is inadequate, shock should first be treated with volume expanders. If necessary, vasopressors should then be used. Renal function should be monitored and supported as needed. Laboratory data indicate Alphalok XR is not dialyzable because it is protein bound.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep away from light and moisture, store below 30°C. Keep away from reach out of the children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Alpha adrenoceptor blocking drugs",
    "dosage": [
      {
        "medication_type": "Prazosin Tablet",
        "information": ": There is evidence that toleration is best when therapy is initiated with a low starting dose. During the first week, the dosage of Prazosin should be adjusted according to the patient's individual toleration. Thereafter the daily dosage is to be adjusted on the basis of the patient's response. The response is usually seen within one to 14 days if it is to occur at any particular dose. When a response is seen, therapy should be continued at that dosage until the degree of response has reached optimum before the next dose increment is added.",
        "instructions": [
          "Hypertension: For maximum benefit, small increases should be continued until the desired effect is achieved or a total daily dosage of 20 mg is reached. A diuretic or adrenergic beta-blocking agent may be added to enhance efficacy. The maintenance dosage of Prazosin may be given as a twice or three times daily regimen.",
          "Patients Receiving No Antihypertensive Therapy. It is recommended that therapy be initiated with 0.5 mg given in the evening at bedtime then 0.5 mg b.i.d. or t.i.d for three to seven days. Unless poor toleration suggests the patient is unusually sensitive, this dosage should be increased to 1 mg given b.i.d. or t.i.d. for a further three to seven days. Thereafter, as determined by the patient's response to the blood pressure lowering effect, the dosage should be increased gradually to a total daily dosage of 20 mg given in divided doses.",
          "Patients Receiving Diuretic Therapy With inadequate Control of Blood Pressure. The diuretic should be reduced to a maintenance dosage level for the particular agent and Prazosin initiated with 0.5 mg h.s then proceeding to 0.5 mg b.i.d or t.i.d. After the initial period of observation, the dosage of Prazosin should be gradually increased as determined by the patient's response.",
          "Patients Receiving Other Antihypertensives But With Inadequate Control. Because some additive effect is anticipated, the other agent dosage level (e.g. beta-adrenergic blocking agents, methyldopa. reserpine, lsnidine etc.) should be reduced and Prazosin initiated at 0.5 mg h.s. then proceeding to 0.5 mg b.i.d, or t.i.d. Subsequent dosage increase should be made depending upon the patient's response. There is evidence that adding Prazosin to beta-adrenergic blocking agents, calcium antagonists or ACE inhibitors may bring about a substantial reduction in blood pressure. Thus, to low initial dosage regimen is strong, recommended.",
          "Patients With Moderate to Severe Grades of Renal Impairment Evidence to date shows that Prazosin does not further compromise renal function when used in patients with renal impairment. Because some patients in this category have responded to small doses of Prazosin , it is recommended that therapy be initiated at 0.5 mg daily and that dosage increases be instituted cautiously."
        ]
      },
      {
        "medication_type": "Left Ventricular Failure",
        "information": ": The recommended starting dose is 0.5 mg two, three or four times a day, Dosage should be titrated according to the patent's clinical response, based on careful monitoring of cardiopulmonary signs and symptoms, and when indicated, hemodynamic studies. Dosage titration steps may be performed as often as every two or three days in patients under close medical supervision. In severely ill, decompensated patients, rapid dosage titiration over one to two days may be indicated and is best done when hemodynamic- monitoring is available In dininai studies, the therapeutic dosages ranged from 4 mg to 20mg daily in divided doses. Adjustment of dosage may be required in the course of Prazosin therapy in some patients to maintain optimal clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5 mg b.i.d., t.i.d. or q.i.d. increasing to 4 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Use Daily Maintenance Dosage",
        "information": ": 4 mg once daily to 20 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Raynaud's Phenomenon And Raynaud's Disease",
        "information": ": The recommended starting dosage is 0.5 mg b.i.d. given for a period of three to seven days. Dosage should be adjusted according to the patient's clinical response.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5mg b.i.d.",
        "instructions": []
      },
      {
        "medication_type": "Usual Daily Maintenance Dosage",
        "information": ": 1mg or 2 mg b.i.d Doses up to 2 mg t.i.d. may be required for some patients.",
        "instructions": []
      },
      {
        "medication_type": "Benign Prostatic Hyperplasia",
        "information": ": The recommended starting dose is 0.5 mg twice daily given for a period of 3 to 7 days and should then be adjusted according to the patient's clinical responses. The usual maintenance dose is 2 mg twice daily. The safety and efficacy of a total daily dosage greater than 4 mg have not been established. Therefore, total daily dosages greater than 4mg should be used with caution.",
        "instructions": []
      },
      {
        "medication_type": "Prazosin XR Tablet",
        "information": ": Prazosin XR Extended-Release Tablets must be swallowed whole and should not be bitten or divided. Therapy for hypertension with Prazosin XR must be initiated at 2.5 mg once daily. The 5 mg dosage form of Prazosin XR is not for initial dosing. Dosage may be increased slowly, in general over a 7 to 14-day period, depending on the response to each dose level. Doses above 20 mg once daily have not been studied. Maintenance Dose: Dosage may be increased as clinically indicated to 20 mg given in once-daily doses. Hypertensive patients controlled on Prazosin Tablets alone or in combination with other antihypertensive medications may be switched to Prazosin XR Extended Release Tablets at the equivalent or nearest higher total daily dose, e.g. Prazosin Tablets 4 mg daily equivalent to Prazosin XR Extended Release Tablets 5 mg once daily. Blood pressure measurements should be taken at the end of the dosing interval to assure adequate blood pressure control is maintained throughout the 24-hour period. Further titration may be necessary in some patients. The addition of a diuretic or other antihypertensive agent to prazosin has been shown to cause an additive hypotensive effect.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:09.140Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e69",
    "original_record": {
      "input_index": 707,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e69"
        },
        "name": "Alphalok XR",
        "strength": "5 mg",
        "generic": "Prazosin Hydrochloride",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Tablet (Extended Release)",
        "source_url": "https://medex.com.bd/brands/31618/alphalok-xr-5-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/3333/alphanate-250-iu-injection",
    "medicine_id": "68c3c09aef5b8f2b163a8e6b",
    "error": "Cannot read properties of null (reading 'length')",
    "fetched_at": "2025-09-19T05:24:10.144Z",
    "original_record": {
      "_id": {
        "$oid": "68c3c09aef5b8f2b163a8e6b"
      },
      "name": "Alphanate",
      "strength": "250 IU/vial",
      "generic": "Alphanate",
      "company": "Grifols Biologicals LLC",
      "medicine_type": "IV Infusion",
      "source_url": "https://medex.com.bd/brands/3333/alphanate-250-iu-injection",
      "_page": 28,
      "image_uri": null,
      "createdAt": {
        "$date": "2025-09-12T06:45:33.175Z"
      },
      "updatedAt": {
        "$date": "2025-09-12T06:45:33.175Z"
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/29288/alphapress-xr-5-mg-tablet",
    "name": "Alphapress XR",
    "dosage_form": "Tablet (Extended Release)",
    "generic": "Prazosin Hydrochloride",
    "strength": "5 mg",
    "company": "Renata PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 17.00",
      "strip_price": "৳ 170.00",
      "pack_size_info": "(3 x 10: ৳ 510.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 17.00",
          "pack_size_info": "(3 x 10: ৳ 510.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 170.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "1 mg (Tablet)",
        "href": "https://medex.com.bd/brands/2586/alphapress-1-mg-tablet?ref=1"
      },
      {
        "text": "2 mg (Tablet)",
        "href": "https://medex.com.bd/brands/2587/alphapress-2-mg-tablet?ref=1"
      },
      {
        "text": "2.5 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/29287/alphapress-xr-25-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/913/prazosin-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Hypertension: Alphapress XR is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a ... Read moreHypertension: Alphapress XR is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a diuretic and/or other antihypertensive drugs as needed for proper patient response. Renal blood flow and glomerular filtration rate are not impaired by long-term oral administration and thus Alphapress XR can be used with safety in hypertensive patients with impaired renal function.Left Ventricular Failure: Alphapress XR is indicated in the treatment of left ventricular failure. Alphapress XR may be added to the therapeutic regimen in those patients who have not shown a satisfactory response or who have become refractory to conventional therapy with diuretics, with or without cardiac glycosides.Raynaud's Phenomenon And Raynaud's Disease: Alphapress XR indicated in the treatment of Raynaud's phenomenon and Raynaud's disease.Benign Prostatic Hyperplasia: Alphapress XR is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia. It is also of value in patients awaiting prostatic surgery.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Prazosin causes a decrease in total peripheral vascular resistance through selective inhibition of postsynaptic alpha-1-adrenoreceptors in vascular smooth muscle. In hypertensive patients, blood pressure is lowered in both the supine and standing positions; this effect is more pronounced on the diastolic blood pressure. Rebound elevation of blood pressure does not occur following abrupt cessation of Prazosin therapy. The therapeutic efficacy of Prazosin in patients with congestive heart failure is ascribed to a reduction in left ventricular filling pressure, reduction in cardiac impedance and an augmentation of cardiac output. The use of Prazosin in congestive heart failure does not provoke a reflex tachycardia and blood pressure reduction is minimal in normotensive patients. Prazosin reduce the severity of the signs, symptoms, frequency and duration of attacks, in patients with Raynaud's disease. In low dosage, antagonism of alpha-1-receptors on prostatic and urethral smooth muscle has been shown to improve the urinary pressure profile in men and to improve symptoms of benign prostatic hyperplasia. Clinical studies have shown that Prazosin therapy is not associated with adverse changes in the serum lipid profile.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alphapress XR XR has been administered without any adverse drug interaction in clinical experience to date with the following:",
        "items": [
          "Cardiac-glycosides-digitalis and digoxin;",
          "Hypoglycemic agents-insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide;",
          "tranquilizers and sedatives-chlordiazepoxide, diazepam and phenobarbital;",
          "antiarrhythmic agents-procainamide, propranolol and quinidine; and",
          "analgesic, antipyretic and anti-inflammatory agents-propxyphene, aspirin, indomethacin and phenylbutazone type."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Prazosin is contraindicated in patients with a known sensitivity to quinazolines.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common reactions associated with Alphapress XR therapy are dizziness, headache, drowsiness, lack of energy, weakness, palpitations and nausea. In most instances, side effects have disappeared with continued therapy or have been tolerated with no decrease in the dosage of the drug. In addition, the following reactions have been associated with Alphapress XR therapy; vomiting diarrhea, constipation, abdominal discomfort and/or pain, liver function abnormalities, pancreatitis, edema, orthostatic hypotension, dyspnea, faintness, tachycardia, nervousness, vertigo, hallucinations, depression, paresthesia, rash, pruritus alopecia, lichen planus, urinary frequency, impotence, incontinence, priapism, blurred vision, reddened solera, epistaxis, tinnitus, dry mouth, nasal congestion, diaphoresis, fever, positive ANA liter, and arthralgia. Some of these reactions have occurred rarely, and in many instances, the exact causal relationships have not been established. Literature reports exist associating Alphapress XR, therapy with a worsening of pre-existing narcolepsy. A causal relationship is uncertain in these cases. The following have been observed in parents being managed for left ventricular failure with Alphapress XR when used in conjunction with cardiac glycosides and diuretics; drowsiness, dizziness, postural hypotension, blurred vision, edema, dry mouth, palpitations, nausea, diarrhea, impotence, headache, and nasal congestion. In most instances, these occurrences have been mild to moderate in severity and have resolved with continued therapy or have been tolerated with no decrease in drug dosage. The most commonly although infrequently reported side effect in the treatment of Raynaud's Phenomenon/Disease was mild dizziness.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although no teratogenic effects were seen in animal testing; the safety of Prazosin use during. pregnancy has not yet been established. The use of prazosin and a beta-blocker for the control of sever hypertension of 44 pregnant women revealed no drug-related fetal adnormalities or adverse effects. Therapy with prazosin was continued for as long as 14 weeks. Prazosin has also been used alone or in combination with other hypotensive agents in severe hypertension or pregnancy. No fetal or neonatal abnormalities have been reported with the use of Prazosin. There are no adequate and well controlled studies that establish the safety of Prazosin in pregnant women. Prazosin should be used during pregnancy only if in the opinion of the physician the potential benefit justifies the potential risk to the mother and fetus. Prazosin has been shown to be excreted in small amounts in human milk. Caution shold be exercised when Prazosin is adminsitered to nursing mothers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Hypertension",
        "information": ": A very small percentage of patients have responded in an abrupt and exaggerated manner to the initial dose of Alphapress XR. Postural hypotension evidenced by dizziness and weakness, or rarely loss of consciousness, has been reported, particularly with the commencement of therapy, but this effect is readily avoided by initiating treatment with a low dose of Alphapress XR XR and with small increases in dosage during the first one to two weeks of therapy. The effect when observed is not related to the severity of hypertension is self-limiting and in most patients does not recur after the initial period of therapy or during subsequent dose titration steps. When instituting therapy with any effective antihypertensive agent, the patient should be advised how to avoid symptoms resulting from postural hypotension and what measures to take should they develop. The patient should be cautioned to avoid situations where injury could result should dizziness or weakness occur during the initiation of Alphapress XR therapy.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": When prazosin is initially administered to patients with left ventricular failure who have undergone vigorous diuretic or other vasodilator treatment, particularly in higher than the recommended starting dose, the resultant decrease in left ventricular filling pressure may be associated with a significant fall in cardiac output and systemic blood pressure. In such patients, observance of the recommended starting dose of prazosin followed by gradual titration is particularly important. (See dosage and administration). In occasional patients with left ventricular failure, the clinical efficacy of Alphapress XR has been reported to diminish after several months of treatment. In these patients, there is usually evidence of weight gain or peripheral edema indicating fluid retention. Since spontaneous deterioration may occur in such severely ill patients a causal relationship to prazosin therapy has not been established. Thus, as with all patients with left ventricular failure, careful adjustment of diuretic dosage according to the patient's clinical condition is required to prevent excessive fluid retention and consequent relief of symptoms. In those patients without evidence of fluid retention, when clinical improvement has diminished; an increase in the dosage, of Alphapress XR will usually restore clinical efficacy.",
        "items": []
      },
      {
        "title": "Raynaud's Phenomenon and Raynaud's Disease",
        "information": ": Because Alphapress XR decreases peripheral vascular resistance, careful monitoring of blood pressure during initial administration and titration of Alphapress XR is suggested. Close observation is especially recommended for patients already taking medication that are known the lower blood pressure.",
        "items": []
      },
      {
        "title": "Benign Prostatic Hyperplasia",
        "information": ": Alphapress XR decreases peripheral vasular resistance and since many patients with this disorder are elderly, careful monitoring of blood pressure during initial administration and during adjustment of the dose of Alphapress XR is suggested. Close observation is especially recommended for patients taking medications that are known to lower blood pressure.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children",
        "information": ": Alphapress XR is not recommended for the treatment of children under the age of 12 years since safe conditions for its use have not been established.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": Alphapress XR is not recommended in the treatment of left ventricular failure due to mechanical obstrcution such as aortic valve stenosis, mitral valve stenosis, pulmonary embolism and restrictive pericardial disease. Adequate data are not yet available to establish efficacy in patients with left ventricular failure due to a recent myocardial infarction.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Accidental ingestion of at least 50 mg of Alphapress XR in a two-year child resulted in profound drowsiness and depressed reflexes, No decrease in blood pressure was noted. Recovery was uneventful. Should overdosage lead to hypotension, support of the cardiovascular system is of first importance. Restoration of blood pressure and normalization of heart rate may be accomplished by keeping the patient in the supine position. If this measure is inadequate, shock should first be treated with volume expanders. If necessary, vasopressors should then be used. Renal function should be monitored and supported as needed. Laboratory data indicate Alphapress XR is not dialyzable because it is protein bound.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep away from light and moisture, store below 30°C. Keep away from reach out of the children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Alpha adrenoceptor blocking drugs",
    "dosage": [
      {
        "medication_type": "Prazosin Tablet",
        "information": ": There is evidence that toleration is best when therapy is initiated with a low starting dose. During the first week, the dosage of Prazosin should be adjusted according to the patient's individual toleration. Thereafter the daily dosage is to be adjusted on the basis of the patient's response. The response is usually seen within one to 14 days if it is to occur at any particular dose. When a response is seen, therapy should be continued at that dosage until the degree of response has reached optimum before the next dose increment is added.",
        "instructions": [
          "Hypertension: For maximum benefit, small increases should be continued until the desired effect is achieved or a total daily dosage of 20 mg is reached. A diuretic or adrenergic beta-blocking agent may be added to enhance efficacy. The maintenance dosage of Prazosin may be given as a twice or three times daily regimen.",
          "Patients Receiving No Antihypertensive Therapy. It is recommended that therapy be initiated with 0.5 mg given in the evening at bedtime then 0.5 mg b.i.d. or t.i.d for three to seven days. Unless poor toleration suggests the patient is unusually sensitive, this dosage should be increased to 1 mg given b.i.d. or t.i.d. for a further three to seven days. Thereafter, as determined by the patient's response to the blood pressure lowering effect, the dosage should be increased gradually to a total daily dosage of 20 mg given in divided doses.",
          "Patients Receiving Diuretic Therapy With inadequate Control of Blood Pressure. The diuretic should be reduced to a maintenance dosage level for the particular agent and Prazosin initiated with 0.5 mg h.s then proceeding to 0.5 mg b.i.d or t.i.d. After the initial period of observation, the dosage of Prazosin should be gradually increased as determined by the patient's response.",
          "Patients Receiving Other Antihypertensives But With Inadequate Control. Because some additive effect is anticipated, the other agent dosage level (e.g. beta-adrenergic blocking agents, methyldopa. reserpine, lsnidine etc.) should be reduced and Prazosin initiated at 0.5 mg h.s. then proceeding to 0.5 mg b.i.d, or t.i.d. Subsequent dosage increase should be made depending upon the patient's response. There is evidence that adding Prazosin to beta-adrenergic blocking agents, calcium antagonists or ACE inhibitors may bring about a substantial reduction in blood pressure. Thus, to low initial dosage regimen is strong, recommended.",
          "Patients With Moderate to Severe Grades of Renal Impairment Evidence to date shows that Prazosin does not further compromise renal function when used in patients with renal impairment. Because some patients in this category have responded to small doses of Prazosin , it is recommended that therapy be initiated at 0.5 mg daily and that dosage increases be instituted cautiously."
        ]
      },
      {
        "medication_type": "Left Ventricular Failure",
        "information": ": The recommended starting dose is 0.5 mg two, three or four times a day, Dosage should be titrated according to the patent's clinical response, based on careful monitoring of cardiopulmonary signs and symptoms, and when indicated, hemodynamic studies. Dosage titration steps may be performed as often as every two or three days in patients under close medical supervision. In severely ill, decompensated patients, rapid dosage titiration over one to two days may be indicated and is best done when hemodynamic- monitoring is available In dininai studies, the therapeutic dosages ranged from 4 mg to 20mg daily in divided doses. Adjustment of dosage may be required in the course of Prazosin therapy in some patients to maintain optimal clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5 mg b.i.d., t.i.d. or q.i.d. increasing to 4 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Use Daily Maintenance Dosage",
        "information": ": 4 mg once daily to 20 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Raynaud's Phenomenon And Raynaud's Disease",
        "information": ": The recommended starting dosage is 0.5 mg b.i.d. given for a period of three to seven days. Dosage should be adjusted according to the patient's clinical response.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5mg b.i.d.",
        "instructions": []
      },
      {
        "medication_type": "Usual Daily Maintenance Dosage",
        "information": ": 1mg or 2 mg b.i.d Doses up to 2 mg t.i.d. may be required for some patients.",
        "instructions": []
      },
      {
        "medication_type": "Benign Prostatic Hyperplasia",
        "information": ": The recommended starting dose is 0.5 mg twice daily given for a period of 3 to 7 days and should then be adjusted according to the patient's clinical responses. The usual maintenance dose is 2 mg twice daily. The safety and efficacy of a total daily dosage greater than 4 mg have not been established. Therefore, total daily dosages greater than 4mg should be used with caution.",
        "instructions": []
      },
      {
        "medication_type": "Prazosin XR Tablet",
        "information": ": Prazosin XR Extended-Release Tablets must be swallowed whole and should not be bitten or divided. Therapy for hypertension with Prazosin XR must be initiated at 2.5 mg once daily. The 5 mg dosage form of Prazosin XR is not for initial dosing. Dosage may be increased slowly, in general over a 7 to 14-day period, depending on the response to each dose level. Doses above 20 mg once daily have not been studied. Maintenance Dose: Dosage may be increased as clinically indicated to 20 mg given in once-daily doses. Hypertensive patients controlled on Prazosin Tablets alone or in combination with other antihypertensive medications may be switched to Prazosin XR Extended Release Tablets at the equivalent or nearest higher total daily dose, e.g. Prazosin Tablets 4 mg daily equivalent to Prazosin XR Extended Release Tablets 5 mg once daily. Blood pressure measurements should be taken at the end of the dosing interval to assure adequate blood pressure control is maintained throughout the 24-hour period. Further titration may be necessary in some patients. The addition of a diuretic or other antihypertensive agent to prazosin has been shown to cause an additive hypotensive effect.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:12.498Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e6e",
    "original_record": {
      "input_index": 710,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e6e"
        },
        "name": "Alphapress XR",
        "strength": "5 mg",
        "generic": "Prazosin Hydrochloride",
        "company": "Renata PLC",
        "medicine_type": "Tablet (Extended Release)",
        "source_url": "https://medex.com.bd/brands/29288/alphapress-xr-5-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/37770/alpk2-original-manual-blood-bp-monitor-device",
    "name": "ALPK2 (Original)",
    "dosage_form": "BP Monitor Device",
    "generic": "BP monitoring device",
    "strength": "Manual blood pressure monitor",
    "company": "Tanaka Sangyo Co. Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 4,000.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "Each device",
          "price": "৳ 4,000.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/2390/bp-monitoring-device/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Blood pressure is a measure of the force of the blood against the wall of a blood vessel. Blood vessels are arteries and veins. They are tubes that carry blood throughout the body. When the heart beats, it pushes blood through these vessels. Blood pressure is a measure of the force on the walls of an ... Read moreBlood pressure is a measure of the force of the blood against the wall of a blood vessel. Blood vessels are arteries and veins. They are tubes that carry blood throughout the body. When the heart beats, it pushes blood through these vessels. Blood pressure is a measure of the force on the walls of an artery when the heart beats and when it relaxes between beats.",
        "items": [
          "Blood pressure is written as 2 numbers, for example, 110/60.",
          "The systolic blood pressure (suh-staa-luhk), the top number, is the pressure of the blood against the artery walls when the heart beats.",
          "The diastolic blood pressure (dai-uh-staa-luhk), the bottom number, is the pressure of the blood against the artery walls between heartbeats.",
          "Blood pressure can change during the day. It is often the lowest in the morning. Things that can affect blood pressure are: emotions, age, medicines, activity, body size, very hot or cold air temperature, and illness, injury, or pain.",
          "A normal ALPK2 (Original) for one child may not be normal for another. For children under age 18 years, a normal ALPK2 (Original) is based on their height. The doctor or health care provider will tell you what is normal for your child."
        ]
      }
    ],
    "mode_of_action": [],
    "interaction": [],
    "contraindications": [],
    "side_effects": [],
    "pregnancy_cat": [],
    "precautions": [],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "How to measure blood pressure using a manual monitor- How to measure blood pressure using an automatic monitor-",
        "items": [
          "Manual, or aneroid, equipment includes a cuff, an attached pump, a stethoscope and a gauge.",
          "This equipment requires coordination. It's difficult to use if you're hearing or visually impaired or if you're unable to perform the hand movements needed to squeeze the bulb and inflate the cuff.",
          "When you're ready to take your blood pressure, sit quietly for three to five minutes beforehand.",
          "To begin, place the cuff on your bare upper arm one inch above the bend of your elbow. Pull the end of the cuff so that it's evenly tight around your arm. You should place it tight enough so that you can only slip two fingertips under the top edge of the cuff. Make sure your skin doesn't pinch when the cuff inflates.",
          "Once the cuff is on, place the disk of the stethoscope facedown under the cuff, just to the inner side of your upper arm.",
          "Next, place the stethoscope earpieces in your ears, with the earpieces facing forward, pointing toward the tip of your nose. Rest the gauge in the open palm of the hand of your cuffed arm so that you can clearly see it.",
          "Then, squeeze the pump rapidly with your opposite hand until the gauge reads 30 points above your usual systolic pressure. (Be sure to inflate the cuff rapidly). Stop squeezing. Turn the knob on the pump toward you (counterclockwise) to let the air out slowly.",
          "Let the pressure fall 2 millimeters, or lines on the dial, per second while listening for your heart sounds. Note the reading when you first hear a heartbeat. This is your systolic pressure.",
          "Note when you no longer hear the beating sounds. This is your diastolic pressure.",
          "Rest quietly and wait about one to two minutes before taking another measurement. Record your numbers either by writing the information down or by entering the information into an electronic personal health record.",
          "To monitor your blood pressure using an automatic blood pressure monitor, find a comfortable place to sit with good back support at a table or desk.",
          "When you're ready to take your blood pressure, sit quietly for three to five minutes beforehand.",
          "Place your feet flat on the floor and rest your arm on a tabletop even with your heart. Lean against the back of the chair. Stretch out your arm, palm upward.",
          "Place the cuff on your bare upper arm one inch above the bend of your elbow. Make sure the tubing falls over the front center of your arm so that the sensor is correctly placed. Pull the end of the cuff so that it's evenly tight around your arm. You should place it tight enough so that you can only slip two fingertips under the top edge of the cuff. Make sure your skin doesn't pinch when the cuff inflates.",
          "To get started, wait a moment, then press start. Remain still and quiet as the machine begins measuring. The cuff will inflate, then slowly deflate so that the machine can take your measurement. When the reading is complete, the monitor displays your blood pressure and pulse on the digital panel. If the monitor doesn't record a reading, reposition the cuff and try again. Rest quietly and wait about one to two minutes before taking another measurement.",
          "Record your numbers, either by writing the information down or by entering the information into an electronic personal health record. Some monitors can upload your blood pressure readings automatically into a computer or mobile device."
        ]
      },
      {
        "title": "How to Take a Blood Pressure Reading-",
        "information": "Have your child rest their arm, palm facing up, where it will stay still. The ALPK2 (Original) cuff will need to be placed at about the same level as the heart. Put the cuff on a bare arm. Press the On/Off/Memory button to turn on the device. For a semi-automatic device: For an automatic device: Keeping a Record:",
        "items": [
          "The bottom edge of the cuff should be about 1 inch above the bend in your child’s elbow.",
          "Find the symbol or arrow on the edge of the cuff to know where to position the cuff over the artery.",
          "Wrap the cuff snugly. The tube(s) should hang freely toward your child’s body.",
          "Before putting on the cuff, make sure that there is no air in it. You may need to push an air release button near the bulb to let out the air.",
          "Put the cuff on and squeeze the bulb quickly to fill (inflate) it with air. The cuff should inflate to a number at least 30 higher than the expected systolic pressure. If your child is taking their own ALPK2 (Original), they should grasp the bulb with the hand opposite the arm the cuff is on.",
          "The cuff will become tight and hurt a little, but only for a few seconds.",
          "The machine will beep to let you know when the cuff is inflated enough. After you hear the beep, press the air release button, and lay down the bulb. Have your child relax and sit quietly. The device will do the rest of the work.",
          "As the device slowly lets air out (deflates), you will see numbers change and a flashing arrow pointing down. When the device senses a pulse, a heart symbol in the display starts to flash. You will hear a beep for each heartbeat.",
          "When done, the display will show the systolic and diastolic blood pressures and the",
          "heart rate.",
          "If the machine was not able to take the ALPK2 (Original), the display would show a flashing arrow pointing up. You will need to start over. This time, pump the bulb a little higher than",
          "30 above what you think the systolic pressure will be. Remind your child to sit still.",
          "After you press the START button, the cuff will fill with air. The device can sense how much to inflate the cuff. It will become tight and hurt a little, but only for a few seconds.",
          "As the device lets air out, you will see numbers and a tiny heart symbol flashing. The flashing heart is your child’s heartbeat.",
          "When done, the display will show the systolic and diastolic blood pressures and the heart rate.",
          "If your child moved or if the cuff was not put on right, the device may show an E or error message. When this happens, repeat steps 1 and 2.",
          "It is important to keep a record of your child's blood pressure. Use the Blood Pressure Record or write the readings down on a calendar. Take the record with you whenever your child sees their doctor or health care provider."
        ]
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": null,
    "dosage": [],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:13.529Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e72",
    "original_record": {
      "input_index": 711,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e72"
        },
        "name": "ALPK2 (Original)",
        "strength": "Manual blood pressure monitor",
        "generic": "BP monitoring device",
        "company": "Tanaka Sangyo Co. Ltd.",
        "medicine_type": "BP Monitor Device",
        "source_url": "https://medex.com.bd/brands/37770/alpk2-original-manual-blood-bp-monitor-device",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/288/alpro-400-mg-chewable-tablet",
    "name": "Alpro",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Pharmadesh Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": null,
      "pack_size_info": "(30's pack: ৳ 120.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(30's pack: ৳ 120.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alpro is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Alpro, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Alpro should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Alpro is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Alpro exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Alpro is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:14.859Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e7a",
    "original_record": {
      "input_index": 712,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e7a"
        },
        "name": "Alpro",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Pharmadesh Laboratories Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/288/alpro-400-mg-chewable-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/10938/alterin-50-mg-tablet",
    "name": "Alterin",
    "dosage_form": "Tablet",
    "generic": "Diclofenac Sodium",
    "strength": "50 mg",
    "company": "Euro Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 1.00",
      "strip_price": "৳ 10.00",
      "pack_size_info": "(10 x 10: ৳ 100.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 1.00",
          "pack_size_info": "(10 x 10: ৳ 100.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 10.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "100 mg (Capsule)",
        "href": "https://medex.com.bd/brands/10939/alterin-tr-100-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/357/diclofenac-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alterin is indicated in-Rheumatology: Inflammatory and degenerative forms of rheumatism, chronic involutive, polyarthritis, ankylosing spondylarthritis, osteoarthritis, spondylarthroses, acute gout, peri-articular rheumatic disorders.Surgery and Traumatology ... Read moreAlterin is indicated in-Rheumatology: Inflammatory and degenerative forms of rheumatism, chronic involutive, polyarthritis, ankylosing spondylarthritis, osteoarthritis, spondylarthroses, acute gout, peri-articular rheumatic disorders.Surgery and Traumatology: Sprain, bruises, dislocations, fractures, softtissue injuries, surgical interventions.Obstetrics and Gynecology: Primary dysmenorrhoea, episiotomy, adnexitis, endometritis, parametritis, salpingitis, and mastitis.Otorhinolaryngology: As pre-operative medication for the prevention of pain, inflammation, and swelling.Dentistry: Post-operative and post-traumatic pain, inflammation, and swelling.Other indications: For the prevention of pain and treatment of inflammation and swelling of patients operated in the urogenital tract, renal and biliary colic.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Dilofenac Sodium is a potent non-steroidal anti-inflammatory drug (NSAID) with pronounced anti-rheumatic, anti-inflammatory, analgesic and antipyretic properties. It has also some uricosuric effect. Diclofenac exerts its effect by inhibiting prostaglandin biosynthesis which plays a major role in causing inflammation, pain and fever. Diclofenac is rapidly and completely absorbed from the gastro-intestinal tract when taken with or after meal. Peak plasma concentrations are reached within an average of 2 hours after ingestion of it. At therapeutic concentrations, it is 99.7% bound to plasma proteins. Diclofenac is metabolized in the liver and undergoes first pass metabolism.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alterin may have the following drug interactions:",
        "items": []
      },
      {
        "title": "Lithium and digoxin",
        "information": ": Alterin may increase plasma concentrations of lithium and digoxin.",
        "items": []
      },
      {
        "title": "Anticoagulants",
        "information": ": There are isolated reports of an increased risk of haemorrhage with the combined use of diclofenac and anticoagulant therapy, although clinical investigations do not appear to indicate any influence on anticoagulant effect.",
        "items": []
      },
      {
        "title": "Antidiabetic agents",
        "information": ": Clinical studies have shown that diclofenac can be given together with oral antidiabetic agents without influencing their clinical effect.",
        "items": []
      },
      {
        "title": "Cyclosporin",
        "information": ": Cases of nephrotoxicity have been reported in patients receiving cyclosporin and diclofenac concomitantly.",
        "items": []
      },
      {
        "title": "Methotrexate",
        "information": ": Cases of serious toxicity have been reported when methotrexate and NSAIDs are given within 24 hours of each other.",
        "items": []
      },
      {
        "title": "Quinolone antimicrobials",
        "information": ": Convulsions may occur due to an interaction between quinolones and NSAIDs. Therefore, caution should be exercised when considering concomitant therapy of NSAID and quinolones.",
        "items": []
      },
      {
        "title": "Other NSAIDs and steroids",
        "information": ": Co-administration of diclofenac with other systemic NSAIDs and steroids may increase the frequency of unwanted effects. With aspirin, the plasma levels of each is lowered, although no clinical significance is known.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated to the patients hypersensitive to any ingredient of the products. Peptic ulcer, hypersensitivity to Diclofenac like other non-steroid anti-inflammatory agents, Diclofenac is also contra-indicated in asthmatic patient in whom attack with asthma, urticaria or acute rhinitis are precipitated by acetylsalicylic acid or by other drugs with prostaglandin synthetase inhibitor. This Gel should not be used under occlusive airtight dressings.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Alterin is generally well tolerated. Adverse effects are mild, rare and transient. At the starting of the treatment, however, patients may be sometimes complaining of epigastric pain, eructation, nausea and diarrhea or dizziness or headache. These effects are usually mild in nature. Peripheral edema and skin reactions, such as rash and eczema have also been encountered. Alterin Gel may cause local irritation and reddening of the skin and skin rash.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "During pregnancy, Diclofenac should be employed only for compelling reasons. The lowest effective dose should be used. These types of drugs are not recommended during the first trimester of pregnancy. In view of insufficient clinical data, Diclofenac Sodium Gel is not recommended during pregnancy. A very insignificant quantity of Diclofenac may be detected in breast milk but no undesirable effects on the infant to be expected.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In rare instances where peptic ulceration or gastrointestinal bleeding occurs in patients under treatment with Alterin. In patients with advanced age should be kept under close observation. Alterin Gel should not be allowed to come in contact with the eyes or mucus membranes, after application the hands should be washed properly and not to be taken by mouth.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light. Store below 30°C. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs)",
    "dosage": [
      {
        "medication_type": "Diclofenac FC Tablet",
        "information": ": Adults: 75-150 mg daily in 2 to 3 divided doses, preferably after food. Dose should be reduced in long term use.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac SR Tablet",
        "information": ":",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 1 tablet daily, taken whole with liquid, preferably at meal times. If necessary, the daily dose can be increased to 150 mg by supplementation with conventional tablets.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 1-3 mg of diclofenac/kg body wt. daily in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly patients",
        "information": ": In elderly or debilitated patients, the lowest effective dosage is recommended, although the pharmacokinetics of diclofenac sodium is not impaired to any clinically relevant extent in elderly patients.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Dispersible Tablet",
        "information": ":",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": The recommended daily dosage is 2-3 tablets and the maximum daily dose is 150 mg. In milder cases, 2 tablets of Diclofenac DT per day are sufficient. Diclofenac DT should preferably be taken before meals.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": Diclofenac is not recommended in children for other indications except juvenile rheumatoid arthritis where the recommended dose is 1-3 mg/kg body weight. Diclofenac DT is to be dropped into a half-glass of water and the liquid is to be stirred to aid dispersion before swallowing. There is no information on the use of Diclofenac DT for more than 03 months.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac TR Capsule",
        "information": ": One capsule daily. Diclofenac TR should be taken preferably after mealtimes.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Suppository",
        "information": ": For adults: 50 mg suppository 2-3 times daily. Maximum daily dose is 150 mg.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac injection",
        "information": ": For adults the usual dose is 1 ampoule daily. In serious cases this dose may be increased up to 2 ampoules daily.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Gel",
        "information": ": For external use only. Depending on the size of area to be treated, 2-4 g of Diclofenac gel should be applied to the skin 3-4 times daily. To the affected area gel should be rubbed in lightly. This gel may also be given in addition to further treatment with other dosage forms of Diclofenac.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:15.835Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e7c",
    "original_record": {
      "input_index": 713,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e7c"
        },
        "name": "Alterin",
        "strength": "50 mg",
        "generic": "Diclofenac Sodium",
        "company": "Euro Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/10938/alterin-50-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/26546/alton-40-mg-injection",
    "name": "Alton",
    "dosage_form": "IV Injection",
    "generic": "Esomeprazole",
    "strength": "40 mg/vial",
    "company": "General Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 100.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "40 mg vial",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "20 mg (Tablet)",
        "href": "https://medex.com.bd/brands/1981/alton-20-mg-tablet?ref=1"
      },
      {
        "text": "40 mg (Tablet)",
        "href": "https://medex.com.bd/brands/1982/alton-40-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/433/esomeprazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alton is indicated:",
        "items": [
          "To relieve from chronic heartburn symptoms and other symptoms associated with GERD",
          "For the healing of erosive esophagitis",
          "For maintenance of healing of erosive esophagitis",
          "In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.",
          "Zollinger-Ellison Syndrome",
          "Acid related Dyspepsia",
          "Duodenal & Gastric ulcer"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole (S-isomer of omeprazole) is the first single optical isomer of proton pump inhibitor, provides better acid control than racemic proton pump inhibitors.Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma ... Read moreEsomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole (S-isomer of omeprazole) is the first single optical isomer of proton pump inhibitor, provides better acid control than racemic proton pump inhibitors.Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals. Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces. Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alton is extensively metabolized in the liver by CYP2C19 and CYP3A4. In vitro and in vivo studies have shown that Alton is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that Alton does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin. Alton may potentially interfere with CYP2C19, the major Alton metabolizing enzyme. Co-administration of Alton 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Alton inhibits gastric acid secretion. Therefore, Alton may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin). Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Alton. Combination Therapy with Clarithromycin: Co-administration of Alton, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of Alton and 14-hydroxyclarithromycin.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Esomeprazole is contraindicated in-patient with known hypersensitivity to any of the formulation.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most frequently occurring adverse events reported with Alton include headache, diarrhoea, nausea, flatulence, abdominal pain, constipation and dry mouth. There are no difference in types of related adverse events seen during maintenance treatment upto 12 months compared to short term treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies in pregnant women. Animal studies have revealed no teratogenic effects. The excretion of esomeprazole in milk has not been studied. Breast-feeding should be therefore be discontinued if the use of esomeprazole is considered essential.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "General",
        "information": ": Symptomatic response to therapy with Alton does not preclude the presence of gastric malignancy.",
        "items": []
      },
      {
        "title": "Information for patients",
        "information": ": Alton capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Alton capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking Alton.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Paediatric Use",
        "information": ": Safety and effectiveness in paediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety and efficacy have been observed between the elderly and younger individuals, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out",
        "items": []
      },
      {
        "title": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is recommended for patients with mild to moderate hepatic insufficiency. However, in patients with severe hepatic insufficiency, a dose of 20 mg once daily should not be exceeded.",
        "items": []
      },
      {
        "title": "Renal Insufficiency",
        "information": ": The Pharmacokinetics of Alton in patients with renal impairment are not expected to be altered relative to healthy volunteers as less than 1% of Alton is excreted unchanged in the urine.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "A single oral dose of Alton at 510 mg/kg (about 103 times the human dose on a body surface area basis), has been lethal to rats. The major signs of acute toxicity are reduced motor activity, changes in respiratory frequency, tremor, ataxia, and intermittent clonic convulsions. There have been no reports of overdose with Alton. No specific antidote for Alton is known. Since Alton is extensively protein bound, it is not expected to be removed by dialysis. In the event of overdosage, treatment should be symptomatic and supportive. As with the management of any overdose, the possibility of multiple drug ingestion should be considered.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": "Tablet or capsule",
        "information": ": should be swallowed whole and taken one hour before a meal.",
        "items": []
      },
      {
        "title": "Oral Suspension",
        "information": ": Whole contents of the packet should be taken into a small glass containing 15 ml. of water. The mixer should be stirred well and leave 2 to 3 minutes to thicken. Stir again and drink within 30 minutes. If any medicine remains after drinking, add more water, stir, and drink immediately. If the suspension is to be administered through a nasogastric or gastric tube, the volume of water in the syringe should be 15 ml. & immediately shake the syringe and leave 2 to 3 minutes to thicken. Shake the syringe and inject it through the nasogastric or gastric tube into the stomach within 30 minutes. An appropriately sized syringe should be used. Shake and flush any remaining contents from the nasogastric or gastric tube into the stomach.",
        "items": []
      },
      {
        "title": "IV Injection",
        "information": ": Solution for injection is prepared by adding 5 ml of 0.9% Sodium Chloride for intravenous injection into the vial containing the dry powder. The reconstituted solution for injection is clear and colorless to very slightly yellow. IV injection must be administrated intravenously over a period of at least 3 minutes. Prepared solution must be used within 12 hours of preparation and can be exposed to normal indoor lighting at a maximum of 30°C.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": "C17H19N3O3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-433-esomeprazole-chemical-structure-Tj2Jfp1VmPkRjNXznKqC.svg"
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Oral dosage form-",
        "instructions": []
      },
      {
        "medication_type": "Healing of Erosive Esophagitis",
        "information": ": 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive",
        "instructions": []
      },
      {
        "medication_type": "Esophagitis",
        "information": ": 20 mg Once Daily (Clinical studies did not extend 6 months).",
        "instructions": []
      },
      {
        "medication_type": "Symptomatic GERD",
        "information": ": 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.",
        "instructions": []
      },
      {
        "medication_type": "Helicobacter Pylori eradication",
        "information": ": Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.",
        "instructions": []
      },
      {
        "medication_type": "Zollinger-Ellison Syndrome",
        "information": ": The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.",
        "instructions": []
      },
      {
        "medication_type": "Acid-related Dyspepsia",
        "information": ": 20-40 mg once daily for 2-4 weeks according to the response.",
        "instructions": []
      },
      {
        "medication_type": "Duodenal ulcer",
        "information": ": 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "IV Injection or IV infusion:",
        "instructions": []
      },
      {
        "medication_type": "GERD with Erosive Esophagitis",
        "information": "- Adult Patients (≥18 years): Pediatric Patients (1 year to 17 years)",
        "instructions": [
          "20 mg or 40 mg once daily",
          "IV Injection: >3 Minutes, IV Infusion: 10-30 minutes",
          "Body weight <55 kg: 10 mg Once daily",
          "Body Weight ≥55 kg: 20 once daily",
          "1 month to <1 year: 0.5 mg/kg once daily",
          "IV Infusion: 10-30 minutes"
        ]
      },
      {
        "medication_type": "Risk reduction of rebleeding of Gastric or Duodenal Ulcers following therapeutic endoscopy in adults",
        "information": "- Adult Patients (≥18 years)",
        "instructions": [
          "80 mg",
          "IV Infusion: 30 minutes, followed by a continuous infusion of 8 mg/h for a total treatment duration of 72 hours."
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alton 40 mg/vial Injection?",
        "answer": [
          "Alton 40 mg/vial Injection is a proton pump inhibitor (PPI). PPIs work by reducing the amount of acid produced in the stomach. Alton 40 mg/vial Injection is used to treat gastroesophageal reflux disease (GERD), ulcers, and other conditions that involve too much stomach acid."
        ]
      },
      {
        "question": "What is Alton 40 mg/vial Injection used for?",
        "answer": [
          "Alton 40 mg/vial Injection has multiple uses. It eases heartburn and relieves GERD symptoms. It also aids in healing erosive esophagitis, a condition caused by stomach acid damaging the esophagus lining. Additionally, Alton 40 mg/vial Injection effectively prevents erosive esophagitis recurrence."
        ]
      },
      {
        "question": "What are the side effects of Alton 40 mg/vial Injection?",
        "answer": [
          "Alton 40 mg/vial Injection may cause common side effects like headaches, diarrhea, nausea, gas, stomach pain, constipation, and dry mouth. There aren't any differences in the types of side effects between long-term (up to 12 months) and short-term use."
        ]
      },
      {
        "question": "Can I take Alton 40 mg/vial Injection if I am pregnant or breastfeeding?",
        "answer": [
          "Alton 40 mg/vial Injection doesn't have any side-effects if you are pregnant or breastfeeding. You still should talk to your doctor about the risks and benefits of taking Alton 40 mg/vial Injection."
        ]
      },
      {
        "question": "How long does it take for Alton 40 mg/vial Injection to work?",
        "answer": [
          "Alton 40 mg/vial Injection usually starts to work within a few hours of taking it."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alton 40 mg/vial Injection is a well-tolerated medicine and provides relief for a long time.",
          "Avoid eating late at night or before bedtime.",
          "Inform your doctor if you get watery diarrhea, fever or stomach pain that does not go away.",
          "Long-term use of Alton 40 mg/vial Injection can cause weak bones and a deficiency of minerals such as magnesium. Take adequate dietary intake of calcium and magnesium or their supplements as prescribed by your doctor.",
          "Consult your doctor right away if you develop decreased urination, edema (swelling due to fluid retention), lower back pain, nausea, fatigue, and rash or fever. These could be signs of a kidney problem."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:24:16.945Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e7f",
    "original_record": {
      "input_index": 714,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e7f"
        },
        "name": "Alton",
        "strength": "40 mg/vial",
        "generic": "Esomeprazole",
        "company": "General Pharmaceuticals Ltd.",
        "medicine_type": "IV Injection",
        "source_url": "https://medex.com.bd/brands/26546/alton-40-mg-injection",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/25540/altovas-10-mg-tablet",
    "name": "Altovas",
    "dosage_form": "Tablet",
    "generic": "Atorvastatin Calcium",
    "strength": "10 mg",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 10.00",
      "strip_price": "৳ 100.00",
      "pack_size_info": "(3 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.00",
          "pack_size_info": "(3 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "20 mg (Tablet)",
        "href": "https://medex.com.bd/brands/25541/altovas-20-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/92/atorvastatin-calcium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Altovas is indicated as an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B (Apo-B) and triglycerides levels in following diseases when response to diet and other non-pharmacological measures is inadequate. Altovas is indicated as an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B (Apo-B) and triglycerides levels in following diseases when response to diet and other non-pharmacological measures is inadequate.",
        "items": [
          "To reduce total cholesterol and LDL cholesterol in patients with heterozygous and homozygous familial hypercholesterolemia.",
          "To reduce total cholesterol and LDL cholesterol in patients with heterozygous and homozygous familial hypercholesterolemia.",
          "To reduce elevated cholesterol and triglycerides in patient with mixed dyslipidemia (Fredrickson Type Ia and Ib).",
          "For the treatment of patients with elevated serum triglyceride levels in hypertriglyceridaemia (Fredrickson Type IV).",
          "For the treatment of patients with dysbetalipoproteinaemia (Fredrickson Type III).",
          "To reduce cardiac ischaemic events in patients with asymptomatic or mild to moderate symptomatic coronary artery disease with elevated LDL-cholesterol level.",
          "To reduce total and LDL-cholesterol concentrations patients with hypercholesterolemia associated with or exacerbated by diabetes mellitus or renal transplantation."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Atorvastatin is a selective inhibitor of HMG-CoA reductase. This enzyme is the rate-limiting enzyme responsible for the conversion of HMG-CoA to mevalonate, a precursor of sterols, including cholesterol. Atorvastatin lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.",
        "items": []
      },
      {
        "title": "Absorption",
        "information": ": Atorvastatin is rapidly absorbed after oral administration; maximum plasma concentrations occur within 1 to 2 hours. Extent of absorption increases in proportion to Atorvastatin dose. The absolute bioavailability of Atorvastatin (parent drug) is approximately 14% and the systemic availability of HMG-CoA reductase inhibitory activity is approximately 30%.",
        "items": []
      },
      {
        "title": "Distribution",
        "information": ": Mean volume of distribution of Atorvastatin is approximately 381 liters. Atorvastatin is 98% bound to plasma proteins. A blood/plasma ratio of approximately 0.25 indicates poor drug penetration into red blood cells. Based on observations in rats, Atorvastatin is likely to be secreted in human milk.",
        "items": []
      },
      {
        "title": "Metabolism",
        "information": ": Atorvastatin is extensively metabolized to ortho- and parahydroxylated derivatives and various beta-oxidation products. In vitro inhibition of HMG-CoA reductase by ortho- and parahydroxylated metabolites is equivalent to that of Atorvastatin. Approximately 70% of circulating inhibitory activity for HMG-CoA reductase is attributed to active metabolites. In vitro studies suggest the importance of Atorvastatin metabolism by cytochrome P450 3A4, consistent with increased plasma concentrations of Atorvastatin in humans following coadministration with erythromycin, a known inhibitor of this isozymes. In animals, the ortho-hydroxy metabolite undergoes further glucuronidation.",
        "items": []
      },
      {
        "title": "Excretion",
        "information": ": Atorvastatin and its metabolites are eliminated primarily in bile following hepatic and/or extra-hepatic metabolism; however, the drug does not appear to undergo enterohepatic recirculation. Mean plasma elimination half-life of Atorvastatin in humans is approximately 14 hours, but the half-life of inhibitory activity for HMG-CoA reductase is 20 to 30 hours due to the contribution of active metabolites. Less than 2% of a dose of Atorvastatin is recovered in urine following oral administration.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (nicotinic acid), erythromycin, azole antifungals.",
        "items": []
      },
      {
        "title": "Antacid",
        "information": ": When atorvastatin and antacid suspension were coadministered, plasma concentrations of atorvastatin decreased approximately 35%. However, LDL-C reduction was not altered.",
        "items": []
      },
      {
        "title": "Colestipol",
        "information": ": Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and atorvastatin were coadministered. However, LDL-C reduction was greater when atorvastatin and colestipol were coadministered than when either drug was given alone.",
        "items": []
      },
      {
        "title": "Digoxin",
        "information": ": When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%. Patients taking digoxin should be monitored appropriately.",
        "items": []
      },
      {
        "title": "Erythromycin",
        "information": ": In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4.",
        "items": []
      },
      {
        "title": "Oral Contraceptives",
        "information": ": Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%. These increases should be considered when selecting an oral contraceptive for a woman taking atorvastatin.",
        "items": []
      },
      {
        "title": "Warfarin",
        "information": ": Altovas had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Atorvastatin should not be used in patient with hypersensitivity to any component of this medication. Atorvastatin is contraindicated in active liver disease or unexplained persistent elevations of serum transaminases. It is also contraindicated in patient with history of serious adverse reaction to prior administration of HMG-CoA reductase inhibitors.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Altovas is generally well-tolerated. The most frequent side effects related to Altovas are constipation, flatulence, dyspepsia, abdominal pain. Other side effects includes infection, headache, back pain, rash, asthenia, arthralgia, myalgia.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Atorvastatin is contraindicated during pregnancy. Safety in pregnant women has not been established. No controlled clinical trials with atorvastatin have been conducted in pregnant women. Rare reports of congenital anomalies following intrauterine exposure to HMG-CoA reductase inhibitors have been received. Animal studies have shown toxicity to reproduction. Maternal treatment with atorvastatin may reduce the fetal levels of mevalonate which is a precursor of cholesterol biosynthesis. Atorvastatin should not be used in women who are pregnant, trying to become pregnant or suspect they are pregnant. Treatment with atorvastatin should be suspended for the duration of pregnancy or until it has been determined that the woman is not pregnant",
        "items": []
      },
      {
        "title": "Lactation",
        "information": ": It is not known whether atorvastatin or its metabolites are excreted in human milk. In rats, plasma concentrations of atorvastatin and its active metabolites are similar to those in milk. Because of the potential for serious adverse reactions, women taking atorvastatin should not breastfeed their infants. Atorvastatin is contraindicated during breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Liver effects: Liver function tests should be performed before the initiation of treatment and periodically thereafter. Altovas should be used with caution in patients who consume substantial quantities of alcohol or have a history of liver disease. Altovas therapy should be discontinued if markedly elevated CPK levels occur or myopathy is diagnosed or suspected.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric",
        "information": ": Plasma concentrations of Altovas are higher (approximately 40% for Cmax and 30% for AUC) in healthy elderly subjects (age 65 years) than in young adults. Clinical data suggest a greater degree of LDL-lowering at any dose of drug in the elderly patient population compared to younger adults.",
        "items": []
      },
      {
        "title": "Pediatric",
        "information": ": Pharmacokinetic data in the pediatric population are not available.",
        "items": []
      },
      {
        "title": "Gender",
        "information": ": There is no clinically significant difference in LDL-C reduction with Altovas between men and women.",
        "items": []
      },
      {
        "title": "Renal Insufficiency",
        "information": ": Renal disease has no influence on the plasma concentrations or LDL-C reduction of Altovas; thus, dose adjustment in patients with renal dysfunction is not necessary.",
        "items": []
      },
      {
        "title": "Hemodialysis",
        "information": ": Hemodialysis is not expected to significantly enhance clearance of Altovas since the drug is extensively bound to plasma proteins.",
        "items": []
      },
      {
        "title": "Hepatic Insufficiency",
        "information": ": In patients with chronic alcoholic liver disease, plasma concentrations of Altovas are markedly increased.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Specific treatment is not available for atorvastatin overdose. The patient should be treated symptomatically and supportive measures instituted, as required. Liver function tests should be performed and serum CK levels should be monitored. Due to extensive atorvastatin binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin clearance.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C33H35FN2O5",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-92-atorvastatin-calcium-chemical-structure-vKDE8RIA4syu8MLTgdLW.svg"
    },
    "therapeutic_class": "Other Anti-anginal & Anti-ischaemic drugs, Statins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Primary hypercholesterolaemia and combined hyperlipidaemia-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": Usually 10 mg once daily; if necessary, may be increased at intervals of at least 4 weeks to max. 80 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Child (10-18 years)",
        "information": ": Initially 10 mg once daily, increased if necessary at intervals of at least 4 weeks to usual max. 20 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Familial hypercholesterolaemia-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": Initially 10 mg daily, increased at intervals of at least 4 weeks to 40 mg once daily; if necessary, further increased to max. 80 mg once daily (or 40 mg once daily combined with anion-exchange resin in heterozygous familial hypercholesterolaemia).",
        "instructions": []
      },
      {
        "medication_type": "Child (10-18 years)",
        "information": ": Initially 10 mg once daily, increased if necessary at intervals of at least 4 weeks to usual max. 80 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Prevention of cardiovascular events-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": Initially 10 mg once daily adjusted according to response.",
        "instructions": []
      },
      {
        "medication_type": "Another guideline",
        "information": ": The patient should be placed on a standard cholesterol-lowering diet before receiving Atorvastatin and should continue on this diet during treatment with Atorvastatin. The recommended starting dose of Atorvastatin is 10 or 20 mg once daily. Patients who require a large reduction in LDL-C (more than 45%) may be started at 40 mg once daily. The dosage range of Atorvastatin is 10 to 80 mg once daily. Atorvastatin can be administered as a single dose at any time of the day, with or without food. After initiation of Atorvastatin lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly. In hypercholesterolemia in Pediatric Patients (10-17 years of age) the recommended starting dose of Atorvastatin is 10 mg/day; the maximum recommended dose is 20 mg/day (doses greater than 20 mg have not been studied in this patient population). Doses should be individualized according to the recommended goal of therapy. Adjustments should be made at intervals of 4 weeks or more.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Altovas 10 mg Tablet?",
        "answer": [
          "Altovas 10 mg Tablet is a selective inhibitor of HMG-CoA reductase. It is used to avoid heart attacks and Primary Hypercholesterolemia. It is also used to treat conditions such as Mixed Dyslipidemia and Hypertriglyceridemia."
        ]
      },
      {
        "question": "How should I take Altovas 10 mg Tablet?",
        "answer": [
          "Altovas 10 mg Tablet should be taken by mouth once daily, at the same time each day. It can be taken with or without food."
        ]
      },
      {
        "question": "What are the uses of Altovas 10 mg Tablet?",
        "answer": [
          "Altovas 10 mg Tablet is used for the treatment of diseases like Mixed Dyslipidemia and Hypertriglyceridemia. Besides these, it can also be used to treat conditions like heart attacks and Primary Hypercholesterolemia."
        ]
      },
      {
        "question": "What are the Side Effects of Altovas 10 mg Tablet?",
        "answer": [
          "This is a list of possible side-effects which may occur due to the constituting ingredients of Altovas 10 mg Tablet. These side-effects have been observed and not necessarily occur. Some of these side-effects may be serious. These include cough, muscle pain, breathing difficulty and running nose."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Altovas 10 mg Tablet?",
        "answer": [
          "Altovas 10 mg Tablet should be stored at room temperature, away from heat and direct light. Keep it away from the reach of children and pets."
        ]
      },
      {
        "question": "Is Altovas 10 mg Tablet used for lowering cholesterol?",
        "answer": [
          "Altovas 10 mg Tablet comes under the class of drugs termed as statins and helps in decreasing the level of lipids or fats. It is used to lower cholesterol and triglycerides present in the blood. However, you must take a cholesterol-lowering diet during the course of treatment."
        ]
      },
      {
        "question": "Will taking Altovas 10 mg Tablet increase my risk of diabetes?",
        "answer": [
          "If you have type 2 diabetes, then consuming Altovas 10 mg Tablet can slightly affect your health as Altovas 10 mg Tablet is known to increase the blood sugar levels. In such a case, regular monitoring of blood sugar level during the course of treatment is important."
        ]
      },
      {
        "question": "For how long do I need to take Altovas 10 mg Tablet? Is it safe for long-term use?",
        "answer": [
          "Altovas 10 mg Tablet should be taken for a duration that a doctor has prescribed it. If you stop taking this medicine without completing the full course, then it can worsen your condition. This medicine is considered safe for long term use if you take it exactly as directed by the doctor."
        ]
      },
      {
        "question": "Does Altovas 10 mg Tablet cause weight loss?",
        "answer": [
          "No studies report that Altovas 10 mg Tablet can cause weight loss. This is a very unusual side effect. If you encounter weight loss after the course of medication, then doctor consultation is suggested."
        ]
      },
      {
        "question": "Can I stop taking Altovas 10 mg Tablet?",
        "answer": [
          "Do not stop taking Altovas 10 mg Tablet without informing your doctor. Completing the course of medication is necessary or it can worsen your condition."
        ]
      },
      {
        "question": "Does Altovas 10 mg Tablet cause memory loss?",
        "answer": [
          "Memory loss is a very rare side effect of Altovas 10 mg Tablet. You must consult a doctor if you experience it."
        ]
      },
      {
        "question": "Does Altovas 10 mg Tablet make you tired?",
        "answer": [
          "Altovas 10 mg Tablet can make you feel tired. Although the exact reason behind this is still not known."
        ]
      },
      {
        "question": "Can Altovas 10 mg Tablet be prescribed to children?",
        "answer": [
          "Altovas 10 mg Tablet should be used by adults. Children above 10 years of age can also use it however caution must be exercised. Altovas 10 mg Tablet should not be given to children who are less than 10 years old."
        ]
      },
      {
        "question": "Is Altovas 10 mg Tablet a blood thinner?",
        "answer": [
          "Altovas 10 mg Tablet does not cause thinning of the blood. This medication lowers cholesterol and prevents the chances of stroke and heart attack."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "In general, Altovas 10 mg Tablet is safe. It may cause diarrhea, gas or an upset stomach. If any of these happen to you, take it with food.",
          "Inform your doctor if you experience fatigue, muscle weakness or muscle pain.",
          "Your doctor may check your liver function before starting the treatment and regularly thereafter. Inform your doctor if you notice signs of liver problems such as stomach pains, unusually dark urine or yellowing of skin or eyes.",
          "Inform your doctor if you have kidney disease, liver disease or diabetes before starting treatment with this medicine. If you are diabetic, monitor your blood sugar level regularly as Altovas 10 mg Tablet may cause an increase in your blood sugar level.",
          "Do not take Altovas 10 mg Tablet if you are pregnant, planning a pregnancy or breastfeeding."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:24:18.124Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e83",
    "original_record": {
      "input_index": 715,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e83"
        },
        "name": "Altovas",
        "strength": "10 mg",
        "generic": "Atorvastatin Calcium",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/25540/altovas-10-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/25541/altovas-20-mg-tablet",
    "name": "Altovas",
    "dosage_form": "Tablet",
    "generic": "Atorvastatin Calcium",
    "strength": "20 mg",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 18.00",
      "strip_price": "৳ 180.00",
      "pack_size_info": "(3 x 10: ৳ 540.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 18.00",
          "pack_size_info": "(3 x 10: ৳ 540.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 180.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/25540/altovas-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/92/atorvastatin-calcium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Altovas is indicated as an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B (Apo-B) and triglycerides levels in following diseases when response to diet and other non-pharmacological measures is inadequate. Altovas is indicated as an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B (Apo-B) and triglycerides levels in following diseases when response to diet and other non-pharmacological measures is inadequate.",
        "items": [
          "To reduce total cholesterol and LDL cholesterol in patients with heterozygous and homozygous familial hypercholesterolemia.",
          "To reduce total cholesterol and LDL cholesterol in patients with heterozygous and homozygous familial hypercholesterolemia.",
          "To reduce elevated cholesterol and triglycerides in patient with mixed dyslipidemia (Fredrickson Type Ia and Ib).",
          "For the treatment of patients with elevated serum triglyceride levels in hypertriglyceridaemia (Fredrickson Type IV).",
          "For the treatment of patients with dysbetalipoproteinaemia (Fredrickson Type III).",
          "To reduce cardiac ischaemic events in patients with asymptomatic or mild to moderate symptomatic coronary artery disease with elevated LDL-cholesterol level.",
          "To reduce total and LDL-cholesterol concentrations patients with hypercholesterolemia associated with or exacerbated by diabetes mellitus or renal transplantation."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Atorvastatin is a selective inhibitor of HMG-CoA reductase. This enzyme is the rate-limiting enzyme responsible for the conversion of HMG-CoA to mevalonate, a precursor of sterols, including cholesterol. Atorvastatin lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.",
        "items": []
      },
      {
        "title": "Absorption",
        "information": ": Atorvastatin is rapidly absorbed after oral administration; maximum plasma concentrations occur within 1 to 2 hours. Extent of absorption increases in proportion to Atorvastatin dose. The absolute bioavailability of Atorvastatin (parent drug) is approximately 14% and the systemic availability of HMG-CoA reductase inhibitory activity is approximately 30%.",
        "items": []
      },
      {
        "title": "Distribution",
        "information": ": Mean volume of distribution of Atorvastatin is approximately 381 liters. Atorvastatin is 98% bound to plasma proteins. A blood/plasma ratio of approximately 0.25 indicates poor drug penetration into red blood cells. Based on observations in rats, Atorvastatin is likely to be secreted in human milk.",
        "items": []
      },
      {
        "title": "Metabolism",
        "information": ": Atorvastatin is extensively metabolized to ortho- and parahydroxylated derivatives and various beta-oxidation products. In vitro inhibition of HMG-CoA reductase by ortho- and parahydroxylated metabolites is equivalent to that of Atorvastatin. Approximately 70% of circulating inhibitory activity for HMG-CoA reductase is attributed to active metabolites. In vitro studies suggest the importance of Atorvastatin metabolism by cytochrome P450 3A4, consistent with increased plasma concentrations of Atorvastatin in humans following coadministration with erythromycin, a known inhibitor of this isozymes. In animals, the ortho-hydroxy metabolite undergoes further glucuronidation.",
        "items": []
      },
      {
        "title": "Excretion",
        "information": ": Atorvastatin and its metabolites are eliminated primarily in bile following hepatic and/or extra-hepatic metabolism; however, the drug does not appear to undergo enterohepatic recirculation. Mean plasma elimination half-life of Atorvastatin in humans is approximately 14 hours, but the half-life of inhibitory activity for HMG-CoA reductase is 20 to 30 hours due to the contribution of active metabolites. Less than 2% of a dose of Atorvastatin is recovered in urine following oral administration.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (nicotinic acid), erythromycin, azole antifungals.",
        "items": []
      },
      {
        "title": "Antacid",
        "information": ": When atorvastatin and antacid suspension were coadministered, plasma concentrations of atorvastatin decreased approximately 35%. However, LDL-C reduction was not altered.",
        "items": []
      },
      {
        "title": "Colestipol",
        "information": ": Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and atorvastatin were coadministered. However, LDL-C reduction was greater when atorvastatin and colestipol were coadministered than when either drug was given alone.",
        "items": []
      },
      {
        "title": "Digoxin",
        "information": ": When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%. Patients taking digoxin should be monitored appropriately.",
        "items": []
      },
      {
        "title": "Erythromycin",
        "information": ": In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4.",
        "items": []
      },
      {
        "title": "Oral Contraceptives",
        "information": ": Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%. These increases should be considered when selecting an oral contraceptive for a woman taking atorvastatin.",
        "items": []
      },
      {
        "title": "Warfarin",
        "information": ": Altovas had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Atorvastatin should not be used in patient with hypersensitivity to any component of this medication. Atorvastatin is contraindicated in active liver disease or unexplained persistent elevations of serum transaminases. It is also contraindicated in patient with history of serious adverse reaction to prior administration of HMG-CoA reductase inhibitors.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Altovas is generally well-tolerated. The most frequent side effects related to Altovas are constipation, flatulence, dyspepsia, abdominal pain. Other side effects includes infection, headache, back pain, rash, asthenia, arthralgia, myalgia.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Atorvastatin is contraindicated during pregnancy. Safety in pregnant women has not been established. No controlled clinical trials with atorvastatin have been conducted in pregnant women. Rare reports of congenital anomalies following intrauterine exposure to HMG-CoA reductase inhibitors have been received. Animal studies have shown toxicity to reproduction. Maternal treatment with atorvastatin may reduce the fetal levels of mevalonate which is a precursor of cholesterol biosynthesis. Atorvastatin should not be used in women who are pregnant, trying to become pregnant or suspect they are pregnant. Treatment with atorvastatin should be suspended for the duration of pregnancy or until it has been determined that the woman is not pregnant",
        "items": []
      },
      {
        "title": "Lactation",
        "information": ": It is not known whether atorvastatin or its metabolites are excreted in human milk. In rats, plasma concentrations of atorvastatin and its active metabolites are similar to those in milk. Because of the potential for serious adverse reactions, women taking atorvastatin should not breastfeed their infants. Atorvastatin is contraindicated during breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Liver effects: Liver function tests should be performed before the initiation of treatment and periodically thereafter. Altovas should be used with caution in patients who consume substantial quantities of alcohol or have a history of liver disease. Altovas therapy should be discontinued if markedly elevated CPK levels occur or myopathy is diagnosed or suspected.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric",
        "information": ": Plasma concentrations of Altovas are higher (approximately 40% for Cmax and 30% for AUC) in healthy elderly subjects (age 65 years) than in young adults. Clinical data suggest a greater degree of LDL-lowering at any dose of drug in the elderly patient population compared to younger adults.",
        "items": []
      },
      {
        "title": "Pediatric",
        "information": ": Pharmacokinetic data in the pediatric population are not available.",
        "items": []
      },
      {
        "title": "Gender",
        "information": ": There is no clinically significant difference in LDL-C reduction with Altovas between men and women.",
        "items": []
      },
      {
        "title": "Renal Insufficiency",
        "information": ": Renal disease has no influence on the plasma concentrations or LDL-C reduction of Altovas; thus, dose adjustment in patients with renal dysfunction is not necessary.",
        "items": []
      },
      {
        "title": "Hemodialysis",
        "information": ": Hemodialysis is not expected to significantly enhance clearance of Altovas since the drug is extensively bound to plasma proteins.",
        "items": []
      },
      {
        "title": "Hepatic Insufficiency",
        "information": ": In patients with chronic alcoholic liver disease, plasma concentrations of Altovas are markedly increased.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Specific treatment is not available for atorvastatin overdose. The patient should be treated symptomatically and supportive measures instituted, as required. Liver function tests should be performed and serum CK levels should be monitored. Due to extensive atorvastatin binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin clearance.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C33H35FN2O5",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-92-atorvastatin-calcium-chemical-structure-vKDE8RIA4syu8MLTgdLW.svg"
    },
    "therapeutic_class": "Other Anti-anginal & Anti-ischaemic drugs, Statins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Primary hypercholesterolaemia and combined hyperlipidaemia-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": Usually 10 mg once daily; if necessary, may be increased at intervals of at least 4 weeks to max. 80 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Child (10-18 years)",
        "information": ": Initially 10 mg once daily, increased if necessary at intervals of at least 4 weeks to usual max. 20 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Familial hypercholesterolaemia-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": Initially 10 mg daily, increased at intervals of at least 4 weeks to 40 mg once daily; if necessary, further increased to max. 80 mg once daily (or 40 mg once daily combined with anion-exchange resin in heterozygous familial hypercholesterolaemia).",
        "instructions": []
      },
      {
        "medication_type": "Child (10-18 years)",
        "information": ": Initially 10 mg once daily, increased if necessary at intervals of at least 4 weeks to usual max. 80 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Prevention of cardiovascular events-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": Initially 10 mg once daily adjusted according to response.",
        "instructions": []
      },
      {
        "medication_type": "Another guideline",
        "information": ": The patient should be placed on a standard cholesterol-lowering diet before receiving Atorvastatin and should continue on this diet during treatment with Atorvastatin. The recommended starting dose of Atorvastatin is 10 or 20 mg once daily. Patients who require a large reduction in LDL-C (more than 45%) may be started at 40 mg once daily. The dosage range of Atorvastatin is 10 to 80 mg once daily. Atorvastatin can be administered as a single dose at any time of the day, with or without food. After initiation of Atorvastatin lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly. In hypercholesterolemia in Pediatric Patients (10-17 years of age) the recommended starting dose of Atorvastatin is 10 mg/day; the maximum recommended dose is 20 mg/day (doses greater than 20 mg have not been studied in this patient population). Doses should be individualized according to the recommended goal of therapy. Adjustments should be made at intervals of 4 weeks or more.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Altovas 20 mg Tablet?",
        "answer": [
          "Altovas 20 mg Tablet is a selective inhibitor of HMG-CoA reductase. It is used to avoid heart attacks and Primary Hypercholesterolemia. It is also used to treat conditions such as Mixed Dyslipidemia and Hypertriglyceridemia."
        ]
      },
      {
        "question": "How should I take Altovas 20 mg Tablet?",
        "answer": [
          "Altovas 20 mg Tablet should be taken by mouth once daily, at the same time each day. It can be taken with or without food."
        ]
      },
      {
        "question": "What are the uses of Altovas 20 mg Tablet?",
        "answer": [
          "Altovas 20 mg Tablet is used for the treatment of diseases like Mixed Dyslipidemia and Hypertriglyceridemia. Besides these, it can also be used to treat conditions like heart attacks and Primary Hypercholesterolemia."
        ]
      },
      {
        "question": "What are the Side Effects of Altovas 20 mg Tablet?",
        "answer": [
          "This is a list of possible side-effects which may occur due to the constituting ingredients of Altovas 20 mg Tablet. These side-effects have been observed and not necessarily occur. Some of these side-effects may be serious. These include cough, muscle pain, breathing difficulty and running nose."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Altovas 20 mg Tablet?",
        "answer": [
          "Altovas 20 mg Tablet should be stored at room temperature, away from heat and direct light. Keep it away from the reach of children and pets."
        ]
      },
      {
        "question": "Is Altovas 20 mg Tablet used for lowering cholesterol?",
        "answer": [
          "Altovas 20 mg Tablet comes under the class of drugs termed as statins and helps in decreasing the level of lipids or fats. It is used to lower cholesterol and triglycerides present in the blood. However, you must take a cholesterol-lowering diet during the course of treatment."
        ]
      },
      {
        "question": "Will taking Altovas 20 mg Tablet increase my risk of diabetes?",
        "answer": [
          "If you have type 2 diabetes, then consuming Altovas 20 mg Tablet can slightly affect your health as Altovas 20 mg Tablet is known to increase the blood sugar levels. In such a case, regular monitoring of blood sugar level during the course of treatment is important."
        ]
      },
      {
        "question": "For how long do I need to take Altovas 20 mg Tablet? Is it safe for long-term use?",
        "answer": [
          "Altovas 20 mg Tablet should be taken for a duration that a doctor has prescribed it. If you stop taking this medicine without completing the full course, then it can worsen your condition. This medicine is considered safe for long term use if you take it exactly as directed by the doctor."
        ]
      },
      {
        "question": "Does Altovas 20 mg Tablet cause weight loss?",
        "answer": [
          "No studies report that Altovas 20 mg Tablet can cause weight loss. This is a very unusual side effect. If you encounter weight loss after the course of medication, then doctor consultation is suggested."
        ]
      },
      {
        "question": "Can I stop taking Altovas 20 mg Tablet?",
        "answer": [
          "Do not stop taking Altovas 20 mg Tablet without informing your doctor. Completing the course of medication is necessary or it can worsen your condition."
        ]
      },
      {
        "question": "Does Altovas 20 mg Tablet cause memory loss?",
        "answer": [
          "Memory loss is a very rare side effect of Altovas 20 mg Tablet. You must consult a doctor if you experience it."
        ]
      },
      {
        "question": "Does Altovas 20 mg Tablet make you tired?",
        "answer": [
          "Altovas 20 mg Tablet can make you feel tired. Although the exact reason behind this is still not known."
        ]
      },
      {
        "question": "Can Altovas 20 mg Tablet be prescribed to children?",
        "answer": [
          "Altovas 20 mg Tablet should be used by adults. Children above 10 years of age can also use it however caution must be exercised. Altovas 20 mg Tablet should not be given to children who are less than 10 years old."
        ]
      },
      {
        "question": "Is Altovas 20 mg Tablet a blood thinner?",
        "answer": [
          "Altovas 20 mg Tablet does not cause thinning of the blood. This medication lowers cholesterol and prevents the chances of stroke and heart attack."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "In general, Altovas 20 mg Tablet is safe. It may cause diarrhea, gas or an upset stomach. If any of these happen to you, take it with food.",
          "Inform your doctor if you experience fatigue, muscle weakness or muscle pain.",
          "Your doctor may check your liver function before starting the treatment and regularly thereafter. Inform your doctor if you notice signs of liver problems such as stomach pains, unusually dark urine or yellowing of skin or eyes.",
          "Inform your doctor if you have kidney disease, liver disease or diabetes before starting treatment with this medicine. If you are diabetic, monitor your blood sugar level regularly as Altovas 20 mg Tablet may cause an increase in your blood sugar level.",
          "Do not take Altovas 20 mg Tablet if you are pregnant, planning a pregnancy or breastfeeding."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:24:19.253Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e84",
    "original_record": {
      "input_index": 716,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e84"
        },
        "name": "Altovas",
        "strength": "20 mg",
        "generic": "Atorvastatin Calcium",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/25541/altovas-20-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/21448/altrax-40-mg-syrup",
    "name": "Altrax",
    "dosage_form": "Syrup",
    "generic": "Levamisole Hydrochloride",
    "strength": "40 mg/5 ml",
    "company": "Alkad Laboratories",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "15 ml bottle",
          "price": "৳ 15.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/674/levamisole-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Altrax is indicated in- Effective against Enterobius vermi-cularis, Trichuris trichiura, Strongyloide stercoralis and Trichostrongylus colubriformis etc.",
        "items": [
          "Ascariasis",
          "Hookworm infections"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Levamisole is the active laevo-isomer of tetramisole. It works by paralysing susceptible intestinal worms which are then excreted from the intestines. Levamisole also enhances cellular immune responses in humans.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "May increase toxicity of phenytoin. Increases bioavailability of ivermectin; decreases bioavailability of albendazole. Alcohol causes disulfiram-like reaction.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients hypersensitive to Levamisole. Levamisole should not be given during pregnancy.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects are infrequent. They are usually mild and transient and include nausea, vomiting, abdominal pain, giddiness (dizziness) and headache. An encephalopathy like syndrome has been reported to have occurred in a few patients two or three weeks after treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although studies in animals have shown that Levamisole produces no teratogenic effects, current medical practice requires that the benefits of any drug used during pregnancy should be weighed against the possible dangers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Effect on ability to drive or operate machinery",
        "information": ": There is no evidence to suggest that Altrax , used for anthelmintic purpose, will produce sedation. Mild and transient giddiness is an infrequent side-effect of treatment. No precautions are suggested concerning the ability to drive or operate machinery. In case of concurrent microfilaraemia transient fever may occur.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep all medicines out of reach of children. Store in a cool and dry place protected from light",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": null,
        "information": "The following doses of Levamisole are given as a single administration, preferably after a light meal.",
        "instructions": []
      },
      {
        "medication_type": "Age 1-4 year",
        "information": ": 1 Tablets or 5 ml Syrup",
        "instructions": []
      },
      {
        "medication_type": "Age 5-15 year",
        "information": ": 2 Tablets or 10 ml Syrup",
        "instructions": []
      },
      {
        "medication_type": "Age 16 year and over",
        "information": ": 3 Tablets or 15 ml Syrup",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "In cases of severe hookworm infection it is suggested that a second standard dose be given one or seven days after the first, whichever timing is feasible.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:20.376Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e85",
    "original_record": {
      "input_index": 717,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e85"
        },
        "name": "Altrax",
        "strength": "40 mg/5 ml",
        "generic": "Levamisole Hydrochloride",
        "company": "Alkad Laboratories",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/21448/altrax-40-mg-syrup",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/446/altrip-625-mg-tablet",
    "name": "Altrip",
    "dosage_form": "Tablet",
    "generic": "Almotriptan",
    "strength": "6.25 mg",
    "company": "NIPRO JMI Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 25.08",
      "strip_price": "৳ 250.80",
      "pack_size_info": "(1 x 10: ৳ 250.80)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 25.08",
          "pack_size_info": "(1 x 10: ৳ 250.80)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 250.80",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/44/almotriptan/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Altrip is prescribed to treat the acute headache phase of migraine attacks with or without aura. Altrip is the only oral triptan approved in the USA for the treatment of migraine in adolescent from 12 to 17 years of age.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Almotriptan is a selective and potent serotonin (5-hydroxytryptamine 1B/1D) agonist. Almotriptan binds to specific serotonin receptors on meningeal arteries inhibiting the release of vasoactive peptides and causing constriction of the arteries. It has a limited effect on arteries supplying blood to the brain and little effect on cardiac and pulmonary vessels.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "These drugs have been reported to cause prolonged vasospastic reactions. Cases of life-threatening serotonin syndrome have been reported during combined use of triptans and selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs).",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "As with other 5-HT1B/1D receptor agonists, almotriptan should not be used in patients with a history, symptoms or signs of ischaemic heart disease (myocardial infarction, angina pectoris, documented silent ischaemia, Prinzmetal's angina) or severe hypertension and uncontrolled mild or moderate hypertension. Concomitant administration with ergotamine, ergotamine derivatives (including methysergide) and other 5-HT1B/1D agonists is contraindicated.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Serious cardiac reactions, including myocardial infarction, have occurred following the use of Altrip malate Tablets. These reactions are extremely rare and most have been reported in patients with risk factors predictive of CAD (Coronary Artery Disease).",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. There is no data regarding excretion of almotriptan in human milk.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Hypersensitivity to the active substance or to any of the excipients. Patients with severe hepatic impairment, with a previous cerebrovascular accident (CVA) or transient ischaemic attack (TIA) Peripheral vascular disease.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30° C temperature in a dry place. Protected from light. Do not freeze. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "5-HT Agonists",
    "dosage": [
      {
        "medication_type": "Acute Treatment of Migraine Attacks",
        "information": ": The recommended dose of Almotriptan in adults and adolescents age 12 to 17 years is 6.25 mg to 12.5 mg, with the 12.5 mg dose tending to be a more effective dose in adults. If the headache is relieved after the initial almotriptan malate dose but returns, the dose may be repeated after 2 hours. The maximum daily dose should not exceed 25 mg. The safety of treating an average of more than four migraines in a 30-day period has not been established.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": The recommended starting dose of almotriptan malate in patients with hepatic impairment is 6.25 mg. The maximum daily dose should not exceed 12.5 mg over a 24-hour period",
        "instructions": []
      },
      {
        "medication_type": "Renal Impairment",
        "information": ": The recommended starting dose of almotriptan malate in patients with severe renal impairment is 6.25 mg. The maximum daily dose should not exceed 12.5 mg over a 24-hour period",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:21.403Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e86",
    "original_record": {
      "input_index": 718,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e86"
        },
        "name": "Altrip",
        "strength": "6.25 mg",
        "generic": "Almotriptan",
        "company": "NIPRO JMI Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/446/altrip-625-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/14746/altrum-gold-tablet",
    "name": "Altrum Gold",
    "dosage_form": "Tablet",
    "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
    "strength": null,
    "company": "Ziska Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 7.00",
      "strip_price": null,
      "pack_size_info": "(1 x 15: ৳ 105.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 7.00",
          "pack_size_info": "(1 x 15: ৳ 105.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/781/multivitamin-multimineral-a-z-gold-preparation/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Altrum Gold is indicated for the prevention and treatment of vitamins & minerals deficiencies. As a complete daily nutritional supplement, it is also indicated to meet the increased demand for vitamins and minerals in the conditions like physical and emotional stress, chronic diseases, infection illness, osteoporosis, injuries or wound, surgery, poor digestion, old age, pregnancy and lactation, poor appetite, excess dieting, exposure to environmental pollution, heavy exercise etc.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a film coated tablet, which combines 32 high potency vitamins and minerals. This preparation maintains a healthy body and active life-style.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No drug interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally, Altrum Gold is well tolerated. Diarrhoea may occasionally occur during treatment with beta carotene and the skin may assume a slightly yellow discoloration. Vitamin C and vitamin E may cause diarrhoea and other gastrointestinal disturbances.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Recommended by the consultation with physician.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Long term intake of high level of vitamin A (excluding that sourced from beta carotene) may increase the risk of osteoporosis in postmenopausal women.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Multi-vitamin & Multi-mineral combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "One tablet daily or as recommended by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:22.396Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e87",
    "original_record": {
      "input_index": 719,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e87"
        },
        "name": "Altrum Gold",
        "strength": null,
        "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
        "company": "Ziska Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/14746/altrum-gold-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/492/alucil-s-400-mg-chewable-tablet",
    "name": "Alucil-S",
    "dosage_form": "Chewable Tablet",
    "generic": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicone",
    "strength": "400 mg+400 mg+30 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.00",
      "strip_price": "৳ 20.00",
      "pack_size_info": "(10 x 10: ৳ 200.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.00",
          "pack_size_info": "(10 x 10: ৳ 200.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 20.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "(400 mg+400 mg+30 mg)/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/455/alucil-s-400-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/20/aluminium-hydroxide-magnesium-hydroxide-simethicone/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This is indicated for symptomatic relief of hyperacidity associated with the peptic ulcer, gastritis, peptic oesophagitis, gastric hyperacidity, heartburn, sour stomach or hiatus hernia. It is effective in the prevention of stress ulceration and GI bleeding. It acts as an antiflatulent to alleviate the symptoms of gas including post operative gas pain. This rapidly relieves acid pain, disperses gastric foam and facilitates eructation of gas and air.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the mixture of non-systemic acid neutralizing substances and antiflatulent. This preparation offers reliability as well as long action. Aluminium Hydroxide and Magnesium Hydroxide induce the relief of ulcer by neutralizing gastric acid secreted from parietal cells of the stomach. The clinical use of simethicone is based on its antifoam properties. Simethicone spreads on the surface of aqueous liquids, forming a film of low surface tension and causing collapse of foam bubbles. Simethicone repeatedly allows mucous surrounded gas bubbles in the GI tract to coalesce and be expelled. This is used in the treatment of flatulence and meteorism for the elimination of gas, air or foam from the gastro-intestinal tract prior to radiography and for the relief of abdominal distension and dyspepsia. Simethicone is physiologically inert; it does not appeared to be absorbed from the GI tract to interfere with gastric secretion or absorption of nutrients. Following oral administration, the drug is excreted unchanged in the feces.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "All antacids may increase or decrease the rate and/or extent of absorption of concomitantly administered oral drugs. Antacids decrease the bioavailability of theophyline, tetracycline, quinolone antibiotics, isoniazide, ketoconazole, ethambutol, some antimuscarinic drugs, benzodiazepines, phenothiazines, ranitidine, indomethacine, nitrofurantoin, fluoride, phosphate, propanolol, atenolol, digoxins, vitamins etc. Antacids increase the bioavailability of some drugs; e.g. sulphonamides, levodopa, valproic acid, enteric coated aspirin etc.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This should not be administered in patients with renal failure or hypophosphataemia or in those who are severely debilitated. It is also contraindicated in alkalosis and hypermagnesaemia, where abdominal distention may be due to partial or complete intestinal obstruction.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects are uncommon. Occasionally, if excessive amount is consumed, diarrhea, constipation or regurgitation may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "It is advised to avoid antacid preparations in the first trimester of pregnancy.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "This should be used with caution in patients with kidney disease.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ": 1-2 tablets 1-3 hours after meal and at bed time or as directed by the physician.",
        "instructions": []
      },
      {
        "medication_type": "Suspension",
        "information": ": 1-2 teaspoonful 1-3 hours after meal and at bedtime or as directed by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:23.508Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e8a",
    "original_record": {
      "input_index": 720,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e8a"
        },
        "name": "Alucil-S",
        "strength": "400 mg+400 mg+30 mg",
        "generic": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicone",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/492/alucil-s-400-mg-chewable-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/182/aluric-100-mg-tablet",
    "name": "Aluric",
    "dosage_form": "Tablet",
    "generic": "Allopurinol",
    "strength": "100 mg",
    "company": "Sonear Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.10",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 410.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.10",
          "pack_size_info": "(100's pack: ৳ 410.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/17/allopurinol/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aluric is indicated for reducing urate/uric acid formation in conditions where urate/uric acid deposition has already occurred (e.g. gouty arthritis, skin tophi, nephrolithiasis). Aluric is indicated for management of 2,8-dihydroxyadenine (2,8-DHA) renal stones related to deficient activity ... Read moreAluric is indicated for reducing urate/uric acid formation in conditions where urate/uric acid deposition has already occurred (e.g. gouty arthritis, skin tophi, nephrolithiasis). Aluric is indicated for management of 2,8-dihydroxyadenine (2,8-DHA) renal stones related to deficient activity of adenine phospho ribosyltransferase. Aluric is indicated for the management of recurrent mixed calcium oxalate renal stones in the presence of hyperuricosuria, when fluid, dietary and similar measures have failed.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Allopurinol is a xanthine oxidase inhibitor which is administered orally. It acts on purine catabolism without disrupting the biosynthesis of purines. It reduces the production of uric acid by inhibiting the biochemical reactions immediately preceding its formation. Allopurinol is a structural analogue of the natural purine base, hypoxanthine. It is an inhibitor of xanthine oxidase, the enzyme responsible for the conversion of hypoxanthine to xanthine and xanthine to uric acid, the end product of purine metabolism. Allopurinol is approximately 90% absorbed from the GI tract. Peak plasma levels generally occur at 1.5 hours to 4.5 hours. It has a plasma half life of about 1 to 2 hours. Approximately 20% of the ingested Allopurinol is excreted in the faeces.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "When 6-mercaptopurine or azathioprine is given concurrently with Aluric, only one-quarter of the usual dose of 6- mercaptopurine or azathioprine should be given because inhibition of xanthine oxidase will prolong their activity. Evidence suggests that the plasma half-life of vidarabine is increased in the presence of Aluric. When the two products are used concomitantly extra vigilance is necessary, to recognise enhanced toxic effects. Theophylline levels should be monitored in patients starting or increasing Aluric therapy. An increase in frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with Aluric compared to patients who are not receiving both drugs. Reports suggest that the plasma concentration of ciclosporin may be increased during concomitant treatment with Aluric.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Allopurinol tablet is contra-indicated in patients with known hypersensitive to allopurinol.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rashes, gastro intestinal disorder’s, rearly malaise, headache, vertigo, drowsiness, visual and test disturbances, hypertension, alopecia, hepatotoxicity, neuropathy, gynaeconastia and blood disorders.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There is inadequate evidence of safety of Allopurinol in human pregnancy. Use in pregnancy only when there is no safer alternative and when the disease itself carries risk for the mother or unborn child. There are no data concerning the effects of allopurinol or its metabolites on the breast-feed baby.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Aluric should be withdrawn immediately when a skin rash or other evidence of sensitivity occurs. Reduced doses should be used in patients with hepatic or renal impairment. Patients under treatment for hypertension or cardiac insufficiency may have some concomitant impairment of renal function and Aluric should be used with care in this group.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Ingestion of up to 22.5 g Aluric without adverse effect has been reported. Symptoms and signs including nausea, vomiting, diarrhoea and dizziness have been reported in a patient who ingested 20 gm Aluric. Adequate hydration to maintain optimum diuresis facilitates excretion of Aluric and its metabolites. If considered necessary haemodialysis may be used.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs used in Gout",
    "dosage": [
      {
        "medication_type": "Adults",
        "information": ": Allopurinol should be introduced at low dosage e.g. 100 mg/day to reduce the risk of adverse reactions and increased only if the serum urate response is unsatisfactory. Extra caution should be exercised if renal function is poor. The following dosage schedules are suggested:",
        "instructions": [
          "100 to 200 mg daily in mild conditions,",
          "300 to 600 mg daily in moderately severe conditions,",
          "700 to 900 mg daily in severe conditions."
        ]
      },
      {
        "medication_type": "Children",
        "information": ": Children under 15 years: 10 to 20 mg/kg body weight/day up to a maximum of 400 mg daily. Use in children is rarely indicated, except in malignant conditions (especially leukaemia) and certain enzyme disorders such as Lesch-Nyhan syndrome.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": In the absence of specific data, the lowest dosage which produces satisfactory urate reduction should be used.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in renal impairment",
        "information": ": In severe renal insufficiency, it may be advisable to use less than 100 mg per day or to use single doses of 100mg at longer intervals than one day.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:24.593Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e8c",
    "original_record": {
      "input_index": 721,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e8c"
        },
        "name": "Aluric",
        "strength": "100 mg",
        "generic": "Allopurinol",
        "company": "Sonear Laboratories Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/182/aluric-100-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30124/alurol-100-mg-tablet",
    "name": "Alurol",
    "dosage_form": "Tablet",
    "generic": "Allopurinol",
    "strength": "100 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": "৳ 40.00",
      "pack_size_info": "(10 x 10: ৳ 400.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(10 x 10: ৳ 400.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/17/allopurinol/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alurol is indicated for reducing urate/uric acid formation in conditions where urate/uric acid deposition has already occurred (e.g. gouty arthritis, skin tophi, nephrolithiasis). Alurol is indicated for management of 2,8-dihydroxyadenine (2,8-DHA) renal stones related to deficient activity ... Read moreAlurol is indicated for reducing urate/uric acid formation in conditions where urate/uric acid deposition has already occurred (e.g. gouty arthritis, skin tophi, nephrolithiasis). Alurol is indicated for management of 2,8-dihydroxyadenine (2,8-DHA) renal stones related to deficient activity of adenine phospho ribosyltransferase. Alurol is indicated for the management of recurrent mixed calcium oxalate renal stones in the presence of hyperuricosuria, when fluid, dietary and similar measures have failed.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Allopurinol is a xanthine oxidase inhibitor which is administered orally. It acts on purine catabolism without disrupting the biosynthesis of purines. It reduces the production of uric acid by inhibiting the biochemical reactions immediately preceding its formation. Allopurinol is a structural analogue of the natural purine base, hypoxanthine. It is an inhibitor of xanthine oxidase, the enzyme responsible for the conversion of hypoxanthine to xanthine and xanthine to uric acid, the end product of purine metabolism. Allopurinol is approximately 90% absorbed from the GI tract. Peak plasma levels generally occur at 1.5 hours to 4.5 hours. It has a plasma half life of about 1 to 2 hours. Approximately 20% of the ingested Allopurinol is excreted in the faeces.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "When 6-mercaptopurine or azathioprine is given concurrently with Alurol, only one-quarter of the usual dose of 6- mercaptopurine or azathioprine should be given because inhibition of xanthine oxidase will prolong their activity. Evidence suggests that the plasma half-life of vidarabine is increased in the presence of Alurol. When the two products are used concomitantly extra vigilance is necessary, to recognise enhanced toxic effects. Theophylline levels should be monitored in patients starting or increasing Alurol therapy. An increase in frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with Alurol compared to patients who are not receiving both drugs. Reports suggest that the plasma concentration of ciclosporin may be increased during concomitant treatment with Alurol.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Allopurinol tablet is contra-indicated in patients with known hypersensitive to allopurinol.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rashes, gastro intestinal disorder’s, rearly malaise, headache, vertigo, drowsiness, visual and test disturbances, hypertension, alopecia, hepatotoxicity, neuropathy, gynaeconastia and blood disorders.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There is inadequate evidence of safety of Allopurinol in human pregnancy. Use in pregnancy only when there is no safer alternative and when the disease itself carries risk for the mother or unborn child. There are no data concerning the effects of allopurinol or its metabolites on the breast-feed baby.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Alurol should be withdrawn immediately when a skin rash or other evidence of sensitivity occurs. Reduced doses should be used in patients with hepatic or renal impairment. Patients under treatment for hypertension or cardiac insufficiency may have some concomitant impairment of renal function and Alurol should be used with care in this group.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Ingestion of up to 22.5 g Alurol without adverse effect has been reported. Symptoms and signs including nausea, vomiting, diarrhoea and dizziness have been reported in a patient who ingested 20 gm Alurol. Adequate hydration to maintain optimum diuresis facilitates excretion of Alurol and its metabolites. If considered necessary haemodialysis may be used.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs used in Gout",
    "dosage": [
      {
        "medication_type": "Adults",
        "information": ": Allopurinol should be introduced at low dosage e.g. 100 mg/day to reduce the risk of adverse reactions and increased only if the serum urate response is unsatisfactory. Extra caution should be exercised if renal function is poor. The following dosage schedules are suggested:",
        "instructions": [
          "100 to 200 mg daily in mild conditions,",
          "300 to 600 mg daily in moderately severe conditions,",
          "700 to 900 mg daily in severe conditions."
        ]
      },
      {
        "medication_type": "Children",
        "information": ": Children under 15 years: 10 to 20 mg/kg body weight/day up to a maximum of 400 mg daily. Use in children is rarely indicated, except in malignant conditions (especially leukaemia) and certain enzyme disorders such as Lesch-Nyhan syndrome.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": In the absence of specific data, the lowest dosage which produces satisfactory urate reduction should be used.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in renal impairment",
        "information": ": In severe renal insufficiency, it may be advisable to use less than 100 mg per day or to use single doses of 100mg at longer intervals than one day.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:25.635Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e8d",
    "original_record": {
      "input_index": 722,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e8d"
        },
        "name": "Alurol",
        "strength": "100 mg",
        "generic": "Allopurinol",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/30124/alurol-100-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/518/alverin-60-mg-tablet",
    "name": "Alverin",
    "dosage_form": "Tablet",
    "generic": "Alverine Citrate",
    "strength": "60 mg",
    "company": "Rangs Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 5.02",
      "strip_price": "৳ 50.20",
      "pack_size_info": "(3 x 10: ৳ 150.60)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.02",
          "pack_size_info": "(3 x 10: ৳ 150.60)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 50.20",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/49/alverine-citrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alverin is indicated in-",
        "items": [
          "Irritable Bowel Syndrome",
          "Bowel movement disturbances caused by small sacs or pouches in the wall of the gut (diverticular disease)",
          "Abdominal pain associated with menstrual periods (Primary dysmenorrhea)",
          "Relief of other conditions associated with spasm of involuntary muscle"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alverine Citrate is a smooth muscle relaxant. Smooth muscle is a type of muscle that is not under voluntary control; it is the muscle present in places such as the gut and uterus. Alverine Citrate acts directly on the muscle in the gut, causing it to relax. This prevents the muscle spasm which occur in the gut in conditions such as irritable bowel syndrome and diverticular disease. Alverine Citrate also relaxes the smooth muscle in the uterus. It is therefore also used to treat painful menstruation, which is caused by muscle spasm in the uterus (dysmenorrhea).",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "There are no drug interactions reported with this medicine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Paralytic ileus or known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Possible side effects may include nausea, headache, dizziness, itching, rash and allergic reactions.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although no teratogenic effects have been reported, use during pregnancy or lactation is not recommended as evidence of safety in preclinical studies are limited.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Avoid Alverin in patients with intestinal obstruction or paralytic ileus.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Children under 12 years: Not recommended",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Can produce hypotension and atropine like-toxic effects. Management for overdose is as like as atropine poisoning with continuation of supportive therapy for hypotension.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, away from light. Keep all medicines out of the reach of children. Store below 25°C temperature.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anticholinergics",
    "dosage": [
      {
        "medication_type": "Adult",
        "information": ": Orally: 60-120 mg 1-3 times daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:26.647Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e93",
    "original_record": {
      "input_index": 723,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e93"
        },
        "name": "Alverin",
        "strength": "60 mg",
        "generic": "Alverine Citrate",
        "company": "Rangs Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/518/alverin-60-mg-tablet",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33318/alvit-gold-syrup",
    "name": "Alvit Gold",
    "dosage_form": "Syrup",
    "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
    "strength": null,
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 85.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 85.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/781/multivitamin-multimineral-a-z-gold-preparation/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alvit Gold is indicated for the prevention and treatment of vitamins & minerals deficiencies. As a complete daily nutritional supplement, it is also indicated to meet the increased demand for vitamins and minerals in the conditions like physical and emotional stress, chronic diseases, infection illness, osteoporosis, injuries or wound, surgery, poor digestion, old age, pregnancy and lactation, poor appetite, excess dieting, exposure to environmental pollution, heavy exercise etc.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a film coated tablet, which combines 32 high potency vitamins and minerals. This preparation maintains a healthy body and active life-style.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No drug interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally, Alvit Gold is well tolerated. Diarrhoea may occasionally occur during treatment with beta carotene and the skin may assume a slightly yellow discoloration. Vitamin C and vitamin E may cause diarrhoea and other gastrointestinal disturbances.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Recommended by the consultation with physician.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Long term intake of high level of vitamin A (excluding that sourced from beta carotene) may increase the risk of osteoporosis in postmenopausal women.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Multi-vitamin & Multi-mineral combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "One tablet daily or as recommended by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:27.725Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e95",
    "original_record": {
      "input_index": 724,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e95"
        },
        "name": "Alvit Gold",
        "strength": null,
        "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/33318/alvit-gold-syrup",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33319/alvit-gold-tablet",
    "name": "Alvit Gold",
    "dosage_form": "Tablet",
    "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
    "strength": null,
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 9.60",
      "strip_price": null,
      "pack_size_info": "(5 x 6: ৳ 288.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 9.60",
          "pack_size_info": "(5 x 6: ৳ 288.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/781/multivitamin-multimineral-a-z-gold-preparation/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alvit Gold is indicated for the prevention and treatment of vitamins & minerals deficiencies. As a complete daily nutritional supplement, it is also indicated to meet the increased demand for vitamins and minerals in the conditions like physical and emotional stress, chronic diseases, infection illness, osteoporosis, injuries or wound, surgery, poor digestion, old age, pregnancy and lactation, poor appetite, excess dieting, exposure to environmental pollution, heavy exercise etc.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a film coated tablet, which combines 32 high potency vitamins and minerals. This preparation maintains a healthy body and active life-style.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No drug interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally, Alvit Gold is well tolerated. Diarrhoea may occasionally occur during treatment with beta carotene and the skin may assume a slightly yellow discoloration. Vitamin C and vitamin E may cause diarrhoea and other gastrointestinal disturbances.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Recommended by the consultation with physician.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Long term intake of high level of vitamin A (excluding that sourced from beta carotene) may increase the risk of osteoporosis in postmenopausal women.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Multi-vitamin & Multi-mineral combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "One tablet daily or as recommended by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:29.063Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e96",
    "original_record": {
      "input_index": 725,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e96"
        },
        "name": "Alvit Gold",
        "strength": null,
        "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/33319/alvit-gold-tablet",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33320/alvita-100-mg-tablet",
    "name": "Alvita",
    "dosage_form": "Tablet",
    "generic": "Vitamin B1, B6 & B12",
    "strength": "100 mg+200 mg+200 mcg",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 7.00",
      "strip_price": "৳ 70.00",
      "pack_size_info": "(3 x 10: ৳ 210.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 7.00",
          "pack_size_info": "(3 x 10: ৳ 210.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 70.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1135/vitamin-b1-b6-b12/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alvita is indicated where a deficiency of the relevant vitamins exists. It is indicated for the treatment of following diseases: Polyneuropathy of any origin such alcoholic or toxiconeuropathies as-diabetic, Neuritis, Neuralgia, Cervical Syndrome, Shoulder-arm syndrome, Lumbago, Sciatica, Myalgia, Intercostal neuralgia, Herpes Zoster, Trigeminal Neuralgia, Supportive treatment in facial paresis.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Vitamin B1 converts carbohydrates, fatty acids and amino acids into energy, promotes healthy nerves, improves mood, strengthens the heart. Vitamin B6 forms RBCs, helps cells to make proteins, manufactures neurotransmitters e.g. serotonin and releases stored forms of energy, helps to prevent CVS diseases and stroke, helps to lift depression and eases insomnia. Vitamin B12 is essential for cell replication and important for RBC production, prevents anemia, helps to prevent depression, reduces nerve pain, numbness, tingling and lowers the risk of heart diseases. The vitamin ingredients are absorbed well in per oral reception. It is widely distributed to most tissues and appears in breast milk. Within the cell, thiamine is mostly present as diphosphate. Thiamine is not stored to any appreciable extent in the body and amounts in excess of the body’s requirements are excreted in the urine as unchanged thiamine or as metabolites. Pyridoxine, pyridoxal and pyridoxamine are readily absorbed from the GIT following oral administration and are converted to the active forms of pyridoxal phosphate an pyridoxamine phosphate. They are stored mainly in liver where there is oxidation to 4-pyridoxic acid and other inactive metabolites, which are excreted in urine. As the dose increases, proportionally greater amounts are excreted unchanged in the urine.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No drug interaction has been reported yet.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Vitamin B1, Vitamin B6 and Vitamin B12 is contraindicated in patients on levodopa therapy, and in patients with hypersensitivity to any of the ingredients of the preparation.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally well tolerated but allergic reactions may be observed in few cases.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Oral tablet form is recommended but due to the presence of benzyl alcohol, injection is not recommended during pregnancy & lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Cyanocobalamin should not be given in patients with subacute degeneration of the spinal cord. Cyanocobalamin is not suitable form of vitamin B12 for the treatment of optic neuropathies associated with raised plasma concentrations of cyanocobalamin.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "No overdosage symptoms are to be expected in the recommended dosage. If there is known overdose then treatment is symptomatic & supportive.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep out of reach of children. Store in a cool (below 25°C temperature) and dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Specific combined vitamin preparations, Vaccines, Anti-sera & Immunoglobulin",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet: 1-3 Tablets per day or as advised by the physician. Injection:",
        "instructions": []
      },
      {
        "medication_type": "In severe (acute) cases",
        "information": ": 1 injection daily until the acute symptoms subside or taken as advised by the physician.",
        "instructions": []
      },
      {
        "medication_type": "In mild cases",
        "information": ": 1 injection 2-3 times per week. Ampoules are preferably injected intramuscularly.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Use in children: There is no information on the use of this drug in children.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Alvita 100 mg+200 mg+200 mcg Tablet?",
        "answer": [
          "Vitamin B1 converts carbohydrates, fatty acids and amino acids into energy,",
          "Vitamin B6 forms RBCs,",
          "Vitamin B12 is essential for cell replication."
        ]
      },
      {
        "question": "What is Alvita 100 mg+200 mg+200 mcg Tablet used for?",
        "answer": [
          "Alvita 100 mg+200 mg+200 mcg Tablet is indicated where a deficiency of the relevant vitamins exists."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:24:30.210Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e99",
    "original_record": {
      "input_index": 726,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e99"
        },
        "name": "Alvita",
        "strength": "100 mg+200 mg+200 mcg",
        "generic": "Vitamin B1, B6 & B12",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/33320/alvita-100-mg-tablet",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/38710/alvonib-80-mg-tablet",
    "name": "Alvonib",
    "dosage_form": "Tablet",
    "generic": "Osimertinib",
    "strength": "80 mg",
    "company": "Pharmasia Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 500.00",
      "strip_price": "৳ 5,000.00",
      "pack_size_info": "(1 x 10: ৳ 5,000.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 500.00",
          "pack_size_info": "(1 x 10: ৳ 5,000.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 5,000.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1296/osimertinib/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alvonib is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test. Alvonib is indicated for the treatment ... Read moreAlvonib is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations, as detected by an FDA-approved test. Alvonib is indicated for the treatment of patients with metastatic EGFR T790M mutation-positive NSCLC, as detected by an FDA-approved test, whose disease has progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Osimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR), which binds irreversibly to certain mutant forms of EGFR (T790M, L858R, and exon 19 deletion) at approximately 9-fold lower concentrations than wild-type. In cultured cells and animal tumor implantation models, Osimertinib exhibited anti-tumor activity against NSCLC lines harboring EGFR-mutations (T790M/L858R, L858R, T790M/exon 19 deletion, and exon 19 deletion) and, to a lesser extent, wild-type EGFR amplifications. Two pharmacologically-active metabolites (AZ7550 and AZ5104 circulating at approximately 10% of the parent) with similar inhibitory profiles to Osimertinib have been identified in the plasma after oral administration of Osimertinib. AZ7550 showed a similar potency to Osimertinib, while AZ5104 showed greater potency against exon 19 deletion and T790M mutants (approximately 8-fold) and wild- type (approximately 15-fold) EGFR. In vitro, Osimertinib also inhibited the activity of HER2, HER3, HER4, ACK1, and BLK at clinically relevant concentrations. The area under the plasma concentration-time curve (AUC) and maximal plasma concentration (C max ) of Osimertinib increased dose proportionally over 20 to 240 mg dose range (i.e., 0.25 to 3 times the recommended dosage) after oral administration and exhibited linear pharmacokinetics (PK). Administration of Osimertinib orally once daily resulted in approximately 3-fold accumulation withsteady state exposures achieved after 15 days of dosing. At steady state, the C max to C min (minimal concentration) ratio was 1.6-fold.",
        "items": []
      },
      {
        "title": "Absorption",
        "information": ": The median time to C max of Osimertinib was 6 hours (range 3-24 hours). Following administration of a 20 mg Osimertinib tablets with a high-fat, high-calorie meal (containing approximately 58 grams of fat and 1000 calories), the C max and AUC of Osimertinib were compared to that under fasting conditions.",
        "items": []
      },
      {
        "title": "Distribution",
        "information": ": The mean volume of distribution at steady-state (Vss/F) of Osimertinib was 986 L. Plasma protein binding of Osimertinib was 95%.",
        "items": []
      },
      {
        "title": "Elimination",
        "information": ": Osimertinib plasma concentrations decreased with time and a population estimated mean half-life of Osimertinib was 48 hours, and oral clearance (CL/F) was 14.2 (L/h).",
        "items": []
      },
      {
        "title": "Metabolism",
        "information": ": The main metabolic pathways of Osimertinib were oxidation (predominantly CYP3A) and dealkylation in vitro. Two pharmacologically active metabolites (AZ7550 and AZ5104) have been identified in the plasma after Osimertinib oral administration. The geometric mean exposure (AUC) of each metabolite (AZ5104 and AZ7550) was approximately 10% of the exposure of Osimertinib at steady-state.",
        "items": []
      },
      {
        "title": "Excretion",
        "information": ": Osimertinib is primarily eliminated in the feces (68%) and to a lesser extent in the urine (14%). Unchanged Osimertinib accounted for approximately 2% of the elimination.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Strong CYP3A Inhibitors",
        "information": ": Avoid concomitant administration of Alvonib with strong CYP3A inhibitors, including macrolide antibiotics (e.g., Telithromycin), antifungals (e.g., Itraconazole), antivirals (e.g., Ritonavir), Nefazodone, as concomitant use of strong CYP3A inhibitors may increase Alvonib plasma concentrations. If no other alternative exists, monitor patients more closely for adverse reactions of Alvonib.",
        "items": []
      },
      {
        "title": "Strong CYP3A Inducers",
        "information": ": Avoid concomitant administration of Alvonib with strong CYP3A inducers (e.g., Phenytoin, Rifampicin, Carbamazepine, St. John's Wort) as strong CYP3A inducers may decrease Alvonib plasma concentrations.",
        "items": []
      },
      {
        "title": "Effect on other drugs",
        "information": ": Avoid concomitant administration of Alvonib with drugs that are sensitive substrates of CYP3A, breast cancer resistance protein (BCRP), or CYP1A2 with narrow therapeutic indices, including but not limited to Fentanyl, Cyclosporine, Quinidine, Ergot Alkaloids, Phenytoin, Carbamazepine, as Alvonib may increase or decrease plasma concentrations of these drugs.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Most common adverse reactions (≥20%) were diarrhea, rash, dry skin, nail toxicity, stomatitis, fatigue and decreased appetite.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Osimertinib can cause fetal harm when administered to a pregnant woman. There are no available data on Osimertinib use in pregnant women. There are no data on the presence of Osimertinib in human milk, the effects of Osimertinib on the breastfed infant or on milk production.",
        "items": []
      },
      {
        "title": "Contraception",
        "information": ": Females: Advise females of reproductive potential to use effective contraception during treatment with Osimertinib and for 6 weeks after the final dose. Males: Advise male patients with female partners of reproductive potential to use effective contraception during and for 4 months following the final dose of Osimertinib.",
        "items": []
      },
      {
        "title": "Infertility",
        "information": ": Based on animal studies, Osimertinib may impair fertility in females and males of reproductive potential. The effects on female fertility showed a trend toward reversibility. It is not known whether the effects on male fertility are reversible.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Interstitial Lung Disease (ILD)/Pneumonitis",
        "information": ": Interstitial lung disease (ILD)/pneumonitis occurred in 3.9% of the 1142 Alvonib-treated patients; 0.4% of cases were fatal.",
        "items": []
      },
      {
        "title": "QTc Interval Prolongation",
        "information": ": Monitor electrocardiograms and electrolytes in patients who have a history or predisposition for QTc prolongation, or those who are taking medications that are known to prolong the QTc interval. Withhold then restart at a reduced dose or permanently discontinue Alvonib.",
        "items": []
      },
      {
        "title": "Cardiomyopathy",
        "information": ": Occurred in 1.4% of patients. Assess left ventricular ejection fraction (LVEF) before treatment and then every 3 months thereafter.",
        "items": []
      },
      {
        "title": "Embryo-Fetal Toxicity",
        "information": ": Alvonib can cause fetal harm. Advise females of potential risk to the fetus and to use effective contraception during treatment with Alvonib and for 6 weeks after final dose. Advise males to use effective contraception for 4 months, after the last dose of Alvonib.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "No clinically significant differences in the pharmacokinetics of Alvonib were observed based on age, sex, ethnicity, body weight, baseline albumin, line of therapy, smoking status, mild (ClCr 60-89 ml/min), moderate (ClCr 30-59 ml/min, as estimated by C-G), or severe (ClCr 15-29 ml/min) renal impairment, or mild (total bilirubin ≤ ULN and AST > ULN or total bilirubin between 1 to 1.5 times ULN and any AST) or moderate (total bilirubin between 1.5 to 3 times ULN and any AST) hepatic impairment. The pharmacokinetics of Alvonib in patients with end-stage renal disease (ClCr <15 ml/min) or with severe hepatic impairment (total bilirubin between 3 to 10 times ULN and any AST) are unknown.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety and effectiveness of Alvonib in pediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in effectiveness were observed based on age. Exploratory analysis suggest a higher incidence of Grade 3 and 4 adverse reactions (32% versus 25%) and more frequent dose modifications for adverse reactions (13.4% versus 9.3%) and more frequent dose modifications for adverse reactions (13.4% versus 7.6%) in patients 65 years or older as compared to those younger than 65 years.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": No dose adjustment is recommended in patients with mild, moderate or severe renal impairment. There is no recommended dose of Alvonib for patients with end-stage renal disease.",
        "items": []
      },
      {
        "title": "Hepatic Impairment",
        "information": ": There is no recommended dose for Alvonib for patients with severe hepatic impairment.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C. Protect from moisture & light. Safely throw away medicine that is out of date or that you no longer need. Keep Alvonib and all medicines out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cytotoxic Chemotherapy",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended dose of Osimertinib is 80 mg tablet once a day until disease progression or unacceptable toxicity. Osimertinib can be taken with or without food. If a dose of Osimertinib is missed, do not make up the missed dose and take the next dose as scheduled. Disperse tablet in 60 ml (2 ounces) of non-carbonated water only. Stir until tablet is dispersed into small pieces (the tablet will not completely dissolve) and swallow immediately. Do not crush, heat, or ultrasonicate during preparation. Rinse the container with 120 ml to 240 ml (4 to 8 ounces) of water and immediately drink. If administration via nasogastric tube is required, disperse the tablet as above in 15 ml of non-carbonated water, and then use an additional 15 ml of water to transfer any residues to the syringe. The resulting 30 ml liquid should be administered as per the nasogastric tube instructions with appropriate water flushes (approximately 30 ml).",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:31.359Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e9c",
    "original_record": {
      "input_index": 727,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e9c"
        },
        "name": "Alvonib",
        "strength": "80 mg",
        "generic": "Osimertinib",
        "company": "Pharmasia Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/38710/alvonib-80-mg-tablet",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33321/alzema-01-1-ointment",
    "name": "Alzema",
    "dosage_form": "Ointment",
    "generic": "Dithranol + Boric Acid + Salicylic Acid",
    "strength": "0.1%+1%+2%",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 35.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "10 gm tube",
          "price": "৳ 35.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/147/dithranol-boric-acid-salicylic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "এই অয়েন্টমেন্ট নিন্মোক্ত উপসর্গে নির্দেশিত-",
        "items": [
          "দাদ",
          "কাউর",
          "সোরাইসিস"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": "ডাইথ্রানল",
        "information": ": ডাইথ্রানল চর্মের এপিডার্মাল কোষে ATP সরবরাহ বন্ধ করে দিতে পারে, ফলে Keratinocytes এ শক্তি সরবরাহ বন্ধ হয়ে যায়। এই প্রক্রিয়া অন্ততঃ পক্ষে আংশিক ভাবে সোরাইসিসের উপর ডাইথ্রানলের আরোগ্যকর কার্যকারিতা ব্যাখ্যা করা যেতে পারে। ইহার ছত্রাক ধ্বংসের ক্ষমতা রয়েছে।",
        "items": []
      },
      {
        "title": "স্যালিসাইলিক এসিড",
        "information": ": ইহা একটি Keratolytic agent. স্যালিসাইলিক এসিড desquamation এর গতি বাড়িয়ে দেয়, ফলে এই প্রক্রিয়ার মাধ্যমে আক্রমণকারী ছত্রাক দূরীভূত করে এবং ঔষধ চর্মের ভিতরে প্রবেশে সহায়তা করে। Keratolysis প্রক্রিয়ায় চর্মের এপিডার্মিসের শক্ত অংশ (horny layer) খসে যায়। স্যালিসাইলিক এসিড আন্তঃকোষীয় সংযোজক পদার্থকে (Intercellular cement) দ্রবীভূত করে desquamation প্রক্রিয়া সম্পন্ন করে। উক্ত সংযোজক পদার্থ চর্মের Stratum Corneum এর আঁইশকে Scales সংযুক্ত করে রাখে। স্যালিসাইলিক এসিড প্রধানতঃ খোলস বা আঁইশ খসানো বর্ধিত করে এর কার্যকারিতা প্রদর্শন করে।",
        "items": []
      },
      {
        "title": "বোরিক এসিড",
        "information": ": এর ব্যাক্টেরিয়া এবং ছত্রাকের উৎপাদন দমনের (bacteriostatic and fungistatic properties) ক্ষমতা রয়েছে।",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "If you use other drugs or over the counter products at the same time, the effects of this ointment may change. This may increase your risk for side-effects or cause your drug not to work properly. Tell your doctor about all the drugs, vitamins, and herbal supplements you are using, so that you doctor can help you prevent or manage drug interactions. this ointment may interact with the following drugs and products:",
        "items": [
          "Fluocinolone",
          "Hydroquinone",
          "Isotretinoin",
          "None reported",
          "Riboflavin",
          "Tretinoin"
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to this ointment is a contraindication. In addition, this ointment should not be used if you have the following conditions:",
        "items": [
          "Acute or actively inflamed psoriatic eruptions",
          "After shaving or bathing",
          "Avoid use on dentures",
          "Breastfeeding",
          "Children",
          "Do not apply bandage or heating pad",
          "Facial psoriasis",
          "Genital warts",
          "Hypersensitivity",
          "Hypersensitivity to this drug"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following is a list of possible side-effects that may occur from all constituting ingredients of this ointment. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.",
        "items": [
          "Contact allergic reactions",
          "Irritation in skin areas surrounding treated lesions",
          "Soreness",
          "Temporary discoloration of hair and fingernails",
          "Mild cold or burning sensation at the site of application",
          "Severe allergic reaction",
          "Cardiovascular defects",
          "Skeletal variations",
          "Mild kidney lesions",
          "Infertility"
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Not recommended during pregnancy. FDA has not yet classified the drug into a specified pregnancy category.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "ক্ষতস্থানের বাইরে স্বাভাবিক চর্মে এবং চোখ বা চোখের নিকটবর্তী স্থানে এই টপিক্যাল অয়েন্টমেন্ট ব্যবহার নিষেধ। এই মলমের কোন উপাদানের প্রতি সংবেদনশীলতা থাকলে এর ব্যবহার করা যাবে না। মলম ব্যবহারের পর ভাল করে হাত ধুয়ে ফেলতে হবে।",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store medicines at room temperature, away from heat and direct light. Do not freeze medicines unless required by package insert. Keep medicines away from children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Dithranol & combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": null,
        "instructions": [
          "ক্ষতস্থান গরম পানিতে খুব ভাল করে ধুয়ে ফেলুন।",
          "তারপর শুকনো ক্ষতস্থানে অল্প পরিমাণে মলম লাগিয়ে দিন (ক্ষতের বাইরে লাগাবেন না)।",
          "মলম দিনে একবার, প্রয়োজনবোধে বা চিকিৎসকের পরামর্শ অনুসারে দুইবার ক্ষত না সারা পর্যন্ত নিয়মিতভাবে ব্যবহার করুন।",
          "ক্ষত সেরে যাবার পর সম্পূর্ণভাবে আরোগ্য হওয়ার জন্য ৩-৪ দিন পর্যন্ত সামান্য পরিমাণ ব্যবহার করুন।"
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:32.588Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ea3",
    "original_record": {
      "input_index": 728,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ea3"
        },
        "name": "Alzema",
        "strength": "0.1%+1%+2%",
        "generic": "Dithranol + Boric Acid + Salicylic Acid",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Ointment",
        "source_url": "https://medex.com.bd/brands/33321/alzema-01-1-ointment",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/205/alzolam-05-mg-tablet",
    "name": "Alzolam",
    "dosage_form": "Tablet",
    "generic": "Alprazolam",
    "strength": "0.5 mg",
    "company": "Sun Pharmaceutical (Bangladesh) Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 3.00",
      "strip_price": "৳ 30.00",
      "pack_size_info": "(10 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.00",
          "pack_size_info": "(10 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/204/alzolam-025-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/18/alprazolam/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alzolam is indicated in-",
        "items": [
          "Anxiety disorder",
          "Short term relief of anxiety",
          "Anxiety associated with depression",
          "Panic disorder, with or without agoraphobia."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alprazolam is a triazole analog of the 1,4-benzodiazepine class of drugs. It is an anxiolytic with hypnotic and anticonvulsive properties. Alprazolam is presumed to produce its effects via interacting with the Gamma Aminobutyric Acid (GABA)- benzodiazepine receptor complex. Like all benzodiazepines, it causes a dose-related CNS depressant activity varying from mild impairment of task performance to hypnosis.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The CNS-depressant action of Alzolam may be aggravated by concomitant use of other psychotropic drugs, anticonvulsants, antihistaminics, alcohol and oral ontraceptives.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects, if occur, are generally observed at the beginning of therapy and usually disappear upon continued medication. The most frequent side effects are drowsiness and light-headedness. The other side effects, that may occur include depression, headache, confusion, dry mouth, constipation, etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Alprazolam has been categorized in pregnancy category D; that means, it should be avoided in pregnancy. Like other benzodiazepines, Alprazolam is assumed to be excreted in breast milk. Therefore, nursing should not be undertaken by mothers who must use Alprazolam.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Because Alzolam may produce psychological and physical dependence, the increment of dose or abrupt discontinuation of Alzolam therapy should not be done without the physician's advice. The duration of therapy must be determined by the physicians. Alzolam should be administered with caution to patients with hepatic or renal disease, chronic pulmonary insufficiency, or sleep apnea.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "The safety and effectiveness of Alzolam in individuals below 18 years of age have not been established.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Manifestations of Alzolam overdosage include somnolence, confusion, impaired coordination, diminished reflexes, and coma. In such cases of overdosage general supportive measures should be employed along with immediate gastric lavage.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Benzodiazepine sedatives",
    "dosage": [
      {
        "medication_type": null,
        "information": "Treatment should be initiated with a dose of 0.25 to 0.5 mg three times daily. Depending on the response, dose may be increased at intervals of 3 to 4 days in increments of no more than 1 mg/day. The maximum dose should not exceed 4 mg/day. Occasional patients with panic disorder may need as much as 10 mg a day to achieve a successful response and in these cases periodic reassessment and consideration of dosage adjustment is required. Dosage should be individualized for maximum beneficial effect with the lowest possible dose. If side-effects occur at starting dose, dose may be lowered. When discontinuing therapy, dosage should be reduced gradually by no more than 0.5 mg every three days. In elderly patients or in patients with advanced liver disease, the usual starting dose is 0.25 mg, two or three times daily and may be gradually increased if needed and tolerated. Alprazolam 1 mg should be administered once daily, preferably in the morning by patients who are on multiple dosage regimens of Alprazolam 0.25/0.5 mg. The tablets should be taken intact, they should not be chewed, crushed, or broken.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:33.704Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ea4",
    "original_record": {
      "input_index": 729,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ea4"
        },
        "name": "Alzolam",
        "strength": "0.5 mg",
        "generic": "Alprazolam",
        "company": "Sun Pharmaceutical (Bangladesh) Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/205/alzolam-05-mg-tablet",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/8545/am-200-mg-suspension",
    "name": "AM",
    "dosage_form": "Powder for Suspension",
    "generic": "Azithromycin Dihydrate",
    "strength": "200 mg/5 ml",
    "company": "Reliance Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 130.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "30 ml bottle",
          "price": "৳ 130.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "500 mg (Tablet)",
        "href": "https://medex.com.bd/brands/8544/am-500-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/100/azithromycin-dihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "AM is indicated for infections (caused by susceptible organisms) in lower respiratory tract infections including bronchitis and pneumonia, in upper respiratory tract infections including sinusitis and pharyngitis/tonsillitis, in otitis media, and in skin and soft tissue infections. In sexually transmitted diseases in men and women, AM is indicated in the treatment of non-gonococcal urethritis and cervicitis due to Chlamydia trachomatis.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Azithromycin is acid-stable and can therefore be taken orally with no need of protection from gastric acids. It is readily absorbed; its absorption is greater on an empty stomach. Time to peak concentration in adults is 2.1 to 3.2 hours for oral dosage forms. Due to the high concentration in phagocytes, azithromycin is actively transported to the site of infection. During active phagocytosis, large concentrations of azithromycin are released. The concentration of azithromycin in the tissues can be over 50 times higher than in plasma. This is due to ion trapping and the high lipid solubility. Azithromycin's half-life allows a large single dose to be administered and yet maintain bacteriostatic levels in the infected tissue for several days. Following a single 500 mg dose, plasma concentrations of azithromycin declined in a polyphasic pattern with a mean apparent plasma clearance of 630 mL/min and a terminal elimination half life of 68 hours. The prolonged terminal half-life is thought to be due to extensive uptake and subsequent release of drug from tissues. Biliary excretion of azithromycin, predominantly unchanged, is a major route of elimination. Over the course of a week, approximately 6% of the administered dose appears as unchanged drug in urine. Microbiology: Azithromycin acts by binding to the 50S ribosomal subunit of susceptible microorganisms and, thus, interfering with microbial protein synthesis. Nucleic acid synthesis is not affected. Azithromycin has been shown to be active against most isolates of the following microorganisms, both in vitro and in clinical infections:",
        "items": [
          "Aerobic and facultative gram-positive microorganisms: Staphylococcus aureus, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes",
          "Aerobic and facultative gram-negative microorganisms: Haemophilus ducreyi, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae",
          "Other microorganisms: Chlamydia pneumoniae, Chlamydia trachomatis , Mycoplasma pneumoniae , Betalactamase production should have no effect on azithromycin activity.",
          "Aerobic and facultative gram-positive microorganisms: Streptococci (Groups C,F,G), Viridans group streptococci",
          "Aerobic and facultative gram-negative microorganisms: Bordetella pertussis, Legionella pneumophila",
          "Anaerobic microorganisms: Peptostreptococcus species, Prevotella bivia"
        ]
      }
    ],
    "interaction": [
      {
        "title": "Antacid",
        "information": ": In patients receiving azithromycin and antacids, azithromycin should be taken at least 1 hour before or 2 hours after the antacid. Carbamazepine: In a pharmacokinetic interaction study in healthy volunteers, no significant effect was observed on the plasma levels of carbamazepine or its active metabolite.",
        "items": []
      },
      {
        "title": "Cyclosporin",
        "information": ": Some of the related macrolide antibiotics interfere with the metabolism of cyclosporin. In the absence of conclusive data from pharmacokinetic studies or clinical data investigating potential interactions between azithromycin and cyclosporine, caution should be exercised before co-administration of these two drugs. If coadministrations is necessary, cyclosporin levels should be monitored and the dose adjusted accordingly.",
        "items": []
      },
      {
        "title": "Digoxin",
        "information": ": Some of the macrolide antibiotics have been reported to impair the metabolism of digoxin (in the gut) in some patients. Therefore, in patients receiving concomitant azithromycin and digoxin the possibility of raised digoxin levels should be borne in mind and digoxin levels monitored.",
        "items": []
      },
      {
        "title": "Ergot derivatives",
        "information": ": Because of the theoretical possibility of ergotism, azithromycin and ergot derivatives should not be co-administered.",
        "items": []
      },
      {
        "title": "Methylprednisolone",
        "information": ": In a pharmacokinetic interaction study in healthy volunteers, azithromycin had no significant effect on the pharmacokinetics of methylprednisolone.",
        "items": []
      },
      {
        "title": "Theophylline",
        "information": ": There is no evidence of any pharmacokinetic interaction when azithromycin and theophylline are co-administered to healthy volunteers. In general, however, theophylline levels should be monitored.",
        "items": []
      },
      {
        "title": "Warfarin",
        "information": ": In a pharmacodynamic interaction study, azithromycin did not alter the anticoagulant effect of a single 15 mg dose of warfarin administered to healthy volunteers. AM and warfarin may be co-administered, but monitoring of the prothrombin time should be continued as routinely performed.",
        "items": []
      },
      {
        "title": "Terfenadine",
        "information": ": AM did not affect the pharmacokinetics of terfenadine administered at the recommended dose of 60 mg every 12 hours. Addition of azithromycin did not result in any significant changes in cardiac repolarisation (QTc interval) measured during the steady state dosing of terfenadine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Azithromycin Dihydrate is contraindicated in patients hypersensitive to Azithromycin or any other macrolide antibiotic. Co-administration of ergot derivatives and Azithromycin is contraindicated. Azithromycin is contraindicated in patients with hepatic diseases.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "AM is well tolerated with a low incidence of side-effects. Most side-effects observed were mild to moderate in severity. The majority of side-effects were gastrointestinal in origin with nauseas, abdominal discomfort (pain/cramps), vomiting, flatulence, diarrhoea and loose stools being occasionally observed. Allergic reactions such as rash or photosensitivity have occurred and there have also been rare reports of serious hypersensitivity reactions. Reversible elevations in liver transaminases have been seen with a frequency similar to the comparative macrolides and penicillins used in clinical trials. Rarely, cases of cholestatic jaundice have been observed. Transient mild reductions in neutrofil counts have occasionally been observed in clinical trials, although a causal relationship to azithromycin has not been established. Hearing impairment: In investigational studies where higher doses were used for prolonged periods of time, reversible hearing impairment was seen in some patients.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category of Azithromycin Dihydrate is B. Animal reproduction studies have demonstrated that Azithromycin has no evidence of harm to the fetus. There are no adequate and well controlled studies in pregnant women. Since animal reproduction studies are not always predictive of human response, Azithromycin should be used during pregnancy only if adequate alternatives are not available. It is not known whether Azithromycin is secreted in breast milk. So, caution should be exercised when Azithromycin is administered to nursing women.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with erythromycin and other macrolides, rare serious allergic reactions, including angioneurotic oedema and anaphylaxis, has been reported. Some of these reactions with azithromycin have resulted in recurrent symptoms and required a long period of observation and treatment.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Use in renal impairment",
        "information": ": No dose adjustment is needed in patients with mild renal impairment (creatinine clearance >40 ml/min), but there are no data regarding azithromycin in patients with more severe renal impairment, thus caution should be exercised in using azithromycin in these patients.",
        "items": []
      },
      {
        "title": "Use in hepatic impairment",
        "information": ": As the liver is the principal route of excretion of azithromycin, it should not be used in patients with hepatic disease.",
        "items": []
      },
      {
        "title": "Effects on ability to drive and use machines",
        "information": ": There is no evidence to suggest that azithromycin may have an effect on a patient’s ability to drive or operate machinery.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no data on overdosage with AM. Typical symptoms of overdosage with macrolide antibiotics include hearing loss, severe nausea, vomiting and diarrhoea. Gastric lavage and general supportive measures are indicated.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Reconstitution procedure of suspension-",
        "items": []
      },
      {
        "title": null,
        "information": "Azithromycin should be taken at least 1 hour before or 2 hours after meal.",
        "items": [
          "Step 01: Shake the bottle well to loosen the powder.",
          "Step 02: Add boiled and cooled water up to the water mark of the bottle label.",
          "Step 03: Shake until powder is completely mixed with water."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": "C38H72N2O12",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-100-azithromycin-dihydrate-chemical-structure-tFo4BQqfsRzQwcODCGo2.svg"
    },
    "therapeutic_class": "Macrolides",
    "dosage": [
      {
        "medication_type": "Oral",
        "information": "-",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 500 mg once daily orally for 3 days or 500 mg once on day 1, then 250 mg once on days 2-5 for 4 days. For sexually transmitted diseases caused by Chlamydia trachomatis in adults, the dose is 1 gm given as a single dose or 500 mg once on day 1, followed by 250 mg once daily for next 2 days may also be given.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ":",
        "instructions": [
          "10 mg/kg body weight once daily for 3 days for child over 6 months",
          "200 mg (1 teaspoonful) for 3 days if body weight is 15-25 kg",
          "300 mg (1½ teaspoonfuls) for 3 days if body weight is 26-35 kg; 400 mg (2 teaspoonfuls) for 3 days if body weight is 36-45 kg.",
          "In typhoid fever, 500 mg (2½ teaspoonfuls) once daily for 7-10 days is given."
        ]
      },
      {
        "medication_type": "Azithromycin Injection (For IV Infusion only)",
        "information": ": The recommended dose of Azithromycin for injection for the treatment of adult patients with community-acquired pneumonia due to the indicated organisms is:",
        "instructions": [
          "500 mg as a single daily dose by the intravenous route for at least two days. Intravenous therapy should be followed by Azithromycin by the oral route at a single, daily dose of 500 mg, administered as two 250-mg tablets to complete a 7 to 10-day course of therapy. The timing of the switch to oral therapy should be done at the discretion of the physician and in accordance with clinical response.",
          "The recommended dose of Azithromycin for the treatment of adult patients with pelvic inflammatory disease due to the indicated organisms is: 500 mg as a single daily dose by the intravenous route for one or two days. Intravenous therapy should be followed by Azithromycin by the oral route at a single, daily dose of 250 mg to complete a 7-day course of therapy. The timing of the switch to oral therapy should be done at the discretion of the physician and in accordance with clinical response. If anaerobic microorganisms are suspected of contributing to the infection, an antimicrobial agent with anaerobic activity should be administered in combination with Azithromycin.",
          "Safety and effectiveness of azithromycin for injection in children or adolescents under 16 years have not been established."
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is AM 200 mg/5 ml Syrup?",
        "answer": [
          "AM 200 mg/5 ml Syrup performs its action by preventing the synthesis of essential proteins required by bacteria to carry out vital functions."
        ]
      },
      {
        "question": "What are the uses of AM 200 mg/5 ml Syrup?",
        "answer": [
          "AM 200 mg/5 ml Syrup is used for the treatment and prevention of community-acquired pneumonia, pharyngitis/tonsillitis, and skin and soft tissue infections."
        ]
      },
      {
        "question": "What are the Side Effects of AM 200 mg/5 ml Syrup?",
        "answer": [
          "Side effects include diarrhea, dry or scaly skin, abdominal pain, difficult or painful urination, vomiting, fever, acid or sour stomach, aggression or anger, excessive air or gas in the stomach, and heartburn."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal AM 200 mg/5 ml Syrup?",
        "answer": [
          "AM 200 mg/5 ml Syrup should be kept in a cool dry place and its original packaging. Make sure this medication remains unreachable to children and pets. The patient should consult a doctor for its further uses."
        ]
      },
      {
        "question": "Can the use of AM 200 mg/5 ml Syrup cause diarrhea?",
        "answer": [
          "Yes, the use of AM 200 mg/5 ml Syrup can cause diarrhea. It is an antibiotic that kills harmful bacteria. However, it also affects the helpful bacteria in your stomach or intestine and causes diarrhea. If you are experiencing severe diarrhea, consult your doctor immediately."
        ]
      },
      {
        "question": "Is AM 200 mg/5 ml Syrup safe?",
        "answer": [
          "AM 200 mg/5 ml Syrup is safe if used at prescribed doses as advised by your doctor."
        ]
      },
      {
        "question": "Is AM 200 mg/5 ml Syrup an antibiotic?",
        "answer": [
          "Yes, AM 200 mg/5 ml Syrup is an antibiotic that belongs to a class of antibiotics known as macrolides."
        ]
      },
      {
        "question": "What if I don't get better even after taking AM 200 mg/5 ml Syrup?",
        "answer": [
          "You should inform your doctor if you do not notice any improvement in your symptoms after 3 days of taking AM 200 mg/5 ml Syrup and if your symptoms get worse."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Do not skip any doses of AM 200 mg/5 ml Syrup and finish the full course of treatment even if you feel better. Stopping it early may make the infection to come back and harder to treat.",
          "Take AM 200 mg/5 ml Syrup 1 hour before or two hours after food.",
          "Do not take antacids 2 hours before or after taking AM 200 mg/5 ml Syrup.",
          "Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it doesn't stop or if you find blood in your stools.",
          "Stop taking AM 200 mg/5 ml Syrup and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:24:34.810Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ea8",
    "original_record": {
      "input_index": 730,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ea8"
        },
        "name": "AM",
        "strength": "200 mg/5 ml",
        "generic": "Azithromycin Dihydrate",
        "company": "Reliance Pharmaceuticals Ltd.",
        "medicine_type": "Powder for Suspension",
        "source_url": "https://medex.com.bd/brands/8545/am-200-mg-suspension",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/11902/amarin-15-mg-syrup",
    "name": "Amarin",
    "dosage_form": "Syrup",
    "generic": "Pheniramine Maleate",
    "strength": "15 mg/5 ml",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 20.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 20.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "22.7 mg (Tablet)",
        "href": "https://medex.com.bd/brands/11901/amarin-227-mg-tablet?ref=1"
      },
      {
        "text": "45.5 mg/2 ml (Injection)",
        "href": "https://medex.com.bd/brands/11903/amarin-455-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/878/pheniramine-maleate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amarin is indicated for- Amarin is indicated for-",
        "items": [
          "Allergic conditions including hay fever, drug rashes, angioneurotic edema, serum sickness, allergic conjunctivitis, food allergy etc.",
          "Conditions of the respiratory tract that are accompanied by increased secretion, including vasomotor rhinitis and acute rhinitis.",
          "Allergic conditions including hay fever, drug rashes, angioneurotic edema, serum sickness, allergic conjunctivitis, food allergy etc.",
          "Conditions of the respiratory tract that are accompanied by increased secretion, including vasomotor rhinitis and acute rhinitis.",
          "All itching skin conditions, including neurodermatitis, eczema of any origin, lichen planus, acute and chronic urticaria, pruritis of the anus or genitals, pruritus in icterus and diabetes, radiation sickness etc.",
          "Prevention and treatment of motion sickness.",
          "Prevention and treatment of nausea, vomiting and vertigo due to Meniere’s disease and other labyrinthine disturbances."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Pheniramine competes with histamine for the histamine H1 receptor, acting as an inverse agonist once bound. The reduction in H1 receptor activity is responsible for reduced itching as well as reduced vasodilation and capillary leakage leading to less redness and edema. This can be seen in the suppression of the histamine-induced wheal (swelling) and flare (vasodilation) response. Inverse agonism of the H1 receptor in the CNS is also responsible for the sedation produced by first-generation antihistamines like pheniramine. The binding of pheniramine to H4 receptors, and subsequent inverse agonism, may also contribute to reduced itching by antagonizing inflammation.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": null,
        "items": [
          "MAO-inhibitors may prolong and intensify the anticholinergic effect of pheniramine (see Contraindications).",
          "Adverse CNS effects of pheniramine may be enhanced when it is taken with alcohol or other CNS depressants (eg. hypnotics, sedatives, tranquilizers).",
          "Atropine and related drugs may enhance the anticholinergic activity of pheniramine."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Patients with hypersensitivity to pheniramine or any other ingredient (eg. Methyl hydroxybenzoate or propyl hydroxybenzoate in the syrup).",
          "Patients with symptomatic prostatic hypertrophy.",
          "Patients receiving MAO-inhibitor therapy.",
          "Newborn and premature infants."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse reaction is sedation, which often disappears after a few days if tolerance is acquired. Hypersensitivity reactions have been reported.",
        "items": [
          "Central Nervous System: Lassitude, dizziness, tinnitus, inability to concentrate, incoordination, irritability, insomnia and tremors. Agitation and convulsions, especially in children and restlessness, disorientation and hallucinations in adults, are common symptoms following overdose.",
          "Gastrointestinal: Nausea, vomiting, diarrhoea, colic, epigastric pain, anorexia, dryness of mouth and constipation.",
          "Genitourinary: Urinary retention.",
          "Cardiovascular: Palpitations, headache.",
          "Ocular: Blurred vision, increased intraocular pressure.",
          "Musculoskeletal: Muscular weakness.",
          "Haematological: Rare cases of blood dyscrasias including agranulocytosis and haemolytic anaemia have been reported."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "pregnancy Category A. Use only if strictly indicated. Use only if strictly indicated.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Amarin may cause drowsiness. Both the dosage and the time of administration should be carefully considered in patients whose activities (e.g. driving a car or operating machinery) demand special concentration.",
          "Patients should be cautioned against the simultaneous ingestion of alcohol and other central nervous system depressants. Amarin may possibly be hallucinogenic in toxic doses. Due to the possible CNS stimulating effects of antihistamines, pheniramine has the potential for abuse.",
          "Due to the anticholinergic effect of pheniramine, caution and close monitoring are required if it is used in patients with conditions such as prostatic hypertrophy, narrow angle glaucoma, asthma or severe cardiovascular disease.",
          "The anti-emetic effect of pheniramine may mask the signs of other conditions. Products containing pheniramine should not be taken on an empty stomach."
        ]
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": "Symptoms",
        "information": ": Antihistamine drugs in toxic doses produce a complex of CNS excitatory and depressant effects. Accidental ingestion in small children has resulted in convulsions and sometimes death.",
        "items": []
      },
      {
        "title": "Management",
        "information": ": As there is no specific antidote, treatment should be symptomatic and supportive. Induction of vomiting should only be used immediately after ingestion as the sedative action of any absorbed antihistamine can lead to life-threatening pulmonary aspiration during emesis. Gastric lavage with a cuffed endotracheal tube in situ may be useful for some time after ingestion of antihistamines as their anticholinergic action slows down gastric emptying. Stimulants should not be used as they may precipitate convulsions. Diazepam or short-acting barbiturates may be used to control convulsions. Vasopressors may be used to treat hypotension. Mechanical support of respiration may be required if respiration is seriously depressed. Continuous ECG monitoring is recommended if cardiac toxicity develops, which can be treated with centrally-acting anticholinesterases such as physostigmine.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Amarin is a competitive H1 histamine receptor antagonist. Like other alkylamine antihistamines it is also antagonist of muscarinic cholinergic receptors and possesses local anesthetic properties. However, the concentration required for the latter effect is probably not achieved at therapeutic dose",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": null,
        "information": "Doses must be individually determined in all cases and should be taken with or soon after food. Treatment should be commenced at the lowest possible dose because experience has shown that antihistamines are often effective at low doses. The maximum dose of 3 mg/kg per day should not be exceeded. Elderly patients should use the adult dose with caution. To prevent travel sickness, it is recommended that the first dose be taken at least 30 minutes before traveling. Due to the risk of drowsiness, the patient should not drive a motor vehicle or operate machinery after taking a dose. Pheniramine Maleate tablets:",
        "instructions": []
      },
      {
        "medication_type": "In adults and children over 10 years of age",
        "information": ": Treatment is commenced with half a tablet taken up to three times daily. This dose may be increased to one tablet taken up to three times daily if required.",
        "instructions": []
      },
      {
        "medication_type": "Children 5-10 years of age",
        "information": ": Half a tablet up to three times daily. Pheniramine Maleate tablets are not recommended in children under 5 years of age.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:35.954Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eab",
    "original_record": {
      "input_index": 731,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eab"
        },
        "name": "Amarin",
        "strength": "15 mg/5 ml",
        "generic": "Pheniramine Maleate",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/11902/amarin-15-mg-syrup",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/11903/amarin-455-mg-injection",
    "name": "Amarin",
    "dosage_form": "IM/IV Injection",
    "generic": "Pheniramine Maleate",
    "strength": "45.5 mg/2 ml",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 7.48",
      "strip_price": null,
      "pack_size_info": "(5 x 5: ৳ 187.00)",
      "packages": [
        {
          "label": "2 ml ampoule",
          "price": "৳ 7.48",
          "pack_size_info": "(5 x 5: ৳ 187.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "22.7 mg (Tablet)",
        "href": "https://medex.com.bd/brands/11901/amarin-227-mg-tablet?ref=1"
      },
      {
        "text": "15 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/11902/amarin-15-mg-syrup?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/878/pheniramine-maleate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amarin is indicated for- Amarin is indicated for-",
        "items": [
          "Allergic conditions including hay fever, drug rashes, angioneurotic edema, serum sickness, allergic conjunctivitis, food allergy etc.",
          "Conditions of the respiratory tract that are accompanied by increased secretion, including vasomotor rhinitis and acute rhinitis.",
          "Allergic conditions including hay fever, drug rashes, angioneurotic edema, serum sickness, allergic conjunctivitis, food allergy etc.",
          "Conditions of the respiratory tract that are accompanied by increased secretion, including vasomotor rhinitis and acute rhinitis.",
          "All itching skin conditions, including neurodermatitis, eczema of any origin, lichen planus, acute and chronic urticaria, pruritis of the anus or genitals, pruritus in icterus and diabetes, radiation sickness etc.",
          "Prevention and treatment of motion sickness.",
          "Prevention and treatment of nausea, vomiting and vertigo due to Meniere’s disease and other labyrinthine disturbances."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Pheniramine competes with histamine for the histamine H1 receptor, acting as an inverse agonist once bound. The reduction in H1 receptor activity is responsible for reduced itching as well as reduced vasodilation and capillary leakage leading to less redness and edema. This can be seen in the suppression of the histamine-induced wheal (swelling) and flare (vasodilation) response. Inverse agonism of the H1 receptor in the CNS is also responsible for the sedation produced by first-generation antihistamines like pheniramine. The binding of pheniramine to H4 receptors, and subsequent inverse agonism, may also contribute to reduced itching by antagonizing inflammation.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": null,
        "items": [
          "MAO-inhibitors may prolong and intensify the anticholinergic effect of pheniramine (see Contraindications).",
          "Adverse CNS effects of pheniramine may be enhanced when it is taken with alcohol or other CNS depressants (eg. hypnotics, sedatives, tranquilizers).",
          "Atropine and related drugs may enhance the anticholinergic activity of pheniramine."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Patients with hypersensitivity to pheniramine or any other ingredient (eg. Methyl hydroxybenzoate or propyl hydroxybenzoate in the syrup).",
          "Patients with symptomatic prostatic hypertrophy.",
          "Patients receiving MAO-inhibitor therapy.",
          "Newborn and premature infants."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse reaction is sedation, which often disappears after a few days if tolerance is acquired. Hypersensitivity reactions have been reported.",
        "items": [
          "Central Nervous System: Lassitude, dizziness, tinnitus, inability to concentrate, incoordination, irritability, insomnia and tremors. Agitation and convulsions, especially in children and restlessness, disorientation and hallucinations in adults, are common symptoms following overdose.",
          "Gastrointestinal: Nausea, vomiting, diarrhoea, colic, epigastric pain, anorexia, dryness of mouth and constipation.",
          "Genitourinary: Urinary retention.",
          "Cardiovascular: Palpitations, headache.",
          "Ocular: Blurred vision, increased intraocular pressure.",
          "Musculoskeletal: Muscular weakness.",
          "Haematological: Rare cases of blood dyscrasias including agranulocytosis and haemolytic anaemia have been reported."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "pregnancy Category A. Use only if strictly indicated. Use only if strictly indicated.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Amarin may cause drowsiness. Both the dosage and the time of administration should be carefully considered in patients whose activities (e.g. driving a car or operating machinery) demand special concentration.",
          "Patients should be cautioned against the simultaneous ingestion of alcohol and other central nervous system depressants. Amarin may possibly be hallucinogenic in toxic doses. Due to the possible CNS stimulating effects of antihistamines, pheniramine has the potential for abuse.",
          "Due to the anticholinergic effect of pheniramine, caution and close monitoring are required if it is used in patients with conditions such as prostatic hypertrophy, narrow angle glaucoma, asthma or severe cardiovascular disease.",
          "The anti-emetic effect of pheniramine may mask the signs of other conditions. Products containing pheniramine should not be taken on an empty stomach."
        ]
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": "Symptoms",
        "information": ": Antihistamine drugs in toxic doses produce a complex of CNS excitatory and depressant effects. Accidental ingestion in small children has resulted in convulsions and sometimes death.",
        "items": []
      },
      {
        "title": "Management",
        "information": ": As there is no specific antidote, treatment should be symptomatic and supportive. Induction of vomiting should only be used immediately after ingestion as the sedative action of any absorbed antihistamine can lead to life-threatening pulmonary aspiration during emesis. Gastric lavage with a cuffed endotracheal tube in situ may be useful for some time after ingestion of antihistamines as their anticholinergic action slows down gastric emptying. Stimulants should not be used as they may precipitate convulsions. Diazepam or short-acting barbiturates may be used to control convulsions. Vasopressors may be used to treat hypotension. Mechanical support of respiration may be required if respiration is seriously depressed. Continuous ECG monitoring is recommended if cardiac toxicity develops, which can be treated with centrally-acting anticholinesterases such as physostigmine.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Amarin is a competitive H1 histamine receptor antagonist. Like other alkylamine antihistamines it is also antagonist of muscarinic cholinergic receptors and possesses local anesthetic properties. However, the concentration required for the latter effect is probably not achieved at therapeutic dose",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": null,
        "information": "Doses must be individually determined in all cases and should be taken with or soon after food. Treatment should be commenced at the lowest possible dose because experience has shown that antihistamines are often effective at low doses. The maximum dose of 3 mg/kg per day should not be exceeded. Elderly patients should use the adult dose with caution. To prevent travel sickness, it is recommended that the first dose be taken at least 30 minutes before traveling. Due to the risk of drowsiness, the patient should not drive a motor vehicle or operate machinery after taking a dose. Pheniramine Maleate tablets:",
        "instructions": []
      },
      {
        "medication_type": "In adults and children over 10 years of age",
        "information": ": Treatment is commenced with half a tablet taken up to three times daily. This dose may be increased to one tablet taken up to three times daily if required.",
        "instructions": []
      },
      {
        "medication_type": "Children 5-10 years of age",
        "information": ": Half a tablet up to three times daily. Pheniramine Maleate tablets are not recommended in children under 5 years of age.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:37.184Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eac",
    "original_record": {
      "input_index": 732,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eac"
        },
        "name": "Amarin",
        "strength": "45.5 mg/2 ml",
        "generic": "Pheniramine Maleate",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "IM/IV Injection",
        "source_url": "https://medex.com.bd/brands/11903/amarin-455-mg-injection",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/26827/amaryl-m-2-mg-tablet",
    "name": "Amaryl M",
    "dosage_form": "Tablet (Prolonged Release)",
    "generic": "Glimepiride + Metformin",
    "strength": "2 mg+500 mg",
    "company": "Synovia Pharma PLC.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 18.00",
      "strip_price": "৳ 180.00",
      "pack_size_info": "(3 x 10: ৳ 540.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 18.00",
          "pack_size_info": "(3 x 10: ৳ 540.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 180.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "1 mg+500 mg (PR Tablet)",
        "href": "https://medex.com.bd/brands/26826/amaryl-m-1-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1471/glimepiride-metformin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amaryl M tablet is indicated as an adjunct to diet and exercise in type 2 diabetes mellitus patients-",
        "items": [
          "In case that the monotherapy with glimepiride or metformin does not result in adequate glycemic control.",
          "Replacement of combination therapy of glimepiride and metformin."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. The primary mechanism of action of Glimepiride appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. In addition, extrapancreatic effects like reduction of basal hepatic glucose production, increased peripheral tissue sensitivity to insulin and glucose uptake may also play role in the activity of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic action of a single dose of Glimepiride persists for 24 hours. Metformin Hydrochloride is a biguanide type oral antihyperglycemic drug used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose. Its mechanism of action is different from those of sulfonylureas and it does not produce hypoglycemia. Metformin Hydrochloride decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by an increase in peripheral glucose uptake and utilization.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "For Glimepiride: For Metformin: Concomitant use not recommended: Organic cation transporters (OCT): Metformin is a substrate of both transporters OCT1 and OCT2. Co-administration of metformin with: Caution is therefore advised, especially in patients with renal impairment, when these drugs are coadministered with metformin, as metformin plasma concentration may increase. If needed, dose adjustment of metformin may be considered as OCT inhibitors/inducers may alter the efcacy of metformin.",
        "items": [
          "Glimepiride is metabolized by cytochrome P450 2C9 (CYP2C9). This should be taken into account when glimepiride is coadministered with inducers (e.g. rifampicin) or inhibitors (e.g. fuconazole) of CYP 2C9.",
          "Potentiation of the blood-glucose-lowering efect and, thus, in some instances hypoglycaemia may occur when one of the following drugs is taken, for example: insulin and other, oral antidiabetics; ACE inhibitors; anabolic steroids and male sex hormones; chloramphenicol; coumarin derivatives; cyclophosphamide; disopyramide; fenfuramine; fenyramidol; fbrates; fuoxetine; guanethidine; ifosfamide; MAO inhibitors; miconazole; fuconazole; para-aminosalicylic acid; pentoxifylline (high dose parenteral); phenylbutazone; azapropazone; oxyphenbutazone; probenecid; quinolones; salicylates; sulfnpyrazone; clarithromycin; sulfonamide antibiotics; tetracyclines; tritoqualine; trofosfamide.",
          "Weakening of the blood-glucose-lowering efect and, thus raised blood glucose levels may occur when one of the following drugs is taken, for example: acetazolamide; barbiturates; corticosteroids; diazoxide; diuretics; epinephrine (adrenaline) and other sympathomimetic agents; glucagon; laxatives (after protracted use); nicotinic acid (in high doses); oestrogens and progestogens; phenothiazines; phenytoin; rifampicin; thyroid hormones.",
          "H2 receptor antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of the blood-glucose-lowering efect. Under the infuence of sympatholytic drugs such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation to hypoglycaemia may be reduced or absent.",
          "Both acute and chronic alcohol intake may potentiate or weaken the blood-glucose-lowering action of glimepiride in an unpredictable fashion.",
          "The efect of coumarin derivatives may be potentiated or weakened.",
          "Bile acid sequestrant: Colesevelam binds to glimepiride and reduces glimepiride absorption from the gastrointestinal tract. Glimepiride should be administered at least 4 hours prior to colesevelam.",
          "Alcohol: Alcohol intoxication is associated with an increased risk of lactic acidosis, particularly in case of fasting, malnutrition or hepatic insufciency. Avoid consumption of alcohol and alcohol-containing medications",
          "Iodinated contrast agents: Metformin must be discontinued prior to, or at the time of the imaging procedure and not restarted until at least 48 hours after, provided that renal function has been re-evaluated and found to be stable.",
          "Combinations requiring precautions for use: Some medicinal products can adversely afect renal function which may increase the risk of lactic Acidosis. When starting or using such products in combination with metformin, close monitoring of renal function is necessary. Glucocorticoids, beta-2-agonists, and diuretics have intrinsic hyperglycemic activity. Inform the patient and perform more frequent blood glucose monitoring. ACE-inhibitors may decrease the blood glucose levels. Metformin may decrease the anticoagulant efect of phenprocoumon. Therefore, a close monitoring of the INR is recommended. Levothyroxine can reduce the hypoglycemic efect of metformin. Monitoring of blood glucose levels is recommended, especially when thyroid hormone therapy is initiated or stopped, and the dosage of metformin must be adjusted if necessary.",
          "Inhibitors of OCT1 (such as verapamil) may reduce efcacy of metformin.",
          "Inducers of OCT1 (such as rifampicin) may increase gastrointestinal absorption and efcacy of metformin.",
          "Inhibitors of OCT2 (such as cimetidine, dolutegravir, ranolazine, trimethoprime, vandetanib, isavuconazole) may decrease the renal elimination of metformin and thus lead to an increase in metformin plasma concentration.",
          "Inhibitors of both OCT1 and OCT2 (such as crizotinib, olaparib) may alter efcacy and renal elimination of metformin."
        ]
      }
    ],
    "contraindications": [
      {
        "title": "For Glimepiride",
        "information": "- No experience has been gained concerning the use of glimepiride in patients with severe impairment of liver function and in dialysis patients. In patients with severe impairment of hepatic function, change-over to insulin is indicated, not least to achieve optimal metabolic control.",
        "items": [
          "In patients hypersensitive to glimepiride, metformin, other sulfonylureas, other sulfonamides, or any of the excipients of Amaryl M.",
          "In pregnant women.",
          "In breastfeeding women."
        ]
      },
      {
        "title": "For Metformin",
        "information": "-",
        "items": [
          "Hypersensitivity to metformin or any of the excipients.",
          "Any type of acute metabolic acidosis such as lactic acidosis Diabetic ketoacidosis, diabetic pre-coma.",
          "Severe Renal failure or renal disfunction (e.g., serum creatine levels >135 μmol/L in males and >110 μmol/L in females), GFR < 30 mL/min.",
          "Acute conditions with the potential to alter renal function such as Dehydration, severe infection, intravascular administration of iodinated contrast agents etc.",
          "Acute or chronic disease which may cause tissue hypoxia such as cardiac or respiratory failure, recent myocardial infarction, shock",
          "Hepatic insufciency.",
          "Acute alcohol intoxication, alcoholism.",
          "Lactation."
        ]
      }
    ],
    "side_effects": [
      {
        "title": "For Glimepiride",
        "information": ": Metabolism and nutrition disorders- Eye disorders: Especially at the start of treatment, there may be temporary visual impairment due to the change in blood glucose levels. The cause is a temporary alteration in the turgidity and hence the refractive index of the lens, this being dependent on blood glucose level. Gastrointestinal disorders- Blood and lymphatic system disorders- Skin and subcutaneous tissue disorders: Alopecia (frequency not known) General disorders- Investigations: Glimepiride, like all sulfonylureas, can cause weight gain (frequency not known)",
        "items": [
          "As a result of the blood-glucose-lowering action of glimepiride, Hypoglycaemia which may also be prolonged.",
          "The clinical picture of a severe hypoglycaemic attack may resemble that of a stroke.",
          "Occasionally, Gastrointestinal symptoms such as nausea, vomiting, sensations of pressure or fulness in the epigastrium, abdominal pain and diarrhea may occur.",
          "In isolated cases, there may be hepatitis, elevation of liver enzyme levels and/or cholestasis and jaundice, which may progress to life-threatening liver failure.",
          "Dysgeusia (frequency not known)",
          "Changes in the blood picture may occur: Rarely, thrombocytopenia and, in isolated cases, leucopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis or pancytopenia may develop. Cases of severe thrombocytopenia with platelet count less than 10,000/μl and thrombocytopenic purpura have been reported in post-marketing experience (frequency not known).",
          "Occasionally, Allergic or pseudo allergic reactions may occur, e.g. in the form of itching, urticaria or rashes. Such mild reactions may develop into serious reactions with dyspnoea and a fall in blood pressure, sometimes progressing to shock.",
          "In isolated cases, a decrease in serum sodium concentration and allergic vasculitis or hypersensitivity of the skin to light may occur."
        ]
      },
      {
        "title": "For Metformin",
        "information": ":",
        "items": [
          "Gastrointestinal symptoms such as nausea, vomiting, diarrhoea, abdominal pain and loss of appetite (>10%) are very common. These occur most frequently during initiation of therapy and resolve spontaneously in most cases.",
          "Metallic taste (3%) is common",
          "Decrease of vitamin B12 absorption with decrease of serum levels has been observed in patients treated long-term with metformin and appears generally to be without clinical signifcance (<0.01%). However, Cases of peripheral neuropathy in patients with vitamin B12 defciency have been reported in post-marketing experience (frequency not known). (frequency unknown)",
          "Lactic acidosis (0.03 cases/1000 patient-years) is very rare",
          "Hemolytic anemia (frequency unknown)",
          "Reduction of thyrotropin level in patients with hypothyroidism (frequency unknown)",
          "Hypomagnesemia in the context of diarrhea (frequency unknown)",
          "Encephalopathy (frequency unknown)",
          "Photosensitivity (frequency unknown)",
          "Hepatobiliary disorders: Reports of liver function tests abnormalities and hepatitis resolving upon metformin discontinuation"
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy- Lactation-",
        "items": [
          "For Glimepiride: Glimepiride must not be taken during pregnancy. Otherwise, there is risk of harm to the child. The patient must change over to insulin during pregnancy. Patients planning a pregnancy must inform their physician. It is recommended that such patients change over to insulin.",
          "For Metformin: When the patient plans to become pregnant and during pregnancy, diabetes should not be treated with metformin but insulin should be used to maintain blood glucose levels as close to normal as possible in order to lower the risk of fetal malformations associated with abnormal blood glucose levels.",
          "For Glimepiride: To prevent possible ingestion with the breast milk and possible harm to the child, glimepiride must not be taken by breast-feeding women. If necessary the patient must change over to insulin, or must stop breastfeeding.",
          "For Metformin: Metformin is excreted into milk in lactating rats. Similar data is not available in humans and a decision should be made whether to discontinue nursing or to discontinue metformin, taking into account the importance of the compound to the mother."
        ]
      }
    ],
    "precautions": [
      {
        "title": "For Glimepiride",
        "information": ": In the initial weeks of treatment, the risk of hypoglycemia may be increased and necessitates especially careful monitoring. If risk factors for hypoglycemia are present, it may be necessary to adjust the dosage of glimepiride or the entire therapy. This also applies whenever illness occurs during therapy or the patient's life-style changes. It is known from other sulfonylureas that, despite initially successful countermeasures, hypoglycaemia may recur. Patients must, therefore, remain under close observation. Severe hypoglycaemia further requires immediate treatment and follow-up by a physician and, in some circumstances, in-patient hospital care. Treatment of patients with G6PD-defciency with sulfonylurea agents can lead to hemolytic anaemia. Since glimepiride belongs to the class of sulfonylurea agents, caution should be used in patients with G6PD-defciency and a non-sulfonylurea alternative should be considered.",
        "items": []
      },
      {
        "title": "For Metformin",
        "information": ": Regular monitoring of thyroid-stimulating hormone (TSH) levels is recommended in patients withhypothyroidism. Long-term treatment with metformin has been associated with a decrease in vitamin B12 serumlevels which may cause peripheral neuropathy. Monitoring of the vitamin B12 level is recommended.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children",
        "information": ": Data is insufficient to recommend pediatric use of this tablet.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": A GFR should be assessed before initiation of treatment with metformin-containing products and at least annually thereafter. In patients at increased risk of further progression of renal impairment and in the elderly, renal function should be assessed more frequently, e.g. every 3-6 months. The maximum daily dose of metformin should preferably be divided into 2-3 daily doses. Factors that may increase the risk of lactic acidosis should be reviewed before considering the initiation of metformin in patients with GFR<60 mL/min. If no adequate strength of this tablet is available, individual monocomponents should be used instead of the fixed dose combination. GFR 60-89 ml/min: GFR 45-59 ml/min: GFR 30-44 ml/min: GFR <30 ml/min:",
        "items": [
          "Metformin: Maximum daily dose is 3000 mg. Dose reduction may be considered in relation to declining renal function.",
          "Glimepiride: The highest recommended dose per day should be 8 mg of glimepiride.",
          "Metformin: Maximum daily dose is 2000 mg. The starting dose is at most half of the maximum dose.",
          "Metformin: Maximum daily dose is 1000 mg. The starting dose is at most half of the maximum dose.",
          "Metformin: Metformin is contraindicated",
          "Glimepiride: Change-over to insulin is indicated, not least to achieve optimal metabolic control."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": "For Glimepiride",
        "information": ": Acute overdosage, as well as long-term treatment with too high a dose of glimepiride, may lead to severe life-threatening hypoglycaemia. As soon as an overdose of glimepiride has been discovered, a physician must be notifed without delay. The patient must immediately take sugar, if possible in the form of glucose unless a physician has already undertaken responsibility for treating the overdose. Careful monitoring is essential until the physician is confdent that the patient is out of danger. It must be remembered that hypoglycaemia may recur after initial recovery. Admission to hospital may sometimes be necessary even as a precautionary measure. In particular, signifcant overdoses and severe reactions with signs such as loss of consciousness or other serious neurological disorders are medical emergencies and require immediate treatment and admission to hospital. If, for example, the patient is unconscious, an intravenous injection of concentrated glucose solution is indicated (for adults starting with 40 ml of 20% solution, for example). Alternatively in adults, administration of glucagon, e.g. in doses of 0.5 to 1 mg i.v., s.c. or i.m., may be considered. In particular when treating hypoglycaemia due to accidental intake of glimepiride in infants and young children, the dose of glucose given must be very carefully adjusted in view of the possibility of producing dangerous hyperglycaemia, and must be controlled by close monitoring of blood glucose. Patients who have ingested life-threatening amounts of glimepiride require detoxifcation (e.g. by gastric lavage and medicinal charcoal). After acute glucose replacement has been completed it is usually necessary to give an intravenous glucose infusion in lower concentration so as to ensure that the hypoglycaemia does not recur. The patient's blood glucose level should be carefully monitored for at least 24 hours. In severe cases with a protracted course, hypoglycaemia, or the danger of slipping back into hypoglycaemia, may persist for several days.",
        "items": []
      },
      {
        "title": "For Metformin",
        "information": ": Hypoglycaemia has not been seen with metformin doses of up to 85 g, although Lactic acidosis has occurred in such circumstances. High overdose or concomitant risks of metformin may lead to lactic acidosis Lactic acidosis is a medical emergency and must be treated in hospital. The most efective method to remove lactate and metformin is haemodialysis. Pancreatitis may occur in the context of a metformin overdose.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (not exceeding 25°C) and dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "This tablet must be swallowed whole and not crushed or chewed.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Combination Oral hypoglycemic preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": null,
        "instructions": [
          "The dosage of this tablet is governed by the desired blood glucose level. The dosage of this tablet must be the lowest which is sufficient to achieve the desired metabolic control. During treatment with this tablet glucose levels in blood and urine must be measured regularly.",
          "Mistakes, e.g. forgetting to take a dose, must never be corrected by subsequently taking a larger dose.",
          "As an improvement in control of diabetes is, in itself, associated with higher insulin sensitivity, glimepiride requirements may fall as treatment proceeds. To avoid hypoglycaemia timely dose reduction or cessation of this tablet therapy must therefore be considered.",
          "The highest recommended dose per day should be 8 mg of glimepiride and 2000 mg of metformin.",
          "In order to avoid hypoglycaemia the starting dose of this tablet should not exceed the daily doses of glimepiride or metformin already being taken.",
          "When switching from combination therapy of glimepiride plus metformin as separate tablets, this combination should be administered on the basis of dosage currently being taken."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:38.312Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eb2",
    "original_record": {
      "input_index": 733,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eb2"
        },
        "name": "Amaryl M",
        "strength": "2 mg+500 mg",
        "generic": "Glimepiride + Metformin",
        "company": "Synovia Pharma PLC.",
        "medicine_type": "Tablet (Prolonged Release)",
        "source_url": "https://medex.com.bd/brands/26827/amaryl-m-2-mg-tablet",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28014/ambeecal-d-500-mg-tablet",
    "name": "Ambeecal-D",
    "dosage_form": "Tablet",
    "generic": "Elemental Calcium + Vitamin D3",
    "strength": "500 mg+200 IU",
    "company": "Ambee Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 3.31",
      "strip_price": null,
      "pack_size_info": "(1 x 15: ৳ 49.65)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.31",
          "pack_size_info": "(1 x 15: ৳ 49.65)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/169/elemental-calcium-vitamin-d3/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambeecal-D tablet is used for treatment of osteoporosis, osteomalacia, rickets, tetany and in parathyroid disease. Calcium supplements are often used to ensure adequate dietary intake in conditions such as pregnancy & lactation, osteogenesis and tooth formation (adjunct with definite treatment) and therapy with anti-seizure medications. It is also used as routine supplement and phosphate binder in chronic renal failure.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the preparation of Calcium Carbonate and Vitamin D3 (Cholecalciferol). Calcium is necessary for many normal functions of our body, especially bone formation and maintenance. Vitamin D3 helps for the absorption & reabsorption of Calcium. Vitamin D3 also stimulates bone formation. Clinical studies showed that Calcium and Vitamin D3 all together helps in bone growth, and in prevention of osteoporosis & bone fracture.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "It has possible interaction with calcium, aluminium or magnesium containing antacids & other calcium supplements, calcitriol & other vitamin D3 supplements; digoxin, tetracycline, doxycycline, minocycline or oxytetracycline.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in case of hypercalcaemia, hyperthyroidism, renal calculi & nephrolithiasis and Zollinger-Ellison Syndrome.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "It is generally well tolerated. If there is experience like nausea, vomiting, stomach cramps, dry mouth, increased thirst, increased urination while taking, noticed to physicians. Constipation may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "This combination should be used as directed by physician during pregnancy or while breast-feeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "If there is any pre-existing heart disease or kidney disease, precautions should be taken.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Symptoms of overdosage may include nausea and vomiting, severe drowsiness, dry mouth, loss of appetite, metallic taste, stomach cramps, diarrhea, headache, constipation.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Specific mineral & vitamin combined preparations",
    "dosage": [
      {
        "medication_type": "Calcium 500 mg and Vitamin D3 200 IU Tablet",
        "information": ": 2 tablets daily or 1 tablet twice daily. It is best taken with or just after a meal to improve absorption.",
        "instructions": []
      },
      {
        "medication_type": "Calcium 500 mg and Vitamin D3 400 IU Tablet",
        "information": ": 1 tablet twice daily. It is best taken with or just after a meal to improve absorption.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:39.416Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eb5",
    "original_record": {
      "input_index": 734,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eb5"
        },
        "name": "Ambeecal-D",
        "strength": "500 mg+200 IU",
        "generic": "Elemental Calcium + Vitamin D3",
        "company": "Ambee Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/28014/ambeecal-d-500-mg-tablet",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/536/ambeet-75-mg-capsule",
    "name": "Ambeet",
    "dosage_form": "Capsule (Sustained Release)",
    "generic": "Ambroxol Hydrochloride",
    "strength": "75 mg",
    "company": "Ethical Drugs Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 5.00",
      "strip_price": "৳ 30.00",
      "pack_size_info": "(5 x 6: ৳ 150.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.00",
          "pack_size_info": "(5 x 6: ৳ 150.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "15 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/535/ambeet-15-mg-syrup?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambeet is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambeet should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambeet might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambeet should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:40.520Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eb8",
    "original_record": {
      "input_index": 735,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eb8"
        },
        "name": "Ambeet",
        "strength": "75 mg",
        "generic": "Ambroxol Hydrochloride",
        "company": "Ethical Drugs Limited",
        "medicine_type": "Capsule (Sustained Release)",
        "source_url": "https://medex.com.bd/brands/536/ambeet-75-mg-capsule",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28020/ambeexin-125-mg-pediatric-drop",
    "name": "Ambeexin",
    "dosage_form": "Pediatric Drops",
    "generic": "Amoxicillin Trihydrate",
    "strength": "125 mg/1.25 ml",
    "company": "Ambee Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 28.42",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "15 ml bottle",
          "price": "৳ 28.42",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/6422/ambeexin-125-mg-suspension?ref=1"
      },
      {
        "text": "250 mg (Capsule)",
        "href": "https://medex.com.bd/brands/28016/ambeexin-250-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/69/amoxicillin-trihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambeexin is indicated in the treatment of infections due to susceptible ß-lactamase negative strains of microorganisms. These infections include Ambeexin is indicated in the treatment of infections due to susceptible ß-lactamase negative strains of microorganisms. These infections include",
        "items": [
          "Ear, nose and throat infections (i.e. otitis media, sinusitis, tonsillitis, pharyngitis, laryngitis)",
          "Lower respiratory tract infections (i.e. pneumonia, acute and chronic bronchitis lung abscess, empyema, bronchiectasis)",
          "Ear, nose and throat infections (i.e. otitis media, sinusitis, tonsillitis, pharyngitis, laryngitis)",
          "Lower respiratory tract infections (i.e. pneumonia, acute and chronic bronchitis lung abscess, empyema, bronchiectasis)",
          "Skin and soft tissue infections (i.e. cellulitis, carbuncles, furunculosis, infected wounds, abscess)",
          "Genito-urinary tract infections (i.e. pyelonephritis, cystitis and urethritis)",
          "Venereal disease (i.e. acute uncomplicated gonorrhoea)",
          "In dental abscess, it is used as short-term therapy.",
          "It is also indicated in combination with Clarithromycin and Lansoprazole (as triple therapy), for the treatment of patients with H. pylori infection and duodenal ulcer disease and to reduce the risk of duodenal ulcer recurrence."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Amoxicillin is a broad spectrum penicillin. It is effective against a wide range of Gram-positive and Gram-negative bacteria. It acts through the inhibition of biosynthesis of cell wall. Amoxicillin is stable in the presence of gastric acid and is rapidly absorbed after oral administration. After an oral dose, peak plasma concentration of Amoxicillin is reached within 1 to 2 hours. Amoxicillin is widely distributed at varying concentration in body tissues and fluids.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concurrent use of Ambeexin and Probenecid may result in increased and prolonged blood levels of Ambeexin. Ambeexin may affect the gut flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral estrogen/progesterone contraceptives.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Amoxicillin is contraindicated in penicillin hypersensitive patients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects are mild and transient in nature. This may include diarrhoea, indigestion or occasionally rash. Pseudo-membranous colitis has been reported rarely.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA pregnancy category of Amoxicillin is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Amoxicillin has been shown to be excreted in human milk. So, caution should be exercised when Amoxicillin is administered to a lactating mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "The possibility of superinfections with mycotic or bacterial pathogens should be kept in mind during therapy. If superinfections occur, Ambeexin should be discontinued and appropriate therapy should be instituted.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Reconstituted suspension can be administered by adding the required amount of suspension to milk, fruit juice, water. These preparations should then be taken immediately.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Broad spectrum penicillins",
    "dosage": [
      {
        "medication_type": "Adult",
        "information": ": 250 mg three times daily, increasing up to 500 mg three times daily for severe infections.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(up to 10 years of age) : 125 mg three times daily, increasing up to 250 mg three times daily for severe infections.",
        "instructions": []
      },
      {
        "medication_type": "Severe or recurrent purulent respiratory infection",
        "information": ": 3 gm every 12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Otitis media",
        "information": ": Recommended dose is 1 g three times daily for adult and 40 mg/kg body weight daily in 3 divided doses for children (max. 3 g daily).",
        "instructions": []
      },
      {
        "medication_type": "Pneumonia",
        "information": ": Recommended dose is 500-1000 mg three times daily.",
        "instructions": []
      },
      {
        "medication_type": "Dental abscess",
        "information": ": Recommended dose is 3 gm, repeated after 10-12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Urinary tract infections",
        "information": ": Recommended dose is 3 gm, repeated after 10-12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Gonorrhoea",
        "information": ": Single dose of 2-3 gm with Probenecid 1 gm is recommended (Probenecid is contraindicated in children under 2 years).",
        "instructions": []
      },
      {
        "medication_type": "In renal impairment",
        "information": ": it may be necessary to reduce the total daily dosage.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:41.557Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eba",
    "original_record": {
      "input_index": 736,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eba"
        },
        "name": "Ambeexin",
        "strength": "125 mg/1.25 ml",
        "generic": "Amoxicillin Trihydrate",
        "company": "Ambee Pharmaceuticals Ltd.",
        "medicine_type": "Pediatric Drops",
        "source_url": "https://medex.com.bd/brands/28020/ambeexin-125-mg-pediatric-drop",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/537/ambix-15-mg-syrup",
    "name": "Ambix",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Modern Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 40.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambix is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambix should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambix might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambix should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:42.662Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ec0",
    "original_record": {
      "input_index": 737,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ec0"
        },
        "name": "Ambix",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Modern Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/537/ambix-15-mg-syrup",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/4026/ambolin-15-mg-syrup",
    "name": "Ambolin",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Virgo Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 40.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "6 mg/ml (Drops)",
        "href": "https://medex.com.bd/brands/539/ambolin-6-mg-pediatric-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambolin is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambolin should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambolin might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambolin should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:43.766Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ec6",
    "original_record": {
      "input_index": 738,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ec6"
        },
        "name": "Ambolin",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Virgo Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/4026/ambolin-15-mg-syrup",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/548/amboten-6-mg-pediatric-drop",
    "name": "Amboten",
    "dosage_form": "Pediatric Drops",
    "generic": "Ambroxol Hydrochloride",
    "strength": "6 mg/ml",
    "company": "Eskayef Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 35.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "15 ml bottle",
          "price": "৳ 35.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "15 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/547/amboten-15-mg-syrup?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amboten is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Amboten should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Amboten might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Amboten should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:45.113Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ed1",
    "original_record": {
      "input_index": 739,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ed1"
        },
        "name": "Amboten",
        "strength": "6 mg/ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Eskayef Pharmaceuticals Ltd.",
        "medicine_type": "Pediatric Drops",
        "source_url": "https://medex.com.bd/brands/548/amboten-6-mg-pediatric-drop",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/549/amboxol-15-mg-syrup",
    "name": "Amboxol",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Kumudini Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 42.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 42.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "6 mg/ml (Drops)",
        "href": "https://medex.com.bd/brands/25516/amboxol-6-mg-pediatric-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amboxol is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Amboxol should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Amboxol might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Amboxol should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:46.144Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ed2",
    "original_record": {
      "input_index": 740,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ed2"
        },
        "name": "Amboxol",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Kumudini Pharma Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/549/amboxol-15-mg-syrup",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/550/ambozin-15-mg-syrup",
    "name": "Ambozin",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Rephco Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 40.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "75 mg (SR Capsule)",
        "href": "https://medex.com.bd/brands/551/ambozin-sr-75-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambozin is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambozin should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambozin might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambozin should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:47.252Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ed4",
    "original_record": {
      "input_index": 741,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ed4"
        },
        "name": "Ambozin",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Rephco Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/550/ambozin-15-mg-syrup",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/35317/ambrokof-15-mg-syrup",
    "name": "Ambrokof",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Euro Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 45.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 45.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambrokof is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambrokof should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambrokof might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambrokof should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:48.591Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eda",
    "original_record": {
      "input_index": 742,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eda"
        },
        "name": "Ambrokof",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Euro Pharma Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/35317/ambrokof-15-mg-syrup",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28784/ambronaaf-15-mg-syrup",
    "name": "Ambronaaf",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Naafco Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 50.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 50.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambronaaf is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambronaaf should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambronaaf might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambronaaf should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:49.640Z",
    "medicine_id": "68c3c09aef5b8f2b163a8edc",
    "original_record": {
      "input_index": 743,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8edc"
        },
        "name": "Ambronaaf",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Naafco Pharma Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/28784/ambronaaf-15-mg-syrup",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/553/ambronil-15-mg-syrup",
    "name": "Ambronil",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Orion Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 50.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 50.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "6 mg/ml (Drops)",
        "href": "https://medex.com.bd/brands/554/ambronil-6-mg-pediatric-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambronil is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambronil should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambronil might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambronil should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:50.734Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ede",
    "original_record": {
      "input_index": 744,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ede"
        },
        "name": "Ambronil",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Orion Pharma Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/553/ambronil-15-mg-syrup",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/558/ambroton-15-mg-syrup",
    "name": "Ambroton",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Novatek Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 40.13",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 40.13",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambroton is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambroton should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambroton might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambroton should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:51.863Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ee4",
    "original_record": {
      "input_index": 745,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ee4"
        },
        "name": "Ambroton",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Novatek Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/558/ambroton-15-mg-syrup",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/561/ambrox-sr-75-mg-capsule",
    "name": "Ambrox SR",
    "dosage_form": "Capsule (Sustained Release)",
    "generic": "Ambroxol Hydrochloride",
    "strength": "75 mg",
    "company": "Square Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5.50",
      "strip_price": "৳ 55.00",
      "pack_size_info": "(3 x 10: ৳ 165.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.50",
          "pack_size_info": "(3 x 10: ৳ 165.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 55.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "15 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/559/ambrox-15-mg-syrup?ref=1"
      },
      {
        "text": "6 mg/ml (Drops)",
        "href": "https://medex.com.bd/brands/560/ambrox-6-mg-pediatric-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambrox SR is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambrox SR should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambrox SR might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambrox SR should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:52.889Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ee8",
    "original_record": {
      "input_index": 746,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ee8"
        },
        "name": "Ambrox SR",
        "strength": "75 mg",
        "generic": "Ambroxol Hydrochloride",
        "company": "Square Pharmaceuticals PLC",
        "medicine_type": "Capsule (Sustained Release)",
        "source_url": "https://medex.com.bd/brands/561/ambrox-sr-75-mg-capsule",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/18093/ambuterol-5-mg-oral-solution",
    "name": "Ambuterol",
    "dosage_form": "Oral Solution",
    "generic": "Bambuterol Hydrochloride",
    "strength": "5 mg/5 ml",
    "company": "APC Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 20.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 20.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/106/bambuterol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambuterol is indicated for",
        "items": [
          "Bronchial asthma",
          "Chronic bronchitis",
          "Emphysema",
          "Other lung diseases where bronchospasm is a complicating factor."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Bambuterol, a prodrug of terbutaline, is a long acting ß2 adrenergic receptor agonist used in the treatment of asthma. Bambuterol is an adrenergic ß2 receptor agonist which predominantly stimulates ß2 receptor, thus producing relaxation of bronchial smooth muscle, inhibition of release of endogenous spasmogens, inhibition of edema caused by endogenous mediators & increased mucocilliary clearance.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Succinylcholin, MAOIs (monoamine oxidase inhibitors), ß2-blockers, corticosteroids, diuretics, muscle relaxants, sympathomimetic xanthine derivatives.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hepatic impairment, liver cirrhosis or severely impaired liver function.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Fatigue, nausea, palpitation, headache, dizziness & tremor.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although no teratogenic effects have been observed in animal after administration of bambuterol, caution is recommended during first trimester of pregnancy. It is not known whether bambuterol or intermediary metabolites pass over to breast milk, so caution is recommended if bambuterol is administered to patients who are breast feeding. Terbutalin passes over to breast milk but an influence on the child is unlikely with therapeutic doses. Transient hypoglycemia has been reported in new born pre-term infants after maternal ß2 agonist treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Dose should be reduced in patients with severely impaired renal function, patiensts with genetic deficiencies of plasma cholineterase, patient with severe ischemic heart disease.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "No case of bambuterol overdosage has yet been reported in human. It is likely that overdosing would result in high levels of terbutaline & therefore the same symptoms & signs may include: headache, anxiety, tremor, nausea, tonic muscle cramps, palpitations, tachycardia & cardiac arrythmias. A fall in blood pressure sometimes occurs after terbutaline overdosage. Laboratory findings: hyperglycaemia and lactacidosis sometimes occur. High doses of ß2-agonists may cause hypokalemia as a result of redistribution of potassium.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Short-acting selective & β2-adrenoceptor stimulants",
    "dosage": [
      {
        "medication_type": "Children 2-5 years",
        "information": ": The recommended normal dose 10 mg (10 ml syrup).",
        "instructions": []
      },
      {
        "medication_type": "Children 6-12 years",
        "information": ": The recommended normal dose 10 mg (10 ml syrup). The dose may be increased to 20 mg.",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": The recommended initial dose 10 mg. The dose may be increased to 20 mg after 1-2 weeks depending on the clinical effect.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:54.207Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eed",
    "original_record": {
      "input_index": 747,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eed"
        },
        "name": "Ambuterol",
        "strength": "5 mg/5 ml",
        "generic": "Bambuterol Hydrochloride",
        "company": "APC Pharma Ltd.",
        "medicine_type": "Oral Solution",
        "source_url": "https://medex.com.bd/brands/18093/ambuterol-5-mg-oral-solution",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30577/amdopril-5-mg-tablet",
    "name": "Amdopril",
    "dosage_form": "Tablet",
    "generic": "Perindopril Arginine + Amlodipine",
    "strength": "5 mg+5 mg",
    "company": "Beximco Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 21.00",
      "strip_price": "৳ 210.00",
      "pack_size_info": "(3 x 10: ৳ 630.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 21.00",
          "pack_size_info": "(3 x 10: ৳ 630.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 210.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1468/perindopril-arginine-amlodipine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amdopril is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. Treatment should not be initiated with Amdopril.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Perindopril, a pro-drug, is hydrolyzed to perindoprilat, which inhibits ACE in humans and in animals. ACE is a peptidyl dipeptidase that catalyzes the conversion of the inactive decapeptide, angiotensin I, to the vasoconstrictor substance angiotensin II. Angiotensin II is a potent peripheral vasoconstrictor, which stimulates aldosterone secretion by the adrenal cortex, and provides negative feedback on renin secretion. Inhibition of ACE results in decreased plasma angiotensin II, leading to decreased vasoconstriction, increased plasma renin activity and decreased aldosterone secretion. The latter results in diuresis and natriuresis and may be associated with an increase in serum potassium Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. Experimental data suggest that amlodipine binds to both dihydropyridine and nondihydropyridine binding sites. The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels. Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells. Negative inotropic effects can be detected in vitro but such effects have not been seen in intact animals at therapeutic doses.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Baclofen may increase the antihypertensive effect of Amdopril. Monitor blood pressure and renal function, and adjust the dose of Amdopril if necessary. Combined use of these medicines may increase the hypotensive effects of perindopril and amlodipine. Combined use with nitroglycerine and other nitrates or other vasodilators, may further reduce blood pressure and therefore should be considered with caution.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This combination is contraindicated:",
        "items": [
          "In patients with a history of previous hypersensitivity to either of the active ingredients; perindopril or amlodipine, ACE inhibitors, dihydropyridines or excipient ingredients present in this combination.",
          "During pregnancy and for lactating women."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most commonly reported adverse reactions with perindopril and amlodipine given separately are: oedema, somnolence, dizziness, headache (especially at the beginning of the treatment), dysgeusia, paraesthesia, visual impairment (including diplopia), tinnitus, vertigo, palpitations, flushing, hypotension (and effects related to hypotension), dyspnoea, cough, abdominal pain, nausea, vomiting, dyspepsia, change of bowel habit, diarrhoea, constipation, pruritus, rash, exanthema, joint swelling (ankle swelling), muscle spasms, fatigue, asthenia.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "This combination should not be initiated during pregnancy and lactation. Patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. When pregnancy is diagnosed, treatment with this combination should be stopped immediately, and, if appropriate, alternative treatment should be started.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As Amdopril contains lactose monohydrate, patients with rare hereditary problems of galactose intolerance, glucose galactose malabsorption, or total lactase deficiency should not take Amdopril. Since ACE inhibitors reduce angiotensin II formation resulting in decreased production of aldosterone, increases in serum potassium have been observed in some patients treated with ACE inhibitors including perindopril. Serum electrolytes (including sodium potassium and urea) should be measured from time to time when ACE inhibitors are given especially in combination with diuretics.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Paediatric use: Use of Amdopril in children is not recommended as no data establishing safety or effectiveness in children are available.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a dry place below 25⁰C. Keep the container tightly closed and protect from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Combined antihypertensive preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "perindopril arginine & amlodipine is as substitution therapy for patients already controlled with separate doses of perindopril (5 or 10 mg) and amlodipine (5 or 10 mg), given concurrently at the dose level. Treatment should not be initiated with this combination. Food intake may reduce hepatic biotransformation of perindopril to perindoprilat. Recommended treatment is one tablet per day as a single dose, preferably to be taken in the morning and before a meal. As perindopril and amlodipine may be used for different clinical indications, dose adjustments should be based on clinical judgment and the individual patient profile. Adjustments can be made by decreasing or increasing the dose of either perindopril and/or amlodipine using separate perindopril and/or amlodipine products within the recommended dose range until clinical stability is re-established. Consult the Product Information of the individual perindopril and/or amlodipine products being used when adjusting the dose. In the event that down-titration is required, adjustments using amlodipine 2.5 mg or a dose of perindopril equivalent to perindopril arginine 2.5 mg, as separate products should be considered until clinical stability is re-established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:55.470Z",
    "medicine_id": "68c3c09aef5b8f2b163a8efa",
    "original_record": {
      "input_index": 748,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8efa"
        },
        "name": "Amdopril",
        "strength": "5 mg+5 mg",
        "generic": "Perindopril Arginine + Amlodipine",
        "company": "Beximco Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/30577/amdopril-5-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/715/amdova-5-mg-tablet",
    "name": "Amdova",
    "dosage_form": "Tablet",
    "generic": "Amlodipine Besilate + Atorvastatin",
    "strength": "5 mg+10 mg",
    "company": "Beximco Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 11.00",
      "strip_price": "৳ 110.00",
      "pack_size_info": "(3 x 10: ৳ 330.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 11.00",
          "pack_size_info": "(3 x 10: ৳ 330.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 110.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/68/amlodipine-besilate-atorvastatin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Patients in whom treatment with Amlodipin and Atorvastatin is appropriate at the dose presented, which include hypertension, chronic stable angina, an adjunct to diet for hypercholesterolemia and in hypertensive patients with multiple risk factors for CHD to reduce the risk of nonfatal MI and nonfatal ... Read morePatients in whom treatment with Amlodipin and Atorvastatin is appropriate at the dose presented, which include hypertension, chronic stable angina, an adjunct to diet for hypercholesterolemia and in hypertensive patients with multiple risk factors for CHD to reduce the risk of nonfatal MI and nonfatal stroke.Amlodipine: Atorvastatin: Atorvastatin is indicated as an adjunct to diet to reduce elevated total cholesterol, LDL- cholesterol, apolipoprotein B and triglyceride levels in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (Fredrickson Types lla and llb), adjunctive therapy to diet for the treatment of patients with elevated serum triglyceride levels (Fredrickson Type IV), for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson Type III) who do not respond adequately to diet, to reduce total-C and LDL-C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are unavailable. At the time of hospitalization for an acute coronary event, consideration can be given to initiating drug therapy at discharge if the LDL-C level is >100 mg/dL (NCEP-ATP III). Prior to initiating therapy with Atorvastatin, secondary causes for hypercholesterolemia (e.g., poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinemias, obstructive liver disease, other drug therapy, and alcoholism) should be excluded, and a lipid profile performed to measure total-C, LDL-C, HDL-C, and TG.",
        "items": [
          "Hypertension: Amlodipine is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents;",
          "Coronary Artery Disease (CAD): Chronic Stable Angina: Amlodipine is indicated for the treatment of chronic stable angina. Amlodipine may be used alone or in combination with other antianginal or antihypertensive agents; Vasospastic",
          "Angina (Prinzmetal's or Variant Angina): Amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine may be used as monotherapy or in combination with other antianginal drugs.",
          "Angiographically Documented CAD: In patients with recently documented CAD by angiography and without heart failure or an ejection fraction <40%, Amlodipine is indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "It is a combination product containing Amlodipine Besilate BP equivalent to 5 mg Amlodipine, a calcium channel blocker and Atorvastatin calcium INN equivalent to 10 mg Atorvastatin, a statin (HMG-CoA reductase inhibitor). Amlodipine is a peripheral arterial vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure. Atorvastatin calcium is a synthetic lipid-lowering agent. It is an inhibitor of 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA). This enzyme catalyzes the conversion of HMG-CoAto mevatonate, an early and rate limiting step in the synthesis of cholesterol.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Drug interaction with atorvastatin: The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (nicotinic acid), erythromycin, azole antifungals. When atorvastatin and antacid suspension containing magnesium and aluminum hydroxide were co administered, plasma concentrations of atorvastatin decreased approximately 35%. However, LDL-C reduction was not altered. Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and atorvastatin were co administered. However, LDL-C reduction was greater when atorvastatin and colestipol were co-administered than when either drug was given alone. When multiple doses of atorvastatin and digoxin were co-administered, steady state plasma digoxin concentrations increased by approximately 20%. Patients taking digoxin should be monitored appropriately. In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with co- administration of atorvastatin and erythromycin. Co- administration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinylestradiol by approximately 30% and 20%. These increases should be considered when selecting an oral contraceptive for a woman taking atorvastatin. Drug interaction with amlodipine: Amlodipine may potentiate the effect of other antihypertensive (e.g.Beta-blockers, ACE inhibitors, Alpha-1-blockers and Diuretics). In clinical interaction studies, Amlodipine did not affect the pharmacokinetics of Atorvastatin, Digoxin, Warfarin or Cyclosporine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Amlodipine: Amlodipine is contraindicated in patients with known hypersensitivity to Amlodipine. Atorvastatin: Contraindicated in hypersensitivity to any component of this medication. Active liver disease or unexplained persistent elevations of serum transaminases exceed three times the upper limit of normal.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Amlodipine",
        "information": ": General: Since the vasodilatation induced by Amlodipine is gradual in onset, acute hypotension has rarely been reported after oral administration of Amlodipine. Nonetheless, caution should be exercised when administering Amlodipine as with any other peripheral vasodilator particularly in patients with severe aortic stenosis. Use in Patients with Congestive Heart Failure: Although hemodynamic studies and a controlled trial in Class-II-III heart failure patients have shown that Amlodipine did not lead to clinical deterioration as measured by exercise tolerance, left ventricular ejection fraction, and clinical symptoms. In general, all calcium channel blockers should be used with caution in patients with heart failure. Beta-blocker Rhabdomyolysis with acute renal failure secondary to myoglobinuria has been reported with other drugs in this class.",
        "items": []
      },
      {
        "title": "Atorvastatin",
        "information": ": Atorvastatin may cause an elevation in serum creatine phosphokinase levels. This should be considered in the differential diagnosis of chest pain in patients on therapy with Atorvastatin. Uncomplicated myalgia has been reported in Atorvastatin-treated patients. Atorvastatin therapy should be discontinued if markedly elevated CPK levels occur or myopathy is diagnosed or suspected. Side effects: Atorvastatin is generally well tolerated. Adverse effects reported commonly include constipation, flatulence, dyspepsia, abdominal pain, headache, nausea, myalgia, diarrhea, asthenia and insomnia.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Safety in pregnancy has not been established. Use of HMG-CoA reductase inhibitors during breastfeeding is not recommended.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Warning: Increased Angina and/or Myocardial Infarction Rarely, patients, particularly those with severe obstructive coronary artery disease, have developed documented increased frequency, duration and/or severity of angina or acute myocardial infarction on starting calcium channel blocker therapy or at the time of dosage increase. The mechanism of this effect has not been elucidated. Liver Dysfunction. HMG-CoA reductase inhibitors, like some other lipid-lowering therapies, have been associated with biochemical abnormalities of liver function. Precaution Amlodipine: General: Since the vasodilatation induced by Amlodipine is gradual in onset, acute hypotension has rarely been reported after oral administration of Amlodipine. Nonetheless, caution should be exercised when administering Amlodipine as with any other peripheral vasodilator particularly in patients with severe aortic stenosis. Use in Patients with Congestive Heart Failure: Although hemodynamic studies and a controlled trial in Class-II-III heart failure patients have shown that Amlodipine did not lead to clinical deterioration as measured by exercise tolerance, left ventricular ejection fraction, and clinical symptoms. In general, all calcium channel blockers should be used with caution in patients with heart failure. Atorvastatin: Rhabdomyolysis with acute renal failure secondary to myoglobinuria has been reported with other drugs in this class. Atorvastatin may cause an elevation in serum creatine phosphokinase levels. This should be considered in the differential diagnosis of chest pain in patients on therapy with Atorvastatin. Uncomplicated myalgia has been reported in Atorvastatin-treated patients. Atorvastatin therapy should be discontinued if markedly elevated CPK levels occur or myopathy is diagnosed or suspected.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatrics",
        "information": ": Safety and efficacy of Atorvastatin have not been established in children.",
        "items": []
      },
      {
        "title": "Geriatrics",
        "information": ": Efficacy and safety in older patients using recommended doses is similar to that seen in the general population.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place. Protect from light and moisture. Keep all medicines out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-anginal & lipid lowering drugs",
    "dosage": [
      {
        "medication_type": "Amlodipine",
        "information": ": The usual initial antihypertensive oral dose is 5 mg once daily with a maximum dose of 10 mg once daily. Elderly individuals or patients with hepatic insufficiency may be started on 2.5 mg once daily dose and this dose may be used when adding Amlodipine to other antihypertensive therapy. Dosage should be adjusted according to each patient's need. The recommended dose for chronic stable or vasospastic angina is 5-10 mg, with the lower dose suggested in the elderly and in patients with hepatic insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Atorvastatin",
        "information": ":",
        "instructions": [
          "The patient should be placed on a standard cholesterol-lowering diet before receiving Atorvastatin and should continue on this diet during treatment with Atorvastatin Hypercholesterolemia (Heterozygous Familial and Nonfamilial) and Mixed Dyslipidemia (Fredrickson Types IIa and IIb): The recommended starting dose of Atorvastatin is 10 mg daily. The dosage range is 10 to 80 mg once daily. Atorvastatin can be administered as a single dose at any time of the day with or without food.",
          "Homozygous Familial Hypercholesterolemia: The dosage of Atorvastatin in patients with homozygous FH is 10 to 80 mg daily.",
          "Patients with renal insufficiency: Renal disease has no influence on the plasma concentrations or lipid effects of Atorvastatin; thus no adjustment of dose is required. Hemodialysis is not expected to significantly enhance the clearance of Atorvastatin since the drug is extensively bound to plasma proteins.",
          "Patients with hepatic dysfunction: In patients with moderate to severe hepatic dysfunction, the therapeutic response to Atorvastatin is unaffected but exposure to the drug is greatly increased."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:56.552Z",
    "medicine_id": "68c3c09aef5b8f2b163a8efb",
    "original_record": {
      "input_index": 749,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8efb"
        },
        "name": "Amdova",
        "strength": "5 mg+10 mg",
        "generic": "Amlodipine Besilate + Atorvastatin",
        "company": "Beximco Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/715/amdova-5-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/5181/ameloss-5-mg-tablet",
    "name": "Ameloss",
    "dosage_form": "Tablet",
    "generic": "Donepezil Hydrochloride",
    "strength": "5 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 10.00",
      "strip_price": "৳ 100.00",
      "pack_size_info": "(3 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.00",
          "pack_size_info": "(3 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/386/donepezil-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ameloss is indicated for the symptomatic treatment of mild to moderate dementia of Alzheimer's type.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Donepezil Hydrochloride is a centrally acting anticholinesterase agent. It binds reversibly with acetylcholinesterase and inactivates it, thus inhibiting hydrolysis of acetylcholine. As a result the concentration of acetylcholine increases at cholinergic synapses in the brain.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Drugs with anticholinergic properties and which cross into the brain, such as atropine, benztropine produce the opposite effects of Ameloss and should be avoided during therapy with donepezil. Medication with carbamazepine, dexamethasone, phenobarbital, phenytoin may reduce the effect of donepezil whereas ketoconazole, quinidine, cimetidine may increase the effects.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Donepezil is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally well tolerated but some patients may experience nausea, vomiting & diarrhoea. These adverse events are of mild intensity and transient, resolving during continued treatment without the need for dose modification. Less frequent side effects are insomnia, fatigue, anorexia, muscle cramps, generalized seizure etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well controlled studies in pregnant woman. Donepezil should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Donepezil Hydrochloride is secreted in human breast milk or not. Donepezil is not indicated in nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be taken in sick sinus syndrome or other supraventricular conduction abnormalities, patients at risk of developing peptic ulcers, asthma, obstructive airway disease and during anaesthetic procedure.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal & hepatic impairment:",
        "information": "A similar dose schedule can be followed for patients with renal or mild to moderate hepatic impairment as clearance of Ameloss is not affected by these conditions.",
        "items": []
      },
      {
        "title": "Use in children:",
        "information": "There are no adequate and well controlled trials in document to safety and efficacy of Ameloss in any illness occurring in children. Ameloss is not recommended for use in children.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Symptoms of overdose includes nausea, vomiting, salivation. Over dosage with very high dose of donepezil may result in cholinergic crisis characterized by severe nausea, vomiting, salivation, bradycardia, hypotension, increasing muscle weakness, respiratory depression, collapse and convulsion. As in any case of over dose, general supportive measures should be utilized. In case of cholinergic crisis hospitalization of the patient is required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Dementia",
    "dosage": [
      {
        "medication_type": null,
        "information": "5 mg once daily orally at bed time. The 5 mg/day dose should be maintained for at least one month in order to allow the earliest clinical responses to treatment to be assessed and to allow steady-state concentrations of donepezil hydrochloride to be achieved. Following a one-month clinical assessment of treatment at 5 mg/day, the dose can be increased to 10 mg/day (once-a-day dosing). Since food does not affect the rate or extent of absorption of donepezil, it can be administered with or without food.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:57.559Z",
    "medicine_id": "68c3c09aef5b8f2b163a8efe",
    "original_record": {
      "input_index": 750,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8efe"
        },
        "name": "Ameloss",
        "strength": "5 mg",
        "generic": "Donepezil Hydrochloride",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/5181/ameloss-5-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/568/amibac-500-mg-injection",
    "name": "Amibac",
    "dosage_form": "IM/IV Injection",
    "generic": "Amikacin",
    "strength": "500 mg/2 ml",
    "company": "Popular Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 48.18",
      "strip_price": null,
      "pack_size_info": "(2 x 5: ৳ 481.80)",
      "packages": [
        {
          "label": "2 ml ampoule",
          "price": "৳ 48.18",
          "pack_size_info": "(2 x 5: ৳ 481.80)"
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      },
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/54/amikacin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amibac is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria. Amibac is effective in bacterial septicemia (including neonatal sepsis); in serious infections of the respiratory tract, bones and joints, central nervous system (including ... Read moreAmibac is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria. Amibac is effective in bacterial septicemia (including neonatal sepsis); in serious infections of the respiratory tract, bones and joints, central nervous system (including meningitis) and skin and soft tissue; intra-abdominal infections (including peritonitis); and in burns and postoperative infections (including postvascular surgery). Clinical studies have shown Amibac also to be effective in serious complicated and recurrent urinary tract infections due to those organisms.Amibac was effective in infections caused by gentamicin and/or tobramycin-resistant strains of Gram-negative organisms, particularly Proteus rettgeri, Providencia stuartii, Serratia marcescens, and Pseudomonas aeruginosa.Amibac has also been shown to be effective in staphylococci infections and may be considered as initial therapy under certain conditions in the treatment of known or suspected staphylococcal disease such as, severe infections where the causative organism may be either a Gram-negative bacterium or a staphylococcus.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Amikacin Sulfate is a semi-synthetic aminoglycoside antibiotic. Amikacin is active in vitro against pseudomonas species, Escherichia coli, Proteus species, Providencia species, Klebsiella-Enterobacter species, Acinetobacter species, and Citrobacter freundii. When strains of the above organisms are found to be resistant to other aminoglycosides, including Gentamicin, TobrAmykin and KanAmykin, many are susceptible to Amikacin. Amikacin sulfate is active in vitro against penicillinase and nonpenicillinase-producing Staphylococcus species including methicillin-resistant strains.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concurrent administration of Amibac with myorelaxants leads to potentiation of their effects and there is a possibility of cessation of the breathing. The combination with other Aminoglycoside antibiotics should be avoided because of the augmentation of their ototoxic and nephrotoxic effects. Concurrent administration of Amibac with fast acting diuretics increases the risk of ototoxicity in patients with renal failure. Combination with Cephalosporins or Polymixins increases the risk of nephrotoxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Amikacin Injection is contraindicated in patients with a known history of hypersensitivity to Amikacin, any constituents of the injection.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The adverse effects have been reported with the use of Amibac are tinnitus, vertigo, partial reversible or irreversible deafness, skin rash, drug fever, headache, paraesthesia, nausea and vomiting.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Amikacin rapidly crosses the placenta into the foetal circulation and amniotic fluid and there is a potential risk of ototoxicity in the foetus. There is no information available regarding the safety of this drug during breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Since Amibac is present in high concentrations in the renal excretory system, patients should be well hydrated to minimize chemical irritation of the renal tubules. If azotemia increases, treatment should be stopped. Monitoring of renal function during treatment with aminoglycosides is particularly important.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Safety and effectiveness of Amibac for injection in children or adolescents under 16 years have not been established",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "In the event of overdose or toxic reaction, peritoneal dialysis or haemodialysis will aid in the removal of Amibac from the blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": "Intramuscular or intravenous administration",
        "information": ": For most infections the intramuscular route is preferred, but in life threatening infections, or in patients in whom intramuscular injection route is not feasible the intravenous route may be used.",
        "items": []
      },
      {
        "title": "Intraperitoneal use",
        "information": ": Amikacin may be used as an irrigant after recovery from anesthesia in concentration of 0.25%.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Aminoglycosides",
    "dosage": [
      {
        "medication_type": "Adults and children",
        "information": ": 15 mg/kg/day in two equally-divided doses (equivalent to 500 mg bid in adults). Use of the 100 mg is recommended for children for the accurate measurement of the appropriate dose.",
        "instructions": []
      },
      {
        "medication_type": "Neonates and premature children",
        "information": ": An initial loading dose of 10 mg/kg followed by 15 mg/kg/day in two equally divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": Amikacin is excreted by the renal route. Renal function should be assessed whenever possible and dosage adjusted as described under impaired renal function.",
        "instructions": []
      },
      {
        "medication_type": "Life-threatening infections and/or those caused by Pseudomonas",
        "information": ": The adult dose may be increased to 500 mg every eight hours but should neither exceed 1.5g/day nor be administered for a period longer than 10 days. A maximum total adult dose of 15g should not be exceeded.",
        "instructions": []
      },
      {
        "medication_type": "Urinary tract infections",
        "information": "(other than pseudomonal infections): 7.5mg/kg/day in two equally divided doses (equivalent to 250 mg b.i.d. in adults).",
        "instructions": []
      },
      {
        "medication_type": "Impaired renal function",
        "information": ": In patients with impaired renal function, the daily dose should be reduced and/or the intervals between doses increased to avoid accumulation of the drug.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:58.887Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f08",
    "original_record": {
      "input_index": 751,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f08"
        },
        "name": "Amibac",
        "strength": "500 mg/2 ml",
        "generic": "Amikacin",
        "company": "Popular Pharmaceuticals Ltd.",
        "medicine_type": "IM/IV Injection",
        "source_url": "https://medex.com.bd/brands/568/amibac-500-mg-injection",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/24603/amiclean-75-mg-tablet",
    "name": "AmiClean",
    "dosage_form": "Tablet",
    "generic": "Sodium Thiosulfate",
    "strength": "7.5 mg",
    "company": "Amico Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 0.60",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 60.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 0.60",
          "pack_size_info": "(100's pack: ৳ 60.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "15 mg (Tablet)",
        "href": "https://medex.com.bd/brands/24604/amiclean-15-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1003/sodium-thiosulfate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "AmiClean is indicated for sequential use with sodium nitrite for treatment of acute cyanide poisoning that is judged to be life threatening. Use with caution if the diagnosis of cyanide poisoning is uncertain.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Sodium thiosulfate acts as an antidote in the treatment of cyanide poisoning. It acts as a sulphur-donating substrate for the enzyme rhodanese, thus speeding up the conversion of cyanide to thiocyanide, which is relatively non toxic. It is often used in combination with sodium nitrite but may be used alone in less severe poisoning.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Formal drug interaction studies have not been conducted with AmiClean.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Osmotic disturbances. Oral: catharsis (at high doses).",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. There are no adequate and well controlled studies in pregnant women. Sodium Thiosulfate Injection should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether sodium thiosulfate is excreted in human milk. Because Sodium Thiosulfate Injection may be administered in life-threatening situations, breast-feeding is not a contraindication to its use. Because many drugs are excreted in human milk, caution should be exercised following Sodium Thiosulfate Injection administration to a nursing woman. There are no data to determine when breastfeeding may be safely restarted following administration of sodium thiosulfate.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "AmiClean drug product may contain trace impurities of sodium sulfite. The presence of a trace amount of sulfites in AmiClean should not deter administration of the drug for treatment of emergency situations, even if the patient is sulfite-sensitive.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": There are case reports in the medical literature of sodium nitrite in conjunction with AmiClean being administered to pediatric patients with cyanide poisoning; however, there have been no clinical studies to evaluate the safety or efficacy of AmiClean in the pediatric population.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": AmiClean is known to be substantially excreted by the kidney, and the risk of adverse reactions to AmiClean may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is limited information about the effects of large doses of AmiClean in humans. Oral administration of 3 g AmiClean per day for 1-2 weeks in humans resulted in reductions in room air arterial oxygen saturation to as low as 75%, which was due to a rightward shift in the oxygen hemoglobin dissociation curve. The subjects returned to baseline oxygen saturations 1 week after discontinuation of AmiClean. A single intravenous administration of 20 mL of 10% AmiClean reportedly did not change oxygen saturations.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at controlled room temperature between 20°C and 25°C. Protect from direct light. Do not freeze.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antidote preparations",
    "dosage": [
      {
        "medication_type": "Adult:",
        "information": "To be given after 300 mg of sodium nitrite has been admin over 5-20 min: 12.5 g of sodium thiosulfate (50 ml of a 25% solution or 25 ml of a 50% solution) given over 10 min. Methaemoglobin concentration should not exceed 30-40%. If symptoms of cyanide toxicity recur, the doses of nitrite and thiosulfate may be repeated after 30 min at half the initial doses.",
        "instructions": []
      },
      {
        "medication_type": "Child:",
        "information": "To be given after 4-10 mg/kg of sodium nitrite (max: 300 mg) has been admin: 400 mg/kg of sodium thiosulfate, as a 25 or 50% solution (max: 12.5 g). Methaemoglobin concentration should not exceed 30-40%. If symptoms of cyanide toxicity recur, the doses of nitrite and thiosulfate may be repeated after 30 min at half the initial doses.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:24:59.839Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f0a",
    "original_record": {
      "input_index": 752,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f0a"
        },
        "name": "AmiClean",
        "strength": "7.5 mg",
        "generic": "Sodium Thiosulfate",
        "company": "Amico Laboratories Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/24603/amiclean-75-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/20436/amelex-05-mg-tablet",
    "name": "Amelex",
    "dosage_form": "Tablet",
    "generic": "Flupentixol + Melitracen",
    "strength": "0.5 mg+10 mg",
    "company": "Apollo Pharmaceutical Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/485/flupentixol-melitracen/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Flupentixol and Melitracen tablet is indicated in-",
        "items": [
          "Anxiety",
          "Depression",
          "Apathy",
          "Psychogenic depression.",
          "Depressive neurosses.",
          "Masked depression.",
          "Psychosomatic affections accompanied by anxiety and apathy.",
          "Menopausal depressions.",
          "Dysphoria and depression in alcoholics and drug addicts."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This consists of two well known and well proven compounds: flupentixol-a neuroleptic with anxiolytic and antidepressant properties of its own when given in small doses, and melitracen-a bipolar thymoleptic with activating properties in low doses. In combination the compounds render a preparation with antidepressant, anxiolytic and activating properties. Maximal serum concentration is reached in about 4 hours after oral administration of flupentixol and in about 4 hours after oral administration of melitracen. The biological half-life of flupentixol is about 35 hours and that of melitracen is about 19 hours. The combination of flupentixol and melitracen does not seem to influence the pharmacokinetic properties of the individual compounds.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "This tablet may enhance the response to alcohol, barbiturates and other CNS depressants. Simultaneous administration of MAO-inhibitors may cause hypertensive crises. Neuroleptics and thymoleptics reduce the antihypertensive effect of guanethidine and similar acting compounds and thymoleptics enhance the effects of adrenaline and noradrenaline.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "The immediate recovery phase after myocardial infarction.",
          "Defects in bundle-branch conduction.",
          "Untreated narrow-angle glaucoma.",
          "Acute alcohol, barbiturate and opiate intoxications.",
          "This tablet should not be given to patients who have received an MAO-inhibitor within two weeks.",
          "Not recommended for excitable or overactive patients since its activating effect may lead to exaggeration of these characteristics."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In the recommended doses side effects are rare. These could be transient restlessness and insomnia.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "This tablet should preferably not be given during pregnancy and lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "If previously the patient has been treated with tranquillizers with sedative effect these should be withdrawn gradually.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In cases of overdosage the symptoms of intoxications by melitracen, especially of anticholinergic nature, dominate. More rarely extrapyramidal symptoms due to flupentixol occur. Symptomatic and Supportive. Gastric lavage should be carried out as soon as possible and activated charcoal may be administered. Measures aimed at supporting the respiratory and cardiovascular systems should be instituted. Epinephrine (adrenaline) must not be used for such patients. Convulsions may be treated with diazepam and extrapyramidal symptoms with biperiden.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at a temperature not exceeding 30°C in a dry place. Protect from light. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Combined anxiolytics & anti-depressant drugs",
    "dosage": [
      {
        "medication_type": "Adults",
        "information": ": Usually 2 tablets orally daily in the morning and noon. In severe cases, the morning dose may be increased to 2 tablets.",
        "instructions": []
      },
      {
        "medication_type": "Elderly patients",
        "information": ": 1 tablet in the morning.",
        "instructions": []
      },
      {
        "medication_type": "Maintenance dose",
        "information": ": Usually 1 tablet orally in the morning. In cases of insomnia or severe restlessness, additional treatment with a sedative in the acute phase is recommended.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Amelex 0.5 mg+10 mg Tablet?",
        "answer": [
          "Amelex 0.5 mg+10 mg Tablet consists of Flupentixol & Melitracen. This is used to treat in Anxiety, Depression, Apathym, Psychogenic depression, Depressive neurosses, Masked depression, Menopausal depressions."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Amelex 0.5 mg+10 mg Tablet helps treat anxiety and depression.",
          "Use caution while driving or doing anything that requires concentration as Amelex 0.5 mg+10 mg Tablet can cause dizziness and sleepiness.",
          "Avoid drinking alcohol while taking Amelex 0.5 mg+10 mg Tablet because Amelex 0.5 mg+10 mg Tablet can make drowsiness worse.",
          "Amelex 0.5 mg+10 mg Tablet can cause changes in your blood sugar levels. Monitor your blood sugar regularly.",
          "Inform your doctor if you have liver disease, thyroid disorder, severe heart disease, or a urinary disorder.",
          "Talk to your doctor if you notice sudden mood changes or develop suicidal thoughts.",
          "Let your doctor know you are taking Amelex 0.5 mg+10 mg Tablet before undergoing any surgical procedure."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:01.452Z",
    "medicine_id": "68c3c09aef5b8f2b163a8efd",
    "original_record": {
      "input_index": 753,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8efd"
        },
        "name": "Amelex",
        "strength": "0.5 mg+10 mg",
        "generic": "Flupentixol + Melitracen",
        "company": "Apollo Pharmaceutical Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/20436/amelex-05-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34196/ameloss-m-14-mg-capsule",
    "name": "Ameloss M",
    "dosage_form": "Capsule (Extended Release)",
    "generic": "Memantine + Donepezil",
    "strength": "14 mg+10 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": "৳ 250.00",
      "pack_size_info": "(2 x 10: ৳ 500.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 25.00",
          "pack_size_info": "(2 x 10: ৳ 500.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 250.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "7 mg+10 mg (Capsule)",
        "href": "https://medex.com.bd/brands/34195/ameloss-m-7-mg-capsule?ref=1"
      },
      {
        "text": "28 mg+10 mg (Capsule)",
        "href": "https://medex.com.bd/brands/34197/ameloss-m-28-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1658/memantine-donepezil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Memantine and donepezil hydrochlorides extended-release capsules are a combination of memantine hydrochloride, an NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor, indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Memantine and donepezil hydrochlorides extended-release capsules contain two approved medications: memantine hydrochloride extended-release and donepezil hydrochloride. Each of those medications is postulated to have a different mechanism in Alzheimer’s disease.",
        "items": []
      },
      {
        "title": "Memantine",
        "information": ": Persistent activation of central nervous system NMDA receptors by the excitatory amino acid glutamate has been hypothesized to contribute to the symptomatology of Alzheimer’s disease. Memantine is postulated to exert its therapeutic effect through its action as a low to moderate affinity uncompetitive (open channel) NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels. There is no evidence that memantine prevents or slows neurodegeneration in patients with Alzheimer’s disease.",
        "items": []
      },
      {
        "title": "Donepezil",
        "information": ": Current theories on the pathogenesis of the cognitive signs and symptoms of Alzheimer’s disease attribute some of them to a deficiency of cholinergic neurotransmission. Donepezil is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine in the central nervous system through reversible inhibition of its hydrolysis by acetylcholinesterase. There is no evidence that donepezil prevents or slows neurodegeneration in patients with Alzheimer’s disease.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Combined use with NMDA antagonists: use with caution. Memantine and donepezil hydrochlorides extended-release may interfere with anticholinergic medications. Concomitant administration of succinylcholine, similar neuromuscular blocking agents, or cholinergic agonists may lead to synergistic effect.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Memantine and donepezil hydrochlorides extended-release capsules are contraindicated in patients with known hypersensitivity to memantine hydrochloride, donepezil hydrochloride, piperidine derivatives, or to any excipients used in the formulation.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse reactions, occurring at a frequency of at least 5% and greater than placebo with memantine hydrochloride extended-release 28 mg/day, were headache, diarrhea, and dizziness. The most common adverse reactions occurring at a frequency of at least 5% in patients receiving donepezil and at twice or more the placebo rate, include diarrhea, anorexia, vomiting, nausea, and ecchymosis.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data on the developmental risk associated with the use of memantine and donepezil hydrochlorides extended-release capsules or its active ingredients (memantine hydrochloride and donepezil hydrochloride) in pregnant women. There are no data on the presence of memantine or donepezil in human milk, the effects on the breastfed infant, or the effects of memantine and donepezil hydrochlorides extended-release capsules or its metabolites on milk production.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Memantine and donepezil hydrochlorides extended-release is likely to exaggerate succinylcholine-type muscle relaxation during anesthesia.",
          "Memantine and donepezil hydrochlorides extended-release may have vagotonic effects on the sinoatrial and atrioventricular nodes manifesting as bradycardia or heart block.",
          "Monitor patients for symptoms of active or occult gastrointestinal bleeding, especially those at increased risk for developing ulcers.",
          "Memantine and donepezil hydrochlorides extended-release can cause diarrhea, nausea, and vomiting.",
          "Memantine and donepezil hydrochlorides extended-release may cause bladder outflow obstructions.",
          "Conditions that raise urine pH may decrease the urinary elimination of memantine, resulting in increased plasma levels of memantine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Safety and effectiveness of memantine and donepezil hydrochlorides extended-release in pediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Renal Impairment",
        "information": ": No dosage adjustment is needed in patients with mild or moderate renal impairment.",
        "items": []
      },
      {
        "title": "Hepatic Impairment",
        "information": ": No dosage adjustment is needed in patients with mild or moderate hepatic impairment. Memantine and donepezil hydrochlorides extended-release has not been studied in patients with severe hepatic impairment",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-Alzheimer drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "For patients on donepezil hydrochloride 10 mg only, the recommended starting dose of memantine and donepezil hydrochlorides extended-release capsules is 7 mg/10 mg, taken once daily in the evening. The dose should be increased in 7 mg increments to the recommended maintenance dose of 28 mg/10 mg. The minimum recommended interval between dose increases is one week. Patients on memantine hydrochloride (10 mg twice daily or 28 mg extended-release once daily) and donepezil hydrochloride 10 mg once daily can be switched to memantine and donepezil hydrochlorides extended- release capsules 28 mg/10 mg, taken once daily in the evening. Memantine and donepezil hydrochlorides extended- release capsules can be taken with or without food, whole or sprinkled on applesauce; do not divide, chew, or crush. Severe renal impairment: the recommended maintenance dose for memantine and donepezil hydrochlorides extended-release capsules is 14 mg/10 mg once daily in the evening.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:02.422Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eff",
    "original_record": {
      "input_index": 754,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eff"
        },
        "name": "Ameloss M",
        "strength": "14 mg+10 mg",
        "generic": "Memantine + Donepezil",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Capsule (Extended Release)",
        "source_url": "https://medex.com.bd/brands/34196/ameloss-m-14-mg-capsule",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/10059/amezol-200-mg-suspension",
    "name": "Amezol",
    "dosage_form": "Oral Suspension",
    "generic": "Metronidazole",
    "strength": "200 mg/5 ml",
    "company": "Cosmic Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 28.50",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 28.50",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "400 mg (Tablet)",
        "href": "https://medex.com.bd/brands/10058/amezol-400-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/751/metronidazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amezol is indicated in the treatment of following diseases: Amezol is indicated in the treatment of following diseases:",
        "items": [
          "The prevention of post-operative infections due to anaerobic bacteria (particularly species of bacteroides and anaerobic streptococci).",
          "The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, pelvic abscess, pelvic cellulitis and post-operative wound infections caused by anaerobes.",
          "The prevention of post-operative infections due to anaerobic bacteria (particularly species of bacteroides and anaerobic streptococci).",
          "The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, pelvic abscess, pelvic cellulitis and post-operative wound infections caused by anaerobes.",
          "In the treatment of urogenital trichomoniasis.",
          "Bacterial vaginosis (also known as non-specific vaginitis).",
          "All forms of amoebiasis (intestinal, extra-intestinal disease and that of symptomless cyst passers).",
          "Giardiasis.",
          "Acute ulcerative gingivitis.",
          "Anaerobically infected leg ulcers and pressure sores.",
          "Acute dental infections due to anaerobic organisms.",
          "Antibiotic associated pseudomembranus colitis."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Metronidazole is a member of the imidazole class of antibacterial drug and is classified therapeutically as an antiprotozoal agent. The 5-nitro group of Metronidazole is reduced by anaerobes metabolically. Studies have demonstrated that the reduced form of this drug interacts with DNA and gives bactericidal action of Metronidazole.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": null,
        "items": [
          "Disulfiram: Psychotic reactions have been reported in patients who were using Amezol and disulfiram concurrently.",
          "Alcohol: Alcoholic beverages and drugs containing alcohol should not be consumed during therapy and for at least one day afterwards because of the possibility of a disulfiram-like (antabuse effect) reaction (flushing, vomiting, tachycardia). Oral anticoagulant therapy (warfarin type): Potentiation of the anticoagulant effect and increased hemorrhagic risk caused by decreased hepatic catabolism. In case of co-administration, prothrombin time should be more frequently monitored and anticoagulant therapy adjusted during treatment with Amezol.",
          "Lithium: Plasma levels of lithium may be increased by Amezol.",
          "Cyclosporin: Serum cyclosporin and serum creatinine should be closely monitored when co-administration is necessary.",
          "Phenytoin or phenobarbital: increased elimination of Amezol resulting in reduced plasma levels.",
          "5-Fluorouracil: Reduced clearance of 5-fluorouracil resulting in increased toxicity of 5-fluorouracil.",
          "Busulfan: Plasma levels of busulfan may be increased by Amezol, which may lead to severe busulfan toxicity."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Metronidazole is contraindicated in patients with a history of hypersensitivity to Metronidazole or other Nitroimidazole derivatives.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Metallic taste, nausea, vomiting, diarrhoea, drowsiness, rashes may be observed during treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Metronidazole is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Metronidazole have been shown to be excreted in human milk. So, caution should be exercised when Metronidazole is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "If for compelling reasons, Amezol must be administered longer than the usually recommended duration, it is recommended that hematological tests, especially leucocyte count should be carried out regularly and that patients should be monitored for adverse reactions such as peripheral or central neuropathy (such as paresthesia, ataxia, dizziness, convulsive seizures).",
          "Amezol should be administered with caution to patients with hepatic encephalopathy.",
          "Patients should be warned that Amezol may darken urine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic impairment",
        "information": ": Amezol is mainly metabolised by hepatic oxidation. Substantial impairment of Amezol clearance may occur in the presence of advanced hepatic insufficiency. Significant cumulation may occur in patients with hepatic encephalopathy and the resulting high plasma concentrations of Amezol may contribute to the symptoms of the encephalopathy. Amezol should therefore, be administered with caution to patients with hepatic encephalopathy. The daily dosage should be reduced to one third and may be administered once daily. Patients should be warned that Amezol may darken urine.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": The elimination half-life of Amezol remains unchanged in the presence of renal failure. The dosage of Amezol therefore needs no reduction. Such patients however retain the metabolites of Amezol. The clinical significance of this is not known at present. In patients undergoing haemodialysis Amezol and metabolites are efficiently removed during an eight hour period of dialysis. Amezol should therefore be re-administered immediately after haemodialysis. No routine adjustment in the dosage of Amezol need be made in patients with renal failure undergoing intermittent peritoneal dialysis (IDP) or continuous ambulatory peritoneal dialysis (CAPD).",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Single oral doses of Amezol, up to 12 g have been reported in suicide attempts and accidental overdoses. Symptoms were limited to vomiting, ataxia and slight disorientation. There is no specific antidote for Amezol overdosages. In case of suspected massive overdosages, a symptomatic and supportive treatment should be instituted.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C. Keep protected from light. Keep medicines out of the reach of children. Do not use later than the date of expiry.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Amoebicides, Anti-diarrhoeal Antiprotozoal",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet and Suspension: Trichomoniasis (Adults & Children over 10 yrs)- Trichomoniasis (Children)- Intestinal amoebiasis (Adults & Children over 10 yrs)- Intestinal amoebiasis (Children)- Extra-intestinal & Asymptomatic amoebiasis (Adults & Children over 10 yrs)- Extra-intestinal & Asymptomatic amoebiasis (Children)- Giardiasis (Adults & Children over 10 yrs)- Giardiasis (Children)- Acute ulcerative gingivitis (Adults & Children over 10 yrs)- Acute ulcerative gingivitis (Children)- Acute dental infections (Adults & Children over 10 yrs)- Bacterial Vaginosis (Adults & Children over 10 yrs)- Leg ulcers and pressure sores (Adults & Children over 10 yrs)- Anaerobic infections (Adults & Children over 10 yrs)- Anaerobic infections (Children)- Surgical prophylaxis (Adults & Children over 10 yrs)- Surgical prophylaxis (Children)- Vaginal Gel: The recommended dose is one applicator full of Metronidazole gel (approximately 5 grams containing approximately 37.5 mg of Metronidazole) intravaginally once or twice a day for 5 days. For once a day dosing, Metronidazole gel should be administered at bedtime. Suppository: Anaerobic Infections-",
        "instructions": [
          "200 mg tid or 400 mg bid for 7 days",
          "800 mg in the morning and 1-2 gm at night for 2 days",
          "2 gm as a single dose for 1 days",
          "Children 7-10 yrs: 100 mg tid",
          "Children 3-7 yrs: 100 mg bid",
          "Children 1-3 yrs: 50 mg tid",
          "800 mg tid for 5 days",
          "Children 7-10 yrs: 400 mg tid",
          "Children 3-7 yrs: 200 mg qid",
          "Children 1-3 yrs: 200 mg tid",
          "400-800 mg tid for 5-10 days",
          "Children 7-10 yrs: 200-400 mg tid",
          "Children 3-7 yrs: 100-200 mg qid",
          "Children 1-3 yrs: 100-200 mg tid",
          "2 gm once daily for 3 days",
          "Children 7-10 yrs: 1 gm once daily",
          "Children 3-7 yrs: 600-800 mg once daily",
          "Children 1-3 yrs: 500 mg once daily",
          "200 mg tid for 3 days",
          "Children 7-10 yrs: 100 mg tid",
          "Children 3-7 yrs: 100 mg bid",
          "Children 1-3 yrs: 50 mg tid",
          "200 mg tid for 3-7 days",
          "400 mg bid for 7 days",
          "2 gm as a single dose for 1 days",
          "400 mg tid for 7 days",
          "800 mg initially and then 400 mg tid for 7 days",
          "Children 1-10 yrs: 7.5 mg/kg tid",
          "400 mg tid started 24 hours before surgery for 1 days",
          "Children 1-10 yrs: 7.5 mg/kg tid"
        ]
      },
      {
        "medication_type": "Adults",
        "information": ": 1 g every 8 hours for 3 days, then 1 g every 12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 5-10 years: 500 mg every 8 hours for 3 days, then every 12 hours, Over 10 years adult dose.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Surgical Prophylaxis-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": 1 g 2 hours before surgery; up to 3 further doses of 1 g may be given every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 5-10 years: 500 mg 2 hours before surgery; up to 3 further doses of 500 mg may be given every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "IV Infusion: Metronidazole intravenous infusion requires no dilution and should not be mixed with any other drugs prior to administration.",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 12 years",
        "information": ": Infuse 500 mg 8 hourly at a rate of 5 ml/minute and a maximum of 4 g should not be exceeded during a 24-hour period. Treatment for 7 days is sufficient for most patients, but treatment can be extended, especially for cases where reinfection is likely. For surgical prophylaxis, administration shortly before surgery should be followed by 8-hourly doses for the next 24 hours.",
        "instructions": []
      },
      {
        "medication_type": "Children under 12 years",
        "information": ": 7.5 mg/kg body weight/day every 8 hours at a rate of 5 ml/minute.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Amezol 200 mg/5 ml Suspension?",
        "answer": [
          "Amezol 200 mg/5 ml Suspension is an antibiotic medication that performs its action by preventing the growth of bacterias and parasites."
        ]
      },
      {
        "question": "What are the uses of Amezol 200 mg/5 ml Suspension?",
        "answer": [
          "Amezol 200 mg/5 ml Suspension is used for the treatment and prevention from viral and parasitic infections. It also prevents bacterial infections such as cold, cough, flu and vaginal infections. It also controls liver, skin, joints, brain and respiratory tract infections."
        ]
      },
      {
        "question": "What are the side effects of Amezol 200 mg/5 ml Suspension?",
        "answer": [
          "Some side effects of Amezol 200 mg/5 ml Suspension which are diarrhoea, headache, weakness, painful urination, trouble sleeping, numbness, muscle weakness and mouth ulcer."
        ]
      },
      {
        "question": "How long do I need to use Amezol 200 mg/5 ml Suspension before I see improvement of my conditions?",
        "answer": [
          "Amezol 200 mg/5 ml Suspension takes 1 or 2 days before you see an improvement in your health conditions."
        ]
      },
      {
        "question": "What are the contraindications to Amezol 200 mg/5 ml Suspension?",
        "answer": [
          "Amezol 200 mg/5 ml Suspension should not be used if you have the following conditions such as hives, flushing, nasal congestion, dryness of the mouth, fever, etc."
        ]
      },
      {
        "question": "Is Amezol 200 mg/5 ml Suspension safe to use when pregnant?",
        "answer": [
          "Amezol 200 mg/5 ml Suspension is not recommended for use in pregnant women unless absolutely necessary."
        ]
      },
      {
        "question": "Will Amezol 200 mg/5 ml Suspension be more effective if taken in more than the recommended dose?",
        "answer": [
          "No, taking higher than the recommended dose of Amezol 200 mg/5 ml Suspension lead to increased chances of side effects such as diarrhoea, excessive production of urine, headache, nausea, pain in the upper part of the stomach, painful and difficult urination, serious eating disorder (anorexia), etc."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Amezol 200 mg/5 ml Suspension treats infections caused by bacteria and parasites.",
          "Amezol 200 mg/5 ml Suspension may cause side effects like nausea, stomach upset, and a metallic taste in the mouth.",
          "Amezol 200 mg/5 ml Suspension used in a high dose or for a prolonged time increases the risk of side effects such as nerve damage. Take it only as prescribed by your doctor.",
          "Do not drink alcohol during or for 2-3 days after treatment with this medicine. You may develop nausea, vomiting, flushing and headache.",
          "Inform your doctor if you have liver disease. Your dose may need to be adjusted in severe liver disease."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:03.580Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f04",
    "original_record": {
      "input_index": 755,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f04"
        },
        "name": "Amezol",
        "strength": "200 mg/5 ml",
        "generic": "Metronidazole",
        "company": "Cosmic Pharma Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/10059/amezol-200-mg-suspension",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/789/amicard-plus-5-mg-tablet",
    "name": "Amicard Plus",
    "dosage_form": "Tablet",
    "generic": "Amlodipine Besilate + Atenolol",
    "strength": "5 mg+50 mg",
    "company": "Aexim Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 8.00",
      "strip_price": "৳ 80.00",
      "pack_size_info": "(5 x 10: ৳ 400.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.00",
          "pack_size_info": "(5 x 10: ৳ 400.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 80.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/63/amlodipine-besilate-atenolol/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This is indicated in-",
        "items": [
          "Patients with essential hypertension",
          "Patients with angina pectoris & hypertension as co-existing diseases",
          "ln post Ml patients",
          "ln patients with refractory angina pectoris where nitrate therapy has failed."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a fixed-dose combination of Amlodipine and Atenolol. Amlodipine is a dihydropyridine calcium antagonist that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle; it has a greater effect on vascular smooth muscle than on cardiac muscle. Amlodipine is a peripheral vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure. Amlodipine reduces tone, decreases coronary vasoreactivity and lowers cardiac demand by reducing afterload. Atenolol is a cardioselective beta-blocker. The cardio-selectivity is dose-related. Atenolol causes a reduction in blood pressure by lowering cardiac output, decreasing the plasma renin activity and sympathetic outflow from CNS. Atenolol also causes a reduction in myocardial oxygen demand by virtue of its negative inotropic and negative chronotropic effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Disopyramide",
        "information": ": Atenolol reduces the clearance of disopyramide by 20%. Additive negative inotropic effects on the heart may be produced.",
        "items": []
      },
      {
        "title": "Ampicillin",
        "information": ": at doses of 1 gm and above may reduce Atenolol levels.",
        "items": []
      },
      {
        "title": "Oral antidiabetics and insulin",
        "information": ": Beta-blockers may decrease tissue sensitivity to insulin and inhibit insulin secretion e.g. in response to oral antidiabetics. Atenolol has less potential for these actions.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to either component, sinus bradycardia, second and higher degrees of heart block, cardiogenic shock, hypotension, congestive heart failure, poor left ventricular function.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The combination of Amlodipine and Atenolol is well tolerated. Overall side-effects include fatigue, headache, edema, nausea, drowsiness, anxiety and depression.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The combination should be used during pregnancy only if the expected benefit outweighs the potential fetal risk. The combination should not be used by nursing mothers. If its use is considered necessary, breast-feeding should be stopped.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Bronchospasm",
        "information": ": The combination should be used with caution in patients with airway obstruction.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": The combination can be used in patients with renal impairment. However, caution may be necessary if the creatinine clearance is less than 30 ml/min because of possible reduction in the excretion of unchanged Atenolol.",
        "items": []
      },
      {
        "title": "Hepatic impairment",
        "information": ": Caution may be necessary in the use of the combination in patients with severe liver damage because of prolongation of the elimination half-life of Amlodipine.",
        "items": []
      },
      {
        "title": "Drug withdrawal",
        "information": ": Since coronary heart disease may exist without being recognized, patients should be warned against stopping the drug suddenly. Any discontinuation should be gradual and under observation.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Though not documented, hypotension and less frequently congestive cardiac failure may occur in cases of overdosage. Unabsorbed drugs may be removed by gastric lavage or administration of activated charcoal. Symptomatic treatment is suggested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Combined antihypertensive preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended dosage is Amlodipine and Atenolol 5/25 mg tablet once daily. If necessary, the dosage may be increased to 5/25 mg two tablets daily or as advised by the physicians. The dosage however should be individualized.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:04.808Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f09",
    "original_record": {
      "input_index": 756,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f09"
        },
        "name": "Amicard Plus",
        "strength": "5 mg+50 mg",
        "generic": "Amlodipine Besilate + Atenolol",
        "company": "Aexim Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/789/amicard-plus-5-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34198/amidol-370-mg-injection",
    "name": "Amidol",
    "dosage_form": "Injection",
    "generic": "Iopamidol",
    "strength": "370 mg/100 ml",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 2,636.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml vial",
          "price": "৳ 2,636.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "370 mg/50 ml (Injection)",
        "href": "https://medex.com.bd/brands/21057/amidol-370-mg-injection?ref=1"
      },
      {
        "text": "300 mg/50 ml (Injection)",
        "href": "https://medex.com.bd/brands/21058/amidol-300-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/623/iopamidol/brand-names",
    "indications": [
      {
        "title": "Neuroradiology:",
        "information": "Lumber myelography, thoraco-cervical myelography.",
        "items": []
      },
      {
        "title": "Angiography:",
        "information": "Cerebral angiography, selective coronary angiography, left ventriculography, aortography, angiocadiography, selective visceral arteriography, peripheral arteriography, digital subtraction angiography, venography, urography.",
        "items": []
      },
      {
        "title": "Other diagnostic procedures:",
        "information": "Contrast enhancement in CT scanning, arthrography, fistulography.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Iopamidol, an organic Iodine compound and used as a non-ionic water soluble radiographic contrast medium. Iopamidol blocks X-rays as they pass through the body, thereby allowing body structures not containing Iodine to be visualized. The degree of opacity produced by Iopamidol is directly proportional to the total amount of the iodinated contrast agent in the path of the X-rays. The visualization of body structures is dependent upon the distribution and elimination of Iopamidol.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Thyroid function test-use of Amidol 370/300 may interfere with tests or thyroid function. Biguanide oral anti-diabetic agents e.g. Metformin, are excreted unchanged through the kidneys. They therefore compete for excretion in the kidneys with contrast media and this could lead to reduction in kidney function. Patient with NIDDM who are taking Metformin or other biguanides should therefore be instructed not to take any doses of Metformin for 48 hours before or 48 hours after the x-ray examination.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "There are no definite or absolute contraindications to the use of Amidol, with the possible exception of waldenstrom's macroglobulinemia, multiple myeloma and severe liver and kidney disease.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The use of organic Iodine compounds may cause untoward side effects and manifestations of anaphylaxis. The symptoms include nausea, vomiting, widespread erythema, generalized heat sensation, headache, coryza, fever, sweating, asthenia, dizziness, pallor, dyspnea, and moderate hypotension. Skin reactions occur in the form of various types of rash or diffuse blister formation. More severe reactions involving the cardiovascular system such as peripheral vasodilation with pronounced hypotension, tachycardia, dyspnea, agitation, cyanosis and loss of consciousness, may require emergency treatment. During intracardiac and /or coronary arteriography, ventricular arrhythmia may infrequently occur. Hyperthyroidism may recur in patients previously treated for graves disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "In pregnant women, Iopamidol injection should be administered only if the procedure is considered essential by the physician. Fertility and mutagenicity studies have shown that Iopamidol has no influence on these parameters. Teratogenicity studies in rats and rabbits have shown no influence of Iopamidol up to 8.2 g/kg (rat) and 4.1 g/kg (rabbit).",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Amidol 370/300 should not be drawn into the syringe until immediately before use. The bottle, once opened, must be used immediately. In consideration of possible serious side effect the use of organoiodinate contrast media should be limited to cases for which there is a precise need for radiographic contrast examination. This should be evaluated according to clinical status of the patient, in particular in relation to pathologies of the cardiovascular, urinary or hepatobiliary system. In particular contrast media designed for cardioangiography should be used in hospitals or clinics equipped and staffed for intensive care in emergencies. For other diagnostic procedures requiring the use of iodinised contrast media, in the public or institutions where such procedures take place, resuscitation equipment and therapeutic measures should be immediately available. When examining small children or babies, do not limit fluid intake before administering a hypertonic contrast solution. Also correct any existing water and electrolyte imbalance. X-ray examination of woman should also, if possible be conducted during the pre-ovulation phage of menstrual cycle. In patients scheduled for thyroid examination with a radioactive Iodine tracer, one must take into consideration that Iodine uptake in the thyroid gland will be reduced for several days (up to two weeks) after dosing with an iodinised contrast medium that is eliminated through kidney. Biguanide oral anti diabetic agents e.g. Metformin, are excreted unchanged through the kidneys. They therefore compete for excretion in the kidneys with contrast media and this could lead to reduction in kidney function. Patient with NIDDM who are taking Metformin or other biguanides should therefore be instructed not to take any doses of Metformin for 48 hours before and 48 hours after the X-ray examination.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Treatments of an overdose is directed toward the support of all vital functions and prompt institution of symptomatic therapy.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep Amidol away from light. Store below 30°C. Exceptionally crystallization of Amidol injections can occur. It has been shown that such a phenomenon is caused by a damaged container and therefore the product should not be used in this case. The bottle once opened, must be used immediately. Any residue of contrast medium must be discarded.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Neuroradiology: Angiography: Urography:",
        "items": [
          "Lumber myelography: A slow sub-arachnoid injection is made through a fine lumber puncture needle into one of the lower interspinous spaces (L3-L4 or L4-L5). Optimum contrast appears immediately after injections and films should be obtained promptly.",
          "Thoraco-cervical myelography: Following a slow sub-arachnoid injection the patient should be turned on his/her side and tilted 10-20 degree head down under fluoroscopic control. In this manner it is possible to control movement of the contrast medium column into the dorsal region.",
          "If the cervical region is to be examined, the contrast medium should be run into the cervical region first, before the examination of the dorsal areas where it is progressively diluted. Iopamidol 300/370 may also be injected sub-occipitally or by lateral puncture technique. Care should be taken to ensure that the contrast medium does not move intracranially. It is generally recommended that in intrathecal use the patient should remain with a raised bed head and be kept well hydrated; following hydration it is preferable that the patient be allowed to be ambulatory.",
          "Cerebral angiography: Any current technique is suitable for radiological visualization of the cerebral vasculature with Iopamidol 370/300 injection. Carotid and vertebral angiography, performed by catheterization or percutaneous injection techniques, require rapid injection which, if necessary, may be repeated.",
          "Peripheral arteriography and venography: Percutaneous injection into the appropriate blood vessel is used for visualization of peripheral arteries and veins.",
          "Angiocardiography, left ventriculography, selective coronary arteriography: Iopamidol 370/300 injection may be administered by rapid injection through a catheter into a suitable peripheral artery or vein. It can also be introduced under pressure through a cardiac catheter in to any of the heart chambers, or injected into large vessel for immediate visualization. The contrast medium may also be administered during selective catheterization of the coronary arteries.",
          "Aortography: The contrast medium may be introduced directly or by intra-arterial injection for visualization of the aorta and its main branches.",
          "Selective visceral angiography: Visualization can be achieved by selective catheterization and injection into the hepatic, coeliac or mesenteric arteries.",
          "Digital subtraction angiography: For cardiac imaging, the contrast medium may be administered intra-arterially by selective catheterization to provide substrated images. Iopamidol 370/300 injected intravenously either centrally or peripherally is also recommended for use this modality."
        ]
      },
      {
        "title": null,
        "information": "Other diagnostic procedures:",
        "items": [
          "The contrast medium injected intravenously and rapidly eliminated through the kidneys. In patients with severe renal failure, high dose urography should be used.",
          "Arthrography: Visualization of joint cavities and articular surfaces can be achieved either single or double contrast examination.",
          "Contrast enhancement in CT scanning: Contrast enhancement for brain scans can be achieved between one and three minutes after i.v. injection. Iopamidol 370/300 are also be used for total body scanning examinations after i.v.administration as a bolus, as a drip infusion or by combination of the two methods."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Contrast medium for diagnostic procedures",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adult dosage: Children: Angiography: Cerebral angiography: Iopamidol 370, 6-13 ml Selective coronary arteriography: Iopamidol 370, 4-8 ml/artery Peripheral arteriography: Iopamidol 370, 20-50 ml Venography: Iopamidol 370, 24-60 ml Angiocardiography: Iopamidol 370, 30-80 ml Left ventriculography: Iopamidol 370, 30-80 ml Percutaneous transfemoral or renal arteriography: Iopamidol 370, 30 ml Selective renal arteriography: Iopamidol 370, 5-10 ml Hepatic angiography: Iopamidol 370, 70 ml Coeliac angiography: Iopamidol 370, 40-70 ml Superior mesenteric angiography: Iopamidol 370, 25-50 ml Inferior mesenteric angiography: Iopamidol 370, 5-30 ml Digital subtraction angiography: 30-50 ml (10-20 ml/sec) of Iopamidol 370, IV 25 ml (left ventricle), 2-5 ml (coronary arteries), 15 ml/sec. of Iopamidol 370 i.a for cardiac imaging",
        "instructions": [
          "Neurology: Lumber myelography: Iopamidol 370, 6-13 ml",
          "Thoraco-cervical myelography: Iopamidol 370, 6-13 ml",
          "Urography: Iopamidol 370, 40-80 ml IV up to 1.5 ml/kg in severe renal disease.",
          "Usual Dose: 1-2.5 ml/kg",
          "Other Diagnostic Procedure: Contrast enhancement in CT scanning: Iopamidol 370, 0.5-2.0 ml/kg"
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:06.023Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f11",
    "original_record": {
      "input_index": 757,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f11"
        },
        "name": "Amidol",
        "strength": "370 mg/100 ml",
        "generic": "Iopamidol",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Injection",
        "source_url": "https://medex.com.bd/brands/34198/amidol-370-mg-injection",
        "_page": 34,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/11383/amifen-500-mg-tablet",
    "name": "Amifen",
    "dosage_form": "Tablet",
    "generic": "Mefenamic acid",
    "strength": "500 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5.02",
      "strip_price": "৳ 50.20",
      "pack_size_info": "(5 x 10: ৳ 251.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.02",
          "pack_size_info": "(5 x 10: ৳ 251.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 50.20",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "50 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/11384/amifen-50-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/721/mefenamic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amifen is indicated for-",
        "items": [
          "Fever",
          "Toothache",
          "Headache",
          "Migraine",
          "Primary dysmenorrhoea",
          "Menorrhagia",
          "Mild to moderate pain in rheumatoid arthritis and osteoarthritis",
          "Traumatic pain",
          "Low-back pain",
          "Juvenile chronic arthritis in children etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Mefenamic acid contains Mefenamic Acid which is a nonsteroidal agent with demonstrated analgesic, anti-inflammatory and antipyretic activity due to its dual action on prostaglandins. It inhibits the enzymes of prostaglandin synthetase and also antagonizes the actions of prostaglandin at the receptor sites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Aspirin",
        "information": ": As other NSAIDs, concomitant administration of Amifen and Aspirin is not generally recommended because of the potential of increased adverse effects.",
        "items": []
      },
      {
        "title": "Warfarin",
        "information": ": Amifen can inhibit platelet aggregation and may prolong the prothrombin time in patients on warfarin therapy",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with known hypersensitivity to Mefenamic Acid. It should not be used in patients with peptic ulcer, inflammatory bowel diseases, hepatic or renal impairment. It is also contraindicated in patients, whom aspirin and/or other NSAID's have induced symptoms of bronchospasm, skin rashes etc.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most frequently reported adverse experiences occurring in approximately 1-10% of patients are gastrointestinal: abdominal pain, constipation, diarrhoea, dyspepsia, flatulence, nausea, Gl ulcers, vomiting, dizziness, abnormal renal function, pruritus, rashes.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The safety of Mefenamic acid on reproductive capacity and pregnancy has not been established. Thus, mefenamic acid should be used in women of childbearing potential and during pregnancy only when the potential benefits are expected to outweigh the potential risks. Trace amounts of Mefenamic acid may be present in breast milk and transmitted to the nursing infant. Thus Mefenamic acid should not be taken by the nursing mother because of the effects of this class of drugs on the infant's cardiovascular system.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "It should be administered with caution in allergic diseases especially in asthma. The treatment should be withdrawn in diarrhoea, rashes, cholestatic jaundice, thrombocytopenia, haemolytic anaemia.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep away from light, store in a cool and dry place. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs)",
    "dosage": [
      {
        "medication_type": "Adult",
        "information": ":",
        "instructions": [
          "500 mg dose should be given to adults upto three times (1.5 gm total) per day with meals. The dosage may be reduced to 1 tablet (250 mg) three times daily.",
          "In case of menorrhagia: 500 mg three times daily with meals and from the onset of menses and continued according to the judgement of the physician."
        ]
      },
      {
        "medication_type": "Children",
        "information": ": Treatment should not be continued for more than 7 days except on the advice of a physician.",
        "instructions": [
          "6 months to 1 year: 5 ml three times/day.",
          "2-4 years: 10 ml three times/day.",
          "5-8 years: 10 ml four times /day.",
          "9-12 years: 15 ml four times/day."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:07.562Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f12",
    "original_record": {
      "input_index": 758,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f12"
        },
        "name": "Amifen",
        "strength": "500 mg",
        "generic": "Mefenamic acid",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/11383/amifen-500-mg-tablet",
        "_page": 34,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/25460/ah-400-mg-chewable-tablet",
    "name": "AH",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Drug International Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5.05",
      "strip_price": "৳ 40.40",
      "pack_size_info": "(3 x 8: ৳ 121.20)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.05",
          "pack_size_info": "(3 x 8: ৳ 121.20)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 40.40",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "200 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/25461/ah-200-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "AH is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving AH, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. AH should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "AH is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. AH exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of AH is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:08.805Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d24",
    "original_record": {
      "input_index": 759,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d24"
        },
        "name": "AH",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Drug International Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/25460/ah-400-mg-chewable-tablet",
        "_page": 17,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/27401/aid-50-mg-tablet",
    "name": "Aid",
    "dosage_form": "Tablet",
    "generic": "Diclofenac Sodium",
    "strength": "50 mg",
    "company": "Premier Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 0.80",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 80.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 0.80",
          "pack_size_info": "(100's pack: ৳ 80.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "100 mg (Capsule)",
        "href": "https://medex.com.bd/brands/27400/aid-tr-100-mg-capsule?ref=1"
      },
      {
        "text": "100 mg (SR Tablet)",
        "href": "https://medex.com.bd/brands/27433/aid-sr-100-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/357/diclofenac-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aid is indicated in-Rheumatology: Inflammatory and degenerative forms of rheumatism, chronic involutive, polyarthritis, ankylosing spondylarthritis, osteoarthritis, spondylarthroses, acute gout, peri-articular rheumatic disorders.Surgery and Traumatology ... Read moreAid is indicated in-Rheumatology: Inflammatory and degenerative forms of rheumatism, chronic involutive, polyarthritis, ankylosing spondylarthritis, osteoarthritis, spondylarthroses, acute gout, peri-articular rheumatic disorders.Surgery and Traumatology: Sprain, bruises, dislocations, fractures, softtissue injuries, surgical interventions.Obstetrics and Gynecology: Primary dysmenorrhoea, episiotomy, adnexitis, endometritis, parametritis, salpingitis, and mastitis.Otorhinolaryngology: As pre-operative medication for the prevention of pain, inflammation, and swelling.Dentistry: Post-operative and post-traumatic pain, inflammation, and swelling.Other indications: For the prevention of pain and treatment of inflammation and swelling of patients operated in the urogenital tract, renal and biliary colic.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Dilofenac Sodium is a potent non-steroidal anti-inflammatory drug (NSAID) with pronounced anti-rheumatic, anti-inflammatory, analgesic and antipyretic properties. It has also some uricosuric effect. Diclofenac exerts its effect by inhibiting prostaglandin biosynthesis which plays a major role in causing inflammation, pain and fever. Diclofenac is rapidly and completely absorbed from the gastro-intestinal tract when taken with or after meal. Peak plasma concentrations are reached within an average of 2 hours after ingestion of it. At therapeutic concentrations, it is 99.7% bound to plasma proteins. Diclofenac is metabolized in the liver and undergoes first pass metabolism.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Aid may have the following drug interactions:",
        "items": []
      },
      {
        "title": "Lithium and digoxin",
        "information": ": Aid may increase plasma concentrations of lithium and digoxin.",
        "items": []
      },
      {
        "title": "Anticoagulants",
        "information": ": There are isolated reports of an increased risk of haemorrhage with the combined use of diclofenac and anticoagulant therapy, although clinical investigations do not appear to indicate any influence on anticoagulant effect.",
        "items": []
      },
      {
        "title": "Antidiabetic agents",
        "information": ": Clinical studies have shown that diclofenac can be given together with oral antidiabetic agents without influencing their clinical effect.",
        "items": []
      },
      {
        "title": "Cyclosporin",
        "information": ": Cases of nephrotoxicity have been reported in patients receiving cyclosporin and diclofenac concomitantly.",
        "items": []
      },
      {
        "title": "Methotrexate",
        "information": ": Cases of serious toxicity have been reported when methotrexate and NSAIDs are given within 24 hours of each other.",
        "items": []
      },
      {
        "title": "Quinolone antimicrobials",
        "information": ": Convulsions may occur due to an interaction between quinolones and NSAIDs. Therefore, caution should be exercised when considering concomitant therapy of NSAID and quinolones.",
        "items": []
      },
      {
        "title": "Other NSAIDs and steroids",
        "information": ": Co-administration of diclofenac with other systemic NSAIDs and steroids may increase the frequency of unwanted effects. With aspirin, the plasma levels of each is lowered, although no clinical significance is known.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated to the patients hypersensitive to any ingredient of the products. Peptic ulcer, hypersensitivity to Diclofenac like other non-steroid anti-inflammatory agents, Diclofenac is also contra-indicated in asthmatic patient in whom attack with asthma, urticaria or acute rhinitis are precipitated by acetylsalicylic acid or by other drugs with prostaglandin synthetase inhibitor. This Gel should not be used under occlusive airtight dressings.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Aid is generally well tolerated. Adverse effects are mild, rare and transient. At the starting of the treatment, however, patients may be sometimes complaining of epigastric pain, eructation, nausea and diarrhea or dizziness or headache. These effects are usually mild in nature. Peripheral edema and skin reactions, such as rash and eczema have also been encountered. Aid Gel may cause local irritation and reddening of the skin and skin rash.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "During pregnancy, Diclofenac should be employed only for compelling reasons. The lowest effective dose should be used. These types of drugs are not recommended during the first trimester of pregnancy. In view of insufficient clinical data, Diclofenac Sodium Gel is not recommended during pregnancy. A very insignificant quantity of Diclofenac may be detected in breast milk but no undesirable effects on the infant to be expected.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In rare instances where peptic ulceration or gastrointestinal bleeding occurs in patients under treatment with Aid. In patients with advanced age should be kept under close observation. Aid Gel should not be allowed to come in contact with the eyes or mucus membranes, after application the hands should be washed properly and not to be taken by mouth.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light. Store below 30°C. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs)",
    "dosage": [
      {
        "medication_type": "Diclofenac FC Tablet",
        "information": ": Adults: 75-150 mg daily in 2 to 3 divided doses, preferably after food. Dose should be reduced in long term use.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac SR Tablet",
        "information": ":",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 1 tablet daily, taken whole with liquid, preferably at meal times. If necessary, the daily dose can be increased to 150 mg by supplementation with conventional tablets.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 1-3 mg of diclofenac/kg body wt. daily in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly patients",
        "information": ": In elderly or debilitated patients, the lowest effective dosage is recommended, although the pharmacokinetics of diclofenac sodium is not impaired to any clinically relevant extent in elderly patients.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Dispersible Tablet",
        "information": ":",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": The recommended daily dosage is 2-3 tablets and the maximum daily dose is 150 mg. In milder cases, 2 tablets of Diclofenac DT per day are sufficient. Diclofenac DT should preferably be taken before meals.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": Diclofenac is not recommended in children for other indications except juvenile rheumatoid arthritis where the recommended dose is 1-3 mg/kg body weight. Diclofenac DT is to be dropped into a half-glass of water and the liquid is to be stirred to aid dispersion before swallowing. There is no information on the use of Diclofenac DT for more than 03 months.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac TR Capsule",
        "information": ": One capsule daily. Diclofenac TR should be taken preferably after mealtimes.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Suppository",
        "information": ": For adults: 50 mg suppository 2-3 times daily. Maximum daily dose is 150 mg.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac injection",
        "information": ": For adults the usual dose is 1 ampoule daily. In serious cases this dose may be increased up to 2 ampoules daily.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Gel",
        "information": ": For external use only. Depending on the size of area to be treated, 2-4 g of Diclofenac gel should be applied to the skin 3-4 times daily. To the affected area gel should be rubbed in lightly. This gel may also be given in addition to further treatment with other dosage forms of Diclofenac.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:10.052Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d26",
    "original_record": {
      "input_index": 760,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d26"
        },
        "name": "Aid",
        "strength": "50 mg",
        "generic": "Diclofenac Sodium",
        "company": "Premier Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/27401/aid-50-mg-tablet",
        "_page": 17,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/27433/aid-sr-100-mg-tablet",
    "name": "Aid SR",
    "dosage_form": "Tablet (Sustained Release)",
    "generic": "Diclofenac Sodium",
    "strength": "100 mg",
    "company": "Premier Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 3.00",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.00",
          "pack_size_info": "(100's pack: ৳ 300.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "100 mg (Capsule)",
        "href": "https://medex.com.bd/brands/27400/aid-tr-100-mg-capsule?ref=1"
      },
      {
        "text": "50 mg (Tablet)",
        "href": "https://medex.com.bd/brands/27401/aid-50-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/357/diclofenac-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aid SR is indicated in-Rheumatology: Inflammatory and degenerative forms of rheumatism, chronic involutive, polyarthritis, ankylosing spondylarthritis, osteoarthritis, spondylarthroses, acute gout, peri-articular rheumatic disorders.Surgery and Traumatology ... Read moreAid SR is indicated in-Rheumatology: Inflammatory and degenerative forms of rheumatism, chronic involutive, polyarthritis, ankylosing spondylarthritis, osteoarthritis, spondylarthroses, acute gout, peri-articular rheumatic disorders.Surgery and Traumatology: Sprain, bruises, dislocations, fractures, softtissue injuries, surgical interventions.Obstetrics and Gynecology: Primary dysmenorrhoea, episiotomy, adnexitis, endometritis, parametritis, salpingitis, and mastitis.Otorhinolaryngology: As pre-operative medication for the prevention of pain, inflammation, and swelling.Dentistry: Post-operative and post-traumatic pain, inflammation, and swelling.Other indications: For the prevention of pain and treatment of inflammation and swelling of patients operated in the urogenital tract, renal and biliary colic.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Dilofenac Sodium is a potent non-steroidal anti-inflammatory drug (NSAID) with pronounced anti-rheumatic, anti-inflammatory, analgesic and antipyretic properties. It has also some uricosuric effect. Diclofenac exerts its effect by inhibiting prostaglandin biosynthesis which plays a major role in causing inflammation, pain and fever. Diclofenac is rapidly and completely absorbed from the gastro-intestinal tract when taken with or after meal. Peak plasma concentrations are reached within an average of 2 hours after ingestion of it. At therapeutic concentrations, it is 99.7% bound to plasma proteins. Diclofenac is metabolized in the liver and undergoes first pass metabolism.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Aid SR may have the following drug interactions:",
        "items": []
      },
      {
        "title": "Lithium and digoxin",
        "information": ": Aid SR may increase plasma concentrations of lithium and digoxin.",
        "items": []
      },
      {
        "title": "Anticoagulants",
        "information": ": There are isolated reports of an increased risk of haemorrhage with the combined use of diclofenac and anticoagulant therapy, although clinical investigations do not appear to indicate any influence on anticoagulant effect.",
        "items": []
      },
      {
        "title": "Antidiabetic agents",
        "information": ": Clinical studies have shown that diclofenac can be given together with oral antidiabetic agents without influencing their clinical effect.",
        "items": []
      },
      {
        "title": "Cyclosporin",
        "information": ": Cases of nephrotoxicity have been reported in patients receiving cyclosporin and diclofenac concomitantly.",
        "items": []
      },
      {
        "title": "Methotrexate",
        "information": ": Cases of serious toxicity have been reported when methotrexate and NSAIDs are given within 24 hours of each other.",
        "items": []
      },
      {
        "title": "Quinolone antimicrobials",
        "information": ": Convulsions may occur due to an interaction between quinolones and NSAIDs. Therefore, caution should be exercised when considering concomitant therapy of NSAID and quinolones.",
        "items": []
      },
      {
        "title": "Other NSAIDs and steroids",
        "information": ": Co-administration of diclofenac with other systemic NSAIDs and steroids may increase the frequency of unwanted effects. With aspirin, the plasma levels of each is lowered, although no clinical significance is known.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated to the patients hypersensitive to any ingredient of the products. Peptic ulcer, hypersensitivity to Diclofenac like other non-steroid anti-inflammatory agents, Diclofenac is also contra-indicated in asthmatic patient in whom attack with asthma, urticaria or acute rhinitis are precipitated by acetylsalicylic acid or by other drugs with prostaglandin synthetase inhibitor. This Gel should not be used under occlusive airtight dressings.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Aid SR is generally well tolerated. Adverse effects are mild, rare and transient. At the starting of the treatment, however, patients may be sometimes complaining of epigastric pain, eructation, nausea and diarrhea or dizziness or headache. These effects are usually mild in nature. Peripheral edema and skin reactions, such as rash and eczema have also been encountered. Aid SR Gel may cause local irritation and reddening of the skin and skin rash.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "During pregnancy, Diclofenac should be employed only for compelling reasons. The lowest effective dose should be used. These types of drugs are not recommended during the first trimester of pregnancy. In view of insufficient clinical data, Diclofenac Sodium Gel is not recommended during pregnancy. A very insignificant quantity of Diclofenac may be detected in breast milk but no undesirable effects on the infant to be expected.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In rare instances where peptic ulceration or gastrointestinal bleeding occurs in patients under treatment with Aid SR. In patients with advanced age should be kept under close observation. Aid SR Gel should not be allowed to come in contact with the eyes or mucus membranes, after application the hands should be washed properly and not to be taken by mouth.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light. Store below 30°C. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs)",
    "dosage": [
      {
        "medication_type": "Diclofenac FC Tablet",
        "information": ": Adults: 75-150 mg daily in 2 to 3 divided doses, preferably after food. Dose should be reduced in long term use.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac SR Tablet",
        "information": ":",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 1 tablet daily, taken whole with liquid, preferably at meal times. If necessary, the daily dose can be increased to 150 mg by supplementation with conventional tablets.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 1-3 mg of diclofenac/kg body wt. daily in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly patients",
        "information": ": In elderly or debilitated patients, the lowest effective dosage is recommended, although the pharmacokinetics of diclofenac sodium is not impaired to any clinically relevant extent in elderly patients.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Dispersible Tablet",
        "information": ":",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": The recommended daily dosage is 2-3 tablets and the maximum daily dose is 150 mg. In milder cases, 2 tablets of Diclofenac DT per day are sufficient. Diclofenac DT should preferably be taken before meals.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": Diclofenac is not recommended in children for other indications except juvenile rheumatoid arthritis where the recommended dose is 1-3 mg/kg body weight. Diclofenac DT is to be dropped into a half-glass of water and the liquid is to be stirred to aid dispersion before swallowing. There is no information on the use of Diclofenac DT for more than 03 months.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac TR Capsule",
        "information": ": One capsule daily. Diclofenac TR should be taken preferably after mealtimes.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Suppository",
        "information": ": For adults: 50 mg suppository 2-3 times daily. Maximum daily dose is 150 mg.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac injection",
        "information": ": For adults the usual dose is 1 ampoule daily. In serious cases this dose may be increased up to 2 ampoules daily.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Gel",
        "information": ": For external use only. Depending on the size of area to be treated, 2-4 g of Diclofenac gel should be applied to the skin 3-4 times daily. To the affected area gel should be rubbed in lightly. This gel may also be given in addition to further treatment with other dosage forms of Diclofenac.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:11.147Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d27",
    "original_record": {
      "input_index": 761,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d27"
        },
        "name": "Aid SR",
        "strength": "100 mg",
        "generic": "Diclofenac Sodium",
        "company": "Premier Pharmaceuticals Ltd.",
        "medicine_type": "Tablet (Sustained Release)",
        "source_url": "https://medex.com.bd/brands/27433/aid-sr-100-mg-tablet",
        "_page": 17,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33582/airmont-10-mg-tablet",
    "name": "Airmont",
    "dosage_form": "Tablet",
    "generic": "Montelukast Sodium",
    "strength": "10 mg",
    "company": "Goodman Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 13.00",
      "strip_price": "৳ 130.00",
      "pack_size_info": "(3 x 10: ৳ 390.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 13.00",
          "pack_size_info": "(3 x 10: ৳ 390.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 130.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/768/montelukast-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Airmont is indicated for:",
        "items": [
          "Prophylaxis and chronic treatment of asthma",
          "Acute prevention of Exercise-Induced Bronchoconstriction (EIB)",
          "Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT 1 ). The cysteinyl leukotrienes (LTC 4 , LTD 4 , LTE 4 ) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma & allergic rhinitis, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Airmont has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions. In drug interaction studies, the recommended clinical dose of Airmont did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1mg/ethinyl estradiol 35mcg), terfenadine, digoxin, and warfarin. Although additional specific interaction studies were not performed, Airmont was used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of clinical adverse interactions. These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines and decongestants. Phenobarbital, which induces hepatic metabolism, decreased the AUC of Airmont approximately 40% following a single 10mg dose of Airmont. No dosage adjustment for Airmont is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with Airmont.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Montelukast is contraindicated in patients who are hypersensitive to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Common",
        "information": ": Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.",
        "items": []
      },
      {
        "title": "Uncommon",
        "information": ": Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.",
        "items": []
      },
      {
        "title": "Rare",
        "information": ": Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Montelukast crosses the placenta following oral dosing in rats and rabbits. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Montelukast should be used during pregnancy only if clearly needed. Because many drugs are excreted in human milk, caution should be exercised when Montelukast is given to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Airmont is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Patients should be advised to have appropriate rescue medication available. Therapy with Airmont can be continued during acute exacerbations of asthma. While the dose of inhaled corticosteroid may be reduced gradually under medical supervision, Airmont should not be abruptly substituted for inhaled or oral corticosteroids. Airmont should not be used as monotherapy for the treatment and management of exercise induced bronchospasm. Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Airmont. Although Airmont is effective in improving airway function in asthmatics with documented aspirin sensitivity, it has not been shown to truncate bronchoconstrictor response to aspirin and other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Airmont and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C35H36ClNO3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg"
    },
    "therapeutic_class": "Leukotriene receptor antagonists",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adults and adolescents with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for adults and adolescents 15 years of age and older",
        "information": ": Montelukast 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Pediatric patients with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 to 14 years of age",
        "information": ": Montelukast 5 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 2 years to 5 years of age",
        "information": ": Montelukast 4 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 months to 5 years of age",
        "information": ": Montelukast 4 mg oral granules once daily. This can be administered either directly in the mouth, or mixed with a spoonful of cold water or soft food at room temperature",
        "instructions": []
      },
      {
        "medication_type": "Use in the pediatric patient",
        "information": ": The safety and efficacy of Montelukast have been established in adequate and well-controlled studies in pediatric patients with asthma 6 months to 14 years of age. Safety and efficacy profiles in this age group are similar to those seen in adults.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is required in patients with mild-to-moderate hepatic insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": No dosage adjustment is recommended in patients with renal insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Elderly use",
        "information": ": The pharmacokinetic profile and the oral bioavailability of a single 10-mg oral dose of montelukast are similar in elderly and younger adults. The plasma half-life of montelukast is slightly longer in the elderly. No dosage adjustment in the elderly is required.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Airmont 10 mg Tablet?",
        "answer": [
          "Airmont 10 mg Tablet is a selective and orally active leukotriene receptor antagonist."
        ]
      },
      {
        "question": "What is Airmont 10 mg Tablet used for?",
        "answer": [
          "Airmont 10 mg Tablet is commonly used to treat asthma or allergic rhinitis. It helps keep airways open and easy breathing by blocking leukotrienes."
        ]
      },
      {
        "question": "How soon can the effect of Airmont 10 mg Tablet be observed?",
        "answer": [
          "The effect of Airmont 10 mg Tablet can be observed after 1-3 hours of administration. Airmont 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks and needs to be taken daily to work properly."
        ]
      },
      {
        "question": "How long does the effect of Airmont 10 mg Tablet last?",
        "answer": [
          "The effect of Airmont 10 mg Tablet lasts for an average duration of 24 hours."
        ]
      },
      {
        "question": "Should I use Airmont 10 mg Tablet empty stomach?",
        "answer": [
          "Airmont 10 mg Tablet may be taken with or without food as prescribed by your doctor."
        ]
      },
      {
        "question": "What if I miss a dose of Airmont 10 mg Tablet?",
        "answer": [
          "If you miss a dose, you may take it as soon as possible. But if it is almost time for your next dose, just skip that dose. Do not double up on doses."
        ]
      },
      {
        "question": "Are there any pregnancy warnings for Airmont 10 mg Tablet?",
        "answer": [
          "Use of Airmont 10 mg Tablet in pregnant women should be avoided unless clearly needed."
        ]
      },
      {
        "question": "General Instructions",
        "answer": [
          "Take Airmont 10 mg Tablet exactly as prescribed by your doctor.",
          "Do not change your Airmont 10 mg Tablet dose or stop using asthma medication without your doctor's advice.",
          "Airmont 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working.",
          "Avoid situations or activities that may trigger an asthma attack.",
          "Talk to your doctor before using Airmont 10 mg Tablet if you're pregnant or breastfeeding. They can help you decide if it's the right choice for you."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:12.273Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d30",
    "original_record": {
      "input_index": 762,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d30"
        },
        "name": "Airmont",
        "strength": "10 mg",
        "generic": "Montelukast Sodium",
        "company": "Goodman Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/33582/airmont-10-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/21316/airnaaf-1-mg-syrup",
    "name": "Airnaaf",
    "dosage_form": "Syrup",
    "generic": "Ketotifen Fumarate",
    "strength": "1 mg/5 ml",
    "company": "Naafco Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 75.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 75.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/649/ketotifen-fumarate-oral/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Airnaaf is indicated in the following conditions-",
        "items": [
          "For the prophylactic treatment of bronchial asthma.",
          "Symptomatic treatment of allergic conditions including rhinitis and conjunctivitis.",
          "For alleviating the complications of itching, pain and tenderness associated with neurofibroma.",
          "Symptomatic treatment of allergy such as hayfever, urticaria."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ketotifen has anti-allergic properties and has been used similarly, to sodium chromoglycate in the prophylactic treatment of asthma. It also has the properties of an antihistamine. Ketotifen possesses marked anti-anaphylactic properties and is effective in preventing an asthmatic attacks. Ketotifen exerts as sustained inhibitory effect on histamine reactions, which can be clearly dissociated from its anti-anaphylactic properties. Experimental investigations in asthmatic subjects have shown that Ketotifen is as effective orally as a selective mast cell stabilizer administered by inhalation. Antihistamines were ineffective in those tests. The effectiveness of Ketotifen has been studied in long-term clinical trials. Asthma attacks were reduced in number, severity and duration and in some cases, the patients were completely freed from attacks. Progressive reduction of corticosteroids and/or bronchodilators was also possible. The prophylactic activity of Ketotifen may take several weeks to become fully established. Ketotifen will not abort established attacks of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Airnaaf may potentiate the effects of sedatives, hypnotics, antihistamines and alcohols. A reversible fall in the platelet count has been observed in a few patients receiving Tifen concomitantly with oral antidiabetic agents and it has been suggested that Airnaaf should therefore be avoided.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "A reversible fall in the platelet count has been observed in a few patients receiving Ketotifen concomitantly with oral antidiabetic agent and it has been suggested that this combination should therefore be avoided. Although there is no evidence of any teratogenic effect, recommendations for Ketotifen in pregnancy or when breast feeding can not be given.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Drowsiness and in isolated cases, dry mouth and slight dizziness may occur at the beginning of treatment but usually disappear spontaneously after a few days.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although there is no evidence of any teratogenic effect, Ketotifen in pregnancy and lactation is not recommended.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "It is important to continue the previous treatment for a minimum of two weeks after starting Airnaaf to avoid the possibility of exacerbation of asthma. This applies specially to systemic corticosteroids and ACTH because of the possible existence of adrenocortical insufficiency in steroid dependent patient. If inter current infection occurs, Airnaaf treatment must be supplemented by specific antimicrobial therapy. During the first day of treatment with Airnaaf, reactions may be impaired and patients should be warned not to take charge of vehicle or machinery until the effect of Airnaaf treatment on the individual is known. Patients should be advised to avoid alcoholic drinks. Airnaaf may potentiate the effects of sedatives, hypnotics, antihistamines and alcohol.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "The reported features of overdosage include confusion, drowsiness, headache, bradycardia, respiratory depression etc. should be watched for. Elimination of the drug with gastric lavage or emessis is recommended. Otherwise, general supportive treatment is all that is required shall be instituted.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protect from light. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C19H19NOS",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-649-ketotifen-fumarate-oral-chemical-structure-WOrxlxSmVByavydbYqzn.svg"
    },
    "therapeutic_class": "Cromoglycate & related drugs",
    "dosage": [
      {
        "medication_type": "Adults",
        "information": ": 1 mg twice daily with food. If necessary the dose may be increased to 2 mg twice daily in severe cases.",
        "instructions": []
      },
      {
        "medication_type": "Children above 3 years",
        "information": ": 1 mg twice daily with food. Patients known to be easily sedated should begin treatment with 0.5 to 1 mg at night for the first few days or as directed by the physician.",
        "instructions": []
      },
      {
        "medication_type": "Use in elderly",
        "information": ": Same as adult dose or as advised by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Airnaaf 1 mg/5 ml Syrup?",
        "answer": [
          "Airnaaf 1 mg/5 ml Syrup is an antihistamine medication and a mast cell stabilizer used to treat allergic conditions such as conjunctivitis, asthma, and urticaria (hives)."
        ]
      },
      {
        "question": "What is Airnaaf 1 mg/5 ml Syrup used for?",
        "answer": [
          "Airnaaf 1 mg/5 ml Syrup is indicated in bronchial asthma, rhinitis, conjunctivitis, hayfever, urticaria."
        ]
      },
      {
        "question": "Are there any pregnancy warnings?",
        "answer": [
          "Asthafen 1mg tablet may be unsafe to use during pregnancy."
        ]
      },
      {
        "question": "Are there any breast-feeding warnings?",
        "answer": [
          "Unknown. Human and animal studies are not available. Please consult your doctor."
        ]
      },
      {
        "question": "Does this affect kidney function?",
        "answer": [
          "There is no data available. Please consult doctor before consuming the drug."
        ]
      },
      {
        "question": "Does this affect liver function?",
        "answer": [
          "There is no data available. Please consult doctor before consuming the drug."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:13.555Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d31",
    "original_record": {
      "input_index": 763,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d31"
        },
        "name": "Airnaaf",
        "strength": "1 mg/5 ml",
        "generic": "Ketotifen Fumarate (Oral)",
        "company": "Naafco Pharma Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/21316/airnaaf-1-mg-syrup",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30889/airpro-1-mg-syrup",
    "name": "Airpro",
    "dosage_form": "Syrup",
    "generic": "Levosalbutamol",
    "strength": "1 mg/5 ml",
    "company": "Everest Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 45.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 45.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/683/levosalbutamol-oral/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Airpro is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Levosalbutamol is a single isomer beta 2-agonist that differs from racemic salbutamol by elimination of (S)-salbutamol. Levosalbutamol is an effective bronchodilator whose primary mechanism of action is unimpeded by (S)-salbutamol. Thus, when compared with racemic salbutamol, clinically comparable bronchodilation can be achieved with doses that substantially lessen beta-mediated side effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Other short acting sympathomimetic bronchodilators or epinephrine should be used with caution with Airpro. If additional adrenergic drugs are to be administered by any route, they will be used with caution to avoid deleterious cardiovascular effects.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Levosalbutamol is contraindicated in patients with a history of hypersensitivity to levosalbutamol or any of its components.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Hypocalcaemia, palpitation, fine tremors of the skeletal muscle and muscle cramps may occur. The other likely side effects are nausea, vomiting, burning substernal or epigastric pain and diarrhoea.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The drug should be used during pregnancy only if the potential benefit justifies the potential risk of the fetus. It is not known whether Levosalbutamol is excreted in human milk. Caution should be exercised when oral Levosalbutamol is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Particular caution is advised in acute severe asthma as this effect may be potentiated by hypoxia and by concomitant treatment with xanthine derivatives, steroids and diuretics. Serum potassium levels should be monitored in such situations.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "The expected symptoms with over dosage are those of excessive beta-adrenergic stimulation and the symptoms listed under side effects. In the event of serious poisoning, the stomach should be emptied and, if necessary, a beta-blocker administered with caution in patients with a history of bronchospasm.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep all medicines out of reach of children. Store in a cool and dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Short-acting selective & β2-adrenoceptor stimulants",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet- Syrup-",
        "instructions": [
          "Adults and adolescents above 12 years: 1-2 mg three times daily.",
          "Children (6 -11 years): 1 mg three times daily.",
          "Adults : 5-10 ml three times daily.",
          "Childrn (6-11 years): 5 ml three times daily."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:14.661Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d32",
    "original_record": {
      "input_index": 764,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d32"
        },
        "name": "Airpro",
        "strength": "1 mg/5 ml",
        "generic": "Levosalbutamol (Oral)",
        "company": "Everest Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/30889/airpro-1-mg-syrup",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/3804/airup-10-mg-tablet",
    "name": "Airup",
    "dosage_form": "Tablet",
    "generic": "Montelukast Sodium",
    "strength": "10 mg",
    "company": "Pharmasia Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 16.00",
      "strip_price": "৳ 240.00",
      "pack_size_info": "(3 x 15: ৳ 720.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 16.00",
          "pack_size_info": "(3 x 15: ৳ 720.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 240.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg (Chew. Tablet)",
        "href": "https://medex.com.bd/brands/26990/airup-5-mg-chewable-tablet?ref=1"
      },
      {
        "text": "4 mg (Chew. Tablet)",
        "href": "https://medex.com.bd/brands/34684/airup-4-mg-chewable-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/768/montelukast-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Airup is indicated for:",
        "items": [
          "Prophylaxis and chronic treatment of asthma",
          "Acute prevention of Exercise-Induced Bronchoconstriction (EIB)",
          "Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT 1 ). The cysteinyl leukotrienes (LTC 4 , LTD 4 , LTE 4 ) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma & allergic rhinitis, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Airup has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions. In drug interaction studies, the recommended clinical dose of Airup did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1mg/ethinyl estradiol 35mcg), terfenadine, digoxin, and warfarin. Although additional specific interaction studies were not performed, Airup was used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of clinical adverse interactions. These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines and decongestants. Phenobarbital, which induces hepatic metabolism, decreased the AUC of Airup approximately 40% following a single 10mg dose of Airup. No dosage adjustment for Airup is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with Airup.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Montelukast is contraindicated in patients who are hypersensitive to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Common",
        "information": ": Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.",
        "items": []
      },
      {
        "title": "Uncommon",
        "information": ": Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.",
        "items": []
      },
      {
        "title": "Rare",
        "information": ": Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Montelukast crosses the placenta following oral dosing in rats and rabbits. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Montelukast should be used during pregnancy only if clearly needed. Because many drugs are excreted in human milk, caution should be exercised when Montelukast is given to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Airup is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Patients should be advised to have appropriate rescue medication available. Therapy with Airup can be continued during acute exacerbations of asthma. While the dose of inhaled corticosteroid may be reduced gradually under medical supervision, Airup should not be abruptly substituted for inhaled or oral corticosteroids. Airup should not be used as monotherapy for the treatment and management of exercise induced bronchospasm. Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Airup. Although Airup is effective in improving airway function in asthmatics with documented aspirin sensitivity, it has not been shown to truncate bronchoconstrictor response to aspirin and other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Airup and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C35H36ClNO3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg"
    },
    "therapeutic_class": "Leukotriene receptor antagonists",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adults and adolescents with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for adults and adolescents 15 years of age and older",
        "information": ": Montelukast 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Pediatric patients with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 to 14 years of age",
        "information": ": Montelukast 5 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 2 years to 5 years of age",
        "information": ": Montelukast 4 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 months to 5 years of age",
        "information": ": Montelukast 4 mg oral granules once daily. This can be administered either directly in the mouth, or mixed with a spoonful of cold water or soft food at room temperature",
        "instructions": []
      },
      {
        "medication_type": "Use in the pediatric patient",
        "information": ": The safety and efficacy of Montelukast have been established in adequate and well-controlled studies in pediatric patients with asthma 6 months to 14 years of age. Safety and efficacy profiles in this age group are similar to those seen in adults.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is required in patients with mild-to-moderate hepatic insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": No dosage adjustment is recommended in patients with renal insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Elderly use",
        "information": ": The pharmacokinetic profile and the oral bioavailability of a single 10-mg oral dose of montelukast are similar in elderly and younger adults. The plasma half-life of montelukast is slightly longer in the elderly. No dosage adjustment in the elderly is required.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Airup 10 mg Tablet?",
        "answer": [
          "Airup 10 mg Tablet is a selective and orally active leukotriene receptor antagonist."
        ]
      },
      {
        "question": "What is Airup 10 mg Tablet used for?",
        "answer": [
          "Airup 10 mg Tablet is commonly used to treat asthma or allergic rhinitis. It helps keep airways open and easy breathing by blocking leukotrienes."
        ]
      },
      {
        "question": "How soon can the effect of Airup 10 mg Tablet be observed?",
        "answer": [
          "The effect of Airup 10 mg Tablet can be observed after 1-3 hours of administration. Airup 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks and needs to be taken daily to work properly."
        ]
      },
      {
        "question": "How long does the effect of Airup 10 mg Tablet last?",
        "answer": [
          "The effect of Airup 10 mg Tablet lasts for an average duration of 24 hours."
        ]
      },
      {
        "question": "Should I use Airup 10 mg Tablet empty stomach?",
        "answer": [
          "Airup 10 mg Tablet may be taken with or without food as prescribed by your doctor."
        ]
      },
      {
        "question": "What if I miss a dose of Airup 10 mg Tablet?",
        "answer": [
          "If you miss a dose, you may take it as soon as possible. But if it is almost time for your next dose, just skip that dose. Do not double up on doses."
        ]
      },
      {
        "question": "Are there any pregnancy warnings for Airup 10 mg Tablet?",
        "answer": [
          "Use of Airup 10 mg Tablet in pregnant women should be avoided unless clearly needed."
        ]
      },
      {
        "question": "General Instructions",
        "answer": [
          "Take Airup 10 mg Tablet exactly as prescribed by your doctor.",
          "Do not change your Airup 10 mg Tablet dose or stop using asthma medication without your doctor's advice.",
          "Airup 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working.",
          "Avoid situations or activities that may trigger an asthma attack.",
          "Talk to your doctor before using Airup 10 mg Tablet if you're pregnant or breastfeeding. They can help you decide if it's the right choice for you."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:15.778Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d33",
    "original_record": {
      "input_index": 765,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d33"
        },
        "name": "Airup",
        "strength": "10 mg",
        "generic": "Montelukast Sodium",
        "company": "Pharmasia Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/3804/airup-10-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/26990/airup-5-mg-chewable-tablet",
    "name": "Airup",
    "dosage_form": "Chewable Tablet",
    "generic": "Montelukast Sodium",
    "strength": "5 mg",
    "company": "Pharmasia Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 8.00",
      "strip_price": "৳ 80.00",
      "pack_size_info": "(3 x 10: ৳ 240.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.00",
          "pack_size_info": "(3 x 10: ৳ 240.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 80.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/3804/airup-10-mg-tablet?ref=1"
      },
      {
        "text": "4 mg (Chew. Tablet)",
        "href": "https://medex.com.bd/brands/34684/airup-4-mg-chewable-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/768/montelukast-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Airup is indicated for:",
        "items": [
          "Prophylaxis and chronic treatment of asthma",
          "Acute prevention of Exercise-Induced Bronchoconstriction (EIB)",
          "Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT 1 ). The cysteinyl leukotrienes (LTC 4 , LTD 4 , LTE 4 ) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma & allergic rhinitis, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Airup has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions. In drug interaction studies, the recommended clinical dose of Airup did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1mg/ethinyl estradiol 35mcg), terfenadine, digoxin, and warfarin. Although additional specific interaction studies were not performed, Airup was used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of clinical adverse interactions. These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines and decongestants. Phenobarbital, which induces hepatic metabolism, decreased the AUC of Airup approximately 40% following a single 10mg dose of Airup. No dosage adjustment for Airup is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with Airup.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Montelukast is contraindicated in patients who are hypersensitive to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Common",
        "information": ": Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.",
        "items": []
      },
      {
        "title": "Uncommon",
        "information": ": Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.",
        "items": []
      },
      {
        "title": "Rare",
        "information": ": Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Montelukast crosses the placenta following oral dosing in rats and rabbits. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Montelukast should be used during pregnancy only if clearly needed. Because many drugs are excreted in human milk, caution should be exercised when Montelukast is given to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Airup is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Patients should be advised to have appropriate rescue medication available. Therapy with Airup can be continued during acute exacerbations of asthma. While the dose of inhaled corticosteroid may be reduced gradually under medical supervision, Airup should not be abruptly substituted for inhaled or oral corticosteroids. Airup should not be used as monotherapy for the treatment and management of exercise induced bronchospasm. Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Airup. Although Airup is effective in improving airway function in asthmatics with documented aspirin sensitivity, it has not been shown to truncate bronchoconstrictor response to aspirin and other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Airup and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C35H36ClNO3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg"
    },
    "therapeutic_class": "Leukotriene receptor antagonists",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adults and adolescents with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for adults and adolescents 15 years of age and older",
        "information": ": Montelukast 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Pediatric patients with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 to 14 years of age",
        "information": ": Montelukast 5 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 2 years to 5 years of age",
        "information": ": Montelukast 4 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 months to 5 years of age",
        "information": ": Montelukast 4 mg oral granules once daily. This can be administered either directly in the mouth, or mixed with a spoonful of cold water or soft food at room temperature",
        "instructions": []
      },
      {
        "medication_type": "Use in the pediatric patient",
        "information": ": The safety and efficacy of Montelukast have been established in adequate and well-controlled studies in pediatric patients with asthma 6 months to 14 years of age. Safety and efficacy profiles in this age group are similar to those seen in adults.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is required in patients with mild-to-moderate hepatic insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": No dosage adjustment is recommended in patients with renal insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Elderly use",
        "information": ": The pharmacokinetic profile and the oral bioavailability of a single 10-mg oral dose of montelukast are similar in elderly and younger adults. The plasma half-life of montelukast is slightly longer in the elderly. No dosage adjustment in the elderly is required.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Airup 5 mg Chew. Tablet?",
        "answer": [
          "Airup 5 mg Chew. Tablet is a selective and orally active leukotriene receptor antagonist."
        ]
      },
      {
        "question": "What is Airup 5 mg Chew. Tablet used for?",
        "answer": [
          "Airup 5 mg Chew. Tablet is commonly used to treat asthma or allergic rhinitis. It helps keep airways open and easy breathing by blocking leukotrienes."
        ]
      },
      {
        "question": "How soon can the effect of Airup 5 mg Chew. Tablet be observed?",
        "answer": [
          "The effect of Airup 5 mg Chew. Tablet can be observed after 1-3 hours of administration. Airup 5 mg Chew. Tablet is not a fast-acting rescue medicine for asthma attacks and needs to be taken daily to work properly."
        ]
      },
      {
        "question": "How long does the effect of Airup 5 mg Chew. Tablet last?",
        "answer": [
          "The effect of Airup 5 mg Chew. Tablet lasts for an average duration of 24 hours."
        ]
      },
      {
        "question": "Should I use Airup 5 mg Chew. Tablet empty stomach?",
        "answer": [
          "Airup 5 mg Chew. Tablet may be taken with or without food as prescribed by your doctor."
        ]
      },
      {
        "question": "What if I miss a dose of Airup 5 mg Chew. Tablet?",
        "answer": [
          "If you miss a dose, you may take it as soon as possible. But if it is almost time for your next dose, just skip that dose. Do not double up on doses."
        ]
      },
      {
        "question": "Are there any pregnancy warnings for Airup 5 mg Chew. Tablet?",
        "answer": [
          "Use of Airup 5 mg Chew. Tablet in pregnant women should be avoided unless clearly needed."
        ]
      },
      {
        "question": "General Instructions",
        "answer": [
          "Take Airup 5 mg Chew. Tablet exactly as prescribed by your doctor.",
          "Do not change your Airup 5 mg Chew. Tablet dose or stop using asthma medication without your doctor's advice.",
          "Airup 5 mg Chew. Tablet is not a fast-acting rescue medicine for asthma attacks. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working.",
          "Avoid situations or activities that may trigger an asthma attack.",
          "Talk to your doctor before using Airup 5 mg Chew. Tablet if you're pregnant or breastfeeding. They can help you decide if it's the right choice for you."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:17.057Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d34",
    "original_record": {
      "input_index": 766,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d34"
        },
        "name": "Airup",
        "strength": "5 mg",
        "generic": "Montelukast Sodium",
        "company": "Pharmasia Limited",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/26990/airup-5-mg-chewable-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/22627/airway-5-mg-tablet",
    "name": "Airway",
    "dosage_form": "Tablet",
    "generic": "Montelukast Sodium",
    "strength": "5 mg",
    "company": "One Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 8.00",
      "strip_price": "৳ 80.00",
      "pack_size_info": "(2 x 10: ৳ 160.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.00",
          "pack_size_info": "(2 x 10: ৳ 160.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 80.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/22628/airway-10-mg-tablet?ref=1"
      },
      {
        "text": "4 mg (Tablet)",
        "href": "https://medex.com.bd/brands/27988/airway-4-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/768/montelukast-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Airway is indicated for:",
        "items": [
          "Prophylaxis and chronic treatment of asthma",
          "Acute prevention of Exercise-Induced Bronchoconstriction (EIB)",
          "Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT 1 ). The cysteinyl leukotrienes (LTC 4 , LTD 4 , LTE 4 ) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma & allergic rhinitis, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Airway has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions. In drug interaction studies, the recommended clinical dose of Airway did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1mg/ethinyl estradiol 35mcg), terfenadine, digoxin, and warfarin. Although additional specific interaction studies were not performed, Airway was used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of clinical adverse interactions. These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines and decongestants. Phenobarbital, which induces hepatic metabolism, decreased the AUC of Airway approximately 40% following a single 10mg dose of Airway. No dosage adjustment for Airway is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with Airway.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Montelukast is contraindicated in patients who are hypersensitive to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Common",
        "information": ": Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.",
        "items": []
      },
      {
        "title": "Uncommon",
        "information": ": Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.",
        "items": []
      },
      {
        "title": "Rare",
        "information": ": Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Montelukast crosses the placenta following oral dosing in rats and rabbits. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Montelukast should be used during pregnancy only if clearly needed. Because many drugs are excreted in human milk, caution should be exercised when Montelukast is given to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Airway is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Patients should be advised to have appropriate rescue medication available. Therapy with Airway can be continued during acute exacerbations of asthma. While the dose of inhaled corticosteroid may be reduced gradually under medical supervision, Airway should not be abruptly substituted for inhaled or oral corticosteroids. Airway should not be used as monotherapy for the treatment and management of exercise induced bronchospasm. Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Airway. Although Airway is effective in improving airway function in asthmatics with documented aspirin sensitivity, it has not been shown to truncate bronchoconstrictor response to aspirin and other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Airway and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C35H36ClNO3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg"
    },
    "therapeutic_class": "Leukotriene receptor antagonists",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adults and adolescents with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for adults and adolescents 15 years of age and older",
        "information": ": Montelukast 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Pediatric patients with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 to 14 years of age",
        "information": ": Montelukast 5 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 2 years to 5 years of age",
        "information": ": Montelukast 4 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 months to 5 years of age",
        "information": ": Montelukast 4 mg oral granules once daily. This can be administered either directly in the mouth, or mixed with a spoonful of cold water or soft food at room temperature",
        "instructions": []
      },
      {
        "medication_type": "Use in the pediatric patient",
        "information": ": The safety and efficacy of Montelukast have been established in adequate and well-controlled studies in pediatric patients with asthma 6 months to 14 years of age. Safety and efficacy profiles in this age group are similar to those seen in adults.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is required in patients with mild-to-moderate hepatic insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": No dosage adjustment is recommended in patients with renal insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Elderly use",
        "information": ": The pharmacokinetic profile and the oral bioavailability of a single 10-mg oral dose of montelukast are similar in elderly and younger adults. The plasma half-life of montelukast is slightly longer in the elderly. No dosage adjustment in the elderly is required.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Airway 5 mg Tablet?",
        "answer": [
          "Airway 5 mg Tablet is a selective and orally active leukotriene receptor antagonist."
        ]
      },
      {
        "question": "What is Airway 5 mg Tablet used for?",
        "answer": [
          "Airway 5 mg Tablet is commonly used to treat asthma or allergic rhinitis. It helps keep airways open and easy breathing by blocking leukotrienes."
        ]
      },
      {
        "question": "How soon can the effect of Airway 5 mg Tablet be observed?",
        "answer": [
          "The effect of Airway 5 mg Tablet can be observed after 1-3 hours of administration. Airway 5 mg Tablet is not a fast-acting rescue medicine for asthma attacks and needs to be taken daily to work properly."
        ]
      },
      {
        "question": "How long does the effect of Airway 5 mg Tablet last?",
        "answer": [
          "The effect of Airway 5 mg Tablet lasts for an average duration of 24 hours."
        ]
      },
      {
        "question": "Should I use Airway 5 mg Tablet empty stomach?",
        "answer": [
          "Airway 5 mg Tablet may be taken with or without food as prescribed by your doctor."
        ]
      },
      {
        "question": "What if I miss a dose of Airway 5 mg Tablet?",
        "answer": [
          "If you miss a dose, you may take it as soon as possible. But if it is almost time for your next dose, just skip that dose. Do not double up on doses."
        ]
      },
      {
        "question": "Are there any pregnancy warnings for Airway 5 mg Tablet?",
        "answer": [
          "Use of Airway 5 mg Tablet in pregnant women should be avoided unless clearly needed."
        ]
      },
      {
        "question": "General Instructions",
        "answer": [
          "Take Airway 5 mg Tablet exactly as prescribed by your doctor.",
          "Do not change your Airway 5 mg Tablet dose or stop using asthma medication without your doctor's advice.",
          "Airway 5 mg Tablet is not a fast-acting rescue medicine for asthma attacks. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working.",
          "Avoid situations or activities that may trigger an asthma attack.",
          "Talk to your doctor before using Airway 5 mg Tablet if you're pregnant or breastfeeding. They can help you decide if it's the right choice for you."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:18.117Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d36",
    "original_record": {
      "input_index": 767,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d36"
        },
        "name": "Airway",
        "strength": "5 mg",
        "generic": "Montelukast Sodium",
        "company": "One Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/22627/airway-5-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/22628/airway-10-mg-tablet",
    "name": "Airway",
    "dosage_form": "Tablet",
    "generic": "Montelukast Sodium",
    "strength": "10 mg",
    "company": "One Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 17.00",
      "strip_price": "৳ 170.00",
      "pack_size_info": "(3 x 10: ৳ 510.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 17.00",
          "pack_size_info": "(3 x 10: ৳ 510.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 170.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/22627/airway-5-mg-tablet?ref=1"
      },
      {
        "text": "4 mg (Tablet)",
        "href": "https://medex.com.bd/brands/27988/airway-4-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/768/montelukast-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Airway is indicated for:",
        "items": [
          "Prophylaxis and chronic treatment of asthma",
          "Acute prevention of Exercise-Induced Bronchoconstriction (EIB)",
          "Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT 1 ). The cysteinyl leukotrienes (LTC 4 , LTD 4 , LTE 4 ) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma & allergic rhinitis, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Airway has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions. In drug interaction studies, the recommended clinical dose of Airway did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1mg/ethinyl estradiol 35mcg), terfenadine, digoxin, and warfarin. Although additional specific interaction studies were not performed, Airway was used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of clinical adverse interactions. These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines and decongestants. Phenobarbital, which induces hepatic metabolism, decreased the AUC of Airway approximately 40% following a single 10mg dose of Airway. No dosage adjustment for Airway is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with Airway.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Montelukast is contraindicated in patients who are hypersensitive to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Common",
        "information": ": Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.",
        "items": []
      },
      {
        "title": "Uncommon",
        "information": ": Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.",
        "items": []
      },
      {
        "title": "Rare",
        "information": ": Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Montelukast crosses the placenta following oral dosing in rats and rabbits. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Montelukast should be used during pregnancy only if clearly needed. Because many drugs are excreted in human milk, caution should be exercised when Montelukast is given to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Airway is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Patients should be advised to have appropriate rescue medication available. Therapy with Airway can be continued during acute exacerbations of asthma. While the dose of inhaled corticosteroid may be reduced gradually under medical supervision, Airway should not be abruptly substituted for inhaled or oral corticosteroids. Airway should not be used as monotherapy for the treatment and management of exercise induced bronchospasm. Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Airway. Although Airway is effective in improving airway function in asthmatics with documented aspirin sensitivity, it has not been shown to truncate bronchoconstrictor response to aspirin and other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Airway and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C35H36ClNO3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg"
    },
    "therapeutic_class": "Leukotriene receptor antagonists",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adults and adolescents with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for adults and adolescents 15 years of age and older",
        "information": ": Montelukast 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Pediatric patients with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 to 14 years of age",
        "information": ": Montelukast 5 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 2 years to 5 years of age",
        "information": ": Montelukast 4 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 months to 5 years of age",
        "information": ": Montelukast 4 mg oral granules once daily. This can be administered either directly in the mouth, or mixed with a spoonful of cold water or soft food at room temperature",
        "instructions": []
      },
      {
        "medication_type": "Use in the pediatric patient",
        "information": ": The safety and efficacy of Montelukast have been established in adequate and well-controlled studies in pediatric patients with asthma 6 months to 14 years of age. Safety and efficacy profiles in this age group are similar to those seen in adults.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is required in patients with mild-to-moderate hepatic insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": No dosage adjustment is recommended in patients with renal insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Elderly use",
        "information": ": The pharmacokinetic profile and the oral bioavailability of a single 10-mg oral dose of montelukast are similar in elderly and younger adults. The plasma half-life of montelukast is slightly longer in the elderly. No dosage adjustment in the elderly is required.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Airway 10 mg Tablet?",
        "answer": [
          "Airway 10 mg Tablet is a selective and orally active leukotriene receptor antagonist."
        ]
      },
      {
        "question": "What is Airway 10 mg Tablet used for?",
        "answer": [
          "Airway 10 mg Tablet is commonly used to treat asthma or allergic rhinitis. It helps keep airways open and easy breathing by blocking leukotrienes."
        ]
      },
      {
        "question": "How soon can the effect of Airway 10 mg Tablet be observed?",
        "answer": [
          "The effect of Airway 10 mg Tablet can be observed after 1-3 hours of administration. Airway 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks and needs to be taken daily to work properly."
        ]
      },
      {
        "question": "How long does the effect of Airway 10 mg Tablet last?",
        "answer": [
          "The effect of Airway 10 mg Tablet lasts for an average duration of 24 hours."
        ]
      },
      {
        "question": "Should I use Airway 10 mg Tablet empty stomach?",
        "answer": [
          "Airway 10 mg Tablet may be taken with or without food as prescribed by your doctor."
        ]
      },
      {
        "question": "What if I miss a dose of Airway 10 mg Tablet?",
        "answer": [
          "If you miss a dose, you may take it as soon as possible. But if it is almost time for your next dose, just skip that dose. Do not double up on doses."
        ]
      },
      {
        "question": "Are there any pregnancy warnings for Airway 10 mg Tablet?",
        "answer": [
          "Use of Airway 10 mg Tablet in pregnant women should be avoided unless clearly needed."
        ]
      },
      {
        "question": "General Instructions",
        "answer": [
          "Take Airway 10 mg Tablet exactly as prescribed by your doctor.",
          "Do not change your Airway 10 mg Tablet dose or stop using asthma medication without your doctor's advice.",
          "Airway 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working.",
          "Avoid situations or activities that may trigger an asthma attack.",
          "Talk to your doctor before using Airway 10 mg Tablet if you're pregnant or breastfeeding. They can help you decide if it's the right choice for you."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:19.263Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d37",
    "original_record": {
      "input_index": 768,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d37"
        },
        "name": "Airway",
        "strength": "10 mg",
        "generic": "Montelukast Sodium",
        "company": "One Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/22628/airway-10-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34763/ajwa-10-mg-tablet",
    "name": "Ajwa",
    "dosage_form": "Tablet",
    "generic": "Atorvastatin Calcium",
    "strength": "10 mg",
    "company": "Desh Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 10.00",
      "strip_price": "৳ 100.00",
      "pack_size_info": "(3 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.00",
          "pack_size_info": "(3 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/92/atorvastatin-calcium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ajwa is indicated as an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B (Apo-B) and triglycerides levels in following diseases when response to diet and other non-pharmacological measures is inadequate. Ajwa is indicated as an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B (Apo-B) and triglycerides levels in following diseases when response to diet and other non-pharmacological measures is inadequate.",
        "items": [
          "To reduce total cholesterol and LDL cholesterol in patients with heterozygous and homozygous familial hypercholesterolemia.",
          "To reduce total cholesterol and LDL cholesterol in patients with heterozygous and homozygous familial hypercholesterolemia.",
          "To reduce elevated cholesterol and triglycerides in patient with mixed dyslipidemia (Fredrickson Type Ia and Ib).",
          "For the treatment of patients with elevated serum triglyceride levels in hypertriglyceridaemia (Fredrickson Type IV).",
          "For the treatment of patients with dysbetalipoproteinaemia (Fredrickson Type III).",
          "To reduce cardiac ischaemic events in patients with asymptomatic or mild to moderate symptomatic coronary artery disease with elevated LDL-cholesterol level.",
          "To reduce total and LDL-cholesterol concentrations patients with hypercholesterolemia associated with or exacerbated by diabetes mellitus or renal transplantation."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Atorvastatin is a selective inhibitor of HMG-CoA reductase. This enzyme is the rate-limiting enzyme responsible for the conversion of HMG-CoA to mevalonate, a precursor of sterols, including cholesterol. Atorvastatin lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.",
        "items": []
      },
      {
        "title": "Absorption",
        "information": ": Atorvastatin is rapidly absorbed after oral administration; maximum plasma concentrations occur within 1 to 2 hours. Extent of absorption increases in proportion to Atorvastatin dose. The absolute bioavailability of Atorvastatin (parent drug) is approximately 14% and the systemic availability of HMG-CoA reductase inhibitory activity is approximately 30%.",
        "items": []
      },
      {
        "title": "Distribution",
        "information": ": Mean volume of distribution of Atorvastatin is approximately 381 liters. Atorvastatin is 98% bound to plasma proteins. A blood/plasma ratio of approximately 0.25 indicates poor drug penetration into red blood cells. Based on observations in rats, Atorvastatin is likely to be secreted in human milk.",
        "items": []
      },
      {
        "title": "Metabolism",
        "information": ": Atorvastatin is extensively metabolized to ortho- and parahydroxylated derivatives and various beta-oxidation products. In vitro inhibition of HMG-CoA reductase by ortho- and parahydroxylated metabolites is equivalent to that of Atorvastatin. Approximately 70% of circulating inhibitory activity for HMG-CoA reductase is attributed to active metabolites. In vitro studies suggest the importance of Atorvastatin metabolism by cytochrome P450 3A4, consistent with increased plasma concentrations of Atorvastatin in humans following coadministration with erythromycin, a known inhibitor of this isozymes. In animals, the ortho-hydroxy metabolite undergoes further glucuronidation.",
        "items": []
      },
      {
        "title": "Excretion",
        "information": ": Atorvastatin and its metabolites are eliminated primarily in bile following hepatic and/or extra-hepatic metabolism; however, the drug does not appear to undergo enterohepatic recirculation. Mean plasma elimination half-life of Atorvastatin in humans is approximately 14 hours, but the half-life of inhibitory activity for HMG-CoA reductase is 20 to 30 hours due to the contribution of active metabolites. Less than 2% of a dose of Atorvastatin is recovered in urine following oral administration.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (nicotinic acid), erythromycin, azole antifungals.",
        "items": []
      },
      {
        "title": "Antacid",
        "information": ": When atorvastatin and antacid suspension were coadministered, plasma concentrations of atorvastatin decreased approximately 35%. However, LDL-C reduction was not altered.",
        "items": []
      },
      {
        "title": "Colestipol",
        "information": ": Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and atorvastatin were coadministered. However, LDL-C reduction was greater when atorvastatin and colestipol were coadministered than when either drug was given alone.",
        "items": []
      },
      {
        "title": "Digoxin",
        "information": ": When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%. Patients taking digoxin should be monitored appropriately.",
        "items": []
      },
      {
        "title": "Erythromycin",
        "information": ": In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4.",
        "items": []
      },
      {
        "title": "Oral Contraceptives",
        "information": ": Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%. These increases should be considered when selecting an oral contraceptive for a woman taking atorvastatin.",
        "items": []
      },
      {
        "title": "Warfarin",
        "information": ": Ajwa had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Atorvastatin should not be used in patient with hypersensitivity to any component of this medication. Atorvastatin is contraindicated in active liver disease or unexplained persistent elevations of serum transaminases. It is also contraindicated in patient with history of serious adverse reaction to prior administration of HMG-CoA reductase inhibitors.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Ajwa is generally well-tolerated. The most frequent side effects related to Ajwa are constipation, flatulence, dyspepsia, abdominal pain. Other side effects includes infection, headache, back pain, rash, asthenia, arthralgia, myalgia.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Atorvastatin is contraindicated during pregnancy. Safety in pregnant women has not been established. No controlled clinical trials with atorvastatin have been conducted in pregnant women. Rare reports of congenital anomalies following intrauterine exposure to HMG-CoA reductase inhibitors have been received. Animal studies have shown toxicity to reproduction. Maternal treatment with atorvastatin may reduce the fetal levels of mevalonate which is a precursor of cholesterol biosynthesis. Atorvastatin should not be used in women who are pregnant, trying to become pregnant or suspect they are pregnant. Treatment with atorvastatin should be suspended for the duration of pregnancy or until it has been determined that the woman is not pregnant",
        "items": []
      },
      {
        "title": "Lactation",
        "information": ": It is not known whether atorvastatin or its metabolites are excreted in human milk. In rats, plasma concentrations of atorvastatin and its active metabolites are similar to those in milk. Because of the potential for serious adverse reactions, women taking atorvastatin should not breastfeed their infants. Atorvastatin is contraindicated during breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Liver effects: Liver function tests should be performed before the initiation of treatment and periodically thereafter. Ajwa should be used with caution in patients who consume substantial quantities of alcohol or have a history of liver disease. Ajwa therapy should be discontinued if markedly elevated CPK levels occur or myopathy is diagnosed or suspected.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric",
        "information": ": Plasma concentrations of Ajwa are higher (approximately 40% for Cmax and 30% for AUC) in healthy elderly subjects (age 65 years) than in young adults. Clinical data suggest a greater degree of LDL-lowering at any dose of drug in the elderly patient population compared to younger adults.",
        "items": []
      },
      {
        "title": "Pediatric",
        "information": ": Pharmacokinetic data in the pediatric population are not available.",
        "items": []
      },
      {
        "title": "Gender",
        "information": ": There is no clinically significant difference in LDL-C reduction with Ajwa between men and women.",
        "items": []
      },
      {
        "title": "Renal Insufficiency",
        "information": ": Renal disease has no influence on the plasma concentrations or LDL-C reduction of Ajwa; thus, dose adjustment in patients with renal dysfunction is not necessary.",
        "items": []
      },
      {
        "title": "Hemodialysis",
        "information": ": Hemodialysis is not expected to significantly enhance clearance of Ajwa since the drug is extensively bound to plasma proteins.",
        "items": []
      },
      {
        "title": "Hepatic Insufficiency",
        "information": ": In patients with chronic alcoholic liver disease, plasma concentrations of Ajwa are markedly increased.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Specific treatment is not available for atorvastatin overdose. The patient should be treated symptomatically and supportive measures instituted, as required. Liver function tests should be performed and serum CK levels should be monitored. Due to extensive atorvastatin binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin clearance.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C33H35FN2O5",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-92-atorvastatin-calcium-chemical-structure-vKDE8RIA4syu8MLTgdLW.svg"
    },
    "therapeutic_class": "Other Anti-anginal & Anti-ischaemic drugs, Statins",
    "dosage": [
      {
        "medication_type": null,
        "information": "Primary hypercholesterolaemia and combined hyperlipidaemia-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": Usually 10 mg once daily; if necessary, may be increased at intervals of at least 4 weeks to max. 80 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Child (10-18 years)",
        "information": ": Initially 10 mg once daily, increased if necessary at intervals of at least 4 weeks to usual max. 20 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Familial hypercholesterolaemia-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": Initially 10 mg daily, increased at intervals of at least 4 weeks to 40 mg once daily; if necessary, further increased to max. 80 mg once daily (or 40 mg once daily combined with anion-exchange resin in heterozygous familial hypercholesterolaemia).",
        "instructions": []
      },
      {
        "medication_type": "Child (10-18 years)",
        "information": ": Initially 10 mg once daily, increased if necessary at intervals of at least 4 weeks to usual max. 80 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Prevention of cardiovascular events-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": Initially 10 mg once daily adjusted according to response.",
        "instructions": []
      },
      {
        "medication_type": "Another guideline",
        "information": ": The patient should be placed on a standard cholesterol-lowering diet before receiving Atorvastatin and should continue on this diet during treatment with Atorvastatin. The recommended starting dose of Atorvastatin is 10 or 20 mg once daily. Patients who require a large reduction in LDL-C (more than 45%) may be started at 40 mg once daily. The dosage range of Atorvastatin is 10 to 80 mg once daily. Atorvastatin can be administered as a single dose at any time of the day, with or without food. After initiation of Atorvastatin lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly. In hypercholesterolemia in Pediatric Patients (10-17 years of age) the recommended starting dose of Atorvastatin is 10 mg/day; the maximum recommended dose is 20 mg/day (doses greater than 20 mg have not been studied in this patient population). Doses should be individualized according to the recommended goal of therapy. Adjustments should be made at intervals of 4 weeks or more.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Ajwa 10 mg Tablet?",
        "answer": [
          "Ajwa 10 mg Tablet is a selective inhibitor of HMG-CoA reductase. It is used to avoid heart attacks and Primary Hypercholesterolemia. It is also used to treat conditions such as Mixed Dyslipidemia and Hypertriglyceridemia."
        ]
      },
      {
        "question": "How should I take Ajwa 10 mg Tablet?",
        "answer": [
          "Ajwa 10 mg Tablet should be taken by mouth once daily, at the same time each day. It can be taken with or without food."
        ]
      },
      {
        "question": "What are the uses of Ajwa 10 mg Tablet?",
        "answer": [
          "Ajwa 10 mg Tablet is used for the treatment of diseases like Mixed Dyslipidemia and Hypertriglyceridemia. Besides these, it can also be used to treat conditions like heart attacks and Primary Hypercholesterolemia."
        ]
      },
      {
        "question": "What are the Side Effects of Ajwa 10 mg Tablet?",
        "answer": [
          "This is a list of possible side-effects which may occur due to the constituting ingredients of Ajwa 10 mg Tablet. These side-effects have been observed and not necessarily occur. Some of these side-effects may be serious. These include cough, muscle pain, breathing difficulty and running nose."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Ajwa 10 mg Tablet?",
        "answer": [
          "Ajwa 10 mg Tablet should be stored at room temperature, away from heat and direct light. Keep it away from the reach of children and pets."
        ]
      },
      {
        "question": "Is Ajwa 10 mg Tablet used for lowering cholesterol?",
        "answer": [
          "Ajwa 10 mg Tablet comes under the class of drugs termed as statins and helps in decreasing the level of lipids or fats. It is used to lower cholesterol and triglycerides present in the blood. However, you must take a cholesterol-lowering diet during the course of treatment."
        ]
      },
      {
        "question": "Will taking Ajwa 10 mg Tablet increase my risk of diabetes?",
        "answer": [
          "If you have type 2 diabetes, then consuming Ajwa 10 mg Tablet can slightly affect your health as Ajwa 10 mg Tablet is known to increase the blood sugar levels. In such a case, regular monitoring of blood sugar level during the course of treatment is important."
        ]
      },
      {
        "question": "For how long do I need to take Ajwa 10 mg Tablet? Is it safe for long-term use?",
        "answer": [
          "Ajwa 10 mg Tablet should be taken for a duration that a doctor has prescribed it. If you stop taking this medicine without completing the full course, then it can worsen your condition. This medicine is considered safe for long term use if you take it exactly as directed by the doctor."
        ]
      },
      {
        "question": "Does Ajwa 10 mg Tablet cause weight loss?",
        "answer": [
          "No studies report that Ajwa 10 mg Tablet can cause weight loss. This is a very unusual side effect. If you encounter weight loss after the course of medication, then doctor consultation is suggested."
        ]
      },
      {
        "question": "Can I stop taking Ajwa 10 mg Tablet?",
        "answer": [
          "Do not stop taking Ajwa 10 mg Tablet without informing your doctor. Completing the course of medication is necessary or it can worsen your condition."
        ]
      },
      {
        "question": "Does Ajwa 10 mg Tablet cause memory loss?",
        "answer": [
          "Memory loss is a very rare side effect of Ajwa 10 mg Tablet. You must consult a doctor if you experience it."
        ]
      },
      {
        "question": "Does Ajwa 10 mg Tablet make you tired?",
        "answer": [
          "Ajwa 10 mg Tablet can make you feel tired. Although the exact reason behind this is still not known."
        ]
      },
      {
        "question": "Can Ajwa 10 mg Tablet be prescribed to children?",
        "answer": [
          "Ajwa 10 mg Tablet should be used by adults. Children above 10 years of age can also use it however caution must be exercised. Ajwa 10 mg Tablet should not be given to children who are less than 10 years old."
        ]
      },
      {
        "question": "Is Ajwa 10 mg Tablet a blood thinner?",
        "answer": [
          "Ajwa 10 mg Tablet does not cause thinning of the blood. This medication lowers cholesterol and prevents the chances of stroke and heart attack."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "In general, Ajwa 10 mg Tablet is safe. It may cause diarrhea, gas or an upset stomach. If any of these happen to you, take it with food.",
          "Inform your doctor if you experience fatigue, muscle weakness or muscle pain.",
          "Your doctor may check your liver function before starting the treatment and regularly thereafter. Inform your doctor if you notice signs of liver problems such as stomach pains, unusually dark urine or yellowing of skin or eyes.",
          "Inform your doctor if you have kidney disease, liver disease or diabetes before starting treatment with this medicine. If you are diabetic, monitor your blood sugar level regularly as Ajwa 10 mg Tablet may cause an increase in your blood sugar level.",
          "Do not take Ajwa 10 mg Tablet if you are pregnant, planning a pregnancy or breastfeeding."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:21.515Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d3e",
    "original_record": {
      "input_index": 769,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d3e"
        },
        "name": "Ajwa",
        "strength": "10 mg",
        "generic": "Atorvastatin Calcium",
        "company": "Desh Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/34763/ajwa-10-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31608/akicin-100-mg-injection",
    "name": "Akicin",
    "dosage_form": "IM/IV Injection",
    "generic": "Amikacin",
    "strength": "100 mg/2 ml",
    "company": "Square Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 16.05",
      "strip_price": null,
      "pack_size_info": "(2 x 5: ৳ 160.50)",
      "packages": [
        {
          "label": "2 ml ampoule",
          "price": "৳ 16.05",
          "pack_size_info": "(2 x 5: ৳ 160.50)"
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "500 mg/2 ml (Injection)",
        "href": "https://medex.com.bd/brands/574/akicin-500-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/54/amikacin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Akicin is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria. Akicin is effective in bacterial septicemia (including neonatal sepsis); in serious infections of the respiratory tract, bones and joints, central nervous system (including ... Read moreAkicin is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria. Akicin is effective in bacterial septicemia (including neonatal sepsis); in serious infections of the respiratory tract, bones and joints, central nervous system (including meningitis) and skin and soft tissue; intra-abdominal infections (including peritonitis); and in burns and postoperative infections (including postvascular surgery). Clinical studies have shown Akicin also to be effective in serious complicated and recurrent urinary tract infections due to those organisms.Akicin was effective in infections caused by gentamicin and/or tobramycin-resistant strains of Gram-negative organisms, particularly Proteus rettgeri, Providencia stuartii, Serratia marcescens, and Pseudomonas aeruginosa.Akicin has also been shown to be effective in staphylococci infections and may be considered as initial therapy under certain conditions in the treatment of known or suspected staphylococcal disease such as, severe infections where the causative organism may be either a Gram-negative bacterium or a staphylococcus.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Amikacin Sulfate is a semi-synthetic aminoglycoside antibiotic. Amikacin is active in vitro against pseudomonas species, Escherichia coli, Proteus species, Providencia species, Klebsiella-Enterobacter species, Acinetobacter species, and Citrobacter freundii. When strains of the above organisms are found to be resistant to other aminoglycosides, including Gentamicin, TobrAmykin and KanAmykin, many are susceptible to Amikacin. Amikacin sulfate is active in vitro against penicillinase and nonpenicillinase-producing Staphylococcus species including methicillin-resistant strains.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concurrent administration of Akicin with myorelaxants leads to potentiation of their effects and there is a possibility of cessation of the breathing. The combination with other Aminoglycoside antibiotics should be avoided because of the augmentation of their ototoxic and nephrotoxic effects. Concurrent administration of Akicin with fast acting diuretics increases the risk of ototoxicity in patients with renal failure. Combination with Cephalosporins or Polymixins increases the risk of nephrotoxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Amikacin Injection is contraindicated in patients with a known history of hypersensitivity to Amikacin, any constituents of the injection.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The adverse effects have been reported with the use of Akicin are tinnitus, vertigo, partial reversible or irreversible deafness, skin rash, drug fever, headache, paraesthesia, nausea and vomiting.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Amikacin rapidly crosses the placenta into the foetal circulation and amniotic fluid and there is a potential risk of ototoxicity in the foetus. There is no information available regarding the safety of this drug during breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Since Akicin is present in high concentrations in the renal excretory system, patients should be well hydrated to minimize chemical irritation of the renal tubules. If azotemia increases, treatment should be stopped. Monitoring of renal function during treatment with aminoglycosides is particularly important.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Safety and effectiveness of Akicin for injection in children or adolescents under 16 years have not been established",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "In the event of overdose or toxic reaction, peritoneal dialysis or haemodialysis will aid in the removal of Akicin from the blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": "Intramuscular or intravenous administration",
        "information": ": For most infections the intramuscular route is preferred, but in life threatening infections, or in patients in whom intramuscular injection route is not feasible the intravenous route may be used.",
        "items": []
      },
      {
        "title": "Intraperitoneal use",
        "information": ": Amikacin may be used as an irrigant after recovery from anesthesia in concentration of 0.25%.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Aminoglycosides",
    "dosage": [
      {
        "medication_type": "Adults and children",
        "information": ": 15 mg/kg/day in two equally-divided doses (equivalent to 500 mg bid in adults). Use of the 100 mg is recommended for children for the accurate measurement of the appropriate dose.",
        "instructions": []
      },
      {
        "medication_type": "Neonates and premature children",
        "information": ": An initial loading dose of 10 mg/kg followed by 15 mg/kg/day in two equally divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": Amikacin is excreted by the renal route. Renal function should be assessed whenever possible and dosage adjusted as described under impaired renal function.",
        "instructions": []
      },
      {
        "medication_type": "Life-threatening infections and/or those caused by Pseudomonas",
        "information": ": The adult dose may be increased to 500 mg every eight hours but should neither exceed 1.5g/day nor be administered for a period longer than 10 days. A maximum total adult dose of 15g should not be exceeded.",
        "instructions": []
      },
      {
        "medication_type": "Urinary tract infections",
        "information": "(other than pseudomonal infections): 7.5mg/kg/day in two equally divided doses (equivalent to 250 mg b.i.d. in adults).",
        "instructions": []
      },
      {
        "medication_type": "Impaired renal function",
        "information": ": In patients with impaired renal function, the daily dose should be reduced and/or the intervals between doses increased to avoid accumulation of the drug.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:22.670Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d41",
    "original_record": {
      "input_index": 770,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d41"
        },
        "name": "Akicin",
        "strength": "100 mg/2 ml",
        "generic": "Amikacin",
        "company": "Square Pharmaceuticals PLC",
        "medicine_type": "IM/IV Injection",
        "source_url": "https://medex.com.bd/brands/31608/akicin-100-mg-injection",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33867/akno-10-mg-capsule",
    "name": "Akno",
    "dosage_form": "Capsule",
    "generic": "Isotretinoin",
    "strength": "10 mg",
    "company": "Drug International Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 40.00",
      "strip_price": "৳ 600.00",
      "pack_size_info": "(1 x 15: ৳ 600.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 40.00",
          "pack_size_info": "(1 x 15: ৳ 600.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 600.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/640/isotretinoin-oral/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Akno capsule is indicated in severe forms of acne (such as nodular or conglobate acne or acne at risk of permanent scarring) resistant to adequate courses of standard therapy with systemic antibacterials and topical therapy.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Isotretinoin produces its effects through altering progress through the cell cycle, cell differentiation, survival, and apoptosis. These actions reduce sebum production, preventing the blockage of pores, and growth of acne causing bacteria. Isotretinoin and 4-oxo-isotretinoin both significantly reduce the production of sebum. Isotretinoin has little to no affinity for retinol binding proteins (RBPs) and retinoic acid nuclear receptors (RARs). Tretinoin and 4-oxo-tretinion bind to the RAR-γ receptor, which is suspected to be part of the action of acne treatment by isotretinoin. Isotretinoin induces apoptosis in sebocytes, leading to a decrease in sebum production. Isotretinoin also reduces the formation of comedones by reducing hyperkeratinization through an unknown mechanism. Isotretinoin does not directly kill bacteria but it does reduce the size of sebum ducts and makes the microenvironment less hospitable to acne causing bacteria. It may also increase immune mechanisms and alter chemotaxis of monocytes to reduce inflammation.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Additive adverse effects with vit A or its derivatives. Decreased efficacy of microdosed progesterone (use 2 forms of contraception).Increased risk of local irritation with topical keratolytic or exfoliative anti-acne agents. Oxidising agents (e.g. benzoyl peroxide) may reduce the efficacy of topical Akno.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Isotretinoin is contraindicated in women who are pregnant or breastfeeding. Isotretinoin is contraindicated in women of childbearing potential unless all of the conditions of the Pregnancy Prevention Programme are met. Isotretinoin is also contraindicated in patients with hypersensitivity to Isotretinoin or to any of the excipients. Isotretinoin is also contraindicated in patients with hepatic insufficiency, with excessively elevated blood lipid values, with hypervitaminosis A, receiving concomitant treatment with tetracyclines. This medicinal product is contraindicated in women of childbearing potential unless all of the following conditions of the Pregnancy Prevention Programme are met: She has severe acne (such as nodular or conglobate acne or acne at risk of permanent scarring) resistant to adequate courses of standard therapy with systemic anti-bacterials and topical therapy. She understands the teratogenic risk. She understands the need for rigorous follow-up, on a monthly basis. She understands and accepts the need for effective contraception, without interruption, 1 month before starting treatment, throughout the duration of treatment and 1 month after the end of treatment. At least one and preferably two complementary forms of contraception including a barrier method should be used. Even if she has amenorrhea she must follow all of the advice on effective contraception. She should be capable of complying with effective contraceptive measures. She is informed and understands the potential consequences of pregnancy and the need to rapidly consult if there is a risk of pregnancy. She understands the need and accepts to undergo pregnancy testing before, during and 5 weeks after the end of treatment. She has acknowledged that she has understood the hazards and necessary precautions associated with the use of Isotretinoin. These conditions also concern women who are not currently sexually active unless the prescriber considers that there are compelling reasons to indicate that there is no risk of pregnancy. The prescriber must ensure that the patient complies with the conditions for pregnancy prevention as listed above, including confirmation that she has an adequate level of understanding. The patient has acknowledged the aforementioned conditions. The patient has used at least one and preferably two methods of effective contraception including a barrier method for at least 1 month prior to starting treatment and is continuing to use effective contraception throughout the treatment period and for at least 1 month after cessation of treatment. Negative pregnancy test results have been obtained before, during and 5 weeks after the end of treatment. The dates and results of pregnancy tests should be documented.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Some of the side effects associated with the use of Akno are dose-related. The side effects are generally reversible after altering the dose or discontinuation of treatment, however some may persist after treatment has stopped. The following symptoms are the most commonly reported undesirable effects with Akno: dryness of the skin, dryness of the mucosae e.g. of the lips (cheilitis), the nasal mucosa (epistaxis) and the eyes (conjunctivitis). The incidence of the adverse events was calculated from pooled clinical trial data involving 824 patients and from post-marketing data. Frequency categories are defined as Very common (³1/10), Common (³1/100 to <1/10), Uncommon (³1/1,000 to <1/100), Rare (³1/10,000 to <1/1,000), Very rare (³1/10,000 to <1/1,000) and not known (cannot be estimated from the available data. Infections: Very Rare: Gram positive (mucocutaneous) bacterial infection Blood and lymphatic system disorders: Very common: Anaemia, red blood cell sedimentation rate increased, thrombocytopenia, thrombocytosis; Common: Neutropenia; Very Rare: Lymphadenopathy Immune system disorders: Rare: Allergic skin reaction, anaphylactic reactions, hypersensitivity Metabolism and nutrition disorders: Very Rare: Diabetes mellitus, hyperuricaemia Psychiatric disorders: Rare: Depression, depression aggravated, aggressive tendencies, anxiety, mood alterations. Very Rare: Abnormal behaviour, psychotic disorder, suicidal ideation suicide attempt, suicide Nervous system disorders: Common: Headache; Very Rare: Benign intracranial hypertension, convulsions, drowsiness, dizziness Eye disorders: Very Common: Blepharitis, conjunctivitis, dry eye, eye irritation; Very Rare: Blurred vision, cataract, colour blindness (colour vision deficiencies), contact lens intolerance, corneal opacity, decreased night vision, keratitis, papilloedema (as sign of benign intracranial hypertension), photophobia, visual disturbances. Ear and labyrinth disorders: Very Rare: Hearing impaired Vascular disorders: Very Rare: Vasculitis (for example Wegener's granulomatosis, allergic vasculitis) Respiratory, thoracic and mediastinal disorders: Common: Epistaxis, nasal dryness, nasopharyngitis, Very Rare: Bronchospasm (particularly in patients with asthma), hoarseness Gastrointestinal disorders: Very Rare: Colitis, ileitis, dry throat, gastrointestinal haemorrhage, haemorrhagic diarrhoea and inflammatory bowel disease, nausea, pancreatitis Hepatobiliary disorders: Very Common: Transaminase increased; Very rare: Hepatitis Skin and subcutaneous tissues disorders: Very Common: Pruritus, rash erythematous, dermatitis, cheilitis, dry skin, localised exfoliation, skin fragility (risk of frictional trauma), Rare: Alopecia, Very Rare: Acne fulminans, acne aggravated (acne flare), erythema (facial), exanthema, hair disorders, hirsutism, nail dystrophy, paronychia, photosensitivity reaction, pyogenic granuloma, skin hyperpigmentation, sweating increased. Musculo-skeletal and connective tissue disorders: Very Common: Arthralgia, myalgia, back pain (particularly in children and adolescent patients), Very Rare: Arthritis, calcinosis (calcification of ligaments and tendons), epiphyses premature fusion, exostosis, (hyperostosis), reduced bone density, tendonitis. Renal and urinary disorders: Very Rare: Glomerulonephritis. General disorders and administration site conditions: Very Rare: Granulation tissue (increased formation of), malaise. Overdose Akno is a derivative of vitamin A. Although the acute toxicity of Akno is low, signs of hypervitaminosis A could appear in cases of accidental overdose. Manifestations of acute vitamin A toxicity include severe headache, nausea or vomiting, drowsiness, irritability and pruritus. Signs and symptoms of accidental or deliberate overdosage with Akno would probably be similar. These symptoms would be expected to be reversible and to subside without the need for treatment. Pharmaceutical precautions Store in a cool and dry place protected from light.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy is an absolute contraindication to treatment with Isotretinoin. If pregnancy does occur in spite of these precautions during treatment with Isotretinoin or in the month following, there is a great risk of very severe and serious malformation of the foetus. The foetal malformations associated with exposure to Isotretinoin include central nervous system abnormalities (hydrocephalus, cerebellar malformation/abnormalities, microcephaly), facial dysmorphia, cleft palate, external ear abnormalities (absence of external ear, small or absent external auditory canals), eye abnormalities (microphthalmia), cardiovascular abnormalities (conotruncal malformations such as tetralogy of Fallot, transposition of great vessels, septal defects), thymus gland abnormality and parathyroid gland abnormalities. There is also an increased incidence of spontaneous abortion. If pregnancy occurs in a woman treated with Isotretinoin, treatment must be stopped and the patient should be referred to a physician specialised or experienced in teratology for evaluation and advice. Isotretinoin is highly lipophilic, therefore the passage of Isotretinoin into human milk is very likely. Due to the potential for adverse effects in the child exposed via mothers’ milk, the use of Isotretinoin is contraindicated in nursing mothers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Contraception",
        "information": ": Female patients must be provided with comprehensive information on pregnancy prevention and should be referred for contraceptive advice if they are not using effective contraception. As a minimum requirement, female patients at potential risk of pregnancy must use at least one effective method of contraception. Preferably the patient should use two complementary forms of contraception including a barrier method. Contraception should be continued for at least 1 month after stopping treatment with Akno, even in patients with amenorrhea.",
        "items": []
      },
      {
        "title": "Pregnancy testing",
        "information": ": According to local practice, medically supervised pregnancy tests with a minimum sensitivity of 25mIU/mL are recommended to be performed in the first 3 days of the menstrual cycle, as follows.",
        "items": []
      },
      {
        "title": "Prior to starting therapy",
        "information": ": In order to exclude the possibility of pregnancy prior to starting contraception, it is recommended that an initial medically supervised pregnancy test should be performed and its date and result recorded. In patients without regular menses, the timing of this pregnancy test should reflect the sexual activity of the patient and should be undertaken approximately 3 weeks after the patient last had unprotected sexual intercourse. The prescriber should educate the patient about contraception. A medically supervised pregnancy test should also be performed during the consultation when Akno is prescribed or in the 3 days prior to the visit to the prescriber, and should have been delayed until the patient had been using effective contraception for at least 1 month. This test should ensure the patient is not pregnant when she starts treatment with Akno.",
        "items": []
      },
      {
        "title": "Follow-up visits",
        "information": ": Follow-up visits should be arranged at 28 day intervals. The need for repeated medically supervised pregnancy tests every month should be determined according to local practice including consideration of the patient’s sexual activity and recent menstrual history (abnormal menses, missed periods or amenorrhea). Where indicated, follow-up pregnancy tests should be performed on the day of the prescribing visit or in the 3 days prior to the visit to the prescriber.",
        "items": []
      },
      {
        "title": "End of treatment",
        "information": ": Five weeks after stopping treatment, women should undergo a final pregnancy test to exclude pregnancy.",
        "items": []
      },
      {
        "title": "Prescribing and dispensing restrictions",
        "information": ": Prescriptions of Akno for women of childbearing potential should be limited to 30 days of treatment and continuation of treatment requires a new prescription. Ideally, pregnancy testing, issuing a prescription and dispensing of Akno should occur on the same day. Dispensing of Akno should occur within a maximum of 7 days of the prescription.",
        "items": []
      },
      {
        "title": "Male patients",
        "information": ": The available data suggest that the level of maternal exposure from the semen of the patients receiving Akno, is not of a sufficient magnitude to be associated with the teratogenic effects of Akno. Male patients should be reminded that they must not share their medication with anyone, particularly not females.",
        "items": []
      },
      {
        "title": "Additional precautions",
        "information": ": Patients should be instructed never to give this medicinal product to another person, and to return any unused capsules to their pharmacist at the end of treatment. Patients should not donate blood during therapy and for 1 month following discontinuation of Akno because of the potential risk to the foetus of a pregnant transfusion recipient.",
        "items": []
      },
      {
        "title": "Psychiatric disorders",
        "information": ": Depression, depression aggravated, anxiety, aggressive tendencies, mood alterations, psychotic symptoms, and very rarely, suicidal ideation, suicide attempts and suicide have been reported in patients treated with Akno. Particular care needs to be taken in patients with a history of depression and all patients should be monitored for signs of depression and referred for appropriate treatment if necessary. However, discontinuation of Akno may be insufficient to alleviate symptoms and therefore further psychiatric or psychological evaluation may be necessary.",
        "items": []
      },
      {
        "title": "Skin and subcutaneous tissues disorders",
        "information": ": Acute exacerbation of acne is occasionally seen during the initial period but this subsides with continued treatment, usually within 7-10 days, and usually does not require dose adjustment. Exposure to intense sunlight or to UV rays should be avoided. Where necessary a sun-protection product with a high protection factor of at least SPF 15 should be used. Aggressive chemical dermabrasion and cutaneous laser treatment should be avoided in patients on Akno for a period of 5-6 months after the end of the treatment because of the risk of hypertrophic scarring in atypical areas and more rarely post inflammatory hyper or hypopigmentation in treated areas. Wax depilation should be avoided in patients on Akno for at least a period of 6 months after treatment because of the risk of epidermal stripping. Concurrent administration of Akno with topical keratolytic or exfoliative anti-acne agents should be avoided as local irritation may increase. Patients should be advised to use a skin moisturising ointment or cream and a lip balm from the start of treatment as Akno is likely to cause dryness of the skin and lips. There have been post-marketing reports of severe skin reactions (e.g. erythema multiforme (EM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)) associated with Akno use. As these events may be difficult to distinguish from other skin reactions that may occur, patients should be advised of the signs and symptoms and monitored closely for severe skin reactions. If a severe skin reaction is suspected, Akno treatment should be discontinued. Allergic reactions: Anaphylactic reactions have been rarely reported, in some cases after previous topical exposure to retinoids. Allergic cutaneous reactions are reported infrequently. Serious cases of allergic vasculitis, often with purpura (bruises and red patches) of the extremities and extracutaneous involvement have been reported. Severe allergic reactions necessitate interruption of therapy and careful monitoring.",
        "items": []
      },
      {
        "title": "Eye disorders",
        "information": ": Dry eyes, corneal opacities, decreased night vision and keratitis usually resolve after discontinuation of therapy. Dry eyes can be helped by the application of a lubricating eye ointment or by the application of tear replacement therapy. Intolerance to contact lenses may occur which may necessitate the patient to wear glasses during treatment. Decreased night vision has also been reported and the onset in some patients was sudden. Withdrawal of Akno may be necessary.",
        "items": []
      },
      {
        "title": "Musculo-skeletal and connective tissue disorders",
        "information": ": Myalgia, arthralgia and increased serum creatine phosphokinase values have been reported in patients receiving Akno, particularly in those undertaking vigorous physical activity. Bone changes including premature epiphyseal closure, hyperostosis, and calcification of tendons and ligaments have occurred after several years of administration at very high doses for treating disorders of keratinisation. The dose levels, duration of treatment and total cumulative dose in these patients generally far exceeded those recommended for the treatment of acne.",
        "items": []
      },
      {
        "title": "Benign intracranial hypertension",
        "information": ": Cases of benign intracranial hypertension have been reported, some of which involved concomitant use of tetracyclines. Signs and symptoms of benign intracranial hypertension include headache, nausea and vomiting, visual disturbances and papilloedema. Patients who develop benign intracranial hypertension should discontinue Akno immediately.",
        "items": []
      },
      {
        "title": "Hepatobiliary disorders",
        "information": ": Liver enzymes should be checked before treatment, 1 month after the start of treatment, and subsequently at 3 monthly intervals unless more frequent monitoring is clinically indicated. Transient and reversible increases in liver transaminases have been reported. In many cases these changes have been within the normal range and values have returned to baseline levels during treatment. However, in the event of persistent clinically relevant elevation of transaminase levels, reduction of the dose or discontinuation of treatment should be considered.",
        "items": []
      },
      {
        "title": "Renal insufficiency",
        "information": ": Renal insufficiency and renal failure do not affect the pharmacokinetics of Akno. Therefore, Akno can be given to patients with renal insufficiency. However, it is recommended that patients are started on a low dose and titrated up to the maximum tolerated dose.",
        "items": []
      },
      {
        "title": "Lipid Metabolism",
        "information": ": Serum lipids (fasting values) should be checked before treatment, 1 month after the start of treatment, and subsequently at 3 monthly intervals unless more frequent monitoring is clinically indicated. Elevated serum lipid values usually return to normal on reduction of the dose or discontinuation of treatment and may also respond to dietary measures. Akno has been associated with an increase in plasma triglyceride levels. Akno should be discontinued if hypertriglyceridaemia cannot be controlled at an acceptable level or if symptoms of pancreatitis occur. Levels in excess of 800mg/dL or 9mmol/L are sometimes associated with acute pancreatitis, which may be fatal.",
        "items": []
      },
      {
        "title": "Gastrointestinal disorders",
        "information": ": Akno has been associated with inflammatory bowel disease (including regional ileitis) in patients without a prior history of intestinal disorders. Patients experiencing severe (hemorrhagic) diarrhoea should discontinue Akno immediately.",
        "items": []
      },
      {
        "title": "High Risk Patients",
        "information": ": In patients with diabetes, obesity, alcoholism or a lipid metabolism disorder undergoing treatment with Akno, more frequent checks of serum values for lipids and/or blood glucose may be necessary. Elevated fasting blood sugars have been reported, and new cases of diabetes have been diagnosed during Akno therapy.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Oral retinoids for Acne",
    "dosage": [
      {
        "medication_type": null,
        "information": "The capsules should be taken with food once or twice daily. Isotretinoin should only be prescribed by or under the supervision of physicians with expertise in the use of systemic retinoids for the treatment of severe acne and a full understanding of the risks of Isotretinoin therapy and monitoring requirements.",
        "instructions": []
      },
      {
        "medication_type": "Adults including adolescents and the elderly",
        "information": ": Isotretinoin therapy should be started at a dose of 0.5 mg/kg daily. The therapeutic response to Isotretinoin and some of the adverse effects are dose-related and vary between patients. This necessitates individual dosage adjustment during therapy. For most patients, the dose ranges from 0.5-1.0 mg/kg per day. Long-term remission and relapse rates are more closely related to the total dose administered than to either duration of treatment or daily dose. It has been shown that no substantial additional benefit is to be expected beyond a cumulative treatment dose of 120-150 mg/kg. The duration of treatment will depend on the individual daily dose. A treatment course of 16-24 weeks is normally sufficient to achieve remission. In the majority of patients, complete clearing of the acne is obtained with a single treatment course. In the event of a definite relapse a further course of Isotretinoin therapy may be considered using the same daily dose and cumulative treatment dose. As further improvement of the acne can be observed up to 8 weeks after discontinuation of treatment, a further course of treatment should not be considered until at least this period has elapsed.",
        "instructions": []
      },
      {
        "medication_type": "Patients with severe renal insufficiency",
        "information": ": In patients with severe renal insufficiency treatment should be started at a lower dose (e.g. 10 mg/day). The dose should then be increased up to 1 mg/kg/day or until the patient is receiving the maximum tolerated dose.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": Isotretinoin is not indicated for the treatment of prepubertal acne and is not recommended in patients less than 12 years of age due to a lack of data on efficacy and safety.",
        "instructions": []
      },
      {
        "medication_type": "Patients with intolerance",
        "information": ": In patients who show severe intolerance to the recommended dose, treatment may be continued at a lower dose with the consequences of a longer therapy duration and a higher risk of relapse. In order to achieve the maximum possible efficacy in these patients the dose should normally be continued at the highest tolerated dose.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:23.884Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d45",
    "original_record": {
      "input_index": 771,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d45"
        },
        "name": "Akno",
        "strength": "10 mg",
        "generic": "Isotretinoin (Oral)",
        "company": "Drug International Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/33867/akno-10-mg-capsule",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33315/al-d3-40000-iu-capsule",
    "name": "AL-D3",
    "dosage_form": "Capsule",
    "generic": "Cholecalciferol [Vitamin D3]",
    "strength": "40000 IU",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": "৳ 250.00",
      "pack_size_info": "(1 x 10: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 25.00",
          "pack_size_info": "(1 x 10: ৳ 250.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 250.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "20000 IU (Capsule)",
        "href": "https://medex.com.bd/brands/33314/al-d3-20000-iu-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/252/cholecalciferol-vitamin-d3/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Vitamin D3 deficiency can occur in people whose exposure to sunlight is limited and in those whose diet is deficient in vitamin D3.",
        "items": [
          "AL-D3 is essential for the effective calcium and phosphate absorption required for healthy bones and teeth, preventing rickets, osteomalacia and osteoporosis.",
          "AL-D3 is also essential to prevent pre-eclampsia during pregnancy and breast feeding as it is an essential nutrient for a growing infant.",
          "AL-D3 has vital role on immunity boost up."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The active form of Vitamin D3, Calcitriol, exerts its effect by binding to the Vitamin D receptors (VDRs) which are widely distributed through many body tissues.Vitamin D3 has a half life of about 50 days as it is fat soluble.Vitamin D3 is absorbed in the small intestine and bound to specific a-globulins and transported to the liver where it is metabolised to 25-hydroxy Vitamin D3 (Calcidiol). A second hydroxylation to 1,25-dihydroxy Vitamin D3 (Calcitriol) occurs in the kidney. This metabolite is responsible for the vitamin's ability to increase the absorption of calcium. Non-metabolised Vitamin D3 is stored in tissues such as fat and muscle.Vitamin D3 is eliminated via faeces and urine.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Drug interaction with medication",
        "information": ": Concomitant treatment with phenytoin or barbiturates can decrease the effect of vitamin D because of metabolic activation. Concomitant use of glucocorticoids can decrease the effect of vitamin D. The effectsof digitalis and other cardiac glycosides may be accentuated with the oral administration of calcium combined with vitamin D. Strict medical supervision is needed and, if necessary monitoring of ECG and calcium. Simultaneous treatment with ion exchange resins such as cholestyramine or laxatives such as paraffin oil may reduce the gastrointestinal absorption of vitamin D. The cytotoxic agent actinomycin and imidazole antifungal agents interfere with vitamin D activity by inhibiting the conversion of 25-hydroxyvitamin D to 1, 25-dihydroxyvitamin D by the kidney enzyme, 25-hydroxyvitamin D-1-hydroxylase.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Vitamin D3 is contraindicated in all diseases associated with hypercalcaemia. It is also contraindicated in patients with known hypersensitivity to Vitamin D3 (or medicines of the same class) and any of the excipients. It is contraindicated if there is evidence of Vitamin D3 toxicity.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally all nutritional supplements are considered to be safe and well tolerable. However, few most common side effects can generally occur including hypocalcaemia syndrome or calcium intoxication (depending on the severity and duration of hypocalcaemia), occasional acute symptoms include anorexia, headache, nausea, vomiting, abdominal pain or stomach ache and constipation with the administration of colecalciferol.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Studies have shown safe use of doses up to 4000 IU during pregnancy. The recommended daily intake for pregnant women is 400 IU, however, in women who are considered to be Vitamin D3 deficient a higher dose may be required. During pregnancy women should follow the advice of their medical practitioner as their requirements may vary depending on the severity of their disease and their response to treatment Vitamin D3 and its metabolites are excreted in breast milk. Overdose in infants induced by nursing mothers has not been observed; however, when prescribing additional vitamin D3 to a breast-fed child the practitioner should consider the dose of any additional vitamin D3 given to the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Plasma-calcium concentration should be monitored at intervals in patients receiving high doses of Vitamin D3, in renal impairment, and during pregnancy & lactation. People using Digoxin and Thiazide Diuretics should consult a health care practitioner before supplementing with Vitamin D3. People with liver or kidney disease, primary hyperthyroidism, lymphoma, tuberculosis and granulomatous disease should consult a health care practitioner before supplementing with Vitamin D3.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "The most serious consequence of acute or chronic overdose is hypercalcaemia due to vitamin D toxicity. Symptoms may include nausea, vomiting, polyuria, anorexia, weakness, apathy, thirst and constipation. Chronic overdoses can lead to vascular and organ calcification as a result of hypercalcaemia. Treatment should consist of stopping all intakes of vitamin D and rehydration.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (below 25°C) and dry place protected from light. Keep away from the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Vitamin in bone formation, Vitamin-D preparations",
    "dosage": [
      {
        "medication_type": "For capsule",
        "information": ": Adults:",
        "instructions": [
          "Treatment of Vitamin D3 deficiency: 40000 IU once weekly for 7 weeks. Doses for maintenance therapy is 1400-2000 IU/day. To confirm the target level of 25 hydroxyvitamin D, measurement of it should be determined 3-4 months after initiating the maintenance therapy.",
          "Prevention of Vitamin D3 deficiency: 20000 IU every 4 weeks. Higher doses may be required in certain situations.",
          "Addition to specific therapy for osteoporosis: 20000 IU once a month."
        ]
      },
      {
        "medication_type": "For capsule",
        "information": ": Children (12-18 years):",
        "instructions": [
          "Treatment of Vitamin D3 deficiency: 20000 IU once every 2 weeks for 6 weeks.",
          "Prevention of Vitamin D3 deficiency: 20000 IU every 6 weeks."
        ]
      },
      {
        "medication_type": "For film-coated tablet",
        "information": ": 1000 IU (1-2 tablets) daily, or as directed by physician. Take the medicine with food or within 1 hour after a meal.",
        "instructions": []
      },
      {
        "medication_type": "For oroflash or chewable tablets",
        "information": ": 1000 IU to 2000 IU daily, or as directed by physician. Take the medicine with food or within 1 hour after a meal. Place the tablet in mouth swallow after chewing.",
        "instructions": []
      },
      {
        "medication_type": "For Oral Solution",
        "information": ":",
        "instructions": [
          "Up to one year: 400 IU once a day or as directed by the physician.",
          "1 year to 18 years: 600 IU once a day or as directed by the physician."
        ]
      },
      {
        "medication_type": "Injection",
        "information": ": For treatment-",
        "instructions": [
          "Rickets: 1 ampoule every 2 weeks for one month then 1 ampoule for every 4 months",
          "Osteoporosis: 1 ampoule every 2 weeks for 3 months",
          "Osteomalacia: 1 ampoule every 2 weeks for 3 months",
          "Tetany caused by hypocalcaemia: 1 ampoule for every 4 months which may be increased to 2 ampoules",
          "Menopause: 1 ampoule for every 6 months",
          "Vitamin 03 deficiency: 1 ampoule can be repeated 1 to 6 months later"
        ]
      },
      {
        "medication_type": "Injection",
        "information": ": For prevention- Direction of use of Injection-",
        "instructions": [
          "Pregnancy: 1/2 ampoule at 6th or 7th months",
          "During breastfeeding: 1/2 ampoule for every 6 months",
          "Children up to 5 years: 1 ampoule for every 6 months",
          "Adolescent: 1 ampoule for every 6 months",
          "Elderly Dosages: 1/2 ampoule for every 3 months."
        ]
      },
      {
        "medication_type": "For oral use",
        "information": "-",
        "instructions": [
          "Step-1: Place the thumb on ampoule and break the upper narrow part of the ampoule.",
          "Step-2: Pour out the solution of the ampoule in a spoon.",
          "Step-3: Mix the solution with water or milk before oral use."
        ]
      },
      {
        "medication_type": "For lM use",
        "information": "-",
        "instructions": [
          "Step-1: Place the thumb on ampoule and break the upper narrow part of the ampoule.",
          "Step-2: Then use as IM injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:25.197Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d49",
    "original_record": {
      "input_index": 772,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d49"
        },
        "name": "AL-D3",
        "strength": "40000 IU",
        "generic": "Cholecalciferol [Vitamin D3]",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/33315/al-d3-40000-iu-capsule",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/9715/alaclov-500-mg-tablet",
    "name": "Alaclov",
    "dosage_form": "Tablet",
    "generic": "Valacyclovir",
    "strength": "500 mg",
    "company": "ACI Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 40.27",
      "strip_price": "৳ 402.70",
      "pack_size_info": "(1 x 10: ৳ 402.70)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 40.27",
          "pack_size_info": "(1 x 10: ৳ 402.70)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 402.70",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1115/valacyclovir/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Varicella zoster virus (VZV) infections: Alaclov is indicated for the treatment of herpes zoster (shingles) and ophthalmic zoster in immunocompetent adults. It also is indicated for the treatment of herpes zoster in adult patients with mild or moderate immunosuppression. Herpes simplex virus (HSV) ... Read moreVaricella zoster virus (VZV) infections: Alaclov is indicated for the treatment of herpes zoster (shingles) and ophthalmic zoster in immunocompetent adults. It also is indicated for the treatment of herpes zoster in adult patients with mild or moderate immunosuppression. Herpes simplex virus (HSV) infections.Treatment and suppression of HSV infections of the skin and mucous membranes including:",
        "items": [
          "Treatment of first-episode of genital herpes in immunocompetent adults and adolescents and in Immunocompromised adults",
          "treatment of recurrences of genital herpes in immunocompetent adults and adolescents, and in immunocompromised adults",
          "suppression of recurrent genital herpes in immunocompetent adults and adolescents and in immunocompromised adults",
          "Treatment and suppression of recurrent ocular HSV infections.",
          "Cytomegalovirus (CMV) infections: Alaclov is indicated for the prophylaxis of CMV infection and disease following solid organ transplantation in adults and adolescents."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Valacyclovir is the hydrochloride salt of L-valyl ester of the antiviral drug acyclovir. Valacyclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Valacyclovir lessens the symptoms of infections and shortens the length of time of sickness. Valacyclovir is used in the treatment and suppression of genital herpes, shingles and cold sores.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The combination of Alaclov with nephrotoxic medicinal products should be made with caution, especially in subjects with impaired renal function, and warrants regular monitoring of renal function. This applies to concomitant administration with aminoglycosides, organoplatinum compounds, iodinated contrast media, methotrexate, pentamidine, foscarnet, ciclosporin, and tacrolimus. Aciclovir is eliminated primarily unchanged in the urine via active renal tubular secretion. Following 1000mg Alaclov, cimetidine and probenecid reduce aciclovir renal clearance and increase the AUC of aciclovir by about 25% and 45%, respectively, by inhibition of the active renal secretion of aciclovir. Cimetidine and probenecid taken together with Alaclov increased aciclovir AUC by about 65%. Other medicinal products (including e.g. tenofovir) administered concurrently that compete with or inhibit active tubular secretion may increase aciclovir concentrations by this mechanism. Similarly, Alaclov administration may increase plasma concentrations of the concurrently administered substance. In patients receiving higher aciclovir exposures from Alaclov, caution is required during concurrent administration with drugs which inhibit active renal tubular secretion. Increases in plasma AUCs of aciclovir and of the inactive metabolite of mycophenolatemotefil have been shown when the drugs are co-administered. No changes in peak concentrations or AUCs are observed with co-administration of Alaclov and mycophenolatemofetil in healthy volunteers. There is limited clinical experience with the use of Alaclov.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to Valacyclovir or aciclovir or any of the excipients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects reported in at least one indication by patients treated with Alaclov in clinical trials were headache and nausea. Other side effects include: Blood and lymphatic system disorders: leucopenia, thrombocytopenia, Leucopenia is mainly reported in immunocompromised patients. Immune system disorders: Anaphylaxis. Psychiatric and nervous system disorders: Dizziness, confusion, hallucinations, decreased concentrations, tremor, agitation, ataxia, dysarthria, convulsions, encephalopathy, coma, psychotic symptoms. Respiratory disorders: Dyspnea. Gastrointestinal disorders: Vomiting, diarrhea, abdominal discomfort. Hepato-biliary disorders: Reversible increases in liver function tests. Skin and subcutaneous tissue disorders: Rashes including photosensitivity, pruritus, urticaria. Renal system disorders: Renal pain, renal impairment (especially in elderly patients or in patients with renal impairment receiving higher than the recommended doses). Renal pain may be associated with renal failure.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "A limited amount of data on the use of Valacyclovir and a moderate amount of data on the use of aciclovir in pregnancy is available from pregnancy registries and postmarketing experience indicate no malformative or foeto/neonatal toxicity. Animal studies do not show reproductive toxicity for Valacyclovir. Valacyclovir should only be used in pregnancy if the potential benefits of treatment outweigh the potential risk. Use in lactation: Aciclovir, the principle metabolite of Valacyclovir, is excreted in breast milk. However, at therapeutic doses of Valacyclovir, no effects on the breastfed newborns/infants are anticipated since the dose ingested by the child is less than 2% of the therapeutic dose of intravenous aciclovir for treatment of neonatal herpes. Valacyclovir should be used with caution during breast feeding and only when clinically indicated.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Hydration status",
        "information": ": Care should be taken to ensure adequate fluid intake in patients who are at risk of dehydration, particularly the elderly.",
        "items": []
      },
      {
        "title": "Use in patients with renal impairment and in elderly patients",
        "information": ": Aciclovir is eliminated by renal clearance; therefore the dose of Alaclov must be reduced in patients with renal impairment. Elderly patients are likely to have reduced renal function and therefore the need for dose reduction must be considered in this group of patients. Both elderly patients and patients with renal impairment are at increased risk of developing neurological side-effects and should be closely monitored for evidence of these effects. In the reported cases, these reactions were generally reversible on discontinuation of treatment.",
        "items": []
      },
      {
        "title": "Use of higher dose of Alaclov in hepatic impairment and liver transplantation",
        "information": ": There are no data available on the use of higher doses of Alaclov (4000mg or more per day) in patients with liver disease. Specific studies of Alaclov have not been conducted in liver transplantation, and hence caution should be exercised when administering daily doses greater than 4000mg to these patients.",
        "items": []
      },
      {
        "title": "Use for zoster treatment",
        "information": ": Clinical response should be closely monitored, particularly in immunocompromised patients. Consideration should be given to intravenous antiviral therapy when response to oral therapy is considered insufficient. Patients with complicated herpes zoster, i.e. those with visceral involvement, disseminated zoster, motor neuropathies, encephalitis and cerebrovascular complications should be treated with intravenous antiviral therapy. Moreover, immunocom-promised patients with ophthalmic zoster or those with a high risk for disease dissemination and visceral organ involvement should be treated with intravenous antiviral therapy.",
        "items": []
      },
      {
        "title": "Transmission of genital herpes",
        "information": ": Patients should be advised to avoid intercourse when symptoms are present even if treatment with an antiviral has been initiated.",
        "items": []
      },
      {
        "title": "Use of ocular HSV infections",
        "information": ": Clinical response should be closely monitored in these patients. Consideration should be given to intravenous antiviral therapy when response to oral therapy is unlikely to be sufficient.",
        "items": []
      },
      {
        "title": "Use in CMV infections",
        "information": ": Data on the efficacy of Alaclov from transplant patients at high risk of CMV disease indicate that Alaclov should only be used in these patients when safety concerns preclude the use of valganciclovir or ganciclovir. High dose Alaclov as required for CMV prophylaxis may result in more frequent adverse events than observed with lower doses administered for other indications. Patients should be closely monitored for changes in renal function, and doses adjusted accordingly.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Acute renal failure and neurological symptoms, including confusion, hallucinations, agitation, decreased consciousness and coma have been reported in patients receiving overdoses of Alaclov. Nausea and vomiting may also occur. Caution is required to prevent inadvertent overdosing. Many of the reported cases involved renally impaired and elderly patients receiving repeated overdoses, due to lack of appropriate dosage reduction. Patients should be observed closely for signs of toxicity. Hemodialysis significantly enhances the removal of aciclovir from the blood and may, therefore, be considered a management option in the event of symptomatic overdose.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in cool & dry place, away from children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Herpes simplex & Varicella-zoster virus infections",
    "dosage": [
      {
        "medication_type": "Varicella zoster virus (VZV) infections- herpes zoster",
        "information": ": Patients should be advised to start treatment as soon as possible after a diagnosis of herpes zoster. There are no data on treatment started more than 72 hours after onset of the zoster rash. Immunocompetent Adults: The dose in immunocompetent patients is Valacyclovir 1000mg (1 Valacyclovir 1000mg tablet) three times daily for 7 days (3000mg total daily dose).",
        "instructions": []
      },
      {
        "medication_type": "Immunocompromised Adults",
        "information": ": The dose in immunocompromised patients is Valacyclovir 1000mg (1 Valacyclovir 1000mg tablet) 3 times daily for at least 7 days (3000mg total daily dose) and for 2 days following crusting of lesions. In immunocompromised patients, antiviral treatment is suggested for patients presenting within one week of vesicle formation or at any time before full crusting of lesions.",
        "instructions": []
      },
      {
        "medication_type": "Treatment of herpes simplex virus (HSV) infections in adults and adolescents (>12 years)",
        "information": ": Immunocompetent Adults and Adolescents (³12 years): The dose is Valacyclovir 500mg (1 Valacyclovir 500mg tablet) to be taken twice daily (1000mg total daily dose). This dose should be reduced according to creatinine clearance. For recurrent episodes, treatment should be for 3 to 5 days. For initial episodes, which can be more severe, treatment may have to be extended to 10 days. Dosing should begin as early as possible. For recurrent episodes of herpes simplex, this should ideally be during the prodromal period or immediately upon appearance of the first signs or symptoms. Valacyclovir can prevent lesion development when taken at the first signs and symptoms of an HSV recurrence.",
        "instructions": []
      },
      {
        "medication_type": "Herpes labialis",
        "information": ": For herpes labialis (cold sores), Valacyclovir 2000mg (2 Valacyclovir 1000mg tablet) twice daily for one day is effective treatment in adults and adolescents. The second dose should be taken about 12 h (no sooner than 6 h) after the first dose. This dose should be reduced according to creatinine clearance. When using this dosing regimen, treatment should not exceed one day, since this has been shown not to provide additional clinical benefit. Therapy should be initiated at the earliest symptom of a cold sore (e.g. tingling, itching or burning).",
        "instructions": []
      },
      {
        "medication_type": "Immunocompromised Adults",
        "information": ": The dosage is Valacyclovir 1000mg (1 Valacyclovir 1000mg tablet) twice daily for at least 5 days, following assessment of the severity of the clinical condition and immunological status of the patient. For initial episodes, which can be more severe, treatment may have to be extended to ten days. Dosing should begin as early as possible. This dose should be reduced according to creatinine clearance. For maximum clinical benefit, the treatment should be started within 48 hours. A strict monitoring of the evolution of lesions is advised.Suppression of recurrences of herpes simplex virus (HSV) infections in adults and adolescents (12 years)",
        "instructions": []
      },
      {
        "medication_type": "Immunocompetent Adults and Adolescents (12 years)",
        "information": ": The dose is Valacyclovir 500mg (1 Valacyclovir 500mg tablet) to be taken once daily. Some patients with very frequent recurrences (10/year in absence of therapy) may gain additional benefit from the daily dose of Valacyclovir 500mg (1 Valacyclovir 500mg tablet) being taken as a divided dose (250mg twice daily). Treatment should be re-evaluated after 6 to 12 months of therapy.",
        "instructions": []
      },
      {
        "medication_type": "Immunocompromised Adults",
        "information": ": The dose is Valacyclovir 500mg (1 Valacyclovir 500mg tablet) twice daily. Treatment should be re-evaluated after 6 to 12 months of therapy. Prophylaxis of cytomegalovirus (CMV) infection and disease in adults and adolescents (12 years) The dosage of Valacyclovir is 2000mg (2 Valacyclovir 1000 mg tablet) four times a day, to be initiated as early as possible post-transplant. This dose should be reduced according to creatinine clearance.The duration of treatment will usually be 90 days, but may need to be extended in high-risk patients.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:26.307Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d4c",
    "original_record": {
      "input_index": 773,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d4c"
        },
        "name": "Alaclov",
        "strength": "500 mg",
        "generic": "Valacyclovir",
        "company": "ACI Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/9715/alaclov-500-mg-tablet",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/15974/aladay-01-eye-drop",
    "name": "Aladay",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Olopatadine Hydrochloride",
    "strength": "0.1%",
    "company": "Eskayef Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 110.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 110.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.2% (Eye Drop)",
        "href": "https://medex.com.bd/brands/15975/aladay-ds-02-eye-drop?ref=1"
      },
      {
        "text": "0.7% (Eye Drop)",
        "href": "https://medex.com.bd/brands/29404/aladay-max-07-eye-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/823/olopatadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Patadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.... Read morePatadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.Aladay Nasal Spray is an H1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older.Aladay tablet is indicated in the treatment of allergic rhinitis (swelling of the nasal membranescaused by an allergy to pollen and mold spores in the air) and allergic skin conditions. It helps to relieve allergy symptoms such as skin rashes, swelling, hives (itchy, painful eruptions that sting), itching, sneezing, runny or stuffy nose.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Olopatadine, an antihistamine, works by blocking the action of histamine in the body, which reduces allergy symptoms. Olopatadine hydrochloride treats sneezing, itching, runny nose, and other nasal symptoms of allergies.",
        "items": []
      },
      {
        "title": "Mode of Action",
        "information": ": Olopatadine is an anti-allergic molecule that works via several mechanisms. As a mast cell stabilizer, it stabilizes rodent basophils and human conjunctival mast cells and inhibits the immunologically-stimulated release of histamine. Olopatadine acts as an antagonist at the histamine H1 receptors with high selectivity, Upon binding, olopatadine blocks the H1 receptor signaling pathway, inhibiting the release of inflammatory mediators, such as tryptase, prostaglandin D2, TNF-alpha, as well as pro-inflammatory cytokines.",
        "items": []
      },
      {
        "title": "Pharmacokinetics",
        "information": ": Absorption: Olopatadine was absorbed with individual peak plasma concentrations observed between 30 minutes and 1 hour after twice daily intranasal administration of Olopatadine Nasal Spray. Distribution: The protein binding of olopatadine was moderate at approximately 55% in human serum, and independent of drug concentration over the range of 0.1 to 1000 ng/mL. Metabolism: Olopatadine is not extensively metabolized. Based on plasma metabolite profiles of olopatadine, at least six minor metabolites circulate in human plasma. Elimination: The plasma elimination half-life of olopatadine is 8 to 12 hours. Olopatadine is mainly eliminated through urinary excretion",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Formal drug-drug interaction studies were not conducted for Aladay Nasal Spray. Drug interactions with inhibitors of liver enzymes are not anticipated because olopatadine is eliminated predominantly by renal excretion. Drug interactions involving P450 inhibition and plasma protein binding are also not expected.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in persons with a known hypersensitivity to any component of this product. Olopatadine 5 mg tablet is not recommended for use if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions to make sure this medicine is safe for you.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rarely headaches have been reported. Other adverse effects: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Olopatadine was found not to be teratogenic in rats and rabbits. There are, however, no adequate and well controlled studies in pregnant women. This drug should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Olopatadine is administered to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients should be advised not to wear a contact lens if their eye is red. Aladay ophthalmic solution should not be used to treat contact lens related irritation. Benzalkonium Chloride, preservative of Patadin, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least 10 minutes after instillation of Patadin eye drops before they insert their contact lenses. The treatment should be discontinued in the presence of an allergic reaction. Before initial use, Aladay Nasal Spray by releasing 5 sprays or until a fine mist appears. When Aladay Nasal Spray has not been used for more than 7 days, re-prime by releasing 2 sprays. Avoid spraying Aladay Nasal Spray into the eyes. Patients should be informed to avoid spraying Aladay Nasal Spray in their eyes. Olonex Tablet should be used as prescribed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid taking more than the recommended dose. Do not stop taking this medicine without consulting your doctor, as your symptoms may reoccur.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety or effectiveness have been observed betweents.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no information on Aladay overdose. However, excessive use of any medication can have serious consequences. If you suspect an overdose, seek medical attention without delay.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at room temperature and protect from light. It is desirable that the contents should not be used more than one month after first opening of the bottle.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "How to use the Nasal Spray- Cleaning: The nasal spray should be cleaned at least once a week. The procedures are as follows-",
        "items": [
          "Shake the bottle gently and remove the dust cover.",
          "Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath the bottle. Press down until a fine spray appears. If using for the first time or if you have not used it for a week or more, press the nasal applicator several times until a fine moist comes out from the container.",
          "Gently blow the nose to clear the nostrils.",
          "Close one nostril and carefully insert the nasal applicator into the open nostril. Tilt your head forward slightly and keep the spray upright. Breathe in through your nose and while breathing in, press the white-collar of nasal applicator firmly down once to release a spray.",
          "Breathe out through your mouth.",
          "Repeat the above steps in the same/ other nostril for consecutive doses.",
          "Remove the dust cover.",
          "Gently pull off the nasal applicator.",
          "Wash the applicator and dust cover in warm water.",
          "Shake off the excess water and leave to dry in a normal place. Avoid to apply additional heat.",
          "Gently push the applicator back on the top of the bottle and re-fix the dust cover."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ophthalmic Non-Steroid drugs",
    "dosage": [
      {
        "medication_type": "Eye Drops",
        "information": "-",
        "instructions": [
          "0.1%: One drop in each affected eye two times per day at an interval of 6 to 8 hours.",
          "0.2%: One drop in the affected eye once a day.",
          "0.7%: One drop in each affected eye once a day."
        ]
      },
      {
        "medication_type": "Nasal Spray",
        "information": "-",
        "instructions": [
          "Administer Olopatadine Nasal Spray by the intranasal route only.",
          "Adults and Adolescents 12 years of age and older: Two sprays per nostril twice daily.\\",
          "Children 6 to 11 years of age: One spray per nostril twice daily."
        ]
      },
      {
        "medication_type": "Tablet",
        "information": "-",
        "instructions": [
          "Adults: Take 1 tablet (5 mg of the active ingredient) at a time, twice daily, in the morning and before going to bed. The dosage may be adjusted according to the disease, age or symptoms.",
          "Children 7 years old or over: Take 1 tablet (5 mg) at a time, twice daily, in the morning and before going to bed.",
          "If you miss a dose, take a dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time. Do not stop taking this medicine unless your doctor instructs you to do so."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:27.374Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d50",
    "original_record": {
      "input_index": 774,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d50"
        },
        "name": "Aladay",
        "strength": "0.1%",
        "generic": "Olopatadine Hydrochloride",
        "company": "Eskayef Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/15974/aladay-01-eye-drop",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/29404/aladay-max-07-eye-drop",
    "name": "Aladay Max",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Olopatadine Hydrochloride",
    "strength": "0.7%",
    "company": "Eskayef Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 250.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 250.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.1% (Eye Drop)",
        "href": "https://medex.com.bd/brands/15974/aladay-01-eye-drop?ref=1"
      },
      {
        "text": "0.2% (Eye Drop)",
        "href": "https://medex.com.bd/brands/15975/aladay-ds-02-eye-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/823/olopatadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Patadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.... Read morePatadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.Aladay Max Nasal Spray is an H1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older.Aladay Max tablet is indicated in the treatment of allergic rhinitis (swelling of the nasal membranescaused by an allergy to pollen and mold spores in the air) and allergic skin conditions. It helps to relieve allergy symptoms such as skin rashes, swelling, hives (itchy, painful eruptions that sting), itching, sneezing, runny or stuffy nose.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Olopatadine, an antihistamine, works by blocking the action of histamine in the body, which reduces allergy symptoms. Olopatadine hydrochloride treats sneezing, itching, runny nose, and other nasal symptoms of allergies.",
        "items": []
      },
      {
        "title": "Mode of Action",
        "information": ": Olopatadine is an anti-allergic molecule that works via several mechanisms. As a mast cell stabilizer, it stabilizes rodent basophils and human conjunctival mast cells and inhibits the immunologically-stimulated release of histamine. Olopatadine acts as an antagonist at the histamine H1 receptors with high selectivity, Upon binding, olopatadine blocks the H1 receptor signaling pathway, inhibiting the release of inflammatory mediators, such as tryptase, prostaglandin D2, TNF-alpha, as well as pro-inflammatory cytokines.",
        "items": []
      },
      {
        "title": "Pharmacokinetics",
        "information": ": Absorption: Olopatadine was absorbed with individual peak plasma concentrations observed between 30 minutes and 1 hour after twice daily intranasal administration of Olopatadine Nasal Spray. Distribution: The protein binding of olopatadine was moderate at approximately 55% in human serum, and independent of drug concentration over the range of 0.1 to 1000 ng/mL. Metabolism: Olopatadine is not extensively metabolized. Based on plasma metabolite profiles of olopatadine, at least six minor metabolites circulate in human plasma. Elimination: The plasma elimination half-life of olopatadine is 8 to 12 hours. Olopatadine is mainly eliminated through urinary excretion",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Formal drug-drug interaction studies were not conducted for Aladay Max Nasal Spray. Drug interactions with inhibitors of liver enzymes are not anticipated because olopatadine is eliminated predominantly by renal excretion. Drug interactions involving P450 inhibition and plasma protein binding are also not expected.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in persons with a known hypersensitivity to any component of this product. Olopatadine 5 mg tablet is not recommended for use if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions to make sure this medicine is safe for you.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rarely headaches have been reported. Other adverse effects: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Olopatadine was found not to be teratogenic in rats and rabbits. There are, however, no adequate and well controlled studies in pregnant women. This drug should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Olopatadine is administered to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients should be advised not to wear a contact lens if their eye is red. Aladay Max ophthalmic solution should not be used to treat contact lens related irritation. Benzalkonium Chloride, preservative of Patadin, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least 10 minutes after instillation of Patadin eye drops before they insert their contact lenses. The treatment should be discontinued in the presence of an allergic reaction. Before initial use, Aladay Max Nasal Spray by releasing 5 sprays or until a fine mist appears. When Aladay Max Nasal Spray has not been used for more than 7 days, re-prime by releasing 2 sprays. Avoid spraying Aladay Max Nasal Spray into the eyes. Patients should be informed to avoid spraying Aladay Max Nasal Spray in their eyes. Olonex Tablet should be used as prescribed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid taking more than the recommended dose. Do not stop taking this medicine without consulting your doctor, as your symptoms may reoccur.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety or effectiveness have been observed betweents.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no information on Aladay Max overdose. However, excessive use of any medication can have serious consequences. If you suspect an overdose, seek medical attention without delay.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at room temperature and protect from light. It is desirable that the contents should not be used more than one month after first opening of the bottle.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "How to use the Nasal Spray- Cleaning: The nasal spray should be cleaned at least once a week. The procedures are as follows-",
        "items": [
          "Shake the bottle gently and remove the dust cover.",
          "Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath the bottle. Press down until a fine spray appears. If using for the first time or if you have not used it for a week or more, press the nasal applicator several times until a fine moist comes out from the container.",
          "Gently blow the nose to clear the nostrils.",
          "Close one nostril and carefully insert the nasal applicator into the open nostril. Tilt your head forward slightly and keep the spray upright. Breathe in through your nose and while breathing in, press the white-collar of nasal applicator firmly down once to release a spray.",
          "Breathe out through your mouth.",
          "Repeat the above steps in the same/ other nostril for consecutive doses.",
          "Remove the dust cover.",
          "Gently pull off the nasal applicator.",
          "Wash the applicator and dust cover in warm water.",
          "Shake off the excess water and leave to dry in a normal place. Avoid to apply additional heat.",
          "Gently push the applicator back on the top of the bottle and re-fix the dust cover."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ophthalmic Non-Steroid drugs",
    "dosage": [
      {
        "medication_type": "Eye Drops",
        "information": "-",
        "instructions": [
          "0.1%: One drop in each affected eye two times per day at an interval of 6 to 8 hours.",
          "0.2%: One drop in the affected eye once a day.",
          "0.7%: One drop in each affected eye once a day."
        ]
      },
      {
        "medication_type": "Nasal Spray",
        "information": "-",
        "instructions": [
          "Administer Olopatadine Nasal Spray by the intranasal route only.",
          "Adults and Adolescents 12 years of age and older: Two sprays per nostril twice daily.\\",
          "Children 6 to 11 years of age: One spray per nostril twice daily."
        ]
      },
      {
        "medication_type": "Tablet",
        "information": "-",
        "instructions": [
          "Adults: Take 1 tablet (5 mg of the active ingredient) at a time, twice daily, in the morning and before going to bed. The dosage may be adjusted according to the disease, age or symptoms.",
          "Children 7 years old or over: Take 1 tablet (5 mg) at a time, twice daily, in the morning and before going to bed.",
          "If you miss a dose, take a dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time. Do not stop taking this medicine unless your doctor instructs you to do so."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:28.820Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d52",
    "original_record": {
      "input_index": 775,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d52"
        },
        "name": "Aladay Max",
        "strength": "0.7%",
        "generic": "Olopatadine Hydrochloride",
        "company": "Eskayef Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/29404/aladay-max-07-eye-drop",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12061/alagra-30-mg-suspension",
    "name": "Alagra",
    "dosage_form": "Oral Suspension",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "30 mg/5 ml",
    "company": "Alco Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 55.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "50 ml bottle",
          "price": "৳ 55.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "120 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12059/alagra-120-mg-tablet?ref=1"
      },
      {
        "text": "180 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12060/alagra-180-mg-tablet?ref=1"
      },
      {
        "text": "60 mg (Tablet)",
        "href": "https://medex.com.bd/brands/27838/alagra-60-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alagra is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alagra is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alagra improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alagra is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alagra significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alagra improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alagra does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alagra with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alagra caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alagra and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alagra should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alagra tablets will produce an effect on the ability to drive or use machines. In objective tests, Alagra has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alagra. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alagra has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alagra from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alagra 30 mg/5 ml Suspension?",
        "answer": [
          "Alagra 30 mg/5 ml Suspension is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alagra 30 mg/5 ml Suspension?",
        "answer": [
          "Alagra 30 mg/5 ml Suspension is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alagra 30 mg/5 ml Suspension?",
        "answer": [
          "Alagra 30 mg/5 ml Suspension has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alagra 30 mg/5 ml Suspension?",
        "answer": [
          "Alagra 30 mg/5 ml Suspension should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alagra 30 mg/5 ml Suspension make you sleepy?",
        "answer": [
          "Yes, Alagra 30 mg/5 ml Suspension can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alagra 30 mg/5 ml Suspension?",
        "answer": [
          "Do not take an overdose of Alagra 30 mg/5 ml Suspension as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alagra 30 mg/5 ml Suspension work?",
        "answer": [
          "Alagra 30 mg/5 ml Suspension starts working within 1 hour of consuming it. The peak benefit of Alagra 30 mg/5 ml Suspension is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alagra 30 mg/5 ml Suspension relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alagra 30 mg/5 ml Suspension can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alagra 30 mg/5 ml Suspension?",
        "answer": [
          "Take some rest after taking Alagra 30 mg/5 ml Suspension if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alagra 30 mg/5 ml Suspension?",
        "answer": [
          "Alagra 30 mg/5 ml Suspension should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alagra 30 mg/5 ml Suspension."
        ]
      },
      {
        "question": "How should I take Alagra 30 mg/5 ml Suspension?",
        "answer": [
          "Alagra 30 mg/5 ml Suspension should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alagra 30 mg/5 ml Suspension?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alagra 30 mg/5 ml Suspension."
        ]
      },
      {
        "question": "Can Alagra 30 mg/5 ml Suspension cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alagra 30 mg/5 ml Suspension is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alagra 30 mg/5 ml Suspension is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alagra 30 mg/5 ml Suspension with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alagra 30 mg/5 ml Suspension may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alagra 30 mg/5 ml Suspension. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:30.014Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d59",
    "original_record": {
      "input_index": 776,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d59"
        },
        "name": "Alagra",
        "strength": "30 mg/5 ml",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Alco Pharma Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/12061/alagra-30-mg-suspension",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/27838/alagra-60-mg-tablet",
    "name": "Alagra",
    "dosage_form": "Tablet",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "60 mg",
    "company": "Alco Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 4.50",
      "strip_price": "৳ 45.00",
      "pack_size_info": "(3 x 10: ৳ 135.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.50",
          "pack_size_info": "(3 x 10: ৳ 135.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 45.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "120 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12059/alagra-120-mg-tablet?ref=1"
      },
      {
        "text": "180 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12060/alagra-180-mg-tablet?ref=1"
      },
      {
        "text": "30 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/12061/alagra-30-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alagra is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alagra is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alagra improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alagra is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alagra significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alagra improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alagra does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alagra with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alagra caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alagra and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alagra should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alagra tablets will produce an effect on the ability to drive or use machines. In objective tests, Alagra has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alagra. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alagra has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alagra from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alagra 60 mg Tablet?",
        "answer": [
          "Alagra 60 mg Tablet is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alagra 60 mg Tablet?",
        "answer": [
          "Alagra 60 mg Tablet is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alagra 60 mg Tablet?",
        "answer": [
          "Alagra 60 mg Tablet has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alagra 60 mg Tablet?",
        "answer": [
          "Alagra 60 mg Tablet should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alagra 60 mg Tablet make you sleepy?",
        "answer": [
          "Yes, Alagra 60 mg Tablet can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alagra 60 mg Tablet?",
        "answer": [
          "Do not take an overdose of Alagra 60 mg Tablet as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alagra 60 mg Tablet work?",
        "answer": [
          "Alagra 60 mg Tablet starts working within 1 hour of consuming it. The peak benefit of Alagra 60 mg Tablet is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alagra 60 mg Tablet relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alagra 60 mg Tablet can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alagra 60 mg Tablet?",
        "answer": [
          "Take some rest after taking Alagra 60 mg Tablet if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alagra 60 mg Tablet?",
        "answer": [
          "Alagra 60 mg Tablet should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alagra 60 mg Tablet."
        ]
      },
      {
        "question": "How should I take Alagra 60 mg Tablet?",
        "answer": [
          "Alagra 60 mg Tablet should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alagra 60 mg Tablet?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alagra 60 mg Tablet."
        ]
      },
      {
        "question": "Can Alagra 60 mg Tablet cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alagra 60 mg Tablet is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alagra 60 mg Tablet is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alagra 60 mg Tablet with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alagra 60 mg Tablet may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alagra 60 mg Tablet. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:31.159Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d5a",
    "original_record": {
      "input_index": 777,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d5a"
        },
        "name": "Alagra",
        "strength": "60 mg",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Alco Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/27838/alagra-60-mg-tablet",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12063/alanil-180-mg-tablet",
    "name": "Alanil",
    "dosage_form": "Tablet",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "180 mg",
    "company": "ACME Laboratories Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 10.00",
      "strip_price": "৳ 100.00",
      "pack_size_info": "(3 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.00",
          "pack_size_info": "(3 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "120 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12062/alanil-120-mg-tablet?ref=1"
      },
      {
        "text": "30 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/12064/alanil-30-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alanil is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alanil is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alanil improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alanil is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alanil significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alanil improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alanil does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alanil with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alanil caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alanil and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alanil should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alanil tablets will produce an effect on the ability to drive or use machines. In objective tests, Alanil has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alanil. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alanil has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alanil from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alanil 180 mg Tablet?",
        "answer": [
          "Alanil 180 mg Tablet is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alanil 180 mg Tablet?",
        "answer": [
          "Alanil 180 mg Tablet is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alanil 180 mg Tablet?",
        "answer": [
          "Alanil 180 mg Tablet has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alanil 180 mg Tablet?",
        "answer": [
          "Alanil 180 mg Tablet should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alanil 180 mg Tablet make you sleepy?",
        "answer": [
          "Yes, Alanil 180 mg Tablet can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alanil 180 mg Tablet?",
        "answer": [
          "Do not take an overdose of Alanil 180 mg Tablet as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alanil 180 mg Tablet work?",
        "answer": [
          "Alanil 180 mg Tablet starts working within 1 hour of consuming it. The peak benefit of Alanil 180 mg Tablet is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alanil 180 mg Tablet relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alanil 180 mg Tablet can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alanil 180 mg Tablet?",
        "answer": [
          "Take some rest after taking Alanil 180 mg Tablet if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alanil 180 mg Tablet?",
        "answer": [
          "Alanil 180 mg Tablet should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alanil 180 mg Tablet."
        ]
      },
      {
        "question": "How should I take Alanil 180 mg Tablet?",
        "answer": [
          "Alanil 180 mg Tablet should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alanil 180 mg Tablet?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alanil 180 mg Tablet."
        ]
      },
      {
        "question": "Can Alanil 180 mg Tablet cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alanil 180 mg Tablet is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alanil 180 mg Tablet is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alanil 180 mg Tablet with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alanil 180 mg Tablet may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alanil 180 mg Tablet. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:32.473Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d5c",
    "original_record": {
      "input_index": 778,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d5c"
        },
        "name": "Alanil",
        "strength": "180 mg",
        "generic": "Fexofenadine Hydrochloride",
        "company": "ACME Laboratories Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12063/alanil-180-mg-tablet",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12064/alanil-30-mg-suspension",
    "name": "Alanil",
    "dosage_form": "Oral Suspension",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "30 mg/5 ml",
    "company": "ACME Laboratories Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 55.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "50 ml bottle",
          "price": "৳ 55.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "120 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12062/alanil-120-mg-tablet?ref=1"
      },
      {
        "text": "180 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12063/alanil-180-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alanil is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alanil is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alanil improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alanil is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alanil significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alanil improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alanil does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alanil with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alanil caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alanil and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alanil should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alanil tablets will produce an effect on the ability to drive or use machines. In objective tests, Alanil has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alanil. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alanil has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alanil from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alanil 30 mg/5 ml Suspension?",
        "answer": [
          "Alanil 30 mg/5 ml Suspension is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alanil 30 mg/5 ml Suspension?",
        "answer": [
          "Alanil 30 mg/5 ml Suspension is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alanil 30 mg/5 ml Suspension?",
        "answer": [
          "Alanil 30 mg/5 ml Suspension has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alanil 30 mg/5 ml Suspension?",
        "answer": [
          "Alanil 30 mg/5 ml Suspension should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alanil 30 mg/5 ml Suspension make you sleepy?",
        "answer": [
          "Yes, Alanil 30 mg/5 ml Suspension can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alanil 30 mg/5 ml Suspension?",
        "answer": [
          "Do not take an overdose of Alanil 30 mg/5 ml Suspension as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alanil 30 mg/5 ml Suspension work?",
        "answer": [
          "Alanil 30 mg/5 ml Suspension starts working within 1 hour of consuming it. The peak benefit of Alanil 30 mg/5 ml Suspension is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alanil 30 mg/5 ml Suspension relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alanil 30 mg/5 ml Suspension can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alanil 30 mg/5 ml Suspension?",
        "answer": [
          "Take some rest after taking Alanil 30 mg/5 ml Suspension if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alanil 30 mg/5 ml Suspension?",
        "answer": [
          "Alanil 30 mg/5 ml Suspension should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alanil 30 mg/5 ml Suspension."
        ]
      },
      {
        "question": "How should I take Alanil 30 mg/5 ml Suspension?",
        "answer": [
          "Alanil 30 mg/5 ml Suspension should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alanil 30 mg/5 ml Suspension?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alanil 30 mg/5 ml Suspension."
        ]
      },
      {
        "question": "Can Alanil 30 mg/5 ml Suspension cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alanil 30 mg/5 ml Suspension is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alanil 30 mg/5 ml Suspension is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alanil 30 mg/5 ml Suspension with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alanil 30 mg/5 ml Suspension may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alanil 30 mg/5 ml Suspension. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:25:42.360Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d5d",
    "original_record": {
      "input_index": 779,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d5d"
        },
        "name": "Alanil",
        "strength": "30 mg/5 ml",
        "generic": "Fexofenadine Hydrochloride",
        "company": "ACME Laboratories Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/12064/alanil-30-mg-suspension",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/37864/alaradate-10-mg-tablet",
    "name": "Alaradate",
    "dosage_form": "Tablet",
    "generic": "Methylphenidate Hydrochloride",
    "strength": "10 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": "৳ 150.00",
      "pack_size_info": "(3 x 10: ৳ 450.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 15.00",
          "pack_size_info": "(3 x 10: ৳ 450.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 150.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/745/methylphenidate-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alaradate tablet is used in the treatment of attention deficit hyper activity disorder (ADHD) and narcolepsy.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "methylphenidate (MPH) has been shown to act as a norepinephrine and dopamine reuptake inhibitor (NDRI), thereby increasing the presence of these neurotransmitters in the extraneuronal space and prolonging their action. There is a dose-related effect of psychostimulants on receptor stimulation, where higher doses are shown to increase norepinephrine (NE) and dopamine (DA) efflux throughout the brain which can result in impaired cognition and locomotor-activating effects. In contrast, low doses are found to selectively activate NE and DE neurotransmission within the prefrontal cortex which is an area of the brain thought to play a prominent role in ADHD pathophysiology, thereby improving clinical efficacy and preventing side effects. The lower doses used to treat ADHD are not associated with the locomotor-activating effects associated with higher doses and instead reduce movement, impulsivity, and increase cognitive function including sustained attention and working memory. Methylphenidate's beneficial effects in sustaining attention have also been shown to be mediated by alpha-1 adrenergic receptor activity. Clinical findings have shown that children with ADHD have an abnormality in the dopamine transporter gene (DAT1), the D4 receptor gene (DRD-4), and/or the D2 receptor gene that may be at least partly overcome by the dopaminergic effects of methylphenidate, suggesting a possible mode of action.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The elimination of phenytoin is slowed by methylphenidate. It may also increase the anticoagulant effect of Coumarin. It also increases the serum concentration of imipramine and desipramine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Methylphenidate is contraindicated in alcoholics, emotionally unstable patients, drug abusers, hypertension, cardiac arrhythmias, psychoses, epilepsy, thyro-toxicosis, glaucoma marked anxiety, severe depression and known sensitivity to methylphenidate.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Sleep disturbances, restlessness, dizziness, headache, tremor, convulsion, rash, pruritis; urticaria, fever, arthralgia, alopecia, exfoliative, dermatitis, erythema multiforme, thrombocytopenic purpuria, thrombocytopenia, Leucopenia, urinary disorder and very rarely liver damage.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The use of methylphenidate in pregnancy and lactation has not been established.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In mild hypertension (contraindicated if moderate or severe)-monitor blood pressure; history of epilepsy; tics and Tourette syndrome. Occasional cystic ovarian swellings in premenopausal women, occasional hypercalcemia if bony metastases; increased risk of thromboembolic events when used with cytotoxics; breast feeding; endometrial changes; porphyria",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (below 25°C) and dry place, away from light. Keep out of reach of the children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Should be taken on an empty stomach. Take 30-45 min before meals. May be taken with or without food. Swallow whole, do not divide/chew/crush.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "CNS stimulant drugs",
    "dosage": [
      {
        "medication_type": "Child",
        "information": ": Over 6 years, initially 5 mg 1-2 times daily, increased if necessary at weekly intervals by 5-10 mg daily to max. 60 mg daily in divided doses; discontinue if no response after one month also suspend periodically to assess child’s condition (usually finally discontinued during or after puberty); Child under 6 years not recommended.",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 10-15 mg daily in divided doses (2-3 times daily). Average dosage is 20-30 mg daily. Some patients may require 40-60 mg daily. Patients who are unable to sleep if medication is taken late in the day should take the last dose before 6 pm.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:43.650Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d5e",
    "original_record": {
      "input_index": 780,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d5e"
        },
        "name": "Alaradate",
        "strength": "10 mg",
        "generic": "Methylphenidate Hydrochloride",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/37864/alaradate-10-mg-tablet",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/19143/alargol-5-mg-syrup",
    "name": "Alargol",
    "dosage_form": "Syrup",
    "generic": "Cetirizine Hydrochloride",
    "strength": "5 mg/5 ml",
    "company": "Ethical Drugs Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 25.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/19144/alargol-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alargol is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Alargol is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Alargol is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Alargol has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Alargol is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:44.698Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d5f",
    "original_record": {
      "input_index": 781,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d5f"
        },
        "name": "Alargol",
        "strength": "5 mg/5 ml",
        "generic": "Cetirizine Hydrochloride",
        "company": "Ethical Drugs Limited",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/19143/alargol-5-mg-syrup",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/19144/alargol-10-mg-tablet",
    "name": "Alargol",
    "dosage_form": "Tablet",
    "generic": "Cetirizine Hydrochloride",
    "strength": "10 mg",
    "company": "Ethical Drugs Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.50",
      "strip_price": "৳ 25.00",
      "pack_size_info": "(10 x 10: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.50",
          "pack_size_info": "(10 x 10: ৳ 250.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 25.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/19143/alargol-5-mg-syrup?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alargol is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Alargol is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Alargol is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Alargol has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Alargol is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:45.937Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d60",
    "original_record": {
      "input_index": 782,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d60"
        },
        "name": "Alargol",
        "strength": "10 mg",
        "generic": "Cetirizine Hydrochloride",
        "company": "Ethical Drugs Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/19144/alargol-10-mg-tablet",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/32197/alaron-5-mg-suspension",
    "name": "Alaron",
    "dosage_form": "Oral Suspension",
    "generic": "Loratadine",
    "strength": "5 mg/5 ml",
    "company": "ACI Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 30.20",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 30.20",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12185/alaron-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/696/loratadine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alaron tablet provides fast, effective relief from the symptoms of seasonal allergic rhinitis, perennial allergic rhinitis and skin allergies including chronic urticaria. It is also effective in alleviating symptoms of allergic rhinitis such as sneezing, nasal discharge, itching, ocular itching ... Read moreAlaron tablet provides fast, effective relief from the symptoms of seasonal allergic rhinitis, perennial allergic rhinitis and skin allergies including chronic urticaria. It is also effective in alleviating symptoms of allergic rhinitis such as sneezing, nasal discharge, itching, ocular itching and burning. Nasal and ocular sign and symptoms are relieved rapidly after oral administration. Alaron tablet is also indicated in idiopathic urticaria. In children over 2 years Alaron tablet is indicated for the symptomatic relief of seasonal allergic rhinitis and allergic skin conditions such as urticaria, nettlerash.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This tablet is a preparation of Loratadine. Loratadine is a non-sedative histamine Hr receptor antagonist with antiallergic properties. Loratadine is a long-acting tricyclic antihistamine with selective peripheral Hi-receptor antagonistic activity and no central sedative or anticholinergic effect. It is rapidly effective and long-lasting, allowing once-a-day administration.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "There are no reports of potentially hazardous interactions with other drugs. In contrast to many other histamine H1 receptor antagonists, Alaron has no potentiating effects when administered concurrently with alcohol, as measured by psychomotor performance studies. Concomitant therapy with drugs that inhibit or are metabolized by hepatic cytochromes P450 3A4 and 2D6 may elevate plasma concentrations of either drug and this mayifesult in adverse effects. Cimetidine inhibits both enzymes while erythromycin or ketoconazole inhibits P450 3A4. These drugs increase Alaron serum concentrations but no adverse effects are reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Loratadine is contraindicated in patients who have shown hypersensitivity or idiosyncrasy to their components.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "During controlled clinical studies the incidence of adverse events, including sedation and anticholinergic effects observed with 10 mg Alaron was comparable to that observed with placebo. Studies on the effect of Alaron on actual driving performance, and on tests of cognitive and psychomotor functioning have shown it to be comparable to placebo.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There is no experience of the use of Loratadine in human pregnancy. Therefore its use during pregnancy is not advisable. Loratadine is excreted in breast milk in a very small amount. So nursing mothers are advised not to take the drug.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be taken in patients with liver impairment or renal insufficiency (eGFR <30 ml/min).",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In adults somnolence, tachycardia and headache have been reported with overdose greater than 10 mg. Extrapyramidal signs and palpitations have been reported in children with overdoses of greater than 10 mg. In the event of overdosage, general symptomatic and supportive measures should be instituted promptly and maintained for as long as necessary. It would seem reasonable to treat patients presenting early after large overdoses with oral activated charcoal. The conscious patients may be induced to vomit or gastric lavage may be performed.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Adults and children over 12 years of age",
        "information": ": One Loratadine tablet once daily. It is usually administered in the morning or when symptoms require treatment.",
        "instructions": []
      },
      {
        "medication_type": "Children 2-12 years",
        "information": ": Body weight over 30 kg: one Loratadine tablet once daily, below 30 kg: half Loratadine tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "Below 2 years of age",
        "information": ": Loratadine tablet is not recommended for use below 2 years of age since safety and efficacy has not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:47.024Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d65",
    "original_record": {
      "input_index": 783,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d65"
        },
        "name": "Alaron",
        "strength": "5 mg/5 ml",
        "generic": "Loratadine",
        "company": "ACI Limited",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/32197/alaron-5-mg-suspension",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/11913/alatin-10-mg-tablet",
    "name": "Alatin",
    "dosage_form": "Tablet",
    "generic": "Cetirizine Hydrochloride",
    "strength": "10 mg",
    "company": "Concord Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.50",
      "strip_price": "৳ 25.00",
      "pack_size_info": "(10 x 10: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.50",
          "pack_size_info": "(10 x 10: ৳ 250.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 25.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alatin is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Alatin is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Alatin is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Alatin has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Alatin is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:49.157Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d6b",
    "original_record": {
      "input_index": 784,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d6b"
        },
        "name": "Alatin",
        "strength": "10 mg",
        "generic": "Cetirizine Hydrochloride",
        "company": "Concord Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/11913/alatin-10-mg-tablet",
        "_page": 20,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/252/alba-400-mg-chewable-tablet",
    "name": "Alba",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Navana Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.50",
      "strip_price": "৳ 4.50",
      "pack_size_info": "(48 x 1: ৳ 216.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.50",
          "pack_size_info": "(48 x 1: ৳ 216.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 4.50",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alba is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Alba, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Alba should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Alba is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Alba exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Alba is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:50.575Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d71",
    "original_record": {
      "input_index": 785,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d71"
        },
        "name": "Alba",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Navana Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/252/alba-400-mg-chewable-tablet",
        "_page": 20,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33305/albet-n-01-05-cream",
    "name": "Albet-N",
    "dosage_form": "Cream",
    "generic": "Betamethasone + Neomycin Sulphate",
    "strength": "0.1%+0.5%",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 15.28",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 gm tube",
          "price": "৳ 15.28",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.1%+0.5% (Ointment)",
        "href": "https://medex.com.bd/brands/33304/albet-n-01-05-ointment?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1226/betamethasone-neomycin-sulphate-topical/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This cream is usually useful for the treatment of superficial infections caused by gram-positive and gram-negative microorganisms. It is also useful in burns, regeneration of new skin in wounds and ulceration, otitis externa, postoperative infections, neuro-dermatitis and eczema. It may be used as an adjunct to systemic steroid therapy in special kind of pyoderma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Betamethasone is an active topical corticosteroid, which produces a rapid response in the inflammatory dermatoses and cures psoriasis types of skin diseases. Neomycin Sulfate is a topical broad-spectrum bactericidal amino-glycoside effective against various kinds of gram-positive and gramnegative pathogens such as Proteus vulgaris, Staphylococcus aureus etc. This preparation has effective penetration and uniform distribution capacity, so it is very effective in hairy and intertriginous places. This preparation is very effective for the treatment of wet ulceration of the skin.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "There are no significant drug interactions reported with Betamethasone Valerate BP and Neomycin Sulphate BP Cream/Ointment.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This preparation is contraindicated to the patients who are hypersensitive to any of its components. It should not be used for the treatment of otitis externa when the eardrum is perforated. It is contraindicated in skin lesions caused by infection with viruses and fungi.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Albet-N is well tolerated. But prolonged and high doses may cause Cushing's syndrome, acne, thinning and dilatation of blood vessels, particularly when occlusive dressings are used.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "This preparation should not be used extensively in pregnancy.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Long term continuous topical therapy of Albet-N should be avoided, which may produce many resistant micro organisms. So, accurate dose of Albet-N should be used in infected areas only.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Aural steroid & antibiotic combined preparations",
    "dosage": [
      {
        "medication_type": "Use in adults",
        "information": ": This preparation should be applied to the affected parts of the skin as a thin layer for 3 to 4 times daily. In chronic conditions, withdrawal of treatment is carried out by decreasing the frequency of application until the cream is applied as infrequently as once a week. Or as directed by the physician.",
        "instructions": []
      },
      {
        "medication_type": "Use in children",
        "information": ": Do not use it on children under 1 year of age. A course of treatment for a child should not normally last more than 5 days unless otherwise stated by your physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:52.153Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d82",
    "original_record": {
      "input_index": 786,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d82"
        },
        "name": "Albet-N",
        "strength": "0.1%+0.5%",
        "generic": "Betamethasone + Neomycin Sulphate (Topical)",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Cream",
        "source_url": "https://medex.com.bd/brands/33305/albet-n-01-05-cream",
        "_page": 20,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/25465/albol-ds-400-mg-chewable-tablet",
    "name": "Albol-DS",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Ethical Drugs Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 3.50",
      "strip_price": "৳ 7.00",
      "pack_size_info": "(30 x 2: ৳ 210.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.50",
          "pack_size_info": "(30 x 2: ৳ 210.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 7.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Albol-DS is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Albol-DS, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Albol-DS should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Albol-DS is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Albol-DS exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Albol-DS is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:53.915Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d8c",
    "original_record": {
      "input_index": 787,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d8c"
        },
        "name": "Albol-DS",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Ethical Drugs Limited",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/25465/albol-ds-400-mg-chewable-tablet",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/37021/albunorm-5-injection",
    "name": "Albunorm",
    "dosage_form": "IV Infusion",
    "generic": "Albumin",
    "strength": "5%",
    "company": "Octapharma S.A.S., France",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 6,924.17",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "250 ml bottle",
          "price": "৳ 6,924.17",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "20% (IV Infusion)",
        "href": "https://medex.com.bd/brands/37022/albunorm-20-injection?ref=1"
      },
      {
        "text": "25% (IV Infusion)",
        "href": "https://medex.com.bd/brands/37023/albunorm-25-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/545/albumin-human/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Shock: Albunorm is indicated in the emergency treatment of shock and in other similar conditions where the restoration of blood volume is urgent. If there has been considerable loss of red blood cells, transfusion with packed red blood cells is indicated.... Read moreShock: Albunorm is indicated in the emergency treatment of shock and in other similar conditions where the restoration of blood volume is urgent. If there has been considerable loss of red blood cells, transfusion with packed red blood cells is indicated.Burns: Albunorm or Albunorm in either normal saline or dextrose is indicated to prevent marked hemoconcentration and to maintain appropriate electrolyte balance.Hypoproteinemia with or without edema: Albunorm is indicated in those clinical situations usually associated with a low concentration of plasma protein and a resulting decreased circulating blood volume. Although diuresis may occur soon after Albunorm administration has been instituted, best results are obtained if Albunorm is continued until the normal serum protein level is regained.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The main function of albumin results from its contribution to plasma colloid oncotic pressure and transport function. Albumin stabilizes circulating blood volume and carries hormones, enzymes, medicines, and toxins. Other physiological functions include antioxidant properties, free radical scavenging, in addition to maintenance capillary membrane integrity. Exogenously administered albumin increases the oncotic pressure of the intravascular system, moving fluids from the interstitial space, thereby decreasing edema and increasing the circulating blood volume. The increase in volume reduces the concentration and viscosity of blood in patients with decreased circulating blood volume while maintaining cardiac output in shock. In dehydrated patients, negligible effects exist on circulating blood volume. In addition to the above albumin replaces protein in patients with hypoproteinemia until the cause of the deficiency can be determined. This drug has thousands of endogenous and exogenous targets. Human albumin also binds and carries a plethora of hydrophobic molecules, such as endogenous (i.e., cholesterol, fatty acids, bilirubin, thyroxine) or exogenous substances (for example, drugs and toxins), transition metal ions, as well as gas (nitric oxide [NO]), with resulting implications for their solubilisation, transport, metabolism, and detoxification.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Albunorm solution should not be mixed by protein hydrolysates or alcoholic solutions. Risk of atypical reactions to ACE inhibitors in patients undergoing therapeutic plasma exchange with Albunorm human replacement.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Albumin (Human) may be contraindicated in patients with severe anemia or cardiac failure and in patients with a history of allergic reactions to human albumin.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Allergic or pyrogenic reactions are characterized primarily by fever and chills; rash, nausea, vomiting, tachycardia and hypotension have also been reported. Should an adverse reaction occur, slow or stop the infusion for a period of time which may result in the disappearance of the symptoms. If administration has been stopped and the patient requires additional Albunorm (Human), material from a different lot should be used. Albunorm (Human), particularly if administered rapidly, may result in vascular overload with resultant pulmonary edema.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Hypertension or low cardiac reserve; additional fluids for dehydrated patients. Monitor for signs of cardiac overload in injured or postoperative patients. May carry risk of viral transmission. Volume admin and rate of infusion must always be individualised according to situation and response. Pregnancy, lactation.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "No clinical studies using Albunorm (Human) have been conducted in pediatric patients. Safety and effectiveness in pediatric patients have not been established. However, extensive experience in patients suggests that children respond to Albunorm (Human) in the same manner as adults.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C. Do not freeze.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Plasma expanders",
    "dosage": [
      {
        "medication_type": "Human albumin 25%",
        "information": "is for intravenous administration only. Human albumin may be diluted with 5% glucose or 0.9% sodium chloride. Concentration, dosage, and infusion-rate should be adjusted to the patient’s individual requirements and indication.",
        "instructions": [
          "Hypovolemia: Initial dose 25 g is suggested.",
          "Hypoalbuminemia: 50-75 gm",
          "Prevention of central volume fluid removed depletion after",
          "paracentesis due to cirrhotic ascites: 6-8 gm for every 1000 mL of ascitic.",
          "OHSS: 50 to 100 gm over 4 hours and repeated at 4-12 hour intervals as necessary. 10-50 gm; single infusion.",
          "ARDS: 25 g over 30 minutes and repeated at 8 hours for 3 days if necessary.",
          "Burns: Determined by direct observation of vital sign or measurement of either plasma oncotic pressure or protein content."
        ]
      },
      {
        "medication_type": "Human albumin 20%",
        "information": ": Measures of adequacy of circulating volume and not plasma albumin levels should be used to determine the dose required. If human albumin is to be administered, haemodynamic performance should be monitored regularly; this may include: The solution can be directly administered by the intravenous route, or it can be diluted in an isotonic solution (e.g. 0.9% sodium chloride). In plasma exchange the infusion rate should be adjusted to the rate of removal.",
        "instructions": [
          "arterial blood pressure and pulse rate",
          "central venous pressure",
          "pulmonary artery wedge pressure",
          "urine output",
          "electrolyte",
          "haematocrit / haemoglobin"
        ]
      },
      {
        "medication_type": "Human albumin 5%",
        "information": "may be given intravenously without further dilution. This concentration is approximately isotonic and iso-osmotic with citrated plasma. Albumin (Human) in this concentration provides additional fluid for plasma volume expansion. Therefore, when it is administered to patients with normal blood volume, the rate of infusion should be slow enough to prevent too rapid expansion of plasma volume. In the treatment of shock in an adult patient an initial dose of 500 mL of the 5% albumin solution is given as rapidly as tolerated. If response within 30 minutes is inadequate, an additional 500 mL of 5% albumin solution may be given. The 50 mL dosage form would be appropriate for pediatric use, with a dose of 10-20 mL per kg of body weight infused intravenously at a rate up to 5-10 mL per minute. Therapy should be guided by the clinical response, blood pressure and an assessment of relative anemia. If more than 1000 mL are given, or if hemorrhage has occurred, the administration of packed red blood cells may be desirable. In severe burns, immediate therapy should include large volumes of crystalloid with lesser amounts of 5% albumin solution to maintain an adequate plasma volume. After the first 24 hours, the ratio of albumin to crystalloid may be increased to establish and maintain a plasma albumin level of about 2.5 g/100 mL or a total serum protein level of about 5.2 g/100 mL. However, an optimal regimen for the use of colloids, electrolytes and water after severe burns has not been established. The infusion of Albumin (Human) as a nutrient in the treatment of chronic hypoproteinemia is not recommended. In acute hypoproteinemia, 5% albumin may be used in replacing the protein lost in hypoproteinemic conditions. However, if edema is present or if large amounts of albumin are lost, Albumin (Human) 25% is preferred because of the greater amount of protein in the concentrated solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:55.105Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d8e",
    "original_record": {
      "input_index": 788,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d8e"
        },
        "name": "Albunorm",
        "strength": "5%",
        "generic": "Albumin (Human)",
        "company": "Discount Pharma",
        "medicine_type": "IV Infusion",
        "source_url": "https://medex.com.bd/brands/37021/albunorm-5-injection",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33965/alburx-25-injection",
    "name": "AlbuRx",
    "dosage_form": "IV Infusion",
    "generic": "Albumin",
    "strength": "25%",
    "company": "CSL Behring AG, Switzerland",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 4,500.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "50 ml bottle",
          "price": "৳ 4,500.00",
          "pack_size_info": null
        },
        {
          "label": "100 ml bottle",
          "price": "৳ 9,000.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "20% (IV Infusion)",
        "href": "https://medex.com.bd/brands/14910/human-albumin-20-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/545/albumin-human/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Shock: AlbuRx is indicated in the emergency treatment of shock and in other similar conditions where the restoration of blood volume is urgent. If there has been considerable loss of red blood cells, transfusion with packed red blood cells is indicated.... Read moreShock: AlbuRx is indicated in the emergency treatment of shock and in other similar conditions where the restoration of blood volume is urgent. If there has been considerable loss of red blood cells, transfusion with packed red blood cells is indicated.Burns: AlbuRx or AlbuRx in either normal saline or dextrose is indicated to prevent marked hemoconcentration and to maintain appropriate electrolyte balance.Hypoproteinemia with or without edema: AlbuRx is indicated in those clinical situations usually associated with a low concentration of plasma protein and a resulting decreased circulating blood volume. Although diuresis may occur soon after AlbuRx administration has been instituted, best results are obtained if AlbuRx is continued until the normal serum protein level is regained.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The main function of albumin results from its contribution to plasma colloid oncotic pressure and transport function. Albumin stabilizes circulating blood volume and carries hormones, enzymes, medicines, and toxins. Other physiological functions include antioxidant properties, free radical scavenging, in addition to maintenance capillary membrane integrity. Exogenously administered albumin increases the oncotic pressure of the intravascular system, moving fluids from the interstitial space, thereby decreasing edema and increasing the circulating blood volume. The increase in volume reduces the concentration and viscosity of blood in patients with decreased circulating blood volume while maintaining cardiac output in shock. In dehydrated patients, negligible effects exist on circulating blood volume. In addition to the above albumin replaces protein in patients with hypoproteinemia until the cause of the deficiency can be determined. This drug has thousands of endogenous and exogenous targets. Human albumin also binds and carries a plethora of hydrophobic molecules, such as endogenous (i.e., cholesterol, fatty acids, bilirubin, thyroxine) or exogenous substances (for example, drugs and toxins), transition metal ions, as well as gas (nitric oxide [NO]), with resulting implications for their solubilisation, transport, metabolism, and detoxification.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "AlbuRx solution should not be mixed by protein hydrolysates or alcoholic solutions. Risk of atypical reactions to ACE inhibitors in patients undergoing therapeutic plasma exchange with AlbuRx human replacement.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Albumin (Human) may be contraindicated in patients with severe anemia or cardiac failure and in patients with a history of allergic reactions to human albumin.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Allergic or pyrogenic reactions are characterized primarily by fever and chills; rash, nausea, vomiting, tachycardia and hypotension have also been reported. Should an adverse reaction occur, slow or stop the infusion for a period of time which may result in the disappearance of the symptoms. If administration has been stopped and the patient requires additional AlbuRx (Human), material from a different lot should be used. AlbuRx (Human), particularly if administered rapidly, may result in vascular overload with resultant pulmonary edema.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Hypertension or low cardiac reserve; additional fluids for dehydrated patients. Monitor for signs of cardiac overload in injured or postoperative patients. May carry risk of viral transmission. Volume admin and rate of infusion must always be individualised according to situation and response. Pregnancy, lactation.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "No clinical studies using AlbuRx (Human) have been conducted in pediatric patients. Safety and effectiveness in pediatric patients have not been established. However, extensive experience in patients suggests that children respond to AlbuRx (Human) in the same manner as adults.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C. Do not freeze.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Plasma expanders",
    "dosage": [
      {
        "medication_type": "Human albumin 25%",
        "information": "is for intravenous administration only. Human albumin may be diluted with 5% glucose or 0.9% sodium chloride. Concentration, dosage, and infusion-rate should be adjusted to the patient’s individual requirements and indication.",
        "instructions": [
          "Hypovolemia: Initial dose 25 g is suggested.",
          "Hypoalbuminemia: 50-75 gm",
          "Prevention of central volume fluid removed depletion after",
          "paracentesis due to cirrhotic ascites: 6-8 gm for every 1000 mL of ascitic.",
          "OHSS: 50 to 100 gm over 4 hours and repeated at 4-12 hour intervals as necessary. 10-50 gm; single infusion.",
          "ARDS: 25 g over 30 minutes and repeated at 8 hours for 3 days if necessary.",
          "Burns: Determined by direct observation of vital sign or measurement of either plasma oncotic pressure or protein content."
        ]
      },
      {
        "medication_type": "Human albumin 20%",
        "information": ": Measures of adequacy of circulating volume and not plasma albumin levels should be used to determine the dose required. If human albumin is to be administered, haemodynamic performance should be monitored regularly; this may include: The solution can be directly administered by the intravenous route, or it can be diluted in an isotonic solution (e.g. 0.9% sodium chloride). In plasma exchange the infusion rate should be adjusted to the rate of removal.",
        "instructions": [
          "arterial blood pressure and pulse rate",
          "central venous pressure",
          "pulmonary artery wedge pressure",
          "urine output",
          "electrolyte",
          "haematocrit / haemoglobin"
        ]
      },
      {
        "medication_type": "Human albumin 5%",
        "information": "may be given intravenously without further dilution. This concentration is approximately isotonic and iso-osmotic with citrated plasma. Albumin (Human) in this concentration provides additional fluid for plasma volume expansion. Therefore, when it is administered to patients with normal blood volume, the rate of infusion should be slow enough to prevent too rapid expansion of plasma volume. In the treatment of shock in an adult patient an initial dose of 500 mL of the 5% albumin solution is given as rapidly as tolerated. If response within 30 minutes is inadequate, an additional 500 mL of 5% albumin solution may be given. The 50 mL dosage form would be appropriate for pediatric use, with a dose of 10-20 mL per kg of body weight infused intravenously at a rate up to 5-10 mL per minute. Therapy should be guided by the clinical response, blood pressure and an assessment of relative anemia. If more than 1000 mL are given, or if hemorrhage has occurred, the administration of packed red blood cells may be desirable. In severe burns, immediate therapy should include large volumes of crystalloid with lesser amounts of 5% albumin solution to maintain an adequate plasma volume. After the first 24 hours, the ratio of albumin to crystalloid may be increased to establish and maintain a plasma albumin level of about 2.5 g/100 mL or a total serum protein level of about 5.2 g/100 mL. However, an optimal regimen for the use of colloids, electrolytes and water after severe burns has not been established. The infusion of Albumin (Human) as a nutrient in the treatment of chronic hypoproteinemia is not recommended. In acute hypoproteinemia, 5% albumin may be used in replacing the protein lost in hypoproteinemic conditions. However, if edema is present or if large amounts of albumin are lost, Albumin (Human) 25% is preferred because of the greater amount of protein in the concentrated solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:56.714Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d91",
    "original_record": {
      "input_index": 789,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d91"
        },
        "name": "AlbuRx",
        "strength": "25%",
        "generic": "Albumin (Human)",
        "company": "International Agencies (Bd.) Limited",
        "medicine_type": "IV Infusion",
        "source_url": "https://medex.com.bd/brands/33965/alburx-25-injection",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/36754/alcasol-1500-mg-oral-solution",
    "name": "Alcasol",
    "dosage_form": "Oral Solution",
    "generic": "Potassium Citrate + Citric Acid",
    "strength": "(1500 mg+250 mg)/5 ml",
    "company": "ACI Limited",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 200.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "200 ml bottle",
          "price": "৳ 200.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/270/potassium-citrate-citric-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alcasol oral solution is indicated in the following cases:",
        "items": [
          "To relieve discomfort in urinary tract infections",
          "To prevent kidney stone",
          "With uricosuric agent to prevent gout",
          "Acidosis caused by kidney diseases"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Potassium Citrate is absorbed and metabolized to potassium bicarbonate, this acting as a systemic alkalizer. The effects are essentially those of chlorides before absorption and those of bicarbonates subsequently. Oxidation is virtually complete so that less than 5% of the potassium citrate is excreted in the urine unchanged.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concurrent administration of potassium-containing medication, potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors or cardiac glycosides may lead to toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "The drug is contraindicated in severe renal impairment with oliguria or azotemia, untreated Addison's disease, acute dehydration, severe myocardial damage and hyperkalemia from any cause.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "This solution is generally well tolerated without any unpleasant side effect when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of hyperkalemia or alkalosis. Potassium intoxication causes listlessness, weakness, mental confusion, tingling of extremities and other symptoms associated with a high concentration of Potassium in the serum.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Potassium Citrate oral solution in pregnant women. Animal studies are insufficient with respect to effects on pregnancy. The potential risk to humans is unknown. Potassium Citrate oral solution should not be used during pregnancy unless clearly necessary and on the advice of a physician.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "The solution should be used with caution in patients with low urinary output. It should be diluted adequately with water to minimize the possibility of gastrointestinal injury associated with the oral ingestion of concentrated Potassium salt preparations; and preferably, to take each dose after meals. Large doses may cause hyperkalemia and alkalosis, especially in the presence of renal disease. Large doses may cause hyperkalemia an alkalosis, especially in the presence of renal disease. Concurrent administration of potassium-containing medication, potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, or cardiac glycosides may lead to toxicity. Do not exceed recommended dosage. Discontinue use if adverse reaction occurs. Should be used with caution by patients with low urinary output unless under the supervision of a physician. As with all liquids containing a high concentration of potassium, patients should be directed to dilute adequately with water to minimize the possibility of gastrointestinal injury associated with the oral ingestion of concentrated potassium salt preparations; and preferable, to take each dose after meals to avoid saline laxative effect.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "The administration of oral Potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious hyperkalemia. However, if excretory mechanisms are impaired, hyperkalemia can result. Hyperkalemia, when detected, must be treated immediately because lethal levels can be reached in a few hours. If hyperkalemia occurs, treatment measures will include the followings: (1) Elimination of foods or medications containing potassium. (2) The intravenous administration of 300 to 500 ml/hr of dextrose solution (10 to 25%), containing 10 units of insulin/20 gm dextrose. (3) The use of exchange resins, hemodialysis or peritoneal dialysis.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Oral Solution is an effective alkalinizing agent useful in those conditions where long-term maintenance of alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be preferable. Alcasol is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. Alcasol alkalinizes the urine without producing a systemic alkalosis in recommended dosage. It is highly palatable, pleasant tasting and tolerable, even when administered for long periods. Potassium Citrate does not neutralize the gastric juice or disturb digestion.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Prevention of repeated kidney stone formation, Urinary Alkalinizing Agent",
    "dosage": [
      {
        "medication_type": null,
        "information": "Oral Solution should be taken diluted in water according to directions, followed by additional water, if desired. Palatability is enhanced if chilled before taking. Proper dilution may help prevent gastrointestinal injury associated with the oral ingestion of concentrated potassium salt preparations. To relieve discomfort in UTI:",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 6 years",
        "information": ": 10 ml 3 times daily, diluted with 1 glass of water.",
        "instructions": []
      },
      {
        "medication_type": "Children 1-6 years",
        "information": ": 5 ml 3 times daily, diluted with ½ glass of water.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "To prevent kidney stones, With a uricosuric agent to prevent gout, Acidosis caused by kidney diseases:",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": 10-15 ml 4 times daily (or as directed by the physician) diluted with 1 glass of water.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric",
        "information": ": 5-10 ml 4 times daily (or as directed by the physician) diluted with ½ glass of water.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:58.077Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d99",
    "original_record": {
      "input_index": 790,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d99"
        },
        "name": "Alcasol",
        "strength": "(1500 mg+250 mg)/5 ml",
        "generic": "Potassium Citrate + Citric Acid",
        "company": "ACI Limited",
        "medicine_type": "Oral Solution",
        "source_url": "https://medex.com.bd/brands/36754/alcasol-1500-mg-oral-solution",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/22988/alchek-ds-02-eye-drop",
    "name": "Alchek DS",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Olopatadine Hydrochloride",
    "strength": "0.2%",
    "company": "Apex Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 180.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 180.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.1% (Eye Drop)",
        "href": "https://medex.com.bd/brands/15976/alchek-01-eye-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/823/olopatadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Patadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.... Read morePatadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.Alchek DS Nasal Spray is an H1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older.Alchek DS tablet is indicated in the treatment of allergic rhinitis (swelling of the nasal membranescaused by an allergy to pollen and mold spores in the air) and allergic skin conditions. It helps to relieve allergy symptoms such as skin rashes, swelling, hives (itchy, painful eruptions that sting), itching, sneezing, runny or stuffy nose.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Olopatadine, an antihistamine, works by blocking the action of histamine in the body, which reduces allergy symptoms. Olopatadine hydrochloride treats sneezing, itching, runny nose, and other nasal symptoms of allergies.",
        "items": []
      },
      {
        "title": "Mode of Action",
        "information": ": Olopatadine is an anti-allergic molecule that works via several mechanisms. As a mast cell stabilizer, it stabilizes rodent basophils and human conjunctival mast cells and inhibits the immunologically-stimulated release of histamine. Olopatadine acts as an antagonist at the histamine H1 receptors with high selectivity, Upon binding, olopatadine blocks the H1 receptor signaling pathway, inhibiting the release of inflammatory mediators, such as tryptase, prostaglandin D2, TNF-alpha, as well as pro-inflammatory cytokines.",
        "items": []
      },
      {
        "title": "Pharmacokinetics",
        "information": ": Absorption: Olopatadine was absorbed with individual peak plasma concentrations observed between 30 minutes and 1 hour after twice daily intranasal administration of Olopatadine Nasal Spray. Distribution: The protein binding of olopatadine was moderate at approximately 55% in human serum, and independent of drug concentration over the range of 0.1 to 1000 ng/mL. Metabolism: Olopatadine is not extensively metabolized. Based on plasma metabolite profiles of olopatadine, at least six minor metabolites circulate in human plasma. Elimination: The plasma elimination half-life of olopatadine is 8 to 12 hours. Olopatadine is mainly eliminated through urinary excretion",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Formal drug-drug interaction studies were not conducted for Alchek DS Nasal Spray. Drug interactions with inhibitors of liver enzymes are not anticipated because olopatadine is eliminated predominantly by renal excretion. Drug interactions involving P450 inhibition and plasma protein binding are also not expected.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in persons with a known hypersensitivity to any component of this product. Olopatadine 5 mg tablet is not recommended for use if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions to make sure this medicine is safe for you.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rarely headaches have been reported. Other adverse effects: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Olopatadine was found not to be teratogenic in rats and rabbits. There are, however, no adequate and well controlled studies in pregnant women. This drug should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Olopatadine is administered to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients should be advised not to wear a contact lens if their eye is red. Alchek DS ophthalmic solution should not be used to treat contact lens related irritation. Benzalkonium Chloride, preservative of Patadin, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least 10 minutes after instillation of Patadin eye drops before they insert their contact lenses. The treatment should be discontinued in the presence of an allergic reaction. Before initial use, Alchek DS Nasal Spray by releasing 5 sprays or until a fine mist appears. When Alchek DS Nasal Spray has not been used for more than 7 days, re-prime by releasing 2 sprays. Avoid spraying Alchek DS Nasal Spray into the eyes. Patients should be informed to avoid spraying Alchek DS Nasal Spray in their eyes. Olonex Tablet should be used as prescribed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid taking more than the recommended dose. Do not stop taking this medicine without consulting your doctor, as your symptoms may reoccur.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety or effectiveness have been observed betweents.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no information on Alchek DS overdose. However, excessive use of any medication can have serious consequences. If you suspect an overdose, seek medical attention without delay.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at room temperature and protect from light. It is desirable that the contents should not be used more than one month after first opening of the bottle.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "How to use the Nasal Spray- Cleaning: The nasal spray should be cleaned at least once a week. The procedures are as follows-",
        "items": [
          "Shake the bottle gently and remove the dust cover.",
          "Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath the bottle. Press down until a fine spray appears. If using for the first time or if you have not used it for a week or more, press the nasal applicator several times until a fine moist comes out from the container.",
          "Gently blow the nose to clear the nostrils.",
          "Close one nostril and carefully insert the nasal applicator into the open nostril. Tilt your head forward slightly and keep the spray upright. Breathe in through your nose and while breathing in, press the white-collar of nasal applicator firmly down once to release a spray.",
          "Breathe out through your mouth.",
          "Repeat the above steps in the same/ other nostril for consecutive doses.",
          "Remove the dust cover.",
          "Gently pull off the nasal applicator.",
          "Wash the applicator and dust cover in warm water.",
          "Shake off the excess water and leave to dry in a normal place. Avoid to apply additional heat.",
          "Gently push the applicator back on the top of the bottle and re-fix the dust cover."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ophthalmic Non-Steroid drugs",
    "dosage": [
      {
        "medication_type": "Eye Drops",
        "information": "-",
        "instructions": [
          "0.1%: One drop in each affected eye two times per day at an interval of 6 to 8 hours.",
          "0.2%: One drop in the affected eye once a day.",
          "0.7%: One drop in each affected eye once a day."
        ]
      },
      {
        "medication_type": "Nasal Spray",
        "information": "-",
        "instructions": [
          "Administer Olopatadine Nasal Spray by the intranasal route only.",
          "Adults and Adolescents 12 years of age and older: Two sprays per nostril twice daily.\\",
          "Children 6 to 11 years of age: One spray per nostril twice daily."
        ]
      },
      {
        "medication_type": "Tablet",
        "information": "-",
        "instructions": [
          "Adults: Take 1 tablet (5 mg of the active ingredient) at a time, twice daily, in the morning and before going to bed. The dosage may be adjusted according to the disease, age or symptoms.",
          "Children 7 years old or over: Take 1 tablet (5 mg) at a time, twice daily, in the morning and before going to bed.",
          "If you miss a dose, take a dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time. Do not stop taking this medicine unless your doctor instructs you to do so."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:25:59.473Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d9f",
    "original_record": {
      "input_index": 791,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d9f"
        },
        "name": "Alchek DS",
        "strength": "0.2%",
        "generic": "Olopatadine Hydrochloride",
        "company": "Apex Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/22988/alchek-ds-02-eye-drop",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/10937/alcofen-sr-100-mg-capsule",
    "name": "Alcofen SR",
    "dosage_form": "Capsule (Sustained Release)",
    "generic": "Diclofenac Sodium",
    "strength": "100 mg",
    "company": "Aexim Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 1.50",
      "strip_price": "৳ 15.00",
      "pack_size_info": "(10 x 10: ৳ 150.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 1.50",
          "pack_size_info": "(10 x 10: ৳ 150.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 15.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "50 mg (Tablet)",
        "href": "https://medex.com.bd/brands/10936/alcofen-50-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/357/diclofenac-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alcofen SR is indicated in-Rheumatology: Inflammatory and degenerative forms of rheumatism, chronic involutive, polyarthritis, ankylosing spondylarthritis, osteoarthritis, spondylarthroses, acute gout, peri-articular rheumatic disorders.Surgery and Traumatology ... Read moreAlcofen SR is indicated in-Rheumatology: Inflammatory and degenerative forms of rheumatism, chronic involutive, polyarthritis, ankylosing spondylarthritis, osteoarthritis, spondylarthroses, acute gout, peri-articular rheumatic disorders.Surgery and Traumatology: Sprain, bruises, dislocations, fractures, softtissue injuries, surgical interventions.Obstetrics and Gynecology: Primary dysmenorrhoea, episiotomy, adnexitis, endometritis, parametritis, salpingitis, and mastitis.Otorhinolaryngology: As pre-operative medication for the prevention of pain, inflammation, and swelling.Dentistry: Post-operative and post-traumatic pain, inflammation, and swelling.Other indications: For the prevention of pain and treatment of inflammation and swelling of patients operated in the urogenital tract, renal and biliary colic.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Dilofenac Sodium is a potent non-steroidal anti-inflammatory drug (NSAID) with pronounced anti-rheumatic, anti-inflammatory, analgesic and antipyretic properties. It has also some uricosuric effect. Diclofenac exerts its effect by inhibiting prostaglandin biosynthesis which plays a major role in causing inflammation, pain and fever. Diclofenac is rapidly and completely absorbed from the gastro-intestinal tract when taken with or after meal. Peak plasma concentrations are reached within an average of 2 hours after ingestion of it. At therapeutic concentrations, it is 99.7% bound to plasma proteins. Diclofenac is metabolized in the liver and undergoes first pass metabolism.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alcofen SR may have the following drug interactions:",
        "items": []
      },
      {
        "title": "Lithium and digoxin",
        "information": ": Alcofen SR may increase plasma concentrations of lithium and digoxin.",
        "items": []
      },
      {
        "title": "Anticoagulants",
        "information": ": There are isolated reports of an increased risk of haemorrhage with the combined use of diclofenac and anticoagulant therapy, although clinical investigations do not appear to indicate any influence on anticoagulant effect.",
        "items": []
      },
      {
        "title": "Antidiabetic agents",
        "information": ": Clinical studies have shown that diclofenac can be given together with oral antidiabetic agents without influencing their clinical effect.",
        "items": []
      },
      {
        "title": "Cyclosporin",
        "information": ": Cases of nephrotoxicity have been reported in patients receiving cyclosporin and diclofenac concomitantly.",
        "items": []
      },
      {
        "title": "Methotrexate",
        "information": ": Cases of serious toxicity have been reported when methotrexate and NSAIDs are given within 24 hours of each other.",
        "items": []
      },
      {
        "title": "Quinolone antimicrobials",
        "information": ": Convulsions may occur due to an interaction between quinolones and NSAIDs. Therefore, caution should be exercised when considering concomitant therapy of NSAID and quinolones.",
        "items": []
      },
      {
        "title": "Other NSAIDs and steroids",
        "information": ": Co-administration of diclofenac with other systemic NSAIDs and steroids may increase the frequency of unwanted effects. With aspirin, the plasma levels of each is lowered, although no clinical significance is known.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated to the patients hypersensitive to any ingredient of the products. Peptic ulcer, hypersensitivity to Diclofenac like other non-steroid anti-inflammatory agents, Diclofenac is also contra-indicated in asthmatic patient in whom attack with asthma, urticaria or acute rhinitis are precipitated by acetylsalicylic acid or by other drugs with prostaglandin synthetase inhibitor. This Gel should not be used under occlusive airtight dressings.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Alcofen SR is generally well tolerated. Adverse effects are mild, rare and transient. At the starting of the treatment, however, patients may be sometimes complaining of epigastric pain, eructation, nausea and diarrhea or dizziness or headache. These effects are usually mild in nature. Peripheral edema and skin reactions, such as rash and eczema have also been encountered. Alcofen SR Gel may cause local irritation and reddening of the skin and skin rash.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "During pregnancy, Diclofenac should be employed only for compelling reasons. The lowest effective dose should be used. These types of drugs are not recommended during the first trimester of pregnancy. In view of insufficient clinical data, Diclofenac Sodium Gel is not recommended during pregnancy. A very insignificant quantity of Diclofenac may be detected in breast milk but no undesirable effects on the infant to be expected.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In rare instances where peptic ulceration or gastrointestinal bleeding occurs in patients under treatment with Alcofen SR. In patients with advanced age should be kept under close observation. Alcofen SR Gel should not be allowed to come in contact with the eyes or mucus membranes, after application the hands should be washed properly and not to be taken by mouth.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light. Store below 30°C. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs)",
    "dosage": [
      {
        "medication_type": "Diclofenac FC Tablet",
        "information": ": Adults: 75-150 mg daily in 2 to 3 divided doses, preferably after food. Dose should be reduced in long term use.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac SR Tablet",
        "information": ":",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 1 tablet daily, taken whole with liquid, preferably at meal times. If necessary, the daily dose can be increased to 150 mg by supplementation with conventional tablets.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 1-3 mg of diclofenac/kg body wt. daily in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly patients",
        "information": ": In elderly or debilitated patients, the lowest effective dosage is recommended, although the pharmacokinetics of diclofenac sodium is not impaired to any clinically relevant extent in elderly patients.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Dispersible Tablet",
        "information": ":",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": The recommended daily dosage is 2-3 tablets and the maximum daily dose is 150 mg. In milder cases, 2 tablets of Diclofenac DT per day are sufficient. Diclofenac DT should preferably be taken before meals.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": Diclofenac is not recommended in children for other indications except juvenile rheumatoid arthritis where the recommended dose is 1-3 mg/kg body weight. Diclofenac DT is to be dropped into a half-glass of water and the liquid is to be stirred to aid dispersion before swallowing. There is no information on the use of Diclofenac DT for more than 03 months.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac TR Capsule",
        "information": ": One capsule daily. Diclofenac TR should be taken preferably after mealtimes.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Suppository",
        "information": ": For adults: 50 mg suppository 2-3 times daily. Maximum daily dose is 150 mg.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac injection",
        "information": ": For adults the usual dose is 1 ampoule daily. In serious cases this dose may be increased up to 2 ampoules daily.",
        "instructions": []
      },
      {
        "medication_type": "Diclofenac Gel",
        "information": ": For external use only. Depending on the size of area to be treated, 2-4 g of Diclofenac gel should be applied to the skin 3-4 times daily. To the affected area gel should be rubbed in lightly. This gel may also be given in addition to further treatment with other dosage forms of Diclofenac.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:00.995Z",
    "medicine_id": "68c3c09aef5b8f2b163a8da4",
    "original_record": {
      "input_index": 792,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8da4"
        },
        "name": "Alcofen SR",
        "strength": "100 mg",
        "generic": "Diclofenac Sodium",
        "company": "Aexim Pharmaceuticals Ltd.",
        "medicine_type": "Capsule (Sustained Release)",
        "source_url": "https://medex.com.bd/brands/10937/alcofen-sr-100-mg-capsule",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/8985/alcot-400-mg-tablet",
    "name": "Alcot",
    "dosage_form": "Tablet",
    "generic": "Sulphamethoxazole + Trimethoprim",
    "strength": "400 mg+80 mg",
    "company": "Pacific Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 1.00",
      "strip_price": "৳ 10.00",
      "pack_size_info": "(10 x 10: ৳ 100.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 1.00",
          "pack_size_info": "(10 x 10: ৳ 100.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 10.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      },
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "(200 mg+40 mg)/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/8987/alcot-200-mg-suspension?ref=1"
      },
      {
        "text": "800 mg+160 mg (Tablet)",
        "href": "https://medex.com.bd/brands/29873/alcot-800-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1024/sulphamethoxazole-trimethoprim/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cotrimoxazole is bactericidal in vitro to a wide range of Gram-positive and Gram-negative organisms, including Streptococcus, Staphylococcus, Pneumococcus, Neisseria, B. catarrhalis, Escherichia coli, Klebsiella, Proteus spp., Haemophilus, Salmonella, Shigella, Vibrio cholerae, Brucella, Pneumocystis ... Read moreCotrimoxazole is bactericidal in vitro to a wide range of Gram-positive and Gram-negative organisms, including Streptococcus, Staphylococcus, Pneumococcus, Neisseria, B. catarrhalis, Escherichia coli, Klebsiella, Proteus spp., Haemophilus, Salmonella, Shigella, Vibrio cholerae, Brucella, Pneumocystis carinii, Nocardia and Bordetella. A particularly high degree of activity is exhibited against Haemophilus influenzae, E. coli and Proteus spp., making Cotrimoxazole particularly suitable for the treatment of chronic bronchitis and urinary tract infections. Cotrimoxazole exerts its bactericidal action by the sequential blockade of two bacterial enzyme systems in the biosynthesis of Folinic acid in the micro-organisms. The synergy thus produced accounts for the high degree of bactericidal activity.Alcot is indicated in:",
        "items": [
          "Respiratory tract infections, including acute and chronic bronchitis (treatment and prophylaxis), bronchiectasis, lung abscess, lobar and broncho-pneumonia, Pneumocystis carinii pneumonitis, sinusitis and otitis media.",
          "Genito-urinary tract infections, including urethritis, acute and chronic cystitis, pyelonephritis, prostatitis and gonorrhoea.",
          "Gastro-intestinal tract infections, caused by Salmonella typhi and Salmonella paratyphi, including the chronic carrier state.",
          "Other infections, caused by a wide range of organisms confirmed to be susceptible to Cotrimoxazole and where the therapeutic benefits are considered to outweigh the possible occurrence of adverse events.",
          "Such infections include acute and chronic osteomyelitis, acute brucellosis, skin infections including pyoderma, abscesses and wound infections, septicaemia, bacillary dysentery and cholera (as an adjuvant to fluid and electrolyte replacement), nocardiosis and mycetoma."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cotrimoxazole having broad spectrum bactericidal activity against a wide range of gram-positive & gram-negative bacteria and some protozoa. Co-trimoxazole containing Trimethoprim and Sulphamethoxazole in a 1:5 combination exerts its bactericidal action by the sequential blockade of two bacterial enzyme systems in the biosynthesis of folinic acid in the microorganism.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to trimethoprim or sulphonamides.",
          "Patients with documented megaloblastic anaemia due to folate deficiency.",
          "Patients showing marked liver parenchymal damage, blood dyscrasia, severe renal insufficiency, glucose 6-phosphate dehydrogenase deficiency."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The side effects like crystalluria, allergic reactions, haemolysis, thrombocytopenia, neutropenia, agranulocytosis etc. have been reported rarely with Sulphamethoxazole-Trimethoprim combination. Other side effects are less serious in nature such as malaise, headache, nausea and vomiting. These are normally transient and do not require withdrawal of treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy and during the nursing period, because sulphonamides pass the placenta and are excreted in the breast milk and may cause kernicterus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Prolonged full dose treatment with sulfamethoxazole-trimethoprim combination is associated with the risk of macrocytic anaemia due to the drug’s interference in the conversion of Folic acid into Folinic acid. If this occurs, it can be reversed by giving Folinic acid. Care should be taken when giving Alcot to diabetic patients receiving sulphonylurea drug for possible potentiation of action of sulphonylurea.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-diarrhoeal Antimicrobial drugs, Sulphonamides & Trimethoprim",
    "dosage": [
      {
        "medication_type": null,
        "information": "Cotrimoxazole double strength tablet: Over 12 years",
        "instructions": []
      },
      {
        "medication_type": "For mild to moderate infections",
        "information": ": 1 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": "For severe infections",
        "information": ": 1.5 tablets twice daily.",
        "instructions": []
      },
      {
        "medication_type": "Long term therapy (>14 days)",
        "information": ": 0.5 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": "Gonorrhoea",
        "information": ": 2 tablets every 12 hours for two days or 2.5 tablets followed by a further dose of 2.5 tablets after 8 hours.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cotrimoxazole tablet: over 12 years",
        "instructions": []
      },
      {
        "medication_type": "For mild to moderate infections",
        "information": ": 2 tablets twice daily.",
        "instructions": []
      },
      {
        "medication_type": "For severe infections",
        "information": ": 2 tablets thrice daily.",
        "instructions": []
      },
      {
        "medication_type": "Long term therapy",
        "information": ": (>14 days): 1 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cotrimoxazole suspension: Under 12 years",
        "instructions": []
      },
      {
        "medication_type": "6-12 years",
        "information": ": 2 teaspoonful twice daily.",
        "instructions": []
      },
      {
        "medication_type": "6 month-5 years",
        "information": ": 1 teaspoonful twice daily.",
        "instructions": []
      },
      {
        "medication_type": "6 weeks-6 months",
        "information": ": 0.5 teaspoonful twice daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:02.261Z",
    "medicine_id": "68c3c09aef5b8f2b163a8da6",
    "original_record": {
      "input_index": 793,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8da6"
        },
        "name": "Alcot",
        "strength": "400 mg+80 mg",
        "generic": "Sulphamethoxazole + Trimethoprim",
        "company": "Pacific Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/8985/alcot-400-mg-tablet",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/8987/alcot-200-mg-suspension",
    "name": "Alcot",
    "dosage_form": "Oral Suspension",
    "generic": "Sulphamethoxazole + Trimethoprim",
    "strength": "(200 mg+40 mg)/5 ml",
    "company": "Pacific Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 20.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 20.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      },
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "400 mg+80 mg (Tablet)",
        "href": "https://medex.com.bd/brands/8985/alcot-400-mg-tablet?ref=1"
      },
      {
        "text": "800 mg+160 mg (Tablet)",
        "href": "https://medex.com.bd/brands/29873/alcot-800-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1024/sulphamethoxazole-trimethoprim/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cotrimoxazole is bactericidal in vitro to a wide range of Gram-positive and Gram-negative organisms, including Streptococcus, Staphylococcus, Pneumococcus, Neisseria, B. catarrhalis, Escherichia coli, Klebsiella, Proteus spp., Haemophilus, Salmonella, Shigella, Vibrio cholerae, Brucella, Pneumocystis ... Read moreCotrimoxazole is bactericidal in vitro to a wide range of Gram-positive and Gram-negative organisms, including Streptococcus, Staphylococcus, Pneumococcus, Neisseria, B. catarrhalis, Escherichia coli, Klebsiella, Proteus spp., Haemophilus, Salmonella, Shigella, Vibrio cholerae, Brucella, Pneumocystis carinii, Nocardia and Bordetella. A particularly high degree of activity is exhibited against Haemophilus influenzae, E. coli and Proteus spp., making Cotrimoxazole particularly suitable for the treatment of chronic bronchitis and urinary tract infections. Cotrimoxazole exerts its bactericidal action by the sequential blockade of two bacterial enzyme systems in the biosynthesis of Folinic acid in the micro-organisms. The synergy thus produced accounts for the high degree of bactericidal activity.Alcot is indicated in:",
        "items": [
          "Respiratory tract infections, including acute and chronic bronchitis (treatment and prophylaxis), bronchiectasis, lung abscess, lobar and broncho-pneumonia, Pneumocystis carinii pneumonitis, sinusitis and otitis media.",
          "Genito-urinary tract infections, including urethritis, acute and chronic cystitis, pyelonephritis, prostatitis and gonorrhoea.",
          "Gastro-intestinal tract infections, caused by Salmonella typhi and Salmonella paratyphi, including the chronic carrier state.",
          "Other infections, caused by a wide range of organisms confirmed to be susceptible to Cotrimoxazole and where the therapeutic benefits are considered to outweigh the possible occurrence of adverse events.",
          "Such infections include acute and chronic osteomyelitis, acute brucellosis, skin infections including pyoderma, abscesses and wound infections, septicaemia, bacillary dysentery and cholera (as an adjuvant to fluid and electrolyte replacement), nocardiosis and mycetoma."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cotrimoxazole having broad spectrum bactericidal activity against a wide range of gram-positive & gram-negative bacteria and some protozoa. Co-trimoxazole containing Trimethoprim and Sulphamethoxazole in a 1:5 combination exerts its bactericidal action by the sequential blockade of two bacterial enzyme systems in the biosynthesis of folinic acid in the microorganism.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to trimethoprim or sulphonamides.",
          "Patients with documented megaloblastic anaemia due to folate deficiency.",
          "Patients showing marked liver parenchymal damage, blood dyscrasia, severe renal insufficiency, glucose 6-phosphate dehydrogenase deficiency."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The side effects like crystalluria, allergic reactions, haemolysis, thrombocytopenia, neutropenia, agranulocytosis etc. have been reported rarely with Sulphamethoxazole-Trimethoprim combination. Other side effects are less serious in nature such as malaise, headache, nausea and vomiting. These are normally transient and do not require withdrawal of treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy and during the nursing period, because sulphonamides pass the placenta and are excreted in the breast milk and may cause kernicterus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Prolonged full dose treatment with sulfamethoxazole-trimethoprim combination is associated with the risk of macrocytic anaemia due to the drug’s interference in the conversion of Folic acid into Folinic acid. If this occurs, it can be reversed by giving Folinic acid. Care should be taken when giving Alcot to diabetic patients receiving sulphonylurea drug for possible potentiation of action of sulphonylurea.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-diarrhoeal Antimicrobial drugs, Sulphonamides & Trimethoprim",
    "dosage": [
      {
        "medication_type": null,
        "information": "Cotrimoxazole double strength tablet: Over 12 years",
        "instructions": []
      },
      {
        "medication_type": "For mild to moderate infections",
        "information": ": 1 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": "For severe infections",
        "information": ": 1.5 tablets twice daily.",
        "instructions": []
      },
      {
        "medication_type": "Long term therapy (>14 days)",
        "information": ": 0.5 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": "Gonorrhoea",
        "information": ": 2 tablets every 12 hours for two days or 2.5 tablets followed by a further dose of 2.5 tablets after 8 hours.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cotrimoxazole tablet: over 12 years",
        "instructions": []
      },
      {
        "medication_type": "For mild to moderate infections",
        "information": ": 2 tablets twice daily.",
        "instructions": []
      },
      {
        "medication_type": "For severe infections",
        "information": ": 2 tablets thrice daily.",
        "instructions": []
      },
      {
        "medication_type": "Long term therapy",
        "information": ": (>14 days): 1 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cotrimoxazole suspension: Under 12 years",
        "instructions": []
      },
      {
        "medication_type": "6-12 years",
        "information": ": 2 teaspoonful twice daily.",
        "instructions": []
      },
      {
        "medication_type": "6 month-5 years",
        "information": ": 1 teaspoonful twice daily.",
        "instructions": []
      },
      {
        "medication_type": "6 weeks-6 months",
        "information": ": 0.5 teaspoonful twice daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:03.503Z",
    "medicine_id": "68c3c09aef5b8f2b163a8da7",
    "original_record": {
      "input_index": 794,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8da7"
        },
        "name": "Alcot",
        "strength": "(200 mg+40 mg)/5 ml",
        "generic": "Sulphamethoxazole + Trimethoprim",
        "company": "Pacific Pharmaceuticals Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/8987/alcot-200-mg-suspension",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/29873/alcot-800-mg-tablet",
    "name": "Alcot",
    "dosage_form": "Tablet",
    "generic": "Sulphamethoxazole + Trimethoprim",
    "strength": "800 mg+160 mg",
    "company": "Pacific Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.00",
      "strip_price": "৳ 20.00",
      "pack_size_info": "(10 x 10: ৳ 200.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.00",
          "pack_size_info": "(10 x 10: ৳ 200.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 20.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      },
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "400 mg+80 mg (Tablet)",
        "href": "https://medex.com.bd/brands/8985/alcot-400-mg-tablet?ref=1"
      },
      {
        "text": "(200 mg+40 mg)/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/8987/alcot-200-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1024/sulphamethoxazole-trimethoprim/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cotrimoxazole is bactericidal in vitro to a wide range of Gram-positive and Gram-negative organisms, including Streptococcus, Staphylococcus, Pneumococcus, Neisseria, B. catarrhalis, Escherichia coli, Klebsiella, Proteus spp., Haemophilus, Salmonella, Shigella, Vibrio cholerae, Brucella, Pneumocystis ... Read moreCotrimoxazole is bactericidal in vitro to a wide range of Gram-positive and Gram-negative organisms, including Streptococcus, Staphylococcus, Pneumococcus, Neisseria, B. catarrhalis, Escherichia coli, Klebsiella, Proteus spp., Haemophilus, Salmonella, Shigella, Vibrio cholerae, Brucella, Pneumocystis carinii, Nocardia and Bordetella. A particularly high degree of activity is exhibited against Haemophilus influenzae, E. coli and Proteus spp., making Cotrimoxazole particularly suitable for the treatment of chronic bronchitis and urinary tract infections. Cotrimoxazole exerts its bactericidal action by the sequential blockade of two bacterial enzyme systems in the biosynthesis of Folinic acid in the micro-organisms. The synergy thus produced accounts for the high degree of bactericidal activity.Alcot is indicated in:",
        "items": [
          "Respiratory tract infections, including acute and chronic bronchitis (treatment and prophylaxis), bronchiectasis, lung abscess, lobar and broncho-pneumonia, Pneumocystis carinii pneumonitis, sinusitis and otitis media.",
          "Genito-urinary tract infections, including urethritis, acute and chronic cystitis, pyelonephritis, prostatitis and gonorrhoea.",
          "Gastro-intestinal tract infections, caused by Salmonella typhi and Salmonella paratyphi, including the chronic carrier state.",
          "Other infections, caused by a wide range of organisms confirmed to be susceptible to Cotrimoxazole and where the therapeutic benefits are considered to outweigh the possible occurrence of adverse events.",
          "Such infections include acute and chronic osteomyelitis, acute brucellosis, skin infections including pyoderma, abscesses and wound infections, septicaemia, bacillary dysentery and cholera (as an adjuvant to fluid and electrolyte replacement), nocardiosis and mycetoma."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cotrimoxazole having broad spectrum bactericidal activity against a wide range of gram-positive & gram-negative bacteria and some protozoa. Co-trimoxazole containing Trimethoprim and Sulphamethoxazole in a 1:5 combination exerts its bactericidal action by the sequential blockade of two bacterial enzyme systems in the biosynthesis of folinic acid in the microorganism.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to trimethoprim or sulphonamides.",
          "Patients with documented megaloblastic anaemia due to folate deficiency.",
          "Patients showing marked liver parenchymal damage, blood dyscrasia, severe renal insufficiency, glucose 6-phosphate dehydrogenase deficiency."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The side effects like crystalluria, allergic reactions, haemolysis, thrombocytopenia, neutropenia, agranulocytosis etc. have been reported rarely with Sulphamethoxazole-Trimethoprim combination. Other side effects are less serious in nature such as malaise, headache, nausea and vomiting. These are normally transient and do not require withdrawal of treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy and during the nursing period, because sulphonamides pass the placenta and are excreted in the breast milk and may cause kernicterus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Prolonged full dose treatment with sulfamethoxazole-trimethoprim combination is associated with the risk of macrocytic anaemia due to the drug’s interference in the conversion of Folic acid into Folinic acid. If this occurs, it can be reversed by giving Folinic acid. Care should be taken when giving Alcot to diabetic patients receiving sulphonylurea drug for possible potentiation of action of sulphonylurea.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-diarrhoeal Antimicrobial drugs, Sulphonamides & Trimethoprim",
    "dosage": [
      {
        "medication_type": null,
        "information": "Cotrimoxazole double strength tablet: Over 12 years",
        "instructions": []
      },
      {
        "medication_type": "For mild to moderate infections",
        "information": ": 1 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": "For severe infections",
        "information": ": 1.5 tablets twice daily.",
        "instructions": []
      },
      {
        "medication_type": "Long term therapy (>14 days)",
        "information": ": 0.5 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": "Gonorrhoea",
        "information": ": 2 tablets every 12 hours for two days or 2.5 tablets followed by a further dose of 2.5 tablets after 8 hours.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cotrimoxazole tablet: over 12 years",
        "instructions": []
      },
      {
        "medication_type": "For mild to moderate infections",
        "information": ": 2 tablets twice daily.",
        "instructions": []
      },
      {
        "medication_type": "For severe infections",
        "information": ": 2 tablets thrice daily.",
        "instructions": []
      },
      {
        "medication_type": "Long term therapy",
        "information": ": (>14 days): 1 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cotrimoxazole suspension: Under 12 years",
        "instructions": []
      },
      {
        "medication_type": "6-12 years",
        "information": ": 2 teaspoonful twice daily.",
        "instructions": []
      },
      {
        "medication_type": "6 month-5 years",
        "information": ": 1 teaspoonful twice daily.",
        "instructions": []
      },
      {
        "medication_type": "6 weeks-6 months",
        "information": ": 0.5 teaspoonful twice daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:04.505Z",
    "medicine_id": "68c3c09aef5b8f2b163a8da8",
    "original_record": {
      "input_index": 795,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8da8"
        },
        "name": "Alcot",
        "strength": "800 mg+160 mg",
        "generic": "Sulphamethoxazole + Trimethoprim",
        "company": "Pacific Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/29873/alcot-800-mg-tablet",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/269/alda-200-mg-suspension",
    "name": "Alda",
    "dosage_form": "Oral Suspension",
    "generic": "Albendazole",
    "strength": "200 mg/5 ml",
    "company": "Supreme Pharmaceutical Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "10 ml bottle",
          "price": "৳ 15.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "400 mg (Chew. Tablet)",
        "href": "https://medex.com.bd/brands/270/alda-ds-400-mg-chewable-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alda is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Alda, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Alda should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Alda is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Alda exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Alda is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:05.600Z",
    "medicine_id": "68c3c09aef5b8f2b163a8da9",
    "original_record": {
      "input_index": 796,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8da9"
        },
        "name": "Alda",
        "strength": "200 mg/5 ml",
        "generic": "Albendazole",
        "company": "Supreme Pharmaceutical Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/269/alda-200-mg-suspension",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/271/aldaben-200-mg-suspension",
    "name": "Aldaben",
    "dosage_form": "Oral Suspension",
    "generic": "Albendazole",
    "strength": "200 mg/5 ml",
    "company": "Ad-din Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 20.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "10 ml bottle",
          "price": "৳ 20.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "400 mg (Chew. Tablet)",
        "href": "https://medex.com.bd/brands/272/aldaben-ds-400-mg-chewable-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aldaben is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Aldaben, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Aldaben should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Aldaben is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Aldaben exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Aldaben is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:06.900Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dab",
    "original_record": {
      "input_index": 797,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dab"
        },
        "name": "Aldaben",
        "strength": "200 mg/5 ml",
        "generic": "Albendazole",
        "company": "Ad-din Pharmaceuticals Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/271/aldaben-200-mg-suspension",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/21490/aldopa-250-mg-tablet",
    "name": "Aldopa",
    "dosage_form": "Tablet",
    "generic": "Levodopa + Carbidopa",
    "strength": "250 mg+25 mg",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 11.80",
      "strip_price": "৳ 118.00",
      "pack_size_info": "(5 x 10: ৳ 590.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 11.80",
          "pack_size_info": "(5 x 10: ৳ 590.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 118.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "100 mg+10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/21489/aldopa-100-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/199/levodopa-carbidopa/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aldopa tablet is indicated for the treatment of Parkinson's disease and syndrome. It is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. This tablet is frequently helpful in the management of tremor, dysphagia, sialorrhea and postural instability associated with Parkinson's disease and syndrome. Levodopa plus carbidopa before physiotherapy increases motor recovery after stroke.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Levodopa, the metabolic precursor of dopamine, crosses the blood-brain barrier and is converted to dopamine in the brain. Carbidopa is a dopa decarboxylase (DDC) inhibitor which reduces the peripheral metabolism of Levodopa to dopamine, and thus, more Levodopa becomes available to the brain.",
        "items": []
      },
      {
        "title": "Levodopa",
        "information": ": Levodopa is the metabolic precursor of dopamine, does cross the blood-brain barrier, and presumably is converted to dopamine in the brain. This is thought to be the mechanism whereby levodopa relieves symptoms of Parkinson's disease.",
        "items": []
      },
      {
        "title": "Carbidopa",
        "information": ": When levodopa is administered orally, it is rapidly decarboxylated to dopamine in extracerebral tissues so that only a small portion of a given dose is transported unchanged to the central nervous system. Carbidopa inhibits the decarboxylation of peripheral levodopa, making more levodopa available for delivery to the brain.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Symptomatic postural hypotension has occurred when Carbidopa-Levodopa is added to the treatment of a patient receiving antihypertensive medicines. Therefore, when therapy with CarbidopaLevodopa is started, dosage adjustment of the antihypertensive medicine may be required. There have been rare reports of adverse reactions, including hypertension and dyskinesia, resulting from the concomitant use of tricyclic antidepressants and Carbidopa-Levodopa. Studies demonstrate a decrease in the bioavailability of Carbidopa and/or Levodopa when it is ingested with ferrous sulphate or ferrous gluconate. Dopamine-2 receptor antagonists (e.g., phenothiazines, butyrophenones and risperidone) and isoniazid may reduce the therapeutic effects of Levodopa. In addition, the beneficial effects of Levodopa in Parkinson's disease have been reported to be reversed by phenytoin and papaverine. Patients taking these medicines with Carbidopa-Levodopa should be carefully observed for loss of therapeutic response. Concomitant therapy with selegiline and Carbidopa-Levodopa may be associated with severe orthostatic hypotension not attributable to Carbidopa-Levodopa alone.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Carbidopa-Levodopa tablet is contraindicated in patients with hypersensitivity to Carbidopa and Levodopa, and in patients with narrow-angle glaucoma. Since Levodopa may activate a malignant melanoma, Carbidopa-Levodopa should not be used in patients with suspicious undiagnosed skin lesions or a history of melanoma.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Adverse effects that occur frequently in patients receiving Carbidopa-Levodopa are those due to the central neuropharmacologic activity of dopamine. These reactions usually can be diminished by dosage reduction. The most common adverse effects are dyskinesias including choreiform, dystonic, and other involuntary movements and nausea.",
        "items": [
          "Body as a whole: syncope, chest pain, anorexia.",
          "Cardiovascular: palpitation, orthostatic effects including hypotensive episodes, hypertension, phlebitis.",
          "Gastrointestinal: vomiting, gastrointestinal bleeding, development of duodenal ulcer, diarrhoea, dark saliva.",
          "Haemotologic: leukopenia, haemolytic and non-haemolytic anaemia, thrombocytopenia, agranulocytosis.",
          "Hypersensitivity: angioedema, urticaria, pruritus, Henoch-Schonlein purpura.",
          "Nervous System: dizziness, somnolence, paresthesia, delusions, hallucinations and paranoid ideation, depression with or without development of suicidal tendencies, dementia, dream abnormalities, agitation, confusion, increased libido.",
          "Respiratory: dyspnea.",
          "Skin: alopecia, rash, dark sweat.",
          "Urogenital: dark urine."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although the effects of CarbidopaLevodopa on human pregnancy are unknown both Levodopa and combinations of Carbidopa and Levodopa have caused visceral and skeletal malformations in rabbits. Therefore, use of CarbidopaLevodopa in women of childbearing potential requires that the anticipated benefits of the medicine be weighed against possible hazards should pregnancy occur. It is not known whether Carbidopa is excreted in human milk. Because many medicines are excreted in human milk and because of the potential for serious adverse reactions in infants, a decision should be made whether to discontinue nursing or to discontinue the use of Carbidopa-Levodopa, taking into account the importance of the medicine to the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Carbidopa-Levodopa is not recommended for the treatment of medicine-induced extrapyramidal reactions. Carbidopa Levodopa may be given to patients already taking Levodopa alone; however, the Levodopa must be discontinued at least 12 hours before Carbidopa-Levodopa started. Dyskinesias may occur in patients previously treated with Levodopa alone because Carbidopa permits more Levodopa to reach the brain and, thus, more dopamine to be formed. The occurrence of dyskinesias may require dosage reduction. All patients should be observed carefully for the development of depression with concomitant suicidal tendencies. Patients with past or current psychoses should be treated with caution. Carbidopa-Levodopa should be administered cautiously to patients with severe cardiovascular or pulmonary disease, bronchial asthma, renal, hepatic or endocrine disease, or a history of peptic ulcer disease or of convulsions. Care should be exercised to patients with a history of myocardial infarction who have atriai, nodal, or ventricular arrhythmia. In such patients, cardiac function should be monitored with particular care during the period of initial dosage administration and titration. Patients with chronic wide-angle glaucoma may be treated cautiously with Carbidopa-Levodopa, provided the intraocular pressure is weli controlled and the patient monitored carefully for changes in intraocular pressure during therapy.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Use in children",
        "information": ": Safety and effectiveness of Carbidopa-Levodopa in infants and children have not been established, and its use in patients below the age of 18 years is not recommended.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antiparkinson drugs",
    "dosage": [
      {
        "medication_type": "If 100/10 mg tablet is used",
        "information": ": Dosage may be initiated with one tablet three or four times a day. Titration upward may be required in some patients to achieve optimum dosage of carbidopa. The dosage may be increased by one tablet every day or every other day until a total of eight tablets (two tablets q.d.s.) is reached.",
        "instructions": []
      },
      {
        "medication_type": "For patients starting with 250/25 mg tablet",
        "information": ": The initial dose is one half taken once or twice daily. However, this may not provide the optimal amount of Carbidopa needed by many patients. If necessary, add one-half every day or every other day until optimal response is reached. The suggested starting dosage for most patients taking more than 1500 mg of Levodopa a day is one tablet of 250/25 mg three or four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Maintenance dose",
        "information": ": Therapy should be individualized and adjusted according to the desired therapeutic response. When more levodopa is requried, 250/25 mg tablet should be substituted at a dosage of one tablet three or four times a day. If necessary, the dosage of 250/25 mg tablet may be increased by half to one tablet every other day to a maximum of eight tablets a day. Experience with a total daily dosage greater than 200 mg Carbidopa is limited.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:08.646Z",
    "medicine_id": "68c3c09aef5b8f2b163a8db3",
    "original_record": {
      "input_index": 798,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8db3"
        },
        "name": "Aldopa",
        "strength": "250 mg+25 mg",
        "generic": "Levodopa + Carbidopa",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/21490/aldopa-250-mg-tablet",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30519/alendon-70-mg-tablet",
    "name": "Alendon",
    "dosage_form": "Tablet",
    "generic": "Alendronic acid",
    "strength": "70 mg",
    "company": "Beximco Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": "৳ 250.00",
      "pack_size_info": "(3 x 10: ৳ 750.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 25.00",
          "pack_size_info": "(3 x 10: ৳ 750.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 250.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/30518/alendon-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/30/alendronic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alendon is indicated for the- Alendon is indicated for the-",
        "items": [
          "Treatment of Osteoporosis in Postmenopausal Women: Alendon is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, Alendon increases bone mass and reduces the incidence of fractures, including those of the hip and spine.",
          "Treatment of Osteoporosis in Postmenopausal Women: Alendon is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, Alendon increases bone mass and reduces the incidence of fractures, including those of the hip and spine.",
          "Prevention of Osteoporosis in Postmenopausal Women: Alendon is indicated for the prevention of postmenopausal osteoporosis.",
          "Treatment to Increase Bone Mass in Men with Osteoporosis: Alendon is indicated for treatment to increase bone mass in men with osteoporosis.",
          "Treatment of Glucocorticoid-Induced Osteoporosis: Alendon is indicated for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density.",
          "Treatment of Paget's Disease of Bone: Alendon is indicated for the treatment of Paget’s disease of bone in men and women. Treatment is indicated in patients with Paget's disease of bone who have alkaline phosphatase at least two times the upper limit of normal, or those who are symptomatic, or those at risk for future complications from their disease."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alendronate is a bisphosphonate that binds to bone hydroxyapatite and specifically inhibits the activity of osteoclasts, the bone-resorbing cells. Alendronate reduces bone resorption with no direct effect on bone formation, although the latter process is ultimately reduced because bone resorption and formation are coupled during bone turnover. Animal studies have indicated the following mode of action. At the cellular level, alendronate shows preferential localization to sites of bone resorption, specifically under osteoclasts. The osteoclasts adhere normally to the bone surface but lack the ruffled border that is indicative of active resorption. Alendronate does not interfere with osteoclast recruitment or attachment, but it does inhibit osteoclast activity. Studies in mice on the localization of radioactive [3H] alendronate in bone showed about 10-fold higher uptake on osteoclast surfaces than on osteoblast surfaces. Bones examined 6 and 49 days after [3H] alendronate administration in rats and mice, respectively, showed that normal bone was formed on top of the alendronate, which was incorporated inside the matrix. While incorporated in bone matrix, alendronate is not pharmacologically active. Thus, alendronate must be continuously administered to suppress osteoclasts on newly formed resorption surfaces. Histomorphometry in baboons and rats showed that alendronate treatment reduces bone turnover (i.e., the number of sites at which bone is remodeled). In addition, bone formation exceeds bone resorption at these remodeling sites, leading to progressive gains in bone mass.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The incidence of upper gastrointestinal side effects are increased with the concomitant use of non-steroidal anti-inflammatory agents and aspirin. Absorption of Alendronate is reduced in the presence of antacids and calcium supplements.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Alendronic acid is contraindicated in patients with the following conditions:",
        "items": [
          "Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia.",
          "Inability to stand or sit upright for at least 30 minutes.",
          "Do not administer Alendronic acid oral solution to patients at increased risk of aspiration.",
          "Hypocalcemia.",
          "Hypersensitivity to any component of this product. Hypersensitivity reactions including urticaria and angioedema have been reported."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The commonest symptomatic side effects are constipation, diarrhoea, oesophageal ulcer, flatulence, dysphagia, musculoskeletal pain, headache, rarely rash, erythema, transient decrease in serum calcium and phosphate, nausea, vomiting, peptic ulceration, hypersensitivity reactions including urticaria and angio-oedema.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Alendronic acid should not be given to pregnant women or nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Upper Gastrointestinal Adverse Reactions can occur. Instruct patients to follow dosing instructions. Discontinue if new or worsening symptoms occur.",
          "Hypocalcemia can worsen and must be corrected prior to use.",
          "Severe Bone, Joint, Muscle Pain may occur. Discontinue use if severe symptoms develop.",
          "Osteonecrosis of the Jaw has been reported.",
          "Atypical Femur Fractures have been reported. Patients with new thigh or groin pain should be evaluated to rule out an incomplete femoral fracture."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Alendon is not indicated for use in pediatric patients.",
        "items": []
      },
      {
        "title": "Renal Impairment",
        "information": ": Alendon is not recommended for patients with creatinine clearance less than 35 mL/min. No dosage adjustment is necessary in patients with creatinine clearance values between 35-60 mL/min.",
        "items": []
      },
      {
        "title": "Hepatic Impairment",
        "information": ": As there is evidence that alendronate is not metabolized or excreted in the bile, no studies were conducted in patients with hepatic impairment. No dosage adjustment is necessary.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a well-closed container at room temperature, 15-30°C",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Bisphosphonate preparations",
    "dosage": [
      {
        "medication_type": "Treatment of Osteoporosis in Postmenopausal Women",
        "information": ": The recommended dosage is one 70 mg tablet once weekly or one bottle of 70 mg oral solution once weekly or one 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "Prevention of Osteoporosis in Postmenopausal Women",
        "information": ": The recommended dosage is one 35 mg tablet once weekly or one 5 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "Treatment to Increase Bone Mass in Men with Osteoporosis",
        "information": ": The recommended dosage is one 70 mg tablet once weekly or one bottle of 70 mg oral solution once weekly or one 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "Treatment of Glucocorticoid-Induced Osteoporosis",
        "information": ": The recommended dosage is one 5 mg tablet once daily, except for postmenopausal women not receiving estrogen, for whom the recommended dosage is one 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "Treatment of Paget's Disease of Bone",
        "information": ": The recommended treatment regimen is 40 mg once a day for six months.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:10.203Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dbb",
    "original_record": {
      "input_index": 799,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dbb"
        },
        "name": "Alendon",
        "strength": "70 mg",
        "generic": "Alendronic acid",
        "company": "Beximco Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/30519/alendon-70-mg-tablet",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12066/alerfex-120-mg-tablet",
    "name": "Alerfex",
    "dosage_form": "Tablet",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "120 mg",
    "company": "Kumudini Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 9.00",
      "strip_price": "৳ 90.00",
      "pack_size_info": "(3 x 10: ৳ 270.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 9.00",
          "pack_size_info": "(3 x 10: ৳ 270.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 90.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "30 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/12067/alerfex-30-mg-suspension?ref=1"
      },
      {
        "text": "180 mg (Tablet)",
        "href": "https://medex.com.bd/brands/34516/alerfex-180-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alerfex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alerfex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alerfex improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alerfex is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alerfex significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alerfex improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alerfex does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alerfex with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alerfex caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alerfex and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alerfex should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alerfex tablets will produce an effect on the ability to drive or use machines. In objective tests, Alerfex has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alerfex. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alerfex has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alerfex from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alerfex 120 mg Tablet?",
        "answer": [
          "Alerfex 120 mg Tablet is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alerfex 120 mg Tablet?",
        "answer": [
          "Alerfex 120 mg Tablet is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alerfex 120 mg Tablet?",
        "answer": [
          "Alerfex 120 mg Tablet has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alerfex 120 mg Tablet?",
        "answer": [
          "Alerfex 120 mg Tablet should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alerfex 120 mg Tablet make you sleepy?",
        "answer": [
          "Yes, Alerfex 120 mg Tablet can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alerfex 120 mg Tablet?",
        "answer": [
          "Do not take an overdose of Alerfex 120 mg Tablet as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alerfex 120 mg Tablet work?",
        "answer": [
          "Alerfex 120 mg Tablet starts working within 1 hour of consuming it. The peak benefit of Alerfex 120 mg Tablet is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alerfex 120 mg Tablet relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alerfex 120 mg Tablet can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alerfex 120 mg Tablet?",
        "answer": [
          "Take some rest after taking Alerfex 120 mg Tablet if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alerfex 120 mg Tablet?",
        "answer": [
          "Alerfex 120 mg Tablet should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alerfex 120 mg Tablet."
        ]
      },
      {
        "question": "How should I take Alerfex 120 mg Tablet?",
        "answer": [
          "Alerfex 120 mg Tablet should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alerfex 120 mg Tablet?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alerfex 120 mg Tablet."
        ]
      },
      {
        "question": "Can Alerfex 120 mg Tablet cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alerfex 120 mg Tablet is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alerfex 120 mg Tablet is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alerfex 120 mg Tablet with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alerfex 120 mg Tablet may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alerfex 120 mg Tablet. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:11.452Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dc6",
    "original_record": {
      "input_index": 800,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dc6"
        },
        "name": "Alerfex",
        "strength": "120 mg",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Kumudini Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12066/alerfex-120-mg-tablet",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12188/aleze-10-mg-tablet",
    "name": "Aleze",
    "dosage_form": "Tablet",
    "generic": "Loratadine",
    "strength": "10 mg",
    "company": "UniMed UniHealth Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 3.50",
      "strip_price": "৳ 35.00",
      "pack_size_info": "(5 x 10: ৳ 175.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.50",
          "pack_size_info": "(5 x 10: ৳ 175.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 35.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/12189/aleze-5-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/696/loratadine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aleze tablet provides fast, effective relief from the symptoms of seasonal allergic rhinitis, perennial allergic rhinitis and skin allergies including chronic urticaria. It is also effective in alleviating symptoms of allergic rhinitis such as sneezing, nasal discharge, itching, ocular itching ... Read moreAleze tablet provides fast, effective relief from the symptoms of seasonal allergic rhinitis, perennial allergic rhinitis and skin allergies including chronic urticaria. It is also effective in alleviating symptoms of allergic rhinitis such as sneezing, nasal discharge, itching, ocular itching and burning. Nasal and ocular sign and symptoms are relieved rapidly after oral administration. Aleze tablet is also indicated in idiopathic urticaria. In children over 2 years Aleze tablet is indicated for the symptomatic relief of seasonal allergic rhinitis and allergic skin conditions such as urticaria, nettlerash.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This tablet is a preparation of Loratadine. Loratadine is a non-sedative histamine Hr receptor antagonist with antiallergic properties. Loratadine is a long-acting tricyclic antihistamine with selective peripheral Hi-receptor antagonistic activity and no central sedative or anticholinergic effect. It is rapidly effective and long-lasting, allowing once-a-day administration.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "There are no reports of potentially hazardous interactions with other drugs. In contrast to many other histamine H1 receptor antagonists, Aleze has no potentiating effects when administered concurrently with alcohol, as measured by psychomotor performance studies. Concomitant therapy with drugs that inhibit or are metabolized by hepatic cytochromes P450 3A4 and 2D6 may elevate plasma concentrations of either drug and this mayifesult in adverse effects. Cimetidine inhibits both enzymes while erythromycin or ketoconazole inhibits P450 3A4. These drugs increase Aleze serum concentrations but no adverse effects are reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Loratadine is contraindicated in patients who have shown hypersensitivity or idiosyncrasy to their components.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "During controlled clinical studies the incidence of adverse events, including sedation and anticholinergic effects observed with 10 mg Aleze was comparable to that observed with placebo. Studies on the effect of Aleze on actual driving performance, and on tests of cognitive and psychomotor functioning have shown it to be comparable to placebo.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There is no experience of the use of Loratadine in human pregnancy. Therefore its use during pregnancy is not advisable. Loratadine is excreted in breast milk in a very small amount. So nursing mothers are advised not to take the drug.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be taken in patients with liver impairment or renal insufficiency (eGFR <30 ml/min).",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In adults somnolence, tachycardia and headache have been reported with overdose greater than 10 mg. Extrapyramidal signs and palpitations have been reported in children with overdoses of greater than 10 mg. In the event of overdosage, general symptomatic and supportive measures should be instituted promptly and maintained for as long as necessary. It would seem reasonable to treat patients presenting early after large overdoses with oral activated charcoal. The conscious patients may be induced to vomit or gastric lavage may be performed.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Adults and children over 12 years of age",
        "information": ": One Loratadine tablet once daily. It is usually administered in the morning or when symptoms require treatment.",
        "instructions": []
      },
      {
        "medication_type": "Children 2-12 years",
        "information": ": Body weight over 30 kg: one Loratadine tablet once daily, below 30 kg: half Loratadine tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "Below 2 years of age",
        "information": ": Loratadine tablet is not recommended for use below 2 years of age since safety and efficacy has not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:12.473Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dd7",
    "original_record": {
      "input_index": 801,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dd7"
        },
        "name": "Aleze",
        "strength": "10 mg",
        "generic": "Loratadine",
        "company": "UniMed UniHealth Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12188/aleze-10-mg-tablet",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/38219/alfagon-150-iu-injection",
    "name": "Alfagon",
    "dosage_form": "SC Injection",
    "generic": "Recombinant Follicle Stimulating Hormone",
    "strength": "150 IU/pre-filled syringe",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 3,000.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "150 IU pre-filled syringe",
          "price": "৳ 3,000.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "75 IU/pre-filled syringe (Injection)",
        "href": "https://medex.com.bd/brands/38218/alfagon-75-iu-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1610/recombinant-follicle-stimulating-hormone-rfsh/brand-names",
    "indications": [
      {
        "title": null,
        "information": "In the Female: In the Female: In the Male: Male infertility treatment in combination with HCG Induction of Spermatogenesis in men deficient spermatogenesis due to Hypogonadotrophic-hypogonadism.",
        "items": [
          "Ovulation Induction: rFSH administered SC with HCG in a sequential manner, which is indicated for ovulation induction in patients who have previously received pituitary suppression.",
          "Multi-follicular Development: During ART: rFSH administered SC in conjunction with HCG is indicated for multiple follicular developments (controlled ovarian stimulation) during ART cycles in patients who have previously received pituitary suppression.",
          "Ovulation Induction: rFSH administered SC with HCG in a sequential manner, which is indicated for ovulation induction in patients who have previously received pituitary suppression.",
          "Multi-follicular Development: During ART: rFSH administered SC in conjunction with HCG is indicated for multiple follicular developments (controlled ovarian stimulation) during ART cycles in patients who have previously received pituitary suppression.",
          "Polycystic Ovarian Syndrome (PCOS): Used to treat Polycystic Ovarian Syndrome (PCOS) related infertility"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "rFSH is a Follicle Stimulating Hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, nonidentical glycoproteins designated as the α- and β subunits. The α- and β-subunits have 92 and 111 amino acids respectively, and their primary and tertiary structure are indistinguishable from those of human Follicle Stimulating Hormone. Recombinant FSH production occurs in genetically modified Chinese Hamster Ovary (CHO) cells cultured in bioreactors. Purification by immunochromatography using an antibody specifically binding FSH results in a highly purified preparation with a consistent FSH isoform profile and a high specific activity. The biological activity of rFSH is determined by measuring the increase in ovary weight in female rats. The in vivo biological activity of rFSH has been calibrated against the first International Standard for Recombinant Human Follicle Stimulating Hormone established in 1995 by the Expert Committee on Biological Standards of the World Health Organization. rFSH contains no Luteinizing Hormone (LH) activity.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Tumors of the ovary, breast, uterus, pituitary or hypothalamus",
          "Pregnancy or lactation",
          "Undiagnosed vaginal bleeding",
          "Hypersensitivity to the active substance or to any of the excipients",
          "Primary ovarian failure",
          "Fibroid tumors of the uterus incompatible with pregnancy",
          "Primary testicular failure."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Alfagon FSH sometimes excites the ovaries too much. This may cause pelvic pain or breathing problems. It may also make you urinate less. In rare cases, patients with this problem have had serious lung problems, including fluid in the lungs, troublebreathing, and worsening of asthma blood clots, Severe Pelvic pain, Chest pain, or Abdominal pain, Nausea, Vomiting, Sudden weight gain, Bloating, Trouble, Breathing. Alfagon FSH may cause twins or multiple births.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy category X. Recombinant FSH must not be used during pregnancy and lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "The presence of uncontrolled non gonodal endocrinopathies (e.g. thyroid, adrenal or pituitary disorders) should be excluded.",
          "In pregnancies occurring after induction of ovulation with gonadotrophin preparations, there is an increased risk of multiple gestations (Multiple birth).",
          "There has been no reports of hypersensitivity to Alfagon FSH, but there remains the possibility of anaphylactic responses.",
          "The first injection of Alfagon FSH should be performed under direct medical supervision.",
          "Since infertile women undergoing assisted reproduction and particularly IVF, often have tubal abnormalities the incidence of ectopic pregnancies might be increased. Early ultrasound confirmation that a pregnancy is intrauterine is therefore important.",
          "Rates of pregnancy loss in women undergoing assisted reproduction techniques are higher than in the normal population.",
          "Unwanted ovarian hyperstimulation in the treatment of female patients, ultrasonographic assessment of follicular development, and determination of oestradiol levels should be performed prior to treatment and at regular intervals during treatment. Apart from the development of a high number of follicles, oestradiol levels may rise very rapidly, e.g. more than a daily doubling for two or three consecutive days, and possibly reaching excessively high values. The diagnosis of ovarian hyperstimulation may be confirmed by ultrasound examination. If this unwanted ovarian hyperstimulation occurs (i.e. not as part of controlled ovarian hyperstimulation in medically assisted reproduction programs), the administration of Alfagon FSH should be discontinued. In that case pregnancy should be avoided and HCG must be withheld, because it may induce in addition to multiple ovulation, the Ovarian Hyperstimulation Syndrome (OHSS).",
          "In men, semen analysis is recommended 4 to 6 months after the beginning of treatment in assessing the response."
        ]
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "No data on acute toxicity of Alfagon FSH in humans is available, but the acute toxicity of Alfagon FSH and of urinary gonadotrophin preparations in animal studies have been shown to be very low. Too high a dosage of Alfagon FSH may lead to hyperstimulation of the ovaries",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at 2°C-8°C (in refrigerator). Do not keep in deep freeze. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "rFSH administered for 7 to 12 days produces ovarian follicular growth in women who do not have primary ovarian failure. Treatment with rFSH in most instances results only in follicular growth and maturation. When sufficient follicular maturation has occurred, HCG must be given to induce ovulation.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Infertility, Trophic Hormones & Related Synthetic Drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "To prevent painful injections and minimize leakage from the injection site rFSH should be slowly administered subcutaneously. The subcutaneous injection site should be alternated to prevent lipoathrophy. Any unused solution should be discarded. Subcutaneous injection of rFSH may be carried out by patient or partner, provided that proper instructions are given by the physician. Self-administration of rFSH should only be performed by patients who are well motivated, adequately trained and with access to expert advice.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Female:",
        "information": "There are great inter and intra-individual variations in the response of the ovaries to exogenous gonadotrophins. This makes it impossible to set an uniform dosage scheme. The dosage should, therefore, be adjusted individually depending on the ovarian response. This requires ultrasonography and monitoring of estradiol levels. There should be consideration to minimize the risk of unwanted ovarian hyperstimulation. rFSH can be given either alone, or in combination with a GnRH analogue to prevent premature luteinisation. In the latter case, especially when using a GnRH agonist, a higher total treatment dose of rFSH may be required to achieve an adequate follicular response. Clinical experience with rFSH is based on up to three treatment cycles in both indications. Overall experience with IVF indicates that in general the treatment success rate remains stable during the first four attempts and gradually declines thereafter.",
        "instructions": []
      },
      {
        "medication_type": "Ovulation Induction in Women",
        "information": ": Starting daily dose of 75 international units (IU) of rFSH is administered subcutaneously or subcutaneous for at least the first 7 days. The dose is increased by 25 or 75 international units (IU) at weekly intervals until follicular growth and/or serum estradiol levels indicate an adequate response. When an acceptable pre-ovulatory state is achieved, final oocyte maturation is achieved with 5000 to 10,000 international units (IU) of human chorionic gonadotropin (HCG). The woman and her partner should have intercourse daily, beginning on the day prior to the administration of HCG and until ovulation becomes apparent.",
        "instructions": []
      },
      {
        "medication_type": "Assisted Reproductive Technology (ART)",
        "information": ": In Women, Starting dose of 150 to 300 international units (IU) of rFSH is administered subcutaneous for at least the first 4 days of treatment. Subsequent doses are adjusted based upon ovarian response as determined by ultrasound evaluation of follicular growth and serum estradiol levels. Final oocyte maturation is induced with a dose of 5000-10000 international units of HCG Oocyte (egg) retrieval is performed 34 to 36 hours later.",
        "instructions": []
      },
      {
        "medication_type": "PCOS",
        "information": ": rFSH injections are therefore given each morning as a subcutaneous injection. It is best to start with the lowest dose of rFSH per day (using 75 IU per day). These doses are used for 4 to 6 days at a time. The ovarian response is determined by measuring estrogen levels in the blood. When the estrogen begins to rise, the rFSH is successfully growing an egg or eggs. If there is no response to a dose of rFSH in 5-6 days of injections the dose will be increased. The normal dose increments are 75 units, 100 units, 150 units and 300 units per day. Most patients respond with 75 IU to 150 IU per day. However it is very important that increments are only made cautiously.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Male",
        "information": ": Induction of Spermatogenesis in Men: Pre-treatment with HCG alone (2500 international units twice weekly) is required. If serum testosterone levels have not normalized after 8 weeks of HCG treatment, the dose may be increased to 5000 international units (IU) twice a week. After normalization of serum testosterone levels, administer 300 international units (IU) per week (300 international units twice weekly or 100 international units three times weekly) of rFSH subcutaneously with the same pre-treatment HCG dose used to normalize testosterone level.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:13.522Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dda",
    "original_record": {
      "input_index": 802,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dda"
        },
        "name": "Alfagon",
        "strength": "150 IU/pre-filled syringe",
        "generic": "Recombinant Follicle Stimulating Hormone (rFSH)",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "SC Injection",
        "source_url": "https://medex.com.bd/brands/38219/alfagon-150-iu-injection",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/27584/alfavir-25-mg-tablet",
    "name": "Alfavir",
    "dosage_form": "Tablet",
    "generic": "Tenofovir Alafenamide",
    "strength": "25 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 90.00",
      "strip_price": "৳ 900.00",
      "pack_size_info": "(2 x 10: ৳ 1,800.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 90.00",
          "pack_size_info": "(2 x 10: ৳ 1,800.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 900.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1357/tenofovir-alafenamide/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alfavir is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Tenofovir alafenamide is a phosphonamidate prodrug of tenofovir (2’-deoxyadenosine monophosphate analog). Tenofovir alafenamide as a lipophilic cell-permeant compound enters primary hepatocytes by passive diffusion and by the hepatic uptake transporters OATP1B1 and OATP1B3. Tenofovir alafenamide is then converted to tenofovir through hydrolysis primarily by carboxylesterase 1 (CES1) in primary hepatocytes. Intracellular tenofovir is subsequently phosphorylated by cellular kinases to the pharmacologically active metabolite tenofovir diphosphate. Tenofovir diphosphate inhibits HBV replication through incorporation into viral DNA by the HBV reverse transcriptase, which results in DNA chain termination. Tenofovir diphosphate is a weak inhibitor of mammalian DNA polymerases that include mitochondrial DNA polymerase γ and there is no evidence of toxicity to mitochondria in cell culture.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Potential for Other Drugs to Affect Alfavir",
        "information": ": Alfavir is a substrate of P-glycoprotein (P-gp) and BCRP. Drugs that strongly affect P-gp and BCRP activity may lead to changes in Alfavir absorption. Drugs that induce P-gp activity are expected to decrease the absorption of Alfavir resulting in decreased plasma concentrations of Alfavir which may lead to loss of therapeutic effect of Alfavir. Coadministration of Alfavir with other drugs that inhibit P-gp and BCRP may increase the absorption & plasma concentration of Alfavir.",
        "items": []
      },
      {
        "title": "Drugs Affecting Renal Function",
        "information": ": Alfavir is primarily excreted by the kidneys by a combination of glomerular filtration and active tubular secretion, coadministration of Alfavir with drugs that reduce renal function or compete for active tubular secretion may increase concentrations of tenofovir and other renally eliminated drugs and this may increase the risk of adverse reactions. Some examples of drugs that are eliminated by active tubular secretion include but are not limited to acyclovir, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin) and high-dose or multiple NSAIDs.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "The following adverse reactions are discussed in other sections of the labeling: The most common side effects are headache, stomach pain, tiredness, cough, nausea, back pain",
        "items": [
          "Lactic Acidosis/Severe Hepatomegaly with Steatosis",
          "Severe Acute Exacerbation of Hepatitis B",
          "New Onset or Worsening of Renal Impairment"
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Based on prospective reports to the APR of over 660 exposures to TAF-containing regimens during pregnancy resulting in live births (including over 520 exposed in the first trimester and over 130 exposed in the second/third trimester), the prevalence of birth defects in live births was 4.2% (95% CI: 2.6% to 6.3%) and 3.0% (95% CI: 0.8% to 7.5%) following first and second/third trimester exposure, respectively, to TAF-containing regimens. Methodologic limitations of the APR include the use of MACDP as the external comparator group. The MACDP population is not disease-specific, evaluates women and infants from a limited geographic area, and does not include outcomes for births that occurred at less than 20 weeks gestation.",
        "items": []
      },
      {
        "title": "Lactation",
        "information": ": It is not known whether Tenofovir alafenamide & its metabolites are present in human breast milk, affect human milk production or have effects on the breastfed infant. Tenofovir has been shown to be present in the milk of lactating rats and rhesus monkeys after administration of TDF. It is not known if tenofovir alafenamide can be present in animal milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Tenofovir alafenamide and any potential adverse effects on the breastfed infant from Tenofovir alafenamide or from the underlying maternal condition.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Severe Acute Exacerbation of Hepatitis B after Discontinuation of Treatment",
        "information": ": Discontinuation of anti-hepatitis B therapy, including Alfavir may result in severe acute exacerbations of hepatitis B. Patients who discontinue Alfavir should be closely monitored with both clinical and laboratory follow-up for at least several months after stopping treatment. If appropriate resumption of antihepatitis B therapy may be warranted.",
        "items": []
      },
      {
        "title": "Risk of Development of HIV-1 Resistance in Patients Coinfected with HBV and HIV-1",
        "information": ": Due to the risk of development of HIV-1 resistance Alfavir alone is not recommended for the treatment of HIV-1 infection. The safety and efficacy of Alfavir have not been established in patients coinfected with HBV and HIV-1. HIV antibody testing should be offered to all HBV-infected patients before initiating therapy with Alfavir and if positive, an appropriate antiretroviral combination regimen that is recommended for patients coinfected with HIV-1 should be used.",
        "items": []
      },
      {
        "title": "New Onset or Worsening Renal Impairment",
        "information": ": Postmarketing cases of renal impairment, including acute renal failure, proximal renal tubulopathy (PRT) and Fanconi syndrome have been reported with TAF-containing products; while most of these cases were characterized by potential confounders that may have contributed to the reported renal events, it is also possible these factors may have predisposed patients to tenofovir- related adverse events. Patients taking tenofovir prodrugs who have impaired renal function and those taking nephrotoxic agents, including non-steroidal anti-inflammatory drugs, are at increased risk of developing renal-related adverse reactions. Prior to or when initiating Alfavir and during treatment with Alfavir on a clinically appropriate schedule, assess serum creatinine, estimated creatinine clearance, urine glucose and urine protein in all patients. In patients with chronic kidney disease, also assess serum phosphorus. Discontinue Alfavir in patients who develop clinically significant decreases in renal function or evidence of Fanconi syndrome.",
        "items": []
      },
      {
        "title": "Lactic Acidosis/Severe Hepatomegaly with Steatosis",
        "information": ": Lactic acidosis and severe hepatomegaly with steatosis including fatal cases have been reported with the use of nucleoside analogs including tenofovir disoproxil fumarate (TDF) another prodrug of tenofovir alone or in combination with other antiretrovirals. Treatment with Alfavir should be suspended in any patient who develops clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity (which may include hepatomegaly and steatosis even in the absence of marked transaminase elevations).",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "If overdose occurs, monitor patient for evidence of toxicity. Treatment of overdosage with Alfavir consists of general supportive measures including monitoring of vital signs as well as observation of the clinical status of the patient. Alfavir is efficiently removed by hemo- dialysis with an extraction coefficient of approximately 54%.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C. Keep it in its original container. protect from light. Keep out of children’s reach.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Hepatic viral infections (Hepatitis B)",
    "dosage": [
      {
        "medication_type": "Testing Prior to Initiation of Tenofovir alafenamide",
        "information": ": Prior to initiation of Tenofovir alafenamide, patients should be tested for HIV-1 infection. Tenofovir alafenamide alone should not be used in patients with HIV-1 infection.",
        "instructions": []
      },
      {
        "medication_type": "Recommended Dosage in Adults",
        "information": ": The recommended dosage of Tenofovir alafenamide is 25 mg (one tablet) taken orally once daily with food.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Patients with Renal Impairment",
        "information": ": No dosage adjustment of Tenofovir alafenamide is required in patients with estimated creatinine clearance greater than or equal to 15 ml per minute or in patients with end stage renal disease (ESRD; estimated creatinine clearance below 15 ml per minute) who are receiving chronic hemodialysis. On days of hemodialysis administer Tenofovir alafenamide after completion of hemodialysis treatment. Tenofovir alafenamide is not recommended in patients with ESRD who are not receiving chronic hemodialysis.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Patients with Hepatic Impairment",
        "information": ": No dosage adjustment of Tenofovir alafenamide is required in patients with mild hepatic impairment (Child-Pugh A). Tenofovir alafenamide is not recommended in patients with decompensated (Child-Pugh B or C) hepatic impairment.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric Use",
        "information": ": Safety and effectiveness of Tenofovir alafenamide in pediatric patients less than 18 years of age have not been established.",
        "instructions": []
      },
      {
        "medication_type": "Geriatric Use",
        "information": ": In clinical trials, Tenofovir alafenamide was administered to 89 subjects aged 65 and over. No clinically significant differences in safety or efficacy have been observed between elderly subjects and subjects between 18 and less than 65 years of age.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:15.019Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dde",
    "original_record": {
      "input_index": 803,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dde"
        },
        "name": "Alfavir",
        "strength": "25 mg",
        "generic": "Tenofovir Alafenamide",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/27584/alfavir-25-mg-tablet",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12069/alfex-30-mg-suspension",
    "name": "Alfex",
    "dosage_form": "Oral Suspension",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "30 mg/5 ml",
    "company": "Medicon Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 48.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "50 ml bottle",
          "price": "৳ 48.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "120 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12068/alfex-120-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alfex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alfex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alfex improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alfex is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alfex significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alfex improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alfex does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alfex with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alfex caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alfex and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alfex should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alfex tablets will produce an effect on the ability to drive or use machines. In objective tests, Alfex has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alfex. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alfex has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alfex from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alfex 30 mg/5 ml Suspension?",
        "answer": [
          "Alfex 30 mg/5 ml Suspension is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alfex 30 mg/5 ml Suspension?",
        "answer": [
          "Alfex 30 mg/5 ml Suspension is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alfex 30 mg/5 ml Suspension?",
        "answer": [
          "Alfex 30 mg/5 ml Suspension has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alfex 30 mg/5 ml Suspension?",
        "answer": [
          "Alfex 30 mg/5 ml Suspension should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alfex 30 mg/5 ml Suspension make you sleepy?",
        "answer": [
          "Yes, Alfex 30 mg/5 ml Suspension can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alfex 30 mg/5 ml Suspension?",
        "answer": [
          "Do not take an overdose of Alfex 30 mg/5 ml Suspension as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alfex 30 mg/5 ml Suspension work?",
        "answer": [
          "Alfex 30 mg/5 ml Suspension starts working within 1 hour of consuming it. The peak benefit of Alfex 30 mg/5 ml Suspension is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alfex 30 mg/5 ml Suspension relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alfex 30 mg/5 ml Suspension can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alfex 30 mg/5 ml Suspension?",
        "answer": [
          "Take some rest after taking Alfex 30 mg/5 ml Suspension if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alfex 30 mg/5 ml Suspension?",
        "answer": [
          "Alfex 30 mg/5 ml Suspension should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alfex 30 mg/5 ml Suspension."
        ]
      },
      {
        "question": "How should I take Alfex 30 mg/5 ml Suspension?",
        "answer": [
          "Alfex 30 mg/5 ml Suspension should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alfex 30 mg/5 ml Suspension?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alfex 30 mg/5 ml Suspension."
        ]
      },
      {
        "question": "Can Alfex 30 mg/5 ml Suspension cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alfex 30 mg/5 ml Suspension is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alfex 30 mg/5 ml Suspension is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alfex 30 mg/5 ml Suspension with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alfex 30 mg/5 ml Suspension may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alfex 30 mg/5 ml Suspension. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:16.180Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ddf",
    "original_record": {
      "input_index": 804,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ddf"
        },
        "name": "Alfex",
        "strength": "30 mg/5 ml",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Medicon Pharmaceuticals Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/12069/alfex-30-mg-suspension",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/17141/alfixim-400-mg-capsule",
    "name": "Alfixim",
    "dosage_form": "Capsule",
    "generic": "Cefixime Trihydrate",
    "strength": "400 mg",
    "company": "Allied Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 50.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 50.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "200 mg (Capsule)",
        "href": "https://medex.com.bd/brands/17140/alfixim-200-mg-capsule?ref=1"
      },
      {
        "text": "100 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/17142/alfixim-100-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/217/cefixime-trihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alfixim is an orally active cephalosporin antibiotic which has marked in-vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organism. It is indicated for the treatment of the following acute infections when caused by susceptible microorganisms.",
        "items": []
      },
      {
        "title": "Upper Respiratory Tract Infections (URTI)",
        "information": ": e.g. otitis media; and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. Lower Respiratory Tract Infections-e.g. bronchitis.",
        "items": []
      },
      {
        "title": "Urinary Tract Infections",
        "information": ": e.g. cystitis, cystourethritis, pyelonephritis. Clinical efficacy has been demonstrated in infections caused by commonly occurring pathogens including Streptococcus pneumonia, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella species, Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis (beta-lactamase positive and negative) and Enterobacter species. Alfixim is highly stable in the presence of beta-lactamase enzymes.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefixime is a third generation semisynthetic cephalosporin antibiotic for oral administration. It is bactericidal against a broad spectrum of gram positive and gram negative bacteria at easily achievable plasma concentrations. It kills bacteria by interfering in the synthesis of bacterial cell wall. It is highly stable in the presence of Beta-lactamase enzyme. As a result, many organisms resistant to penicillins and some cephalsporins due to the presence of beta-lactamases, may be susceptible to Cefixime. Absorption of it is about 40% to 50% whether administered with or without food.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "In common with other cephalosporins, increases in prothrombin times have been noted in a few patients. Care should therefore be taken in patients receiving anticoagulant therapy.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Patients with known hypersensitivity to cephalosporin antibiotics.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Alfixim is generally well tolerated. The majority of adverse reactions observed in clinical trials were mild and self limiting in nature. Gastrointestinal disturbances: The most frequent side-effects seen with Alfixim are diarrhoea and stool changes; diarrhoea has been more commonly associated with higher doses. Other gastrointestinal side-effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting and flatulence. Pseudomembraneous colitis has been reported. Central nervous system: headache and dizziness. Hypersensitivity reactions: allergies in the form of rash, pruritis, urticaria, drug fever and arthralgia have been observed. These reactions usually subsided upon discontinuation of therapy. Hematological and clinical chemistry: thrombocytopenia, leukopenia and eosinophilia have been reported. These reactions were infrequent and reversible. Mild transient change in liver and renal function tests have been observed. Miscellaneous: other possible reactions include genital pruritis and vaginitis.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. It is not known that Cefixime is excreted in human milk. So, caution should be exercised when Cefixime is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Alfixim should be given with caution to patients who have shown hypersensitivity to other drugs. Cephalosporin should be given with caution to penicillin-sensitive patients, as there is some evidence of partial cross-allergenicity between the penicillins and the cephalosporins. Patients have had severe reactions (including anaphylaxis) to both classes of drugs. If an allergic effect occurs with Alfixim, the drug should be discontinued and the patient treated with appropriate agents if necessary. Alfixim should be administered with caution in patients with markedly impaired renal function. Treatment with broad spectrum antibiotics alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is a primary cause of antibiotic-associated diarrhoea. Use in pregnancy and lactation: There are no adequate and well-controlled studies in pregnant women. Alfixim should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Gastric Lavage may be indicated; otherwise, no specific antidote exists. Alfixim is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of Alfixim did not differ from the profile seen in patients treated at the recommended doses.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30ºC temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C16H15N5O7S2",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-217-cefixime-trihydrate-chemical-structure-3Mg9h2a2PuSZaJk4Uj0Z.svg"
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Absorption of Cefixime is not significantly modified by the presence of food. The usual course of treatment is 7 days. This may be continued for up to 14 days if required.",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 10 years",
        "information": ": The recommended adult dosage is 200-400 mg daily according to the severity of the infection, given either as a single dose or in two divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": Elderly patients may be given the same dose as recommended for adults. Renal function should be assessed and dosage should be adjusted in severe renal impairment.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": The recommended dosage for children is 8 mg/kg/day administered as a single dose or in two divided doses. As a general guide for prescribing in children the following daily doses in terms of volume of suspension are suggested:",
        "instructions": [
          "6 months up to 1 year: 3.75 ml daily",
          "Children 1-4 years: 5 ml daily",
          "Children 5-10 years: 10 ml daily"
        ]
      },
      {
        "medication_type": "In typhoid",
        "information": ": the recommended children dose is 5 mg/kg body weight twice daily for 10-14 days.",
        "instructions": []
      },
      {
        "medication_type": "Children weighing more than 50 kg or older than 10 years",
        "information": ": Should be treated with the recommended adult dose 200-400 mg daily depending on the severity of infection.",
        "instructions": []
      },
      {
        "medication_type": "Children aged less than 6 months",
        "information": ": The safety and efficacy of Cefixime has not been established in children aged less than 6 months.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Renal Impairment",
        "information": ": Cefixime may be administered in the presence of impaired renal function. Normal dose and schedule may be given in patients with creatinine clearances of 20 ml/min or greater. In patients whose creatinine clearance is less than 20 ml/min, it is recommended that a dose of 200 mg once daily should not be exceeded. The dose and regimen for patients who are maintained on chronic ambulatory peritoneal dialysis or haemodialysis should follow the same recommendation as that for patients with creatinine clearances of less than 20 ml/min.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Alfixim 400 mg Capsule?",
        "answer": [
          "Alfixim 400 mg Capsule is an antibiotic used to treat bacterial infection. This medicine does not work for viral infections like flu. It works by preventing them from forming the bacterial protective covering (cell wall) which is essential for their development."
        ]
      },
      {
        "question": "What are the uses of Alfixim 400 mg Capsule?",
        "answer": [
          "Alfixim 400 mg Capsule is used for the treatment and prevention from conditions such as Urinary Tract Infection, Tonsillitis, Pharyngitis, and Bronchitis. Apart from these, it can also be used to treat conditions of Fungal and Gonococcal Infections."
        ]
      },
      {
        "question": "What are the Side Effects of Alfixim 400 mg Capsule?",
        "answer": [
          "Alfixim 400 mg Capsule has some commonly reported side effects. Some of these side-effects may be serious. These are Diarrhea, Abdominal pain, Dark or clay-colored stools, Swelling of the face, lips, eyelids, tongue, hands, and feet, Dizziness, Acid or sour stomach, excessive gas in the stomach, Heartburn, Indigestion, Redness of the skin, Chest pain, Sore throat, and Unusual tiredness."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alfixim 400 mg Capsule?",
        "answer": [
          "This medication should be kept in a cool dry place and in its original pack. Make sure Alfixim 400 mg Capsule remains unreachable to children and pets. Proper disposal of the expired and unused medications is important to avoid health problems."
        ]
      },
      {
        "question": "Will Alfixim 400 mg Capsule work for treating cold and flu?",
        "answer": [
          "This medication belongs to an antibiotic class of drugs, hence Alfixim 400 mg Capsule won't work for colds, flu, or other viral infections. If you use antibiotics when they are not needed, it increases your risk of getting an infection later that resists antibiotic treatment."
        ]
      },
      {
        "question": "Is there any special dietary instruction which I should follow?",
        "answer": [
          "Continue your normal diet unless your doctor asks you to change."
        ]
      },
      {
        "question": "Is Alfixim 400 mg Capsule can be used to treat diarrhoea?",
        "answer": [
          "No, Alfixim 400 mg Capsule is not prescribed to treat diarrhoea."
        ]
      },
      {
        "question": "Is it safe to give Alfixim 400 mg Capsule to infants?",
        "answer": [
          "The safety of Alfixim 400 mg Capsule, in case of newborns or infants aging less than 6 months, has not been positively established. Thus you need to consult a doctor before administering this medicine to an infant."
        ]
      },
      {
        "question": "Does Alfixim 400 mg Capsule is a penicillin variant?",
        "answer": [
          "No, Alfixim 400 mg Capsule is not a penicillin variant. This medication belongs to cephalosporin antibiotic and functions in a similar way to that of penicillin. Concurrent use of these two must be discussed with a doctor."
        ]
      },
      {
        "question": "Does Alfixim 400 mg Capsule cause loose-motion?",
        "answer": [
          "Diarrhoea is a known side effect of Alfixim 400 mg Capsule although it has been associated with higher doses only."
        ]
      },
      {
        "question": "Is constipation associated with Alfixim 400 mg Capsule?",
        "answer": [
          "Constipation is an unusual side effect of Alfixim 400 mg Capsule. In case, it causes persistent constipation and seems circumstantially related to the ingestion of this medication, must consult a doctor."
        ]
      },
      {
        "question": "Does Alfixim 400 mg Capsule interact with contraception?",
        "answer": [
          "No such evidence suggested the effect of Alfixim 400 mg Capsule on contraceptive medications."
        ]
      },
      {
        "question": "Can I take acetaminophen along with Alfixim 400 mg Capsule?",
        "answer": [
          "No interactions have been clinically proven between Alfixim 400 mg Capsule and Acetaminophen (Paracetamol). It is advisable to consult a doctor before concurrent use of these two medicines."
        ]
      },
      {
        "question": "How long does Alfixim 400 mg Capsule take to work?",
        "answer": [
          "Alfixim 400 mg Capsule start working as soon after you ingest it. However, it may take a few days to kill the harmful bacteria and relieve the symptoms completely. It is advised to complete the medication course for the suggested days."
        ]
      },
      {
        "question": "What if I do not get better after using Alfixim 400 mg Capsule?",
        "answer": [
          "Inform your doctor if you do not feel better even after finishing the full course of treatment. You must also inform your doctor if the symptoms get worse while using this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Your doctor has prescribed Alfixim 400 mg Capsule to cure your infection and improve your symptoms.",
          "Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection harder to treat.",
          "Take it with food to avoid an upset stomach.",
          "Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it does not stop or if you find blood in your stools.",
          "Avoid consuming alcohol while taking Alfixim 400 mg Capsule as it may cause increased side effects.",
          "Discontinue Alfixim 400 mg Capsule and inform your doctor immediately if you get a rash, itchy skin, swelling of face and mouth, or have difficulty in breathing."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:17.453Z",
    "medicine_id": "68c3c09aef5b8f2b163a8de3",
    "original_record": {
      "input_index": 805,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8de3"
        },
        "name": "Alfixim",
        "strength": "400 mg",
        "generic": "Cefixime Trihydrate",
        "company": "Allied Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/17141/alfixim-400-mg-capsule",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/29461/algecal-dx-600-mg-tablet",
    "name": "Algecal Dx",
    "dosage_form": "Tablet",
    "generic": "Algae Calcium + Vitamin D3",
    "strength": "600 mg+400 IU",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 16.00",
      "strip_price": "৳ 160.00",
      "pack_size_info": "(3 x 10: ৳ 480.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 16.00",
          "pack_size_info": "(3 x 10: ৳ 480.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 160.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "500 mg+200 IU (Tablet)",
        "href": "https://medex.com.bd/brands/28782/algecal-d-500-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1772/algae-calcium-vitamin-d3/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algecal Dx is indicated in following cases-",
        "items": [
          "Treatment of osteoporosis, rickets, osteomalacia, tetany and hypoparathyroidism",
          "In pregnancy and lactation due to increased demand",
          "In kidney disease and pancreatitis",
          "During therapy with antiseizure medications",
          "The prevention and treatment of Calcium and Vitamin D3 deficiency"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Calcium (Algae Source) is an essential element and plays vital role in the body. It makes body's framework stronger by building bones. Clinical evidence suggests that calcium is useful for prevention and treatment of osteoporosis and associated fractures. Vitamin D3 is also essential for healthy bones as it aids in calcium absorption from the Gl tract. In addition to this it stimulates bone formation. Controlled clinical studies show that Calcium and Vitamin D3 have synergistic effects on bone growth as well as in osteoporosis and fracture prevention.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "With medicine: With food and others: No clinically significant food drug interaction have been reported.",
        "items": [
          "Calcium salts reduce absorption of bisphosphonates, ciprofloxacin, fluorides, iron, levothyroxine, tetracycline and zinc",
          "Absorption of calcium salts is reduced by corticosteroids",
          "Increased risk of hypercalcemia when Calcium and Vitamin D3 given with thiazides and related diuretics"
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypocalcemia and hypercalciuria",
          "Metastatic calcification",
          "Hypersensitivity to any of the components of Calcium and Vitamin D3 preparation"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Common side effects of Calcium and Vitamin D3 may include an irregular heartbeat, nausea, dry mouth, weakness, headache, a metallic taste in mouth, muscle or bone pain and drowsiness. Rare side effects are high amount of Calcium in blood, constipation, diarrhoea, loss of appetite.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "During pregnancy & lactation: Calcium and Vitamin D3 should be used considering the risk-benefit ratio.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be taken in patients with renal impairment, sarcoidosis, hypercalcemia and hypercalciuria.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Not recommended for children under 12 years.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "At high doses it may result in nausea, vomiting, dizziness, anorexia, abdominal cramps, headache, constipation etc. Treatment includes cessation of therapy & adequate rehydration.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C and away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Specific mineral & vitamin combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Usual adult dose: 1 tablet in the morning and 1 tablet at night. Tablet should be taken orally.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:18.482Z",
    "medicine_id": "68c3c09aef5b8f2b163a8df0",
    "original_record": {
      "input_index": 806,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8df0"
        },
        "name": "Algecal Dx",
        "strength": "600 mg+400 IU",
        "generic": "Algae Calcium + Vitamin D3",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/29461/algecal-dx-600-mg-tablet",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/16685/algerd-500-mg-suspension",
    "name": "Algerd",
    "dosage_form": "Oral Suspension",
    "generic": "Sodium Alginate + Potassium Bicarbonate",
    "strength": "(500 mg+100 mg)/5 ml",
    "company": "Monicopharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 150.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "200 ml bottle",
          "price": "৳ 150.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/903/sodium-alginate-potassium-bicarbonate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algerd is indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus such as acid regurgitation, heartburn, indigestion for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux esophagitis, including ... Read moreAlgerd is indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus such as acid regurgitation, heartburn, indigestion for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux esophagitis, including symptoms of laryngopharyngeal reflux such as hoarseness and other voice disorders, sore throats and cough. Algerd can also be used to treat the symptoms of gastroesophageal reflux during concomitant treatment with or following the withdrawal of acid suppressing therapy.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the combination of Sodium Alginate and Potassium Bicarbonate. Sodium Alginate is a naturally occurring substance. It reacts with the acid in the stomach to form a gel. Potassium Bicarbonate also reacts with the acid in the stomach to form bubbles of carbon dioxide. These bubbles are trapped by the gel formed by Sodium Alginate and they allow the gel to float like a raft on top of the stomach contents. The raft prevents acid in the stomach from flowing back into the esophagus. This relieves the symptoms of reflux such as heartburn. The mode of action of this is physical and does not depend on absorption into the systemic circulation. The raft lasts for up to 4 hours on top of the stomach contents and is then broken down in the digestive system and excreted in the feces.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "A time interval of 2 hours should be considered between this intake and the administration of other medicinal products, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Sodium alginate and potassium bicarbonate is contraindicated in patients with known hypersensitivity to these.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In addition to the desired effect of the drug, some side effects may appear such as: nausea, constipation, diarrhea or headache. In these cases consult a physician In case too big dosage has been taken, there might appear a sensation of swelling. In this case it is advisable to consult a physician.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "This combination (Sodium Alginate and Potassium Bicarbonate) can be used during pregnancy, if clinically needed. No known effect on breast-fed infants. This combination can be used during breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Sodium Alginate and Potassium Bicarbonate should be prescribed with caution in patients with renal impairment and congestive cardiac failure. Care needs to be taken in treating patients with hypercalcemia, nephrocalcinosis and recurrent calcium-containing renal calculi. There is a possibility of reduced efficacy in patients with very low levels of gastric acid. If symptoms do not improve after seven days, the clinical situation should be reviewed.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Overdosage with this formulation is a rare case. In case of overdose please consult with a registered physician.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ":",
        "instructions": [
          "Adults and children over 12 years: 1-2 tablets 3-4 times daily, after meals and before bedtime.",
          "Children 6-12 years: ½-1 tablet 3-4 times daily, after meals and before bedtime."
        ]
      },
      {
        "medication_type": "Suspension",
        "information": ":",
        "instructions": [
          "Adults and children 12 years and above: 5-10 ml (1-2 teaspoonfuls) 3-4 times daily, after meals and before bedtime.",
          "Children 2-12 years: 2.5-5ml (½-1 teaspoonful) 3-4 times daily, after meals and before bedtime."
        ]
      },
      {
        "medication_type": "Use in children",
        "information": ": This is not recommended under 2 years of age.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": No dose modifications are necessary for this age group.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": No dose modifications are necessary.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": Caution if a highly restricted salt diet is necessary.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:19.456Z",
    "medicine_id": "68c3c09aef5b8f2b163a8df2",
    "original_record": {
      "input_index": 807,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8df2"
        },
        "name": "Algerd",
        "strength": "(500 mg+100 mg)/5 ml",
        "generic": "Sodium Alginate + Potassium Bicarbonate",
        "company": "Monicopharma Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/16685/algerd-500-mg-suspension",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31101/algicar-plus-500-mg-suspension",
    "name": "Algicar Plus",
    "dosage_form": "Oral Suspension",
    "generic": "Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate",
    "strength": "(500 mg+267 mg+160 mg)/10 ml",
    "company": "Techno Drugs Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 250.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "200 ml bottle",
          "price": "৳ 250.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1451/sodium-alginate-sodium-bicarbonate-calcium-carbonate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algicar Plus is indicated in-",
        "items": [
          "Gastric reflux",
          "Heartburn",
          "Indigestion",
          "Flatulence associated with gastric reflux",
          "Heartburn of pregnancy",
          "All cases of epigastric and retrosternal distress where the underlying cause is gastric reflux."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an alginate (Sodium alginate). The suspension work in two ways- The mode of action of the product is physical and does not depend on absorption into the systemic circulation. The product is a combination of two antacids (Calcium Carbonate and Sodium Bicarbonate) and an Alginate. On ingestion, the medicinal product reacts rapidly with gastric acid to form a raft of Alginic Acid gel having a near neutral pH and studies have shown that the raft interacts with and caps the acid pocket in the stomach, reducing esophageal acid exposure. The raft floats on the stomach contents effectively impeding gastro-esophageal reflux, for up to 4 hours, and protecting the esophagus from Acid, Pepsin and Bile.In severe cases the raft itself may be refluxed into the esophagus, in preference to the stomach contents, and exert a demulcent effect. In addition in vitro evidence has shown that the raft has a secondary action and is able to entrap bile and pepsin within it structure, further protecting the esophagus from these gastric components. Calcium Carbonate neutralizes gastric acid to provide fast relief from indigestion and heartburn.This effect is increased by the addition of Sodium Bicarbonate which also has a neutralizing action.",
        "items": [
          "Neutralizing excess stomach acid to relieve the pain & discomfort",
          "Forming a protective barrier over the stomach contents to soothe the burning pain in your chest."
        ]
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "A time-interval of 2 hours should be considered between Algicar Plus intake and the administration of other medicinal products, especially Tetracyclines, Digoxine, Fluoroquinolone, Iron salt, Ketoconazole, Neuroleptics, Thyroid Hormones, Penicillamine, beta-blockers (Atenolol, Metoprolol, Propranolol), Glucocorticoid, Chloroquine and Biphosphonates (diphosphonates) and Estramustine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known or suspected hypersensitivity to the active ingredients or to any of the excipients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In addition to the desired effect of the drug, some side effects may appear such as: constipation, flatulence, stomach cramp or belching. In these cases consult a physician. If too big dose has been taken, there might appear a sensation of swelling. In this case, it is advisable to consult a physician.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Clinical studies in more than 500 pregnant women, as well as a large amount of data from post-marketing experience, indicate no malformative nor feto/neonatal toxicity of the active ingredients. This drug can be used during pregnancy, if clinically needed.",
        "items": []
      },
      {
        "title": "Breastfeeding",
        "information": ": No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breastfeeding.",
        "items": []
      },
      {
        "title": "Fertility",
        "information": ": Pre-clinical investigations have revealed Alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Each 20 ml of dose has a sodium content of 254.5 mg (11.06 mmol). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment. Each 20 ml contains 260 mg (6.5 mmol) of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis, and recurrent calcium containing renal calculi. Treatment of children younger than 12 years of age is not generally recommended, except on medical advice. Algicar Plus is considered high in sodium. This should be taken into account when a highly restricted salt diet is recommended, e.g., in some cases of congestive cardiac failure and renal impairment. Each tablet contains 75 mg of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi. Due to its aspartame content Algicar Plus should not be given to patients with phenylketonuria. If symptoms persist, or treatment is required for more than 7 days continuously, medical advice should be sought. Taking Algicar Plus can mask the symptoms of other more serious, underlying medical conditions. It should not be used in patients with impaired renal function/insufficiency and with hypophosphatemia. This may cause allergic reactions.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In the event of over dosage symptomatic treatment should be given. The patient may notice abdominal distension.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (below 30°C) and dry place, away from light. Keep out of the reach of children. Do not refrigerate or freeze.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": null,
        "information": "For oral suspension:",
        "instructions": []
      },
      {
        "medication_type": "Adult and children over 12 years",
        "information": ":10-20 mL after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children 6 to 12 years",
        "information": ": 5-10 mL after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children under 6 years",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": No dose modifications necessary.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Chewable Tablet should be taken in oral route after being thoroughly chewed. Recommended dose:",
        "instructions": []
      },
      {
        "medication_type": "Adults and children 12 years and over",
        "information": ": Take two to four tablets after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children under 12 years",
        "information": ": Tablets should be given only on medical advice.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": No dose modification necessary.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": Caution if highly restricted salt diet is necessary.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Algicar Plus (500 mg+267 mg+160 mg)/10 ml Suspension?",
        "answer": [
          "Algicar Plus (500 mg+267 mg+160 mg)/10 ml Suspension is the combination of two antacids and an alginate. This is commonly used to treat Gastric reflux, Heartburn, Indigestion, Flatulence associated with gastric reflux."
        ]
      },
      {
        "question": "Is Algicar Plus (500 mg+267 mg+160 mg)/10 ml Suspension safe in pregnancy?",
        "answer": [
          "You can take Algicar Plus (500 mg+267 mg+160 mg)/10 ml Suspension if you are pregnant or breast-feeding."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:20.504Z",
    "medicine_id": "68c3c09aef5b8f2b163a8df5",
    "original_record": {
      "input_index": 808,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8df5"
        },
        "name": "Algicar Plus",
        "strength": "(500 mg+267 mg+160 mg)/10 ml",
        "generic": "Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate",
        "company": "Techno Drugs Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/31101/algicar-plus-500-mg-suspension",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/35183/algicid-plus-250-mg-chewable-tablet",
    "name": "Algicid Plus",
    "dosage_form": "Chewable Tablet",
    "generic": "Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate",
    "strength": "250 mg+133.5 mg+80 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 7.00",
      "strip_price": "৳ 70.00",
      "pack_size_info": "(5 x 10: ৳ 350.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 7.00",
          "pack_size_info": "(5 x 10: ৳ 350.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 70.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "(500 mg+267 mg+160 mg)/10 ml (Suspension)",
        "href": "https://medex.com.bd/brands/26556/algicid-plus-500-mg-suspension?ref=1"
      },
      {
        "text": "(500 mg+213 mg+325 mg)/10 ml (Suspension)",
        "href": "https://medex.com.bd/brands/32170/algicid-dx-500-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1451/sodium-alginate-sodium-bicarbonate-calcium-carbonate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algicid Plus is indicated in-",
        "items": [
          "Gastric reflux",
          "Heartburn",
          "Indigestion",
          "Flatulence associated with gastric reflux",
          "Heartburn of pregnancy",
          "All cases of epigastric and retrosternal distress where the underlying cause is gastric reflux."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an alginate (Sodium alginate). The suspension work in two ways- The mode of action of the product is physical and does not depend on absorption into the systemic circulation. The product is a combination of two antacids (Calcium Carbonate and Sodium Bicarbonate) and an Alginate. On ingestion, the medicinal product reacts rapidly with gastric acid to form a raft of Alginic Acid gel having a near neutral pH and studies have shown that the raft interacts with and caps the acid pocket in the stomach, reducing esophageal acid exposure. The raft floats on the stomach contents effectively impeding gastro-esophageal reflux, for up to 4 hours, and protecting the esophagus from Acid, Pepsin and Bile.In severe cases the raft itself may be refluxed into the esophagus, in preference to the stomach contents, and exert a demulcent effect. In addition in vitro evidence has shown that the raft has a secondary action and is able to entrap bile and pepsin within it structure, further protecting the esophagus from these gastric components. Calcium Carbonate neutralizes gastric acid to provide fast relief from indigestion and heartburn.This effect is increased by the addition of Sodium Bicarbonate which also has a neutralizing action.",
        "items": [
          "Neutralizing excess stomach acid to relieve the pain & discomfort",
          "Forming a protective barrier over the stomach contents to soothe the burning pain in your chest."
        ]
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "A time-interval of 2 hours should be considered between Algicid Plus intake and the administration of other medicinal products, especially Tetracyclines, Digoxine, Fluoroquinolone, Iron salt, Ketoconazole, Neuroleptics, Thyroid Hormones, Penicillamine, beta-blockers (Atenolol, Metoprolol, Propranolol), Glucocorticoid, Chloroquine and Biphosphonates (diphosphonates) and Estramustine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known or suspected hypersensitivity to the active ingredients or to any of the excipients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In addition to the desired effect of the drug, some side effects may appear such as: constipation, flatulence, stomach cramp or belching. In these cases consult a physician. If too big dose has been taken, there might appear a sensation of swelling. In this case, it is advisable to consult a physician.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Clinical studies in more than 500 pregnant women, as well as a large amount of data from post-marketing experience, indicate no malformative nor feto/neonatal toxicity of the active ingredients. This drug can be used during pregnancy, if clinically needed.",
        "items": []
      },
      {
        "title": "Breastfeeding",
        "information": ": No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breastfeeding.",
        "items": []
      },
      {
        "title": "Fertility",
        "information": ": Pre-clinical investigations have revealed Alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Each 20 ml of dose has a sodium content of 254.5 mg (11.06 mmol). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment. Each 20 ml contains 260 mg (6.5 mmol) of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis, and recurrent calcium containing renal calculi. Treatment of children younger than 12 years of age is not generally recommended, except on medical advice. Algicid Plus is considered high in sodium. This should be taken into account when a highly restricted salt diet is recommended, e.g., in some cases of congestive cardiac failure and renal impairment. Each tablet contains 75 mg of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi. Due to its aspartame content Algicid Plus should not be given to patients with phenylketonuria. If symptoms persist, or treatment is required for more than 7 days continuously, medical advice should be sought. Taking Algicid Plus can mask the symptoms of other more serious, underlying medical conditions. It should not be used in patients with impaired renal function/insufficiency and with hypophosphatemia. This may cause allergic reactions.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In the event of over dosage symptomatic treatment should be given. The patient may notice abdominal distension.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (below 30°C) and dry place, away from light. Keep out of the reach of children. Do not refrigerate or freeze.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": null,
        "information": "For oral suspension:",
        "instructions": []
      },
      {
        "medication_type": "Adult and children over 12 years",
        "information": ":10-20 mL after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children 6 to 12 years",
        "information": ": 5-10 mL after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children under 6 years",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": No dose modifications necessary.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Chewable Tablet should be taken in oral route after being thoroughly chewed. Recommended dose:",
        "instructions": []
      },
      {
        "medication_type": "Adults and children 12 years and over",
        "information": ": Take two to four tablets after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children under 12 years",
        "information": ": Tablets should be given only on medical advice.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": No dose modification necessary.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": Caution if highly restricted salt diet is necessary.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Algicid Plus 250 mg+133.5 mg+80 mg Chew. Tablet?",
        "answer": [
          "Algicid Plus 250 mg+133.5 mg+80 mg Chew. Tablet is the combination of two antacids and an alginate. This is commonly used to treat Gastric reflux, Heartburn, Indigestion, Flatulence associated with gastric reflux."
        ]
      },
      {
        "question": "Is Algicid Plus 250 mg+133.5 mg+80 mg Chew. Tablet safe in pregnancy?",
        "answer": [
          "You can take Algicid Plus 250 mg+133.5 mg+80 mg Chew. Tablet if you are pregnant or breast-feeding."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:21.601Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dfa",
    "original_record": {
      "input_index": 809,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dfa"
        },
        "name": "Algicid Plus",
        "strength": "250 mg+133.5 mg+80 mg",
        "generic": "Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/35183/algicid-plus-250-mg-chewable-tablet",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/1430/algin-50-mg-tablet",
    "name": "Algin",
    "dosage_form": "Tablet",
    "generic": "Tiemonium Methylsulfate",
    "strength": "50 mg",
    "company": "Renata PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 8.50",
      "strip_price": "৳ 85.00",
      "pack_size_info": "(10 x 10: ৳ 850.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.50",
          "pack_size_info": "(10 x 10: ৳ 850.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 85.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/1431/algin-10-mg-syrup?ref=1"
      },
      {
        "text": "5 mg/2 ml (Injection)",
        "href": "https://medex.com.bd/brands/1432/algin-5-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1069/tiemonium-methylsulfate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algin is an antispasmodic drug that reduces muscles spasm of the intestine, biliary system, bladder and uterus. It is used in symptomatic treatment of pain related to functional disorders of the digestive tract and biliary system. It is also indicated for the treatment of spasm and pain in urological and gynaecological diseases.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Tiemonium Methylsulphate a competitive antagonist of Acetylcholine, Histamine and strengthens of calcium bond with membrane phospholipids and proteins. Thus inhibits intracellular contractile protein of visceral cell which causes inhibition of visceral spasm and pain.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Algin methylsulphate tablet should not be used with other drugs without prior consult of a registered physician to avoid possible drug interaction.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It should not be used in urethroprostatic disorder involving a risk of urine retension. It is contraindicated in patient with having risk of angle closure glaucoma.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Algin Methylsulphate may have the risk of hypotension & tachycardia in certain individuals.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The results of animal studies of Tiemonium Methylsulphate did not reveal any teratogenic effects; no deformities have been reported up till now with normal use. In absence of sufficient data, prudence should be the rule for nursing mothers although no problems have been reported with normal use.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be taken during treatment of patients with disorders of the prostate. Caution should also be taken in case of chronic bronchitis, coronary insufficiency, ambient hyperthermia, renal & hepatic insufficiency. The risks of visual disturbances can make it dangerous to drive or use machines.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Paediatric use:",
        "information": "safety and effectiveness of Algin methylsulphate in paediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Geriatric use:",
        "information": "Efficacy and safety were maintained with increasing age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is not available data regarding the overdose of Algin methylsulphate tablet.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anticholinergics",
    "dosage": [
      {
        "medication_type": "Tablet/Syrup",
        "information": "-",
        "instructions": [
          "Adult: usual dose is 2-6 tablets or 3-9 teaspoonfuls syrup daily in divided doses.",
          "Children: 3 ml/kg or 6 mg/kg body weight daily in divided doses."
        ]
      },
      {
        "medication_type": "Injection",
        "information": ": 1 injection 3 times daily, through Intravenous route slowly or Intramuscular route.",
        "instructions": []
      },
      {
        "medication_type": "Suppository",
        "information": ": 20 mg suppository two or three times daily, through rectal route.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Algin 50 mg Tablet?",
        "answer": [
          "Algin 50 mg Tablet is an antispasmodic drug that reduces muscles spasm of the intestine, biliary system, bladder and uterus."
        ]
      },
      {
        "question": "What is Algin 50 mg Tablet used for?",
        "answer": [
          "Algin 50 mg Tablet is used for the treatment of pain in digestive tract and biliary system. It is also indicated for the treatment of spasm and pain in urological and gynaecological diseases."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:22.601Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e01",
    "original_record": {
      "input_index": 810,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e01"
        },
        "name": "Algin",
        "strength": "50 mg",
        "generic": "Tiemonium Methylsulfate",
        "company": "Renata PLC",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/1430/algin-50-mg-tablet",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/11152/algirex-120-mg-tablet",
    "name": "Algirex",
    "dosage_form": "Tablet",
    "generic": "Etoricoxib",
    "strength": "120 mg",
    "company": "Ibn Sina Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 14.25",
      "strip_price": "৳ 142.50",
      "pack_size_info": "(2 x 10: ৳ 285.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 14.25",
          "pack_size_info": "(2 x 10: ৳ 285.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 142.50",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "60 mg (Tablet)",
        "href": "https://medex.com.bd/brands/11150/algirex-60-mg-tablet?ref=1"
      },
      {
        "text": "90 mg (Tablet)",
        "href": "https://medex.com.bd/brands/11151/algirex-90-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/446/etoricoxib/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algirex tablet is indicated for the symptomatic relief of-",
        "items": [
          "Osteoarthritis (OA)",
          "Rheumatoid arthritis (RA)",
          "Ankylosing spondylitis, and",
          "The pain and signs of inflammation associated with acute gouty arthritis.",
          "For the short-term treatment of moderate pain associated with dental surgery."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Etoricoxib is a potent, orally active cyclooxygenase-2 (COX-2) specific inhibitor within, and significantly above, the clinical dose range. Two isoforms of cyclooxygenase have been identified: cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). COX-1 is responsible for prostaglandin-mediated normal physiologic functions such as gastric cytoprotection and platelet aggregation. Inhibition of COX-1 by nonselective NSAIDs has been associated with gastric damage and inhibition of platelet aggregation. COX-2 has been shown to be primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever. Selective inhibition of COX-2 by etoricoxib (within the clinical dose range) decreases these clinical signs and symptoms with decreased potential for Gl toxicity and effects on platelet aggregation. Etoricoxib produced dose-dependent inhibition of COX-2 without inhibition of COX-1 at doses up to 150 mg daily. Etoricoxib did not inhibit gastric prostaglandin synthesis.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "With medicine: With food & others: Take without regards to meals.",
        "items": [
          "Oral anticoagulants: In subjects stabilized on chronic warfarin therapy, the administration of Algirex was associated with an increase in prothrombin time.",
          "Diuretics, ACE inhibitors and Angiotensin II Antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs.",
          "Acetylsalicylic Acid: Algirex can be used concomitantly with acetylsalicylic acid at doses used for cardiovascular prophylaxis (low-dose acetylsalicylic acid).",
          "Ciclosporin and tacrolimus: Although this interaction has not been studied with Algirex, coadministration of ciclosporin or tacrolimus with any NSAID may increase the nephrotoxic effect of ciclosporin or tacrolimus.",
          "Lithium: NSAIDs decrease lithium renal excretion and therefore increase lithium plasma levels."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to the active substance or to any of the excipients.",
          "Active peptic ulceration or active gastro-intestinai (Gl) bleeding.",
          "Patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions after taking acetylsalicylic acid or NSAIDs including COX-2 (cyclooxygenase-2) inhibitors.",
          "Pregnancy and lactation.",
          "Severe hepatic dysfunction (serum albumin <25 g/l or Child-Pugh score 10).",
          "Estimated renal creatinine clearance <30 ml/min.",
          "Children and adolescents under 16 years of age.",
          "Inflammatory bowel disease.",
          "Congestive heart failure (NYHA ll-IV).",
          "Patients with hypertension whose blood pressure is persistently elevated above 140/90 mmHg and has not been adequately controlled.",
          "Established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side-effects may include palpitation, fatigue, influenza-like symptoms, ecchymosis; less commonly dry mouth, taste disturbance, mouth ulcer, appetite and weight change, atrial fibrillation, transient ischaemic attack, chest pain, flushing, cough, dyspnoea, epistaxis, anxiety, mental acuity impaired, paraesthesia, electrolyte disturbance, myalgia and arthralgia; very rarely confusion and hallucinations.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The use of Etoricoxib, as with any drug substance known to inhibit COX-2, is not recommended in women attempting to conceive. It is not known whether Etoricoxib is excreted in human milk. Etoricoxib is excreted in the milk of lactating rats. Women who use Etoricoxib must not breastfeed.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Caution is advised with treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly or patients with a prior history of gastrointestinal disease, such as ulceration and Gl bleeding.",
          "Patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with Algirex after careful consideration.",
          "Administration of Algirex may cause a reduction in prostaglandin formation and, secondarily, in renal blood flow, and thereby impair renal function. Monitoring of renal function in such patients should be considered.",
          "Caution should be exercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension and in patients with pre-existing edema from any other reason.",
          "Any patients with symptoms and/or signs suggesting liver dysfunction, or in whom an abnormalliver function test has occurred, should be monitored. If signs of hepatic insufficiency occur, or if persistently abnormal liver function tests (three times the upper limit of normal) are detected, Algirex should be discontinued.",
          "Algirex should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.",
          "Algirex may mask fever and other signs of inflammation. Caution should be exercised when co-administering Algirex with warfarin or other oral anticoagulants."
        ]
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Administration of single doses of Algirex up to 500 mg and multiple doses up to 150 mg/day for 21 days did not result in significant toxicity. In the event of overdose, it is reasonable to employ the usual supportive measures, e.g., remove unabsorbed material from the Gl tract, employ clinical monitoring, and institute supportive therapy, if required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at a temperature of below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C18H15ClN2O2S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-446-etoricoxib-chemical-structure-nEkDifKyFxQ9fjJEG7TQ.svg"
    },
    "therapeutic_class": "Non-steroidal Anti-inflammatory Drugs (NSAIDs)",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adult and adolescent over 16 years:",
        "instructions": []
      },
      {
        "medication_type": "Osteoarthritis",
        "information": ": The recommended dose is 30 mg once daily. In some patients with insufficient relief from symptoms, an increased dose of 60 mg once daily may increase efficacy.",
        "instructions": []
      },
      {
        "medication_type": "Rheumatoid arthritis",
        "information": ": The recommended dose is 90 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Ankylosing spondylitis",
        "information": ": The recommended dose is 90 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Acute gouty arthritis",
        "information": ": The recommended dose is 120 mg once daily. In clinical trials for acute gouty arthritis, Etoricoxib was given for 8 days.",
        "instructions": []
      },
      {
        "medication_type": "Postoperative dental surgery pain",
        "information": ": The recommended dose is 90 mg once daily, limited to a maximum of 3 days.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Some patients may require additional postoperative analgesia. As the cardiovascular risks of Etoricoxib may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient's need for symptomatic relief and response to therapy should be re-evaluated periodically, especially in patients with osteoarthritis.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Algirex 120 mg Tablet?",
        "answer": [
          "Algirex 120 mg Tablet is a selective COX-2 inhibitor. COX-2 has been shown to be primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever. Algirex 120 mg Tablet produced dose-dependent inhibition of COX-2 without inhibition of COX-1 at doses up to 150 mg daily."
        ]
      },
      {
        "question": "What are the uses of Algirex 120 mg Tablet?",
        "answer": [
          "Algirex 120 mg Tablet is indicated for the symptomatic relief of Osteoarthritis (OA), Rheumatoid arthritis (RA), Ankylosing spondylitis."
        ]
      },
      {
        "question": "How long is the duration of effect of Algirex 120 mg Tablet?",
        "answer": [
          "The effect of Algirex 120 mg Tablet lasts for an average duration of 20-24 hours."
        ]
      },
      {
        "question": "What is the onset of action of Algirex 120 mg Tablet?",
        "answer": [
          "The effect of Algirex 120 mg Tablet can be observed within 1-2 hours of administration. The onset is faster if the medicine is taken without food."
        ]
      },
      {
        "question": "Are there any pregnancy warnings of Algirex 120 mg Tablet?",
        "answer": [
          "Women who are pregnant should consult doctor before using Algirex 120 mg Tablet."
        ]
      },
      {
        "question": "Is it habit forming of Algirex 120 mg Tablet?",
        "answer": [
          "No habit forming tendencies were reported."
        ]
      },
      {
        "question": "Are there any breast-feeding warnings of Algirex 120 mg Tablet?",
        "answer": [
          "Algirex 120 mg Tablet is not recommended for use by mothers who are breastfeeding. It should be used only when the potential benefits outweigh the risks associated with usage. Consult your doctor before taking this medicine."
        ]
      },
      {
        "question": "Is Algirex 120 mg Tablet safe with alcohol?",
        "answer": [
          "Algirex 120 mg Tablet is found to be unsafe to consume this medicine with alcohol."
        ]
      },
      {
        "question": "Is Algirex 120 mg Tablet safe to drive while on this medicine?",
        "answer": [
          "Algirex 120 mg Tablet may affect alertness of the patient taking it. Thus patient must avoid driving."
        ]
      },
      {
        "question": "Does Algirex 120 mg Tablet affect kidney function?",
        "answer": [
          "Caution must be taken in patient with kidney disease. Adjustment of dose might be needed. Consult your doctor before taking Algirex 120 mg Tablet. use of this medicine is strictly not recommended in patients with severe kidney disease."
        ]
      },
      {
        "question": "Does Algirex 120 mg Tablet affect liver function?",
        "answer": [
          "Caution must be taken in patient with liver disease. Adjustment of dose might be needed. Consult your doctor before taking Algirex 120 mg Tablet. use of this medicine is strictly not recommended in patients with severe liver disease."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Algirex 120 mg Tablet helps relieve pain and inflammation.",
          "Algirex 120 mg Tablet may cause fewer stomach problems as compared to other NSAIDs like Ibuprofen or Naproxen.",
          "Algirex 120 mg Tablet may cause dizziness and fatigue. Do not drive or do anything requiring concentration until you know how it affects you.",
          "Do not consume alcohol while on treatment with Algirex 120 mg Tablet as it may cause excessive drowsiness.",
          "Regularly monitor your blood pressure while taking this medicine, particularly in the first two weeks after starting treatment.",
          "Inform your doctor if you have a history of stomach ulcers, heart diseases, high blood pressure, and liver or kidney disease.",
          "During long-term treatment, your doctor may want to take regular blood tests to monitor your liver function.",
          "Do not take Algirex 120 mg Tablet if you are pregnant, planning to conceive, or breastfeeding."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:23.682Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e05",
    "original_record": {
      "input_index": 811,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e05"
        },
        "name": "Algirex",
        "strength": "120 mg",
        "generic": "Etoricoxib",
        "company": "Ibn Sina Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/11152/algirex-120-mg-tablet",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/35715/algisum-dx-500-mg-suspension",
    "name": "Algisum DX",
    "dosage_form": "Oral Suspension",
    "generic": "Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate",
    "strength": "(500 mg+213 mg+325 mg)/10 ml",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 290.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "200 ml bottle",
          "price": "৳ 290.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "(500 mg+267 mg+160 mg)/10 ml (Suspension)",
        "href": "https://medex.com.bd/brands/31531/algisum-max-500-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1451/sodium-alginate-sodium-bicarbonate-calcium-carbonate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algisum DX is indicated in-",
        "items": [
          "Gastric reflux",
          "Heartburn",
          "Indigestion",
          "Flatulence associated with gastric reflux",
          "Heartburn of pregnancy",
          "All cases of epigastric and retrosternal distress where the underlying cause is gastric reflux."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an alginate (Sodium alginate). The suspension work in two ways- The mode of action of the product is physical and does not depend on absorption into the systemic circulation. The product is a combination of two antacids (Calcium Carbonate and Sodium Bicarbonate) and an Alginate. On ingestion, the medicinal product reacts rapidly with gastric acid to form a raft of Alginic Acid gel having a near neutral pH and studies have shown that the raft interacts with and caps the acid pocket in the stomach, reducing esophageal acid exposure. The raft floats on the stomach contents effectively impeding gastro-esophageal reflux, for up to 4 hours, and protecting the esophagus from Acid, Pepsin and Bile.In severe cases the raft itself may be refluxed into the esophagus, in preference to the stomach contents, and exert a demulcent effect. In addition in vitro evidence has shown that the raft has a secondary action and is able to entrap bile and pepsin within it structure, further protecting the esophagus from these gastric components. Calcium Carbonate neutralizes gastric acid to provide fast relief from indigestion and heartburn.This effect is increased by the addition of Sodium Bicarbonate which also has a neutralizing action.",
        "items": [
          "Neutralizing excess stomach acid to relieve the pain & discomfort",
          "Forming a protective barrier over the stomach contents to soothe the burning pain in your chest."
        ]
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "A time-interval of 2 hours should be considered between Algisum DX intake and the administration of other medicinal products, especially Tetracyclines, Digoxine, Fluoroquinolone, Iron salt, Ketoconazole, Neuroleptics, Thyroid Hormones, Penicillamine, beta-blockers (Atenolol, Metoprolol, Propranolol), Glucocorticoid, Chloroquine and Biphosphonates (diphosphonates) and Estramustine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known or suspected hypersensitivity to the active ingredients or to any of the excipients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In addition to the desired effect of the drug, some side effects may appear such as: constipation, flatulence, stomach cramp or belching. In these cases consult a physician. If too big dose has been taken, there might appear a sensation of swelling. In this case, it is advisable to consult a physician.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Clinical studies in more than 500 pregnant women, as well as a large amount of data from post-marketing experience, indicate no malformative nor feto/neonatal toxicity of the active ingredients. This drug can be used during pregnancy, if clinically needed.",
        "items": []
      },
      {
        "title": "Breastfeeding",
        "information": ": No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breastfeeding.",
        "items": []
      },
      {
        "title": "Fertility",
        "information": ": Pre-clinical investigations have revealed Alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Each 20 ml of dose has a sodium content of 254.5 mg (11.06 mmol). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment. Each 20 ml contains 260 mg (6.5 mmol) of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis, and recurrent calcium containing renal calculi. Treatment of children younger than 12 years of age is not generally recommended, except on medical advice. Algisum DX is considered high in sodium. This should be taken into account when a highly restricted salt diet is recommended, e.g., in some cases of congestive cardiac failure and renal impairment. Each tablet contains 75 mg of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi. Due to its aspartame content Algisum DX should not be given to patients with phenylketonuria. If symptoms persist, or treatment is required for more than 7 days continuously, medical advice should be sought. Taking Algisum DX can mask the symptoms of other more serious, underlying medical conditions. It should not be used in patients with impaired renal function/insufficiency and with hypophosphatemia. This may cause allergic reactions.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In the event of over dosage symptomatic treatment should be given. The patient may notice abdominal distension.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (below 30°C) and dry place, away from light. Keep out of the reach of children. Do not refrigerate or freeze.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": null,
        "information": "For oral suspension:",
        "instructions": []
      },
      {
        "medication_type": "Adult and children over 12 years",
        "information": ":10-20 mL after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children 6 to 12 years",
        "information": ": 5-10 mL after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children under 6 years",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": No dose modifications necessary.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Chewable Tablet should be taken in oral route after being thoroughly chewed. Recommended dose:",
        "instructions": []
      },
      {
        "medication_type": "Adults and children 12 years and over",
        "information": ": Take two to four tablets after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children under 12 years",
        "information": ": Tablets should be given only on medical advice.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": No dose modification necessary.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": Caution if highly restricted salt diet is necessary.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Algisum DX (500 mg+213 mg+325 mg)/10 ml Suspension?",
        "answer": [
          "Algisum DX (500 mg+213 mg+325 mg)/10 ml Suspension is the combination of two antacids and an alginate. This is commonly used to treat Gastric reflux, Heartburn, Indigestion, Flatulence associated with gastric reflux."
        ]
      },
      {
        "question": "Is Algisum DX (500 mg+213 mg+325 mg)/10 ml Suspension safe in pregnancy?",
        "answer": [
          "You can take Algisum DX (500 mg+213 mg+325 mg)/10 ml Suspension if you are pregnant or breast-feeding."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:24.643Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e09",
    "original_record": {
      "input_index": 812,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e09"
        },
        "name": "Algisum DX",
        "strength": "(500 mg+213 mg+325 mg)/10 ml",
        "generic": "Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/35715/algisum-dx-500-mg-suspension",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31531/algisum-max-500-mg-suspension",
    "name": "Algisum Max",
    "dosage_form": "Oral Suspension",
    "generic": "Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate",
    "strength": "(500 mg+267 mg+160 mg)/10 ml",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 300.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "200 ml bottle",
          "price": "৳ 300.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "(500 mg+213 mg+325 mg)/10 ml (Suspension)",
        "href": "https://medex.com.bd/brands/35715/algisum-dx-500-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1451/sodium-alginate-sodium-bicarbonate-calcium-carbonate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algisum Max is indicated in-",
        "items": [
          "Gastric reflux",
          "Heartburn",
          "Indigestion",
          "Flatulence associated with gastric reflux",
          "Heartburn of pregnancy",
          "All cases of epigastric and retrosternal distress where the underlying cause is gastric reflux."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an alginate (Sodium alginate). The suspension work in two ways- The mode of action of the product is physical and does not depend on absorption into the systemic circulation. The product is a combination of two antacids (Calcium Carbonate and Sodium Bicarbonate) and an Alginate. On ingestion, the medicinal product reacts rapidly with gastric acid to form a raft of Alginic Acid gel having a near neutral pH and studies have shown that the raft interacts with and caps the acid pocket in the stomach, reducing esophageal acid exposure. The raft floats on the stomach contents effectively impeding gastro-esophageal reflux, for up to 4 hours, and protecting the esophagus from Acid, Pepsin and Bile.In severe cases the raft itself may be refluxed into the esophagus, in preference to the stomach contents, and exert a demulcent effect. In addition in vitro evidence has shown that the raft has a secondary action and is able to entrap bile and pepsin within it structure, further protecting the esophagus from these gastric components. Calcium Carbonate neutralizes gastric acid to provide fast relief from indigestion and heartburn.This effect is increased by the addition of Sodium Bicarbonate which also has a neutralizing action.",
        "items": [
          "Neutralizing excess stomach acid to relieve the pain & discomfort",
          "Forming a protective barrier over the stomach contents to soothe the burning pain in your chest."
        ]
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "A time-interval of 2 hours should be considered between Algisum Max intake and the administration of other medicinal products, especially Tetracyclines, Digoxine, Fluoroquinolone, Iron salt, Ketoconazole, Neuroleptics, Thyroid Hormones, Penicillamine, beta-blockers (Atenolol, Metoprolol, Propranolol), Glucocorticoid, Chloroquine and Biphosphonates (diphosphonates) and Estramustine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known or suspected hypersensitivity to the active ingredients or to any of the excipients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In addition to the desired effect of the drug, some side effects may appear such as: constipation, flatulence, stomach cramp or belching. In these cases consult a physician. If too big dose has been taken, there might appear a sensation of swelling. In this case, it is advisable to consult a physician.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Clinical studies in more than 500 pregnant women, as well as a large amount of data from post-marketing experience, indicate no malformative nor feto/neonatal toxicity of the active ingredients. This drug can be used during pregnancy, if clinically needed.",
        "items": []
      },
      {
        "title": "Breastfeeding",
        "information": ": No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breastfeeding.",
        "items": []
      },
      {
        "title": "Fertility",
        "information": ": Pre-clinical investigations have revealed Alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Each 20 ml of dose has a sodium content of 254.5 mg (11.06 mmol). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment. Each 20 ml contains 260 mg (6.5 mmol) of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis, and recurrent calcium containing renal calculi. Treatment of children younger than 12 years of age is not generally recommended, except on medical advice. Algisum Max is considered high in sodium. This should be taken into account when a highly restricted salt diet is recommended, e.g., in some cases of congestive cardiac failure and renal impairment. Each tablet contains 75 mg of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi. Due to its aspartame content Algisum Max should not be given to patients with phenylketonuria. If symptoms persist, or treatment is required for more than 7 days continuously, medical advice should be sought. Taking Algisum Max can mask the symptoms of other more serious, underlying medical conditions. It should not be used in patients with impaired renal function/insufficiency and with hypophosphatemia. This may cause allergic reactions.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In the event of over dosage symptomatic treatment should be given. The patient may notice abdominal distension.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (below 30°C) and dry place, away from light. Keep out of the reach of children. Do not refrigerate or freeze.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": null,
        "information": "For oral suspension:",
        "instructions": []
      },
      {
        "medication_type": "Adult and children over 12 years",
        "information": ":10-20 mL after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children 6 to 12 years",
        "information": ": 5-10 mL after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children under 6 years",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": No dose modifications necessary.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Chewable Tablet should be taken in oral route after being thoroughly chewed. Recommended dose:",
        "instructions": []
      },
      {
        "medication_type": "Adults and children 12 years and over",
        "information": ": Take two to four tablets after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children under 12 years",
        "information": ": Tablets should be given only on medical advice.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": No dose modification necessary.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": Caution if highly restricted salt diet is necessary.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Algisum Max (500 mg+267 mg+160 mg)/10 ml Suspension?",
        "answer": [
          "Algisum Max (500 mg+267 mg+160 mg)/10 ml Suspension is the combination of two antacids and an alginate. This is commonly used to treat Gastric reflux, Heartburn, Indigestion, Flatulence associated with gastric reflux."
        ]
      },
      {
        "question": "Is Algisum Max (500 mg+267 mg+160 mg)/10 ml Suspension safe in pregnancy?",
        "answer": [
          "You can take Algisum Max (500 mg+267 mg+160 mg)/10 ml Suspension if you are pregnant or breast-feeding."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:25.673Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e0a",
    "original_record": {
      "input_index": 813,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e0a"
        },
        "name": "Algisum Max",
        "strength": "(500 mg+267 mg+160 mg)/10 ml",
        "generic": "Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/31531/algisum-max-500-mg-suspension",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/29306/alia-5-mg-tablet",
    "name": "Alia",
    "dosage_form": "Tablet",
    "generic": "Allylestrenol",
    "strength": "5 mg",
    "company": "ACME Laboratories Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 9.00",
      "strip_price": "৳ 90.00",
      "pack_size_info": "(3 x 10: ৳ 270.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 9.00",
          "pack_size_info": "(3 x 10: ৳ 270.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 90.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1369/allylestrenol/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alia is indicated in:",
        "items": [
          "Intra Uterine Growth Retardation (IUGR)",
          "Threatened abortion",
          "Habitual abortion",
          "Threatened premature delivery"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Allylestrenol has been found to have a relatively weak progestational effect on the human endometrium. To obtain a full secretory endometrium in oestrogen-primed castrated women or to postpone menstruation (with an oestrogen added) in normal ovulating women, doses of allylestrenol were required which were higher than those recommended for the treatment/prevention of abortion. In vitro studies have shown that allylestrenol stimulates the synthesis of progesterone in the human placenta. It also brought about a significant (p/. 0,01) increase in the production of some specific placental enzymes (cystine aminopeptidase and heat-stable alkaline phosphatase). Histological and histochemical changes indicating an increased activity have been found in the placenta, particularly in the syncytiotrophoblast of women with a normal and threatened pregnancy, treated with allylestrenol. The stimulatory effect of allylestrenol on placental function was also suggested by the increased level of placental hormones (pregnanediol, oestriol, HCG and HPL) and enzymes (oxytocinase, CAP) in the maternal urine and plasma, which followed the administration of the drug e.g. in the early weeks as well as in the last trimester of pregnancy. A study in full-term pregnant women revealed that allylestrenol in high doses (up to 100 mg daily) did suppress the intensity of spontaneous uterine contractions, but had no effect on the sensitivity of the uterine muscle to oxytocin, and no adverse effect on the progress of normal delivery. Studies in non-pregnant women with and without endocrinological disorders have shown that allylestrenol has no oestrogenic or androgenic properties and no adverse effects on the adrenal function. No abnormal liver function tests or water and salt retention were observed in healthy female volunteers (non pregnant) who were given allylestrenol.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Breast Cancer or history of problem with the breasts like- Nodules,an abnormal Mammogram, or Fibrocystic Diseases.",
          "Severe liver disease such as Cholestatic Jaundice or Hepatitis, Hepatic Cell Tumours, Rotor Syndrome and Dubin Jhonson Syndrome.",
          "Undiagnosed vaginal bleeding",
          "Toxaemia of Pregnancy",
          "Crisis Seizures, Migraines"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Treatment with Alia (especially a long term treatment) is known to cause some gastrointestinal complaints such as vomiting, nausea, and sometimes epigastric discomfort.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Allylestrenol is specifically designed to be taken during pregnancy. It should be discontinued after delivery as it may affect a nursing infant to a small but noticeable degree.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients with the following conditions should be cautious: Heart disease, congestive heart failure, sick sinus syndrome, coronary artery disease, seizures, epilepsy, renal dysfunction, migraine headaches, or breathing diseases including asthma, emphysema, chronic bronchitis, or COPD, breast-feeding.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "It should not be used for children younger than 16 years old.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Symptoms of overdose may include unusual drowsiness; rapid pulse; fainting; unusual muscle movement or rigidity of the face, neck, or limbs; seizures; and loss of consciousness.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Alia is an oral Gestagen. In castrated animals, it has a potent pregnancy-maintaining action without producing hormonal side-effects, in particular no masculinisation of female foetuses. Clinical studies have indicated that Alia stimulates the endocrine function of the trophoblast. In vitro, Alia stimulates the placenta to produce more progesterone. In patients with pregnancy at risk, abnormally low levels of placental hormones (HCG, HPL, oestrogens and progesterone) and some specific enzymes (oxytocinase, CAP) were found to be increased to normal during treatment. In the majority of patients with pregnancy at risk who were treated with Alia the threat of abortion was removed and pregnancy brought to term without complications. Alia is very well tolerated. Side-effects of any importance have not been observed.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Female Sex hormones",
    "dosage": [
      {
        "medication_type": "Intra Uterine Growth Retardation",
        "information": ": 1 tablet three times a day at least two months. Dose to be reduced if symptoms improve.",
        "instructions": []
      },
      {
        "medication_type": "Threatened abortion",
        "information": ": 1 tablet three times daily until symptoms disappear.",
        "instructions": []
      },
      {
        "medication_type": "Habitual abortion",
        "information": ": 1-2 tablets daily as soon as pregnancy is diagnosed. The administration should be continued for at least one month after the end of the critical period.",
        "instructions": []
      },
      {
        "medication_type": "Threatened premature delivery",
        "information": ": Dosage must be determined individually. High dosages (up to 40 mg daily) have been used. In case of a missed dose, it should be taken as soon as the patient remembers & she should continue the regular dosing schedule. A double dose is not recommended.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:26.667Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e0e",
    "original_record": {
      "input_index": 814,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e0e"
        },
        "name": "Alia",
        "strength": "5 mg",
        "generic": "Allylestrenol",
        "company": "ACME Laboratories Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/29306/alia-5-mg-tablet",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28709/alice-6-mg-tablet",
    "name": "Alice",
    "dosage_form": "Tablet",
    "generic": "Ivermectin",
    "strength": "6 mg",
    "company": "Square Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 10.00",
      "strip_price": "৳ 100.00",
      "pack_size_info": "(1 x 10: ৳ 100.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.00",
          "pack_size_info": "(1 x 10: ৳ 100.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "12 mg (Tablet)",
        "href": "https://medex.com.bd/brands/28710/alice-12-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/644/ivermectin-tablet/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alice tablet is indicated for the treatment of- Strongyloidiasis of the intestinal tract: Alice is indicated for the treatment of intestinal ... Read moreAlice tablet is indicated for the treatment of- Strongyloidiasis of the intestinal tract: Alice is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Alice.Onchocerciasis: Alice is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).",
        "items": [
          "Strongyloidiasis",
          "Onchocerciasis",
          "Filariasis",
          "Scabies &",
          "Head lice.",
          "Strongyloidiasis",
          "Onchocerciasis",
          "Filariasis",
          "Scabies &",
          "Head lice."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ivermectin selectively binds and with high affinity to glutamate-gated chloride ion channels, which occur in invertebrate nerve and muscle cells leading to an increase in the permeability of cell membranes to chloride ions with hyperpolarization of the nerve or muscle cell and, ultimately, death of the parasite.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Post-marketing reports of increased INR (International Normalized Ratio) have been rarely reported when Alice was co-administered with warfarin.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients who are hypersensitive to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Strongyloidiasis",
        "information": ": In four clinical studies involving a total of 109 patients given either one or two doses of 170 to 200 mcg/kg of Alice, the following adverse reactions were reported as possibly, probably, or definitely related to Alice.",
        "items": [
          "Body as a whole: asthenia/fatigue (0.9%), abdominal pain (0.9%)",
          "Gastrointestinal: anorexia (0.9%), constipation (0.9%), diarrhea (1.8%), nausea (1.8%), vomiting (0.9%) Nervous System/Psychiatric: dizziness (2.8%), somnolence (0.9%), vertigo (0.9%), tremor (0.9%)",
          "Skin: pruritus (2.8%), rash (0.9%), and urticaria (0.9%)."
        ]
      },
      {
        "title": "Onchocerciasis",
        "information": ": arthralgia/synovitis (19.3%), axillary lymph node enlargement and tenderness (11.0% and 4.4%, respectively), cervical lymph node enlargement and tenderness (5.3% and 1.2%, respectively), inguinal lymph node enlargement and tenderness (12.6% and 13.9%, respectively), other lymph node enlargement and tenderness (3.0% and 1.9%, respectively), pruritus (27.5%), skin involvement including edema, papular and pustular or frank urticarial rash (22.7%), and fever (22.6%), abnormal sensation in the eyes, eyelid edema, anterior uveitis, conjunctivitis, limbitis, keratitis, and chorioretinitis or choroiditis. These have rarely been severe or associated with loss of vision and have generally resolved without corticosteroid treatment. The following adverse reactions have been reported since the drug was registered overseas: hypotension (mainly orthostatic hypotension), worsening of bronchial asthma, toxic epidermal necrolysis, and Stevens-Johnson syndrome.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. Ivermectin does not appear to be selectively fetotoxic to the developing fetus. There are, however, no adequate and well-controlled studies in pregnant women. Ivermectin should not be used during pregnancy since safety in pregnancy has not been established. Nursing Mothers: Ivermectin is excreted in human milk in low concentrations. Treatment of mothers who intend to breast feed should only be undertaken when the risk of delayed treatment to the mother outweighs the possible risk to the newborn",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Historical data have shown that microfilaricidal drugs, such as diethylcarbamazine citrate (DEC-C), might cause cutaneous and/or systemic reactions of varying severity (the Mazzotti reaction) and ophthalmological reactions in patients with onchocerciasis. These reactions are probably due to allergic and inflammatory responses to the death of microfilariae. Patients treated with Alice for onchocerciasis may experience these reactions in addition to clinical adverse reactions possibly, probably, or definitely related to the drug itself. The treatment of severe Mazzotti reactions has not been subjected to controlled clinical trials. Oral hydration, recumbency, intravenous normal saline, and/or parenteral corticosteroids have been used to treat postural hypotension. Antihistamines and/or aspirin have been used for most mild to moderate cases. After treatment with microfilaricidal drugs, patients with hyperreactive onchodermatitis (sowda) may be more likely than others to experience severe adverse reactions, especially edema and aggravation of onchodermatitis. Rarely, patients with onchocerciasis who are also heavily infected with Loa loa may develop a serious or even fatal encephalopathy either spontaneously or following treatment with an effective microfilaricide. In these patients, the following adverse experiences have also been reported: back pain, conjunctival hemorrhage, dyspnea, urinary and/or fecal incontinence, difficulty in standing/walking, mental status changes, confusion, lethargy, stupor, or coma.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Safety and effectiveness in pediatric patients weighing less than 15 kg have not been established.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": Clinical studies of Alice did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, below 30°C. Protect from light. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "For Treatment (If COVIO Positive)",
        "information": ": 2 Tablets of Ivermectin 6 mg once daily for 5 days. (2+0+0 for 5 days).",
        "instructions": []
      },
      {
        "medication_type": "For Prophylaxis",
        "information": ": Single-dose as mentioned below to be taken on Day 1 & same dose on Day 7.",
        "instructions": [
          "Body Weight 15-24 kg: 1 Tablet of Ivermectin 3 mg",
          "Body Weight 25-35 kg: 1 Tablet of Ivermectin 6 mg",
          "Body Weight 36-50 kg: 1 Tablet of Ivermectin 6 mg + 1 Tablet of Ivermectin 3 mg",
          "Body Weight 51-65 kg: 2 Tablets of Ivermectin 6 mg",
          "Body Weight 66-79 kg: 2 Tablets of Ivermectin 6 mg + 1 Tablet of Ivermectin 3 mg",
          "Body Weight >80 kg: 3 Tablets of Ivermectin 6 mg"
        ]
      },
      {
        "medication_type": "Strongyloidiasis",
        "information": ": The recommended dosage of Ivermectin for the treatment of strongyloidiasis is a single oral dose designed to provide approximately 200 mcg/kg of body weight. Patients should take tablets on an empty stomach with water. In general, additional doses are not necessary. However, follow-up stool examinations should be performed to verify eradication of infection. Dosage Guidelines for Ivermectin for Strongyloidiasis:",
        "instructions": [
          "Body Weight (kg) 15-24: Dose 3 mg/kg",
          "Body Weight (kg) 25-35: Dose 6 mg/kg",
          "Body Weight (kg) 36-50: Dose 9 mg/kg",
          "Body Weight (kg) 51-65: Dose 12 mg/kg",
          "Body Weight (kg) 66-79: Dose 15 mg/kg",
          "Body Weight (kg) >80: Dose 200 mcg/kg"
        ]
      },
      {
        "medication_type": "Onchocerciasis",
        "information": ": The recommended dosage of Ivermectin is a single oral dose designed to provide approximately 150 mcg of Ivermectin per kg of body weight on an empty stomach with water, the most commonly used dose interval is 12 months. For the treatment of individual patients, retreatment may be considered at intervals as short as 3 months. Dosage Guidelines for Ivermectin for Onchocerciasis:",
        "instructions": [
          "Body Weight (kg) 15-25: Dose 3 mg/kg",
          "Body Weight (kg) 26-44: Dose 6 mg/kg",
          "Body Weight (kg) 45-64: Dose 9 mg/kg",
          "Body Weight (kg) 65-84: Dose 12 mg/kg",
          "Body Weight (kg) >85: Dose 150 mcg/kg"
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:27.850Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e11",
    "original_record": {
      "input_index": 815,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e11"
        },
        "name": "Alice",
        "strength": "6 mg",
        "generic": "Ivermectin (Tablet)",
        "company": "Square Pharmaceuticals PLC",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/28709/alice-6-mg-tablet",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/15073/alimta-500-mg-injection",
    "name": "Alimta",
    "dosage_form": "IV Infusion",
    "generic": "Pemetrexed",
    "strength": "500 mg/20 ml",
    "company": "Eli Lilly and Company",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 76,000.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "500 mg vial",
          "price": "৳ 76,000.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "100 mg/4 ml (IV Infusion)",
        "href": "https://medex.com.bd/brands/28995/alimta-100-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/870/pemetrexed/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alimta is indicated in Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Alimta is indicated in Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Limitations of Use: Alimta is not indicated for the treatment of patients with squamous cell, non-small cell lung cancer. Mesothelioma: Alimta is indicated, in combination with Cisplatin, for the initial treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery.",
        "items": [
          "in combination with Pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous NSCLC, with no EGFR or ALK genomic tumor aberrations.",
          "in combination with Cisplatin for the initial treatment of patients with locally advanced or metastatic, nonsquamous, non-small cell lung cancer (NSCLC).",
          "in combination with Pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous NSCLC, with no EGFR or ALK genomic tumor aberrations.",
          "in combination with Cisplatin for the initial treatment of patients with locally advanced or metastatic, nonsquamous, non-small cell lung cancer (NSCLC).",
          "as a single agent for the maintenance treatment of patients with locally advanced or metastatic, nonsquamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.",
          "as a single agent for the treatment of patients with recurrent, metastatic non-squamous, NSCLC after prior chemotherapy."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Pemetrexed is a folate analog metabolic inhibitor that disrupts folate-dependent metabolic processes essential for cell replication. In vitro studies show that Pemetrexed inhibits thymidylate synthase (TS), dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase (GARFT), which are folate-dependent enzymes involved in the de novo biosynthesis of thymidine and purine nucleotides. Pemetrexed is taken into cells by membrane carriers such as the reduced folate carrier and membrane folate binding protein transport systems. Once in the cell, Pemetrexed is converted to polyglutamate forms by the enzyme folylpolyglutamate synthetase. The polyglutamate forms are retained in cells and are inhibitors of of TS and GARFT.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": null,
        "items": [
          "Ibuprofen increases exposure (AUC) of Alimta. In patients with creatinine clearance between 45mL/min and 79mL/min",
          "Avoid administration of Ibuprofen for 2 days before, the day of, and 2 days following administration of Alimta.",
          "Monitor patients more frequently for myelosuppression, renal, and gastrointestinal toxicity, if concomitant administration of Ibuprofen cannot be avoided."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Pemetrexed is contraindicated in patients with a history of severe hypersensitivity reaction to Pemetrexed.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": null,
        "items": [
          "Myelosuppression",
          "Renal failure",
          "Bullous and exfoliative skin toxicity",
          "Interstitial",
          "pneumonitis",
          "Radiation recall"
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Can cause fetal harm when administered to a pregnant woman. There are no available data on Pemetrexed use in pregnant women. Pregnant women should be advised of the potential risk to a fetus. There is no information regarding the presence of Pemetrexed or its metabolites in human milk, the effects on the breastfed infant, or the effects on milk production. Because of the potential for serious adverse reactions in breastfed infants from Pemetrexed, advise women not to breastfeed during treatment with Pemetrexed and for one week after last dose.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Myelosuppression and Increased Risk of Myelosuppression without Vitamin",
        "information": ": Supplementation: Alimta can cause severe myelosuppression resulting in a requirement for transfusions and which may lead to neutropenic infection. The risk of myelosuppression is increased in patients who do not receive vitamin supplementation. Supplementation with oral folic acid and intramuscular vitamin B12 should be initiated prior to the first dose of Alimta; vitamin supplementation should be continued during treatment and for 21 days after the last dose of Alimta to reduce the severity of hematologic and gastrointestinal toxicity of Alimta.",
        "items": []
      },
      {
        "title": "Renal Failure",
        "information": ": Alimta can cause severe, and sometimes fatal, renal toxicity. The incidence of renal failure in clinical studies in which patients received Alimta as a single agent ranged from 0.4% to 0.6%. Creatinine clearance should be determined before each dose and periodically monitored renal function during treatment with Alimta. It should be withheld in patients with a creatinine clearance of less than 45mL/minute.",
        "items": []
      },
      {
        "title": "Bullous and Exfoliative Skin Toxicity",
        "information": ": Serious and sometimes fatal, bullous, blistering and exfoliative skin toxicity, including cases suggestive of Stevens-Johnson Syndrome/Toxic epidermal necrolysis can occur with Alimta. It should be permanently discontinued for severe and life-threatening bullous, blistering or exfoliating skin toxicity.",
        "items": []
      },
      {
        "title": "Interstitial Pneumonitis",
        "information": ": Serious interstitial pneumonitis, including fatal cases, can occur with Alimta treatment. Alimta should be withheld for acute onset of new or progressive unexplained pulmonary symptoms such as dyspnea, cough, or fever pending diagnostic evaluation. If pneumonitis is confirmed, Alimta should be permanently discontinued.",
        "items": []
      },
      {
        "title": "Radiation Recall",
        "information": ": Radiation recall can occur with Alimta in patients who have received radiation weeks to years previously. Patients should be monitored for inflammation or blistering in areas of previous radiation treatment. Alimta should be permanently discontinued for signs of radiation recall.",
        "items": []
      },
      {
        "title": "Increased Risk of Toxicity with Ibuprofen in Patients with Renal Impairment",
        "information": ": Exposure to Alimta is increased in patients with mild to moderate renal impairment who take concomitant Ibuprofen, increasing the risks of adverse reactions of Alimta. In patients with Creatinine clearances between 45mL/min and 79mL/min, Ibuprofen administration should be avoided for 2 days before, the day of, and 2 days following administration of Alimta. If concomitant Ibuprofen use cannot be avoided, patients should be monitored more frequently for Alimta adverse reactions, including myelosuppression, renal, and gastrointestinal toxicity.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "No drugs are approved for the treatment of Alimta overdose. Based on animal studies, administration of leucovorin may mitigate the toxicities of Alimta overdosage. It is not known whether Alimta is dialyzable.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C in a cool and dry place, away from sunlight. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Pemetrexed is a cytotoxic drug. Follow applicable special handling and disposal procedures. Calculate the dose of Pemetrexed and determine the number of vials needed. Reconstitute Pemetrexed to achieve a concentration of 25mg/m2L as follows: Gently swirl each vial until the powder is completely dissolved. The resulting solution is clear and ranges in color from. Store reconstituted, preservative-free product under refrigerated conditions (2°-8°C) for no longer than 24 hours from the time of reconstitution. Discard vial after 24 hours. Inspect reconstituted product visually for particulate matter and discoloration prior to further dilution. If particulate matter is observed, discard vial. Withdraw the calculated dose of Pemetrexed from the vial(s) and discard vial with any unused portion. Further dilute Pemetrexed with 0.9% Sodium Chloride Injection (preservative-free) to achieve a total volume of 100mL for intravenous infusion. Store diluted, reconstituted product under refrigerated conditions (2°-8°C) for no more than 24 hours from the time of reconstitution. Discard after 24 hours.",
        "items": [
          "Reconstitute each 100-mg vial with 4.2mL of 0.9% Sodium Chloride Injection, USP (preservative-free)",
          "Reconstitute each 500-mg vial with 20mL of 0.9% Sodium Chloride Injection, USP (preservative-free)",
          "Do not use Calcium-containing solutions for reconstitution."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cytotoxic Chemotherapy",
    "dosage": [
      {
        "medication_type": "Recommended Dosage for Non-Squamous NSCLC",
        "information": ": The recommended dose of Pemetrexed when administered with Pembrolizumab and platinum chemotherapy for the initial treatment of metastatic non-squamous NSCLC in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes administered after Pembrolizumab and prior to Carboplatin or Cisplatin on Day 1 of each 21-day cycle for 4 cycles. Following completion of platinum-based therapy, treatment with Pemetrexed with or without Pembrolizumab is administered until disease progression or unacceptable toxicity.",
        "instructions": []
      },
      {
        "medication_type": "The recommended dose of Pemetrexed when administered with Cisplatin",
        "information": ": for initial treatment of locally advanced or metastatic non-squamous NSCLC in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes administered prior to Cisplatin on Day 1 of each 21-day cycle for up to six cycles in the absence of disease progression or unacceptable toxicity.",
        "instructions": []
      },
      {
        "medication_type": "The recommended dose of Pemetrexed for maintenance treatment of non-squamous NSCLC",
        "information": ": in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle until disease progression or unacceptable toxicity after four cycles of platinum-based first-line chemotherapy.",
        "instructions": []
      },
      {
        "medication_type": "The recommended dose of Pemetrexed for treatment of recurrent non-squamous NSCLC",
        "information": ": in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle until disease progression or unacceptable toxicity.",
        "instructions": []
      },
      {
        "medication_type": "Recommended Dosage for Mesothelioma",
        "information": ": The recommended dose of Pemetrexed when administered with Cisplatin in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle until disease progression or unacceptable toxicity.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:28.968Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e13",
    "original_record": {
      "input_index": 816,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e13"
        },
        "name": "Alimta",
        "strength": "500 mg/20 ml",
        "generic": "Pemetrexed",
        "company": "Healthcare Pharmaceuticals Ltd.",
        "medicine_type": "IV Infusion",
        "source_url": "https://medex.com.bd/brands/15073/alimta-500-mg-injection",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28995/alimta-100-mg-injection",
    "name": "Alimta",
    "dosage_form": "IV Infusion",
    "generic": "Pemetrexed",
    "strength": "100 mg/4 ml",
    "company": "Eli Lilly and Company",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 15,500.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 mg vial",
          "price": "৳ 15,500.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "500 mg/20 ml (IV Infusion)",
        "href": "https://medex.com.bd/brands/15073/alimta-500-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/870/pemetrexed/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alimta is indicated in Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Alimta is indicated in Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Limitations of Use: Alimta is not indicated for the treatment of patients with squamous cell, non-small cell lung cancer. Mesothelioma: Alimta is indicated, in combination with Cisplatin, for the initial treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery.",
        "items": [
          "in combination with Pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous NSCLC, with no EGFR or ALK genomic tumor aberrations.",
          "in combination with Cisplatin for the initial treatment of patients with locally advanced or metastatic, nonsquamous, non-small cell lung cancer (NSCLC).",
          "in combination with Pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous NSCLC, with no EGFR or ALK genomic tumor aberrations.",
          "in combination with Cisplatin for the initial treatment of patients with locally advanced or metastatic, nonsquamous, non-small cell lung cancer (NSCLC).",
          "as a single agent for the maintenance treatment of patients with locally advanced or metastatic, nonsquamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.",
          "as a single agent for the treatment of patients with recurrent, metastatic non-squamous, NSCLC after prior chemotherapy."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Pemetrexed is a folate analog metabolic inhibitor that disrupts folate-dependent metabolic processes essential for cell replication. In vitro studies show that Pemetrexed inhibits thymidylate synthase (TS), dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase (GARFT), which are folate-dependent enzymes involved in the de novo biosynthesis of thymidine and purine nucleotides. Pemetrexed is taken into cells by membrane carriers such as the reduced folate carrier and membrane folate binding protein transport systems. Once in the cell, Pemetrexed is converted to polyglutamate forms by the enzyme folylpolyglutamate synthetase. The polyglutamate forms are retained in cells and are inhibitors of of TS and GARFT.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": null,
        "items": [
          "Ibuprofen increases exposure (AUC) of Alimta. In patients with creatinine clearance between 45mL/min and 79mL/min",
          "Avoid administration of Ibuprofen for 2 days before, the day of, and 2 days following administration of Alimta.",
          "Monitor patients more frequently for myelosuppression, renal, and gastrointestinal toxicity, if concomitant administration of Ibuprofen cannot be avoided."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Pemetrexed is contraindicated in patients with a history of severe hypersensitivity reaction to Pemetrexed.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": null,
        "items": [
          "Myelosuppression",
          "Renal failure",
          "Bullous and exfoliative skin toxicity",
          "Interstitial",
          "pneumonitis",
          "Radiation recall"
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Can cause fetal harm when administered to a pregnant woman. There are no available data on Pemetrexed use in pregnant women. Pregnant women should be advised of the potential risk to a fetus. There is no information regarding the presence of Pemetrexed or its metabolites in human milk, the effects on the breastfed infant, or the effects on milk production. Because of the potential for serious adverse reactions in breastfed infants from Pemetrexed, advise women not to breastfeed during treatment with Pemetrexed and for one week after last dose.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Myelosuppression and Increased Risk of Myelosuppression without Vitamin",
        "information": ": Supplementation: Alimta can cause severe myelosuppression resulting in a requirement for transfusions and which may lead to neutropenic infection. The risk of myelosuppression is increased in patients who do not receive vitamin supplementation. Supplementation with oral folic acid and intramuscular vitamin B12 should be initiated prior to the first dose of Alimta; vitamin supplementation should be continued during treatment and for 21 days after the last dose of Alimta to reduce the severity of hematologic and gastrointestinal toxicity of Alimta.",
        "items": []
      },
      {
        "title": "Renal Failure",
        "information": ": Alimta can cause severe, and sometimes fatal, renal toxicity. The incidence of renal failure in clinical studies in which patients received Alimta as a single agent ranged from 0.4% to 0.6%. Creatinine clearance should be determined before each dose and periodically monitored renal function during treatment with Alimta. It should be withheld in patients with a creatinine clearance of less than 45mL/minute.",
        "items": []
      },
      {
        "title": "Bullous and Exfoliative Skin Toxicity",
        "information": ": Serious and sometimes fatal, bullous, blistering and exfoliative skin toxicity, including cases suggestive of Stevens-Johnson Syndrome/Toxic epidermal necrolysis can occur with Alimta. It should be permanently discontinued for severe and life-threatening bullous, blistering or exfoliating skin toxicity.",
        "items": []
      },
      {
        "title": "Interstitial Pneumonitis",
        "information": ": Serious interstitial pneumonitis, including fatal cases, can occur with Alimta treatment. Alimta should be withheld for acute onset of new or progressive unexplained pulmonary symptoms such as dyspnea, cough, or fever pending diagnostic evaluation. If pneumonitis is confirmed, Alimta should be permanently discontinued.",
        "items": []
      },
      {
        "title": "Radiation Recall",
        "information": ": Radiation recall can occur with Alimta in patients who have received radiation weeks to years previously. Patients should be monitored for inflammation or blistering in areas of previous radiation treatment. Alimta should be permanently discontinued for signs of radiation recall.",
        "items": []
      },
      {
        "title": "Increased Risk of Toxicity with Ibuprofen in Patients with Renal Impairment",
        "information": ": Exposure to Alimta is increased in patients with mild to moderate renal impairment who take concomitant Ibuprofen, increasing the risks of adverse reactions of Alimta. In patients with Creatinine clearances between 45mL/min and 79mL/min, Ibuprofen administration should be avoided for 2 days before, the day of, and 2 days following administration of Alimta. If concomitant Ibuprofen use cannot be avoided, patients should be monitored more frequently for Alimta adverse reactions, including myelosuppression, renal, and gastrointestinal toxicity.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "No drugs are approved for the treatment of Alimta overdose. Based on animal studies, administration of leucovorin may mitigate the toxicities of Alimta overdosage. It is not known whether Alimta is dialyzable.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C in a cool and dry place, away from sunlight. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Pemetrexed is a cytotoxic drug. Follow applicable special handling and disposal procedures. Calculate the dose of Pemetrexed and determine the number of vials needed. Reconstitute Pemetrexed to achieve a concentration of 25mg/m2L as follows: Gently swirl each vial until the powder is completely dissolved. The resulting solution is clear and ranges in color from. Store reconstituted, preservative-free product under refrigerated conditions (2°-8°C) for no longer than 24 hours from the time of reconstitution. Discard vial after 24 hours. Inspect reconstituted product visually for particulate matter and discoloration prior to further dilution. If particulate matter is observed, discard vial. Withdraw the calculated dose of Pemetrexed from the vial(s) and discard vial with any unused portion. Further dilute Pemetrexed with 0.9% Sodium Chloride Injection (preservative-free) to achieve a total volume of 100mL for intravenous infusion. Store diluted, reconstituted product under refrigerated conditions (2°-8°C) for no more than 24 hours from the time of reconstitution. Discard after 24 hours.",
        "items": [
          "Reconstitute each 100-mg vial with 4.2mL of 0.9% Sodium Chloride Injection, USP (preservative-free)",
          "Reconstitute each 500-mg vial with 20mL of 0.9% Sodium Chloride Injection, USP (preservative-free)",
          "Do not use Calcium-containing solutions for reconstitution."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cytotoxic Chemotherapy",
    "dosage": [
      {
        "medication_type": "Recommended Dosage for Non-Squamous NSCLC",
        "information": ": The recommended dose of Pemetrexed when administered with Pembrolizumab and platinum chemotherapy for the initial treatment of metastatic non-squamous NSCLC in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes administered after Pembrolizumab and prior to Carboplatin or Cisplatin on Day 1 of each 21-day cycle for 4 cycles. Following completion of platinum-based therapy, treatment with Pemetrexed with or without Pembrolizumab is administered until disease progression or unacceptable toxicity.",
        "instructions": []
      },
      {
        "medication_type": "The recommended dose of Pemetrexed when administered with Cisplatin",
        "information": ": for initial treatment of locally advanced or metastatic non-squamous NSCLC in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes administered prior to Cisplatin on Day 1 of each 21-day cycle for up to six cycles in the absence of disease progression or unacceptable toxicity.",
        "instructions": []
      },
      {
        "medication_type": "The recommended dose of Pemetrexed for maintenance treatment of non-squamous NSCLC",
        "information": ": in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle until disease progression or unacceptable toxicity after four cycles of platinum-based first-line chemotherapy.",
        "instructions": []
      },
      {
        "medication_type": "The recommended dose of Pemetrexed for treatment of recurrent non-squamous NSCLC",
        "information": ": in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle until disease progression or unacceptable toxicity.",
        "instructions": []
      },
      {
        "medication_type": "Recommended Dosage for Mesothelioma",
        "information": ": The recommended dose of Pemetrexed when administered with Cisplatin in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m2 as an intravenous infusion over 10 minutes on Day 1 of each 21-day cycle until disease progression or unacceptable toxicity.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:30.277Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e14",
    "original_record": {
      "input_index": 817,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e14"
        },
        "name": "Alimta",
        "strength": "100 mg/4 ml",
        "generic": "Pemetrexed",
        "company": "Healthcare Pharmaceuticals Ltd.",
        "medicine_type": "IV Infusion",
        "source_url": "https://medex.com.bd/brands/28995/alimta-100-mg-injection",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/29462/alistin-dt-600-mg-tablet",
    "name": "Alistin DT",
    "dosage_form": "Dispersible Tablet",
    "generic": "Acetylcysteine",
    "strength": "600 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": "৳ 150.00",
      "pack_size_info": "(3 x 10: ৳ 450.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 15.00",
          "pack_size_info": "(3 x 10: ৳ 450.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 150.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "600 mg (Eff. Tablet)",
        "href": "https://medex.com.bd/brands/34390/alistin-ef-600-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/6/acetylcysteine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alistin DT is indicated as an adjuvant treatment in certain clinical condition characterized by the presence of thick and viscous mucoid or mucopurulent secretions such as: Chronic bronchopulmonary diseases (chronic obstructive pulmonary disease, emphysema with bronchitis, chronic asthmatic bronchitis ... Read moreAlistin DT is indicated as an adjuvant treatment in certain clinical condition characterized by the presence of thick and viscous mucoid or mucopurulent secretions such as: Chronic bronchopulmonary diseases (chronic obstructive pulmonary disease, emphysema with bronchitis, chronic asthmatic bronchitis, bronchiectasis); Acute bronchopulmonary diseases (asthma with bronchial mucus plugging, bronchitis, bronchopneumonia, tracheobronchitis, bronchiolitis, pulmonary complications of cystic fibrosis, pulmonary complications associated with surgery).",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Acetylcysteine is a mucolytic agent that reduces the viscosity of secretions probably by the splitting of disulphide bonds in mucoproteins. Moreover it gives antisecretory effect. These results in clearing of respiratory ducts and facilitate breathing. Acetylcysteine also has anti-oxidant properties by reacting with free radicals and also by serving as a precursor to glutathione, which is an important intra and extra-cellular antioxidant. By providing anti-oxidant action, it neutralizes exogenous and endogenous oxidants, which in fact act as pathogens in respiratory inflammations.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The thiol group of Alistin DT can reduce the efficacy of certain antibiotics such as ampicillin, tetracycline, macrolides, cephalosporins, aminoglycosides and amphotericin. Concomitant use of Alistin DT and amoxicillin will increase the level of the antibiotic in tissues. It is, therefore, advisable to use the two medicines 2 hours apart from each other. Alistin DT can increase the inhibitory effect of thrombocyte aggregation and vasodialation by nitroglycerine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Known hypersensitivity to Acetylcysteine. Acetylcysteine contains aspartame, thus it is contraindicated in patients suffering from phenylketonuria.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Like all medicines, Alistin DT can cause side effects, although not everybody gets them. In very rare cases, severe immune reactions may occur such as anaphylactic shock and severe skin reaction. In rare cases the oral administration can be followed by shortness of breath, upset stomach and bronchospasm. The most frequent side effects are headache, increased heart rate, stomatitis, pruritus, urticaria, nausea, vomiting, abdominal pain, fever, decrease in the blood pressure, diarrhoea and noises in the ears.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "In case of pregnancy & lactation the medicine should be taken consulting physician or pharmacist.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients suffering from bronchial asthma must be strictly controlled during the therapy; should bronchospasm occur, the treatment must immediately be suspended. Caution should be taken in patients suffering from or with a history of peptic ulcer. As Viscotin contains sodium (156.9mg per dose) this has to be taken into consideration by patients on a controlled sodium diet. The possible presence of a sulphureous odor does not indicate an alteration of the product but is a characteristic of the active ingredient contained in Alistin DT. It is preferable not to mix other drugs with the Viscotin solution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Overdose of Alistin DT may cause nausea, vomiting or diarrhoea.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antidote preparations, Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": "Effervescent tablet or Dispersible tablet",
        "information": ": Adults and children above 6 years: One effervescent tablet of Acetylcysteine 600 mg a day (preferably in the evening). The duration of treatment should be 5 to 10 days in the acute treatment, whereas it may be continued in the chronic states for several months, according to the advice of the physician. Dissolve the tablets in a glass containing a small quantity of water, mixing it, if necessary, with a spoon. A palatable solution is thus obtained, which can be drunk directly from the glass.",
        "instructions": []
      },
      {
        "medication_type": "Effervescent Granules",
        "information": ": The duration of treatment should be 5 to 10 days in the acute treatment, whereas it may be continued in the chronic states for several months, according to the advice of the physician. Dissolve the contents of the sachets in a glass containing a small quantity of water; mixing it, if necessary, with a spoon. A palatable solution is thus obtained, which can be drunk directly from the glass.",
        "instructions": [
          "Adults and children above 6 years: 1 sachet Acetylcysteine 200 mg or 2 sachets Acetylcysteine 100 mg, 2-3 times a day.",
          "Children (2-6 years of age): 1 sachet Acetylcysteine 100 mg from 2 to 4 times a day, according to the age."
        ]
      },
      {
        "medication_type": "Nebuliser Solution",
        "information": ": The 20% solution may be diluted to a lesser concentration with either Sodium Chloride for injection, Sodium Chloride for inhalation, sterile water for injection, or sterile water for inhalation.",
        "instructions": [
          "Adult: 5-10 ml of 10% or 20% solution by Nebuliser every 6-8 hr PRN.",
          "Children: 1-11 months: 1-2 ml of 20% or 2-4 ml of 10% solution by Nebuliser every 6-8 hr PRN.",
          "12 months-11 years: 3-5 ml of 20% or 6-10 ml of 10% solution by Nebuliser every 6-8 hr PRN.",
          "Below 12 years: 5-10 ml of 10/20% solution by Nebuliser every 6-8 hr PRN."
        ]
      },
      {
        "medication_type": "** Diagnostic Bronchograms",
        "information": ": 1-2 ml of 20% or 2-4 ml of 10% solution 2-3 times by Nebulisation or by instillation intratracheally prior to procedure.",
        "instructions": []
      },
      {
        "medication_type": "** Nebulisation tent or croupette",
        "information": ": This form of administration requires very large volumes of the solution, occasionally as much as 300 ml during a single treatment period. If a tent or croupette must be used, the recommended dose is the volume of acetylcysteine (using 20%) that will maintain a very heavy mist in the tent or croupette for the desired period. Administration for intermittent or continuous prolonged periods, including overnight, may be desirable.",
        "instructions": []
      },
      {
        "medication_type": "** Direct Instillation",
        "information": ": When used by direct instillation, 1-2 ml of a 20% solution may be given as often as every hour. When used for the routine nursing care of patients with tracheostomy, 1-2 ml of a 20% solution may be given every 1-4 hours by instillation into the tracheostomy.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:31.659Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e17",
    "original_record": {
      "input_index": 818,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e17"
        },
        "name": "Alistin DT",
        "strength": "600 mg",
        "generic": "Acetylcysteine",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Dispersible Tablet",
        "source_url": "https://medex.com.bd/brands/29462/alistin-dt-600-mg-tablet",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34390/alistin-ef-600-mg-tablet",
    "name": "Alistin EF",
    "dosage_form": "Effervescent Tablet",
    "generic": "Acetylcysteine",
    "strength": "600 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 20.00",
      "strip_price": "৳ 280.00",
      "pack_size_info": "(1 x 14: ৳ 280.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 20.00",
          "pack_size_info": "(1 x 14: ৳ 280.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 280.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "600 mg (DT)",
        "href": "https://medex.com.bd/brands/29462/alistin-dt-600-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/6/acetylcysteine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alistin EF is indicated as an adjuvant treatment in certain clinical condition characterized by the presence of thick and viscous mucoid or mucopurulent secretions such as: Chronic bronchopulmonary diseases (chronic obstructive pulmonary disease, emphysema with bronchitis, chronic asthmatic bronchitis ... Read moreAlistin EF is indicated as an adjuvant treatment in certain clinical condition characterized by the presence of thick and viscous mucoid or mucopurulent secretions such as: Chronic bronchopulmonary diseases (chronic obstructive pulmonary disease, emphysema with bronchitis, chronic asthmatic bronchitis, bronchiectasis); Acute bronchopulmonary diseases (asthma with bronchial mucus plugging, bronchitis, bronchopneumonia, tracheobronchitis, bronchiolitis, pulmonary complications of cystic fibrosis, pulmonary complications associated with surgery).",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Acetylcysteine is a mucolytic agent that reduces the viscosity of secretions probably by the splitting of disulphide bonds in mucoproteins. Moreover it gives antisecretory effect. These results in clearing of respiratory ducts and facilitate breathing. Acetylcysteine also has anti-oxidant properties by reacting with free radicals and also by serving as a precursor to glutathione, which is an important intra and extra-cellular antioxidant. By providing anti-oxidant action, it neutralizes exogenous and endogenous oxidants, which in fact act as pathogens in respiratory inflammations.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The thiol group of Alistin EF can reduce the efficacy of certain antibiotics such as ampicillin, tetracycline, macrolides, cephalosporins, aminoglycosides and amphotericin. Concomitant use of Alistin EF and amoxicillin will increase the level of the antibiotic in tissues. It is, therefore, advisable to use the two medicines 2 hours apart from each other. Alistin EF can increase the inhibitory effect of thrombocyte aggregation and vasodialation by nitroglycerine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Known hypersensitivity to Acetylcysteine. Acetylcysteine contains aspartame, thus it is contraindicated in patients suffering from phenylketonuria.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Like all medicines, Alistin EF can cause side effects, although not everybody gets them. In very rare cases, severe immune reactions may occur such as anaphylactic shock and severe skin reaction. In rare cases the oral administration can be followed by shortness of breath, upset stomach and bronchospasm. The most frequent side effects are headache, increased heart rate, stomatitis, pruritus, urticaria, nausea, vomiting, abdominal pain, fever, decrease in the blood pressure, diarrhoea and noises in the ears.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "In case of pregnancy & lactation the medicine should be taken consulting physician or pharmacist.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients suffering from bronchial asthma must be strictly controlled during the therapy; should bronchospasm occur, the treatment must immediately be suspended. Caution should be taken in patients suffering from or with a history of peptic ulcer. As Viscotin contains sodium (156.9mg per dose) this has to be taken into consideration by patients on a controlled sodium diet. The possible presence of a sulphureous odor does not indicate an alteration of the product but is a characteristic of the active ingredient contained in Alistin EF. It is preferable not to mix other drugs with the Viscotin solution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Overdose of Alistin EF may cause nausea, vomiting or diarrhoea.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antidote preparations, Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": "Effervescent tablet or Dispersible tablet",
        "information": ": Adults and children above 6 years: One effervescent tablet of Acetylcysteine 600 mg a day (preferably in the evening). The duration of treatment should be 5 to 10 days in the acute treatment, whereas it may be continued in the chronic states for several months, according to the advice of the physician. Dissolve the tablets in a glass containing a small quantity of water, mixing it, if necessary, with a spoon. A palatable solution is thus obtained, which can be drunk directly from the glass.",
        "instructions": []
      },
      {
        "medication_type": "Effervescent Granules",
        "information": ": The duration of treatment should be 5 to 10 days in the acute treatment, whereas it may be continued in the chronic states for several months, according to the advice of the physician. Dissolve the contents of the sachets in a glass containing a small quantity of water; mixing it, if necessary, with a spoon. A palatable solution is thus obtained, which can be drunk directly from the glass.",
        "instructions": [
          "Adults and children above 6 years: 1 sachet Acetylcysteine 200 mg or 2 sachets Acetylcysteine 100 mg, 2-3 times a day.",
          "Children (2-6 years of age): 1 sachet Acetylcysteine 100 mg from 2 to 4 times a day, according to the age."
        ]
      },
      {
        "medication_type": "Nebuliser Solution",
        "information": ": The 20% solution may be diluted to a lesser concentration with either Sodium Chloride for injection, Sodium Chloride for inhalation, sterile water for injection, or sterile water for inhalation.",
        "instructions": [
          "Adult: 5-10 ml of 10% or 20% solution by Nebuliser every 6-8 hr PRN.",
          "Children: 1-11 months: 1-2 ml of 20% or 2-4 ml of 10% solution by Nebuliser every 6-8 hr PRN.",
          "12 months-11 years: 3-5 ml of 20% or 6-10 ml of 10% solution by Nebuliser every 6-8 hr PRN.",
          "Below 12 years: 5-10 ml of 10/20% solution by Nebuliser every 6-8 hr PRN."
        ]
      },
      {
        "medication_type": "** Diagnostic Bronchograms",
        "information": ": 1-2 ml of 20% or 2-4 ml of 10% solution 2-3 times by Nebulisation or by instillation intratracheally prior to procedure.",
        "instructions": []
      },
      {
        "medication_type": "** Nebulisation tent or croupette",
        "information": ": This form of administration requires very large volumes of the solution, occasionally as much as 300 ml during a single treatment period. If a tent or croupette must be used, the recommended dose is the volume of acetylcysteine (using 20%) that will maintain a very heavy mist in the tent or croupette for the desired period. Administration for intermittent or continuous prolonged periods, including overnight, may be desirable.",
        "instructions": []
      },
      {
        "medication_type": "** Direct Instillation",
        "information": ": When used by direct instillation, 1-2 ml of a 20% solution may be given as often as every hour. When used for the routine nursing care of patients with tracheostomy, 1-2 ml of a 20% solution may be given every 1-4 hours by instillation into the tracheostomy.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:32.852Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e18",
    "original_record": {
      "input_index": 819,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e18"
        },
        "name": "Alistin EF",
        "strength": "600 mg",
        "generic": "Acetylcysteine",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Effervescent Tablet",
        "source_url": "https://medex.com.bd/brands/34390/alistin-ef-600-mg-tablet",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/16922/alkatrim-200-mg-suspension",
    "name": "Alkatrim",
    "dosage_form": "Oral Suspension",
    "generic": "Sulphamethoxazole + Trimethoprim",
    "strength": "(200 mg+40 mg)/5 ml",
    "company": "Alkad Laboratories",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 22.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 22.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1024/sulphamethoxazole-trimethoprim/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Cotrimoxazole is bactericidal in vitro to a wide range of Gram-positive and Gram-negative organisms, including Streptococcus, Staphylococcus, Pneumococcus, Neisseria, B. catarrhalis, Escherichia coli, Klebsiella, Proteus spp., Haemophilus, Salmonella, Shigella, Vibrio cholerae, Brucella, Pneumocystis ... Read moreCotrimoxazole is bactericidal in vitro to a wide range of Gram-positive and Gram-negative organisms, including Streptococcus, Staphylococcus, Pneumococcus, Neisseria, B. catarrhalis, Escherichia coli, Klebsiella, Proteus spp., Haemophilus, Salmonella, Shigella, Vibrio cholerae, Brucella, Pneumocystis carinii, Nocardia and Bordetella. A particularly high degree of activity is exhibited against Haemophilus influenzae, E. coli and Proteus spp., making Cotrimoxazole particularly suitable for the treatment of chronic bronchitis and urinary tract infections. Cotrimoxazole exerts its bactericidal action by the sequential blockade of two bacterial enzyme systems in the biosynthesis of Folinic acid in the micro-organisms. The synergy thus produced accounts for the high degree of bactericidal activity.Alkatrim is indicated in:",
        "items": [
          "Respiratory tract infections, including acute and chronic bronchitis (treatment and prophylaxis), bronchiectasis, lung abscess, lobar and broncho-pneumonia, Pneumocystis carinii pneumonitis, sinusitis and otitis media.",
          "Genito-urinary tract infections, including urethritis, acute and chronic cystitis, pyelonephritis, prostatitis and gonorrhoea.",
          "Gastro-intestinal tract infections, caused by Salmonella typhi and Salmonella paratyphi, including the chronic carrier state.",
          "Other infections, caused by a wide range of organisms confirmed to be susceptible to Cotrimoxazole and where the therapeutic benefits are considered to outweigh the possible occurrence of adverse events.",
          "Such infections include acute and chronic osteomyelitis, acute brucellosis, skin infections including pyoderma, abscesses and wound infections, septicaemia, bacillary dysentery and cholera (as an adjuvant to fluid and electrolyte replacement), nocardiosis and mycetoma."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cotrimoxazole having broad spectrum bactericidal activity against a wide range of gram-positive & gram-negative bacteria and some protozoa. Co-trimoxazole containing Trimethoprim and Sulphamethoxazole in a 1:5 combination exerts its bactericidal action by the sequential blockade of two bacterial enzyme systems in the biosynthesis of folinic acid in the microorganism.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to trimethoprim or sulphonamides.",
          "Patients with documented megaloblastic anaemia due to folate deficiency.",
          "Patients showing marked liver parenchymal damage, blood dyscrasia, severe renal insufficiency, glucose 6-phosphate dehydrogenase deficiency."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The side effects like crystalluria, allergic reactions, haemolysis, thrombocytopenia, neutropenia, agranulocytosis etc. have been reported rarely with Sulphamethoxazole-Trimethoprim combination. Other side effects are less serious in nature such as malaise, headache, nausea and vomiting. These are normally transient and do not require withdrawal of treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy and during the nursing period, because sulphonamides pass the placenta and are excreted in the breast milk and may cause kernicterus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Prolonged full dose treatment with sulfamethoxazole-trimethoprim combination is associated with the risk of macrocytic anaemia due to the drug’s interference in the conversion of Folic acid into Folinic acid. If this occurs, it can be reversed by giving Folinic acid. Care should be taken when giving Alkatrim to diabetic patients receiving sulphonylurea drug for possible potentiation of action of sulphonylurea.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-diarrhoeal Antimicrobial drugs, Sulphonamides & Trimethoprim",
    "dosage": [
      {
        "medication_type": null,
        "information": "Cotrimoxazole double strength tablet: Over 12 years",
        "instructions": []
      },
      {
        "medication_type": "For mild to moderate infections",
        "information": ": 1 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": "For severe infections",
        "information": ": 1.5 tablets twice daily.",
        "instructions": []
      },
      {
        "medication_type": "Long term therapy (>14 days)",
        "information": ": 0.5 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": "Gonorrhoea",
        "information": ": 2 tablets every 12 hours for two days or 2.5 tablets followed by a further dose of 2.5 tablets after 8 hours.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cotrimoxazole tablet: over 12 years",
        "instructions": []
      },
      {
        "medication_type": "For mild to moderate infections",
        "information": ": 2 tablets twice daily.",
        "instructions": []
      },
      {
        "medication_type": "For severe infections",
        "information": ": 2 tablets thrice daily.",
        "instructions": []
      },
      {
        "medication_type": "Long term therapy",
        "information": ": (>14 days): 1 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Cotrimoxazole suspension: Under 12 years",
        "instructions": []
      },
      {
        "medication_type": "6-12 years",
        "information": ": 2 teaspoonful twice daily.",
        "instructions": []
      },
      {
        "medication_type": "6 month-5 years",
        "information": ": 1 teaspoonful twice daily.",
        "instructions": []
      },
      {
        "medication_type": "6 weeks-6 months",
        "information": ": 0.5 teaspoonful twice daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:33.928Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e23",
    "original_record": {
      "input_index": 820,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e23"
        },
        "name": "Alkatrim",
        "strength": "(200 mg+40 mg)/5 ml",
        "generic": "Sulphamethoxazole + Trimethoprim",
        "company": "Alkad Laboratories",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/16922/alkatrim-200-mg-suspension",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/29233/alken-1500-mg-oral-solution",
    "name": "Alken",
    "dosage_form": "Oral Solution",
    "generic": "Potassium Citrate + Citric Acid",
    "strength": "(1500 mg+250 mg)/5 ml",
    "company": "Al-Madina Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 100.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 100.00",
          "pack_size_info": null
        },
        {
          "label": "200 ml bottle",
          "price": "৳ 190.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/270/potassium-citrate-citric-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alken oral solution is indicated in the following cases:",
        "items": [
          "To relieve discomfort in urinary tract infections",
          "To prevent kidney stone",
          "With uricosuric agent to prevent gout",
          "Acidosis caused by kidney diseases"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Potassium Citrate is absorbed and metabolized to potassium bicarbonate, this acting as a systemic alkalizer. The effects are essentially those of chlorides before absorption and those of bicarbonates subsequently. Oxidation is virtually complete so that less than 5% of the potassium citrate is excreted in the urine unchanged.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concurrent administration of potassium-containing medication, potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors or cardiac glycosides may lead to toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "The drug is contraindicated in severe renal impairment with oliguria or azotemia, untreated Addison's disease, acute dehydration, severe myocardial damage and hyperkalemia from any cause.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "This solution is generally well tolerated without any unpleasant side effect when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of hyperkalemia or alkalosis. Potassium intoxication causes listlessness, weakness, mental confusion, tingling of extremities and other symptoms associated with a high concentration of Potassium in the serum.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Potassium Citrate oral solution in pregnant women. Animal studies are insufficient with respect to effects on pregnancy. The potential risk to humans is unknown. Potassium Citrate oral solution should not be used during pregnancy unless clearly necessary and on the advice of a physician.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "The solution should be used with caution in patients with low urinary output. It should be diluted adequately with water to minimize the possibility of gastrointestinal injury associated with the oral ingestion of concentrated Potassium salt preparations; and preferably, to take each dose after meals. Large doses may cause hyperkalemia and alkalosis, especially in the presence of renal disease. Large doses may cause hyperkalemia an alkalosis, especially in the presence of renal disease. Concurrent administration of potassium-containing medication, potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, or cardiac glycosides may lead to toxicity. Do not exceed recommended dosage. Discontinue use if adverse reaction occurs. Should be used with caution by patients with low urinary output unless under the supervision of a physician. As with all liquids containing a high concentration of potassium, patients should be directed to dilute adequately with water to minimize the possibility of gastrointestinal injury associated with the oral ingestion of concentrated potassium salt preparations; and preferable, to take each dose after meals to avoid saline laxative effect.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "The administration of oral Potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious hyperkalemia. However, if excretory mechanisms are impaired, hyperkalemia can result. Hyperkalemia, when detected, must be treated immediately because lethal levels can be reached in a few hours. If hyperkalemia occurs, treatment measures will include the followings: (1) Elimination of foods or medications containing potassium. (2) The intravenous administration of 300 to 500 ml/hr of dextrose solution (10 to 25%), containing 10 units of insulin/20 gm dextrose. (3) The use of exchange resins, hemodialysis or peritoneal dialysis.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Oral Solution is an effective alkalinizing agent useful in those conditions where long-term maintenance of alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be preferable. Alken is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. Alken alkalinizes the urine without producing a systemic alkalosis in recommended dosage. It is highly palatable, pleasant tasting and tolerable, even when administered for long periods. Potassium Citrate does not neutralize the gastric juice or disturb digestion.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Prevention of repeated kidney stone formation, Urinary Alkalinizing Agent",
    "dosage": [
      {
        "medication_type": null,
        "information": "Oral Solution should be taken diluted in water according to directions, followed by additional water, if desired. Palatability is enhanced if chilled before taking. Proper dilution may help prevent gastrointestinal injury associated with the oral ingestion of concentrated potassium salt preparations. To relieve discomfort in UTI:",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 6 years",
        "information": ": 10 ml 3 times daily, diluted with 1 glass of water.",
        "instructions": []
      },
      {
        "medication_type": "Children 1-6 years",
        "information": ": 5 ml 3 times daily, diluted with ½ glass of water.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "To prevent kidney stones, With a uricosuric agent to prevent gout, Acidosis caused by kidney diseases:",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": 10-15 ml 4 times daily (or as directed by the physician) diluted with 1 glass of water.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric",
        "information": ": 5-10 ml 4 times daily (or as directed by the physician) diluted with ½ glass of water.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:35.068Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e25",
    "original_record": {
      "input_index": 821,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e25"
        },
        "name": "Alken",
        "strength": "(1500 mg+250 mg)/5 ml",
        "generic": "Potassium Citrate + Citric Acid",
        "company": "Al-Madina Pharmaceuticals Ltd.",
        "medicine_type": "Oral Solution",
        "source_url": "https://medex.com.bd/brands/29233/alken-1500-mg-oral-solution",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/38109/alkixen-250-mg-capsule",
    "name": "Alkixen",
    "dosage_form": "Capsule",
    "generic": "Crizotinib",
    "strength": "250 mg",
    "company": "Everest Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 350.00",
      "strip_price": "৳ 10,500.00",
      "pack_size_info": "(1 x 30: ৳ 10,500.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 350.00",
          "pack_size_info": "(1 x 30: ৳ 10,500.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 10,500.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1379/crizotinib/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alkixen is a kinase inhibitor indicated for the treatment of patients with-",
        "items": [
          "Metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive.",
          "Metastatic NSCLC whose tumors are ROS1-positive."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Crizotinib is an inhibitor of receptor tyrosine kinases including ALK, Hepatocyte Growth Factor Receptor (HGFR, c-Met), ROS1 (c-ros), and Recepteur d'Origine Nantais (RON). Translocations can affect the ALK gene resulting in the expression of oncogenic fusion proteins. The formation of ALK fusion proteins results in activation and dysregulation of the gene’s expression and signaling which can contribute to increased cell proliferation and survival in tumors expressing these proteins. Crizotinib demonstrated concentration-dependent inhibition of ALK, ROS1, and c-Met phosphorylation in cell-based assays using tumor cell lines and demonstrated antitumor activity in mice bearing tumor xenografts that expressed echinoderm microtubule-associated protein-like 4 (EML4)- or nucleophosmin (NPM)-ALK fusion proteins or c-Met.",
        "items": []
      },
      {
        "title": "Absorption",
        "information": ": Following oral single-dose administration, crizotinib was absorbed with median time to achieve peak concentration of 4 to 6 hours. Following crizotinib 250 mg twice daily, steady state was reached within 15 days and remained stable, with a median accumulation ratio of 4.8. Steady state systemic exposure (C.min and AUC) appeared to increase in a greater than dose proportional manner over the dose range of 200-300 mg twice daily. The mean absolute bioavailability of crizotinib was 43% (range: 32% to 66%) following the administration of a single 250 mg oral dose. A high-fat meal reduced crizotinib AUCinf and Cmax by approximately 14%.",
        "items": []
      },
      {
        "title": "Distribution",
        "information": ": The geometric mean volume of distribution (Vss) of crizotinib was 1772 L following intravenous administration of a 50 mg dose, indicating extensive distribution into tissues from the plasma. Binding of crizotinib to human plasma proteins in vitro is 91% and is independent of drug concentration. In vitro studies suggested that crizotinib is a substrate for P-glycoprotcin (P-gp). The blood-to-plasma concentration ratio is approximately 1.",
        "items": []
      },
      {
        "title": "Metabolism",
        "information": ": In vitro studies demonstrated that crizotinib is predominantly metabolized by CYP3A4/5. The primary metabolic pathways in humans were oxidation of the piperidine ring to crizotinib lactam and O dealkylation, with subsequent Phase 2 conjugation of O-dcalkylatcd metabolites.",
        "items": []
      },
      {
        "title": "Elimination",
        "information": ": Following single doses of crizotinib, the mean apparent plasma terminal half-life of crizotinib was 42 hours in patients. Following the administration of a single 250 mg radiolabeled crizotinib dose to healthy subjects, 63% and 22% of the administered dose was recovered in feces and urine, respectively. Unchanged crizotinib represented approximately 53% and 2.3% of the administered dose in feces and urine, respectively. The mean apparent clearance (CL/F) of crizotinib was lower at steady state (60 L/hr) after 250 mg twice daily than that after a single 250 mg oral dose (100 L/hr), which was likely due to auto inhibition of CYP3A by crizotinib after multiple dosing.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "CYP3A Inhibitors",
        "information": ": Concurrent use of Alkixen should be avoided with strong CYP3A inhibitors including but not limited to atazanavir, clarithromycin, indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, troleandomycin, and voriconazole",
        "items": []
      },
      {
        "title": "CYP3A Inducers",
        "information": ": Concurrent use of Alkixen should be avoided with strong CYP3A inducers including but not limited to carbamazepine, phenobarbital, phenytoin, rifabutin, rifampin, and St. John’s Wort",
        "items": []
      },
      {
        "title": "CYP3A Substrates",
        "information": ": Concurrent use of Alkixen should be avoided with CYP3A substrates with narrow therapeutic indices including but not limited to alfentanil, cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse reactions (≥25%) are vision disorders, nausea, diarrhea, vomiting, edema, constipation, elevated transaminases, fatigue, decreased appetite, upper respiratory infection, dizziness, and neuropathy.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Based on its mechanism of action, Crizotinib can cause fetal harm when administered to a pregnant woman. There are no available data on the use of Crizotinib during pregnancy. Females of reproductive potential should be advised of the potential risk to a fetus and use of effective contraception. There is no information regarding the presence of Crizotinib in human milk, the effects on the breastfed infant, or the effects on milk production. Because of the potential for adverse reactions in breastfed infants patients should not breastfeed during treatment with Crizotinib and for 45 days after the final dose.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Hepatotoxicity",
        "information": ": Patients should undergo periodic liver testing. Alkixen should be temporarily suspended, dose reduced or permanently suspended",
        "items": []
      },
      {
        "title": "Interstitial lung disease (ILD)/ Pneumonitis",
        "information": ": Drug should be permanently discontinued in patients with ILD/ Pneumonitis",
        "items": []
      },
      {
        "title": "QT interval prolongation",
        "information": ": Electrocardiograms and electrolytes in patients who have a history of or predisposition for QTc prolongation, or who are taking medications that prolong QT should be monitored. Alkixen should be temporarily suspended, dose reduced or permanently suspended",
        "items": []
      },
      {
        "title": "Bradycardia",
        "information": ": Alkixen can cause bradycardia. Heart rate and blood pressure should be regularly monitored. Alkixen should be temporarily suspended, dose reduced or permanently suspended",
        "items": []
      },
      {
        "title": "Severe visual loss",
        "information": ": Ophthalmological evaluation should be performed. Alkixen should be discontinued in severe visual loss",
        "items": []
      },
      {
        "title": "Embryo-fetal toxicity",
        "information": ": Alkixen can cause fetal harm. Females of reproductive potential should be advised of the potential risk to a fetus and use of effective contraception",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Alkixen is a kinase inhibitor indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive. Alkixen is the first FDA-approved biomarker-driven therapy for both ALK positive and ROS1-positive metastatic NSCLC. It is the only FDA approved drug for ROS 1 positive NSCLC.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Targeted Cancer Therapy",
    "dosage": [
      {
        "medication_type": "Recommended Dose",
        "information": ": 250 mg orally, twice daily",
        "instructions": []
      },
      {
        "medication_type": "Geriatric Use",
        "information": ": No differences in safety or efficacy were observed between older and younger patients. Clinical studies of Crizotinib in patients with ROS1-positive metastatic NSCLC did not include sufficient numbers of patients age 65 years and older to determine whether they respond differently from younger patients",
        "instructions": []
      },
      {
        "medication_type": "Pediatric Dose",
        "information": ": The safety and effectiveness of Crizotinib in pediatric patients have not been established.",
        "instructions": []
      },
      {
        "medication_type": "Renal impairment",
        "information": ": 250 mg orally, once daily in patients with severe renal impairment (creatinine clearance <30 mL/min) not requiring dialysis. No starting dose adjustment is needed for patients with mild (ClCr 60-89 mL/min) or moderate (ClCr 30-59 mL/min) renal impairment based on a population pharmacokinetic analysis.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": Caution should be used in patients with hepatic impairment",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:36.181Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e27",
    "original_record": {
      "input_index": 822,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e27"
        },
        "name": "Alkixen",
        "strength": "250 mg",
        "generic": "Crizotinib",
        "company": "Everest Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/38109/alkixen-250-mg-capsule",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31997/agorest-25-mg-tablet",
    "name": "Agorest",
    "dosage_form": "Tablet",
    "generic": "Agomelatine",
    "strength": "25 mg",
    "company": "Everest Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 35.00",
      "strip_price": "৳ 350.00",
      "pack_size_info": "(2 x 10: ৳ 700.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 35.00",
          "pack_size_info": "(2 x 10: ৳ 700.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 350.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/35/agomelatine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Agorest is indicated for the major depressive disorder in adults especially in non-responders and intolerant to selective serotonin reuptake inhibitors (SSRIs) including prevention of relapse.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Agomelatine is a melatonergic agonist (MT 1 and MT2 receptors) and 5-HT 2C antagonist. Binding studies indicate that agomelatine has no effect on monoamine uptake and no affinity for a, (3 adrenergic, histaminergic, cholinergic, dopaminergic and benzodiazepine receptors. Agomelatine resynchronises circadian rhythms in animal models of circadian rhythm disruption. Agomelatine increases noradrenaline and dopamine release specifically in the frontal cortex and has no influence on the extracellular levels of serotonin.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Agorest is metabolised mainly by cytochrome P450 1A2 (CYP1A2) (90%) and by CYP2C9/19 (10%). Medicinal products that interact with these isoenzymes may decrease or increase the bioavailability of Agorest. Fluvoxamine, a potent CYP1A2 and moderate CYP2C9 inhibitor markedly inhibits the metabolism of Agorest resulting in a 60-fold (range 12-412) increase of Agorest exposure. Consequently, co-administration of Agorest with potent CYP1A2 inhibitors (e.g. fluvoxamine, ciprofloxacin) is contraindicated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to the active substances or to any of the excipients. Hepatic impairment (i.e cirrhosis or active liver disease), or transaminases exceeding 3 times upper limit of normal. Concomitant use of potent CYPIA2 inhibitors (eg. Fluvoxamine, ciprofloxacin).",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The commonly reported adverse effects in the clinical trials of Agorest are headache, nausea and diarrhea. It is found to increase the level of liver enzymes and so monitoring of enzyme level is warranted before starting therapy and therefore every 6 weeks. It is also contraindicated in patients with hepatic impairment. A meta-analysis of the treatment emergent sexual dysfunction with antidepressants has revealed that it has no significant difference with placebo.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Use in pregnancy",
        "information": ": For agomelatine, no clinical data on exposed pregnancies are available. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development. Caution should be exercised when prescribing to pregnant women.",
        "items": []
      },
      {
        "title": "Use in lactation",
        "information": ": It is not known whether agomelatine is excreted into human milk. Agomelatine or its metabolites are excreted in the milk of lactating rats. Potential effects of agomelatine on the breastfeeding infant have not been established. If treatment with agomelatine is considered necessary, breastfeeding should be discontinued.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised before starting treatment and close surveillance should be performed throughout the treatment period in all patients, especially if hepatic injury risk factors or concomitant medicinal products associated with risk of hepatic injury are present. Baseline liver function tests should be undertaken in all patients and treatment should not be initiated in patients with baseline values of ALT and/or AST >3 times upper limit of normal. Agorest should be used with caution in the elderly (≥75 years) due to lack of clinical data. Agorest should not be used for the treatment of major depressive episodes in elderly patients with dementia since the safety and efficacy of Agorest have not been established in these patients. Agorest is not recommended in the treatment of depression in patients under 18 years of age. Agorest should be used with caution in patients with a history of bipolar disorder, mania or hypomania.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is limited experience with Agorest overdose. During the clinical development, there were a few reports of Agorest overdose, taken alone (up to 450 mg) or in combination (up to 525 mg) with other psychotropic medicinal products. Signs and symptoms of overdose were limited and included drowsiness and epigastralgia. No specific antidotes for Agorest are known. Management of overdose should consist of treatment of clinical symptoms and routine monitoring. Medical follow-up in a specialised environment is recommended.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "To be dispensed only on the prescription of a registered physician. Store below 30°C, in a cool and dry place. Keep away from light. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Atypical anti-depressant drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "The effective dose of agomelatine is 25 mg per day given once at bed time for two weeks and can be increased to 50 mg per day in patients with inadequate response. Night time dosing is recommended because agomelatine improves the quality of sleep without day time sedation. For oral administration with or without food. Most adult patients should take a dosage of 25 mg (one tablet) daily. It is usually taking prior to bed time. If no improvement is noticed after two weeks, the dosage can be increased to 50 mg (two tablets) daily.",
        "instructions": []
      },
      {
        "medication_type": "Children under 18 years",
        "information": ": Should be given only on medical advice.",
        "instructions": []
      },
      {
        "medication_type": "Use in children and adolescents",
        "information": ": Agomelatine is not recommended in the treatment of depression in patients <18 years since safety and efficacy of agomelatine have not been established in this age group. In clinical trials among children and adolescents treated with other antidepressants, suicide-related behavior (suicide attempt and suicidal thoughts), and hostility (predominantly aggression, oppositional behavior and anger) were more frequently observed compared to those treated with placebo.",
        "instructions": []
      },
      {
        "medication_type": "Use in the elderly",
        "information": ": The efficacy and safety of agomelatine (25 to 50 mg/day) have been established in elderly patients with MDD (aged <75 years). As efficacy has not been established in every elder patients aged >75 years agomelatine should not be used in this patient group.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:37.260Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d21",
    "original_record": {
      "input_index": 823,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d21"
        },
        "name": "Agorest",
        "strength": "25 mg",
        "generic": "Agomelatine",
        "company": "Everest Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/31997/agorest-25-mg-tablet",
        "_page": 17,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/32793/airflow-10-mg-tablet",
    "name": "AirFlow",
    "dosage_form": "Tablet",
    "generic": "Montelukast Sodium",
    "strength": "10 mg",
    "company": "Ad-din Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 17.50",
      "strip_price": "৳ 175.00",
      "pack_size_info": "(3 x 10: ৳ 525.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 17.50",
          "pack_size_info": "(3 x 10: ৳ 525.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 175.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "4 mg (Chew. Tablet)",
        "href": "https://medex.com.bd/brands/35971/airflow-4-mg-chewable-tablet?ref=1"
      },
      {
        "text": "5 mg (Chew. Tablet)",
        "href": "https://medex.com.bd/brands/35972/airflow-5-mg-chewable-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/768/montelukast-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "AirFlow is indicated for:",
        "items": [
          "Prophylaxis and chronic treatment of asthma",
          "Acute prevention of Exercise-Induced Bronchoconstriction (EIB)",
          "Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT 1 ). The cysteinyl leukotrienes (LTC 4 , LTD 4 , LTE 4 ) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma & allergic rhinitis, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "AirFlow has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions. In drug interaction studies, the recommended clinical dose of AirFlow did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1mg/ethinyl estradiol 35mcg), terfenadine, digoxin, and warfarin. Although additional specific interaction studies were not performed, AirFlow was used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of clinical adverse interactions. These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines and decongestants. Phenobarbital, which induces hepatic metabolism, decreased the AUC of AirFlow approximately 40% following a single 10mg dose of AirFlow. No dosage adjustment for AirFlow is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with AirFlow.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Montelukast is contraindicated in patients who are hypersensitive to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Common",
        "information": ": Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.",
        "items": []
      },
      {
        "title": "Uncommon",
        "information": ": Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.",
        "items": []
      },
      {
        "title": "Rare",
        "information": ": Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Montelukast crosses the placenta following oral dosing in rats and rabbits. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Montelukast should be used during pregnancy only if clearly needed. Because many drugs are excreted in human milk, caution should be exercised when Montelukast is given to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "AirFlow is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Patients should be advised to have appropriate rescue medication available. Therapy with AirFlow can be continued during acute exacerbations of asthma. While the dose of inhaled corticosteroid may be reduced gradually under medical supervision, AirFlow should not be abruptly substituted for inhaled or oral corticosteroids. AirFlow should not be used as monotherapy for the treatment and management of exercise induced bronchospasm. Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking AirFlow. Although AirFlow is effective in improving airway function in asthmatics with documented aspirin sensitivity, it has not been shown to truncate bronchoconstrictor response to aspirin and other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of AirFlow and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C35H36ClNO3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg"
    },
    "therapeutic_class": "Leukotriene receptor antagonists",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adults and adolescents with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for adults and adolescents 15 years of age and older",
        "information": ": Montelukast 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Pediatric patients with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 to 14 years of age",
        "information": ": Montelukast 5 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 2 years to 5 years of age",
        "information": ": Montelukast 4 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 months to 5 years of age",
        "information": ": Montelukast 4 mg oral granules once daily. This can be administered either directly in the mouth, or mixed with a spoonful of cold water or soft food at room temperature",
        "instructions": []
      },
      {
        "medication_type": "Use in the pediatric patient",
        "information": ": The safety and efficacy of Montelukast have been established in adequate and well-controlled studies in pediatric patients with asthma 6 months to 14 years of age. Safety and efficacy profiles in this age group are similar to those seen in adults.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is required in patients with mild-to-moderate hepatic insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": No dosage adjustment is recommended in patients with renal insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Elderly use",
        "information": ": The pharmacokinetic profile and the oral bioavailability of a single 10-mg oral dose of montelukast are similar in elderly and younger adults. The plasma half-life of montelukast is slightly longer in the elderly. No dosage adjustment in the elderly is required.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is AirFlow 10 mg Tablet?",
        "answer": [
          "AirFlow 10 mg Tablet is a selective and orally active leukotriene receptor antagonist."
        ]
      },
      {
        "question": "What is AirFlow 10 mg Tablet used for?",
        "answer": [
          "AirFlow 10 mg Tablet is commonly used to treat asthma or allergic rhinitis. It helps keep airways open and easy breathing by blocking leukotrienes."
        ]
      },
      {
        "question": "How soon can the effect of AirFlow 10 mg Tablet be observed?",
        "answer": [
          "The effect of AirFlow 10 mg Tablet can be observed after 1-3 hours of administration. AirFlow 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks and needs to be taken daily to work properly."
        ]
      },
      {
        "question": "How long does the effect of AirFlow 10 mg Tablet last?",
        "answer": [
          "The effect of AirFlow 10 mg Tablet lasts for an average duration of 24 hours."
        ]
      },
      {
        "question": "Should I use AirFlow 10 mg Tablet empty stomach?",
        "answer": [
          "AirFlow 10 mg Tablet may be taken with or without food as prescribed by your doctor."
        ]
      },
      {
        "question": "What if I miss a dose of AirFlow 10 mg Tablet?",
        "answer": [
          "If you miss a dose, you may take it as soon as possible. But if it is almost time for your next dose, just skip that dose. Do not double up on doses."
        ]
      },
      {
        "question": "Are there any pregnancy warnings for AirFlow 10 mg Tablet?",
        "answer": [
          "Use of AirFlow 10 mg Tablet in pregnant women should be avoided unless clearly needed."
        ]
      },
      {
        "question": "General Instructions",
        "answer": [
          "Take AirFlow 10 mg Tablet exactly as prescribed by your doctor.",
          "Do not change your AirFlow 10 mg Tablet dose or stop using asthma medication without your doctor's advice.",
          "AirFlow 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working.",
          "Avoid situations or activities that may trigger an asthma attack.",
          "Talk to your doctor before using AirFlow 10 mg Tablet if you're pregnant or breastfeeding. They can help you decide if it's the right choice for you."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:38.662Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d2c",
    "original_record": {
      "input_index": 824,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d2c"
        },
        "name": "AirFlow",
        "strength": "10 mg",
        "generic": "Montelukast Sodium",
        "company": "Ad-din Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/32793/airflow-10-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/27988/airway-4-mg-tablet",
    "name": "Airway",
    "dosage_form": "Tablet",
    "generic": "Montelukast Sodium",
    "strength": "4 mg",
    "company": "One Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 6.00",
      "strip_price": "৳ 60.00",
      "pack_size_info": "(3 x 10: ৳ 180.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 6.00",
          "pack_size_info": "(3 x 10: ৳ 180.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 60.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/22627/airway-5-mg-tablet?ref=1"
      },
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/22628/airway-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/768/montelukast-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Airway is indicated for:",
        "items": [
          "Prophylaxis and chronic treatment of asthma",
          "Acute prevention of Exercise-Induced Bronchoconstriction (EIB)",
          "Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT 1 ). The cysteinyl leukotrienes (LTC 4 , LTD 4 , LTE 4 ) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma & allergic rhinitis, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Airway has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions. In drug interaction studies, the recommended clinical dose of Airway did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1mg/ethinyl estradiol 35mcg), terfenadine, digoxin, and warfarin. Although additional specific interaction studies were not performed, Airway was used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of clinical adverse interactions. These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines and decongestants. Phenobarbital, which induces hepatic metabolism, decreased the AUC of Airway approximately 40% following a single 10mg dose of Airway. No dosage adjustment for Airway is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with Airway.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Montelukast is contraindicated in patients who are hypersensitive to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Common",
        "information": ": Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.",
        "items": []
      },
      {
        "title": "Uncommon",
        "information": ": Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.",
        "items": []
      },
      {
        "title": "Rare",
        "information": ": Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Montelukast crosses the placenta following oral dosing in rats and rabbits. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Montelukast should be used during pregnancy only if clearly needed. Because many drugs are excreted in human milk, caution should be exercised when Montelukast is given to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Airway is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Patients should be advised to have appropriate rescue medication available. Therapy with Airway can be continued during acute exacerbations of asthma. While the dose of inhaled corticosteroid may be reduced gradually under medical supervision, Airway should not be abruptly substituted for inhaled or oral corticosteroids. Airway should not be used as monotherapy for the treatment and management of exercise induced bronchospasm. Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Airway. Although Airway is effective in improving airway function in asthmatics with documented aspirin sensitivity, it has not been shown to truncate bronchoconstrictor response to aspirin and other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Airway and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C35H36ClNO3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg"
    },
    "therapeutic_class": "Leukotriene receptor antagonists",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adults and adolescents with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for adults and adolescents 15 years of age and older",
        "information": ": Montelukast 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Pediatric patients with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 to 14 years of age",
        "information": ": Montelukast 5 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 2 years to 5 years of age",
        "information": ": Montelukast 4 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 months to 5 years of age",
        "information": ": Montelukast 4 mg oral granules once daily. This can be administered either directly in the mouth, or mixed with a spoonful of cold water or soft food at room temperature",
        "instructions": []
      },
      {
        "medication_type": "Use in the pediatric patient",
        "information": ": The safety and efficacy of Montelukast have been established in adequate and well-controlled studies in pediatric patients with asthma 6 months to 14 years of age. Safety and efficacy profiles in this age group are similar to those seen in adults.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is required in patients with mild-to-moderate hepatic insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": No dosage adjustment is recommended in patients with renal insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Elderly use",
        "information": ": The pharmacokinetic profile and the oral bioavailability of a single 10-mg oral dose of montelukast are similar in elderly and younger adults. The plasma half-life of montelukast is slightly longer in the elderly. No dosage adjustment in the elderly is required.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Airway 4 mg Tablet?",
        "answer": [
          "Airway 4 mg Tablet is a selective and orally active leukotriene receptor antagonist."
        ]
      },
      {
        "question": "What is Airway 4 mg Tablet used for?",
        "answer": [
          "Airway 4 mg Tablet is commonly used to treat asthma or allergic rhinitis. It helps keep airways open and easy breathing by blocking leukotrienes."
        ]
      },
      {
        "question": "How soon can the effect of Airway 4 mg Tablet be observed?",
        "answer": [
          "The effect of Airway 4 mg Tablet can be observed after 1-3 hours of administration. Airway 4 mg Tablet is not a fast-acting rescue medicine for asthma attacks and needs to be taken daily to work properly."
        ]
      },
      {
        "question": "How long does the effect of Airway 4 mg Tablet last?",
        "answer": [
          "The effect of Airway 4 mg Tablet lasts for an average duration of 24 hours."
        ]
      },
      {
        "question": "Should I use Airway 4 mg Tablet empty stomach?",
        "answer": [
          "Airway 4 mg Tablet may be taken with or without food as prescribed by your doctor."
        ]
      },
      {
        "question": "What if I miss a dose of Airway 4 mg Tablet?",
        "answer": [
          "If you miss a dose, you may take it as soon as possible. But if it is almost time for your next dose, just skip that dose. Do not double up on doses."
        ]
      },
      {
        "question": "Are there any pregnancy warnings for Airway 4 mg Tablet?",
        "answer": [
          "Use of Airway 4 mg Tablet in pregnant women should be avoided unless clearly needed."
        ]
      },
      {
        "question": "General Instructions",
        "answer": [
          "Take Airway 4 mg Tablet exactly as prescribed by your doctor.",
          "Do not change your Airway 4 mg Tablet dose or stop using asthma medication without your doctor's advice.",
          "Airway 4 mg Tablet is not a fast-acting rescue medicine for asthma attacks. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working.",
          "Avoid situations or activities that may trigger an asthma attack.",
          "Talk to your doctor before using Airway 4 mg Tablet if you're pregnant or breastfeeding. They can help you decide if it's the right choice for you."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:39.804Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d38",
    "original_record": {
      "input_index": 825,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d38"
        },
        "name": "Airway",
        "strength": "4 mg",
        "generic": "Montelukast Sodium",
        "company": "One Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/27988/airway-4-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30904/ajardy-10-mg-tablet",
    "name": "Ajardy",
    "dosage_form": "Tablet",
    "generic": "Empagliflozin",
    "strength": "10 mg",
    "company": "Ziska Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": "৳ 250.00",
      "pack_size_info": "(3 x 10: ৳ 750.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 25.00",
          "pack_size_info": "(3 x 10: ৳ 750.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 250.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/30905/ajardy-25-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1275/empagliflozin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ajardy is indicated in:",
        "items": [
          "As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
          "To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor. SGLT2 co-transporters are responsible for reabsorption of glucose from the glomerular filtrate in the kidney. The glucuretic effect resulting from SGLT2 inhibition reduces renal absorption and lowers the renal threshold for glucose, resulting in increased glucose excretion. Additionally, it contributes to reduced hyperglycaemia, assists weight loss, and reduces blood pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Diuretics",
        "information": ": Co-administration of Ajardy with diuretics resulted in increased urine volume.",
        "items": []
      },
      {
        "title": "Insulin or Insulin Secretagogues",
        "information": ": Co-administration of Ajardy with insulin or insulin secretagogues increases the risk for hypoglycemia.",
        "items": []
      },
      {
        "title": "Positive Urine Glucose Test",
        "information": ": Monitoring glycemic control with urine glucose tests is not recommended in patients taking SGLT2 inhibitors as SGLT2 inhibitors increase urinary glucose excretion and will lead to positive urine glucose tests. Use alternative methods to monitor glycemic control.",
        "items": []
      },
      {
        "title": "Interference with 1,5-anhydroglucitol (1,5-AG) Assay",
        "information": ": Monitoring glycemic control with 1,5-AG assay is not recommended as measurements of 1,5-AG are unreliable in assessing glycemic control in patients taking SGLT2 inhibitors. Use alternative methods to monitor glycemic control.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Empagliflozin is contraindicated in patients with history of serious hypersensitivity reaction to Empagliflozin or any of its ingredients, severe renal impairment, end-stage renal disease, or dialysis.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse reactions associated with Ajardy are urinary tract infections and female genital mycotic infections. Others common side effects includes dehydration, hypotension, weakness, dizziness and increased thirstiness.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies of Empagliflozin in pregnant women. Empagliflozin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known if Empagliflozin is excreted in human milk. It is not recommended when breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Assessment of renal function is recommended prior to initiation of Ajardy and periodically thereafter. Ajardy should not initiated in patients with an eGFR less than 45 ml/min/1.73 m 2 . No dose adjustment is needed in patients with an eGFR greater than or equal to 45 ml/min/1.73 m 2 .",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In the event of an overdose with Ajardy the usual supportive measures (e.g., remove unabsorbed material from the gastrointestinal tract, perform clinical monitoring, and institute supportive treatment) should be employed. Removal of Ajardy by hemodialysis has not been studied.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a cool & dry place (below 30° C), protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C23H27ClO7",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-1275-empagliflozin-chemical-structure-Z3X0mrA6UvgM682Jgp8K.svg"
    },
    "therapeutic_class": "Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended dose of Empagliflozin is 10 mg once daily, taken in the morning, with or without food. In patients tolerating Empagliflozin, the dose may be increased to 25 mg once daily. In patients with volume depletion, correcting this condition prior to initiation of Empagliflozin is recommended.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Ajardy 10 mg Tablet?",
        "answer": [
          "Ajardy 10 mg Tablet is a SGLT-2 inhibitor which reduces the reabsorption of glucose from kidney."
        ]
      },
      {
        "question": "What is Ajardy 10 mg Tablet used for?",
        "answer": [
          "Ajardy 10 mg Tablet is commonly used to improve glycemic control in adults."
        ]
      },
      {
        "question": "Are there any pregnancy warnings?",
        "answer": [
          "Ajardy 10 mg Tablet may be unsafe to use during pregnancy."
        ]
      },
      {
        "question": "Are there any breast-feeding warnings?",
        "answer": [
          "Ajardy 10 mg Tablet is probably unsafe to use during breastfeeding."
        ]
      },
      {
        "question": "Does this affect kidney function?",
        "answer": [
          "Ajardy 10 mg Tablet should be used cautiously in patients with an underlying kidney disease."
        ]
      },
      {
        "question": "Does this affect liver function?",
        "answer": [
          "No dose adjustment is needed for patients with the mild to moderate liver disease."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Ajardy 10 mg Tablet is used alone or together with other diabetes medicines to control blood sugar and avoid long-term complications.",
          "Ajardy 10 mg Tablet may cause your body to lose too much fluid (dehydration) or you may urinate more often. Drink plenty of water and stay hydrated.",
          "Ajardy 10 mg Tablet may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.",
          "Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremor and anxiety.",
          "Ajardy 10 mg Tablet can cause genital fungal and/or urinary tract infections (UTIs) in both females and males, so practice good hygiene.",
          "Monitor your blood sugar regularly while taking Ajardy 10 mg Tablet.",
          "Inform your doctor immediately if you experience constant dizziness, joint pain, cold-like symptoms or unexplained nausea/vomiting."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:40.847Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d39",
    "original_record": {
      "input_index": 826,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d39"
        },
        "name": "Ajardy",
        "strength": "10 mg",
        "generic": "Empagliflozin",
        "company": "Ziska Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/30904/ajardy-10-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30906/ajardy-m-5-mg-tablet",
    "name": "Ajardy M",
    "dosage_form": "Tablet",
    "generic": "Empagliflozin + Metformin Hydrochloride",
    "strength": "5 mg+500 mg",
    "company": "Ziska Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": "৳ 120.00",
      "pack_size_info": "(4 x 8: ৳ 480.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 15.00",
          "pack_size_info": "(4 x 8: ৳ 480.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1580/empagliflozin-metformin-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ajardy M tablet is indicated for the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise:",
        "items": [
          "In patients insufficiently controlled on their maximally tolerated dose of Metformin alone",
          "In combination with other medicinal products for the treatment of diabetes, in patients insufficiently controlled with Metformin and these medicinal products",
          "In patients already being treated with the combination of Empagliflozin and Metformin as separate tablets."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Empagliflozin is an inhibitor of Sodium-Glucose Co-Transporter 2 (SGLT2). SGLT2 is the predominant transporter, responsible for reabsorption of glucose from the kidney back into the circulation. By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion. Metformin Hydrochloride is a biguanide type oral antihyperglycemic drug, used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose. It does not produce hypoglycemia. Metformin Hydrochloride decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by an increase in peripheral glucose uptake and utilization.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Diuretics",
        "information": ": Co-administration of Empagliflozin with diuretics resulted in increased urine volume and frequency of voids, which might enhance the potential for volume depletion.",
        "items": []
      },
      {
        "title": "Insulin or Insulin Secretagogues",
        "information": ": Co-administration of Empagliflozin with insulin or insulin secretagogues increases the risk for hypoglycemia.",
        "items": []
      },
      {
        "title": "Positive Urine Glucose Test",
        "information": ": Monitoring glycemic control with urine glucose tests is not recommended in patients taking SGLT2 inhibitors. Use alternative methods to monitor glycemic control.",
        "items": []
      },
      {
        "title": "Drugs that Reduce Metformin Clearance",
        "information": ": Drugs that reduce Metformin clearance (such as ranolazine, vandetanib, dolutegravir, and cimetidine) may increase the accumulation of Metformin.",
        "items": []
      },
      {
        "title": "Carbonic Anhydrase Inhibitors",
        "information": ": Carbonic anhydrase inhibitors may increase risk of lactic acidosis.",
        "items": []
      },
      {
        "title": "Drugs Affecting Glycemic Control",
        "information": ": Thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid produce hoperglycemia. When such drugs are administered to a patient receiving Empagliflozin and Metformin combination, the patient should be closely observed to maintain adequate glycemic control. When such drugs are withdrawn from a patient receiving Empagliflozin and Metformin combination, the patient should be observed closely for hypoglycemia.",
        "items": []
      },
      {
        "title": "Alcohol",
        "information": ": Alcohol can potentiate the effect of Metformin on lactate metabolism. Warn patients against excessive alcohol intake.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to Empagliflozin and Metformin",
          "Any type of acute metabolic acidosis (such as lactic acidosis, diabetic ketoacidosis)",
          "Diabetic pre-coma",
          "Severe renal failure (GFR <30 ml/min)",
          "Acute conditions with the potential to alter renal function such as: dehydration, severe infection, shock",
          "Disease which may cause tissue hypoxia (especially acute disease, or worsening of chronic disease) such as: decompensated heart failure, respiratory failure, recent myocardial infarction, shock",
          "Hepatic impairment, acute alcohol intoxication, alcoholism"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Most common adverse reactions associated with Empagliflozin (5% or greater incidence) were urinary tract infection and female genital mycotic infections. Most common adverse reactions associated with Metformin (>5%) are diarrhea, nausea/vomiting, flatulence, abdominal discomfort, indigestion, asthenia, and headache. The following important adverse reactions are given below:",
        "items": [
          "Very common: Hypoglycemia (when used with sulphonylurea or insulin), Gastrointestinal symptoms",
          "Common: Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection. Urinary tract infection (including pyelonephritis and urosepsis), thirst, taste disturbance, pruritus (generalised), rash, Increased urination, serum lipids increased",
          "Uncommon: Volume depletion, urticaria, dysuria, blood creatinine increased/Glomerular filtration rate decreased, Haematocrit increased",
          "Rare: Diabetic ketoacidosis."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Advise females of the potential risk to a fetus especially during the second and third trimesters. This is not recommended when breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Lactic Acidosis",
        "information": ": Postmarketing cases of Metformin Hydrochloride-associated lactic acidosis. If lactic acidosis is suspected, general supportive measures should be instituted promptly in a hospital setting, along with immediate discontinuation of Ajardy M.",
        "items": []
      },
      {
        "title": "Hypotension",
        "information": ": Before initiating Ajardy M assess and correct volume status in patients with renal impairment, the elderly, in patients with low systolic blood pressure, and in patients on diuretics. Monitor for signs and symptoms of hypotension after initiating therapy and increase monitoring in clinical situations where volume contraction is expected.",
        "items": []
      },
      {
        "title": "Ketoacidosis",
        "information": ": Before initiating Ajardy M assess patients who present with signs and symptoms of metabolic acidosis for ketoacidosis, regardless of blood glucose level. If suspected, discontinue Ajardy M, evaluate and treat promptly.",
        "items": []
      },
      {
        "title": "Acute kidney injury & impairment in renal function",
        "information": ": Consider temporarily discontinuing Ajardy M in settings of reduced oral intake or fluid losses. If acute kidney injury occurs, discontinue Ajardy M promptly and institute treatment.",
        "items": []
      },
      {
        "title": "Urosepsis, Pyelonephritis, Fournier’s gangrene & Genital mycotic infections",
        "information": ": Treatment with SGLT2 inhibitors increases the risk for urinary tract infections. Evaluate patients for signs and symptoms of urinary tract infections and treat promptly, if indicated.",
        "items": []
      },
      {
        "title": "Hypoglycemia",
        "information": ": Consider lowering the dose of insulin secretagogue or insulin to reduce the risk of hypoglycemia when initiating Ajardy M.",
        "items": []
      },
      {
        "title": "Vitamin B12 Deficiency",
        "information": ": Metformin Hydrochloride may lower vitamin B12 levels. Monitor hematologic parameters annually.",
        "items": []
      },
      {
        "title": "Increased LDL-C",
        "information": ": Monitor and treat as appropriate.",
        "items": []
      },
      {
        "title": "Macrovascular Outcomes",
        "information": ": There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Ajardy M.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In controlled clinical studies single doses of up to 800 mg Empagliflozin (equivalent to 32-times the highest recommended daily dose) in healthy volunteers and multiple daily doses of up to 100 mg Empagliflozin (equivalent to 4-times the highest recommended daily dose) in patients with type 2 diabetes did not show any toxicity. Hypoglycaemia has not been seen with Metformin doses of up to 85 g, although lactic acidosis has occurred in such circumstances. Lactic acidosis is a medical emergency and must be treated in hospital. In the event of an overdose, treatment should be initiated as appropriate to the patient's clinical status. The most effective method to remove lactate and Metformin is haemodialysis. The removal of Empagliflozin by haemodialysis has not been studied",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Combination Oral hypoglycemic preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "The dosage should be individualized based on effectiveness and tolerability. Take this combination twice daily with meals. Dose escalation should be gradual to reduce the gastrointestinal side effects due to Metformin Hydrochloride. Maximum recommended daily dose of Metformin Hydrochloride is 2000 mg and Empagliflozin is 25 mg.",
        "instructions": []
      },
      {
        "medication_type": "Recommended individualized starting dose",
        "information": ":",
        "instructions": [
          "In patients on Metformin Hydrochloride, switch to this combination containing Empagliflozin 5 mg with a similar total daily dose of Metformin Hydrochloride.",
          "In patients on Empagliflozin, switch to this combination containing Metformin Hydrochloride 500 mg with a similar total daily dose of Empagliflozin.",
          "In patients already treated with Empagliflozin and Metformin Hydrochloride separately switch to this combination containing the same total daily doses of each component.",
          "In patients with volume depletion not previously treated with Empagliflozin, correct this condition before initiating this combination."
        ]
      },
      {
        "medication_type": "Extended-release formulations",
        "information": ": Individualize starting dose based on the patient’s current drug regimen. Take film coated tablet twice daily with meal and extended-release formulations should be taken once daily with meal, with gradual dose escalation to reduce the Gl adverse effects due to Metformin. Adjust dosing based on effectiveness and tolerability while not exceeding the maximum recommended daily dose of Metformin Hydrochloride 2000 mg and Empagliflozin 25 mg.",
        "instructions": []
      },
      {
        "medication_type": "Renal impaired patient",
        "information": ": Assess renal function before initiating this combination. In patients with an eGFR below 45 mL/min/1.73 m 2 is contraindicated.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric patients under 18 years of age",
        "information": ": Safety and effectiveness in pediatric patients under 18 years of age have not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:42.029Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d3b",
    "original_record": {
      "input_index": 827,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d3b"
        },
        "name": "Ajardy M",
        "strength": "5 mg+500 mg",
        "generic": "Empagliflozin + Metformin Hydrochloride",
        "company": "Ziska Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/30906/ajardy-m-5-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33447/ajuben-12-mg-tablet",
    "name": "Ajuben",
    "dosage_form": "Tablet",
    "generic": "Deutetrabenazine",
    "strength": "12 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 130.00",
      "strip_price": "৳ 1,300.00",
      "pack_size_info": "(1 x 10: ৳ 1,300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 130.00",
          "pack_size_info": "(1 x 10: ৳ 1,300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 1,300.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "6 mg (Tablet)",
        "href": "https://medex.com.bd/brands/33446/ajuben-6-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/2081/deutetrabenazine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ajuben is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of-",
        "items": [
          "Chorea associated with Huntington's disease",
          "Tardive dyskinesia in adults."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The precise mechanism by which deutetrabenazine exerts its anti-chorea effects is unknown but is believed to be related to its effect as a reversible depletor of monoamines (such as dopamine, serotonin, norepinephrine, and histamine) from nerve terminals. The major circulating metabolites (α-dihydrotetrabenazine and β-dihydrotetrabenazine) of deutetrabenazine, are reversible inhibitors of vesicular monoamine transporter 2 (VMAT2), resulting in decreased uptake of monoamines into synaptic vesicles and depletion of monoamine stores.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concomitant use of strong CYP2D6 inhibitors: Maximum recommended dose of Ajuben is 36 mg per day (18 mg twice daily) and alcohol or other sedating drugs- may have additive sedation and somnolence.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Deutetrabenazine is contraindicated in patients with Suicidal, or untreated/inadequately treated depression, Hepatic impairment and in patients Taking MAOIs, reserpine, or tetrabenazine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Most common adverse reactions (>8%) of deutetrabenzine’s are somnolence, diarrhea, dry mouth, and fatigue.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data on the developmental risk associated with the use of deutetrabenazine in pregnant women. There are no data on the presence of deutetrabenazine or its metabolites in human milk, the effects on the breastfed infant, or the effects of the drug on milk production.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients may experience Neuroleptic Malignant Syndrome (discontinue Ajuben if this occurs), Akathisia, agitation, restlessness, and Parkinsonism (reduce the daily dose of Ajuben or discontinue if this occurs) and Sedation/somnolence.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Use in Children",
        "information": ": Safety & effectiveness of deutetrabenzine in infants & children have not been established.",
        "items": []
      },
      {
        "title": "Patients with Hepatic & Renal Impairment",
        "information": ": No clinical studies have been conducted to assess the effect of renal & hepatic impairment on the pharmacokinetics of Ajuben.",
        "items": []
      },
      {
        "title": "Patients with poor CYP2D6 metabolizers",
        "information": ": Maximum recommended dosage of Ajuben in poor CYP2D6 metabolizers is 36 mg per day (i.e., 18 mg twice daily)",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The following adverse reactions occurred with overdosing: acute dystonia, oculogyric crisis, nausea and vomiting, sweating, sedation, hypotension, confusion, diarrhea, hallucinations, rubor, and tremor.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Patients not presently receiving Tetrabenazine:",
        "instructions": []
      },
      {
        "medication_type": "Chorea associated with Huntington’s disease",
        "information": "-",
        "instructions": [
          "Initial dose: 6 mg/day",
          "Maintenance dose: 6 mg-48 mg/day",
          "Maximum dose: 48 mg/day"
        ]
      },
      {
        "medication_type": "Tardive dyskinesia",
        "information": "- Titrate up at weekly intervals by 6 mg per day to a tolerated dose that reduces chorea, up to a maximum recommended daily dosage of 48 mg (24 mg twice daily). Administer total daily dosages of 12 mg or above in two divided doses and administer with foods.",
        "instructions": [
          "Initial dose: 12 mg/day",
          "Maintenance dose: 12 mg-48 mg/day",
          "Maximum dose: 48 mg/day"
        ]
      },
      {
        "medication_type": "Patients receiving Tetrabenazine",
        "information": ": If switching patients from tetrabenazine, discontinue tetrabenazine and initiate deutetrabenazine the following day. The recommended initial dosing regimen of deutetrabenazine in patients switching from tetrabenazine to deutetrabenazine is shown in below chert: Current Tetrabenazine daily dosage Initial regimen of Deutetrabenazine 12.5 mg 6 mg once daily 25 mg 6 mg once daily 37.5 mg 9 mg once daily 50 mg 12 mg once daily 62.5 mg 15 mg once daily 75 mg 18 mg once daily 87.5 mg 21 mg once daily 100 mg 24 mg once daily After patients are switched to deutetrabenazine, the dose may be adjusted at weekly intervals.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:43.212Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d3d",
    "original_record": {
      "input_index": 828,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d3d"
        },
        "name": "Ajuben",
        "strength": "12 mg",
        "generic": "Deutetrabenazine",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/33447/ajuben-12-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28327/akarvia-200-mg-tablet",
    "name": "Akarvia",
    "dosage_form": "Tablet",
    "generic": "Favipiravir",
    "strength": "200 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 200.00",
      "strip_price": "৳ 2,000.00",
      "pack_size_info": "(2 x 10: ৳ 4,000.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 200.00",
          "pack_size_info": "(2 x 10: ৳ 4,000.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 2,000.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1547/favipiravir/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Treatment of novel or re-emerging pandemic influenza virus infections (limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective).",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Favipiravir is a new antiviral drug against influenza. It is metabolized into favipiravir ribosyl triphosphate (favipiravir RTP) by an intracellular enzyme, and favipiravir RTP selectively inhibits RNA polymerase (RNA-dependent RNA polymerase) of the influenza virus, preventing replication of the influenza virus. It is a drug with a mechanism of action different from that of the existing influenza antiviral drugs and effective against all types and sub-types of human influenza A, B, and C viruses in vitro, showing a wide range of anti-viral activity against various influenza virus strains including avian and swine viruses.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "In animal studies, decreased RBC production,and increases in liver function parameters such as AST, ALP, ALT and total bilirubin, and increased vacuolization in hepatocytes. Toxicity information regarding Akarvia in humans is not readily available.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Favipiravir is contraindicated for pregnant women and women who may possibly be pregnant.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Most common side effects are Diarrhea and increase of blood uric acid levels.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Favipiravir may cause delayed development or death of embryos during the early stage of pregnancy. Should not be given during pregnancy.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Akarvia should not be given in pregnant women, requirement of the confirmation of non-pregnancy in women of childbearing potential before use, thorough contraception measures from the start of the treatment to 7 days after the end of the treatment. Caution should be taken for Hepatic and renal impaired patient or use Akarvia as per the direction of registered Physician",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Akarvia is only approved as an experimental drug and still a lot of studies is needed about it’s efficacy and also toxic reactions and use in children.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "In animal studies, decreased RBC production,and increases in liver function parameters such as AST, ALP, ALT and total bilirubin, and increased vacuolization in hepatocytes. Toxicity information regarding Akarvia in humans is not readily available.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Akarvia is approved for manufacture and sale in Japan as an influenza antiviral. It selectively inhibits the RNA polymerase of the influenza virus, an enzyme required for viral replication once human host cells are infected. COVID-19 also uses this enzyme to replicate and is classified into the same type of single-stranded RNA virus as influenza; hence, it is believed that Akarvia may be effective in treating COVID-19. Akarvia is only used when there is an outbreak of novel or re-emerging influenza virus infections in which other influenza antiviral drugs are either not effective or insufficiently effective. Its production and distribution is at the discretion of Japan’s Health, Labor and Welfare Ministry, so has never been distributed in the market and is not available at hospitals and pharmacies in Japan or overseas.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-viral drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "The usual adult dosage is 1600 mg of Favipiravir administered orally twice daily on Day 1, followed by 600 mg orally twice daily from Day 2 to Day 5 or as directed by physicians. The total treatment duration should be 5 days.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:44.272Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d3f",
    "original_record": {
      "input_index": 829,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d3f"
        },
        "name": "Akarvia",
        "strength": "200 mg",
        "generic": "Favipiravir",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/28327/akarvia-200-mg-tablet",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/21153/aknill-005-topical-gel",
    "name": "Aknill",
    "dosage_form": "Topical Gel",
    "generic": "Isotretinoin",
    "strength": "0.05%",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 130.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "10 gm tube",
          "price": "৳ 130.00",
          "pack_size_info": null
        },
        {
          "label": "20 gm tube",
          "price": "৳ 200.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1869/isotretinoin-topical/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aknill topical gel is indicated for the treatment of mild to moderate inflammatory and non-inflammatory acne vulgaris.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Isotretinoin produces its effects through altering progress through the cell cycle, cell differentiation, survival, and apoptosis. These actions reduce sebum production, preventing the blockage of pores, and growth of acne causing bacteria. Isotretinoin and 4-oxo-isotretinoin both significantly reduce the production of sebum. Isotretinoin has little to no affinity for retinol binding proteins (RBPs) and retinoic acid nuclear receptors (RARs). Tretinoin and 4-oxo-tretinion bind to the RAR-γ receptor, which is suspected to be part of the action of acne treatment by isotretinoin. Isotretinoin induces apoptosis in sebocytes, leading to a decrease in sebum production. Isotretinoin also reduces the formation of comedones by reducing hyperkeratinization through an unknown mechanism. Isotretinoin does not directly kill bacteria but it does reduce the size of sebum ducts and makes the microenvironment less hospitable to acne causing bacteria. It may also increase immune mechanisms and alter chemotaxis of monocytes to reduce inflammation.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concomitant topical medication should be used with caution during therapy with Aknill. Particular caution should be exercised when using preparations containing a peeling agent (for example Benzoyl Peroxide) or abrasive cleansers.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Isotretinoin 0.05% gel is contra-indicated in patients with known hypersensitivity to Isotretinoin.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In normal use, Aknill may cause stinging, burning or irritation; erythema and peeling at the site of application may occur. If undue irritation occurs, treatment should be interrupted temporarily and resumed once the reaction subsides. If irritation persists, treatment should be discontinued. Reactions will normally resolve on discontinuation of therapy.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category B. There is inadequate evidence of the safety of topically applied Isotretinoin in human pregnancy. Isotretinoin has been associated with teratogenicity in humans when administered systemically. Reproduction studies conducted in rabbits using Isotretinoin applied topically at up to 60 times the human dose have, however, revealed no harm to the foetus. The use of Isotretinoin should be avoided during pregnancy. Percutaneous absorption of Isotretinoin from Isotretinoin 0.05% gel is negligible. It is not known, however, whether Isotretinoin is excreted in human milk. Isotretinoin should not be used during lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Contact with the mouth, eyes and mucous membranes and with abraded or eczematous skin should be avoided. Care should be taken not to let the medication accumulate in skin fold areas and in the angles of the nose. Application to sensitive areas of skin, such as the neck, should be made with caution. Although Tretinoin has not been shown to initiate or promote carcinogenesis in humans, Tretinoin applied topically to albino hairless mice had resulted in a dose-related acceleration in ultraviolet-B radiation induced cutaneous tumours. The same author also observed the opposite effect in another study of low, non-irritating concentrations of Tretinoin. The significance of these findings as related to man is unknown; however, caution should be observed in patients with a personal or family history of cutaneous epithelioma. Exposure to sunlight of areas treated with Aknill should be avoided or minimised. When exposure to strong sunlight cannot be avoided a sunscreen product and protective clothing should be used. Patients with sunburn should not use Aknill due to the possibility of increased sensitivity to sunlight. The use of sunlamps should be avoided during treatment.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Acute overdosage of Aknill has not been reported to date. Accidental ingestion of Aknill resulting in overdosage of Aknill could be expected to induce symptoms of hypervitaminosis A. These include severe headaches, nausea or vomiting, drowsiness, irritability and pruritus.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Topical retinoid and related preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Apply Isotretinoin 0.05% gel cautiously over the affected area once or twice daily. Patients should be advised that 6-8 weeks of treatment may be required before a therapeutic effect is observed. The safety and efficacy of Isotretinoin have not been established in children since acne vulgaris rarely present in this age group. There are no specific recommendations for use in the elderly. Acne vulgaris does not present in the elderly.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:45.365Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d42",
    "original_record": {
      "input_index": 830,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d42"
        },
        "name": "Aknill",
        "strength": "0.05%",
        "generic": "Isotretinoin (Topical)",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Topical Gel",
        "source_url": "https://medex.com.bd/brands/21153/aknill-005-topical-gel",
        "_page": 18,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/15973/alacot-ds-02-eye-drop",
    "name": "Alacot DS",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Olopatadine Hydrochloride",
    "strength": "0.2%",
    "company": "Square Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 175.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 175.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.1% (Eye Drop)",
        "href": "https://medex.com.bd/brands/15972/alacot-01-eye-drop?ref=1"
      },
      {
        "text": "0.7% (Eye Drop)",
        "href": "https://medex.com.bd/brands/27495/alacot-max-07-eye-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/823/olopatadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Patadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.... Read morePatadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.Alacot DS Nasal Spray is an H1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older.Alacot DS tablet is indicated in the treatment of allergic rhinitis (swelling of the nasal membranescaused by an allergy to pollen and mold spores in the air) and allergic skin conditions. It helps to relieve allergy symptoms such as skin rashes, swelling, hives (itchy, painful eruptions that sting), itching, sneezing, runny or stuffy nose.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Olopatadine, an antihistamine, works by blocking the action of histamine in the body, which reduces allergy symptoms. Olopatadine hydrochloride treats sneezing, itching, runny nose, and other nasal symptoms of allergies.",
        "items": []
      },
      {
        "title": "Mode of Action",
        "information": ": Olopatadine is an anti-allergic molecule that works via several mechanisms. As a mast cell stabilizer, it stabilizes rodent basophils and human conjunctival mast cells and inhibits the immunologically-stimulated release of histamine. Olopatadine acts as an antagonist at the histamine H1 receptors with high selectivity, Upon binding, olopatadine blocks the H1 receptor signaling pathway, inhibiting the release of inflammatory mediators, such as tryptase, prostaglandin D2, TNF-alpha, as well as pro-inflammatory cytokines.",
        "items": []
      },
      {
        "title": "Pharmacokinetics",
        "information": ": Absorption: Olopatadine was absorbed with individual peak plasma concentrations observed between 30 minutes and 1 hour after twice daily intranasal administration of Olopatadine Nasal Spray. Distribution: The protein binding of olopatadine was moderate at approximately 55% in human serum, and independent of drug concentration over the range of 0.1 to 1000 ng/mL. Metabolism: Olopatadine is not extensively metabolized. Based on plasma metabolite profiles of olopatadine, at least six minor metabolites circulate in human plasma. Elimination: The plasma elimination half-life of olopatadine is 8 to 12 hours. Olopatadine is mainly eliminated through urinary excretion",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Formal drug-drug interaction studies were not conducted for Alacot DS Nasal Spray. Drug interactions with inhibitors of liver enzymes are not anticipated because olopatadine is eliminated predominantly by renal excretion. Drug interactions involving P450 inhibition and plasma protein binding are also not expected.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in persons with a known hypersensitivity to any component of this product. Olopatadine 5 mg tablet is not recommended for use if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions to make sure this medicine is safe for you.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rarely headaches have been reported. Other adverse effects: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Olopatadine was found not to be teratogenic in rats and rabbits. There are, however, no adequate and well controlled studies in pregnant women. This drug should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Olopatadine is administered to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients should be advised not to wear a contact lens if their eye is red. Alacot DS ophthalmic solution should not be used to treat contact lens related irritation. Benzalkonium Chloride, preservative of Patadin, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least 10 minutes after instillation of Patadin eye drops before they insert their contact lenses. The treatment should be discontinued in the presence of an allergic reaction. Before initial use, Alacot DS Nasal Spray by releasing 5 sprays or until a fine mist appears. When Alacot DS Nasal Spray has not been used for more than 7 days, re-prime by releasing 2 sprays. Avoid spraying Alacot DS Nasal Spray into the eyes. Patients should be informed to avoid spraying Alacot DS Nasal Spray in their eyes. Olonex Tablet should be used as prescribed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid taking more than the recommended dose. Do not stop taking this medicine without consulting your doctor, as your symptoms may reoccur.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety or effectiveness have been observed betweents.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no information on Alacot DS overdose. However, excessive use of any medication can have serious consequences. If you suspect an overdose, seek medical attention without delay.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at room temperature and protect from light. It is desirable that the contents should not be used more than one month after first opening of the bottle.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "How to use the Nasal Spray- Cleaning: The nasal spray should be cleaned at least once a week. The procedures are as follows-",
        "items": [
          "Shake the bottle gently and remove the dust cover.",
          "Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath the bottle. Press down until a fine spray appears. If using for the first time or if you have not used it for a week or more, press the nasal applicator several times until a fine moist comes out from the container.",
          "Gently blow the nose to clear the nostrils.",
          "Close one nostril and carefully insert the nasal applicator into the open nostril. Tilt your head forward slightly and keep the spray upright. Breathe in through your nose and while breathing in, press the white-collar of nasal applicator firmly down once to release a spray.",
          "Breathe out through your mouth.",
          "Repeat the above steps in the same/ other nostril for consecutive doses.",
          "Remove the dust cover.",
          "Gently pull off the nasal applicator.",
          "Wash the applicator and dust cover in warm water.",
          "Shake off the excess water and leave to dry in a normal place. Avoid to apply additional heat.",
          "Gently push the applicator back on the top of the bottle and re-fix the dust cover."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ophthalmic Non-Steroid drugs",
    "dosage": [
      {
        "medication_type": "Eye Drops",
        "information": "-",
        "instructions": [
          "0.1%: One drop in each affected eye two times per day at an interval of 6 to 8 hours.",
          "0.2%: One drop in the affected eye once a day.",
          "0.7%: One drop in each affected eye once a day."
        ]
      },
      {
        "medication_type": "Nasal Spray",
        "information": "-",
        "instructions": [
          "Administer Olopatadine Nasal Spray by the intranasal route only.",
          "Adults and Adolescents 12 years of age and older: Two sprays per nostril twice daily.\\",
          "Children 6 to 11 years of age: One spray per nostril twice daily."
        ]
      },
      {
        "medication_type": "Tablet",
        "information": "-",
        "instructions": [
          "Adults: Take 1 tablet (5 mg of the active ingredient) at a time, twice daily, in the morning and before going to bed. The dosage may be adjusted according to the disease, age or symptoms.",
          "Children 7 years old or over: Take 1 tablet (5 mg) at a time, twice daily, in the morning and before going to bed.",
          "If you miss a dose, take a dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time. Do not stop taking this medicine unless your doctor instructs you to do so."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:46.422Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d4e",
    "original_record": {
      "input_index": 831,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d4e"
        },
        "name": "Alacot DS",
        "strength": "0.2%",
        "generic": "Olopatadine Hydrochloride",
        "company": "Square Pharmaceuticals PLC",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/15973/alacot-ds-02-eye-drop",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/36130/alafix-1-mg-syrup",
    "name": "Alafix",
    "dosage_form": "Syrup",
    "generic": "Ketotifen Fumarate",
    "strength": "1 mg/5 ml",
    "company": "Jenphar Bangladesh Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 75.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 75.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/649/ketotifen-fumarate-oral/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alafix is indicated in the following conditions-",
        "items": [
          "For the prophylactic treatment of bronchial asthma.",
          "Symptomatic treatment of allergic conditions including rhinitis and conjunctivitis.",
          "For alleviating the complications of itching, pain and tenderness associated with neurofibroma.",
          "Symptomatic treatment of allergy such as hayfever, urticaria."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ketotifen has anti-allergic properties and has been used similarly, to sodium chromoglycate in the prophylactic treatment of asthma. It also has the properties of an antihistamine. Ketotifen possesses marked anti-anaphylactic properties and is effective in preventing an asthmatic attacks. Ketotifen exerts as sustained inhibitory effect on histamine reactions, which can be clearly dissociated from its anti-anaphylactic properties. Experimental investigations in asthmatic subjects have shown that Ketotifen is as effective orally as a selective mast cell stabilizer administered by inhalation. Antihistamines were ineffective in those tests. The effectiveness of Ketotifen has been studied in long-term clinical trials. Asthma attacks were reduced in number, severity and duration and in some cases, the patients were completely freed from attacks. Progressive reduction of corticosteroids and/or bronchodilators was also possible. The prophylactic activity of Ketotifen may take several weeks to become fully established. Ketotifen will not abort established attacks of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alafix may potentiate the effects of sedatives, hypnotics, antihistamines and alcohols. A reversible fall in the platelet count has been observed in a few patients receiving Tifen concomitantly with oral antidiabetic agents and it has been suggested that Alafix should therefore be avoided.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "A reversible fall in the platelet count has been observed in a few patients receiving Ketotifen concomitantly with oral antidiabetic agent and it has been suggested that this combination should therefore be avoided. Although there is no evidence of any teratogenic effect, recommendations for Ketotifen in pregnancy or when breast feeding can not be given.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Drowsiness and in isolated cases, dry mouth and slight dizziness may occur at the beginning of treatment but usually disappear spontaneously after a few days.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although there is no evidence of any teratogenic effect, Ketotifen in pregnancy and lactation is not recommended.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "It is important to continue the previous treatment for a minimum of two weeks after starting Alafix to avoid the possibility of exacerbation of asthma. This applies specially to systemic corticosteroids and ACTH because of the possible existence of adrenocortical insufficiency in steroid dependent patient. If inter current infection occurs, Alafix treatment must be supplemented by specific antimicrobial therapy. During the first day of treatment with Alafix, reactions may be impaired and patients should be warned not to take charge of vehicle or machinery until the effect of Alafix treatment on the individual is known. Patients should be advised to avoid alcoholic drinks. Alafix may potentiate the effects of sedatives, hypnotics, antihistamines and alcohol.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "The reported features of overdosage include confusion, drowsiness, headache, bradycardia, respiratory depression etc. should be watched for. Elimination of the drug with gastric lavage or emessis is recommended. Otherwise, general supportive treatment is all that is required shall be instituted.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protect from light. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C19H19NOS",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-649-ketotifen-fumarate-oral-chemical-structure-WOrxlxSmVByavydbYqzn.svg"
    },
    "therapeutic_class": "Cromoglycate & related drugs",
    "dosage": [
      {
        "medication_type": "Adults",
        "information": ": 1 mg twice daily with food. If necessary the dose may be increased to 2 mg twice daily in severe cases.",
        "instructions": []
      },
      {
        "medication_type": "Children above 3 years",
        "information": ": 1 mg twice daily with food. Patients known to be easily sedated should begin treatment with 0.5 to 1 mg at night for the first few days or as directed by the physician.",
        "instructions": []
      },
      {
        "medication_type": "Use in elderly",
        "information": ": Same as adult dose or as advised by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Alafix 1 mg/5 ml Syrup?",
        "answer": [
          "Alafix 1 mg/5 ml Syrup is an antihistamine medication and a mast cell stabilizer used to treat allergic conditions such as conjunctivitis, asthma, and urticaria (hives)."
        ]
      },
      {
        "question": "What is Alafix 1 mg/5 ml Syrup used for?",
        "answer": [
          "Alafix 1 mg/5 ml Syrup is indicated in bronchial asthma, rhinitis, conjunctivitis, hayfever, urticaria."
        ]
      },
      {
        "question": "Are there any pregnancy warnings?",
        "answer": [
          "Asthafen 1mg tablet may be unsafe to use during pregnancy."
        ]
      },
      {
        "question": "Are there any breast-feeding warnings?",
        "answer": [
          "Unknown. Human and animal studies are not available. Please consult your doctor."
        ]
      },
      {
        "question": "Does this affect kidney function?",
        "answer": [
          "There is no data available. Please consult doctor before consuming the drug."
        ]
      },
      {
        "question": "Does this affect liver function?",
        "answer": [
          "There is no data available. Please consult doctor before consuming the drug."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:49.146Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d54",
    "original_record": {
      "input_index": 832,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d54"
        },
        "name": "Alafix",
        "strength": "1 mg/5 ml",
        "generic": "Ketotifen Fumarate (Oral)",
        "company": "Jenphar Bangladesh Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/36130/alafix-1-mg-syrup",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12055/alafree-120-mg-tablet",
    "name": "Alafree",
    "dosage_form": "Tablet",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "120 mg",
    "company": "Apex Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 8.00",
      "strip_price": "৳ 80.00",
      "pack_size_info": "(3 x 10: ৳ 240.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.00",
          "pack_size_info": "(3 x 10: ৳ 240.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 80.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "30 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/20332/alafree-30-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alafree is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alafree is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alafree improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alafree is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alafree significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alafree improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alafree does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alafree with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alafree caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alafree and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alafree should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alafree tablets will produce an effect on the ability to drive or use machines. In objective tests, Alafree has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alafree. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alafree has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alafree from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alafree 120 mg Tablet?",
        "answer": [
          "Alafree 120 mg Tablet is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alafree 120 mg Tablet?",
        "answer": [
          "Alafree 120 mg Tablet is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alafree 120 mg Tablet?",
        "answer": [
          "Alafree 120 mg Tablet has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alafree 120 mg Tablet?",
        "answer": [
          "Alafree 120 mg Tablet should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alafree 120 mg Tablet make you sleepy?",
        "answer": [
          "Yes, Alafree 120 mg Tablet can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alafree 120 mg Tablet?",
        "answer": [
          "Do not take an overdose of Alafree 120 mg Tablet as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alafree 120 mg Tablet work?",
        "answer": [
          "Alafree 120 mg Tablet starts working within 1 hour of consuming it. The peak benefit of Alafree 120 mg Tablet is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alafree 120 mg Tablet relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alafree 120 mg Tablet can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alafree 120 mg Tablet?",
        "answer": [
          "Take some rest after taking Alafree 120 mg Tablet if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alafree 120 mg Tablet?",
        "answer": [
          "Alafree 120 mg Tablet should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alafree 120 mg Tablet."
        ]
      },
      {
        "question": "How should I take Alafree 120 mg Tablet?",
        "answer": [
          "Alafree 120 mg Tablet should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alafree 120 mg Tablet?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alafree 120 mg Tablet."
        ]
      },
      {
        "question": "Can Alafree 120 mg Tablet cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alafree 120 mg Tablet is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alafree 120 mg Tablet is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alafree 120 mg Tablet with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alafree 120 mg Tablet may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alafree 120 mg Tablet. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:50.212Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d55",
    "original_record": {
      "input_index": 833,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d55"
        },
        "name": "Alafree",
        "strength": "120 mg",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Apex Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12055/alafree-120-mg-tablet",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12059/alagra-120-mg-tablet",
    "name": "Alagra",
    "dosage_form": "Tablet",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "120 mg",
    "company": "Alco Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 7.00",
      "strip_price": "৳ 70.00",
      "pack_size_info": "(6 x 10: ৳ 420.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 7.00",
          "pack_size_info": "(6 x 10: ৳ 420.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 70.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "180 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12060/alagra-180-mg-tablet?ref=1"
      },
      {
        "text": "30 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/12061/alagra-30-mg-suspension?ref=1"
      },
      {
        "text": "60 mg (Tablet)",
        "href": "https://medex.com.bd/brands/27838/alagra-60-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alagra is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alagra is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alagra improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alagra is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alagra significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alagra improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alagra does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alagra with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alagra caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alagra and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alagra should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alagra tablets will produce an effect on the ability to drive or use machines. In objective tests, Alagra has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alagra. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alagra has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alagra from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alagra 120 mg Tablet?",
        "answer": [
          "Alagra 120 mg Tablet is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alagra 120 mg Tablet?",
        "answer": [
          "Alagra 120 mg Tablet is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alagra 120 mg Tablet?",
        "answer": [
          "Alagra 120 mg Tablet has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alagra 120 mg Tablet?",
        "answer": [
          "Alagra 120 mg Tablet should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alagra 120 mg Tablet make you sleepy?",
        "answer": [
          "Yes, Alagra 120 mg Tablet can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alagra 120 mg Tablet?",
        "answer": [
          "Do not take an overdose of Alagra 120 mg Tablet as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alagra 120 mg Tablet work?",
        "answer": [
          "Alagra 120 mg Tablet starts working within 1 hour of consuming it. The peak benefit of Alagra 120 mg Tablet is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alagra 120 mg Tablet relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alagra 120 mg Tablet can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alagra 120 mg Tablet?",
        "answer": [
          "Take some rest after taking Alagra 120 mg Tablet if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alagra 120 mg Tablet?",
        "answer": [
          "Alagra 120 mg Tablet should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alagra 120 mg Tablet."
        ]
      },
      {
        "question": "How should I take Alagra 120 mg Tablet?",
        "answer": [
          "Alagra 120 mg Tablet should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alagra 120 mg Tablet?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alagra 120 mg Tablet."
        ]
      },
      {
        "question": "Can Alagra 120 mg Tablet cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alagra 120 mg Tablet is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alagra 120 mg Tablet is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alagra 120 mg Tablet with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alagra 120 mg Tablet may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alagra 120 mg Tablet. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:51.633Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d57",
    "original_record": {
      "input_index": 834,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d57"
        },
        "name": "Alagra",
        "strength": "120 mg",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Alco Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12059/alagra-120-mg-tablet",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12185/alaron-10-mg-tablet",
    "name": "Alaron",
    "dosage_form": "Tablet",
    "generic": "Loratadine",
    "strength": "10 mg",
    "company": "ACI Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.50",
      "strip_price": "৳ 25.00",
      "pack_size_info": "(10 x 10: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.50",
          "pack_size_info": "(10 x 10: ৳ 250.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 25.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "5 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/32197/alaron-5-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/696/loratadine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alaron tablet provides fast, effective relief from the symptoms of seasonal allergic rhinitis, perennial allergic rhinitis and skin allergies including chronic urticaria. It is also effective in alleviating symptoms of allergic rhinitis such as sneezing, nasal discharge, itching, ocular itching ... Read moreAlaron tablet provides fast, effective relief from the symptoms of seasonal allergic rhinitis, perennial allergic rhinitis and skin allergies including chronic urticaria. It is also effective in alleviating symptoms of allergic rhinitis such as sneezing, nasal discharge, itching, ocular itching and burning. Nasal and ocular sign and symptoms are relieved rapidly after oral administration. Alaron tablet is also indicated in idiopathic urticaria. In children over 2 years Alaron tablet is indicated for the symptomatic relief of seasonal allergic rhinitis and allergic skin conditions such as urticaria, nettlerash.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This tablet is a preparation of Loratadine. Loratadine is a non-sedative histamine Hr receptor antagonist with antiallergic properties. Loratadine is a long-acting tricyclic antihistamine with selective peripheral Hi-receptor antagonistic activity and no central sedative or anticholinergic effect. It is rapidly effective and long-lasting, allowing once-a-day administration.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "There are no reports of potentially hazardous interactions with other drugs. In contrast to many other histamine H1 receptor antagonists, Alaron has no potentiating effects when administered concurrently with alcohol, as measured by psychomotor performance studies. Concomitant therapy with drugs that inhibit or are metabolized by hepatic cytochromes P450 3A4 and 2D6 may elevate plasma concentrations of either drug and this mayifesult in adverse effects. Cimetidine inhibits both enzymes while erythromycin or ketoconazole inhibits P450 3A4. These drugs increase Alaron serum concentrations but no adverse effects are reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Loratadine is contraindicated in patients who have shown hypersensitivity or idiosyncrasy to their components.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "During controlled clinical studies the incidence of adverse events, including sedation and anticholinergic effects observed with 10 mg Alaron was comparable to that observed with placebo. Studies on the effect of Alaron on actual driving performance, and on tests of cognitive and psychomotor functioning have shown it to be comparable to placebo.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There is no experience of the use of Loratadine in human pregnancy. Therefore its use during pregnancy is not advisable. Loratadine is excreted in breast milk in a very small amount. So nursing mothers are advised not to take the drug.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be taken in patients with liver impairment or renal insufficiency (eGFR <30 ml/min).",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In adults somnolence, tachycardia and headache have been reported with overdose greater than 10 mg. Extrapyramidal signs and palpitations have been reported in children with overdoses of greater than 10 mg. In the event of overdosage, general symptomatic and supportive measures should be instituted promptly and maintained for as long as necessary. It would seem reasonable to treat patients presenting early after large overdoses with oral activated charcoal. The conscious patients may be induced to vomit or gastric lavage may be performed.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Adults and children over 12 years of age",
        "information": ": One Loratadine tablet once daily. It is usually administered in the morning or when symptoms require treatment.",
        "instructions": []
      },
      {
        "medication_type": "Children 2-12 years",
        "information": ": Body weight over 30 kg: one Loratadine tablet once daily, below 30 kg: half Loratadine tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "Below 2 years of age",
        "information": ": Loratadine tablet is not recommended for use below 2 years of age since safety and efficacy has not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:52.702Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d64",
    "original_record": {
      "input_index": 835,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d64"
        },
        "name": "Alaron",
        "strength": "10 mg",
        "generic": "Loratadine",
        "company": "ACI Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12185/alaron-10-mg-tablet",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/19129/alartn-5-mg-syrup",
    "name": "Alartn",
    "dosage_form": "Syrup",
    "generic": "Cetirizine Hydrochloride",
    "strength": "5 mg/5 ml",
    "company": "Alkad Laboratories",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 30.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alartn is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Alartn is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Alartn is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Alartn has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Alartn is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:53.786Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d66",
    "original_record": {
      "input_index": 836,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d66"
        },
        "name": "Alartn",
        "strength": "5 mg/5 ml",
        "generic": "Cetirizine Hydrochloride",
        "company": "Alkad Laboratories",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/19129/alartn-5-mg-syrup",
        "_page": 19,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12905/alarup-10-mg-tablet",
    "name": "Alarup",
    "dosage_form": "Tablet",
    "generic": "Rupatadine Fumarate",
    "strength": "10 mg",
    "company": "Popular Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 10.00",
      "strip_price": "৳ 100.00",
      "pack_size_info": "(3 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 10.00",
          "pack_size_info": "(3 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/972/rupatadine-fumarate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alarup is indicated for the symptomatic treatment of Seasonal & Perennial Allergic Rhinitis and Urticaria.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Rupatadine is a long-acting, non-sedative antagonist of histamine H1-receptors. It also antagonizes the platelet activating factor (PAF). Both histamine and PAF cause broncho constriction which leads to an increase in the vascular permeability and act as a mediator in the inflammatory process. With the dual mode of action, Rupatadine shows better therapeutic effect than an isolated antihistamine. Rupatadine possesses other anti allergic properties such as the inhibition of the degranulation of mast cells induced by immunological and non immunological stimuli and inhibition of the release of cytokines, particularly of the tumor necrosis factor alpha (TNF α) in human mastocytes and monocytes.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "With medicine: The concomitant administration of Alarup 20 mg and ketoconazole or erythromycin increases the systemic exposure. Alarup should be used with caution when it is administered concomitantly with these drug substances and other inhibitors of the isozyme CYP3A4. Alarup should be used with caution when it is co-administered with statins, CNS depressants or alcohol. With food: Grapefruit and Grapefruit juice should not be taken simultaneously with Rupatadine",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to Rupatadine or to any of the excipients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Common: Asthenia, dizziness, drowsiness. Uncommon: Appetite increased, arthralgia, back pain, concentration impaired, constipation, cough, diarrhea, dry throat, epistaxis, fever, gastrointestinal discomfort, increased risk of infection, irritability, malaise, myalgia, nasal dryness, nausea, oropharyngeal pain, rash, thirst, vomiting, weight increased. Rare: Palpitations, tachycardia.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There is no clinical data available on the exposure of Rupatadine during pregnancy. Pregnant women should therefore not use Rupatadine unless the potential benefit outweighs the potential risk for the infant. No information is available, whether Rupatadine is excreted in the mother's milk. Therefore, it should not be used during lactation, unless the potential benefits for the mother justify the potential risk to the infant.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Alarup should be used with caution in patients with known prolongation of the QT interval, patients with uncorrected hypokalemia, and patients with ongoing proarrhythmic conditions, such as clinically significant bradycardia or acute myocardial ischemia. Alarup should be used with caution in elderly patients (65 years and older). As there is no clinical experience in patients with impaired kidney or liver function, the use of Alarup 10 mg tablets is at present not recommended in these patients.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Elderly:",
        "information": "Alarup should be used with caution in elderly. No information is available that indicates the requirement of any dose adjustment in this population.",
        "items": []
      },
      {
        "title": "Children:",
        "information": "Neither the safety nor the efficacy of Alarup has been established in patients less than 12 years of age.",
        "items": []
      },
      {
        "title": "Patients with renal or hepatic insufficiency:",
        "information": "Use of Alarup is not recommended in patients with renal or hepatic insufficiency. As no relevant clinical data is available.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The most common adverse reaction was somnolence. If accidental ingestion of very high doses occurs, symptomatic treatment together with the required supportive measures should be given.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C26H26ClN3",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-972-rupatadine-fumarate-chemical-structure-jX5B4fOuuvlUHIyrpxAC.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Adults and adolescents (over 12 years)",
        "information": ": The recommended dose is 10 mg once a day. Rupatadine may be taken with or without food. Children aged 2 to 11 years:",
        "instructions": []
      },
      {
        "medication_type": "Children weighing 25 kg or more",
        "information": ": 1 teaspoonful (5 ml) of the oral solution once daily with or without food.",
        "instructions": []
      },
      {
        "medication_type": "Children weighing equal or more than 10 kg to less than 25 kg",
        "information": ": 1/2 teaspoonful (2.5 ml) oral solution once daily with or without food.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Alarup 10 mg Tablet?",
        "answer": [
          "Alarup 10 mg Tablet is H1-receptors antagonist. It also antagonizes the platelet activating factor (PAF)."
        ]
      },
      {
        "question": "What is Alarup 10 mg Tablet used for?",
        "answer": [
          "Alarup 10 mg Tablet is commonly used to treat seasonal & perennial allergic rhinitis and urticaria."
        ]
      },
      {
        "question": "Are there any pregnancy warnings?",
        "answer": [
          "Alarup 10 mg Tablet is maybe unsafe to use during pregnancy."
        ]
      },
      {
        "question": "Are there any breast-feeding warnings?",
        "answer": [
          "Unknown. Human and animal studies are not available. Please consult your doctor."
        ]
      },
      {
        "question": "Is it safe to drive while on Alarup 10 mg Tablet?",
        "answer": [
          "There is no data available. Please consult doctor before consuming the drug."
        ]
      },
      {
        "question": "Does this affect kidney function?",
        "answer": [
          "Caution should be advised in patients with renal impairment."
        ]
      },
      {
        "question": "Does Alarup 10 mg Tablet affect liver function?",
        "answer": [
          "There is no data available. Please consult doctor before consuming Alarup 10 mg Tablet."
        ]
      },
      {
        "question": "What is the onset of action of Alarup 10 mg Tablet?",
        "answer": [
          "The action is initiated in the first 75 minutes after administration."
        ]
      },
      {
        "question": "How long is the duration of effect?",
        "answer": [
          "The duration of action of Alarup 10 mg Tablet is in between 8 to 10 hrs."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Your doctor has prescribed Alarup 10 mg Tablet to help relieve allergy symptoms such as itching, swelling, and rashes.",
          "As compared to other similar medications, it is much less likely to make you feel sleepy.",
          "Be cautious while driving or doing anything that requires concentration as it can cause dizziness and sleepiness.",
          "Do not drink alcohol while taking this medication as it may cause increased sleepiness.",
          "Stop taking Rupa at least three days before taking an allergy test as it can affect the test results."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:26:54.951Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d67",
    "original_record": {
      "input_index": 837,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d67"
        },
        "name": "Alarup",
        "strength": "10 mg",
        "generic": "Rupatadine Fumarate",
        "company": "Popular Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12905/alarup-10-mg-tablet",
        "_page": 20,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12008/alat-10-mg-tablet",
    "name": "Alat",
    "dosage_form": "Tablet",
    "generic": "Cetirizine Hydrochloride",
    "strength": "10 mg",
    "company": "Premier Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.50",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.50",
          "pack_size_info": "(100's pack: ৳ 250.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alat is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Alat is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Alat is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Alat has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Alat is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:56.224Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d69",
    "original_record": {
      "input_index": 838,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d69"
        },
        "name": "Alat",
        "strength": "10 mg",
        "generic": "Cetirizine Hydrochloride",
        "company": "Premier Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12008/alat-10-mg-tablet",
        "_page": 20,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12014/alater-10-mg-tablet",
    "name": "Alater",
    "dosage_form": "Tablet",
    "generic": "Cetirizine Hydrochloride",
    "strength": "10 mg",
    "company": "Bengal drugs Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.50",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.50",
          "pack_size_info": "(100's pack: ৳ 250.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alater is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Alater is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Alater is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Alater has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Alater is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:57.355Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d6a",
    "original_record": {
      "input_index": 839,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d6a"
        },
        "name": "Alater",
        "strength": "10 mg",
        "generic": "Cetirizine Hydrochloride",
        "company": "Bengal drugs Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12014/alater-10-mg-tablet",
        "_page": 20,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/18066/albafen-10-mg-tablet",
    "name": "Albafen",
    "dosage_form": "Tablet",
    "generic": "Baclofen",
    "strength": "10 mg",
    "company": "Allied Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 8.00",
      "strip_price": null,
      "pack_size_info": "(30's pack: ৳ 240.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.00",
          "pack_size_info": "(30's pack: ৳ 240.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/105/baclofen/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Albafen is indicated in-",
        "items": [
          "spasticity resulting from multiple sclerosis",
          "flexor spasms and concomitant pain, clonus and muscular rigidity",
          "skeletal muscle spasm resulting from rheumatic disorders",
          "spinal cord injuries and other spinal cord diseases",
          "cerebrovascular accidents or neoplastic or degenerative brain disease"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Baclofen inhibits both monosynaptic and polysynaptic reflexes at the spinal level by stimulating the GABA B receptors, which inhibits the release of glutamate and aspartate. It may also act at intraspinal sites producing CNS depression. Baclofen also exerts an antinociceptive effect.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": null,
        "items": [
          "Increased sedation may occur if Albafen is taken with agents acting on the central nervous system, alcohol or synthetic opiates. The risk of respiratory depression is also increased.",
          "Combined treatment with Albafen and antihypertensives is likely to increase the fall in blood pressure; therefore the dosage of antihypertensive medication should be adjusted accordingly.",
          "The concomitant administration of Albafen and tricyclic antidepressants may potentiate the pharmacological effects of Albafen resulting in pronounced muscular hypotonia.",
          "In patients with Parkinsons disease receiving treatment with Albafen and levodopa and carbidopa, there have been several reports of mental confusion, hallucinations, headaches, nausea and agitation.",
          "The concurrent use of MAO inhibitors and Albafen may result in increased CNS depressant effects. Caution is advised and the dosage of one or both agents should be adjusted accordingly.",
          "Caution should be exercised when administering Albafen and magnesium sulphate or other neuromuscular blocking agents since a synergistic effect may theoretically occur."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Baclofen is contraindicated in patients with hypersensitivity to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse reactions associated with Albafen are transient drowsiness, daytime sedation, dizziness, weakness and fatigue.",
        "items": [
          "Central Nervous System: Headache (<10%), insomnia (<10%), and rarely, euphoria, excitement, depression, confusion, hallucinations, paraesthesia, nightmares, muscle pain, tinnitus, slurred speech, co-ordination disorder, tremor, rigidity, dystonia, ataxia, blurred vision, nystagmus, strabismus, miosis, mydriasis, diplopia, dysarthria, epileptic seizures, respiratory depression.",
          "Cardiovascular: Hypotension (<10%), rare instances of dyspnoea, palpitation, chest pain, syncope.",
          "Gastrointestinal: Nausea (approximately 10%), constipation (<10%) and rarely, dry mouth, anorexia, taste disorder, abdominal pain, vomiting, diarrhoea and positive test for occult blood in stool.",
          "Genitourinary: Urinary frequency (<10%) and rarely, enuresis, urinary retention, dysuria, impotence, inability to ejaculate, nocturia, haematuria.",
          "Other: Instances of rash, pruritus, ankle oedema, excessive perspiration, weight gain, nasal congestion, visual disturbances, hepatic function disorders and paradoxical increase in spasticity. Muscular hypotonia of a degree sufficient to make walking or movement difficult may occur but is usually relieved by readjusting the dosage. For this purpose, the daytime dosage may be reduced and the evening dosage increased."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy category B3. Safe use of Baclofen during pregnancy has not been established. Baclofen crosses the placental barrier. Baclofen should only be administered to pregnant women when in the judgement of the physician concludes that the potential benefits outweigh the possible hazards. Baclofen is excreted in breast milk however evidence to date suggests that the quantities are so small that no undesirable effects on the infant would be expected.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Lower doses (approximately 5 mg per day) should be used for patients with impaired renal function or those undergoing chronic haemodialysis.",
          "Patients suffering not only from spasticity but also from psychotic disorders, schizophrenia, depressive or manic disorders or confusional states should be treated cautiously and closely monitored as exacerbations of these disorders may occur.",
          "In patients with epilepsy and muscle spasticity, Albafen may be used under appropriate supervision and provided that adequate anticonvulsive therapy is continued. Lowering of the convulsion threshold may occur and seizures have been reported after the cessation of Albafen therapy or with overdose.",
          "Albafen should be used with caution in patients with or with a history of peptic ulcers, cerebrovascular diseases, or hepatic, renal or respiratory failure.",
          "Careful monitoring of respiratory and cardiovascular function is essential especially in patients with cardiopulmonary disease and respiratory muscle weakness.",
          "During treatment with Albafen, neurogenic disturbances affecting emptying of the bladder may improve. However in patients with preexisting sphincter hypertonia, acute retention of urine may occur. Albafen should be used with caution in these circumstances.",
          "Albafen has not significantly benefited patients with stroke. These patients have also shown poor tolerance to the medicine.",
          "Appropriate laboratory tests should be performed periodically in patients with hepatic diseases or diabetes mellitus to ensure that no medicine induced changes in these underlying diseases have occurred."
        ]
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Gastric lavage is important in case of severe overdose.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Centrally acting Skeletal Muscle Relaxants",
    "dosage": [
      {
        "medication_type": "Adult & children over 10 years",
        "information": ": 5 mg 3 times daily, preferably with or after food, gradually increased; max. 100 mg daily.",
        "instructions": []
      },
      {
        "medication_type": "Children <10 years",
        "information": ": Treatment is usually started with 2.5 mg (2.5 ml) given 4 times daily then raised according to requirement. Daily maintenance dose-",
        "instructions": [
          "12 month-2 years: 10-20 mg (10-20 ml)",
          "2 years-6 years: 20-30 mg (20-30 ml)",
          "6 years-10 years: 30-60 mg (30-60 ml)"
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:58.382Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d72",
    "original_record": {
      "input_index": 840,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d72"
        },
        "name": "Albafen",
        "strength": "10 mg",
        "generic": "Baclofen",
        "company": "Allied Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/18066/albafen-10-mg-tablet",
        "_page": 20,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/442/albasine-30-mg-tablet",
    "name": "Albasine",
    "dosage_form": "Tablet",
    "generic": "Almitrine Bismesylate + Raubasine",
    "strength": "30 mg+10 mg",
    "company": "Drug International Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 12.05",
      "strip_price": "৳ 168.70",
      "pack_size_info": "(3 x 14: ৳ 506.10)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.05",
          "pack_size_info": "(3 x 14: ৳ 506.10)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 168.70",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/39/almitrine-bismesylate-raubasine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This tablet is indicated for-",
        "items": [
          "Reduction of neurological damage & accelerates recovery after cerebral stroke",
          "Minor age-related neurological disorders",
          "Some visual disorders related to the circulation",
          "Some disorders of the inner ear related to circulation (hearing loss, dizziness, buzzing sounds in the ear)."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Almitrine Bismesylate & Raubasine combines raubasine, a vasodilator; and almitrine, a respiratory stimulant. Raubasine has a adrenolytic activity which is predominantly related to a post-synaptic blocking effect. Furthermore, under conditions of cerebral hypoxia, almitrine causes an increase in the partial pressure of oxygen in arterial blood (Pa0 2 ); almitrine causes an increase in the Pa0 2 and an increase in the oxygen saturation in arterial blood (Sa0 2 ), without modifying ventilatory parameters.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Do not associate with MAO-l (monoamine oxidase inhibitor), Not to be used concurrently with other almitrine-containing preparations.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This tablet is contraindicated in patients with hypersensitivity to any of the ingredients of it or severe hepatic impairment.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Weight loss, nausea, sensations of heaviness or burning in the stomach, gastrointestinal disorders, diarrhoea or constipation, insomnia, drowsiness, agitation, anxiety, dizziness, palpitations.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "It is not recommended in pregnancy. It should be used with caution only when the expected benefit to the mother is greater than the possible risk to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Due to the presence of lactose, Albasine should not be used in the case of galactosemia, of glucose and galactose malabsorption syndrome or of lactose deficiency (rare metabolic diseases). Do not exceed the recommended dose.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Signs include tachycardia, arterial hypotension, polypnoea and respiratory alkalosis.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at a cool and dry place, protected from light and moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cerebral vasodilator & Neurosensory oxygenator drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "1 tablet once or twice daily (taken separately, several hours apart), without exceeding 2 tablets per day. Or, as directed by the registered physicians.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:26:59.463Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d75",
    "original_record": {
      "input_index": 841,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d75"
        },
        "name": "Albasine",
        "strength": "30 mg+10 mg",
        "generic": "Almitrine Bismesylate + Raubasine",
        "company": "Drug International Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/442/albasine-30-mg-tablet",
        "_page": 20,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33927/albicon-ds-400-mg-chewable-tablet",
    "name": "Albicon DS",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "The White Horse Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": null,
      "pack_size_info": "(50's pack: ৳ 200.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(50's pack: ৳ 200.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Albicon DS is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Albicon DS, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Albicon DS should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Albicon DS is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Albicon DS exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Albicon DS is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:00.385Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d85",
    "original_record": {
      "input_index": 842,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d85"
        },
        "name": "Albicon DS",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "The White Horse Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/33927/albicon-ds-400-mg-chewable-tablet",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33308/albion-oralsaline-1025-gm-powder",
    "name": "Albion Oralsaline",
    "dosage_form": "Oral Powder",
    "generic": "Oral rehydration salt [glucose based]",
    "strength": "10.25 gm",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 5.00",
      "strip_price": null,
      "pack_size_info": "(20's pack: ৳ 100.00)",
      "packages": [
        {
          "label": "10.25 gm sachet",
          "price": "৳ 5.00",
          "pack_size_info": "(20's pack: ৳ 100.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10.25 gm (Powder)",
        "href": "https://medex.com.bd/brands/36391/oralyte-1025-gm-powder?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/78/oral-rehydration-salt-glucose-based/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Albion Albion Oralsalinesaline helps in replacement of fluid and electrolyte loss due to- Other conditions of fluid loss or lack of intake in patients of all age groups.",
        "items": [
          "Acute diarrhea",
          "Vomiting",
          "Dehydration"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the preparation of oral rehydration salt. It is composed of anhydrous glucose, sodium chloride, potassium chloride and sodium citrate (as dihydrate). This is a single formulation of glucose based oral rehydration salt to treat or prevent dehydration from diarrhea of any etiology, including cholera and in individuals of any age. This also prevents acidosis due to electrolyte imbalance.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "There are no known drug interactions and none well documented.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [],
    "pregnancy_cat": [],
    "precautions": [
      {
        "title": null,
        "information": "Depressed renal function, severe continuing diarrhea or other critical fluid losses may need supplementation with parenteral fluids along with oral saline.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Do not store above 30°C temperature. Keep away from light and wet places. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": null,
        "items": [
          "Disperse the full contents of the sachet in 500 mL (1/2 liter) of pure drinking water.",
          "Do not mix the oral saline with hot water or heat the prepared solution.",
          "Discard the unused prepared oral saline after 12 hours of preparation."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Oral electrolytes preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Daily dose should be equivalent to patients' fluid requirement for maintenance and replenishment of losses. During this therapy, mother should not stop breastfeeding to their child and normal food should be continued in case of adults.",
        "instructions": []
      },
      {
        "medication_type": "Children less than 2 years",
        "information": ": After each loose stool or vomiting 50-100 mL (10 to 20 teaspoonful) of prepared this.",
        "instructions": []
      },
      {
        "medication_type": "Children 2 to 10 years",
        "information": ": After each loose stool or vomiting 100-200 mL (1/2 to 1 glass) of prepared oral saline.",
        "instructions": []
      },
      {
        "medication_type": "Adult and children above 10 years",
        "information": ": After each loose stool or vomiting 200-400 mL (1 to 2 glass) of prepared this.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:02.079Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d88",
    "original_record": {
      "input_index": 843,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d88"
        },
        "name": "Albion Oralsaline",
        "strength": "10.25 gm",
        "generic": "Oral rehydration salt [glucose based]",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Oral Powder",
        "source_url": "https://medex.com.bd/brands/33308/albion-oralsaline-1025-gm-powder",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/268/albrex-400-mg-chewable-tablet",
    "name": "Albrex",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Medimet Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 3.50",
      "strip_price": null,
      "pack_size_info": "(50's pack: ৳ 175.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.50",
          "pack_size_info": "(50's pack: ৳ 175.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Albrex is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Albrex, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Albrex should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Albrex is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Albrex exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Albrex is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:03.251Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d8d",
    "original_record": {
      "input_index": 844,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d8d"
        },
        "name": "Albrex",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Medimet Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/268/albrex-400-mg-chewable-tablet",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/37023/albunorm-25-injection",
    "name": "Albunorm",
    "dosage_form": "IV Infusion",
    "generic": "Albumin",
    "strength": "25%",
    "company": "Octapharma S.A.S., France",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 6,924.17",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "50 ml bottle",
          "price": "৳ 6,924.17",
          "pack_size_info": null
        },
        {
          "label": "100 ml bottle",
          "price": "৳ 13,848.33",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5% (IV Infusion)",
        "href": "https://medex.com.bd/brands/37021/albunorm-5-injection?ref=1"
      },
      {
        "text": "20% (IV Infusion)",
        "href": "https://medex.com.bd/brands/37022/albunorm-20-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/545/albumin-human/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Shock: Albunorm is indicated in the emergency treatment of shock and in other similar conditions where the restoration of blood volume is urgent. If there has been considerable loss of red blood cells, transfusion with packed red blood cells is indicated.... Read moreShock: Albunorm is indicated in the emergency treatment of shock and in other similar conditions where the restoration of blood volume is urgent. If there has been considerable loss of red blood cells, transfusion with packed red blood cells is indicated.Burns: Albunorm or Albunorm in either normal saline or dextrose is indicated to prevent marked hemoconcentration and to maintain appropriate electrolyte balance.Hypoproteinemia with or without edema: Albunorm is indicated in those clinical situations usually associated with a low concentration of plasma protein and a resulting decreased circulating blood volume. Although diuresis may occur soon after Albunorm administration has been instituted, best results are obtained if Albunorm is continued until the normal serum protein level is regained.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The main function of albumin results from its contribution to plasma colloid oncotic pressure and transport function. Albumin stabilizes circulating blood volume and carries hormones, enzymes, medicines, and toxins. Other physiological functions include antioxidant properties, free radical scavenging, in addition to maintenance capillary membrane integrity. Exogenously administered albumin increases the oncotic pressure of the intravascular system, moving fluids from the interstitial space, thereby decreasing edema and increasing the circulating blood volume. The increase in volume reduces the concentration and viscosity of blood in patients with decreased circulating blood volume while maintaining cardiac output in shock. In dehydrated patients, negligible effects exist on circulating blood volume. In addition to the above albumin replaces protein in patients with hypoproteinemia until the cause of the deficiency can be determined. This drug has thousands of endogenous and exogenous targets. Human albumin also binds and carries a plethora of hydrophobic molecules, such as endogenous (i.e., cholesterol, fatty acids, bilirubin, thyroxine) or exogenous substances (for example, drugs and toxins), transition metal ions, as well as gas (nitric oxide [NO]), with resulting implications for their solubilisation, transport, metabolism, and detoxification.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Albunorm solution should not be mixed by protein hydrolysates or alcoholic solutions. Risk of atypical reactions to ACE inhibitors in patients undergoing therapeutic plasma exchange with Albunorm human replacement.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Albumin (Human) may be contraindicated in patients with severe anemia or cardiac failure and in patients with a history of allergic reactions to human albumin.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Allergic or pyrogenic reactions are characterized primarily by fever and chills; rash, nausea, vomiting, tachycardia and hypotension have also been reported. Should an adverse reaction occur, slow or stop the infusion for a period of time which may result in the disappearance of the symptoms. If administration has been stopped and the patient requires additional Albunorm (Human), material from a different lot should be used. Albunorm (Human), particularly if administered rapidly, may result in vascular overload with resultant pulmonary edema.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Hypertension or low cardiac reserve; additional fluids for dehydrated patients. Monitor for signs of cardiac overload in injured or postoperative patients. May carry risk of viral transmission. Volume admin and rate of infusion must always be individualised according to situation and response. Pregnancy, lactation.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "No clinical studies using Albunorm (Human) have been conducted in pediatric patients. Safety and effectiveness in pediatric patients have not been established. However, extensive experience in patients suggests that children respond to Albunorm (Human) in the same manner as adults.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C. Do not freeze.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Plasma expanders",
    "dosage": [
      {
        "medication_type": "Human albumin 25%",
        "information": "is for intravenous administration only. Human albumin may be diluted with 5% glucose or 0.9% sodium chloride. Concentration, dosage, and infusion-rate should be adjusted to the patient’s individual requirements and indication.",
        "instructions": [
          "Hypovolemia: Initial dose 25 g is suggested.",
          "Hypoalbuminemia: 50-75 gm",
          "Prevention of central volume fluid removed depletion after",
          "paracentesis due to cirrhotic ascites: 6-8 gm for every 1000 mL of ascitic.",
          "OHSS: 50 to 100 gm over 4 hours and repeated at 4-12 hour intervals as necessary. 10-50 gm; single infusion.",
          "ARDS: 25 g over 30 minutes and repeated at 8 hours for 3 days if necessary.",
          "Burns: Determined by direct observation of vital sign or measurement of either plasma oncotic pressure or protein content."
        ]
      },
      {
        "medication_type": "Human albumin 20%",
        "information": ": Measures of adequacy of circulating volume and not plasma albumin levels should be used to determine the dose required. If human albumin is to be administered, haemodynamic performance should be monitored regularly; this may include: The solution can be directly administered by the intravenous route, or it can be diluted in an isotonic solution (e.g. 0.9% sodium chloride). In plasma exchange the infusion rate should be adjusted to the rate of removal.",
        "instructions": [
          "arterial blood pressure and pulse rate",
          "central venous pressure",
          "pulmonary artery wedge pressure",
          "urine output",
          "electrolyte",
          "haematocrit / haemoglobin"
        ]
      },
      {
        "medication_type": "Human albumin 5%",
        "information": "may be given intravenously without further dilution. This concentration is approximately isotonic and iso-osmotic with citrated plasma. Albumin (Human) in this concentration provides additional fluid for plasma volume expansion. Therefore, when it is administered to patients with normal blood volume, the rate of infusion should be slow enough to prevent too rapid expansion of plasma volume. In the treatment of shock in an adult patient an initial dose of 500 mL of the 5% albumin solution is given as rapidly as tolerated. If response within 30 minutes is inadequate, an additional 500 mL of 5% albumin solution may be given. The 50 mL dosage form would be appropriate for pediatric use, with a dose of 10-20 mL per kg of body weight infused intravenously at a rate up to 5-10 mL per minute. Therapy should be guided by the clinical response, blood pressure and an assessment of relative anemia. If more than 1000 mL are given, or if hemorrhage has occurred, the administration of packed red blood cells may be desirable. In severe burns, immediate therapy should include large volumes of crystalloid with lesser amounts of 5% albumin solution to maintain an adequate plasma volume. After the first 24 hours, the ratio of albumin to crystalloid may be increased to establish and maintain a plasma albumin level of about 2.5 g/100 mL or a total serum protein level of about 5.2 g/100 mL. However, an optimal regimen for the use of colloids, electrolytes and water after severe burns has not been established. The infusion of Albumin (Human) as a nutrient in the treatment of chronic hypoproteinemia is not recommended. In acute hypoproteinemia, 5% albumin may be used in replacing the protein lost in hypoproteinemic conditions. However, if edema is present or if large amounts of albumin are lost, Albumin (Human) 25% is preferred because of the greater amount of protein in the concentrated solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:04.316Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d90",
    "original_record": {
      "input_index": 845,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d90"
        },
        "name": "Albunorm",
        "strength": "25%",
        "generic": "Albumin (Human)",
        "company": "Discount Pharma",
        "medicine_type": "IV Infusion",
        "source_url": "https://medex.com.bd/brands/37023/albunorm-25-injection",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/32643/alcaft-025-eye-drop",
    "name": "Alcaft",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Alcaftadine",
    "strength": "0.25%",
    "company": "Healthcare Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 450.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 450.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/29/alcaftadine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alcaft eye drops is indicated for the prevention of itching associated with allergic conjunctivitis. Alcaft ophthalmic solution is an H1 receptor antagonist, in a sterile ophthalmic solution for topical ophthalmic use.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This eye drops is a sterile topical ophthalmic solution containing Alcaftadine. Alcaftadine is an histamine receptor antagonist and inhibitor of the release of histamine from mast cell. It is also a potent histamine H2 and H4 receptor antagonist that has demonstrated anti-inflammatory property. In doing so, antihistaminic effect provides relief from itching associated with early phase of ocular allergic response, whereas mast cell stabilization inhibits the release of mediators such as cytokines and lipid mediators that play a role in late-phase response of allergic conjunctivitis.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "Alcaftadine is contraindicated in patients with hypersensitivity to any component in the product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most frequent ocular reactions are eye irritation, burning or/and stinging upon instillation, eye redness and eye pruritus, nasopharyngitis and headache.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy category B. There are however, no adequate and well controlled studies in pregnant women, thus this drug should be used during pregnancy only if clearly needed. It is not known whether this drug is excreted in human milk. Caution should be exercised while administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "To minimize eye injury and contamination of the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle. Patients should be advised not to wear a contact lens if their eye is red. Alcaft should not be used to treat contact lens related irritation and should not be instilled while wearing contact lenses. Remove contact lenses prior to instillation Alcaft. Lenses may be reinserted after 10 minutes following administration. If more than 1 topical ophthalmic medicinal product is being used, each one should be administered at least 5 minutes apart.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Pediatric Use: Safety and effectiveness in pediatric patients below the age of 2 years have not been established.Geriatric Use: No overall differences in safety or effectiveness were observed between elderly and younger subjects.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 25°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ophthalmic Anti-allergic preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adults and children 2 years and over: Instill one drop in each eye once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:05.353Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d97",
    "original_record": {
      "input_index": 846,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d97"
        },
        "name": "Alcaft",
        "strength": "0.25%",
        "generic": "Alcaftadine",
        "company": "Healthcare Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/32643/alcaft-025-eye-drop",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/17366/alcefen-100-mg-tablet",
    "name": "Alcefen",
    "dosage_form": "Tablet",
    "generic": "Aceclofenac",
    "strength": "100 mg",
    "company": "Allied Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/3/aceclofenac/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alcefen is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, toothache, trauma and lumbago.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Aceclofenac is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No significant drug interactions has not been observed but close monitoring of patients is required when it is used with:",
        "items": [
          "Lithium and Digoxin: may increase plasma concentration of lithium and digoxin.",
          "Diuretics: may interact the activity of diuretics.",
          "Anticoagulants: may enhance the activity of anticoagulant.",
          "Methotrexate: may increase the plasma level of methotrexate."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Aceclofenac is contraindicated in patients with known hypersensitivity to it or in whom aspirin or NSAIDs precipitate attacks of asthma.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Alcefen is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The use of Aceclofenac should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised to patients with active or suspected peptic ulcer or gastro-intestinal bleeding moderate to severe hepatic impairment and cardiac or renal impairment. Caution should also be exercised in patients suffering from dizziness or urticaria.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "There are no clinical data on the use of Alcefen in children.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs)",
    "dosage": [
      {
        "medication_type": null,
        "information": "Extended release tablet: The recommended dose in adults is one 200 mg Aceclofenac tablet daily or as prescribed by the physician.Film coated tablet: The recommended dose in adults is 100 mg, twice daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:06.326Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d9b",
    "original_record": {
      "input_index": 847,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d9b"
        },
        "name": "Alcefen",
        "strength": "100 mg",
        "generic": "Aceclofenac",
        "company": "Allied Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/17366/alcefen-100-mg-tablet",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/15976/alchek-01-eye-drop",
    "name": "Alchek",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Olopatadine Hydrochloride",
    "strength": "0.1%",
    "company": "Apex Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 110.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 110.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.2% (Eye Drop)",
        "href": "https://medex.com.bd/brands/22988/alchek-ds-02-eye-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/823/olopatadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Patadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.... Read morePatadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.Alchek Nasal Spray is an H1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older.Alchek tablet is indicated in the treatment of allergic rhinitis (swelling of the nasal membranescaused by an allergy to pollen and mold spores in the air) and allergic skin conditions. It helps to relieve allergy symptoms such as skin rashes, swelling, hives (itchy, painful eruptions that sting), itching, sneezing, runny or stuffy nose.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Olopatadine, an antihistamine, works by blocking the action of histamine in the body, which reduces allergy symptoms. Olopatadine hydrochloride treats sneezing, itching, runny nose, and other nasal symptoms of allergies.",
        "items": []
      },
      {
        "title": "Mode of Action",
        "information": ": Olopatadine is an anti-allergic molecule that works via several mechanisms. As a mast cell stabilizer, it stabilizes rodent basophils and human conjunctival mast cells and inhibits the immunologically-stimulated release of histamine. Olopatadine acts as an antagonist at the histamine H1 receptors with high selectivity, Upon binding, olopatadine blocks the H1 receptor signaling pathway, inhibiting the release of inflammatory mediators, such as tryptase, prostaglandin D2, TNF-alpha, as well as pro-inflammatory cytokines.",
        "items": []
      },
      {
        "title": "Pharmacokinetics",
        "information": ": Absorption: Olopatadine was absorbed with individual peak plasma concentrations observed between 30 minutes and 1 hour after twice daily intranasal administration of Olopatadine Nasal Spray. Distribution: The protein binding of olopatadine was moderate at approximately 55% in human serum, and independent of drug concentration over the range of 0.1 to 1000 ng/mL. Metabolism: Olopatadine is not extensively metabolized. Based on plasma metabolite profiles of olopatadine, at least six minor metabolites circulate in human plasma. Elimination: The plasma elimination half-life of olopatadine is 8 to 12 hours. Olopatadine is mainly eliminated through urinary excretion",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Formal drug-drug interaction studies were not conducted for Alchek Nasal Spray. Drug interactions with inhibitors of liver enzymes are not anticipated because olopatadine is eliminated predominantly by renal excretion. Drug interactions involving P450 inhibition and plasma protein binding are also not expected.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in persons with a known hypersensitivity to any component of this product. Olopatadine 5 mg tablet is not recommended for use if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions to make sure this medicine is safe for you.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rarely headaches have been reported. Other adverse effects: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Olopatadine was found not to be teratogenic in rats and rabbits. There are, however, no adequate and well controlled studies in pregnant women. This drug should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Olopatadine is administered to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients should be advised not to wear a contact lens if their eye is red. Alchek ophthalmic solution should not be used to treat contact lens related irritation. Benzalkonium Chloride, preservative of Patadin, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least 10 minutes after instillation of Patadin eye drops before they insert their contact lenses. The treatment should be discontinued in the presence of an allergic reaction. Before initial use, Alchek Nasal Spray by releasing 5 sprays or until a fine mist appears. When Alchek Nasal Spray has not been used for more than 7 days, re-prime by releasing 2 sprays. Avoid spraying Alchek Nasal Spray into the eyes. Patients should be informed to avoid spraying Alchek Nasal Spray in their eyes. Olonex Tablet should be used as prescribed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid taking more than the recommended dose. Do not stop taking this medicine without consulting your doctor, as your symptoms may reoccur.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety or effectiveness have been observed betweents.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no information on Alchek overdose. However, excessive use of any medication can have serious consequences. If you suspect an overdose, seek medical attention without delay.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at room temperature and protect from light. It is desirable that the contents should not be used more than one month after first opening of the bottle.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "How to use the Nasal Spray- Cleaning: The nasal spray should be cleaned at least once a week. The procedures are as follows-",
        "items": [
          "Shake the bottle gently and remove the dust cover.",
          "Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath the bottle. Press down until a fine spray appears. If using for the first time or if you have not used it for a week or more, press the nasal applicator several times until a fine moist comes out from the container.",
          "Gently blow the nose to clear the nostrils.",
          "Close one nostril and carefully insert the nasal applicator into the open nostril. Tilt your head forward slightly and keep the spray upright. Breathe in through your nose and while breathing in, press the white-collar of nasal applicator firmly down once to release a spray.",
          "Breathe out through your mouth.",
          "Repeat the above steps in the same/ other nostril for consecutive doses.",
          "Remove the dust cover.",
          "Gently pull off the nasal applicator.",
          "Wash the applicator and dust cover in warm water.",
          "Shake off the excess water and leave to dry in a normal place. Avoid to apply additional heat.",
          "Gently push the applicator back on the top of the bottle and re-fix the dust cover."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ophthalmic Non-Steroid drugs",
    "dosage": [
      {
        "medication_type": "Eye Drops",
        "information": "-",
        "instructions": [
          "0.1%: One drop in each affected eye two times per day at an interval of 6 to 8 hours.",
          "0.2%: One drop in the affected eye once a day.",
          "0.7%: One drop in each affected eye once a day."
        ]
      },
      {
        "medication_type": "Nasal Spray",
        "information": "-",
        "instructions": [
          "Administer Olopatadine Nasal Spray by the intranasal route only.",
          "Adults and Adolescents 12 years of age and older: Two sprays per nostril twice daily.\\",
          "Children 6 to 11 years of age: One spray per nostril twice daily."
        ]
      },
      {
        "medication_type": "Tablet",
        "information": "-",
        "instructions": [
          "Adults: Take 1 tablet (5 mg of the active ingredient) at a time, twice daily, in the morning and before going to bed. The dosage may be adjusted according to the disease, age or symptoms.",
          "Children 7 years old or over: Take 1 tablet (5 mg) at a time, twice daily, in the morning and before going to bed.",
          "If you miss a dose, take a dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time. Do not stop taking this medicine unless your doctor instructs you to do so."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:07.377Z",
    "medicine_id": "68c3c09aef5b8f2b163a8d9e",
    "original_record": {
      "input_index": 848,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8d9e"
        },
        "name": "Alchek",
        "strength": "0.1%",
        "generic": "Olopatadine Hydrochloride",
        "company": "Apex Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/15976/alchek-01-eye-drop",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/7102/alclor-125-mg-pediatric-drop",
    "name": "Alclor",
    "dosage_form": "Pediatric Drops",
    "generic": "Cefaclor Monohydrate",
    "strength": "125 mg/1.25 ml",
    "company": "ACME Laboratories Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 135.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "15 ml bottle",
          "price": "৳ 135.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "500 mg (Capsule)",
        "href": "https://medex.com.bd/brands/7100/alclor-500-mg-capsule?ref=1"
      },
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/7101/alclor-125-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/209/cefaclor-monohydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alclor is indicated for the treatment of the following infections: Alclor is indicated for the treatment of the following infections:",
        "items": [
          "Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes",
          "Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes",
          "Respiratory tract infections, including pneumonia, bronchitis, caused by Streptococcus Pneumoniae, Haemophilus Influenzae, and Streptococcus Pyogenes",
          "Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, Staphylococci, and Streptococcus pyogenes",
          "Pharyngitis and Tonsillitis, caused by Streptococcus pyogenes",
          "Urinary tract infections, including pyelonephritis and cystitis, caused by Escherichia coli, Proteus mirabilis, Klebsiella spp., and coagulase-negative Staphylococci",
          "Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cefaclor is a second generation cephalosporin antibiotic which has stability against b-lactamase inactivation and possesses a broad spectrum of activity. Cefaclor is active against the following organisms in vitro: Alpha and beta haemolytic Streptococci, Staphylococci; including coagulase-positive, coagulase negative and penicillinase-producing strains, Streptococcus pneumoniae, Streptococcus pyogenes (Group A b-haemolytic Streptococci), Branhamella catarrhalis, Escherichia coli, Proteus mirabilis, Klebsiella species Haemophilus influenzae, including ampicillin-resistant strains. Cefaclor is generally effective in the eradication of Streptococci from the nasopharynx.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alclor may show a false-positive reaction for glucose in the urine with tests that use Benedict's solution, Fehling's solutions. When Alclor and oral anticoagulants were administered concomitantly there have been reports of increased anticoagulant effect and there have been rare reports of increased prothrombin time, with or without clinical bleeding, in patients receiving Alclor and anticoagulants (Warfarin) concomitantly. It is recommended that in such patients, regular monitoring of prothrombin time should be considered, with adjustment of dosage if necessary.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cefaclor is contraindicated in patients with known allergy to the Cephalosporin group of antibiotics.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastro-intestinal symptoms may occur include diarrhea, nausea and vomiting in some patients receiving Alclor. As with some penicillins and some other Cephalosporins, transient hepatitis and cholestatic jaundice have been reported rarely. Fever, abdominal pain, superinfection, renal dysfunction, toxic nephropathy, hemorrhage, elevated LDH and pancytopenia may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed. Small amounts of Cefaclor have been detected in mother's milk. The effect on nursing infants is not known. Caution should be exercised when Cefaclor is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Prescribing Alclor in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria. Prolonged use of Alclor may result in the overgrowth of nonsusceptible organisms. If superinfection occurs during therapy, appropriate measures should be taken. As with other β-lactam antibiotics, the renal excretion of Alclor is inhibited by Probenecid. Antibiotics, including Cephalosporins, should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. Before therapy with Alclor is instituted, careful inquiry should be made to determine whether the patient has had previous hypersensitivity reactions to Alclor, Cephalosporins, Penicillins or other drugs. If Alclor is to be given to penicillin-sensitive patients, caution should be exercised. Alclor should be administered cautiously to any patient who has demonstrated some form of allergy, particularly to drugs.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "The toxic symptoms following an overdose of Alclor may include nausea, vomiting, epigastric distress, and diarrhea.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at room temperature and protect from light. After reconstitution the suspension can be used within 7 days if kept at room temperature and within 14 days if kept in refrigerator (2-8°C). Always keep the bottle tightly closed.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Second generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "Capsule: Adult dose",
        "information": ": The usual dose is 250 mg every 8 hourly. For severe infections or those caused by less susceptible organisms, doses may be doubled with a maximum dosage of 4 g/day. In case of β-hemolytic Streptococcal infections, therapy should be administered for at least 10 days.",
        "instructions": []
      },
      {
        "medication_type": "Powder for suspension & Pediatric drops: Children",
        "information": ": The usual daily dosage for paediatric patients over 1 month is 20 mg/kg/day in divided doses every 8 hours. In serious infections such as otitis media and infections caused by less susceptible organisms, 40 mg/kg/day are recommended, with a maximum dosage of 1 g/day. Safety and effectiveness of Cefaclor for use in infants less than 1 month of age have not been established. <1 year (9 kg):",
        "instructions": []
      },
      {
        "medication_type": "Powder for suspension",
        "information": ": ½ tsp three times daily",
        "instructions": []
      },
      {
        "medication_type": "Pediatric drops",
        "information": ": 0.625 ml three times daily",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "1-5 years (9 kg-18 kg):",
        "instructions": []
      },
      {
        "medication_type": "Powder for suspension",
        "information": ": 1 tsp three times daily",
        "instructions": []
      },
      {
        "medication_type": "Pediatric drops",
        "information": ": 1.25 ml three times daily",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Over 5 years:",
        "instructions": []
      },
      {
        "medication_type": "Powder for suspension",
        "information": ": 2 tsp three times daily",
        "instructions": []
      },
      {
        "medication_type": "In renal impairment",
        "information": ": Cefaclor may be administered in the presence of impaired renal function. Dose adjustments for patients with moderate or sever renal impairment are not usually required.",
        "instructions": []
      },
      {
        "medication_type": "In patients undergoing haemodialysis",
        "information": ": Haemodialysis shortens serum half-life by 25-30%. In patients undergoing haemodialysis, a predialysis loading dose of 250 mg-1 g is recommended. A maintaining dose of 250-500 mg every 6 hourly during interdialytic period may be used.",
        "instructions": []
      },
      {
        "medication_type": "Geriatric use",
        "information": ": Clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:08.609Z",
    "medicine_id": "68c3c09aef5b8f2b163a8da0",
    "original_record": {
      "input_index": 849,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8da0"
        },
        "name": "Alclor",
        "strength": "125 mg/1.25 ml",
        "generic": "Cefaclor Monohydrate",
        "company": "ACME Laboratories Ltd.",
        "medicine_type": "Pediatric Drops",
        "source_url": "https://medex.com.bd/brands/7102/alclor-125-mg-pediatric-drop",
        "_page": 21,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/20142/alconil-mouthwash",
    "name": "Alconil",
    "dosage_form": "Mouthwash",
    "generic": "Eucalyptol + Menthol + Methyl Salicylate + Thymol + Sodium Fluoride",
    "strength": null,
    "company": "Ziska Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 85.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "120 ml bottle",
          "price": "৳ 85.00",
          "pack_size_info": null
        },
        {
          "label": "250 ml bottle",
          "price": "৳ 150.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/447/eucalyptol-menthol-methyl-salicylate-thymol-sodium-fluoride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alconil mouthwash is indicated in-",
        "items": [
          "Gingivitis",
          "Oral hygiene",
          "Cavities",
          "Bad breath",
          "Plaque",
          "Gum disease",
          "Teeth cleaner &",
          "brighter."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": "Eucalyptol",
        "information": "is a natural organic compound which is a colorless liquid. It is a cyclic ether and a monoterpenoid. Eucalyptol is an ingredient in many brands of mouthwash and cough suppressant. It controls airway mucus hypersecretion and asthma via anti-inflammatory cytokine inhibition.",
        "items": []
      },
      {
        "title": "Menthol:",
        "information": "It provides cooling sensation by stimulation of cooling receptor and gives local anesthetic action",
        "items": []
      },
      {
        "title": "Methyl Salicylate",
        "information": ": It penetrates and reaches at high concentration in pain regions and inhibit the prostaglandin synthesis and relieves pain effectively",
        "items": []
      },
      {
        "title": "Thymol",
        "information": ", one of the chemicals in thyme, is used with another chemical, chlorhexidine, as a dental varnish to prevent tooth decay. In foods, thyme is used as a flavoring agent. In manufacturing, red thyme oil is used in perfumes. It is also used in soaps, cosmetics, and toothpastes.",
        "items": []
      },
      {
        "title": "Fluoride salts",
        "information": "are often added to municipal drinking water (as well as certain food products in some countries) for the purposes of maintaining dental health. The fluoride enhances the strength of teeth by the formation of fluorapatite, a naturally occurring component of tooth enamel. Toothpaste often contains sodium fluoride to prevent cavities, although tin(II) fluoride is generally considered superior for this application.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "There are no known drug interactions and none well documented.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Do not eat or drink for 30 minutes after rinsing. Doing so will diminish the effects of the mouthwash.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category: Not Classified. FDA has not yet classified the drug into a specified pregnancy category.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Should not eat or drink for 30 minutes after rinsing. Children under 12 years of age should be instructed in good rinsing habits to minimize swallowing. Children have to be supervised in rinsing as necessary until they are capable of using without supervision. If more than amount used for rinsing is accidentally swallowed, physicians help should be taken immediately.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool & dry place. Keep out of reach of children. Cold weather may cloud Alconil but its antiseptic & anticavity properties are not affected.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Oral preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Use twice daily after brushing your teeth with toothpaste.Vigorously swish 10 ml of rinse between your teeth for 1 minute and then spit out. Do not swallow the rinse. Do not eat or drink for 30 minutes after rinsing. Supervise children as necessary until capable of using without supervision. Use in Children: According to the consultancy of dentist or physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:09.782Z",
    "medicine_id": "68c3c09aef5b8f2b163a8da5",
    "original_record": {
      "input_index": 850,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8da5"
        },
        "name": "Alconil",
        "strength": null,
        "generic": "Eucalyptol + Menthol + Methyl Salicylate + Thymol + Sodium Fluoride",
        "company": "Ziska Pharmaceuticals Ltd.",
        "medicine_type": "Mouthwash",
        "source_url": "https://medex.com.bd/brands/20142/alconil-mouthwash",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/274/aldes-ds-400-mg-chewable-tablet",
    "name": "Aldes DS",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Desh Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": "৳ 4.00",
      "pack_size_info": "(25 x 1: ৳ 100.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(25 x 1: ৳ 100.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 4.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aldes DS is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Aldes DS, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Aldes DS should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Aldes DS is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Aldes DS exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Aldes DS is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:10.972Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dad",
    "original_record": {
      "input_index": 851,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dad"
        },
        "name": "Aldes DS",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Desh Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/274/aldes-ds-400-mg-chewable-tablet",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/278/aldin-ds-400-mg-chewable-tablet",
    "name": "Aldin DS",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Techno Drugs Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": "৳ 8.00",
      "pack_size_info": "(30 x 2: ৳ 240.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(30 x 2: ৳ 240.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 8.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aldin DS is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Aldin DS, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Aldin DS should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Aldin DS is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Aldin DS exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Aldin DS is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:12.274Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dae",
    "original_record": {
      "input_index": 852,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dae"
        },
        "name": "Aldin DS",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Techno Drugs Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/278/aldin-ds-400-mg-chewable-tablet",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/2854/aldonist-25-mg-tablet",
    "name": "Aldonist",
    "dosage_form": "Tablet",
    "generic": "Eplerenone",
    "strength": "25 mg",
    "company": "UniMed UniHealth Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 45.00",
      "strip_price": "৳ 450.00",
      "pack_size_info": "(3 x 10: ৳ 1,350.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 45.00",
          "pack_size_info": "(3 x 10: ৳ 1,350.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 450.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "50 mg (Tablet)",
        "href": "https://medex.com.bd/brands/2855/aldonist-50-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/421/eplerenone/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aldonist is indicated in",
        "items": [
          "Congestive heart failure after an acute myocardial infarction",
          "Hypertension"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Eplerenone is a blocker of aldosterone binding at the mineralocorticoid receptor. Eplerenone binds to the mineralocorticoid receptor and blocks the binding of aldosterone, a component of the renin-angiotensin-aldosterone-system (RAAS). Aldosterone synthesis, which occurs primarily in the adrenal gland, is modulated by multiple factors, including angiotensin II and non-RAAS mediators such as adrenocorticotropic hormone and potassium. Aldosterone binds to mineralocorticoid receptors in both epithelial (e.g. kidney) and nonepithelial (e.g. heart, blood vessels, and brain) tissues and increases blood pressure through induction of sodium reabsorption and possibly other mechanisms. Eplerenone has been shovvn to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of Eplerenone.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "May increase risk of hyperkalaemia with ACE inhibitors and/or angiotension receptor blocker, ciclosporin, tacrolimus, trimethoprim. May reduce antihypertensive effect with NSAIDs, glucocorticoids, tetracosactide. May enhance hypotensive effect of α1-blockers (e.g. alfuzosin, prazosin), TCAs, amifostine, baclofen, neuroleptics. May increase plasma level with mild to moderate CYP3A4 inhibitors (e.g. fluconazole, erythromycin, saquinavir, amiodarone, diltiazem, verapamil).",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Eplerenone is contraindicated in hyperkalemia, severe renal impairment (creatinine clearance less than 30 ml/min), severe hepatic impairment. Concomitant use with potent CYPBA4 inhibitors like Ketoconazole, Itraconazole, Nefazodone, Troleandomycin, Clarithromycin, Ritonavir, and Nelfinavir or other potassium-sparing diuretics are also contraindicated.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Headache, dizziness, diarrhea, stomach pain, nausea, cough or flu-like symptoms may occur. Symptoms of a serious allergic reaction like: rash, itching, swelling, severe dizziness, trouble breathing can occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies in pregnant women. Eplerenone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. The concentration of Eplerenone in human breast milk after oral administration is unknown. Because many drugs are excreted in human milk and because of the unknown potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Aldonist should be used with caution in hyperkalemia, severe kidney disease, diabetic patients with congestive heart failure after an acute myocardial infarction including those with proteinuria.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Aldonist store below 30°C in a cool and dry place, protected from light and moisture. Keep out of children’s reach.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Potassium-sparing diuretics, Potassium-sparing diuretics & Aldosterone antagonists",
    "dosage": [
      {
        "medication_type": "Congestive heart failure after an acute myocardial infarction",
        "information": ": The recommended dose of Eplerenone is 50 mg once daily. Treatment should be initiated at 25 mg once daily and titrated to the target dose of 50 mg once daily preferably within 4 weeks as tolerated by the patient. Eplerenone may be administered with or without food.",
        "instructions": []
      },
      {
        "medication_type": "Hypertension",
        "information": ": Eplerenone may be used alone or in combination with other antihypertensive agents. The recommended starting dose of Eplerenone is 50 mg administered once daily. For patients with an inadequate blood pressure response to 50mg once daily the dosage of Eplerenone should be increased to 50mg twice daily. Higher dosages of Eplerenone are not recommended either because they have no greater effect on blood pressure than 100 mg or because they are associated with an increased risk of hyperkalemia.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric use",
        "information": ": The safety and effectiveness of Eplerenone has not been established in pediatric patients.",
        "instructions": []
      },
      {
        "medication_type": "Geriatric use",
        "information": ": No differences in overall incidence of effectivity or safety was observed in elderly patients.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:13.530Z",
    "medicine_id": "68c3c09aef5b8f2b163a8db1",
    "original_record": {
      "input_index": 853,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8db1"
        },
        "name": "Aldonist",
        "strength": "25 mg",
        "generic": "Eplerenone",
        "company": "UniMed UniHealth Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/2854/aldonist-25-mg-tablet",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/2855/aldonist-50-mg-tablet",
    "name": "Aldonist",
    "dosage_form": "Tablet",
    "generic": "Eplerenone",
    "strength": "50 mg",
    "company": "UniMed UniHealth Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 85.00",
      "strip_price": "৳ 595.00",
      "pack_size_info": "(2 x 7: ৳ 1,190.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 85.00",
          "pack_size_info": "(2 x 7: ৳ 1,190.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 595.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/2854/aldonist-25-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/421/eplerenone/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aldonist is indicated in",
        "items": [
          "Congestive heart failure after an acute myocardial infarction",
          "Hypertension"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Eplerenone is a blocker of aldosterone binding at the mineralocorticoid receptor. Eplerenone binds to the mineralocorticoid receptor and blocks the binding of aldosterone, a component of the renin-angiotensin-aldosterone-system (RAAS). Aldosterone synthesis, which occurs primarily in the adrenal gland, is modulated by multiple factors, including angiotensin II and non-RAAS mediators such as adrenocorticotropic hormone and potassium. Aldosterone binds to mineralocorticoid receptors in both epithelial (e.g. kidney) and nonepithelial (e.g. heart, blood vessels, and brain) tissues and increases blood pressure through induction of sodium reabsorption and possibly other mechanisms. Eplerenone has been shovvn to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of Eplerenone.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "May increase risk of hyperkalaemia with ACE inhibitors and/or angiotension receptor blocker, ciclosporin, tacrolimus, trimethoprim. May reduce antihypertensive effect with NSAIDs, glucocorticoids, tetracosactide. May enhance hypotensive effect of α1-blockers (e.g. alfuzosin, prazosin), TCAs, amifostine, baclofen, neuroleptics. May increase plasma level with mild to moderate CYP3A4 inhibitors (e.g. fluconazole, erythromycin, saquinavir, amiodarone, diltiazem, verapamil).",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Eplerenone is contraindicated in hyperkalemia, severe renal impairment (creatinine clearance less than 30 ml/min), severe hepatic impairment. Concomitant use with potent CYPBA4 inhibitors like Ketoconazole, Itraconazole, Nefazodone, Troleandomycin, Clarithromycin, Ritonavir, and Nelfinavir or other potassium-sparing diuretics are also contraindicated.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Headache, dizziness, diarrhea, stomach pain, nausea, cough or flu-like symptoms may occur. Symptoms of a serious allergic reaction like: rash, itching, swelling, severe dizziness, trouble breathing can occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies in pregnant women. Eplerenone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. The concentration of Eplerenone in human breast milk after oral administration is unknown. Because many drugs are excreted in human milk and because of the unknown potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Aldonist should be used with caution in hyperkalemia, severe kidney disease, diabetic patients with congestive heart failure after an acute myocardial infarction including those with proteinuria.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Aldonist store below 30°C in a cool and dry place, protected from light and moisture. Keep out of children’s reach.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Potassium-sparing diuretics, Potassium-sparing diuretics & Aldosterone antagonists",
    "dosage": [
      {
        "medication_type": "Congestive heart failure after an acute myocardial infarction",
        "information": ": The recommended dose of Eplerenone is 50 mg once daily. Treatment should be initiated at 25 mg once daily and titrated to the target dose of 50 mg once daily preferably within 4 weeks as tolerated by the patient. Eplerenone may be administered with or without food.",
        "instructions": []
      },
      {
        "medication_type": "Hypertension",
        "information": ": Eplerenone may be used alone or in combination with other antihypertensive agents. The recommended starting dose of Eplerenone is 50 mg administered once daily. For patients with an inadequate blood pressure response to 50mg once daily the dosage of Eplerenone should be increased to 50mg twice daily. Higher dosages of Eplerenone are not recommended either because they have no greater effect on blood pressure than 100 mg or because they are associated with an increased risk of hyperkalemia.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric use",
        "information": ": The safety and effectiveness of Eplerenone has not been established in pediatric patients.",
        "instructions": []
      },
      {
        "medication_type": "Geriatric use",
        "information": ": No differences in overall incidence of effectivity or safety was observed in elderly patients.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:15.165Z",
    "medicine_id": "68c3c09aef5b8f2b163a8db2",
    "original_record": {
      "input_index": 854,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8db2"
        },
        "name": "Aldonist",
        "strength": "50 mg",
        "generic": "Eplerenone",
        "company": "UniMed UniHealth Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/2855/aldonist-50-mg-tablet",
        "_page": 22,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34516/alerfex-180-mg-tablet",
    "name": "Alerfex",
    "dosage_form": "Tablet",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "180 mg",
    "company": "Kumudini Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 8.00",
      "strip_price": "৳ 80.00",
      "pack_size_info": "(2 x 10: ৳ 160.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.00",
          "pack_size_info": "(2 x 10: ৳ 160.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 80.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "120 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12066/alerfex-120-mg-tablet?ref=1"
      },
      {
        "text": "30 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/12067/alerfex-30-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alerfex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alerfex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alerfex improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alerfex is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alerfex significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alerfex improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alerfex does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alerfex with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alerfex caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alerfex and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alerfex should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alerfex tablets will produce an effect on the ability to drive or use machines. In objective tests, Alerfex has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alerfex. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alerfex has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alerfex from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alerfex 180 mg Tablet?",
        "answer": [
          "Alerfex 180 mg Tablet is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alerfex 180 mg Tablet?",
        "answer": [
          "Alerfex 180 mg Tablet is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alerfex 180 mg Tablet?",
        "answer": [
          "Alerfex 180 mg Tablet has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alerfex 180 mg Tablet?",
        "answer": [
          "Alerfex 180 mg Tablet should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alerfex 180 mg Tablet make you sleepy?",
        "answer": [
          "Yes, Alerfex 180 mg Tablet can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alerfex 180 mg Tablet?",
        "answer": [
          "Do not take an overdose of Alerfex 180 mg Tablet as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alerfex 180 mg Tablet work?",
        "answer": [
          "Alerfex 180 mg Tablet starts working within 1 hour of consuming it. The peak benefit of Alerfex 180 mg Tablet is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alerfex 180 mg Tablet relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alerfex 180 mg Tablet can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alerfex 180 mg Tablet?",
        "answer": [
          "Take some rest after taking Alerfex 180 mg Tablet if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alerfex 180 mg Tablet?",
        "answer": [
          "Alerfex 180 mg Tablet should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alerfex 180 mg Tablet."
        ]
      },
      {
        "question": "How should I take Alerfex 180 mg Tablet?",
        "answer": [
          "Alerfex 180 mg Tablet should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alerfex 180 mg Tablet?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alerfex 180 mg Tablet."
        ]
      },
      {
        "question": "Can Alerfex 180 mg Tablet cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alerfex 180 mg Tablet is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alerfex 180 mg Tablet is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alerfex 180 mg Tablet with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alerfex 180 mg Tablet may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alerfex 180 mg Tablet. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:27:16.280Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dc7",
    "original_record": {
      "input_index": 855,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dc7"
        },
        "name": "Alerfex",
        "strength": "180 mg",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Kumudini Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/34516/alerfex-180-mg-tablet",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/19160/alermet-10-mg-tablet",
    "name": "Alermet",
    "dosage_form": "Tablet",
    "generic": "Cetirizine Hydrochloride",
    "strength": "10 mg",
    "company": "Avarox Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 3.00",
      "strip_price": "৳ 30.00",
      "pack_size_info": "(10 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.00",
          "pack_size_info": "(10 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alermet is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Alermet is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Alermet is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Alermet has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Alermet is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:17.418Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dcb",
    "original_record": {
      "input_index": 856,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dcb"
        },
        "name": "Alermet",
        "strength": "10 mg",
        "generic": "Cetirizine Hydrochloride",
        "company": "Avarox Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/19160/alermet-10-mg-tablet",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12228/alertadin-5-mg-tablet",
    "name": "Alertadin",
    "dosage_form": "Tablet",
    "generic": "Desloratadine",
    "strength": "5 mg",
    "company": "Beacon Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 2.51",
      "strip_price": "৳ 25.10",
      "pack_size_info": "(10 x 10: ৳ 251.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.51",
          "pack_size_info": "(10 x 10: ৳ 251.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 25.10",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/329/desloratadine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alertadin is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, such as sneezing, nasal discharge & itching, congestion or stuffiness, as well as ocular itching, tearing and redness, itching of palate and coughing. Alertadin is also indicated for the relief of symptoms associated with chronic idiopathic urticaria such as the relief of itching and the size & number of hives.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Desloratadine, the major active metabolite of Loratadine, is a non-sedating; long acting tricyclic histamine antagonist with selective H1-receptor histamine antagonist activity. Desloratadine also inhibits histamine release from human mast cell.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically relevant drug interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Desloratadine is contraindicated in patients having hypersensitivity to this medication or to any of its ingredients or Loratadine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Less common side effects may include headache, nausea, fatigue, dizziness, pharyngitis, dyspepsia and myalgia.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. The safe use of Desloratadine during pregnancy has not been established. Therefore, Desloratadine is not to be used during pregnancy unless clearly indicated. Desloratadine passes into breast milk, therefore a decision should be made whether to discontinue nursing or to discontinue Desloratadine taking into account the importance of the drug to the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In adult patients with liver or renal impairment: A starting dose of one 5 mg tablet every other day is recommended based on pharmacokinetic data. If the patient has medical or familial history of seizures.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Recommended in the use in children & adolescents.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "No clinically relevant adverse effects have been reported.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool & dry place, protected from light. Store below 30°C. Keep all medicines out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": null,
        "information": "Pediatric drops:",
        "instructions": []
      },
      {
        "medication_type": "Child 6-11 months of age",
        "information": ": 2 ml drops once daily.",
        "instructions": []
      },
      {
        "medication_type": "Child 1-2 years of age",
        "information": ": 2.5 ml drops once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "Child 6-11 months of age",
        "information": ": 2 ml once daily.",
        "instructions": []
      },
      {
        "medication_type": "Child 1-5 years of age",
        "information": ": 2.5 ml once daily.",
        "instructions": []
      },
      {
        "medication_type": "Child 6-11 years of age",
        "information": ": 5 ml once daily.",
        "instructions": []
      },
      {
        "medication_type": "Adults & >12 years of age",
        "information": ": 10 ml once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Tablet:",
        "instructions": []
      },
      {
        "medication_type": "Adults and children 12 years of age and over",
        "information": ": 1 tablet daily",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:19.346Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dcd",
    "original_record": {
      "input_index": 857,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dcd"
        },
        "name": "Alertadin",
        "strength": "5 mg",
        "generic": "Desloratadine",
        "company": "Beacon Pharmaceuticals PLC",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12228/alertadin-5-mg-tablet",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12028/alestin-10-mg-tablet",
    "name": "Alestin",
    "dosage_form": "Tablet",
    "generic": "Ebastine",
    "strength": "10 mg",
    "company": "Novelta Bestway Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 6.00",
      "strip_price": "৳ 60.00",
      "pack_size_info": "(5 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 6.00",
          "pack_size_info": "(5 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 60.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/12029/alestin-5-mg-syrup?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/401/ebastine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alestin is indicated for the symptomatic treatment of:",
        "items": [
          "Seasonal and perennial allergic rhinitis.",
          "Chronic idiopathic urticaria."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ebastine is a long-acting and selective H1-histamine receptor antagonist. After repeated administration, inhibition of peripheral receptors remains at a constant level. Ebastine is rapidly absorbed and undergoes extensive first-pass metabolism following oral administration. Ebastine is almost totally converted to the pharmacologically active acid metabolite, carebastine.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alestin in combination with either ketoconazole or erythromycin increases in plasma level of Alestin and prolonged QTc interval. Alestin does not interact with the pharmacokinetics of theophylline, warfarin, cimetidine, diazepam or alcohol. The sedation effect of alcohol and diazepam may be enhanced.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Patients with a known hypersensitivity to Ebastine or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side-effects are headache, dry mouth and drowsiness. Less commonly reported side effects include abdominal pain, dyspepsia, nausea and insomnia.",
        "items": []
      }
    ],
    "pregnancy_cat": [],
    "precautions": [],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "No clinically meaningful signs or symptoms were observed up to 100 mg given once daily. There is no specific antidote for Alestin. In case of accidental overdoses, gastric lavage, monitoring of vital functions including ECG and symptomatic treatment should be carried out.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C at a cool and dry place, away from light. Keep out of reach of children",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet:",
        "instructions": []
      },
      {
        "medication_type": "Adults (more than 12 years of age)",
        "information": ": 10 mg (one tablet) once daily.",
        "instructions": []
      },
      {
        "medication_type": "Children (6-12 years of age)",
        "information": ": 5 mg (half tablet) once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "Children (2-5 years of age)",
        "information": ": 2.5 ml once daily (upto 5 ml in severe cases such as Perennial Allergic Rhinitis).",
        "instructions": []
      },
      {
        "medication_type": "Children (6-12 years of age)",
        "information": ": 5 ml once daily (upto 10 ml in severe cases such as Perennial Allergic Rhinitis).",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Ebastine may be taken with or without food.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:20.745Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dcf",
    "original_record": {
      "input_index": 858,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dcf"
        },
        "name": "Alestin",
        "strength": "10 mg",
        "generic": "Ebastine",
        "company": "Novelta Bestway Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12028/alestin-10-mg-tablet",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12029/alestin-5-mg-syrup",
    "name": "Alestin",
    "dosage_form": "Syrup",
    "generic": "Ebastine",
    "strength": "5 mg/5 ml",
    "company": "Novelta Bestway Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 80.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "50 ml bottle",
          "price": "৳ 80.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12028/alestin-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/401/ebastine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alestin is indicated for the symptomatic treatment of:",
        "items": [
          "Seasonal and perennial allergic rhinitis.",
          "Chronic idiopathic urticaria."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ebastine is a long-acting and selective H1-histamine receptor antagonist. After repeated administration, inhibition of peripheral receptors remains at a constant level. Ebastine is rapidly absorbed and undergoes extensive first-pass metabolism following oral administration. Ebastine is almost totally converted to the pharmacologically active acid metabolite, carebastine.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alestin in combination with either ketoconazole or erythromycin increases in plasma level of Alestin and prolonged QTc interval. Alestin does not interact with the pharmacokinetics of theophylline, warfarin, cimetidine, diazepam or alcohol. The sedation effect of alcohol and diazepam may be enhanced.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Patients with a known hypersensitivity to Ebastine or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side-effects are headache, dry mouth and drowsiness. Less commonly reported side effects include abdominal pain, dyspepsia, nausea and insomnia.",
        "items": []
      }
    ],
    "pregnancy_cat": [],
    "precautions": [],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "No clinically meaningful signs or symptoms were observed up to 100 mg given once daily. There is no specific antidote for Alestin. In case of accidental overdoses, gastric lavage, monitoring of vital functions including ECG and symptomatic treatment should be carried out.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C at a cool and dry place, away from light. Keep out of reach of children",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet:",
        "instructions": []
      },
      {
        "medication_type": "Adults (more than 12 years of age)",
        "information": ": 10 mg (one tablet) once daily.",
        "instructions": []
      },
      {
        "medication_type": "Children (6-12 years of age)",
        "information": ": 5 mg (half tablet) once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "Children (2-5 years of age)",
        "information": ": 2.5 ml once daily (upto 5 ml in severe cases such as Perennial Allergic Rhinitis).",
        "instructions": []
      },
      {
        "medication_type": "Children (6-12 years of age)",
        "information": ": 5 ml once daily (upto 10 ml in severe cases such as Perennial Allergic Rhinitis).",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Ebastine may be taken with or without food.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:21.762Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dd0",
    "original_record": {
      "input_index": 859,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dd0"
        },
        "name": "Alestin",
        "strength": "5 mg/5 ml",
        "generic": "Ebastine",
        "company": "Novelta Bestway Pharma Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/12029/alestin-5-mg-syrup",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/11916/aletrin-10-mg-tablet",
    "name": "Aletrin",
    "dosage_form": "Tablet",
    "generic": "Cetirizine Hydrochloride",
    "strength": "10 mg",
    "company": "Reman Drug Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.50",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.50",
          "pack_size_info": "(100's pack: ৳ 250.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aletrin is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Aletrin is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Aletrin is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Aletrin has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Aletrin is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:22.976Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dd2",
    "original_record": {
      "input_index": 860,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dd2"
        },
        "name": "Aletrin",
        "strength": "10 mg",
        "generic": "Cetirizine Hydrochloride",
        "company": "Reman Drug Laboratories Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/11916/aletrin-10-mg-tablet",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12189/aleze-5-mg-suspension",
    "name": "Aleze",
    "dosage_form": "Oral Suspension",
    "generic": "Loratadine",
    "strength": "5 mg/5 ml",
    "company": "UniMed UniHealth Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 30.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12188/aleze-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/696/loratadine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aleze tablet provides fast, effective relief from the symptoms of seasonal allergic rhinitis, perennial allergic rhinitis and skin allergies including chronic urticaria. It is also effective in alleviating symptoms of allergic rhinitis such as sneezing, nasal discharge, itching, ocular itching ... Read moreAleze tablet provides fast, effective relief from the symptoms of seasonal allergic rhinitis, perennial allergic rhinitis and skin allergies including chronic urticaria. It is also effective in alleviating symptoms of allergic rhinitis such as sneezing, nasal discharge, itching, ocular itching and burning. Nasal and ocular sign and symptoms are relieved rapidly after oral administration. Aleze tablet is also indicated in idiopathic urticaria. In children over 2 years Aleze tablet is indicated for the symptomatic relief of seasonal allergic rhinitis and allergic skin conditions such as urticaria, nettlerash.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This tablet is a preparation of Loratadine. Loratadine is a non-sedative histamine Hr receptor antagonist with antiallergic properties. Loratadine is a long-acting tricyclic antihistamine with selective peripheral Hi-receptor antagonistic activity and no central sedative or anticholinergic effect. It is rapidly effective and long-lasting, allowing once-a-day administration.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "There are no reports of potentially hazardous interactions with other drugs. In contrast to many other histamine H1 receptor antagonists, Aleze has no potentiating effects when administered concurrently with alcohol, as measured by psychomotor performance studies. Concomitant therapy with drugs that inhibit or are metabolized by hepatic cytochromes P450 3A4 and 2D6 may elevate plasma concentrations of either drug and this mayifesult in adverse effects. Cimetidine inhibits both enzymes while erythromycin or ketoconazole inhibits P450 3A4. These drugs increase Aleze serum concentrations but no adverse effects are reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Loratadine is contraindicated in patients who have shown hypersensitivity or idiosyncrasy to their components.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "During controlled clinical studies the incidence of adverse events, including sedation and anticholinergic effects observed with 10 mg Aleze was comparable to that observed with placebo. Studies on the effect of Aleze on actual driving performance, and on tests of cognitive and psychomotor functioning have shown it to be comparable to placebo.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There is no experience of the use of Loratadine in human pregnancy. Therefore its use during pregnancy is not advisable. Loratadine is excreted in breast milk in a very small amount. So nursing mothers are advised not to take the drug.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be taken in patients with liver impairment or renal insufficiency (eGFR <30 ml/min).",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In adults somnolence, tachycardia and headache have been reported with overdose greater than 10 mg. Extrapyramidal signs and palpitations have been reported in children with overdoses of greater than 10 mg. In the event of overdosage, general symptomatic and supportive measures should be instituted promptly and maintained for as long as necessary. It would seem reasonable to treat patients presenting early after large overdoses with oral activated charcoal. The conscious patients may be induced to vomit or gastric lavage may be performed.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Adults and children over 12 years of age",
        "information": ": One Loratadine tablet once daily. It is usually administered in the morning or when symptoms require treatment.",
        "instructions": []
      },
      {
        "medication_type": "Children 2-12 years",
        "information": ": Body weight over 30 kg: one Loratadine tablet once daily, below 30 kg: half Loratadine tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "Below 2 years of age",
        "information": ": Loratadine tablet is not recommended for use below 2 years of age since safety and efficacy has not been established.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:24.177Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dd6",
    "original_record": {
      "input_index": 861,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dd6"
        },
        "name": "Aleze",
        "strength": "5 mg/5 ml",
        "generic": "Loratadine",
        "company": "UniMed UniHealth Pharmaceuticals Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/12189/aleze-5-mg-suspension",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/3887/alfacort-40-mg-injection",
    "name": "Alfacort",
    "dosage_form": "IM/IA Injection",
    "generic": "Triamcinolone Acetonide",
    "strength": "40 mg/ml",
    "company": "Ziska Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 60.18",
      "strip_price": null,
      "pack_size_info": "(4's pack: ৳ 240.72)",
      "packages": [
        {
          "label": "1 ml vial",
          "price": "৳ 60.18",
          "pack_size_info": "(4's pack: ৳ 240.72)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1361/triamcinolone-acetonide-injection/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Intramuscular: Where oral therapy is not feasible, injectable corticosteroid therapy, including Alfacort injection is indicated for intramuscular use as follows:Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute ... Read moreIntramuscular: Where oral therapy is not feasible, injectable corticosteroid therapy, including Alfacort injection is indicated for intramuscular use as follows:Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis.Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome).Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis.Gastrointestinal diseases: To tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis.Hematologic disorders: Acquired (autoimmune) hemolytic anemia, Diamond-Blackfan anemia, pure red cell aplasia, selected cases of secondary thrombocytopenia.Neoplastic diseases: For the palliative management of leukemias and lymphomas.Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy.Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.Renal diseases: To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus.Respiratory diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis.Miscellaneous: Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy.Intra-articular: The intra-articular or soft tissue administration of Alfacort injection is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis or osteoarthritis.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Triamcinolone Acetonide occurs as a white to cream-colored, crystalline powder having not more than a slight odor and is practically insoluble in water and very soluble in alcohol. It is a synthetic glucocorticoid corticosteroid with anti-inflammatory action. This formulation is suitable for intramuscular and intra-articular use only. Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Naturally occurring glucocorticoids (e.g. hydrocortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Synthetic analogs such as triamcinolone are primarily used for their anti-inflammatory effects in disorders of many organ systems. Triamcinolone injection has an extended duration of effect which may be sustained over a period of several weeks. Studies indicate that following a single intramuscular dose of 60 mg to 100 mg of Triamcinolone Acetonide, adrenal suppression occurs within 24 to 48 hours and then gradually returns to normal, usually in 30 to 40 days. This finding correlates closely with the extended duration of therapeutic action achieved with the drug.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Aminoglutethimide",
        "information": ": Aminoglutethimide may lead to a loss of corticosteroid-induced adrenal suppression.",
        "items": []
      },
      {
        "title": "Amphotericin B injection and potassium-depleting agents",
        "information": ": When corticosteroids are administered concomitantly with potassium-depleting agents (ie, amphotericin B, diuretics), patients should be observed closely for development of hypokalemia. There have been cases reported in which concomitant use of amphotericin B and hydrocortisone was followed by cardiac enlargement and congestive heart failure.",
        "items": []
      },
      {
        "title": "Antibiotics",
        "information": ": Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.",
        "items": []
      },
      {
        "title": "Anticholinesterases",
        "information": ": Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. If possible, anticholinesterase agents should be withdrawn at least 24 hours before initiating corticosteroid therapy.",
        "items": []
      },
      {
        "title": "Anticoagulants, oral",
        "information": ": Coadministration of corticosteroids and warfarin usually results in inhibition of response to warfarin, although there have been some conflicting reports. Therefore, coagulation indices should be monitored frequently to maintain the desired anticoagulant effect.",
        "items": []
      },
      {
        "title": "Antidiabetics",
        "information": ": Because corticosteroids may increase blood glucose concentrations, dosage adjustments of antidiabetic agents may be required.",
        "items": []
      },
      {
        "title": "Antitubercular drugs",
        "information": ": Serum concentrations of isoniazid may be decreased.",
        "items": []
      },
      {
        "title": "Cholestyramine",
        "information": ": Cholestyramine may increase the clearance of corticosteroids.",
        "items": []
      },
      {
        "title": "Cyclosporine",
        "information": ": Increased activity of both cyclosporine and corticosteroids may occur when the two are used concurrently. Convulsions have been reported with this concurrent use.",
        "items": []
      },
      {
        "title": "Digitalis glycosides",
        "information": ": Patients on digitalis glycosides may be at increased risk of arrhythmias due to hypokalemia. Estrogens, including oral contraceptives: Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect.",
        "items": []
      },
      {
        "title": "Hepatic enzyme inducers (eg, barbiturates, phenytoin, carbamazepine, rifampin)",
        "information": ": Drugs which induce hepatic microsomal drug metabolizing enzyme activity may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.",
        "items": []
      },
      {
        "title": "Ketoconazole",
        "information": ": Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to an increased risk of corticosteroid side effects.",
        "items": []
      },
      {
        "title": "Nonsteroidal anti-inflammatory drugs (NSAIDs)",
        "information": ": Concomitant use of aspirin (or other nonsteroidal anti-inflammatory drugs) and corticosteroids increases the risk of gastrointestinal side effects. Aspirin should be used cautiously in conjunction with corticosteroids in hypoprothrombinemia. The clearance of salicylates may be increased with concurrent use of corticosteroids.",
        "items": []
      },
      {
        "title": "Skin tests",
        "information": ": Corticosteroids may suppress reactions to skin tests.",
        "items": []
      },
      {
        "title": "Vaccines",
        "information": ": Patients on prolonged corticosteroid therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response. Corticosteroids may also potentiate the replication of some organisms contained in live attenuated vaccines. Routine administration of vaccines or toxoids should be deferred until corticosteroid therapy is discontinued if possible.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Triamcinolone injection is contraindicated in patients who are hypersensitive to any components of this product. Intramuscular corticosteroid preparations are contraindicated for idiopathic thrombocytopenic purpura.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following adverse reactions may be associated with corticosteroid therapy:",
        "items": []
      },
      {
        "title": "Allergic reactions",
        "information": ": Anaphylactoid reaction, anaphylaxis, angioedema.",
        "items": []
      },
      {
        "title": "Cardiovascular",
        "information": ": Bradycardia, cardiac arrest, cardiac arrhythmias, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertension, tachycardia, thromboembolism, thrombophlebitis, vasculitis.",
        "items": []
      },
      {
        "title": "Dermatologic",
        "information": ": Acne, allergic dermatitis, cutaneous and subcutaneous atrophy, dry scaly skin purpura, rash, sterile abscess, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria.",
        "items": []
      },
      {
        "title": "Endocrine",
        "information": ": Decreased carbohydrate and glucose tolerance, development of cushingoid state, glycosuria, hirsutism, hypertrichosis, increased requirements for insulin or oral hypoglycemic agents in diabetes, manifestations of latent diabetes mellitus, menstrual irregularities, secondary adrenocortical and pituitary unresponsiveness, suppression of growth in pediatric patients.",
        "items": []
      },
      {
        "title": "Fluid and electrolyte disturbances",
        "information": ": Congestive heart failure in susceptible patients, fluid retention, hypokalemic alkalosis, potassium loss, sodium retention.",
        "items": []
      },
      {
        "title": "Gastrointestinal",
        "information": ": Abdominal distention, bowel/bladder dysfunction, elevation in serum liver enzyme levels, hepatomegaly, increased appetite, nausea, pancreatitis, peptic ulcer with possible perforation and hemorrhage, perforation of the small and large intestine, ulcerative esophagitis.",
        "items": []
      },
      {
        "title": "Metabolic",
        "information": ": Negative nitrogen balance due to protein catabolism.",
        "items": []
      },
      {
        "title": "Musculoskeletal",
        "information": ": Aseptic necrosis of femoral and humeral heads, calcinosis, Charcot-like arthropathy, loss of muscle mass, muscle weakness, osteoporosis, pathologic fracture of long bones, post injection flare, steroid myopathy, tendon rupture, vertebral compression fractures.",
        "items": []
      },
      {
        "title": "Neurologic/Psychiatric",
        "information": ": Convulsions, depression, emotional instability, euphoria, headache, increased intracranial pressure with papilledema usually following discontinuation of treatment, insomnia, mood swings, neuritis, neuropathy, paresthesia, personality changes, psychic disorders, vertigo. Arachnoiditis, meningitis, paraparesis/paraplegia and sensory disturbances have occurred after intrathecal administration. Ophthalmic: Exophthalmos, glaucoma, increased intraocular pressure, posterior subcapsular cataracts, rare instances of blindness associated with periocular injections.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. Corticosteroids have been shown to be teratogenic in many species when given in doses equivalent to the human dose. Corticosteroids should be used during pregnancy only if the potential benefit justifies the potential Ask to the fetus. Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. Caution should be exercised when corticosteroids are administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "General",
        "information": ": Alfacort, like many other steroid formulations, is sensitive to heat. Therefore, it should not be autoclaved when it is desirable to sterilize the exterior of the vial. The lowest possible dose of corticosteroid should be used to control the condition under treatment. When reduction in dosage is possible, the reduction should be gradual. Since complications of treatment with glucocorticoids are dependent on the size of the dose and the duration of treatment, a risk/benefit decision most be made in each individual case as to dose and duration of treatment and as to whether daily or intermittent therapy should be used. Cardio-Renal As sodium retention with resultant edema and potassium loss may occur in patients receiving corticosteroids, these agents should be used with caution in patients with congestive heart failure, hypertension or renal insufficiency.",
        "items": []
      },
      {
        "title": "Endocrine",
        "information": ": Drug-induced secondary adrenocortical insufficiency may be minimized by gradual reduction of dosage. This type of relative insufficiency may persist for months after discontinuation of therapy; therefore, in any situation of stress occurring during that period, hormone therapy should be reinstituted. Since mineralocorticoid secretion may be impaired, salt and/or a mineralocorticoid should be administered concurrently.",
        "items": []
      },
      {
        "title": "Gastrointestinal",
        "information": ": Steroids should be used with caution in active or latent peptic ulcers, diverticulitis, fresh intestinal anastomoses, and nonspecific ulcerative colitis, since they may increase the risk of a perforation.",
        "items": []
      },
      {
        "title": "Intra-articular Administration",
        "information": ": Intra-articularly injected corticosteroids may be systemically absorbed. Appropriate examination of any joint fluid present is necessary to exclude a septic process.",
        "items": []
      },
      {
        "title": "Musculoskeletal",
        "information": ": Corticosteroids decrease bone formation and increase bone resorption both through their effect on calcium regulation (ie, decreasing absorption and increasing excretion) and inhibition of osteoblast function.",
        "items": []
      },
      {
        "title": "Neuro-Psychiatric",
        "information": ": Psychic derangements may appear when corticosteroids are used, ranging from euphoria, insomnia, mood swings, personality changes, and severe depression to frank psychotic manifestations. Also, existing emotional instability or psychotic tendencies may be aggravated by corticosteroids.",
        "items": []
      },
      {
        "title": "Ophthalmic",
        "information": ": Intraocular pressure may become elevated in some individuals. If steroid therapy is continued for more than 6 weeks, intraocular pressure should be monitored.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Premature and low-birth-weight infants, as well as patients receiving high dosages, may be more likely to develop toxicity.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety or effectiveness were observed between elderly subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Treatment of acute overdosage is by supportive and symptomatic therapy. For chronic overdosage in the face of severe disease requiring continuous steroid therapy, the dosage of the corticosteroid may be reduced only temporarily or alternate day treatment may be introduced.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at controlled room temperature, 20-25°C, avoid freezing and protect from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Corticosteroid, Glucocorticoids, Triamcinolone & Combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "General",
        "instructions": []
      },
      {
        "medication_type": "Dosage",
        "information": ": The initial dose of Triamcinolone injection may vary from 2.5 mg to 100 mg per day depending on the specific disease entity being treated. However, in certain overwhelming, acute, life-threatening situations, administration in dosages exceeding the usual dosages may be justified. Dosage requirements are variable and must be individualized on the basis of the disease under treatment and the response of the patient.",
        "instructions": []
      },
      {
        "medication_type": "Administration",
        "information": ": Strict aseptic technique is mandatory. The vial should be shaken before use to ensure a uniform suspension. Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Systemic",
        "instructions": []
      },
      {
        "medication_type": "Dosage",
        "information": ": The suggested initial dose is 60 mg, injected deeply into the gluteal muscle. Atrophy of subcutaneous fat may occur if the injection is not properly given. Dosage is usually adjusted within the range of 40 mg to 80 mg, depending upon patient response and duration of relief. However, some patients may be well controlled on doses as low as 20 mg or less. Pediatric patients: The range of initial doses is 0.11 to 1.6 mg/kg/day in 3 or 4 divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Administration",
        "information": ": For systemic therapy, injection should be made deeply into the gluteal muscle. For adults, a minimum needle length of 11/2 inches is recommended. In obese patients, a longer needle may be required. Use alternative sites for subsequent injections.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Local",
        "instructions": []
      },
      {
        "medication_type": "Dosage:",
        "information": "Intra-articular administration: A single local injection of Triamcinolone Acetonide is frequently sufficient, but several injections may be needed for adequate relief of symptoms. Initial dose: 2.5 mg to 5 mg for smaller joints and from 5 mg to 15 mg for larger joints, depending on the specific disease entity being treated. For adults, doses up to 10 mg for smaller areas and up to 40 mg for larger areas have usually been sufficient. Single injections into several joints, up to a total of 80 mg, have been given.",
        "instructions": []
      },
      {
        "medication_type": "Administration",
        "information": ": For treatment of joints, the usual intra-articular injection technique should be followed. If an excessive amount of synovial fluid is present in the joint, some, but not all, should be aspirated to aid in the relief of pain and to prevent undue dilution of the steroid.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:25.359Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dd9",
    "original_record": {
      "input_index": 862,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dd9"
        },
        "name": "Alfacort",
        "strength": "40 mg/ml",
        "generic": "Triamcinolone Acetonide (Injection)",
        "company": "Ziska Pharmaceuticals Ltd.",
        "medicine_type": "IM/IA Injection",
        "source_url": "https://medex.com.bd/brands/3887/alfacort-40-mg-injection",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/38218/alfagon-75-iu-injection",
    "name": "Alfagon",
    "dosage_form": "SC Injection",
    "generic": "Recombinant Follicle Stimulating Hormone",
    "strength": "75 IU/pre-filled syringe",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 1,900.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "75 IU pre-filled syringe",
          "price": "৳ 1,900.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "150 IU/pre-filled syringe (Injection)",
        "href": "https://medex.com.bd/brands/38219/alfagon-150-iu-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1610/recombinant-follicle-stimulating-hormone-rfsh/brand-names",
    "indications": [
      {
        "title": null,
        "information": "In the Female: In the Female: In the Male: Male infertility treatment in combination with HCG Induction of Spermatogenesis in men deficient spermatogenesis due to Hypogonadotrophic-hypogonadism.",
        "items": [
          "Ovulation Induction: rFSH administered SC with HCG in a sequential manner, which is indicated for ovulation induction in patients who have previously received pituitary suppression.",
          "Multi-follicular Development: During ART: rFSH administered SC in conjunction with HCG is indicated for multiple follicular developments (controlled ovarian stimulation) during ART cycles in patients who have previously received pituitary suppression.",
          "Ovulation Induction: rFSH administered SC with HCG in a sequential manner, which is indicated for ovulation induction in patients who have previously received pituitary suppression.",
          "Multi-follicular Development: During ART: rFSH administered SC in conjunction with HCG is indicated for multiple follicular developments (controlled ovarian stimulation) during ART cycles in patients who have previously received pituitary suppression.",
          "Polycystic Ovarian Syndrome (PCOS): Used to treat Polycystic Ovarian Syndrome (PCOS) related infertility"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "rFSH is a Follicle Stimulating Hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, nonidentical glycoproteins designated as the α- and β subunits. The α- and β-subunits have 92 and 111 amino acids respectively, and their primary and tertiary structure are indistinguishable from those of human Follicle Stimulating Hormone. Recombinant FSH production occurs in genetically modified Chinese Hamster Ovary (CHO) cells cultured in bioreactors. Purification by immunochromatography using an antibody specifically binding FSH results in a highly purified preparation with a consistent FSH isoform profile and a high specific activity. The biological activity of rFSH is determined by measuring the increase in ovary weight in female rats. The in vivo biological activity of rFSH has been calibrated against the first International Standard for Recombinant Human Follicle Stimulating Hormone established in 1995 by the Expert Committee on Biological Standards of the World Health Organization. rFSH contains no Luteinizing Hormone (LH) activity.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Tumors of the ovary, breast, uterus, pituitary or hypothalamus",
          "Pregnancy or lactation",
          "Undiagnosed vaginal bleeding",
          "Hypersensitivity to the active substance or to any of the excipients",
          "Primary ovarian failure",
          "Fibroid tumors of the uterus incompatible with pregnancy",
          "Primary testicular failure."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Alfagon FSH sometimes excites the ovaries too much. This may cause pelvic pain or breathing problems. It may also make you urinate less. In rare cases, patients with this problem have had serious lung problems, including fluid in the lungs, troublebreathing, and worsening of asthma blood clots, Severe Pelvic pain, Chest pain, or Abdominal pain, Nausea, Vomiting, Sudden weight gain, Bloating, Trouble, Breathing. Alfagon FSH may cause twins or multiple births.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy category X. Recombinant FSH must not be used during pregnancy and lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "The presence of uncontrolled non gonodal endocrinopathies (e.g. thyroid, adrenal or pituitary disorders) should be excluded.",
          "In pregnancies occurring after induction of ovulation with gonadotrophin preparations, there is an increased risk of multiple gestations (Multiple birth).",
          "There has been no reports of hypersensitivity to Alfagon FSH, but there remains the possibility of anaphylactic responses.",
          "The first injection of Alfagon FSH should be performed under direct medical supervision.",
          "Since infertile women undergoing assisted reproduction and particularly IVF, often have tubal abnormalities the incidence of ectopic pregnancies might be increased. Early ultrasound confirmation that a pregnancy is intrauterine is therefore important.",
          "Rates of pregnancy loss in women undergoing assisted reproduction techniques are higher than in the normal population.",
          "Unwanted ovarian hyperstimulation in the treatment of female patients, ultrasonographic assessment of follicular development, and determination of oestradiol levels should be performed prior to treatment and at regular intervals during treatment. Apart from the development of a high number of follicles, oestradiol levels may rise very rapidly, e.g. more than a daily doubling for two or three consecutive days, and possibly reaching excessively high values. The diagnosis of ovarian hyperstimulation may be confirmed by ultrasound examination. If this unwanted ovarian hyperstimulation occurs (i.e. not as part of controlled ovarian hyperstimulation in medically assisted reproduction programs), the administration of Alfagon FSH should be discontinued. In that case pregnancy should be avoided and HCG must be withheld, because it may induce in addition to multiple ovulation, the Ovarian Hyperstimulation Syndrome (OHSS).",
          "In men, semen analysis is recommended 4 to 6 months after the beginning of treatment in assessing the response."
        ]
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "No data on acute toxicity of Alfagon FSH in humans is available, but the acute toxicity of Alfagon FSH and of urinary gonadotrophin preparations in animal studies have been shown to be very low. Too high a dosage of Alfagon FSH may lead to hyperstimulation of the ovaries",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at 2°C-8°C (in refrigerator). Do not keep in deep freeze. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "rFSH administered for 7 to 12 days produces ovarian follicular growth in women who do not have primary ovarian failure. Treatment with rFSH in most instances results only in follicular growth and maturation. When sufficient follicular maturation has occurred, HCG must be given to induce ovulation.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Infertility, Trophic Hormones & Related Synthetic Drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "To prevent painful injections and minimize leakage from the injection site rFSH should be slowly administered subcutaneously. The subcutaneous injection site should be alternated to prevent lipoathrophy. Any unused solution should be discarded. Subcutaneous injection of rFSH may be carried out by patient or partner, provided that proper instructions are given by the physician. Self-administration of rFSH should only be performed by patients who are well motivated, adequately trained and with access to expert advice.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Female:",
        "information": "There are great inter and intra-individual variations in the response of the ovaries to exogenous gonadotrophins. This makes it impossible to set an uniform dosage scheme. The dosage should, therefore, be adjusted individually depending on the ovarian response. This requires ultrasonography and monitoring of estradiol levels. There should be consideration to minimize the risk of unwanted ovarian hyperstimulation. rFSH can be given either alone, or in combination with a GnRH analogue to prevent premature luteinisation. In the latter case, especially when using a GnRH agonist, a higher total treatment dose of rFSH may be required to achieve an adequate follicular response. Clinical experience with rFSH is based on up to three treatment cycles in both indications. Overall experience with IVF indicates that in general the treatment success rate remains stable during the first four attempts and gradually declines thereafter.",
        "instructions": []
      },
      {
        "medication_type": "Ovulation Induction in Women",
        "information": ": Starting daily dose of 75 international units (IU) of rFSH is administered subcutaneously or subcutaneous for at least the first 7 days. The dose is increased by 25 or 75 international units (IU) at weekly intervals until follicular growth and/or serum estradiol levels indicate an adequate response. When an acceptable pre-ovulatory state is achieved, final oocyte maturation is achieved with 5000 to 10,000 international units (IU) of human chorionic gonadotropin (HCG). The woman and her partner should have intercourse daily, beginning on the day prior to the administration of HCG and until ovulation becomes apparent.",
        "instructions": []
      },
      {
        "medication_type": "Assisted Reproductive Technology (ART)",
        "information": ": In Women, Starting dose of 150 to 300 international units (IU) of rFSH is administered subcutaneous for at least the first 4 days of treatment. Subsequent doses are adjusted based upon ovarian response as determined by ultrasound evaluation of follicular growth and serum estradiol levels. Final oocyte maturation is induced with a dose of 5000-10000 international units of HCG Oocyte (egg) retrieval is performed 34 to 36 hours later.",
        "instructions": []
      },
      {
        "medication_type": "PCOS",
        "information": ": rFSH injections are therefore given each morning as a subcutaneous injection. It is best to start with the lowest dose of rFSH per day (using 75 IU per day). These doses are used for 4 to 6 days at a time. The ovarian response is determined by measuring estrogen levels in the blood. When the estrogen begins to rise, the rFSH is successfully growing an egg or eggs. If there is no response to a dose of rFSH in 5-6 days of injections the dose will be increased. The normal dose increments are 75 units, 100 units, 150 units and 300 units per day. Most patients respond with 75 IU to 150 IU per day. However it is very important that increments are only made cautiously.",
        "instructions": []
      },
      {
        "medication_type": "Dosage in Male",
        "information": ": Induction of Spermatogenesis in Men: Pre-treatment with HCG alone (2500 international units twice weekly) is required. If serum testosterone levels have not normalized after 8 weeks of HCG treatment, the dose may be increased to 5000 international units (IU) twice a week. After normalization of serum testosterone levels, administer 300 international units (IU) per week (300 international units twice weekly or 100 international units three times weekly) of rFSH subcutaneously with the same pre-treatment HCG dose used to normalize testosterone level.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:26.570Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ddb",
    "original_record": {
      "input_index": 863,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ddb"
        },
        "name": "Alfagon",
        "strength": "75 IU/pre-filled syringe",
        "generic": "Recombinant Follicle Stimulating Hormone (rFSH)",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "SC Injection",
        "source_url": "https://medex.com.bd/brands/38218/alfagon-75-iu-injection",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/38335/alfane-300-mg-capsule",
    "name": "Alfane",
    "dosage_form": "Capsule",
    "generic": "Alpha Lipoic Acid",
    "strength": "300 mg",
    "company": "Square Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": "৳ 90.00",
      "pack_size_info": "(5 x 6: ৳ 450.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 15.00",
          "pack_size_info": "(5 x 6: ৳ 450.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 90.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/2054/alpha-lipoic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alfane is a potent antioxidant and has neurotrophic properties. This helps to cope with the pain caused by:",
        "items": [
          "Peripheral and diabetic neuropathies",
          "Sciatica, backache, cervical syndrome, carpal tunnel syndrome",
          "Migraine headaches"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alpha-lipoic acid is an antioxidant that is made naturally in the body and found in foods. It is used to break down carbohydrates and to make energy. Alpha-lipoic acid can be eaten in foods, such as red meat, carrots, beets, spinach, broccoli, and potatoes. It is also available in supplements. Because alpha-lipoic acid seems to work like an antioxidant, it might provide protection to the brain. People most commonly use a -lipoic acid for nerve pain in people with diabetes. It is also used for obesity, altitude sickness, aging skin, high levels of cholesterol or other fats in the blood, and many other purposes. Alpha-lipoic acid is a substance that can be naturally found in animal and plant tissues and maintains its activity both in aqueous cell compartments and in lipid membrane ones. Alpha-lipoic acid has multiple antioxidant mechanisms, including metal chelating, regenerating endogenous antioxidants such as vitamins C and E, and modulating several signaling pathways, Alpha-lipoic acid plays a significant role in managing peripheral neuropathy, particularly diabetic neuropathy, Alpha-lipoic acid can pass easily into the brain, it may help protect the brain and nerve tissue, a-lipoic acid helps lower blood sugar levels. Its ability to kill free radicals may help people with diabetic peripheral neuropathy, who have pain, burning, itching, tingling, and numbness in arms and legs from nerve damage, Alpha-lipoic acid has been found to reduce the expression of GLUT~4s (Glucose transporter type 4) in cells, responsible for glucose uptake, and hence reduce Insulin sensitivity.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alfane-lipoic acid might slow blood clotting. Taking alpha-lipoic acid along with medications that also slow blood clotting might increase the risk of bruising and bleeding. Alfane-lipoic acid might lower blood sugar levels. Taking alpha-lipoic acid along with diabetes medications might cause blood sugar to drop too low.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Alpha-lipoic acid can lower blood sugar levels, so people with diabetes or low blood sugar should take alpha-lipoic acid only under the supervision of their healthcare provider.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects are generally rare. But in rare cases, it may include insomnia, fatigue, diarrhea, and skin rash.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "When taken by mouth, alpha-lipoic acid is possibly safe. It has been used safely during pregnancy in doses of up to 600 mg daily for up to 4 weeks. There is not enough reliable information to know if alpha-lipoic acid is safe to use when breast-feeding. Stay on the safe side and avoid use.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Alfane-lipoic acid is possibly safe for most adults when taken for up to 4 years. It is usually well-tolerated. Alfane-lipoic acid is possibly safe in children aged 10-17 years when taken by mouth in doses up to 600 mg daily for 3 months. But it is possibly unsafe for children to take large amounts of alpha-lipoic acid by mouth.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep away from direct sunlight & moisture. Keep below 30°C temperature in cool & dry place. Keep the medicine out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "For Adult use only. It is recommended to take 2 capsules once daily or 1 capsule twice daily, preferably on an empty stomach or as directed by physicians.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:27.767Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ddc",
    "original_record": {
      "input_index": 864,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ddc"
        },
        "name": "Alfane",
        "strength": "300 mg",
        "generic": "Alpha Lipoic Acid",
        "company": "Square Pharmaceuticals PLC",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/38335/alfane-300-mg-capsule",
        "_page": 23,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12068/alfex-120-mg-tablet",
    "name": "Alfex",
    "dosage_form": "Tablet",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "120 mg",
    "company": "Medicon Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 8.00",
      "strip_price": "৳ 80.00",
      "pack_size_info": "(3 x 10: ৳ 240.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.00",
          "pack_size_info": "(3 x 10: ৳ 240.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 80.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "30 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/12069/alfex-30-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alfex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alfex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alfex improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alfex is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alfex significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alfex improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alfex does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alfex with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alfex caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alfex and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alfex should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alfex tablets will produce an effect on the ability to drive or use machines. In objective tests, Alfex has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alfex. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alfex has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alfex from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alfex 120 mg Tablet?",
        "answer": [
          "Alfex 120 mg Tablet is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alfex 120 mg Tablet?",
        "answer": [
          "Alfex 120 mg Tablet is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alfex 120 mg Tablet?",
        "answer": [
          "Alfex 120 mg Tablet has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alfex 120 mg Tablet?",
        "answer": [
          "Alfex 120 mg Tablet should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alfex 120 mg Tablet make you sleepy?",
        "answer": [
          "Yes, Alfex 120 mg Tablet can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alfex 120 mg Tablet?",
        "answer": [
          "Do not take an overdose of Alfex 120 mg Tablet as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alfex 120 mg Tablet work?",
        "answer": [
          "Alfex 120 mg Tablet starts working within 1 hour of consuming it. The peak benefit of Alfex 120 mg Tablet is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alfex 120 mg Tablet relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alfex 120 mg Tablet can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alfex 120 mg Tablet?",
        "answer": [
          "Take some rest after taking Alfex 120 mg Tablet if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alfex 120 mg Tablet?",
        "answer": [
          "Alfex 120 mg Tablet should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alfex 120 mg Tablet."
        ]
      },
      {
        "question": "How should I take Alfex 120 mg Tablet?",
        "answer": [
          "Alfex 120 mg Tablet should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alfex 120 mg Tablet?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alfex 120 mg Tablet."
        ]
      },
      {
        "question": "Can Alfex 120 mg Tablet cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alfex 120 mg Tablet is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alfex 120 mg Tablet is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alfex 120 mg Tablet with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alfex 120 mg Tablet may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alfex 120 mg Tablet. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:27:29.067Z",
    "medicine_id": "68c3c09aef5b8f2b163a8de0",
    "original_record": {
      "input_index": 865,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8de0"
        },
        "name": "Alfex",
        "strength": "120 mg",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Medicon Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12068/alfex-120-mg-tablet",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/25855/alfradin-500-mg-capsule",
    "name": "Alfradin",
    "dosage_form": "Capsule",
    "generic": "Cephradine",
    "strength": "500 mg",
    "company": "Allied Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 12.50",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.50",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "250 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/25856/alfradin-ds-250-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/232/cephradine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alfradin is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- Alfradin is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- The following microorganisms are susceptible, in vitro to Alfradin:",
        "items": [
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.",
          "Urinary tract infections: cystitis, urethritis and pyelonephritis.",
          "Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.",
          "Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.",
          "Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Alfradin which is unaffected by this enzyme."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.",
        "items": [
          "Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)",
          "Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis",
          "Psychiatric disorders- Unknown: Confusion, sleep disturbances",
          "Nervous system disorders- Unknown: hyperactivity, hypertonia, dizziness, nervousness; Rarely: Headache",
          "Hepatobiliary disorders- Frequency unknown: Liver, enzyme disturbances, transient hepatitis, cholestatic jaundice",
          "Renal and urinary disorders- Unknown: Reversible interstitial nephritis",
          "Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.",
          "Alfradin should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.",
          "Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.",
          "Alfradin may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).",
          "Dosage adjustment is necessary in renal impairment.",
          "Alfradin contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Renal Impairment: The following doses are recommended (based on 500 mg every 6 hours) for patients not on haemodialysis: Recommendations for patients on chronic, intermittent haemodialysis: Additional Information for all patients Regardless of patient age or weight, higher doses of up to 1 gm four times daily may be required for infections which are chronic or severe. Treatment should continue for at least 2 to 3 days after symptoms have resolved or bacteria have been eradicated. To reduce the possibility of rheumatic fever or glomerulonephritis resulting from infections with haemolytic streptococci, treatment should be continued for at least 10 days. Throughout treatment of chronic urinary tract infections and for several months thereafter, regular bacteriological and clinical monitoring is required. Doses below those recommended above should not be prescribed. Paediatric dosages should not exceed those specified for adults, regardless of severity of infection. It may be necessary to continue Alfradin therapy for several weeks in persistent infections. Patients may be transferred from intramuscular/intravenous Alfradin therapy to oral treatment at the same dosage level.",
        "items": [
          "CrCl: >20 ml/min: 500 mg every 6 hours",
          "CrCl: 5-20 ml/min: 250 mg every 6 hours",
          "CrCl: <5 ml/min: 250 mg every 50-70 hours.",
          "250 mg at the start of haemodialysis",
          "250 mg 6 to 12 hours after the start",
          "250 mg 36 to 48 hours after the start",
          "250 mg at the start of the next haemodialysis session if more than 30 hours have elapsed since the last dose."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Alfradin Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Alfradin Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "First generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "For oral administration",
        "information": "- Adults: Children: Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.",
        "instructions": [
          "Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.",
          "Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.",
          "Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.",
          "Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.",
          "Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.",
          "Maximum daily dosage: 4 gm"
        ]
      },
      {
        "medication_type": "For injectable administration",
        "information": "-",
        "instructions": [
          "Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.",
          "Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:30.994Z",
    "medicine_id": "68c3c09aef5b8f2b163a8de7",
    "original_record": {
      "input_index": 866,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8de7"
        },
        "name": "Alfradin",
        "strength": "500 mg",
        "generic": "Cephradine",
        "company": "Allied Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/25855/alfradin-500-mg-capsule",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/25856/alfradin-ds-250-mg-suspension",
    "name": "Alfradin DS",
    "dosage_form": "Powder for Suspension",
    "generic": "Cephradine",
    "strength": "250 mg/5 ml",
    "company": "Allied Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 120.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "500 mg (Capsule)",
        "href": "https://medex.com.bd/brands/25855/alfradin-500-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/232/cephradine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alfradin DS is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- Alfradin DS is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- The following microorganisms are susceptible, in vitro to Alfradin DS:",
        "items": [
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.",
          "Urinary tract infections: cystitis, urethritis and pyelonephritis.",
          "Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.",
          "Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.",
          "Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Alfradin DS which is unaffected by this enzyme."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.",
        "items": [
          "Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)",
          "Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis",
          "Psychiatric disorders- Unknown: Confusion, sleep disturbances",
          "Nervous system disorders- Unknown: hyperactivity, hypertonia, dizziness, nervousness; Rarely: Headache",
          "Hepatobiliary disorders- Frequency unknown: Liver, enzyme disturbances, transient hepatitis, cholestatic jaundice",
          "Renal and urinary disorders- Unknown: Reversible interstitial nephritis",
          "Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.",
          "Alfradin DS should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.",
          "Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.",
          "Alfradin DS may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).",
          "Dosage adjustment is necessary in renal impairment.",
          "Alfradin DS contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Renal Impairment: The following doses are recommended (based on 500 mg every 6 hours) for patients not on haemodialysis: Recommendations for patients on chronic, intermittent haemodialysis: Additional Information for all patients Regardless of patient age or weight, higher doses of up to 1 gm four times daily may be required for infections which are chronic or severe. Treatment should continue for at least 2 to 3 days after symptoms have resolved or bacteria have been eradicated. To reduce the possibility of rheumatic fever or glomerulonephritis resulting from infections with haemolytic streptococci, treatment should be continued for at least 10 days. Throughout treatment of chronic urinary tract infections and for several months thereafter, regular bacteriological and clinical monitoring is required. Doses below those recommended above should not be prescribed. Paediatric dosages should not exceed those specified for adults, regardless of severity of infection. It may be necessary to continue Alfradin DS therapy for several weeks in persistent infections. Patients may be transferred from intramuscular/intravenous Alfradin DS therapy to oral treatment at the same dosage level.",
        "items": [
          "CrCl: >20 ml/min: 500 mg every 6 hours",
          "CrCl: 5-20 ml/min: 250 mg every 6 hours",
          "CrCl: <5 ml/min: 250 mg every 50-70 hours.",
          "250 mg at the start of haemodialysis",
          "250 mg 6 to 12 hours after the start",
          "250 mg 36 to 48 hours after the start",
          "250 mg at the start of the next haemodialysis session if more than 30 hours have elapsed since the last dose."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Alfradin DS Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Alfradin DS Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "First generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "For oral administration",
        "information": "- Adults: Children: Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.",
        "instructions": [
          "Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.",
          "Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.",
          "Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.",
          "Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.",
          "Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.",
          "Maximum daily dosage: 4 gm"
        ]
      },
      {
        "medication_type": "For injectable administration",
        "information": "-",
        "instructions": [
          "Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.",
          "Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:32.405Z",
    "medicine_id": "68c3c09aef5b8f2b163a8de8",
    "original_record": {
      "input_index": 867,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8de8"
        },
        "name": "Alfradin DS",
        "strength": "250 mg/5 ml",
        "generic": "Cephradine",
        "company": "Allied Pharmaceuticals Ltd.",
        "medicine_type": "Powder for Suspension",
        "source_url": "https://medex.com.bd/brands/25856/alfradin-ds-250-mg-suspension",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/32333/algaba-50-mg-capsule",
    "name": "Algaba",
    "dosage_form": "Capsule",
    "generic": "Pregabalin",
    "strength": "50 mg",
    "company": "Al-Madina Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 12.00",
      "strip_price": "৳ 120.00",
      "pack_size_info": "(3 x 10: ৳ 360.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.00",
          "pack_size_info": "(3 x 10: ৳ 360.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "75 mg (Capsule)",
        "href": "https://medex.com.bd/brands/32334/algaba-75-mg-capsule?ref=1"
      },
      {
        "text": "150 mg (Capsule)",
        "href": "https://medex.com.bd/brands/32335/algaba-150-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/919/pregabalin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Film-coated tablet is indicated for: Controlled release tablet is indicated for:",
        "items": [
          "Neuropathic pain associated with diabetic peripheral neuropathy",
          "Postherpetic neuralgia",
          "Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older",
          "Fibromyalgia",
          "Neuropathic pain associated with spinal cord injury",
          "Neuropathic pain associated with diabetic peripheral neuropathy",
          "Postherpetic neuralgia"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABA A , GABA B or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Drug interaction with medication",
        "information": ": Algaba is unlikely to be involved in significant pharmacokinetic drug interactions.",
        "items": []
      },
      {
        "title": "Drug interaction with food and others",
        "information": ": Not applicable.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Algaba should be discontinued immediately in these cases. Algaba should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including Algaba, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with Algaba when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Algaba may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if Algaba is rapidly discontinued. Algaba should be withdrawn gradually over a minimum of 1 week. Algaba may cause peripheral edema. Caution should be exercised when coadministering Algaba and thiazolidinedione antidiabetic agents.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Use in children and adolescents",
        "information": ": Safety and effectiveness in pediatric patients have not been established for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, neuropathic pain associated with spinal cord injury and fibromyalgia. In case of adjunctive therapy for partial onset seizures, safety and effectiveness in pediatric patients below the age of 1 month have not been established. The safety and effectiveness of Algaba extended-release tablet in pediatric patients have not been established.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "In case of overdose with Algaba, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": "Route of administration",
        "information": ": Pregabalin is taken in oral route. It can be taken with or without food. Pregabalin CR tablet should be administered after an evening meal. It should be swallowed whole and should not be split, crushed or chewed. If patients miss taking their dose of Pregabalin CR after an evening meal, then they should take their usual dose of Pregabalin CR prior to bedtime following a snack. If they miss taking the dose of Pregabalin CR prior to bedtime, then they should take their usual dose of Pregabalin CR following a morning meal. If they miss taking the dose of Pregabalin CR following the morning meal, then they should take their usual dose of Pregabalin CR at the usual time that evening following an evening meal. When discontinuing both Pregabalin and Pregabalin CR, it should be gradually tapered over a minimum of 1 week.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": "C8H17NO2",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-919-pregabalin-chemical-structure-dKjKzfuVRrNkwNMBalNK.svg"
    },
    "therapeutic_class": "Adjunct anti-epileptic drugs, Primary anti-epileptic drugs",
    "dosage": [
      {
        "medication_type": "Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN",
        "information": "): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Postherpetic neuralgia in adults (PHN)",
        "information": ": The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day). Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Management of fibromyalgia in adults",
        "information": ": The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).",
        "instructions": []
      },
      {
        "medication_type": "Neuropathic pain associated with spinal cord injury in adults",
        "information": ": The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.",
        "instructions": []
      },
      {
        "medication_type": "Conversion from Pregabalin capsules to Pregabalin CR capsule tablet",
        "information": ": When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal. Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)",
        "instructions": [
          "75 mg/daily: 82.5 mg/day",
          "150 mg/daily: 165 mg/day",
          "225 mg/daily: 247.5 mg/day",
          "300 mg/daily: 330 mg/day",
          "450 mg/daily: 495 mg/day",
          "600 mg/daily: 660 mg/day"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Algaba 50 mg Capsule?",
        "answer": [
          "Algaba 50 mg Capsule is an anticonvulsant and is considered to be the first-line of treatment for neurotic pain, shingles, seizures and fibromyalgia."
        ]
      },
      {
        "question": "How long do I need to use Algaba 50 mg Capsule before I see improvement in my condition?",
        "answer": [
          "Algaba 50 mg Capsule is to be taken till the time you see an improvement in your health conditions."
        ]
      },
      {
        "question": "At what frequency do I need to use Algaba 50 mg Capsule?",
        "answer": [
          "Algaba 50 mg Capsule should be taken in the dosage as prescribed by the doctor."
        ]
      },
      {
        "question": "Should I use Algaba 50 mg Capsule empty stomach, before food or after food?",
        "answer": [
          "Algaba 50 mg Capsule should be taken after food in a prescribed dosage."
        ]
      },
      {
        "question": "What are the instructions for the storage and disposal of Algaba 50 mg Capsule?",
        "answer": [
          "Algaba 50 mg Capsule should be kept in a cool dry place and in its original packaging. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Does Algaba 50 mg Capsule work in the same way for each disease?",
        "answer": [
          "No, Algaba 50 mg Capsule works in different ways for different diseases."
        ]
      },
      {
        "question": "How long do I need to take Algaba 50 mg Capsule?",
        "answer": [
          "The duration of Algaba 50 mg Capsule depends on the condition for which you are consuming this medicine. It is advised to consult the doctor before consuming Algaba 50 mg Capsule."
        ]
      },
      {
        "question": "Is it necessary to continue taking Algaba 50 mg Capsule even if I feel fine?",
        "answer": [
          "Yes, you should not stop taking Algaba 50 mg Capsule even if you feel fine. Consult your doctor before stopping Algaba 50 mg Capsule."
        ]
      },
      {
        "question": "Can I take Diazepam and Algaba 50 mg Capsule together?",
        "answer": [
          "Yes, Algaba 50 mg Capsule and Diazepam can be used together."
        ]
      },
      {
        "question": "Can the use of Algaba 50 mg Capsule cause weight gain?",
        "answer": [
          "Yes, Algaba 50 mg Capsule may cause weight gain because it increases your hunger. Consult a dietician if you have any further concerns to keep your weight stable."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Algaba 50 mg Capsule should be taken as per the dose and duration prescribed by your doctor.",
          "Algaba 50 mg Capsule may cause sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.",
          "Algaba 50 mg Capsule may cause blurring or loss of vision. Inform your doctor immediately if you notice any vision changes.",
          "Inform your doctor if you develop any unusual changes in mood or behavior, new or worsening depression, or suicidal thoughts or behavior.",
          "Do not stop taking Algaba 50 mg Capsule suddenly without talking to your doctor as it may worsen your underlying condition."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:27:33.590Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dea",
    "original_record": {
      "input_index": 868,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dea"
        },
        "name": "Algaba",
        "strength": "50 mg",
        "generic": "Pregabalin",
        "company": "Al-Madina Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/32333/algaba-50-mg-capsule",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28782/algecal-d-500-mg-tablet",
    "name": "Algecal D",
    "dosage_form": "Tablet",
    "generic": "Algae Calcium + Vitamin D3",
    "strength": "500 mg+200 IU",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 11.00",
      "strip_price": "৳ 110.00",
      "pack_size_info": "(3 x 10: ৳ 330.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 11.00",
          "pack_size_info": "(3 x 10: ৳ 330.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 110.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "600 mg+400 IU (Tablet)",
        "href": "https://medex.com.bd/brands/29461/algecal-dx-600-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1772/algae-calcium-vitamin-d3/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algecal D is indicated in following cases-",
        "items": [
          "Treatment of osteoporosis, rickets, osteomalacia, tetany and hypoparathyroidism",
          "In pregnancy and lactation due to increased demand",
          "In kidney disease and pancreatitis",
          "During therapy with antiseizure medications",
          "The prevention and treatment of Calcium and Vitamin D3 deficiency"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Calcium (Algae Source) is an essential element and plays vital role in the body. It makes body's framework stronger by building bones. Clinical evidence suggests that calcium is useful for prevention and treatment of osteoporosis and associated fractures. Vitamin D3 is also essential for healthy bones as it aids in calcium absorption from the Gl tract. In addition to this it stimulates bone formation. Controlled clinical studies show that Calcium and Vitamin D3 have synergistic effects on bone growth as well as in osteoporosis and fracture prevention.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "With medicine: With food and others: No clinically significant food drug interaction have been reported.",
        "items": [
          "Calcium salts reduce absorption of bisphosphonates, ciprofloxacin, fluorides, iron, levothyroxine, tetracycline and zinc",
          "Absorption of calcium salts is reduced by corticosteroids",
          "Increased risk of hypercalcemia when Calcium and Vitamin D3 given with thiazides and related diuretics"
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypocalcemia and hypercalciuria",
          "Metastatic calcification",
          "Hypersensitivity to any of the components of Calcium and Vitamin D3 preparation"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Common side effects of Calcium and Vitamin D3 may include an irregular heartbeat, nausea, dry mouth, weakness, headache, a metallic taste in mouth, muscle or bone pain and drowsiness. Rare side effects are high amount of Calcium in blood, constipation, diarrhoea, loss of appetite.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "During pregnancy & lactation: Calcium and Vitamin D3 should be used considering the risk-benefit ratio.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be taken in patients with renal impairment, sarcoidosis, hypercalcemia and hypercalciuria.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Not recommended for children under 12 years.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "At high doses it may result in nausea, vomiting, dizziness, anorexia, abdominal cramps, headache, constipation etc. Treatment includes cessation of therapy & adequate rehydration.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C and away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Specific mineral & vitamin combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Usual adult dose: 1 tablet in the morning and 1 tablet at night. Tablet should be taken orally.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:34.897Z",
    "medicine_id": "68c3c09aef5b8f2b163a8def",
    "original_record": {
      "input_index": 869,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8def"
        },
        "name": "Algecal D",
        "strength": "500 mg+200 IU",
        "generic": "Algae Calcium + Vitamin D3",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/28782/algecal-d-500-mg-tablet",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/38695/algecal-jr-250-mg-chewable-tablet",
    "name": "Algecal Jr.",
    "dosage_form": "Chewable Tablet",
    "generic": "Algae Calcium",
    "strength": "250 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": "৳ 40.00",
      "pack_size_info": "(5 x 10: ৳ 200.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(5 x 10: ৳ 200.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": null,
    "indications": [
      {
        "title": null,
        "information": "Algecal Jr. is indicated for: Algecal Jr. can also be used as a supplement in cases of: Other indications of Algecal Jr.:",
        "items": [
          "Osteogenesis",
          "Osteomalacia",
          "Hypoparathyroidism",
          "Rickets",
          "Brain development.",
          "Inadequate intake of Calcium in childhood diet",
          "Pregnancy & lactation",
          "Poor absorption during old age.",
          "Pancreatitis",
          "Phosphate binder in chronic renal failure."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Calcium [Algae source] is the combination of Ocean-based Algae source Calcium. This Calcium is extracted from Algas Calcareas, a red Algae found on the shores of South America. Algae source Calcium ensures better absorption than Coral source Calcium or other Calcium Carbonate due to its fibrous chemical structure. Calcium is absorbed in the intestine which then passes into the bloodstream and is deposited into bone. 75% of Calcium from Algae source is absorbed in the intestine. In a USP dissolution test (simulating stomach condition), 97% of Calcium from Algae source goes into solution.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Major interaction",
        "information": ": Intravenous Ceftriaxone & Calcium can cause life-threatening damage to the lungs & kidneys. Calcium should not be given intravenously within 48 hours of IV ceftriaxone.",
        "items": []
      },
      {
        "title": "Minor interaction",
        "information": ": Calcium reduces absorption of tetracycline & fluoride preparations- allow at least 3 hours gap. Thiazide diuretics reduce renal excretion of Calcium. Certain foods (spinach, cereals, milk, and derivatives) may reduce intestinal Calcium uptake.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Increased activity of parathyroid gland Hypercalcemia Kidney stone Extreme loss of body water.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rare: Flatulence, diarrhoea Prolonged use: Rare cases of hypercalcemia reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [],
    "precautions": [
      {
        "title": null,
        "information": "In mild hypercalciuria, reduce the dose to maintain normal serum Calcium concentration. Patients with kidney stone (or history of it) should be advised to increase fluid intake.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep out of reach of children. Store in a dry place, below 25°C, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "One tablet once or twice daily or as recommended by physician",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:37.037Z",
    "medicine_id": "68c3c09aef5b8f2b163a8df1",
    "original_record": {
      "input_index": 870,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8df1"
        },
        "name": "Algecal Jr.",
        "strength": "250 mg",
        "generic": "Algae Calcium",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/38695/algecal-jr-250-mg-chewable-tablet",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/32350/algeum-dx-600-mg-tablet",
    "name": "Algeum-DX",
    "dosage_form": "Tablet",
    "generic": "Algae Calcium + Vitamin D3",
    "strength": "600 mg+400 IU",
    "company": "Radiant Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 15.00",
      "strip_price": "৳ 150.00",
      "pack_size_info": "(3 x 10: ৳ 450.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 15.00",
          "pack_size_info": "(3 x 10: ৳ 450.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 150.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "500 mg+200 IU (Tablet)",
        "href": "https://medex.com.bd/brands/32349/algeum-d-500-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1772/algae-calcium-vitamin-d3/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algeum-DX is indicated in following cases-",
        "items": [
          "Treatment of osteoporosis, rickets, osteomalacia, tetany and hypoparathyroidism",
          "In pregnancy and lactation due to increased demand",
          "In kidney disease and pancreatitis",
          "During therapy with antiseizure medications",
          "The prevention and treatment of Calcium and Vitamin D3 deficiency"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Calcium (Algae Source) is an essential element and plays vital role in the body. It makes body's framework stronger by building bones. Clinical evidence suggests that calcium is useful for prevention and treatment of osteoporosis and associated fractures. Vitamin D3 is also essential for healthy bones as it aids in calcium absorption from the Gl tract. In addition to this it stimulates bone formation. Controlled clinical studies show that Calcium and Vitamin D3 have synergistic effects on bone growth as well as in osteoporosis and fracture prevention.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "With medicine: With food and others: No clinically significant food drug interaction have been reported.",
        "items": [
          "Calcium salts reduce absorption of bisphosphonates, ciprofloxacin, fluorides, iron, levothyroxine, tetracycline and zinc",
          "Absorption of calcium salts is reduced by corticosteroids",
          "Increased risk of hypercalcemia when Calcium and Vitamin D3 given with thiazides and related diuretics"
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypocalcemia and hypercalciuria",
          "Metastatic calcification",
          "Hypersensitivity to any of the components of Calcium and Vitamin D3 preparation"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Common side effects of Calcium and Vitamin D3 may include an irregular heartbeat, nausea, dry mouth, weakness, headache, a metallic taste in mouth, muscle or bone pain and drowsiness. Rare side effects are high amount of Calcium in blood, constipation, diarrhoea, loss of appetite.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "During pregnancy & lactation: Calcium and Vitamin D3 should be used considering the risk-benefit ratio.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be taken in patients with renal impairment, sarcoidosis, hypercalcemia and hypercalciuria.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Not recommended for children under 12 years.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "At high doses it may result in nausea, vomiting, dizziness, anorexia, abdominal cramps, headache, constipation etc. Treatment includes cessation of therapy & adequate rehydration.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C and away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Specific mineral & vitamin combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Usual adult dose: 1 tablet in the morning and 1 tablet at night. Tablet should be taken orally.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:38.114Z",
    "medicine_id": "68c3c09aef5b8f2b163a8df4",
    "original_record": {
      "input_index": 871,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8df4"
        },
        "name": "Algeum-DX",
        "strength": "600 mg+400 IU",
        "generic": "Algae Calcium + Vitamin D3",
        "company": "Radiant Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/32350/algeum-dx-600-mg-tablet",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/16686/algicid-500-mg-chewable-tablet",
    "name": "Algicid",
    "dosage_form": "Chewable Tablet",
    "generic": "Sodium Alginate + Potassium Bicarbonate",
    "strength": "500 mg+100 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5.00",
      "strip_price": "৳ 50.00",
      "pack_size_info": "(10 x 10: ৳ 500.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.00",
          "pack_size_info": "(10 x 10: ৳ 500.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 50.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "(500 mg+100 mg)/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/1396/algicid-500-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/903/sodium-alginate-potassium-bicarbonate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algicid is indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus such as acid regurgitation, heartburn, indigestion for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux esophagitis, including ... Read moreAlgicid is indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus such as acid regurgitation, heartburn, indigestion for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux esophagitis, including symptoms of laryngopharyngeal reflux such as hoarseness and other voice disorders, sore throats and cough. Algicid can also be used to treat the symptoms of gastroesophageal reflux during concomitant treatment with or following the withdrawal of acid suppressing therapy.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the combination of Sodium Alginate and Potassium Bicarbonate. Sodium Alginate is a naturally occurring substance. It reacts with the acid in the stomach to form a gel. Potassium Bicarbonate also reacts with the acid in the stomach to form bubbles of carbon dioxide. These bubbles are trapped by the gel formed by Sodium Alginate and they allow the gel to float like a raft on top of the stomach contents. The raft prevents acid in the stomach from flowing back into the esophagus. This relieves the symptoms of reflux such as heartburn. The mode of action of this is physical and does not depend on absorption into the systemic circulation. The raft lasts for up to 4 hours on top of the stomach contents and is then broken down in the digestive system and excreted in the feces.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "A time interval of 2 hours should be considered between this intake and the administration of other medicinal products, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Sodium alginate and potassium bicarbonate is contraindicated in patients with known hypersensitivity to these.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In addition to the desired effect of the drug, some side effects may appear such as: nausea, constipation, diarrhea or headache. In these cases consult a physician In case too big dosage has been taken, there might appear a sensation of swelling. In this case it is advisable to consult a physician.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "This combination (Sodium Alginate and Potassium Bicarbonate) can be used during pregnancy, if clinically needed. No known effect on breast-fed infants. This combination can be used during breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Sodium Alginate and Potassium Bicarbonate should be prescribed with caution in patients with renal impairment and congestive cardiac failure. Care needs to be taken in treating patients with hypercalcemia, nephrocalcinosis and recurrent calcium-containing renal calculi. There is a possibility of reduced efficacy in patients with very low levels of gastric acid. If symptoms do not improve after seven days, the clinical situation should be reviewed.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Overdosage with this formulation is a rare case. In case of overdose please consult with a registered physician.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ":",
        "instructions": [
          "Adults and children over 12 years: 1-2 tablets 3-4 times daily, after meals and before bedtime.",
          "Children 6-12 years: ½-1 tablet 3-4 times daily, after meals and before bedtime."
        ]
      },
      {
        "medication_type": "Suspension",
        "information": ":",
        "instructions": [
          "Adults and children 12 years and above: 5-10 ml (1-2 teaspoonfuls) 3-4 times daily, after meals and before bedtime.",
          "Children 2-12 years: 2.5-5ml (½-1 teaspoonful) 3-4 times daily, after meals and before bedtime."
        ]
      },
      {
        "medication_type": "Use in children",
        "information": ": This is not recommended under 2 years of age.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": No dose modifications are necessary for this age group.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": No dose modifications are necessary.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": Caution if a highly restricted salt diet is necessary.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:39.319Z",
    "medicine_id": "68c3c09aef5b8f2b163a8df7",
    "original_record": {
      "input_index": 872,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8df7"
        },
        "name": "Algicid",
        "strength": "500 mg+100 mg",
        "generic": "Sodium Alginate + Potassium Bicarbonate",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/16686/algicid-500-mg-chewable-tablet",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/26556/algicid-plus-500-mg-suspension",
    "name": "Algicid Plus",
    "dosage_form": "Oral Suspension",
    "generic": "Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate",
    "strength": "(500 mg+267 mg+160 mg)/10 ml",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 250.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "200 ml bottle",
          "price": "৳ 250.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "(500 mg+213 mg+325 mg)/10 ml (Suspension)",
        "href": "https://medex.com.bd/brands/32170/algicid-dx-500-mg-suspension?ref=1"
      },
      {
        "text": "250 mg+133.5 mg+80 mg (Chew. Tablet)",
        "href": "https://medex.com.bd/brands/35183/algicid-plus-250-mg-chewable-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1451/sodium-alginate-sodium-bicarbonate-calcium-carbonate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algicid Plus is indicated in-",
        "items": [
          "Gastric reflux",
          "Heartburn",
          "Indigestion",
          "Flatulence associated with gastric reflux",
          "Heartburn of pregnancy",
          "All cases of epigastric and retrosternal distress where the underlying cause is gastric reflux."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an alginate (Sodium alginate). The suspension work in two ways- The mode of action of the product is physical and does not depend on absorption into the systemic circulation. The product is a combination of two antacids (Calcium Carbonate and Sodium Bicarbonate) and an Alginate. On ingestion, the medicinal product reacts rapidly with gastric acid to form a raft of Alginic Acid gel having a near neutral pH and studies have shown that the raft interacts with and caps the acid pocket in the stomach, reducing esophageal acid exposure. The raft floats on the stomach contents effectively impeding gastro-esophageal reflux, for up to 4 hours, and protecting the esophagus from Acid, Pepsin and Bile.In severe cases the raft itself may be refluxed into the esophagus, in preference to the stomach contents, and exert a demulcent effect. In addition in vitro evidence has shown that the raft has a secondary action and is able to entrap bile and pepsin within it structure, further protecting the esophagus from these gastric components. Calcium Carbonate neutralizes gastric acid to provide fast relief from indigestion and heartburn.This effect is increased by the addition of Sodium Bicarbonate which also has a neutralizing action.",
        "items": [
          "Neutralizing excess stomach acid to relieve the pain & discomfort",
          "Forming a protective barrier over the stomach contents to soothe the burning pain in your chest."
        ]
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "A time-interval of 2 hours should be considered between Algicid Plus intake and the administration of other medicinal products, especially Tetracyclines, Digoxine, Fluoroquinolone, Iron salt, Ketoconazole, Neuroleptics, Thyroid Hormones, Penicillamine, beta-blockers (Atenolol, Metoprolol, Propranolol), Glucocorticoid, Chloroquine and Biphosphonates (diphosphonates) and Estramustine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known or suspected hypersensitivity to the active ingredients or to any of the excipients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In addition to the desired effect of the drug, some side effects may appear such as: constipation, flatulence, stomach cramp or belching. In these cases consult a physician. If too big dose has been taken, there might appear a sensation of swelling. In this case, it is advisable to consult a physician.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": Clinical studies in more than 500 pregnant women, as well as a large amount of data from post-marketing experience, indicate no malformative nor feto/neonatal toxicity of the active ingredients. This drug can be used during pregnancy, if clinically needed.",
        "items": []
      },
      {
        "title": "Breastfeeding",
        "information": ": No effects of the active substances have been shown in breastfed newborns/infants of treated mothers. This drug can be used during breastfeeding.",
        "items": []
      },
      {
        "title": "Fertility",
        "information": ": Pre-clinical investigations have revealed Alginate has no negative effect on parental or offspring fertility or reproduction. Clinical data do not suggest that this drug has an effect on human fertility.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Each 20 ml of dose has a sodium content of 254.5 mg (11.06 mmol). This should be taken into account when a highly restricted salt diet is recommended, e.g. in some cases of congestive cardiac failure and renal impairment. Each 20 ml contains 260 mg (6.5 mmol) of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis, and recurrent calcium containing renal calculi. Treatment of children younger than 12 years of age is not generally recommended, except on medical advice. Algicid Plus is considered high in sodium. This should be taken into account when a highly restricted salt diet is recommended, e.g., in some cases of congestive cardiac failure and renal impairment. Each tablet contains 75 mg of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi. Due to its aspartame content Algicid Plus should not be given to patients with phenylketonuria. If symptoms persist, or treatment is required for more than 7 days continuously, medical advice should be sought. Taking Algicid Plus can mask the symptoms of other more serious, underlying medical conditions. It should not be used in patients with impaired renal function/insufficiency and with hypophosphatemia. This may cause allergic reactions.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In the event of over dosage symptomatic treatment should be given. The patient may notice abdominal distension.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (below 30°C) and dry place, away from light. Keep out of the reach of children. Do not refrigerate or freeze.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": null,
        "information": "For oral suspension:",
        "instructions": []
      },
      {
        "medication_type": "Adult and children over 12 years",
        "information": ":10-20 mL after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children 6 to 12 years",
        "information": ": 5-10 mL after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children under 6 years",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": No dose modifications necessary.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Chewable Tablet should be taken in oral route after being thoroughly chewed. Recommended dose:",
        "instructions": []
      },
      {
        "medication_type": "Adults and children 12 years and over",
        "information": ": Take two to four tablets after meals and at bedtime, up to four times a day.",
        "instructions": []
      },
      {
        "medication_type": "Children under 12 years",
        "information": ": Tablets should be given only on medical advice.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": No dose modification necessary.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": Caution if highly restricted salt diet is necessary.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Algicid Plus (500 mg+267 mg+160 mg)/10 ml Suspension?",
        "answer": [
          "Algicid Plus (500 mg+267 mg+160 mg)/10 ml Suspension is the combination of two antacids and an alginate. This is commonly used to treat Gastric reflux, Heartburn, Indigestion, Flatulence associated with gastric reflux."
        ]
      },
      {
        "question": "Is Algicid Plus (500 mg+267 mg+160 mg)/10 ml Suspension safe in pregnancy?",
        "answer": [
          "You can take Algicid Plus (500 mg+267 mg+160 mg)/10 ml Suspension if you are pregnant or breast-feeding."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:27:40.380Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dfb",
    "original_record": {
      "input_index": 873,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dfb"
        },
        "name": "Algicid Plus",
        "strength": "(500 mg+267 mg+160 mg)/10 ml",
        "generic": "Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/26556/algicid-plus-500-mg-suspension",
        "_page": 24,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/24561/algicon-500-mg-chewable-tablet",
    "name": "Algicon",
    "dosage_form": "Chewable Tablet",
    "generic": "Sodium Alginate + Potassium Bicarbonate",
    "strength": "500 mg+100 mg",
    "company": "Leon Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 3.01",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 300.95)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.01",
          "pack_size_info": "(100's pack: ৳ 300.95)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "(500 mg+100 mg)/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/24560/algicon-500-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/903/sodium-alginate-potassium-bicarbonate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algicon is indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus such as acid regurgitation, heartburn, indigestion for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux esophagitis, including ... Read moreAlgicon is indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus such as acid regurgitation, heartburn, indigestion for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux esophagitis, including symptoms of laryngopharyngeal reflux such as hoarseness and other voice disorders, sore throats and cough. Algicon can also be used to treat the symptoms of gastroesophageal reflux during concomitant treatment with or following the withdrawal of acid suppressing therapy.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the combination of Sodium Alginate and Potassium Bicarbonate. Sodium Alginate is a naturally occurring substance. It reacts with the acid in the stomach to form a gel. Potassium Bicarbonate also reacts with the acid in the stomach to form bubbles of carbon dioxide. These bubbles are trapped by the gel formed by Sodium Alginate and they allow the gel to float like a raft on top of the stomach contents. The raft prevents acid in the stomach from flowing back into the esophagus. This relieves the symptoms of reflux such as heartburn. The mode of action of this is physical and does not depend on absorption into the systemic circulation. The raft lasts for up to 4 hours on top of the stomach contents and is then broken down in the digestive system and excreted in the feces.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "A time interval of 2 hours should be considered between this intake and the administration of other medicinal products, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Sodium alginate and potassium bicarbonate is contraindicated in patients with known hypersensitivity to these.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In addition to the desired effect of the drug, some side effects may appear such as: nausea, constipation, diarrhea or headache. In these cases consult a physician In case too big dosage has been taken, there might appear a sensation of swelling. In this case it is advisable to consult a physician.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "This combination (Sodium Alginate and Potassium Bicarbonate) can be used during pregnancy, if clinically needed. No known effect on breast-fed infants. This combination can be used during breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Sodium Alginate and Potassium Bicarbonate should be prescribed with caution in patients with renal impairment and congestive cardiac failure. Care needs to be taken in treating patients with hypercalcemia, nephrocalcinosis and recurrent calcium-containing renal calculi. There is a possibility of reduced efficacy in patients with very low levels of gastric acid. If symptoms do not improve after seven days, the clinical situation should be reviewed.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Overdosage with this formulation is a rare case. In case of overdose please consult with a registered physician.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ":",
        "instructions": [
          "Adults and children over 12 years: 1-2 tablets 3-4 times daily, after meals and before bedtime.",
          "Children 6-12 years: ½-1 tablet 3-4 times daily, after meals and before bedtime."
        ]
      },
      {
        "medication_type": "Suspension",
        "information": ":",
        "instructions": [
          "Adults and children 12 years and above: 5-10 ml (1-2 teaspoonfuls) 3-4 times daily, after meals and before bedtime.",
          "Children 2-12 years: 2.5-5ml (½-1 teaspoonful) 3-4 times daily, after meals and before bedtime."
        ]
      },
      {
        "medication_type": "Use in children",
        "information": ": This is not recommended under 2 years of age.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": No dose modifications are necessary for this age group.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": No dose modifications are necessary.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": Caution if a highly restricted salt diet is necessary.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:41.855Z",
    "medicine_id": "68c3c09aef5b8f2b163a8dfd",
    "original_record": {
      "input_index": 874,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8dfd"
        },
        "name": "Algicon",
        "strength": "500 mg+100 mg",
        "generic": "Sodium Alginate + Potassium Bicarbonate",
        "company": "Leon Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/24561/algicon-500-mg-chewable-tablet",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/1397/algisum-500-mg-chewable-tablet",
    "name": "Algisum",
    "dosage_form": "Chewable Tablet",
    "generic": "Sodium Alginate + Potassium Bicarbonate",
    "strength": "500 mg+100 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 3.50",
      "strip_price": "৳ 35.00",
      "pack_size_info": "(5 x 10: ৳ 175.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.50",
          "pack_size_info": "(5 x 10: ৳ 175.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 35.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "(500 mg+100 mg)/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/1398/algisum-500-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/903/sodium-alginate-potassium-bicarbonate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Algisum is indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus such as acid regurgitation, heartburn, indigestion for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux esophagitis, including ... Read moreAlgisum is indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus such as acid regurgitation, heartburn, indigestion for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy, accompanying reflux esophagitis, including symptoms of laryngopharyngeal reflux such as hoarseness and other voice disorders, sore throats and cough. Algisum can also be used to treat the symptoms of gastroesophageal reflux during concomitant treatment with or following the withdrawal of acid suppressing therapy.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the combination of Sodium Alginate and Potassium Bicarbonate. Sodium Alginate is a naturally occurring substance. It reacts with the acid in the stomach to form a gel. Potassium Bicarbonate also reacts with the acid in the stomach to form bubbles of carbon dioxide. These bubbles are trapped by the gel formed by Sodium Alginate and they allow the gel to float like a raft on top of the stomach contents. The raft prevents acid in the stomach from flowing back into the esophagus. This relieves the symptoms of reflux such as heartburn. The mode of action of this is physical and does not depend on absorption into the systemic circulation. The raft lasts for up to 4 hours on top of the stomach contents and is then broken down in the digestive system and excreted in the feces.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "A time interval of 2 hours should be considered between this intake and the administration of other medicinal products, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Sodium alginate and potassium bicarbonate is contraindicated in patients with known hypersensitivity to these.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "In addition to the desired effect of the drug, some side effects may appear such as: nausea, constipation, diarrhea or headache. In these cases consult a physician In case too big dosage has been taken, there might appear a sensation of swelling. In this case it is advisable to consult a physician.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "This combination (Sodium Alginate and Potassium Bicarbonate) can be used during pregnancy, if clinically needed. No known effect on breast-fed infants. This combination can be used during breastfeeding.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Sodium Alginate and Potassium Bicarbonate should be prescribed with caution in patients with renal impairment and congestive cardiac failure. Care needs to be taken in treating patients with hypercalcemia, nephrocalcinosis and recurrent calcium-containing renal calculi. There is a possibility of reduced efficacy in patients with very low levels of gastric acid. If symptoms do not improve after seven days, the clinical situation should be reviewed.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Overdosage with this formulation is a rare case. In case of overdose please consult with a registered physician.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ":",
        "instructions": [
          "Adults and children over 12 years: 1-2 tablets 3-4 times daily, after meals and before bedtime.",
          "Children 6-12 years: ½-1 tablet 3-4 times daily, after meals and before bedtime."
        ]
      },
      {
        "medication_type": "Suspension",
        "information": ":",
        "instructions": [
          "Adults and children 12 years and above: 5-10 ml (1-2 teaspoonfuls) 3-4 times daily, after meals and before bedtime.",
          "Children 2-12 years: 2.5-5ml (½-1 teaspoonful) 3-4 times daily, after meals and before bedtime."
        ]
      },
      {
        "medication_type": "Use in children",
        "information": ": This is not recommended under 2 years of age.",
        "instructions": []
      },
      {
        "medication_type": "Elderly",
        "information": ": No dose modifications are necessary for this age group.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": No dose modifications are necessary.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": Caution if a highly restricted salt diet is necessary.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:42.923Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e07",
    "original_record": {
      "input_index": 875,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e07"
        },
        "name": "Algisum",
        "strength": "500 mg+100 mg",
        "generic": "Sodium Alginate + Potassium Bicarbonate",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/1397/algisum-500-mg-chewable-tablet",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28710/alice-12-mg-tablet",
    "name": "Alice",
    "dosage_form": "Tablet",
    "generic": "Ivermectin",
    "strength": "12 mg",
    "company": "Square Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 20.00",
      "strip_price": "৳ 200.00",
      "pack_size_info": "(1 x 10: ৳ 200.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 20.00",
          "pack_size_info": "(1 x 10: ৳ 200.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 200.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "6 mg (Tablet)",
        "href": "https://medex.com.bd/brands/28709/alice-6-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/644/ivermectin-tablet/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alice tablet is indicated for the treatment of- Strongyloidiasis of the intestinal tract: Alice is indicated for the treatment of intestinal ... Read moreAlice tablet is indicated for the treatment of- Strongyloidiasis of the intestinal tract: Alice is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Alice.Onchocerciasis: Alice is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).",
        "items": [
          "Strongyloidiasis",
          "Onchocerciasis",
          "Filariasis",
          "Scabies &",
          "Head lice.",
          "Strongyloidiasis",
          "Onchocerciasis",
          "Filariasis",
          "Scabies &",
          "Head lice."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ivermectin selectively binds and with high affinity to glutamate-gated chloride ion channels, which occur in invertebrate nerve and muscle cells leading to an increase in the permeability of cell membranes to chloride ions with hyperpolarization of the nerve or muscle cell and, ultimately, death of the parasite.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Post-marketing reports of increased INR (International Normalized Ratio) have been rarely reported when Alice was co-administered with warfarin.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients who are hypersensitive to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Strongyloidiasis",
        "information": ": In four clinical studies involving a total of 109 patients given either one or two doses of 170 to 200 mcg/kg of Alice, the following adverse reactions were reported as possibly, probably, or definitely related to Alice.",
        "items": [
          "Body as a whole: asthenia/fatigue (0.9%), abdominal pain (0.9%)",
          "Gastrointestinal: anorexia (0.9%), constipation (0.9%), diarrhea (1.8%), nausea (1.8%), vomiting (0.9%) Nervous System/Psychiatric: dizziness (2.8%), somnolence (0.9%), vertigo (0.9%), tremor (0.9%)",
          "Skin: pruritus (2.8%), rash (0.9%), and urticaria (0.9%)."
        ]
      },
      {
        "title": "Onchocerciasis",
        "information": ": arthralgia/synovitis (19.3%), axillary lymph node enlargement and tenderness (11.0% and 4.4%, respectively), cervical lymph node enlargement and tenderness (5.3% and 1.2%, respectively), inguinal lymph node enlargement and tenderness (12.6% and 13.9%, respectively), other lymph node enlargement and tenderness (3.0% and 1.9%, respectively), pruritus (27.5%), skin involvement including edema, papular and pustular or frank urticarial rash (22.7%), and fever (22.6%), abnormal sensation in the eyes, eyelid edema, anterior uveitis, conjunctivitis, limbitis, keratitis, and chorioretinitis or choroiditis. These have rarely been severe or associated with loss of vision and have generally resolved without corticosteroid treatment. The following adverse reactions have been reported since the drug was registered overseas: hypotension (mainly orthostatic hypotension), worsening of bronchial asthma, toxic epidermal necrolysis, and Stevens-Johnson syndrome.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. Ivermectin does not appear to be selectively fetotoxic to the developing fetus. There are, however, no adequate and well-controlled studies in pregnant women. Ivermectin should not be used during pregnancy since safety in pregnancy has not been established. Nursing Mothers: Ivermectin is excreted in human milk in low concentrations. Treatment of mothers who intend to breast feed should only be undertaken when the risk of delayed treatment to the mother outweighs the possible risk to the newborn",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Historical data have shown that microfilaricidal drugs, such as diethylcarbamazine citrate (DEC-C), might cause cutaneous and/or systemic reactions of varying severity (the Mazzotti reaction) and ophthalmological reactions in patients with onchocerciasis. These reactions are probably due to allergic and inflammatory responses to the death of microfilariae. Patients treated with Alice for onchocerciasis may experience these reactions in addition to clinical adverse reactions possibly, probably, or definitely related to the drug itself. The treatment of severe Mazzotti reactions has not been subjected to controlled clinical trials. Oral hydration, recumbency, intravenous normal saline, and/or parenteral corticosteroids have been used to treat postural hypotension. Antihistamines and/or aspirin have been used for most mild to moderate cases. After treatment with microfilaricidal drugs, patients with hyperreactive onchodermatitis (sowda) may be more likely than others to experience severe adverse reactions, especially edema and aggravation of onchodermatitis. Rarely, patients with onchocerciasis who are also heavily infected with Loa loa may develop a serious or even fatal encephalopathy either spontaneously or following treatment with an effective microfilaricide. In these patients, the following adverse experiences have also been reported: back pain, conjunctival hemorrhage, dyspnea, urinary and/or fecal incontinence, difficulty in standing/walking, mental status changes, confusion, lethargy, stupor, or coma.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Safety and effectiveness in pediatric patients weighing less than 15 kg have not been established.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": Clinical studies of Alice did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, below 30°C. Protect from light. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "For Treatment (If COVIO Positive)",
        "information": ": 2 Tablets of Ivermectin 6 mg once daily for 5 days. (2+0+0 for 5 days).",
        "instructions": []
      },
      {
        "medication_type": "For Prophylaxis",
        "information": ": Single-dose as mentioned below to be taken on Day 1 & same dose on Day 7.",
        "instructions": [
          "Body Weight 15-24 kg: 1 Tablet of Ivermectin 3 mg",
          "Body Weight 25-35 kg: 1 Tablet of Ivermectin 6 mg",
          "Body Weight 36-50 kg: 1 Tablet of Ivermectin 6 mg + 1 Tablet of Ivermectin 3 mg",
          "Body Weight 51-65 kg: 2 Tablets of Ivermectin 6 mg",
          "Body Weight 66-79 kg: 2 Tablets of Ivermectin 6 mg + 1 Tablet of Ivermectin 3 mg",
          "Body Weight >80 kg: 3 Tablets of Ivermectin 6 mg"
        ]
      },
      {
        "medication_type": "Strongyloidiasis",
        "information": ": The recommended dosage of Ivermectin for the treatment of strongyloidiasis is a single oral dose designed to provide approximately 200 mcg/kg of body weight. Patients should take tablets on an empty stomach with water. In general, additional doses are not necessary. However, follow-up stool examinations should be performed to verify eradication of infection. Dosage Guidelines for Ivermectin for Strongyloidiasis:",
        "instructions": [
          "Body Weight (kg) 15-24: Dose 3 mg/kg",
          "Body Weight (kg) 25-35: Dose 6 mg/kg",
          "Body Weight (kg) 36-50: Dose 9 mg/kg",
          "Body Weight (kg) 51-65: Dose 12 mg/kg",
          "Body Weight (kg) 66-79: Dose 15 mg/kg",
          "Body Weight (kg) >80: Dose 200 mcg/kg"
        ]
      },
      {
        "medication_type": "Onchocerciasis",
        "information": ": The recommended dosage of Ivermectin is a single oral dose designed to provide approximately 150 mcg of Ivermectin per kg of body weight on an empty stomach with water, the most commonly used dose interval is 12 months. For the treatment of individual patients, retreatment may be considered at intervals as short as 3 months. Dosage Guidelines for Ivermectin for Onchocerciasis:",
        "instructions": [
          "Body Weight (kg) 15-25: Dose 3 mg/kg",
          "Body Weight (kg) 26-44: Dose 6 mg/kg",
          "Body Weight (kg) 45-64: Dose 9 mg/kg",
          "Body Weight (kg) 65-84: Dose 12 mg/kg",
          "Body Weight (kg) >85: Dose 150 mcg/kg"
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:44.043Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e10",
    "original_record": {
      "input_index": 876,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e10"
        },
        "name": "Alice",
        "strength": "12 mg",
        "generic": "Ivermectin (Tablet)",
        "company": "Square Pharmaceuticals PLC",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/28710/alice-12-mg-tablet",
        "_page": 25,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/33515/alk-90-mg-tablet",
    "name": "ALK",
    "dosage_form": "Tablet",
    "generic": "Brigatinib",
    "strength": "90 mg",
    "company": "Jenphar Bangladesh Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 1,200.00",
      "strip_price": "৳ 8,400.00",
      "pack_size_info": "(1 x 7: ৳ 8,400.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 1,200.00",
          "pack_size_info": "(1 x 7: ৳ 8,400.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 8,400.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1641/brigatinib/brand-names",
    "indications": [
      {
        "title": null,
        "information": "ALK is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic Non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to Crizotinib.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Brigatinib is a tyrosine kinase inhibitor with in vitro activity at clinically achievable concentrations against multiple kinases including ALK, ROS1, insulin-like growth factor-1 receptor (IGF-1R), and FLT-3 as well as EGFR deletion and point mutations. Brigatinib inhibited autophosphorylation of ALK and ALK-mediated phosphorylation of the downstream signaling proteins STAT3, AKT, ERK1/2, and S6 in in-vitro and in vivo assays. Brigatinib also inhibited the in vitro proliferation of cell lines expressing EML4-ALK and NPM ALK fusion proteins and demonstrated dose-dependent inhibition of EML4-ALK-positive NSCLC xenograft growth in mice. Brigatinib exposure-response relationships and the time course of the pharmacodynamic response are unknown.",
        "items": []
      },
      {
        "title": "Absorption",
        "information": ": Following administration of single oral doses of Brigatinib of 30 to 240 mg, the median time to peak concentration (Tmax) ranged from 1 to 4 hours.",
        "items": []
      },
      {
        "title": "Distribution",
        "information": ": Brigatinib is 66% bound to human plasma proteins and the binding is not concentration-dependent in vitro. The blood to plasma concentration ratio is 0.69. Following oral administration of Brigatinib 180 mg once daily, the mean apparent volume of distribution (Vz/F) of Brigatinib at steady-state was 153 L.",
        "items": []
      },
      {
        "title": "Elimination",
        "information": ": Following oral administration of Brigatinib 180 mg once daily, the mean apparent oral clearance (CL/F) of Brigatinib at steady-state is 12.7 L/h and the mean plasma elimination half-life is 25 hours.",
        "items": []
      },
      {
        "title": "Metabolism",
        "information": ": Brigatinib is primarily metabolized by CYP2C8 and CYP3A4 in vitro. Following oral administration of a single 180 mg dose of radiolabeled Brigatinib to healthy subjects, N-demethylation and cysteine conjugation were the two major metabolic pathways. Unchanged Brigatinib (92%) and its primary metabolite, AP26123 (3.5%), were the major circulating radioactive components. The steady-state AUC of AP26123 was less than 10% of AUC of Brigatinib exposure in patients. The metabolite, AP26123, inhibited ALK with approximately 3-fold lower potency than Brigatinib in vitro.",
        "items": []
      },
      {
        "title": "Excretion",
        "information": ": Following oral administration of a single 180 mg dose of radiolabeled Brigatinib to healthy subjects, 65% of the administered dose was recovered in feces and 25% of the administered dose was recovered in urine. Unchanged Brigatinib represented 41% and 86% of the total radioactivity in feces and urine, respectively.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Drugs that may Increase ALK Plasma Concentrations",
        "information": ": Strong CYP3A Inhibitors: Coadministration of Itraconazole, a strong CYP3A inhibitor, increased ALK plasma concentrations and may result in increased adverse reactions. Concomitant use of strong CYP3A inhibitors with ALK, including but not limited to certain Antivirals (e.g., Boceprevir, Cobicistat, Indinavir, Lopinavir, Nelfinavir, Ritonavir, Saquinavir), Macrolide antibiotics (e.g., Clarithromycin), Antifungals (e.g., Itraconazole, Ketoconazole, Posaconazole, Voriconazole), and Conivaptan should be avoided. Grapefruit or grapefruit juice should be avoided as it may also increase plasma concentrations of ALK. If concomitant use of a strong CYP3A inhibitor cannot be avoided, the dose of ALK should be reduced by approximately 50%.",
        "items": []
      },
      {
        "title": "Drugs that may Decrease ALK Plasma Concentrations",
        "information": ": Strong CYP3A Inducers: Coadministration of ALK with Rifampin, a strong CYP3A inducer, decreased ALK plasma concentrations and may result in decreased efficacy. Concomitant use of strong CYP3A inducers with ALK should be avoided, including but not limited to Rifampin, Carbamazepine, Phenytoin, and St. John's Wort.",
        "items": []
      },
      {
        "title": "Drugs that may have their Plasma Concentrations altered by ALK",
        "information": ": CYP3A Substrates: ALK induces CYP3A in vitro and may decrease concentrations of CYP3A substrates. Coadministration of ALUNBRIG with CYP3A substrates, including hormonal contraceptives, can result in decreased concentrations and loss of efficacy of CYP3A substrates.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with known hypersensitivity to Brigatinib or any other components of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": null,
        "items": [
          "Interstitial Lung Disease (ILD)/Pneumonitis",
          "Hypertension",
          "Bradycardia",
          "Visual Disturbance",
          "Creatine Phosphokinase (CPK) Elevation",
          "Pancreatic Enzyme Elevation",
          "Hyperglycemia"
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": "Pregnancy",
        "information": ": There are no clinical data on the use of Brigatinib in pregnant women. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, advise the patient of the potential risk to a fetus.",
        "items": []
      },
      {
        "title": "Lactation",
        "information": ": There are no data regarding the secretion of Brigatinib in human milk or its effects on the breastfed infant or milk production. Because of the potential for adverse reactions in breastfed infants, lactating women should be advised not to breastfeed during treatment with Brigatinib and for 1 week following the final dose.",
        "items": []
      },
      {
        "title": "Females Reproductive Potential",
        "information": ": Females of reproductive potential should be advised to use effective non-hormonal contraception during treatment with Brigatinib and for at least 4 months after the final dose. Patients should be counseled to use a non-hormonal method of contraception since Brigatinib can render some hormonal contraceptives ineffective.",
        "items": []
      },
      {
        "title": "Males Reproductive Potential",
        "information": ": Because of the potential for genotoxicity, males with female partners of reproductive potential should be advised to use effective contraception during treatment with Brigatinib and for at least 3 months after the final dose.",
        "items": []
      },
      {
        "title": "Infertility",
        "information": ": Based on findings in male reproductive organs in animals, Brigatinib may cause reduced fertility in males.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Interstitial Lung Disease (ILD)/Pneumonitis",
        "information": ": Severe, life-threatening, and fatal pulmonary adverse reactions consistent with interstitial lung disease (ILD)/pneumonitis have occurred with ALK. It should be withheld in any patient with new or worsening respiratory symptoms, and promptly evaluate for ILD/pneumonitis or other causes of respiratory symptoms (e.g., pulmonary embolism, tumor progression, and infectious pneumonia). ALK should be discontinued permanently for Grade 3 or 4 ILD/pneumonitis or recurrence of Grade 1 or 2 ILD/pneumonitis.",
        "items": []
      },
      {
        "title": "Hypertension",
        "information": ": Hypertension was reported in 11% of patients in the 90 mg group who received ALK and 21% of patients in the 90-180 mg group. Grade 3 hypertension occurred in 5.9% of patients overall. Blood pressure should be controlled prior to treatment with ALK. Blood pressure should be monitored after 2 weeks and at least monthly thereafter during treatment with ALK. It should be withheld for Grade 3 hypertension despite optimal antihypertensive therapy. Permanent discontinuation of treatment should be considered with ALK for Grade 4 hypertension or recurrence of Grade 3 hypertension. Caution should be used when administering ALK in combination with antihypertensive agents that cause bradycardia.",
        "items": []
      },
      {
        "title": "Bradycardia",
        "information": ": Bradycardia can occur with ALK. Heart rate and blood pressure should be monitored during treatment with ALK. Patients should be monitored more frequently if concomitant use of drug known to cause bradycardia cannot be avoided.",
        "items": []
      },
      {
        "title": "Visual Disturbanc",
        "information": "e: Adverse reactions leading to visual disturbance including blurred vision, diplopia, and reduced visual acuity, were reported in 7.3% of patients receiving ALK in the 90 mg group and 10% of patients in the 90-180 mg group. Patients should be advised to report any visual symptoms. ALK should be withheld and obtained an ophthalmologic evaluation in patients with new or worsening visual symptoms of Grade 2 or greater severity. Upon recovery of Grade 2 or Grade 3 visual disturbances to Grade 1 severity or baseline, ALK should be resumed at a reduced dose. Treatment with ALK should be permanently discontinued for Grade 4 visual disturbances.",
        "items": []
      },
      {
        "title": "Creatine Phosphokinase (CPK) Elevation",
        "information": ": Creatine phosphokinase (CPK) elevation occurred in 27% of patients receiving ALK in the 90 mg group and 48% of patients in the 90 mg-180 mg group. Patients should be advised to report any unexplained muscle pain, tenderness, or weakness. CPK levels should be monitored during ALK treatment. ALK should be withheld for Grade 3 or 4 CPK elevation.",
        "items": []
      },
      {
        "title": "Pancreatic Enzyme Elevation",
        "information": ": Amylase elevation occurred in 27% of patients in the 90 mg group and 39% of patients in the 90→180 mg group. Lipase elevations occurred in 21% of patients in the 90 mg group and 45% of patients in the 90→180 mg group. Lipase and amylase should be monitored during treatment with ALK. ALK should be withheld for Grade 3 or 4 pancreatic enzyme elevation.",
        "items": []
      },
      {
        "title": "Hyperglycemia",
        "information": ": 43% of patients who received ALK experienced new or worsening hyperglycemia. Grade 3 hyperglycemia, based on laboratory assessment of serum fasting glucose levels, occurred in 3.7% of patients. Two of 20 (10%) patients with diabetes ALK or glucose intolerance at baseline required initiation of insulin while receiving ALK. Fasting serum glucose should be assessed prior to initiation of ALK and monitored periodically thereafter. Antihyperglycemic medications should be initiated or optimized as needed. If adequate hyperglycemic control cannot be achieved with optimal medical management, ALK should be withheld until adequate hyperglycemic control is achieved and considered reducing the dose of ALK.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cytotoxic Chemotherapy",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended dosing regimen for Brigatinib is: Brigatinib should be administered until disease progression or unacceptable toxicity. If Brigatinib is interrupted for 14 days or longer for reasons other than adverse reactions, treatment should be resumed at 90 mg once daily for 7 days before increasing to the previously tolerated dose. Brigatinib may be taken with or without food. Patients should be instructed to swallow tablets whole. Tablets should not be crushed or chewed. If a dose of Brigatinib is missed or vomiting occurs after taking a dose, an additional dose should not be administered and take the next dose of Brigatinib should be taken at the scheduled time. Pediatric Use: The safety and efficacy of Brigatinib in pediatric patients have not been established.",
        "instructions": [
          "90 mg orally once daily for the first 7 days;",
          "If 90 mg is tolerated during the first 7 days, the dose should be increased to 180 mg orally once daily."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:45.451Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e1b",
    "original_record": {
      "input_index": 877,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e1b"
        },
        "name": "ALK",
        "strength": "90 mg",
        "generic": "Brigatinib",
        "company": "Jenphar Bangladesh Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/33515/alk-90-mg-tablet",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34532/alkalina-600-mg-tablet",
    "name": "Alkalina",
    "dosage_form": "Tablet",
    "generic": "Sodium Bicarbonate",
    "strength": "600 mg",
    "company": "Radiant Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 7.00",
      "strip_price": "৳ 70.00",
      "pack_size_info": "(6 x 10: ৳ 420.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 7.00",
          "pack_size_info": "(6 x 10: ৳ 420.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 70.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/992/sodium-bicarbonate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alkalina is indicated in- 1. Management of acidosis in cardiac arrest. 2. Alkalinization of urine. 3. Management of metabolic acidosis in:",
        "items": [
          "Severe renal disease",
          "Uncontrolled diabetes",
          "Circulatory insufficiency from shock or dehydration",
          "Severe primary lactic acidosis"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Sodium bicarbonate is a systemic alkalizer, which increases plasma bicarbonate, buffers excess hydrogen ion concentration, and raises blood pH, thereby reversing the clinical manifestations of acidosis. It is also a urinary alkalizer, increasing the excretion of free bicarbonate ions in the urine, thus effectively raising the urinary pH. It also replenishes electrolyte imbalance in severe diarrhea where the loss of bicarbonate can be significant.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Some drugs that may interact with Alkalina are",
        "information": ": Aspirin and other salicylates, memantine, medications with enteric coating. Potentially hazardous interactions with Corticosteroids and Corticotropin, Alkalis, Calcium, Diuretics and Potassium. It can decrease the effectiveness of certain drugs including Ampicillin, Atazanavir, Ketoconazole, Itraconazole, Iron supplements, Sucralfate etc.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This drug is contraindicated in hypersensitivity hypoventilatory states, excessive chloride depletion owing to continuous gastric fluid loss from vomiting or GI suctioning, metabolic and/or respiratory alkalosis, hypocalcemia and diuretics known to produce hypochloremic alkalosis.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Common side effects: Notify your doctor you develop any of the following effects:",
        "items": [
          "Headache",
          "Nausea",
          "Irritability",
          "Muscle weakness",
          "Slow reflexes",
          "Confusion",
          "Swelling of the feet or ankles",
          "Black tar-like stools",
          "Coffee-ground vomit"
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Pregnant women: Based on animal data showing adverse renal effects, it is not recommended during the second and third trimesters of pregnancy. It may worsen high blood pressure. This medication may pass into breast milk.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be taken for patients with pre-existing heart disease, kidney disease, liver disease, high blood pressure, any allergies because this medication contains salt (sodium), do not use it if you are on a salt restricted diet.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "If alkalosis results, the bicarbonate should be stopped and the patient managed according to the degree of alkalosis present. 0.9% sodium chloride injection intravenous may be given; potassium chloride also may be indicated if there is hypokalemia. Severe alkalosis may be accompanied by hyperirritability or tetany and these symptoms may be controlled by calcium gluconate. An acidifying agent such as ammonium chloride may also be indication in severe alkalosis",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Do not store above 30°C, protect from light & moisture. Keep the medicine out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Intravenous fluid preparations, Urinary Alkalinizing Agent",
    "dosage": [
      {
        "medication_type": "Oral",
        "information": ": The usual dose is 300 mg to 2 grams, 1 to 4 times daily.",
        "instructions": []
      },
      {
        "medication_type": "Intravenous",
        "information": "(Severe metabolic acidosis):",
        "instructions": [
          "Adult: By slow inj of a hypertonic solution of up to 8.4% (1000 mmol/L), or by continuous infusion of a weaker solution, usually 1.26% (150 mmol/L). For correction of acidosis during advanced cardiac life support procedures, 50 ml of an 8.4% solution may be given.",
          "Elderly: Dosage adjustments may be required."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:46.835Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e1c",
    "original_record": {
      "input_index": 878,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e1c"
        },
        "name": "Alkalina",
        "strength": "600 mg",
        "generic": "Sodium Bicarbonate",
        "company": "Radiant Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/34532/alkalina-600-mg-tablet",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/22335/alkazol-200-mg-suspension",
    "name": "Alkazol",
    "dosage_form": "Oral Suspension",
    "generic": "Metronidazole",
    "strength": "200 mg/5 ml",
    "company": "Alkad Laboratories",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 24.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 24.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/751/metronidazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alkazol is indicated in the treatment of following diseases: Alkazol is indicated in the treatment of following diseases:",
        "items": [
          "The prevention of post-operative infections due to anaerobic bacteria (particularly species of bacteroides and anaerobic streptococci).",
          "The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, pelvic abscess, pelvic cellulitis and post-operative wound infections caused by anaerobes.",
          "The prevention of post-operative infections due to anaerobic bacteria (particularly species of bacteroides and anaerobic streptococci).",
          "The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, pelvic abscess, pelvic cellulitis and post-operative wound infections caused by anaerobes.",
          "In the treatment of urogenital trichomoniasis.",
          "Bacterial vaginosis (also known as non-specific vaginitis).",
          "All forms of amoebiasis (intestinal, extra-intestinal disease and that of symptomless cyst passers).",
          "Giardiasis.",
          "Acute ulcerative gingivitis.",
          "Anaerobically infected leg ulcers and pressure sores.",
          "Acute dental infections due to anaerobic organisms.",
          "Antibiotic associated pseudomembranus colitis."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Metronidazole is a member of the imidazole class of antibacterial drug and is classified therapeutically as an antiprotozoal agent. The 5-nitro group of Metronidazole is reduced by anaerobes metabolically. Studies have demonstrated that the reduced form of this drug interacts with DNA and gives bactericidal action of Metronidazole.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": null,
        "items": [
          "Disulfiram: Psychotic reactions have been reported in patients who were using Alkazol and disulfiram concurrently.",
          "Alcohol: Alcoholic beverages and drugs containing alcohol should not be consumed during therapy and for at least one day afterwards because of the possibility of a disulfiram-like (antabuse effect) reaction (flushing, vomiting, tachycardia). Oral anticoagulant therapy (warfarin type): Potentiation of the anticoagulant effect and increased hemorrhagic risk caused by decreased hepatic catabolism. In case of co-administration, prothrombin time should be more frequently monitored and anticoagulant therapy adjusted during treatment with Alkazol.",
          "Lithium: Plasma levels of lithium may be increased by Alkazol.",
          "Cyclosporin: Serum cyclosporin and serum creatinine should be closely monitored when co-administration is necessary.",
          "Phenytoin or phenobarbital: increased elimination of Alkazol resulting in reduced plasma levels.",
          "5-Fluorouracil: Reduced clearance of 5-fluorouracil resulting in increased toxicity of 5-fluorouracil.",
          "Busulfan: Plasma levels of busulfan may be increased by Alkazol, which may lead to severe busulfan toxicity."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Metronidazole is contraindicated in patients with a history of hypersensitivity to Metronidazole or other Nitroimidazole derivatives.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Metallic taste, nausea, vomiting, diarrhoea, drowsiness, rashes may be observed during treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Metronidazole is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Metronidazole have been shown to be excreted in human milk. So, caution should be exercised when Metronidazole is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "If for compelling reasons, Alkazol must be administered longer than the usually recommended duration, it is recommended that hematological tests, especially leucocyte count should be carried out regularly and that patients should be monitored for adverse reactions such as peripheral or central neuropathy (such as paresthesia, ataxia, dizziness, convulsive seizures).",
          "Alkazol should be administered with caution to patients with hepatic encephalopathy.",
          "Patients should be warned that Alkazol may darken urine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic impairment",
        "information": ": Alkazol is mainly metabolised by hepatic oxidation. Substantial impairment of Alkazol clearance may occur in the presence of advanced hepatic insufficiency. Significant cumulation may occur in patients with hepatic encephalopathy and the resulting high plasma concentrations of Alkazol may contribute to the symptoms of the encephalopathy. Alkazol should therefore, be administered with caution to patients with hepatic encephalopathy. The daily dosage should be reduced to one third and may be administered once daily. Patients should be warned that Alkazol may darken urine.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": The elimination half-life of Alkazol remains unchanged in the presence of renal failure. The dosage of Alkazol therefore needs no reduction. Such patients however retain the metabolites of Alkazol. The clinical significance of this is not known at present. In patients undergoing haemodialysis Alkazol and metabolites are efficiently removed during an eight hour period of dialysis. Alkazol should therefore be re-administered immediately after haemodialysis. No routine adjustment in the dosage of Alkazol need be made in patients with renal failure undergoing intermittent peritoneal dialysis (IDP) or continuous ambulatory peritoneal dialysis (CAPD).",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Single oral doses of Alkazol, up to 12 g have been reported in suicide attempts and accidental overdoses. Symptoms were limited to vomiting, ataxia and slight disorientation. There is no specific antidote for Alkazol overdosages. In case of suspected massive overdosages, a symptomatic and supportive treatment should be instituted.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C. Keep protected from light. Keep medicines out of the reach of children. Do not use later than the date of expiry.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Amoebicides, Anti-diarrhoeal Antiprotozoal",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet and Suspension: Trichomoniasis (Adults & Children over 10 yrs)- Trichomoniasis (Children)- Intestinal amoebiasis (Adults & Children over 10 yrs)- Intestinal amoebiasis (Children)- Extra-intestinal & Asymptomatic amoebiasis (Adults & Children over 10 yrs)- Extra-intestinal & Asymptomatic amoebiasis (Children)- Giardiasis (Adults & Children over 10 yrs)- Giardiasis (Children)- Acute ulcerative gingivitis (Adults & Children over 10 yrs)- Acute ulcerative gingivitis (Children)- Acute dental infections (Adults & Children over 10 yrs)- Bacterial Vaginosis (Adults & Children over 10 yrs)- Leg ulcers and pressure sores (Adults & Children over 10 yrs)- Anaerobic infections (Adults & Children over 10 yrs)- Anaerobic infections (Children)- Surgical prophylaxis (Adults & Children over 10 yrs)- Surgical prophylaxis (Children)- Vaginal Gel: The recommended dose is one applicator full of Metronidazole gel (approximately 5 grams containing approximately 37.5 mg of Metronidazole) intravaginally once or twice a day for 5 days. For once a day dosing, Metronidazole gel should be administered at bedtime. Suppository: Anaerobic Infections-",
        "instructions": [
          "200 mg tid or 400 mg bid for 7 days",
          "800 mg in the morning and 1-2 gm at night for 2 days",
          "2 gm as a single dose for 1 days",
          "Children 7-10 yrs: 100 mg tid",
          "Children 3-7 yrs: 100 mg bid",
          "Children 1-3 yrs: 50 mg tid",
          "800 mg tid for 5 days",
          "Children 7-10 yrs: 400 mg tid",
          "Children 3-7 yrs: 200 mg qid",
          "Children 1-3 yrs: 200 mg tid",
          "400-800 mg tid for 5-10 days",
          "Children 7-10 yrs: 200-400 mg tid",
          "Children 3-7 yrs: 100-200 mg qid",
          "Children 1-3 yrs: 100-200 mg tid",
          "2 gm once daily for 3 days",
          "Children 7-10 yrs: 1 gm once daily",
          "Children 3-7 yrs: 600-800 mg once daily",
          "Children 1-3 yrs: 500 mg once daily",
          "200 mg tid for 3 days",
          "Children 7-10 yrs: 100 mg tid",
          "Children 3-7 yrs: 100 mg bid",
          "Children 1-3 yrs: 50 mg tid",
          "200 mg tid for 3-7 days",
          "400 mg bid for 7 days",
          "2 gm as a single dose for 1 days",
          "400 mg tid for 7 days",
          "800 mg initially and then 400 mg tid for 7 days",
          "Children 1-10 yrs: 7.5 mg/kg tid",
          "400 mg tid started 24 hours before surgery for 1 days",
          "Children 1-10 yrs: 7.5 mg/kg tid"
        ]
      },
      {
        "medication_type": "Adults",
        "information": ": 1 g every 8 hours for 3 days, then 1 g every 12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 5-10 years: 500 mg every 8 hours for 3 days, then every 12 hours, Over 10 years adult dose.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Surgical Prophylaxis-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": 1 g 2 hours before surgery; up to 3 further doses of 1 g may be given every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 5-10 years: 500 mg 2 hours before surgery; up to 3 further doses of 500 mg may be given every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "IV Infusion: Metronidazole intravenous infusion requires no dilution and should not be mixed with any other drugs prior to administration.",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 12 years",
        "information": ": Infuse 500 mg 8 hourly at a rate of 5 ml/minute and a maximum of 4 g should not be exceeded during a 24-hour period. Treatment for 7 days is sufficient for most patients, but treatment can be extended, especially for cases where reinfection is likely. For surgical prophylaxis, administration shortly before surgery should be followed by 8-hourly doses for the next 24 hours.",
        "instructions": []
      },
      {
        "medication_type": "Children under 12 years",
        "information": ": 7.5 mg/kg body weight/day every 8 hours at a rate of 5 ml/minute.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Alkazol 200 mg/5 ml Suspension?",
        "answer": [
          "Alkazol 200 mg/5 ml Suspension is an antibiotic medication that performs its action by preventing the growth of bacterias and parasites."
        ]
      },
      {
        "question": "What are the uses of Alkazol 200 mg/5 ml Suspension?",
        "answer": [
          "Alkazol 200 mg/5 ml Suspension is used for the treatment and prevention from viral and parasitic infections. It also prevents bacterial infections such as cold, cough, flu and vaginal infections. It also controls liver, skin, joints, brain and respiratory tract infections."
        ]
      },
      {
        "question": "What are the side effects of Alkazol 200 mg/5 ml Suspension?",
        "answer": [
          "Some side effects of Alkazol 200 mg/5 ml Suspension which are diarrhoea, headache, weakness, painful urination, trouble sleeping, numbness, muscle weakness and mouth ulcer."
        ]
      },
      {
        "question": "How long do I need to use Alkazol 200 mg/5 ml Suspension before I see improvement of my conditions?",
        "answer": [
          "Alkazol 200 mg/5 ml Suspension takes 1 or 2 days before you see an improvement in your health conditions."
        ]
      },
      {
        "question": "What are the contraindications to Alkazol 200 mg/5 ml Suspension?",
        "answer": [
          "Alkazol 200 mg/5 ml Suspension should not be used if you have the following conditions such as hives, flushing, nasal congestion, dryness of the mouth, fever, etc."
        ]
      },
      {
        "question": "Is Alkazol 200 mg/5 ml Suspension safe to use when pregnant?",
        "answer": [
          "Alkazol 200 mg/5 ml Suspension is not recommended for use in pregnant women unless absolutely necessary."
        ]
      },
      {
        "question": "Will Alkazol 200 mg/5 ml Suspension be more effective if taken in more than the recommended dose?",
        "answer": [
          "No, taking higher than the recommended dose of Alkazol 200 mg/5 ml Suspension lead to increased chances of side effects such as diarrhoea, excessive production of urine, headache, nausea, pain in the upper part of the stomach, painful and difficult urination, serious eating disorder (anorexia), etc."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alkazol 200 mg/5 ml Suspension treats infections caused by bacteria and parasites.",
          "Alkazol 200 mg/5 ml Suspension may cause side effects like nausea, stomach upset, and a metallic taste in the mouth.",
          "Alkazol 200 mg/5 ml Suspension used in a high dose or for a prolonged time increases the risk of side effects such as nerve damage. Take it only as prescribed by your doctor.",
          "Do not drink alcohol during or for 2-3 days after treatment with this medicine. You may develop nausea, vomiting, flushing and headache.",
          "Inform your doctor if you have liver disease. Your dose may need to be adjusted in severe liver disease."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:27:47.924Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e24",
    "original_record": {
      "input_index": 879,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e24"
        },
        "name": "Alkazol",
        "strength": "200 mg/5 ml",
        "generic": "Metronidazole",
        "company": "Alkad Laboratories",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/22335/alkazol-200-mg-suspension",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/23724/alkurin-1500-mg-oral-solution",
    "name": "Alkurin",
    "dosage_form": "Oral Solution",
    "generic": "Potassium Citrate + Citric Acid",
    "strength": "(1500 mg+250 mg)/5 ml",
    "company": "Ibn Sina Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 200.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "200 ml bottle",
          "price": "৳ 200.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/270/potassium-citrate-citric-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alkurin oral solution is indicated in the following cases:",
        "items": [
          "To relieve discomfort in urinary tract infections",
          "To prevent kidney stone",
          "With uricosuric agent to prevent gout",
          "Acidosis caused by kidney diseases"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Potassium Citrate is absorbed and metabolized to potassium bicarbonate, this acting as a systemic alkalizer. The effects are essentially those of chlorides before absorption and those of bicarbonates subsequently. Oxidation is virtually complete so that less than 5% of the potassium citrate is excreted in the urine unchanged.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concurrent administration of potassium-containing medication, potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors or cardiac glycosides may lead to toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "The drug is contraindicated in severe renal impairment with oliguria or azotemia, untreated Addison's disease, acute dehydration, severe myocardial damage and hyperkalemia from any cause.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "This solution is generally well tolerated without any unpleasant side effect when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of hyperkalemia or alkalosis. Potassium intoxication causes listlessness, weakness, mental confusion, tingling of extremities and other symptoms associated with a high concentration of Potassium in the serum.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Potassium Citrate oral solution in pregnant women. Animal studies are insufficient with respect to effects on pregnancy. The potential risk to humans is unknown. Potassium Citrate oral solution should not be used during pregnancy unless clearly necessary and on the advice of a physician.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "The solution should be used with caution in patients with low urinary output. It should be diluted adequately with water to minimize the possibility of gastrointestinal injury associated with the oral ingestion of concentrated Potassium salt preparations; and preferably, to take each dose after meals. Large doses may cause hyperkalemia and alkalosis, especially in the presence of renal disease. Large doses may cause hyperkalemia an alkalosis, especially in the presence of renal disease. Concurrent administration of potassium-containing medication, potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, or cardiac glycosides may lead to toxicity. Do not exceed recommended dosage. Discontinue use if adverse reaction occurs. Should be used with caution by patients with low urinary output unless under the supervision of a physician. As with all liquids containing a high concentration of potassium, patients should be directed to dilute adequately with water to minimize the possibility of gastrointestinal injury associated with the oral ingestion of concentrated potassium salt preparations; and preferable, to take each dose after meals to avoid saline laxative effect.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "The administration of oral Potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious hyperkalemia. However, if excretory mechanisms are impaired, hyperkalemia can result. Hyperkalemia, when detected, must be treated immediately because lethal levels can be reached in a few hours. If hyperkalemia occurs, treatment measures will include the followings: (1) Elimination of foods or medications containing potassium. (2) The intravenous administration of 300 to 500 ml/hr of dextrose solution (10 to 25%), containing 10 units of insulin/20 gm dextrose. (3) The use of exchange resins, hemodialysis or peritoneal dialysis.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Oral Solution is an effective alkalinizing agent useful in those conditions where long-term maintenance of alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be preferable. Alkurin is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. Alkurin alkalinizes the urine without producing a systemic alkalosis in recommended dosage. It is highly palatable, pleasant tasting and tolerable, even when administered for long periods. Potassium Citrate does not neutralize the gastric juice or disturb digestion.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Prevention of repeated kidney stone formation, Urinary Alkalinizing Agent",
    "dosage": [
      {
        "medication_type": null,
        "information": "Oral Solution should be taken diluted in water according to directions, followed by additional water, if desired. Palatability is enhanced if chilled before taking. Proper dilution may help prevent gastrointestinal injury associated with the oral ingestion of concentrated potassium salt preparations. To relieve discomfort in UTI:",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 6 years",
        "information": ": 10 ml 3 times daily, diluted with 1 glass of water.",
        "instructions": []
      },
      {
        "medication_type": "Children 1-6 years",
        "information": ": 5 ml 3 times daily, diluted with ½ glass of water.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "To prevent kidney stones, With a uricosuric agent to prevent gout, Acidosis caused by kidney diseases:",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": 10-15 ml 4 times daily (or as directed by the physician) diluted with 1 glass of water.",
        "instructions": []
      },
      {
        "medication_type": "Pediatric",
        "information": ": 5-10 ml 4 times daily (or as directed by the physician) diluted with ½ glass of water.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:49.211Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e29",
    "original_record": {
      "input_index": 880,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e29"
        },
        "name": "Alkurin",
        "strength": "(1500 mg+250 mg)/5 ml",
        "generic": "Potassium Citrate + Citric Acid",
        "company": "Ibn Sina Pharmaceuticals Ltd.",
        "medicine_type": "Oral Solution",
        "source_url": "https://medex.com.bd/brands/23724/alkurin-1500-mg-oral-solution",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/14187/allbeevit-m-tablet",
    "name": "Allbeevit-M",
    "dosage_form": "Tablet",
    "generic": "Multivitamin & Multimineral",
    "strength": null,
    "company": "Medimet Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 1.50",
      "strip_price": null,
      "pack_size_info": "(24's pack: ৳ 36.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 1.50",
          "pack_size_info": "(24's pack: ৳ 36.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/777/multivitamin-multimineral/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allbeevit-M is indicated for the treatment and/or prevention of vitamin and mineral deficiencies associated with restricted diets, improper food intake, alcoholism and decreased absorption. It is also indicated in patients with increased requirements for vitamins and minerals due to acute and chronic ... Read moreAllbeevit-M is indicated for the treatment and/or prevention of vitamin and mineral deficiencies associated with restricted diets, improper food intake, alcoholism and decreased absorption. It is also indicated in patients with increased requirements for vitamins and minerals due to acute and chronic diseases, pregnancy, lactation, menopause, infections, during treatment with antibiotics, convalescence etc. To prevent the occurrence of serious birth defects periconceptional (from three months before conception up to the first trimester of pregnancy) supplementation with this tablet is required.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Vitamins and minerals are essential for normal metabolic functions including hematopoiesis. The members of vitamin B-group are components of enzyme system that regulate various stages of carbohydrate, fat and protein metabolism, each of the components playing a specific biological role. Vitamin C is involved in tissue repair and collagen formation. Vitamin A plays an essential role in the function of retina and is essential for growth and differentiation of epithelial tissue. Vitamin E is an antioxidant which preserves essential cellular constituents. Vitamin D is supplemented for prevention and cure of nutritional and metabolic rickets and for treatment of hypoparathyroidism. Iron, Copper, Manganese, Zinc serve as catalysts in enzyme systems which perform vital cellular functions.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "This is contraindicated in patients hypersensitive to any of its components. This is not intended for treatment of severe specific deficiencies of vitamins or minerals. It is not recommended for patients undergoing treatment with levodopa as pyridoxine decreases the efficacy of levodopa. During the first trimester of pregnancy, larger doses of vitamin A (more than 10 tablets per day) may be teratogenic.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects have been reported with specific vitamins & minerals, but at level substantially higher than those in this tablet. Iron has been associated with gastrointestinal intolerance in some patients.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "During the first trimester of pregnancy, recommended daily dose should not be exceeded. Because larger doses of Vitamin-A (multiple tablets per day) may be teratogenic.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Not intended for treatment of pernicious anemia or other megaloblastic anemia where vitamin B12 is deficient.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Multi-vitamin & Multi-mineral combined preparations, Specific mineral & vitamin combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Orally one tablet daily for adult and children over 5 years of age or as directed by the physicians.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:50.907Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e2f",
    "original_record": {
      "input_index": 881,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e2f"
        },
        "name": "Allbeevit-M",
        "strength": null,
        "generic": "Multivitamin & Multimineral",
        "company": "Medimet Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/14187/allbeevit-m-tablet",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/15978/alleloc-01-eye-drop",
    "name": "Alleloc",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Olopatadine Hydrochloride",
    "strength": "0.1%",
    "company": "Navana Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 100.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "0.2% (Eye Drop)",
        "href": "https://medex.com.bd/brands/15999/alleloc-ds-02-eye-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/823/olopatadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Patadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.... Read morePatadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.Alleloc Nasal Spray is an H1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older.Alleloc tablet is indicated in the treatment of allergic rhinitis (swelling of the nasal membranescaused by an allergy to pollen and mold spores in the air) and allergic skin conditions. It helps to relieve allergy symptoms such as skin rashes, swelling, hives (itchy, painful eruptions that sting), itching, sneezing, runny or stuffy nose.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Olopatadine, an antihistamine, works by blocking the action of histamine in the body, which reduces allergy symptoms. Olopatadine hydrochloride treats sneezing, itching, runny nose, and other nasal symptoms of allergies.",
        "items": []
      },
      {
        "title": "Mode of Action",
        "information": ": Olopatadine is an anti-allergic molecule that works via several mechanisms. As a mast cell stabilizer, it stabilizes rodent basophils and human conjunctival mast cells and inhibits the immunologically-stimulated release of histamine. Olopatadine acts as an antagonist at the histamine H1 receptors with high selectivity, Upon binding, olopatadine blocks the H1 receptor signaling pathway, inhibiting the release of inflammatory mediators, such as tryptase, prostaglandin D2, TNF-alpha, as well as pro-inflammatory cytokines.",
        "items": []
      },
      {
        "title": "Pharmacokinetics",
        "information": ": Absorption: Olopatadine was absorbed with individual peak plasma concentrations observed between 30 minutes and 1 hour after twice daily intranasal administration of Olopatadine Nasal Spray. Distribution: The protein binding of olopatadine was moderate at approximately 55% in human serum, and independent of drug concentration over the range of 0.1 to 1000 ng/mL. Metabolism: Olopatadine is not extensively metabolized. Based on plasma metabolite profiles of olopatadine, at least six minor metabolites circulate in human plasma. Elimination: The plasma elimination half-life of olopatadine is 8 to 12 hours. Olopatadine is mainly eliminated through urinary excretion",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Formal drug-drug interaction studies were not conducted for Alleloc Nasal Spray. Drug interactions with inhibitors of liver enzymes are not anticipated because olopatadine is eliminated predominantly by renal excretion. Drug interactions involving P450 inhibition and plasma protein binding are also not expected.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in persons with a known hypersensitivity to any component of this product. Olopatadine 5 mg tablet is not recommended for use if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions to make sure this medicine is safe for you.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rarely headaches have been reported. Other adverse effects: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Olopatadine was found not to be teratogenic in rats and rabbits. There are, however, no adequate and well controlled studies in pregnant women. This drug should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Olopatadine is administered to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients should be advised not to wear a contact lens if their eye is red. Alleloc ophthalmic solution should not be used to treat contact lens related irritation. Benzalkonium Chloride, preservative of Patadin, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least 10 minutes after instillation of Patadin eye drops before they insert their contact lenses. The treatment should be discontinued in the presence of an allergic reaction. Before initial use, Alleloc Nasal Spray by releasing 5 sprays or until a fine mist appears. When Alleloc Nasal Spray has not been used for more than 7 days, re-prime by releasing 2 sprays. Avoid spraying Alleloc Nasal Spray into the eyes. Patients should be informed to avoid spraying Alleloc Nasal Spray in their eyes. Olonex Tablet should be used as prescribed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid taking more than the recommended dose. Do not stop taking this medicine without consulting your doctor, as your symptoms may reoccur.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety or effectiveness have been observed betweents.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no information on Alleloc overdose. However, excessive use of any medication can have serious consequences. If you suspect an overdose, seek medical attention without delay.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at room temperature and protect from light. It is desirable that the contents should not be used more than one month after first opening of the bottle.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "How to use the Nasal Spray- Cleaning: The nasal spray should be cleaned at least once a week. The procedures are as follows-",
        "items": [
          "Shake the bottle gently and remove the dust cover.",
          "Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath the bottle. Press down until a fine spray appears. If using for the first time or if you have not used it for a week or more, press the nasal applicator several times until a fine moist comes out from the container.",
          "Gently blow the nose to clear the nostrils.",
          "Close one nostril and carefully insert the nasal applicator into the open nostril. Tilt your head forward slightly and keep the spray upright. Breathe in through your nose and while breathing in, press the white-collar of nasal applicator firmly down once to release a spray.",
          "Breathe out through your mouth.",
          "Repeat the above steps in the same/ other nostril for consecutive doses.",
          "Remove the dust cover.",
          "Gently pull off the nasal applicator.",
          "Wash the applicator and dust cover in warm water.",
          "Shake off the excess water and leave to dry in a normal place. Avoid to apply additional heat.",
          "Gently push the applicator back on the top of the bottle and re-fix the dust cover."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ophthalmic Non-Steroid drugs",
    "dosage": [
      {
        "medication_type": "Eye Drops",
        "information": "-",
        "instructions": [
          "0.1%: One drop in each affected eye two times per day at an interval of 6 to 8 hours.",
          "0.2%: One drop in the affected eye once a day.",
          "0.7%: One drop in each affected eye once a day."
        ]
      },
      {
        "medication_type": "Nasal Spray",
        "information": "-",
        "instructions": [
          "Administer Olopatadine Nasal Spray by the intranasal route only.",
          "Adults and Adolescents 12 years of age and older: Two sprays per nostril twice daily.\\",
          "Children 6 to 11 years of age: One spray per nostril twice daily."
        ]
      },
      {
        "medication_type": "Tablet",
        "information": "-",
        "instructions": [
          "Adults: Take 1 tablet (5 mg of the active ingredient) at a time, twice daily, in the morning and before going to bed. The dosage may be adjusted according to the disease, age or symptoms.",
          "Children 7 years old or over: Take 1 tablet (5 mg) at a time, twice daily, in the morning and before going to bed.",
          "If you miss a dose, take a dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time. Do not stop taking this medicine unless your doctor instructs you to do so."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:52.025Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e30",
    "original_record": {
      "input_index": 882,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e30"
        },
        "name": "Alleloc",
        "strength": "0.1%",
        "generic": "Olopatadine Hydrochloride",
        "company": "Navana Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/15978/alleloc-01-eye-drop",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12017/allercet-10-mg-tablet",
    "name": "Allercet",
    "dosage_form": "Tablet",
    "generic": "Cetirizine Hydrochloride",
    "strength": "10 mg",
    "company": "Marksman Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.50",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.50",
          "pack_size_info": "(100's pack: ৳ 250.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/12018/allercet-5-mg-syrup?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allercet is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Allercet is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Allercet is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Allercet has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Allercet is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:53.395Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e32",
    "original_record": {
      "input_index": 883,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e32"
        },
        "name": "Allercet",
        "strength": "10 mg",
        "generic": "Cetirizine Hydrochloride",
        "company": "Marksman Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/12017/allercet-10-mg-tablet",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34618/allet-max-07-eye-drop",
    "name": "Allet Max",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Olopatadine Hydrochloride",
    "strength": "0.7%",
    "company": "Healthcare Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 250.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 250.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.1% (Eye Drop)",
        "href": "https://medex.com.bd/brands/15995/allet-01-eye-drop?ref=1"
      },
      {
        "text": "0.2% (Eye Drop)",
        "href": "https://medex.com.bd/brands/16000/allet-ds-02-eye-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/823/olopatadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Patadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.... Read morePatadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.Allet Max Nasal Spray is an H1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older.Allet Max tablet is indicated in the treatment of allergic rhinitis (swelling of the nasal membranescaused by an allergy to pollen and mold spores in the air) and allergic skin conditions. It helps to relieve allergy symptoms such as skin rashes, swelling, hives (itchy, painful eruptions that sting), itching, sneezing, runny or stuffy nose.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Olopatadine, an antihistamine, works by blocking the action of histamine in the body, which reduces allergy symptoms. Olopatadine hydrochloride treats sneezing, itching, runny nose, and other nasal symptoms of allergies.",
        "items": []
      },
      {
        "title": "Mode of Action",
        "information": ": Olopatadine is an anti-allergic molecule that works via several mechanisms. As a mast cell stabilizer, it stabilizes rodent basophils and human conjunctival mast cells and inhibits the immunologically-stimulated release of histamine. Olopatadine acts as an antagonist at the histamine H1 receptors with high selectivity, Upon binding, olopatadine blocks the H1 receptor signaling pathway, inhibiting the release of inflammatory mediators, such as tryptase, prostaglandin D2, TNF-alpha, as well as pro-inflammatory cytokines.",
        "items": []
      },
      {
        "title": "Pharmacokinetics",
        "information": ": Absorption: Olopatadine was absorbed with individual peak plasma concentrations observed between 30 minutes and 1 hour after twice daily intranasal administration of Olopatadine Nasal Spray. Distribution: The protein binding of olopatadine was moderate at approximately 55% in human serum, and independent of drug concentration over the range of 0.1 to 1000 ng/mL. Metabolism: Olopatadine is not extensively metabolized. Based on plasma metabolite profiles of olopatadine, at least six minor metabolites circulate in human plasma. Elimination: The plasma elimination half-life of olopatadine is 8 to 12 hours. Olopatadine is mainly eliminated through urinary excretion",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Formal drug-drug interaction studies were not conducted for Allet Max Nasal Spray. Drug interactions with inhibitors of liver enzymes are not anticipated because olopatadine is eliminated predominantly by renal excretion. Drug interactions involving P450 inhibition and plasma protein binding are also not expected.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in persons with a known hypersensitivity to any component of this product. Olopatadine 5 mg tablet is not recommended for use if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions to make sure this medicine is safe for you.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rarely headaches have been reported. Other adverse effects: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Olopatadine was found not to be teratogenic in rats and rabbits. There are, however, no adequate and well controlled studies in pregnant women. This drug should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Olopatadine is administered to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients should be advised not to wear a contact lens if their eye is red. Allet Max ophthalmic solution should not be used to treat contact lens related irritation. Benzalkonium Chloride, preservative of Patadin, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least 10 minutes after instillation of Patadin eye drops before they insert their contact lenses. The treatment should be discontinued in the presence of an allergic reaction. Before initial use, Allet Max Nasal Spray by releasing 5 sprays or until a fine mist appears. When Allet Max Nasal Spray has not been used for more than 7 days, re-prime by releasing 2 sprays. Avoid spraying Allet Max Nasal Spray into the eyes. Patients should be informed to avoid spraying Allet Max Nasal Spray in their eyes. Olonex Tablet should be used as prescribed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid taking more than the recommended dose. Do not stop taking this medicine without consulting your doctor, as your symptoms may reoccur.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety or effectiveness have been observed betweents.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no information on Allet Max overdose. However, excessive use of any medication can have serious consequences. If you suspect an overdose, seek medical attention without delay.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at room temperature and protect from light. It is desirable that the contents should not be used more than one month after first opening of the bottle.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "How to use the Nasal Spray- Cleaning: The nasal spray should be cleaned at least once a week. The procedures are as follows-",
        "items": [
          "Shake the bottle gently and remove the dust cover.",
          "Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath the bottle. Press down until a fine spray appears. If using for the first time or if you have not used it for a week or more, press the nasal applicator several times until a fine moist comes out from the container.",
          "Gently blow the nose to clear the nostrils.",
          "Close one nostril and carefully insert the nasal applicator into the open nostril. Tilt your head forward slightly and keep the spray upright. Breathe in through your nose and while breathing in, press the white-collar of nasal applicator firmly down once to release a spray.",
          "Breathe out through your mouth.",
          "Repeat the above steps in the same/ other nostril for consecutive doses.",
          "Remove the dust cover.",
          "Gently pull off the nasal applicator.",
          "Wash the applicator and dust cover in warm water.",
          "Shake off the excess water and leave to dry in a normal place. Avoid to apply additional heat.",
          "Gently push the applicator back on the top of the bottle and re-fix the dust cover."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ophthalmic Non-Steroid drugs",
    "dosage": [
      {
        "medication_type": "Eye Drops",
        "information": "-",
        "instructions": [
          "0.1%: One drop in each affected eye two times per day at an interval of 6 to 8 hours.",
          "0.2%: One drop in the affected eye once a day.",
          "0.7%: One drop in each affected eye once a day."
        ]
      },
      {
        "medication_type": "Nasal Spray",
        "information": "-",
        "instructions": [
          "Administer Olopatadine Nasal Spray by the intranasal route only.",
          "Adults and Adolescents 12 years of age and older: Two sprays per nostril twice daily.\\",
          "Children 6 to 11 years of age: One spray per nostril twice daily."
        ]
      },
      {
        "medication_type": "Tablet",
        "information": "-",
        "instructions": [
          "Adults: Take 1 tablet (5 mg of the active ingredient) at a time, twice daily, in the morning and before going to bed. The dosage may be adjusted according to the disease, age or symptoms.",
          "Children 7 years old or over: Take 1 tablet (5 mg) at a time, twice daily, in the morning and before going to bed.",
          "If you miss a dose, take a dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time. Do not stop taking this medicine unless your doctor instructs you to do so."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:54.724Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e3e",
    "original_record": {
      "input_index": 884,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e3e"
        },
        "name": "Allet Max",
        "strength": "0.7%",
        "generic": "Olopatadine Hydrochloride",
        "company": "Healthcare Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/34618/allet-max-07-eye-drop",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/281/almex-200-mg-suspension",
    "name": "Almex",
    "dosage_form": "Oral Suspension",
    "generic": "Albendazole",
    "strength": "200 mg/5 ml",
    "company": "Square Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 23.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "10 ml bottle",
          "price": "৳ 23.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "400 mg (Chew. Tablet)",
        "href": "https://medex.com.bd/brands/282/almex-400-mg-chewable-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Almex is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Almex, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Almex should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Almex is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Almex exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Almex is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:55.974Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e48",
    "original_record": {
      "input_index": 885,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e48"
        },
        "name": "Almex",
        "strength": "200 mg/5 ml",
        "generic": "Albendazole",
        "company": "Square Pharmaceuticals PLC",
        "medicine_type": "Oral Suspension",
        "source_url": "https://medex.com.bd/brands/281/almex-200-mg-suspension",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/284/almin-400-mg-chewable-tablet",
    "name": "Almin",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Kumudini Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": "৳ 8.00",
      "pack_size_info": "(25 x 2: ৳ 200.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(25 x 2: ৳ 200.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 8.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "200 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/283/almin-200-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Almin is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Almin, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Almin should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Almin is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Almin exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Almin is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:57.343Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e4a",
    "original_record": {
      "input_index": 886,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e4a"
        },
        "name": "Almin",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Kumudini Pharma Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/284/almin-400-mg-chewable-tablet",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/13740/allbeevit-5-mg-syrup",
    "name": "Allbeevit",
    "dosage_form": "Syrup",
    "generic": "Vitamin B complex",
    "strength": "(5 mg+2 mg+2 mg+20 mg)/5 ml",
    "company": "Medimet Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 25.00",
          "pack_size_info": null
        },
        {
          "label": "200 ml bottle",
          "price": "৳ 43.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg+2 mg+2 mg+20 mg (Tablet)",
        "href": "https://medex.com.bd/brands/13737/allbeevit-5-mg-tablet?ref=1"
      },
      {
        "text": "5 mg+2 mg+2 mg+20 mg (Capsule)",
        "href": "https://medex.com.bd/brands/13738/allbeevit-5-mg-capsule?ref=1"
      },
      {
        "text": "5 mg+2 mg+2 mg+20 mg (Tablet)",
        "href": "https://medex.com.bd/brands/13739/allbeevit-5-mg-tablet?ref=1"
      },
      {
        "text": "(50 mg+5.48 mg+100 mg+5 mg+10 mg)/2 ml (Injection)",
        "href": "https://medex.com.bd/brands/13741/allbeevit-50-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1131/vitamin-b-complex/brand-names",
    "indications": [
      {
        "title": null,
        "information": "It is indicated in the vitamin B-Complex deficiency states like beriberi, Wernicke's encephalopathy, loss of appetite, cheilosis, glossitis, angular stomatitis, keratitis, seborrhoeic dermatitis, pellagra, photophobia, peripheral neuritis, corneal vascularization, in conditions causing depletion, or ... Read moreIt is indicated in the vitamin B-Complex deficiency states like beriberi, Wernicke's encephalopathy, loss of appetite, cheilosis, glossitis, angular stomatitis, keratitis, seborrhoeic dermatitis, pellagra, photophobia, peripheral neuritis, corneal vascularization, in conditions causing depletion, or reduced absorption of vitamins such as gastrointestinal disorders, chronic alcoholism, febrile illness, prolonged or wasting diseases, hyperthyroidism or poorly controlled diabetes, and conditions resulting in increased requirement for B-Complex vitamins e.g. pregnancy, severe burns and recovery from surgery.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a well balanced combination of B-Complex vitamins which is specially formulated for prophylactic or therapeutic nutritional supplementation in conditions requiring water soluble B-Complex vitamins. Vitamins are essential for normal metabolic functions including hematopoiesis. The B-Complex vitamins are necessary for the conversion of carbohydrate, protein and fat into tissue and energy.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Pyridoxine may increase the peripheral metabolism of levodopa, reducing therapeutic efficacy in patients with Parkinson's disease.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to any of its components.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Adverse reactions have been reported with specific vitamins, and generally at levels substantially higher than those in Orabex. However, allergic and idiosyncratic reactions are possible at lower levels.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The recommended dose should not be exceeded without medical advice.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "It should be given cautiously to patients taking levodopa as pyridoxine reduces the effect of levodopa. Hypersensitivity may develop in patients previously given thiamine, specially after repeated injections of concentrated solution; give subsequent injections with care. Discontinue drug if untoward reactions develop. Intramuscular administration may cause transient pain; when used undiluted, administer slowly.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 25°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Specific combined vitamin preparations",
    "dosage": [
      {
        "medication_type": "Tablet and Capsule",
        "information": ": 1-2 tablets/capsules thrice daily.",
        "instructions": []
      },
      {
        "medication_type": "Syrup",
        "information": ": 2-3 teaspoonful daily or as directed by the physician.",
        "instructions": []
      },
      {
        "medication_type": "Injection",
        "information": ": It is used when the oral route is not feasible or when rapid correction of vitamin B-group is needed. It can be given intramuscularly or intravenously (slowly) in a dose of 2 mL daily or as advised by the Registered Physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:27:58.737Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e2b",
    "original_record": {
      "input_index": 887,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e2b"
        },
        "name": "Allbeevit",
        "strength": "(5 mg+2 mg+2 mg+20 mg)/5 ml",
        "generic": "Vitamin B complex",
        "company": "Medimet Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/13740/allbeevit-5-mg-syrup",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/12018/allercet-5-mg-syrup",
    "name": "Allercet",
    "dosage_form": "Syrup",
    "generic": "Cetirizine Hydrochloride",
    "strength": "5 mg/5 ml",
    "company": "Marksman Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 14.80",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 14.80",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/12017/allercet-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allercet is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Allercet is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Allercet is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Allercet has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Allercet is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:00.092Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e33",
    "original_record": {
      "input_index": 888,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e33"
        },
        "name": "Allercet",
        "strength": "5 mg/5 ml",
        "generic": "Cetirizine Hydrochloride",
        "company": "Marksman Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/12018/allercet-5-mg-syrup",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/29924/allergan-5-mg-oral-solution",
    "name": "Allergan",
    "dosage_form": "Oral Solution",
    "generic": "Promethazine Hydrochloride",
    "strength": "5 mg/5 ml",
    "company": "Cipla Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 24.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 24.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1346/promethazine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergan is indicated in-",
        "items": [
          "Potent long-acting antihistamine with additional anti-emetic and sedative/calming effects.",
          "Indicated in symptomatic treatment of allergic conditions of the respiratory tract and skin.",
          "Sensitization reactions to drug or foreign proteins, anaphylactic reactions.",
          "For sedation, allergic rhinitis, urticaria and insomnia.",
          "As an adjunct in pre-operative sedation in surgery and obstetrics.",
          "As a paediatric sedative"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Promethazine is a phenothiazine derivative which blocks postsynaptic mesolimbic dopaminergic receptors in the brain. It exhibits strong α-adrenergic blocking effect and depresses the release of hypothalamic and hypophyseal hormones. It competes with histamine for the H1-receptor; muscarinic blocking effect may be responsible for antiemetic activity. It also reduces stimuli to the brainstem reticular system. Promethazine is well absorbed from the gastrointestinal tract. Clinical effects are apparent within 20 minutes after oral administration and generally last four to six hours, although they may persist as long as 12 hours. Promethazine is metabolized by the liver to a variety of compounds; the sulfoxides of promethazine and N-demethylpromethazine are the predominant metabolites appearing in the urine.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": null,
        "items": [
          "Allergan may enhance the action of any anticholinergic agent, tricyclic antidepressant, sedative or hypnotic, Alcohol should be avoided during drug treatment.",
          "Phenergan may interfere with immunologic urine pregnancy tests to produce false-positive or false-negative results.",
          "Phenergan should be discontinued at least 72 hours before the start of skin tests using allergen extracts as it may inhibit the cutaneous histamine response thus producing false-negative results."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Promethazine is contraindicated for use in children less than two years of age",
          "Hypersensitivity to promethazine or to any of the excipients.",
          "Phenergan should not be used in patients who are in a coma or suffering from CNS depression of any cause. It must not be given to neonates or premature infants.",
          "Phenergan should be avoided in patients who have been taking monoamine oxidase inhibitors within the previous 14 days"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Use Allergan only as recommended. Do not exceed the recommended dose. There have been case reports of promethazine abuse. Do not take for longer than 10 days.",
        "items": [
          "Nervous system disorders: Frequency Unknown: Neuroleptic Malignant Syndrome the elderly are particularly susceptible to the anticholinergic efects and confusion due to Allergan, somnolence, dizziness, headaches, extrapyramidal efects including muscle spasm, tic-like movements of the head and face. A very serious and sometimes deadly health problem called neuroleptic malignant syndrome (NMS) may happen. Stop treatment and call your doctor right away if you have high fever, muscle cramps or stifness, dizziness, very bad headache, fast heartbeat, confusion, agitation, hallucinations, or are sweating a lot.",
          "Immune System Disorders- Frequency unknown: Allergic reactions, including urticaria, rash, pruritus, and anaphylaxis, have been reported.",
          "Skin and Subcutaneous Tissue Disorders- Frequency unknown: Photosensitivity reaction",
          "Metabolism and Nutrition Disorders- Frequency unknown: Anorexia",
          "Gastrointestinal Disorders- Frequency unknown: Epigastric discomfort, dry mouth",
          "Eye Disorders- Frequency unknown: Blurred vision",
          "Blood and Lymphatic System Disorders- Frequency unknown: Blood dyscrasias including hemolytic anemia, agranulocytosis",
          "Renal and Urinary Disorders- Frequency unknown: Urinary retention",
          "Psychiatric Disorders- Frequency unknown: Infants, newborns and premature are susceptible to the anticholinergic efects of promethazine, while other children may display paradoxical hyperexcitability, restlessness, nightmares, disorientation",
          "Cardiac Disorders- Frequency unknown: Palpitations, arrhythmias",
          "Vascular disorders- Frequency unknown: Hypotension",
          "Hepatobiliary disorders- Frequency unknown: Jaundice",
          "General Disorders and Administration Site Conditions- Frequency unknown: Tiredness"
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There is epidemiological evidence for the safety of promethazine in pregnancy and animal studies have shown no hazard, nevertheless, it should not be used in pregnancy unless the physician considers it essential. The use of Phenergan is not recommended in the two weeks prior to delivery in view of the risk of irritability and excitement in the neonate. When promethazine has been given in high doses during late pregnancy, promethazine has caused prolonged neurological disturbances in the infant. Promethazine should be used in pregnancy only if the potential benefts to the patient are weighed against the possible risk to the fetus. Promethazine is excreted in breastmilk. There are risks of neonatal irritability and excitement.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "The use of promethazine should be avoided in children and adolescents with signs and symptoms suggestive of Reye’s syndrome.",
          "Allergan may thicken or dry lung secretions and impair expectoration. It should therefore be used with caution in patients with asthma, bronchitis or bronchiectasis.",
          "Use with care in patients with severe coronary artery disease.",
          "Use with care in patients with narrow angle glaucoma.",
          "Use with care in patients with epilepsy.",
          "Use with care in patients with hepatic insufciency.",
          "Use with care in patients with renal insufciency.",
          "Caution should be exercised in patients with bladder neck obstruction.",
          "Caution should be exercised in patients with pyloro-duodenal obstruction."
        ]
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Symptoms of severe over dosage are variable. They are characterised in children by various combinations of excitation, ataxia, incoordination, athetosis and hallucinations, while adults may become drowsy and lapse into coma. Convulsions may occur in both adults and children; coma or excitement may precede their occurrence. Tachycardia may develop. Cardiorespiratory depression is uncommon. If the patient is seen soon enough after ingestion, it should be possible to induce vomiting with ipecacuanha despite the antiemetic efect of promethazine; alternatively, gastric lavage may be used. Treatment is otherwise supportive with attention to maintenance of adequate respiratory and circulatory status. Convulsions should be treated with diazepam or other suitable anticonvulsant.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from light. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-emetic drugs, Miscellaneous sedatives & hypnotics, Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Oral dose-",
        "information": "Adults: Initial dose one 25 mg tablet at night; may be increased to two or three 25 mg tablets at night if necessary. In allergic conditions more frequently administration, twice or three times daily, may be necessary, starting with one or two 10 mg tablets and increasing as required. Elderly: No specific dosage recommendations. Children: They may be treated more conveniently by the elixir containing 5 mg/5 ml. As an antihistamine in allergy: As a sedative:",
        "instructions": [
          "Children of 2-5 years: 5-15 mg",
          "Children of 5-10 years: 10-25 mg",
          "In the case where two doses in 24 hours are required, the lower dose stated should be given.",
          "Children of 2-5 years: 15-20 mg",
          "Children of 5-10 years: 20-25 mg",
          "Given as a single night-time dose"
        ]
      },
      {
        "medication_type": "Parenteral dose",
        "information": "-",
        "instructions": [
          "Adult: 25-50 mg by deep intramuscular injection or, in emergency, by slow intravenous injection after dilution of the 2.5% solution to 10 times its volume with water for injection. The maximum parenteral dose is 100 mg.",
          "Children: 5-10 years: 6.25 to 12.5 mg by deep I.M. Injection"
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:01.386Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e34",
    "original_record": {
      "input_index": 889,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e34"
        },
        "name": "Allergan",
        "strength": "5 mg/5 ml",
        "generic": "Promethazine Hydrochloride",
        "company": "Cipla Limited",
        "medicine_type": "Oral Solution",
        "source_url": "https://medex.com.bd/brands/29924/allergan-5-mg-oral-solution",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/3713/allerkit-1-mg-syrup",
    "name": "Allerkit",
    "dosage_form": "Syrup",
    "generic": "Ketotifen Fumarate",
    "strength": "1 mg/5 ml",
    "company": "Monicopharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 40.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/649/ketotifen-fumarate-oral/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allerkit is indicated in the following conditions-",
        "items": [
          "For the prophylactic treatment of bronchial asthma.",
          "Symptomatic treatment of allergic conditions including rhinitis and conjunctivitis.",
          "For alleviating the complications of itching, pain and tenderness associated with neurofibroma.",
          "Symptomatic treatment of allergy such as hayfever, urticaria."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ketotifen has anti-allergic properties and has been used similarly, to sodium chromoglycate in the prophylactic treatment of asthma. It also has the properties of an antihistamine. Ketotifen possesses marked anti-anaphylactic properties and is effective in preventing an asthmatic attacks. Ketotifen exerts as sustained inhibitory effect on histamine reactions, which can be clearly dissociated from its anti-anaphylactic properties. Experimental investigations in asthmatic subjects have shown that Ketotifen is as effective orally as a selective mast cell stabilizer administered by inhalation. Antihistamines were ineffective in those tests. The effectiveness of Ketotifen has been studied in long-term clinical trials. Asthma attacks were reduced in number, severity and duration and in some cases, the patients were completely freed from attacks. Progressive reduction of corticosteroids and/or bronchodilators was also possible. The prophylactic activity of Ketotifen may take several weeks to become fully established. Ketotifen will not abort established attacks of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Allerkit may potentiate the effects of sedatives, hypnotics, antihistamines and alcohols. A reversible fall in the platelet count has been observed in a few patients receiving Tifen concomitantly with oral antidiabetic agents and it has been suggested that Allerkit should therefore be avoided.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "A reversible fall in the platelet count has been observed in a few patients receiving Ketotifen concomitantly with oral antidiabetic agent and it has been suggested that this combination should therefore be avoided. Although there is no evidence of any teratogenic effect, recommendations for Ketotifen in pregnancy or when breast feeding can not be given.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Drowsiness and in isolated cases, dry mouth and slight dizziness may occur at the beginning of treatment but usually disappear spontaneously after a few days.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although there is no evidence of any teratogenic effect, Ketotifen in pregnancy and lactation is not recommended.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "It is important to continue the previous treatment for a minimum of two weeks after starting Allerkit to avoid the possibility of exacerbation of asthma. This applies specially to systemic corticosteroids and ACTH because of the possible existence of adrenocortical insufficiency in steroid dependent patient. If inter current infection occurs, Allerkit treatment must be supplemented by specific antimicrobial therapy. During the first day of treatment with Allerkit, reactions may be impaired and patients should be warned not to take charge of vehicle or machinery until the effect of Allerkit treatment on the individual is known. Patients should be advised to avoid alcoholic drinks. Allerkit may potentiate the effects of sedatives, hypnotics, antihistamines and alcohol.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "The reported features of overdosage include confusion, drowsiness, headache, bradycardia, respiratory depression etc. should be watched for. Elimination of the drug with gastric lavage or emessis is recommended. Otherwise, general supportive treatment is all that is required shall be instituted.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, protect from light. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C19H19NOS",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-649-ketotifen-fumarate-oral-chemical-structure-WOrxlxSmVByavydbYqzn.svg"
    },
    "therapeutic_class": "Cromoglycate & related drugs",
    "dosage": [
      {
        "medication_type": "Adults",
        "information": ": 1 mg twice daily with food. If necessary the dose may be increased to 2 mg twice daily in severe cases.",
        "instructions": []
      },
      {
        "medication_type": "Children above 3 years",
        "information": ": 1 mg twice daily with food. Patients known to be easily sedated should begin treatment with 0.5 to 1 mg at night for the first few days or as directed by the physician.",
        "instructions": []
      },
      {
        "medication_type": "Use in elderly",
        "information": ": Same as adult dose or as advised by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Allerkit 1 mg/5 ml Syrup?",
        "answer": [
          "Allerkit 1 mg/5 ml Syrup is an antihistamine medication and a mast cell stabilizer used to treat allergic conditions such as conjunctivitis, asthma, and urticaria (hives)."
        ]
      },
      {
        "question": "What is Allerkit 1 mg/5 ml Syrup used for?",
        "answer": [
          "Allerkit 1 mg/5 ml Syrup is indicated in bronchial asthma, rhinitis, conjunctivitis, hayfever, urticaria."
        ]
      },
      {
        "question": "Are there any pregnancy warnings?",
        "answer": [
          "Asthafen 1mg tablet may be unsafe to use during pregnancy."
        ]
      },
      {
        "question": "Are there any breast-feeding warnings?",
        "answer": [
          "Unknown. Human and animal studies are not available. Please consult your doctor."
        ]
      },
      {
        "question": "Does this affect kidney function?",
        "answer": [
          "There is no data available. Please consult doctor before consuming the drug."
        ]
      },
      {
        "question": "Does this affect liver function?",
        "answer": [
          "There is no data available. Please consult doctor before consuming the drug."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:28:02.696Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e35",
    "original_record": {
      "input_index": 890,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e35"
        },
        "name": "Allerkit",
        "strength": "1 mg/5 ml",
        "generic": "Ketotifen Fumarate (Oral)",
        "company": "Monicopharma Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/3713/allerkit-1-mg-syrup",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/11918/allernil-5-mg-syrup",
    "name": "Allernil",
    "dosage_form": "Syrup",
    "generic": "Cetirizine Hydrochloride",
    "strength": "5 mg/5 ml",
    "company": "Kemiko Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 25.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/11917/allernil-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/234/cetirizine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allernil is indicated for the relief of symptoms associated with seasonal & perennial allergic rhinitis. It is also indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria and allergen induced asthma.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cetirizine Hydrochloride is a potent H1 receptor antagonist without any significant anticholinergic and antiserotonic effects. At pharmacologically active dose levels, it has almost no drowsiness effect and does not cause behavioral changes. It inhibits the histamine-mediated early phase of the allergic reaction and also reduces the migration of inflammatory cells and the release of mediators associated with the late phase of the allergic reaction. Pharmacokinetics: Cetirizine 10 mg achieves peak plasma concentrations of 257 mcg/L within one hour of administration (980 mcg/L in children). Food does not affect the extent of absorption, but it may slightly reduce the rate. Peak blood levels 0.3 micrograms/ml are reached between thirty & sixty minutes after administration of 10 mg dose of Cetirizine. Its plasma half-life is approximately 11 hours. Absorption is very consistent from one subject to the next. Its renal clearance is 30 ml/minute and the excretion half-life is approximately nine hours.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically significant drug interactions have been found with Theophylline, Azithromycin, Pseudoephedrine, Ketoconazole or Erythromycin and with other drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in patients with a history of hypersensitivity to Cetirizine or hydroxyzine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common side effects that occurred more frequently on Allernil is somnolence.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Cetirizine Hydrochloride is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Cetirizine Hydrochloride has been shown to be excreted in human milk. So, caution should be exercised when Cetirizine Hydrochloride is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised when driving a car or operating a heavy machinery.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic or renal insufficiency",
        "information": ": In patients with mild to moderate hepatic and renal impairment, total body clearance of Allernil is reduced and AUC and half-life increased by about 2 to 3 fold. Clearance is reduced in proportion to the decline in creatinine clearance. Plasma levels are unaffected by hemodialysis. The plasma elimination half-life in dialysis patients is approximately 20 hours and the plasma AUC is increased by about threefold.",
        "items": []
      },
      {
        "title": "Pediatric Use",
        "information": ": The safety of Allernil has been demonstrated in pediatric patients aged 6 months to 5 years.",
        "items": []
      },
      {
        "title": "Elderly use",
        "information": ": The clearance of Allernil is reduced in elderly patients, but only in proportion to the decrease in creatinine clearance.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Sedating Anti-histamine",
    "dosage": [
      {
        "medication_type": "Cetirizine oral dosage form",
        "information": ":",
        "instructions": [
          "Adults and Children 6 years and older: 1 tablet or 2 teaspoonfuls daily (or 1 teaspoonful twice daily).",
          "Children 2-6 years: 1 teaspoonful once daily or 1/2 teaspoonful twice daily.",
          "Children 6 months to 2 years : 1/2 teaspoonful once daily. The dose in children 12-23 months of age can be increased to a maximum dose as 1/2 teaspoonful every 12 hours."
        ]
      },
      {
        "medication_type": "Cetirizine injectable dosage form",
        "information": ": Cetirizine is a single use injectable product for intravenous administration only. The recommended dosage regimen is once every 24 hours as needed for treatment of acute urticaria. Administer Cetirizine as an intravenous push over a period of 1 to 2 minutes. Cetirizine is not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.",
        "instructions": [
          "Adults and adolescents 12 years of age and older: The recommended dosage is 10 mg administered by intravenous injection.",
          "Children 6 to 11 years of age: The recommended dosage is 5 mg or 10 mg depending on symptom severity administered by intravenous injection.",
          "Children 6 months to 5 years of age: The recommended dosage is 2.5 mg administered by intravenous injection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:04.056Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e38",
    "original_record": {
      "input_index": 891,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e38"
        },
        "name": "Allernil",
        "strength": "5 mg/5 ml",
        "generic": "Cetirizine Hydrochloride",
        "company": "Kemiko Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/11918/allernil-5-mg-syrup",
        "_page": 26,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31418/allertin-125-mg-oral-solution",
    "name": "Allertin",
    "dosage_form": "Oral Solution",
    "generic": "Bilastine",
    "strength": "12.5 mg/5 ml",
    "company": "Navana Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 120.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "60 ml bottle",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "20 mg (Tablet)",
        "href": "https://medex.com.bd/brands/30398/allertin-20-mg-tablet?ref=1"
      },
      {
        "text": "10 mg (DT)",
        "href": "https://medex.com.bd/brands/33724/allertin-odt-10-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1457/bilastine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allertin is indicated for the symptomatic treatment of- Allertin is also used to relieve the symptoms of hay fever (sneezing, itchy, runny, blocked-nose and red and watery eyes).",
        "items": [
          "Allergic rhino conjunctivitis (seasonal and perennial) and",
          "Urticaria"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Bilastine is a potent, effective, non-sedating, long-acting histamine antagonist with selective & high affinity to H1 receptor (3 times higher than Cetirizine and 5 times higher than Fexofenadine). Even at a high concentration, Bilastine does not show affinity for the 30 other receptors including muscarinic, serotonergic, dopaminergic and noradrenergic receptors, for the other histamine receptor subtypes (H2, H3 and H4). It shows excellent safety profile and very favorable pharmacokinetic characteristics. Bilastine doesn’t undergo any metabolism to be active. Bilastine is excreted by feces (non -systemic) & urine (systemic) approximately 66.35% & 28.31% respectively.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concomitant use of Allertin with ketoconazole, erythromycin, cyclosporine or diltiazem increases the concentration of Allertin. But these changes do not appear to affect the safety profile of any of the drugs. Intake of alcohol and 20 mg Allertin shows same psychomotor performance similar to that of alcohol and placebo. Concomitant intake of Allertin 20 mg and lorazepam 3 mg for 8 days did not potentiate the depressant CNS effects of lorazepam.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most commonly reported side effects in clinical trial are headache, dizziness, somnolence and fatigue. These adverse events occurred with a comparable frequency in patients receiving placebo.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no or limited amount of data from the use of Bilastine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, parturition or postnatal development. As a precautionary measure, it is preferable to avoid the use of Bilastine during pregnancy. The excretion of Bilastine in milk has not been studied in humans. A decision must be made taking into account the benefit of breast-feeding for the child and the benefit of Bilastine therapy for the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Treatment with Allertin 20 mg does not affect the driving performance. However, patients should be informed that very rarely some people experience drowsiness, which may affect their ability to drive or use machines. In clinical trials elderly patients (≥65 years) showed no difference in effcacy or safety with respect to younger patients. The maximum plasma concentration of Allertin after administration of 20 mg in patients with severe renal impairment is below the safety threshold of most common adverse e?ects and cardiac or CNS safety. No dosage adjustment is necessary in patients with renal impairment. Allertin is not metabolized in human. Since renal elimination is the major excretion, biliary excretion is expected to be only marginally involved in the elimination of Allertin. Changes in liver function are not expected to have a clinically relevant influence.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Efficacy and safety of Allertin in children under 2 years of age have not been established and there is little clinical experience in children aged 2 to 5 years, therefore Allertin should not be used in these age groups.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "In clinical trials, after administration of Allertin at doses 10 to 11 times the therapeutic dose (220 mg as single dose; or 200 mg/day for 7 days) frequency of treatment-emergent adverse events was two times higher than with placebo. The adverse reactions most frequently reported were dizziness, headache and nausea. No serious adverse events and no significant prolongation in the QTc interval were reported.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, protected from light and moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C28H37N3O3",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-1457-bilastine-chemical-structure-PylLjWiPzmvT6LbGl8QG.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Adults & adolescents (12 years of age and over)",
        "information": ": 20 mg tablet once daily for symptomatic relief of allergic rhinitis, urticaria and allergic rhinoconjunctivitis. The maximum recommended daily dose is 20 mg Bilastine (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken. 20 mg Bilastine tablet (1 tablet) once daily should be swallowed with water on an empty stomach to achieve optimal exposure to Bilastine.",
        "instructions": []
      },
      {
        "medication_type": "Children between 6 to 11 years",
        "information": ": 10 mg mouth dissolving tablet for the symptomatic relief of allergic rhinitis, allergic rhinoconjunctivitis and urticaria. The Mouth dissolving tablet is for oral use only. It should be placed in the mouth. It will disperse rapidly in saliva and can be easily swallowed. Alternatively, the mouth dissolving tablet can be dispersed in a tea spoon of water before being swallowed by the children. The maximum recommended daily dose for children in between 6 to 11 years is 10 mg Bilastine mouth dissolving tablet (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken.",
        "instructions": []
      },
      {
        "medication_type": "Children between 2 to 11 years",
        "information": ": 4 ml once daily.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Allertin 12.5 mg/5 ml Solution?",
        "answer": [
          "Allertin 12.5 mg/5 ml Solution is H1 receptor antagnist. It is commonly used to treat Allergic rhino conjunctivitis (seasonal and perennial) and Urticaria."
        ]
      },
      {
        "question": "Are there any pregnancy warnings of Allertin 12.5 mg/5 ml Solution?",
        "answer": [
          "Limited information is available. Allertin 12.5 mg/5 ml Solution is recommended to be used only after consulting a doctor for pregnant women."
        ]
      },
      {
        "question": "Are there any breast-feeding warnings of Allertin 12.5 mg/5 ml Solution?",
        "answer": [
          "It is advised to consult your doctor before taking Allertin 12.5 mg/5 ml Solution if you are breast feeding a baby as relevant information is not available."
        ]
      },
      {
        "question": "Does Allertin 12.5 mg/5 ml Solution safe with alcohol?",
        "answer": [
          "Excessive intake of alcohol should be avoided during the course of medication as it can increase sleepiness."
        ]
      },
      {
        "question": "Does Allertin 12.5 mg/5 ml Solution affect kidney function?",
        "answer": [
          "It is important to consult a doctor to know the dose adjustment for patients suffering from kidney diseases."
        ]
      },
      {
        "question": "Does Allertin 12.5 mg/5 ml Solution affect liver function?",
        "answer": [
          "Relevant information is not available. Please consult to know if any dose adjustment is needed in patients with liver impairment."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Your doctor has prescribed Allertin 12.5 mg/5 ml Solution to help relieve allergy symptoms such as itching, swelling, and rashes.",
          "As compared to other similar medications, it is much less likely to make you feel sleepy.",
          "Be cautious while driving or doing anything that requires concentration as it can cause dizziness and sleepiness.",
          "Do not drink alcohol while taking this medication as it may cause increased sleepiness.",
          "Stop taking Allertin 12.5 mg/5 ml Solution at least three days before taking an allergy test as it can affect the test results."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:28:05.628Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e3a",
    "original_record": {
      "input_index": 892,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e3a"
        },
        "name": "Allertin",
        "strength": "12.5 mg/5 ml",
        "generic": "Bilastine",
        "company": "Navana Pharmaceuticals Ltd.",
        "medicine_type": "Oral Solution",
        "source_url": "https://medex.com.bd/brands/31418/allertin-125-mg-oral-solution",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/15995/allet-01-eye-drop",
    "name": "Allet",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Olopatadine Hydrochloride",
    "strength": "0.1%",
    "company": "Healthcare Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 110.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 110.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.2% (Eye Drop)",
        "href": "https://medex.com.bd/brands/16000/allet-ds-02-eye-drop?ref=1"
      },
      {
        "text": "0.7% (Eye Drop)",
        "href": "https://medex.com.bd/brands/34618/allet-max-07-eye-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/823/olopatadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Patadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.... Read morePatadin eye drops is indicated for the treatment of signs and symptoms (itchy, watery, red and swollen eyes and/or eyelids) of allergic conjunctivitis including vernal keratoconjunctivitis, vernal keratitis, blepharitis, blepharoconjunctivitis and giant papillary conjunctivitis.Allet Nasal Spray is an H1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older.Allet tablet is indicated in the treatment of allergic rhinitis (swelling of the nasal membranescaused by an allergy to pollen and mold spores in the air) and allergic skin conditions. It helps to relieve allergy symptoms such as skin rashes, swelling, hives (itchy, painful eruptions that sting), itching, sneezing, runny or stuffy nose.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Olopatadine, an antihistamine, works by blocking the action of histamine in the body, which reduces allergy symptoms. Olopatadine hydrochloride treats sneezing, itching, runny nose, and other nasal symptoms of allergies.",
        "items": []
      },
      {
        "title": "Mode of Action",
        "information": ": Olopatadine is an anti-allergic molecule that works via several mechanisms. As a mast cell stabilizer, it stabilizes rodent basophils and human conjunctival mast cells and inhibits the immunologically-stimulated release of histamine. Olopatadine acts as an antagonist at the histamine H1 receptors with high selectivity, Upon binding, olopatadine blocks the H1 receptor signaling pathway, inhibiting the release of inflammatory mediators, such as tryptase, prostaglandin D2, TNF-alpha, as well as pro-inflammatory cytokines.",
        "items": []
      },
      {
        "title": "Pharmacokinetics",
        "information": ": Absorption: Olopatadine was absorbed with individual peak plasma concentrations observed between 30 minutes and 1 hour after twice daily intranasal administration of Olopatadine Nasal Spray. Distribution: The protein binding of olopatadine was moderate at approximately 55% in human serum, and independent of drug concentration over the range of 0.1 to 1000 ng/mL. Metabolism: Olopatadine is not extensively metabolized. Based on plasma metabolite profiles of olopatadine, at least six minor metabolites circulate in human plasma. Elimination: The plasma elimination half-life of olopatadine is 8 to 12 hours. Olopatadine is mainly eliminated through urinary excretion",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Formal drug-drug interaction studies were not conducted for Allet Nasal Spray. Drug interactions with inhibitors of liver enzymes are not anticipated because olopatadine is eliminated predominantly by renal excretion. Drug interactions involving P450 inhibition and plasma protein binding are also not expected.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "It is contraindicated in persons with a known hypersensitivity to any component of this product. Olopatadine 5 mg tablet is not recommended for use if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions to make sure this medicine is safe for you.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Rarely headaches have been reported. Other adverse effects: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Olopatadine was found not to be teratogenic in rats and rabbits. There are, however, no adequate and well controlled studies in pregnant women. This drug should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk. Nevertheless, caution should be exercised when Olopatadine is administered to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients should be advised not to wear a contact lens if their eye is red. Allet ophthalmic solution should not be used to treat contact lens related irritation. Benzalkonium Chloride, preservative of Patadin, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least 10 minutes after instillation of Patadin eye drops before they insert their contact lenses. The treatment should be discontinued in the presence of an allergic reaction. Before initial use, Allet Nasal Spray by releasing 5 sprays or until a fine mist appears. When Allet Nasal Spray has not been used for more than 7 days, re-prime by releasing 2 sprays. Avoid spraying Allet Nasal Spray into the eyes. Patients should be informed to avoid spraying Allet Nasal Spray in their eyes. Olonex Tablet should be used as prescribed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid taking more than the recommended dose. Do not stop taking this medicine without consulting your doctor, as your symptoms may reoccur.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety or effectiveness have been observed betweents.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no information on Allet overdose. However, excessive use of any medication can have serious consequences. If you suspect an overdose, seek medical attention without delay.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at room temperature and protect from light. It is desirable that the contents should not be used more than one month after first opening of the bottle.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "How to use the Nasal Spray- Cleaning: The nasal spray should be cleaned at least once a week. The procedures are as follows-",
        "items": [
          "Shake the bottle gently and remove the dust cover.",
          "Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath the bottle. Press down until a fine spray appears. If using for the first time or if you have not used it for a week or more, press the nasal applicator several times until a fine moist comes out from the container.",
          "Gently blow the nose to clear the nostrils.",
          "Close one nostril and carefully insert the nasal applicator into the open nostril. Tilt your head forward slightly and keep the spray upright. Breathe in through your nose and while breathing in, press the white-collar of nasal applicator firmly down once to release a spray.",
          "Breathe out through your mouth.",
          "Repeat the above steps in the same/ other nostril for consecutive doses.",
          "Remove the dust cover.",
          "Gently pull off the nasal applicator.",
          "Wash the applicator and dust cover in warm water.",
          "Shake off the excess water and leave to dry in a normal place. Avoid to apply additional heat.",
          "Gently push the applicator back on the top of the bottle and re-fix the dust cover."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ophthalmic Non-Steroid drugs",
    "dosage": [
      {
        "medication_type": "Eye Drops",
        "information": "-",
        "instructions": [
          "0.1%: One drop in each affected eye two times per day at an interval of 6 to 8 hours.",
          "0.2%: One drop in the affected eye once a day.",
          "0.7%: One drop in each affected eye once a day."
        ]
      },
      {
        "medication_type": "Nasal Spray",
        "information": "-",
        "instructions": [
          "Administer Olopatadine Nasal Spray by the intranasal route only.",
          "Adults and Adolescents 12 years of age and older: Two sprays per nostril twice daily.\\",
          "Children 6 to 11 years of age: One spray per nostril twice daily."
        ]
      },
      {
        "medication_type": "Tablet",
        "information": "-",
        "instructions": [
          "Adults: Take 1 tablet (5 mg of the active ingredient) at a time, twice daily, in the morning and before going to bed. The dosage may be adjusted according to the disease, age or symptoms.",
          "Children 7 years old or over: Take 1 tablet (5 mg) at a time, twice daily, in the morning and before going to bed.",
          "If you miss a dose, take a dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and follow your regular dosing schedule. You should never take two doses at one time. Do not stop taking this medicine unless your doctor instructs you to do so."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:06.732Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e3c",
    "original_record": {
      "input_index": 893,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e3c"
        },
        "name": "Allet",
        "strength": "0.1%",
        "generic": "Olopatadine Hydrochloride",
        "company": "Healthcare Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/15995/allet-01-eye-drop",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/14085/allion-gold-tablet",
    "name": "Allion Gold",
    "dosage_form": "Tablet",
    "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
    "strength": null,
    "company": "Beacon Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 12.00",
      "strip_price": "৳ 360.00",
      "pack_size_info": "(1 x 30: ৳ 360.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.00",
          "pack_size_info": "(1 x 30: ৳ 360.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 360.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/781/multivitamin-multimineral-a-z-gold-preparation/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allion Gold is indicated for the prevention and treatment of vitamins & minerals deficiencies. As a complete daily nutritional supplement, it is also indicated to meet the increased demand for vitamins and minerals in the conditions like physical and emotional stress, chronic diseases, infection illness, osteoporosis, injuries or wound, surgery, poor digestion, old age, pregnancy and lactation, poor appetite, excess dieting, exposure to environmental pollution, heavy exercise etc.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a film coated tablet, which combines 32 high potency vitamins and minerals. This preparation maintains a healthy body and active life-style.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No drug interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally, Allion Gold is well tolerated. Diarrhoea may occasionally occur during treatment with beta carotene and the skin may assume a slightly yellow discoloration. Vitamin C and vitamin E may cause diarrhoea and other gastrointestinal disturbances.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Recommended by the consultation with physician.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Long term intake of high level of vitamin A (excluding that sourced from beta carotene) may increase the risk of osteoporosis in postmenopausal women.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Multi-vitamin & Multi-mineral combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "One tablet daily or as recommended by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:07.799Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e3f",
    "original_record": {
      "input_index": 894,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e3f"
        },
        "name": "Allion Gold",
        "strength": null,
        "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
        "company": "Beacon Pharmaceuticals PLC",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/14085/allion-gold-tablet",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/438/allynol-5-mg-tablet",
    "name": "Allynol",
    "dosage_form": "Tablet",
    "generic": "Allylestrenol",
    "strength": "5 mg",
    "company": "Popular Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 8.00",
      "strip_price": "৳ 120.00",
      "pack_size_info": "(3 x 15: ৳ 360.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.00",
          "pack_size_info": "(3 x 15: ৳ 360.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1369/allylestrenol/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allynol is indicated in:",
        "items": [
          "Intra Uterine Growth Retardation (IUGR)",
          "Threatened abortion",
          "Habitual abortion",
          "Threatened premature delivery"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Allylestrenol has been found to have a relatively weak progestational effect on the human endometrium. To obtain a full secretory endometrium in oestrogen-primed castrated women or to postpone menstruation (with an oestrogen added) in normal ovulating women, doses of allylestrenol were required which were higher than those recommended for the treatment/prevention of abortion. In vitro studies have shown that allylestrenol stimulates the synthesis of progesterone in the human placenta. It also brought about a significant (p/. 0,01) increase in the production of some specific placental enzymes (cystine aminopeptidase and heat-stable alkaline phosphatase). Histological and histochemical changes indicating an increased activity have been found in the placenta, particularly in the syncytiotrophoblast of women with a normal and threatened pregnancy, treated with allylestrenol. The stimulatory effect of allylestrenol on placental function was also suggested by the increased level of placental hormones (pregnanediol, oestriol, HCG and HPL) and enzymes (oxytocinase, CAP) in the maternal urine and plasma, which followed the administration of the drug e.g. in the early weeks as well as in the last trimester of pregnancy. A study in full-term pregnant women revealed that allylestrenol in high doses (up to 100 mg daily) did suppress the intensity of spontaneous uterine contractions, but had no effect on the sensitivity of the uterine muscle to oxytocin, and no adverse effect on the progress of normal delivery. Studies in non-pregnant women with and without endocrinological disorders have shown that allylestrenol has no oestrogenic or androgenic properties and no adverse effects on the adrenal function. No abnormal liver function tests or water and salt retention were observed in healthy female volunteers (non pregnant) who were given allylestrenol.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Breast Cancer or history of problem with the breasts like- Nodules,an abnormal Mammogram, or Fibrocystic Diseases.",
          "Severe liver disease such as Cholestatic Jaundice or Hepatitis, Hepatic Cell Tumours, Rotor Syndrome and Dubin Jhonson Syndrome.",
          "Undiagnosed vaginal bleeding",
          "Toxaemia of Pregnancy",
          "Crisis Seizures, Migraines"
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Treatment with Allynol (especially a long term treatment) is known to cause some gastrointestinal complaints such as vomiting, nausea, and sometimes epigastric discomfort.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Allylestrenol is specifically designed to be taken during pregnancy. It should be discontinued after delivery as it may affect a nursing infant to a small but noticeable degree.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Patients with the following conditions should be cautious: Heart disease, congestive heart failure, sick sinus syndrome, coronary artery disease, seizures, epilepsy, renal dysfunction, migraine headaches, or breathing diseases including asthma, emphysema, chronic bronchitis, or COPD, breast-feeding.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "It should not be used for children younger than 16 years old.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Symptoms of overdose may include unusual drowsiness; rapid pulse; fainting; unusual muscle movement or rigidity of the face, neck, or limbs; seizures; and loss of consciousness.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Allynol is an oral Gestagen. In castrated animals, it has a potent pregnancy-maintaining action without producing hormonal side-effects, in particular no masculinisation of female foetuses. Clinical studies have indicated that Allynol stimulates the endocrine function of the trophoblast. In vitro, Allynol stimulates the placenta to produce more progesterone. In patients with pregnancy at risk, abnormally low levels of placental hormones (HCG, HPL, oestrogens and progesterone) and some specific enzymes (oxytocinase, CAP) were found to be increased to normal during treatment. In the majority of patients with pregnancy at risk who were treated with Allynol the threat of abortion was removed and pregnancy brought to term without complications. Allynol is very well tolerated. Side-effects of any importance have not been observed.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Female Sex hormones",
    "dosage": [
      {
        "medication_type": "Intra Uterine Growth Retardation",
        "information": ": 1 tablet three times a day at least two months. Dose to be reduced if symptoms improve.",
        "instructions": []
      },
      {
        "medication_type": "Threatened abortion",
        "information": ": 1 tablet three times daily until symptoms disappear.",
        "instructions": []
      },
      {
        "medication_type": "Habitual abortion",
        "information": ": 1-2 tablets daily as soon as pregnancy is diagnosed. The administration should be continued for at least one month after the end of the critical period.",
        "instructions": []
      },
      {
        "medication_type": "Threatened premature delivery",
        "information": ": Dosage must be determined individually. High dosages (up to 40 mg daily) have been used. In case of a missed dose, it should be taken as soon as the patient remembers & she should continue the regular dosing schedule. A double dose is not recommended.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:11.408Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e44",
    "original_record": {
      "input_index": 895,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e44"
        },
        "name": "Allynol",
        "strength": "5 mg",
        "generic": "Allylestrenol",
        "company": "Popular Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/438/allynol-5-mg-tablet",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/17550/almasil-ms-400-mg-chewable-tablet",
    "name": "Almasil MS",
    "dosage_form": "Chewable Tablet",
    "generic": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicone",
    "strength": "400 mg+400 mg+30 mg",
    "company": "United Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 0.75",
      "strip_price": "৳ 7.52",
      "pack_size_info": "(25 x 10: ৳ 188.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 0.75",
          "pack_size_info": "(25 x 10: ৳ 188.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 7.52",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "(400 mg+400 mg+30 mg)/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/17560/almasil-ms-400-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/20/aluminium-hydroxide-magnesium-hydroxide-simethicone/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This is indicated for symptomatic relief of hyperacidity associated with the peptic ulcer, gastritis, peptic oesophagitis, gastric hyperacidity, heartburn, sour stomach or hiatus hernia. It is effective in the prevention of stress ulceration and GI bleeding. It acts as an antiflatulent to alleviate the symptoms of gas including post operative gas pain. This rapidly relieves acid pain, disperses gastric foam and facilitates eructation of gas and air.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is the mixture of non-systemic acid neutralizing substances and antiflatulent. This preparation offers reliability as well as long action. Aluminium Hydroxide and Magnesium Hydroxide induce the relief of ulcer by neutralizing gastric acid secreted from parietal cells of the stomach. The clinical use of simethicone is based on its antifoam properties. Simethicone spreads on the surface of aqueous liquids, forming a film of low surface tension and causing collapse of foam bubbles. Simethicone repeatedly allows mucous surrounded gas bubbles in the GI tract to coalesce and be expelled. This is used in the treatment of flatulence and meteorism for the elimination of gas, air or foam from the gastro-intestinal tract prior to radiography and for the relief of abdominal distension and dyspepsia. Simethicone is physiologically inert; it does not appeared to be absorbed from the GI tract to interfere with gastric secretion or absorption of nutrients. Following oral administration, the drug is excreted unchanged in the feces.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "All antacids may increase or decrease the rate and/or extent of absorption of concomitantly administered oral drugs. Antacids decrease the bioavailability of theophyline, tetracycline, quinolone antibiotics, isoniazide, ketoconazole, ethambutol, some antimuscarinic drugs, benzodiazepines, phenothiazines, ranitidine, indomethacine, nitrofurantoin, fluoride, phosphate, propanolol, atenolol, digoxins, vitamins etc. Antacids increase the bioavailability of some drugs; e.g. sulphonamides, levodopa, valproic acid, enteric coated aspirin etc.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This should not be administered in patients with renal failure or hypophosphataemia or in those who are severely debilitated. It is also contraindicated in alkalosis and hypermagnesaemia, where abdominal distention may be due to partial or complete intestinal obstruction.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects are uncommon. Occasionally, if excessive amount is consumed, diarrhea, constipation or regurgitation may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "It is advised to avoid antacid preparations in the first trimester of pregnancy.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "This should be used with caution in patients with kidney disease.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antacids",
    "dosage": [
      {
        "medication_type": "Tablet",
        "information": ": 1-2 tablets 1-3 hours after meal and at bed time or as directed by the physician.",
        "instructions": []
      },
      {
        "medication_type": "Suspension",
        "information": ": 1-2 teaspoonful 1-3 hours after meal and at bedtime or as directed by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:12.779Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e45",
    "original_record": {
      "input_index": 896,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e45"
        },
        "name": "Almasil MS",
        "strength": "400 mg+400 mg+30 mg",
        "generic": "Aluminium Hydroxide + Magnesium Hydroxide + Simethicone",
        "company": "United Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/17550/almasil-ms-400-mg-chewable-tablet",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/282/almex-400-mg-chewable-tablet",
    "name": "Almex",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Square Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5.02",
      "strip_price": "৳ 20.08",
      "pack_size_info": "(12 x 4: ৳ 240.96)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.02",
          "pack_size_info": "(12 x 4: ৳ 240.96)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 20.08",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "200 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/281/almex-200-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Almex is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Almex, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Almex should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Almex is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Almex exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Almex is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:13.826Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e47",
    "original_record": {
      "input_index": 897,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e47"
        },
        "name": "Almex",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Square Pharmaceuticals PLC",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/282/almex-400-mg-chewable-tablet",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/445/almitan-625-mg-tablet",
    "name": "Almitan",
    "dosage_form": "Tablet",
    "generic": "Almotriptan",
    "strength": "6.25 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": "৳ 100.00",
      "pack_size_info": "(1 x 4: ৳ 100.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 25.00",
          "pack_size_info": "(1 x 4: ৳ 100.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 100.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/44/almotriptan/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Almitan is prescribed to treat the acute headache phase of migraine attacks with or without aura. Almitan is the only oral triptan approved in the USA for the treatment of migraine in adolescent from 12 to 17 years of age.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Almotriptan is a selective and potent serotonin (5-hydroxytryptamine 1B/1D) agonist. Almotriptan binds to specific serotonin receptors on meningeal arteries inhibiting the release of vasoactive peptides and causing constriction of the arteries. It has a limited effect on arteries supplying blood to the brain and little effect on cardiac and pulmonary vessels.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "These drugs have been reported to cause prolonged vasospastic reactions. Cases of life-threatening serotonin syndrome have been reported during combined use of triptans and selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs).",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "As with other 5-HT1B/1D receptor agonists, almotriptan should not be used in patients with a history, symptoms or signs of ischaemic heart disease (myocardial infarction, angina pectoris, documented silent ischaemia, Prinzmetal's angina) or severe hypertension and uncontrolled mild or moderate hypertension. Concomitant administration with ergotamine, ergotamine derivatives (including methysergide) and other 5-HT1B/1D agonists is contraindicated.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Serious cardiac reactions, including myocardial infarction, have occurred following the use of Almitan malate Tablets. These reactions are extremely rare and most have been reported in patients with risk factors predictive of CAD (Coronary Artery Disease).",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. There is no data regarding excretion of almotriptan in human milk.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Hypersensitivity to the active substance or to any of the excipients. Patients with severe hepatic impairment, with a previous cerebrovascular accident (CVA) or transient ischaemic attack (TIA) Peripheral vascular disease.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30° C temperature in a dry place. Protected from light. Do not freeze. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "5-HT Agonists",
    "dosage": [
      {
        "medication_type": "Acute Treatment of Migraine Attacks",
        "information": ": The recommended dose of Almotriptan in adults and adolescents age 12 to 17 years is 6.25 mg to 12.5 mg, with the 12.5 mg dose tending to be a more effective dose in adults. If the headache is relieved after the initial almotriptan malate dose but returns, the dose may be repeated after 2 hours. The maximum daily dose should not exceed 25 mg. The safety of treating an average of more than four migraines in a 30-day period has not been established.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Impairment",
        "information": ": The recommended starting dose of almotriptan malate in patients with hepatic impairment is 6.25 mg. The maximum daily dose should not exceed 12.5 mg over a 24-hour period",
        "instructions": []
      },
      {
        "medication_type": "Renal Impairment",
        "information": ": The recommended starting dose of almotriptan malate in patients with severe renal impairment is 6.25 mg. The maximum daily dose should not exceed 12.5 mg over a 24-hour period",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:15.105Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e4c",
    "original_record": {
      "input_index": 898,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e4c"
        },
        "name": "Almitan",
        "strength": "6.25 mg",
        "generic": "Almotriptan",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/445/almitan-625-mg-tablet",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/6420/almoxil-125-mg-suspension",
    "name": "Almoxil",
    "dosage_form": "Powder for Suspension",
    "generic": "Amoxicillin Trihydrate",
    "strength": "125 mg/5 ml",
    "company": "Aexim Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 45.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 45.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "500 mg (Capsule)",
        "href": "https://medex.com.bd/brands/6419/almoxil-500-mg-capsule?ref=1"
      },
      {
        "text": "250 mg (Capsule)",
        "href": "https://medex.com.bd/brands/28134/almoxil-250-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/69/amoxicillin-trihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Almoxil is indicated in the treatment of infections due to susceptible ß-lactamase negative strains of microorganisms. These infections include Almoxil is indicated in the treatment of infections due to susceptible ß-lactamase negative strains of microorganisms. These infections include",
        "items": [
          "Ear, nose and throat infections (i.e. otitis media, sinusitis, tonsillitis, pharyngitis, laryngitis)",
          "Lower respiratory tract infections (i.e. pneumonia, acute and chronic bronchitis lung abscess, empyema, bronchiectasis)",
          "Ear, nose and throat infections (i.e. otitis media, sinusitis, tonsillitis, pharyngitis, laryngitis)",
          "Lower respiratory tract infections (i.e. pneumonia, acute and chronic bronchitis lung abscess, empyema, bronchiectasis)",
          "Skin and soft tissue infections (i.e. cellulitis, carbuncles, furunculosis, infected wounds, abscess)",
          "Genito-urinary tract infections (i.e. pyelonephritis, cystitis and urethritis)",
          "Venereal disease (i.e. acute uncomplicated gonorrhoea)",
          "In dental abscess, it is used as short-term therapy.",
          "It is also indicated in combination with Clarithromycin and Lansoprazole (as triple therapy), for the treatment of patients with H. pylori infection and duodenal ulcer disease and to reduce the risk of duodenal ulcer recurrence."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Amoxicillin is a broad spectrum penicillin. It is effective against a wide range of Gram-positive and Gram-negative bacteria. It acts through the inhibition of biosynthesis of cell wall. Amoxicillin is stable in the presence of gastric acid and is rapidly absorbed after oral administration. After an oral dose, peak plasma concentration of Amoxicillin is reached within 1 to 2 hours. Amoxicillin is widely distributed at varying concentration in body tissues and fluids.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concurrent use of Almoxil and Probenecid may result in increased and prolonged blood levels of Almoxil. Almoxil may affect the gut flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral estrogen/progesterone contraceptives.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Amoxicillin is contraindicated in penicillin hypersensitive patients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects are mild and transient in nature. This may include diarrhoea, indigestion or occasionally rash. Pseudo-membranous colitis has been reported rarely.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA pregnancy category of Amoxicillin is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Amoxicillin has been shown to be excreted in human milk. So, caution should be exercised when Amoxicillin is administered to a lactating mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "The possibility of superinfections with mycotic or bacterial pathogens should be kept in mind during therapy. If superinfections occur, Almoxil should be discontinued and appropriate therapy should be instituted.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Reconstituted suspension can be administered by adding the required amount of suspension to milk, fruit juice, water. These preparations should then be taken immediately.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Broad spectrum penicillins",
    "dosage": [
      {
        "medication_type": "Adult",
        "information": ": 250 mg three times daily, increasing up to 500 mg three times daily for severe infections.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(up to 10 years of age) : 125 mg three times daily, increasing up to 250 mg three times daily for severe infections.",
        "instructions": []
      },
      {
        "medication_type": "Severe or recurrent purulent respiratory infection",
        "information": ": 3 gm every 12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Otitis media",
        "information": ": Recommended dose is 1 g three times daily for adult and 40 mg/kg body weight daily in 3 divided doses for children (max. 3 g daily).",
        "instructions": []
      },
      {
        "medication_type": "Pneumonia",
        "information": ": Recommended dose is 500-1000 mg three times daily.",
        "instructions": []
      },
      {
        "medication_type": "Dental abscess",
        "information": ": Recommended dose is 3 gm, repeated after 10-12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Urinary tract infections",
        "information": ": Recommended dose is 3 gm, repeated after 10-12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Gonorrhoea",
        "information": ": Single dose of 2-3 gm with Probenecid 1 gm is recommended (Probenecid is contraindicated in children under 2 years).",
        "instructions": []
      },
      {
        "medication_type": "In renal impairment",
        "information": ": it may be necessary to reduce the total daily dosage.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:16.373Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e4e",
    "original_record": {
      "input_index": 899,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e4e"
        },
        "name": "Almoxil",
        "strength": "125 mg/5 ml",
        "generic": "Amoxicillin Trihydrate",
        "company": "Aexim Pharmaceuticals Ltd.",
        "medicine_type": "Powder for Suspension",
        "source_url": "https://medex.com.bd/brands/6420/almoxil-125-mg-suspension",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/13393/alneed-gold-capsule",
    "name": "Alneed Gold",
    "dosage_form": "Capsule",
    "generic": "Iron Polymaltose Complex + Folic Acid + Zinc + Vitamin B-Complex",
    "strength": null,
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 6.00",
      "strip_price": "৳ 60.00",
      "pack_size_info": "(5 x 10: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 6.00",
          "pack_size_info": "(5 x 10: ৳ 300.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 60.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/405/iron-polymaltose-complex-folic-acid-zinc-vitamin-b-complex/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This is indicated for the treatment and prophylaxis of Zinc, Iron, Folic Acid, Vitamin B Complex deficiency, especially during pregnancy and lactation.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a special preparation of Iron Polymaltose Complex, Folic Acid, Zinc, and B vitamins. Iron Polymaltose Complex is a water soluble, macromolecular complex of poly nuclear iron (III) hydroxide and partially hydrolysed dextrin (Polymaltose). It does not interact with the food components and other medications and so there is no decrease in bioavailability of Iron Polymaltose Complex. This makes sure that with the consumption of this complex, iron gets utilized at a faster rate in the haemoglobin synthesis. Folic acid prevents neural tube defects. Zinc is essential for many metabolic processes, blood formation, wound healing and for immune system. Thiamine is essential for the functioning of the nervous and digestive systems. Riboflavin is important for digestion, immune system support and energy production. Pyridoxin is important for brain development, production of red blood cells, metabolism of proteins and to reduce morning sickness. Nicotinamide is important for energy, blood pressure and circulation.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No drug interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally well tolerated. However, a few allergic reactions may be seen.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Recommended during pregnancy & lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Care should be taken in patients who may develop iron overloads, such as those with haemochromatosis, haemolytic anaemia or red cell aplasia. Iron chelates with tetracycline and absorption may be impaired.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children below 6 years. Avoid higher doses if you have liver disease or hemochromatosis; excess can cause bloody diarrhea, vomiting, acidosis, darkened stools, abdominal pain. Symptoms may clear in a few hours. Riboflavin is reported to be completely safe and no toxic symptoms have been reported so far. Higher doses of Nicotinamide may cause vomiting, diarrhea. Sensory neuropathy was observed in individuals consuming more than 200 mg Pyridoxine for very long periods. No case of Folic acid overdose has been reported. Zinc toxicity has been seen in both acute and chronic forms. Ingestion of 150 to 450 mg of zinc per day has been associated with low copper status, altered iron function, reduced immune function, and reduced levels of high-density lipoproteins. So, Zinc at its RDA dosage does not cause any significant effect.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Do not store above 30°C. Keep away from light and out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Iron & Vitamin Combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "One capsule daily. In more severe cases, 2 capsules a day may be required or as directed by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:17.422Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e52",
    "original_record": {
      "input_index": 900,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e52"
        },
        "name": "Alneed Gold",
        "strength": null,
        "generic": "Iron Polymaltose Complex + Folic Acid + Zinc + Vitamin B-Complex",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/13393/alneed-gold-capsule",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/32414/alodia-25-mg-tablet",
    "name": "Alodia",
    "dosage_form": "Tablet",
    "generic": "Alogliptin Benzoate",
    "strength": "25 mg",
    "company": "ACME Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 22.00",
      "strip_price": "৳ 220.00",
      "pack_size_info": "(3 x 10: ৳ 660.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 22.00",
          "pack_size_info": "(3 x 10: ৳ 660.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 220.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "12.5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/33972/alodia-125-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1871/alogliptin-benzoate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alodia is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type-2 diabetes mellitus.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alogliptin is a DPP-4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus. Increased concentrations of the incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are released into the bloodstream from the small intestine in response to meals. These hormones cause insulin release from the pancreatic beta cells in a glucose-dependent manner but are inactivated by the DPP-4 enzyme within minutes. GLP-1 also lowers glucagon secretion from pancreatic alpha cells, reducing hepatic glucose production. In patients with type 2 diabetes, concentrations of GLP-1 are reduced but the insulin response to GLP-1 is preserved.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alodia is primarily renally excreted. Cytochrome (CYP) P450-related metabolism is negligible. No significant drug-drug interactions are observed with the CYP-substrates or inhibitors tested or with renally excreted drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "History of a serious hypersensitivity reaction to Alogliptin-containing products, such as anaphylaxis, angioedema or severe cutaneous adverse reactions.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Common side effects are nasopharyngitis, headache and upper respiratory tract infection.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category B. No adequate or well-controlled studies in pregnant women have been conducted with Alogliptin. Alogliptin tablets should be used during pregnancy only if clearly needed. It is not known whether Alogliptintin is excreted in human milk. caution should be exercised when Alogliptin is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Acute pancreatitis",
        "information": ": If pancreatitis is suspected, promptly Alodia should be discontinued.",
        "items": []
      },
      {
        "title": "Hypersensitivity",
        "information": ": There have been postmarketing reports of serious hypersensitivity reactions in patients treated with Alodia such as anaphylaxis, angioedema and severe cutaneous adverse reactions. In such cases, promptly Alodia should be discontinued.",
        "items": []
      },
      {
        "title": "Hepatic effects",
        "information": ": Postmarketing reports of hepatic failure, sometimes fatal. Causality can not be excluded. If liver injury is detected, promptly interrupt Alodia and assess patient for probable cause, then treat cause if possible, to resolution or stabilization. Do not restart Alodia if liver injury is confirmed and no alternative etiology can be found.",
        "items": []
      },
      {
        "title": "Hypoglycemia",
        "information": ": When an insulin secretagogue (e.g. sulfonylurea) or insulin is used in combination with Alodia, a lower dose of the insulin secretagogue or insulin may be required to minimize the risk of hypoglycaemia.",
        "items": []
      },
      {
        "title": "Macrovascular outcomes",
        "information": ": There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Alodia or any other antidiabetic drug.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Safety and effectiveness of Alodia in pediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": Of the total number of patients (N=8507) in clinical safety and efficacy studies treated with Alodia, 2064 (24.3%) patients were 65 years and older and 341 (4%) patients were 75 years and older. No overall differences in safety or effectiveness were observed between patients 65 years and over and younger patients. While this clinical experience has not identified differences in responses between the elderly and younger patients, greater sensitivity of some older individuals cannot be ruled out.",
        "items": []
      },
      {
        "title": "Hepatic Impairment",
        "information": ": No dose adjustments are required in patients with mild to moderate hepatic impairment (Child-Pugh Grade A and B) based on insignificant change in systemic exposures (e.g., AUC) compared to subjects with normal hepatic function in a pharmacokinetic study. Alodia has not been studied in patients with severe hepatic impairment (Child-Pugh Grade C). Use caution when administering Alodia to patients with liver disease.",
        "items": []
      },
      {
        "title": "Patients with Renal Impairment",
        "information": ":",
        "items": [
          "No dose adjustment of Alodia is necessary for patients with mild renal impairment (creatinine clearance ≥60 mL/min).",
          "The dose of Alodia is 12.5 mg once daily for patients with moderate renal impairment (creatinine clearance ≥30 to <60 mL/min).",
          "The dose of Alodia is 6.25 mg once daily for patients with severe renal impairment (creatinine clearance ≥15 to <30 mL/min) or with end-stage renal disease (ESRD) (creatinine clearance <15 mL/min or requiring hemodialysis).",
          "Patients requiring hemodialysis can receive their dose of alogliptin without regard to the timing of the dialysis."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The highest doses of Alodia administered in clinical trials were single doses of 800 mg to healthy subjects and doses of 400 mg once daily for 14 days to patients with type 2 diabetes (equivalent to 32 times and 16 times the maximum recommended clinical dose of 25 mg, respectively). No serious adverse events were observed at these doses. In the event of an overdose, it is reasonable to institute the necessary clinical monitoring and supportive therapy as dictated by the patient's clinical status. Per clinical judgment, it may be reasonable to initiate removal of unabsorbed material from the gastrointestinal tract. Alodia is minimally dialyzable; over a 3-hour hemodialysis session, approximately 7% of the drug was removed. Therefore, hemodialysis is unlikely to be beneficial in an overdose situation. It is not known if Alodia is dialyzable by peritoneal dialysis.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Dipeptidyl Peptidase-4 (DPP-4) inhibitor",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended dose in patients with normal renal function or mild renal impairment is 25 mg once daily or as directed by the physicians.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:18.792Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e54",
    "original_record": {
      "input_index": 901,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e54"
        },
        "name": "Alodia",
        "strength": "25 mg",
        "generic": "Alogliptin Benzoate",
        "company": "ACME Laboratories Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/32414/alodia-25-mg-tablet",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30977/aloglip-25-mg-tablet",
    "name": "Aloglip",
    "dosage_form": "Tablet",
    "generic": "Alogliptin Benzoate",
    "strength": "25 mg",
    "company": "Navana Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 22.00",
      "strip_price": "৳ 220.00",
      "pack_size_info": "(3 x 10: ৳ 660.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 22.00",
          "pack_size_info": "(3 x 10: ৳ 660.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 220.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "6.25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/30990/aloglip-625-mg-tablet?ref=1"
      },
      {
        "text": "12.5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/30991/aloglip-125-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1871/alogliptin-benzoate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aloglip is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type-2 diabetes mellitus.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alogliptin is a DPP-4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus. Increased concentrations of the incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are released into the bloodstream from the small intestine in response to meals. These hormones cause insulin release from the pancreatic beta cells in a glucose-dependent manner but are inactivated by the DPP-4 enzyme within minutes. GLP-1 also lowers glucagon secretion from pancreatic alpha cells, reducing hepatic glucose production. In patients with type 2 diabetes, concentrations of GLP-1 are reduced but the insulin response to GLP-1 is preserved.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Aloglip is primarily renally excreted. Cytochrome (CYP) P450-related metabolism is negligible. No significant drug-drug interactions are observed with the CYP-substrates or inhibitors tested or with renally excreted drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "History of a serious hypersensitivity reaction to Alogliptin-containing products, such as anaphylaxis, angioedema or severe cutaneous adverse reactions.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Common side effects are nasopharyngitis, headache and upper respiratory tract infection.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category B. No adequate or well-controlled studies in pregnant women have been conducted with Alogliptin. Alogliptin tablets should be used during pregnancy only if clearly needed. It is not known whether Alogliptintin is excreted in human milk. caution should be exercised when Alogliptin is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Acute pancreatitis",
        "information": ": If pancreatitis is suspected, promptly Aloglip should be discontinued.",
        "items": []
      },
      {
        "title": "Hypersensitivity",
        "information": ": There have been postmarketing reports of serious hypersensitivity reactions in patients treated with Aloglip such as anaphylaxis, angioedema and severe cutaneous adverse reactions. In such cases, promptly Aloglip should be discontinued.",
        "items": []
      },
      {
        "title": "Hepatic effects",
        "information": ": Postmarketing reports of hepatic failure, sometimes fatal. Causality can not be excluded. If liver injury is detected, promptly interrupt Aloglip and assess patient for probable cause, then treat cause if possible, to resolution or stabilization. Do not restart Aloglip if liver injury is confirmed and no alternative etiology can be found.",
        "items": []
      },
      {
        "title": "Hypoglycemia",
        "information": ": When an insulin secretagogue (e.g. sulfonylurea) or insulin is used in combination with Aloglip, a lower dose of the insulin secretagogue or insulin may be required to minimize the risk of hypoglycaemia.",
        "items": []
      },
      {
        "title": "Macrovascular outcomes",
        "information": ": There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Aloglip or any other antidiabetic drug.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Safety and effectiveness of Aloglip in pediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": Of the total number of patients (N=8507) in clinical safety and efficacy studies treated with Aloglip, 2064 (24.3%) patients were 65 years and older and 341 (4%) patients were 75 years and older. No overall differences in safety or effectiveness were observed between patients 65 years and over and younger patients. While this clinical experience has not identified differences in responses between the elderly and younger patients, greater sensitivity of some older individuals cannot be ruled out.",
        "items": []
      },
      {
        "title": "Hepatic Impairment",
        "information": ": No dose adjustments are required in patients with mild to moderate hepatic impairment (Child-Pugh Grade A and B) based on insignificant change in systemic exposures (e.g., AUC) compared to subjects with normal hepatic function in a pharmacokinetic study. Aloglip has not been studied in patients with severe hepatic impairment (Child-Pugh Grade C). Use caution when administering Aloglip to patients with liver disease.",
        "items": []
      },
      {
        "title": "Patients with Renal Impairment",
        "information": ":",
        "items": [
          "No dose adjustment of Aloglip is necessary for patients with mild renal impairment (creatinine clearance ≥60 mL/min).",
          "The dose of Aloglip is 12.5 mg once daily for patients with moderate renal impairment (creatinine clearance ≥30 to <60 mL/min).",
          "The dose of Aloglip is 6.25 mg once daily for patients with severe renal impairment (creatinine clearance ≥15 to <30 mL/min) or with end-stage renal disease (ESRD) (creatinine clearance <15 mL/min or requiring hemodialysis).",
          "Patients requiring hemodialysis can receive their dose of alogliptin without regard to the timing of the dialysis."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The highest doses of Aloglip administered in clinical trials were single doses of 800 mg to healthy subjects and doses of 400 mg once daily for 14 days to patients with type 2 diabetes (equivalent to 32 times and 16 times the maximum recommended clinical dose of 25 mg, respectively). No serious adverse events were observed at these doses. In the event of an overdose, it is reasonable to institute the necessary clinical monitoring and supportive therapy as dictated by the patient's clinical status. Per clinical judgment, it may be reasonable to initiate removal of unabsorbed material from the gastrointestinal tract. Aloglip is minimally dialyzable; over a 3-hour hemodialysis session, approximately 7% of the drug was removed. Therefore, hemodialysis is unlikely to be beneficial in an overdose situation. It is not known if Aloglip is dialyzable by peritoneal dialysis.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Dipeptidyl Peptidase-4 (DPP-4) inhibitor",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended dose in patients with normal renal function or mild renal impairment is 25 mg once daily or as directed by the physicians.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:20.167Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e59",
    "original_record": {
      "input_index": 902,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e59"
        },
        "name": "Aloglip",
        "strength": "25 mg",
        "generic": "Alogliptin Benzoate",
        "company": "Navana Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/30977/aloglip-25-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28/alona-100-mg-tablet",
    "name": "Alona",
    "dosage_form": "Tablet",
    "generic": "Aceclofenac",
    "strength": "100 mg",
    "company": "Kemiko Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.01",
      "strip_price": null,
      "pack_size_info": "(50's pack: ৳ 200.50)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.01",
          "pack_size_info": "(50's pack: ৳ 200.50)"
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/3/aceclofenac/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alona is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, toothache, trauma and lumbago.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Aceclofenac is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No significant drug interactions has not been observed but close monitoring of patients is required when it is used with:",
        "items": [
          "Lithium and Digoxin: may increase plasma concentration of lithium and digoxin.",
          "Diuretics: may interact the activity of diuretics.",
          "Anticoagulants: may enhance the activity of anticoagulant.",
          "Methotrexate: may increase the plasma level of methotrexate."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Aceclofenac is contraindicated in patients with known hypersensitivity to it or in whom aspirin or NSAIDs precipitate attacks of asthma.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Alona is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The use of Aceclofenac should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised to patients with active or suspected peptic ulcer or gastro-intestinal bleeding moderate to severe hepatic impairment and cardiac or renal impairment. Caution should also be exercised in patients suffering from dizziness or urticaria.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "There are no clinical data on the use of Alona in children.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs)",
    "dosage": [
      {
        "medication_type": null,
        "information": "Extended release tablet: The recommended dose in adults is one 200 mg Aceclofenac tablet daily or as prescribed by the physician.Film coated tablet: The recommended dose in adults is 100 mg, twice daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:21.450Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e5a",
    "original_record": {
      "input_index": 903,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e5a"
        },
        "name": "Alona",
        "strength": "100 mg",
        "generic": "Aceclofenac",
        "company": "Kemiko Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/28/alona-100-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/31446/alopin-5-mg-tablet",
    "name": "Alopin",
    "dosage_form": "Tablet",
    "generic": "Amlodipine Besilate",
    "strength": "5 mg",
    "company": "Silco Pharmaceutical Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": "৳ 40.00",
      "pack_size_info": "(5 x 10: ৳ 200.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(5 x 10: ৳ 200.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/62/amlodipine-besilate/brand-names",
    "indications": [
      {
        "title": "Essential hypertension",
        "information": ": Alopin is efficacious as monotherapy in the treatment of hypertension. It may be used in combination with other antihypertensive agents.",
        "items": []
      },
      {
        "title": "Angina pectoris",
        "information": ": Alopin is indicated for the treatment of chronic stable angina pectoris and is efficacious as monotherapy. It may be used in combination with other antianginal agents.",
        "items": []
      },
      {
        "title": "Vasospastic angina",
        "information": ": Alopin is indicated for the treatment of confirmed or suspected vasospastic angina. It may be used as monotherapy or in combination with other antianginal drugs.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Amlodipine is a dihydropyridine calcium-channel blocker, with a long duration of action, used for the treatment of hypertension and angina pectoris. Amlodipine influences the myocardial cells, the cells within the specialized conducting system of the heart, and the cells of vascular smooth muscle. Administration of Amlodipine results primarily in vasodilation, with reduced peripheral resistance, blood pressure and afterload, increased coronary blood flow and a reflex increase in coronary heart rate. This in turn results in an increase in myocardial oxygen supply and cardiac output.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Drug Interactions- Other Significant Interactions-",
        "items": [
          "Potentially hazardous interactions: Little or no data are available in patients with markedly impaired cardiac left ventricular function; however, as with other calcium antagonist drugs, the combination of Alopin and p-blockers should be avoided in such patients.",
          "Digoxin: Absence of any interaction between Alopin and Digoxin in healthy volunteers has been documented in a controlled clinical study.",
          "Cimetidine: An unpublished clinical study indicated no interaction between, Alopin and Cimetidine in healthy volunteers.",
          "Warfarin: An unpublished clinical study in healthy volunteers indicates that Alopin did not significantly alter the effect of Warfarin on prothrombin time.",
          "Food: Food does not alter the rate or extent of absorption of Alopin."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to dihydropyridine derivatives. Pregnant woman.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse effects of amlodipine are associated with vasodilatory action, such as dizziness, flushing, headache, hypotension and peripheral edema. Gastrointestinal disturbances, increased micturition frequency, lethargy, eye pain and mental depression may also occur. A paradoxical increase in ischaemic chest pain may occur at the start of the treatment and in a few patients excessive fall in blood pressure has led to cerebral or myocardial ischaemia or transient blindness. Rashes, fever and abnormalities in liver function due to hypersensitivity reaction of Alopin may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. There are no adequate and well-controlled studies of Amlodipine in pregnant women. Amlodipine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Amlodipine is excreted in human milk. In the absence of this information, it is recommended that nursing be discontinued while Amlodipine is administered.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Precaution should be taken in patients with hepatic impairment and during pregnancy and breast feeding.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children with hypertension from 6 years to 17 years of age",
        "information": ": 2.5 mg once daily as a starting dose, up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in pediatric patients.",
        "items": []
      },
      {
        "title": "Children under 6 years old",
        "information": ": The effect of amlodipine on blood pressure in patients less than 6 years of age is not known.",
        "items": []
      },
      {
        "title": "Elderly",
        "information": ": Alopin used at similar doses in elderly or younger patients is equally well tolerated. Normal dosage regimens are recommended in the elderly, but increase of the dosage should take place with care.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment, therefore the normal dosage is recommended. Alopin is not dialysable.",
        "items": []
      },
      {
        "title": "Hepatic impairment",
        "information": ": Dosage recommendations have not been established in patients with mild to moderate hepatic impairment; therefore dose selection should be cautions and should start at the lower end of the dosing range. The pharmacokinetics of Alopin have not been studied in severe hepatic impairment. Alopin should be initiated at the lowest dose (2.5 mg once daily) and titrated slowly in patients with severe hepatic impairment.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": "Symptoms",
        "information": ": Available data suggest that large overdosage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged systemic hypotension up to and including shock with fatal outcome have been reported.",
        "items": []
      },
      {
        "title": "Management",
        "information": ": Clinically significant hypotension due to amlodipine overdosage calls for active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities, and attention to circulating fluid volume and urine output. A vasoconstrictor may be helpful in restoring vascular tone and blood pressure, provided that there is no contraindication to its use. Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade. Gastric lavage may be worthwhile in some cases. In healthy volunteers the use of charcoal up to 2 hours after administration of amlodipine 10 mg has been shown to reduce the absorption rate of amlodipine. Since amlodipine is highly protein-bound, dialysis is not likely to be of benefit.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep all medicines out of reach of children. Store in a cool & dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Calcium-channel blockers",
    "dosage": [
      {
        "medication_type": "Hypertension",
        "information": ": Usual dose is 5 mg once daily. The maximum dose is 10 mg once daily. Elderly patients with hepatic insufficiency may be started on 2.5 mg once daily; this dose may also be used when adding Amlodipine to other antihypertensive therapy.",
        "instructions": []
      },
      {
        "medication_type": "Angina (Chronic stable or Vasospastic)",
        "information": ": 5 to 10 mg, using the lower dose for elderly and in patients with hepatic insufficiency. Most patients require 10 mg. Administrations: May be taken without regard to meals.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:22.729Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e5b",
    "original_record": {
      "input_index": 904,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e5b"
        },
        "name": "Alopin",
        "strength": "5 mg",
        "generic": "Amlodipine Besilate",
        "company": "Silco Pharmaceutical Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/31446/alopin-5-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/27839/aloran-5-mg-tablet",
    "name": "Aloran",
    "dosage_form": "Tablet",
    "generic": "Desloratadine",
    "strength": "5 mg",
    "company": "Alco Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 2.51",
      "strip_price": "৳ 25.10",
      "pack_size_info": "(5 x 10: ৳ 125.50)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.51",
          "pack_size_info": "(5 x 10: ৳ 125.50)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 25.10",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/329/desloratadine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aloran is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, such as sneezing, nasal discharge & itching, congestion or stuffiness, as well as ocular itching, tearing and redness, itching of palate and coughing. Aloran is also indicated for the relief of symptoms associated with chronic idiopathic urticaria such as the relief of itching and the size & number of hives.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Desloratadine, the major active metabolite of Loratadine, is a non-sedating; long acting tricyclic histamine antagonist with selective H1-receptor histamine antagonist activity. Desloratadine also inhibits histamine release from human mast cell.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No clinically relevant drug interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Desloratadine is contraindicated in patients having hypersensitivity to this medication or to any of its ingredients or Loratadine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Less common side effects may include headache, nausea, fatigue, dizziness, pharyngitis, dyspepsia and myalgia.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. The safe use of Desloratadine during pregnancy has not been established. Therefore, Desloratadine is not to be used during pregnancy unless clearly indicated. Desloratadine passes into breast milk, therefore a decision should be made whether to discontinue nursing or to discontinue Desloratadine taking into account the importance of the drug to the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In adult patients with liver or renal impairment: A starting dose of one 5 mg tablet every other day is recommended based on pharmacokinetic data. If the patient has medical or familial history of seizures.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Recommended in the use in children & adolescents.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "No clinically relevant adverse effects have been reported.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool & dry place, protected from light. Store below 30°C. Keep all medicines out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": null,
        "information": "Pediatric drops:",
        "instructions": []
      },
      {
        "medication_type": "Child 6-11 months of age",
        "information": ": 2 ml drops once daily.",
        "instructions": []
      },
      {
        "medication_type": "Child 1-2 years of age",
        "information": ": 2.5 ml drops once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "Child 6-11 months of age",
        "information": ": 2 ml once daily.",
        "instructions": []
      },
      {
        "medication_type": "Child 1-5 years of age",
        "information": ": 2.5 ml once daily.",
        "instructions": []
      },
      {
        "medication_type": "Child 6-11 years of age",
        "information": ": 5 ml once daily.",
        "instructions": []
      },
      {
        "medication_type": "Adults & >12 years of age",
        "information": ": 10 ml once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Tablet:",
        "instructions": []
      },
      {
        "medication_type": "Adults and children 12 years of age and over",
        "information": ": 1 tablet daily",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:24.094Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e5c",
    "original_record": {
      "input_index": 905,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e5c"
        },
        "name": "Aloran",
        "strength": "5 mg",
        "generic": "Desloratadine",
        "company": "Alco Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/27839/aloran-5-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/785/aloten-forte-5-mg-tablet",
    "name": "Aloten Forte",
    "dosage_form": "Tablet",
    "generic": "Amlodipine Besilate + Atenolol",
    "strength": "5 mg+50 mg",
    "company": "Kemiko Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 4.51",
      "strip_price": "৳ 45.10",
      "pack_size_info": "(5 x 10: ৳ 225.50)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.51",
          "pack_size_info": "(5 x 10: ৳ 225.50)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 45.10",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg+25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/784/aloten-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/63/amlodipine-besilate-atenolol/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This is indicated in-",
        "items": [
          "Patients with essential hypertension",
          "Patients with angina pectoris & hypertension as co-existing diseases",
          "ln post Ml patients",
          "ln patients with refractory angina pectoris where nitrate therapy has failed."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a fixed-dose combination of Amlodipine and Atenolol. Amlodipine is a dihydropyridine calcium antagonist that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle; it has a greater effect on vascular smooth muscle than on cardiac muscle. Amlodipine is a peripheral vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure. Amlodipine reduces tone, decreases coronary vasoreactivity and lowers cardiac demand by reducing afterload. Atenolol is a cardioselective beta-blocker. The cardio-selectivity is dose-related. Atenolol causes a reduction in blood pressure by lowering cardiac output, decreasing the plasma renin activity and sympathetic outflow from CNS. Atenolol also causes a reduction in myocardial oxygen demand by virtue of its negative inotropic and negative chronotropic effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Disopyramide",
        "information": ": Atenolol reduces the clearance of disopyramide by 20%. Additive negative inotropic effects on the heart may be produced.",
        "items": []
      },
      {
        "title": "Ampicillin",
        "information": ": at doses of 1 gm and above may reduce Atenolol levels.",
        "items": []
      },
      {
        "title": "Oral antidiabetics and insulin",
        "information": ": Beta-blockers may decrease tissue sensitivity to insulin and inhibit insulin secretion e.g. in response to oral antidiabetics. Atenolol has less potential for these actions.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to either component, sinus bradycardia, second and higher degrees of heart block, cardiogenic shock, hypotension, congestive heart failure, poor left ventricular function.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The combination of Amlodipine and Atenolol is well tolerated. Overall side-effects include fatigue, headache, edema, nausea, drowsiness, anxiety and depression.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The combination should be used during pregnancy only if the expected benefit outweighs the potential fetal risk. The combination should not be used by nursing mothers. If its use is considered necessary, breast-feeding should be stopped.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Bronchospasm",
        "information": ": The combination should be used with caution in patients with airway obstruction.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": The combination can be used in patients with renal impairment. However, caution may be necessary if the creatinine clearance is less than 30 ml/min because of possible reduction in the excretion of unchanged Atenolol.",
        "items": []
      },
      {
        "title": "Hepatic impairment",
        "information": ": Caution may be necessary in the use of the combination in patients with severe liver damage because of prolongation of the elimination half-life of Amlodipine.",
        "items": []
      },
      {
        "title": "Drug withdrawal",
        "information": ": Since coronary heart disease may exist without being recognized, patients should be warned against stopping the drug suddenly. Any discontinuation should be gradual and under observation.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Though not documented, hypotension and less frequently congestive cardiac failure may occur in cases of overdosage. Unabsorbed drugs may be removed by gastric lavage or administration of activated charcoal. Symptomatic treatment is suggested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Combined antihypertensive preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended dosage is Amlodipine and Atenolol 5/25 mg tablet once daily. If necessary, the dosage may be increased to 5/25 mg two tablets daily or as advised by the physicians. The dosage however should be individualized.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:25.567Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e5e",
    "original_record": {
      "input_index": 906,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e5e"
        },
        "name": "Aloten Forte",
        "strength": "5 mg+50 mg",
        "generic": "Amlodipine Besilate + Atenolol",
        "company": "Kemiko Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/785/aloten-forte-5-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/32337/alovit-bz-tablet",
    "name": "Alovit BZ",
    "dosage_form": "Tablet",
    "generic": "Vitamin B Complex + Zinc",
    "strength": null,
    "company": "Al-Madina Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.50",
      "strip_price": "৳ 75.00",
      "pack_size_info": "(1 x 30: ৳ 75.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.50",
          "pack_size_info": "(1 x 30: ৳ 75.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 75.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1133/vitamin-b-complex-zinc/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alovit BZ is indicated for the treatment and prevention of zinc and vitamin B deficiencies.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Zinc is vital for many biological functions such as immunity enhancement, wound healing, digestion, reproduction, physical growth and mental development. Zinc supports normal growth and development during pregnancy, childhood, and adolescence. Zinc also has some antioxidant properties. Zinc is used to treat ADHD (Attention Deficit Hyper-activity Disorder) in children. In adult, due to zinc deficiency loss of appetite, poor sense of taste and smell, tendency towards depression, white marks on fingernails, frequent infections, low fertility, prostate problems, mental problems, poor wound healing, a poor immune system, diarrhoea, mental lethargy, rough skin and weight loss may occur. B-Vitamins are needed to release energy from food. They play an important role in ensuring healthy brain and nerve function, healthy red blood cells formation in children & adults. They are specially needed for healthy growth and development of children. B-Vitamin deficiencies in adult cause profound fatigue and various types of neurologic manifestations, which may include weakness, poor balance, confusion, irritability, memory loss, nervousness, tingling of the limbs and loss of coordination. Additional symptoms of vitamin B deficiency are sleep disturbances, nausea, poor appetite, frequent infections, and skin lesions.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concomitant intake of tetracyclines and zinc may decrease the Gl absorption and serum levels of tetracyclines. Similarly concomitant administration of zinc and fluroquinolones may decrease the Gl absorption and serum levels of some fluroquinolones. Coadministration of Niacin and HMG-CoA reductase inhibitors (eg. lovastatin) may result mayopathy and rhabdomyolysis. Pyridoxine reduces levodopa's effectiveness by increasing its peripheral metabolism. Co-administration of pyridoxine with phenytoin may decrease serum levels of phenytoin.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Vitamin B Complex & Zinc is contraindicated in patients with a known hypersensitivity to any of the ingredients of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "This is generally well tolerated. However, a few side effects like nausea, vomiting, diarrhoea & stomach upset may occur. Side effects have been reported with specific vitamins but generally at levels substantially higher than recommended doses.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "This is recommended in pregnancy and lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "In acute renal failure, zinc accumulation may occur, so dosage adjustment is needed. This is not intended for the treatment of severe specific deficiencies.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "In case of overdosage, initially epigastric pain, diarrhoea and vomiting can occur. In that case, one should seek emergency medical attention. Initially, an emetic should be given and then gastric lavage and general supportive measures should be employed.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool & dry place, protected from light. Keep all medicines out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Specific mineral & vitamin combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "Syrup-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": 10 ml (2 teaspoonful) 2 to 3 times daily or as recommended by the physician.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 10 ml (2 teaspoonful) 1 to 3 times daily or as recommended by the physician.",
        "instructions": []
      },
      {
        "medication_type": "Infants",
        "information": ": 5 ml (1 teaspoonful) 1 to 2 times daily or as recommended by the physician.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Tablet-",
        "instructions": []
      },
      {
        "medication_type": "Adults & Children over 30 kg",
        "information": ": 1 to 2 tablets 2 to 3 times daily or as recommended by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:27.178Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e5f",
    "original_record": {
      "input_index": 907,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e5f"
        },
        "name": "Alovit BZ",
        "strength": null,
        "generic": "Vitamin B Complex + Zinc",
        "company": "Al-Madina Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/32337/alovit-bz-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/15941/alpatin-005-eye-drop",
    "name": "Alpatin",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Epinastine Hydrochloride",
    "strength": "0.05%",
    "company": "Beximco Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 150.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 150.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/419/epinastine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alpatin sterile ophthalmic solution is indicated for the treatment of signs and symptoms of allergic conditions of the anterior segment of the eye.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Epinastine is a topically active antihistamine that antagonizes both histamine H 1 and H 2 receptors. Moreover, it has mast cell stabilizing activity and prevents the release of inflammatory mediators from the blood vessel. Epinastine does not penetrate the blood-brain barrier and therefore is not expected to induce side effects on the central nervous system.",
        "items": []
      }
    ],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients who are hypersensitive to Epinastine or to any of the components of this preparation.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most frequently reported side effects are mild burning sensation, folliculosis, hyperemia, pruritus, cold symptoms and upper respiratory infections.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies on pregnant women. Epinastine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Epinastine is excreted in human milk. Caution should be exercised when Epinastine is administered to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "For ophthalmic use only. Patients should be advised not to wear contact lenses if their eye is red.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Use in children",
        "information": ": Safety and effectiveness in children below the age of 3 years have not been established.",
        "items": []
      },
      {
        "title": "Use in elderly patients",
        "information": ": No overall differences in safety and effectiveness have been observed between elderly and other adult patients.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool & dry place, protect from light. Do not use longer than one month after the first opening. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Ophthalmic Non-Steroid drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "Instill 1 drop in the affected eye(s) twice daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:28.221Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e63",
    "original_record": {
      "input_index": 908,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e63"
        },
        "name": "Alpatin",
        "strength": "0.05%",
        "generic": "Epinastine Hydrochloride",
        "company": "Beximco Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/15941/alpatin-005-eye-drop",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/26818/alphagan-p-015-eye-drop",
    "name": "Alphagan P",
    "dosage_form": "Ophthalmic Solution",
    "generic": "Brimonidine Tartrate",
    "strength": "0.15%",
    "company": "Allergan Pharmaceuticals International Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 664.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "5 ml drop",
          "price": "৳ 664.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/139/brimonidine-tartrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alphagan P 0.2% ophthalmic solution is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Alphagan P 0.15% ophthalmic solution is indicated for the control of intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension. Alphagan P 0.025% ophthalmic solution relieves redness of the eye due to minor eye irritations.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Brimonidine is an α-2 adrenoreceptor agonist that is more selective for the α-2 adrenoreceptor than α-1. Topical administration of Brimonidine Tartrate eye drops decreases intraocular pressure (IOP) in humans. When used as directed Brimonidine Tartrate have the action of reducing elevated IOP with minimal effect on cardiovascular parametres. Brimonidine Tartrate eye drops have a rapid onset of action with the peak ocular hypotensive effect occurring at two hours post-dosing. The duration of effect is 12 hours or greater. Fluorophotometric studies in animals and humans suggest that Brimonidine Tartrate has a dual mechanism of action. Brimonidine Tartrate eye drops lower IOP by reducing aqueous humor production and enhancing uveoscleral outflow.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Although specific drug interaction studies have not been conducted with Alphagan P ophthalmic solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, or anesthetics) should be considered. Alpha-agonists, as a class, may reduce pulse and blood pressure. Caution in using concomitant drugs such as beta-blockers (ophthalmic and systemic), antihypertensives and/or cardiac glycosides is advised. Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine. It is not known whether the concurrent use of these agents with Alphagan P ophthalmic solution in humans can lead to resulting interference with the IOP lowering effect. No data on the level of circulating catecholamines after administration of Alphagan P ophthalmic solution are available. Caution, however, is advised in patients taking Tricyclic antidepressants which can affect the metabolism and uptake of circulating amines.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Brimonidine Tartrate ophthalmic solution is contraindicated in patients with hypersensitivity to Brimonidine Tartrate. It is also contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Adverse events occurring in approximately 10-30% of the subjects, in descending order of incidence, included oral dryness, ocular hyperemia, burning and stinging, headache, blurring, foreign body sensation, fatigue/drowsiness, conjunctival follicles, ocular allergic reactions, and ocular pruritus. Events occurring in approximately 3-9% of the subjects, in descending order included corneal staining/erosion, photophobia, eyelid erythema, ocular ache/pain, ocular dryness, tearing, upper respiratory symptoms, eyelid edema, conjunctival edema, dizziness, blepharitis, ocular irritation, gastrointestinal symptoms, asthenia, conjunctival blanching, abnormal vision and muscular pain. The following adverse reactions were reported in less than 3% of the patients: lid crusting, conjunctival hemorrhage, abnormal taste, insomnia, conjunctival discharge, depression, hypertension, anxiety, palpitations/arrhythmias, nasal dryness and syncope.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies in pregnant women. In animal studies, Brimonidine crossed the placenta and entered into the fetal circulation to a limited extent. Brimonidine Tartrate ophthalmic solution 0.2% should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus. It is not known whether this drug is excreted in human milk; in animal studies Brimonidine Tartrate was excreted in breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Although Alphagan P ophthalmic solution had minimal effect on the blood pressure of patients in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease. Alphagan P ophthalmic solution should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension or thromboangiitis obliterans.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C in a cool and dry place protected from light. Keep out of reach of children. Do not touch the dropper tip to surfaces since this may contaminate the solution. Do not use after 30 days of first opening.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Opsonin pharma has launched the preservative-free sterile eye drops preparation with OSD (Ophthalmic squeeze dispenser) for the first time in Bangladesh. Alphagan P ophthalmic solution is an alpha-adrenergic receptor agonist. It has a peak ocular hypotensive effect occurring at two hours postdosing. Fluorophotometric studies in animals and humans suggest that Alphagan P has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for miotics and glaucoma",
    "dosage": [
      {
        "medication_type": "0.2% ophthalmic solution",
        "information": ": The recommended dose is one drop of 0.2% ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart. This ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.",
        "instructions": []
      },
      {
        "medication_type": "0.15% ophthalmic solution",
        "information": ": The recommended dose is one drop of 0.15% ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart.",
        "instructions": []
      },
      {
        "medication_type": "0.025% ophthalmic solution",
        "information": ": Instill 1 drop in the affected eye(s) every 6-8 hours. Do not use it more than 4 times daily. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:29.530Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e65",
    "original_record": {
      "input_index": 909,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e65"
        },
        "name": "Alphagan P",
        "strength": "0.15%",
        "generic": "Brimonidine Tartrate",
        "company": "Eskayef Pharmaceuticals Ltd.",
        "medicine_type": "Ophthalmic Solution",
        "source_url": "https://medex.com.bd/brands/26818/alphagan-p-015-eye-drop",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/29287/alphapress-xr-25-mg-tablet",
    "name": "Alphapress XR",
    "dosage_form": "Tablet (Extended Release)",
    "generic": "Prazosin Hydrochloride",
    "strength": "2.5 mg",
    "company": "Renata PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 12.00",
      "strip_price": "৳ 120.00",
      "pack_size_info": "(3 x 10: ৳ 360.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.00",
          "pack_size_info": "(3 x 10: ৳ 360.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "1 mg (Tablet)",
        "href": "https://medex.com.bd/brands/2586/alphapress-1-mg-tablet?ref=1"
      },
      {
        "text": "2 mg (Tablet)",
        "href": "https://medex.com.bd/brands/2587/alphapress-2-mg-tablet?ref=1"
      },
      {
        "text": "5 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/29288/alphapress-xr-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/913/prazosin-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Hypertension: Alphapress XR is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a ... Read moreHypertension: Alphapress XR is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a diuretic and/or other antihypertensive drugs as needed for proper patient response. Renal blood flow and glomerular filtration rate are not impaired by long-term oral administration and thus Alphapress XR can be used with safety in hypertensive patients with impaired renal function.Left Ventricular Failure: Alphapress XR is indicated in the treatment of left ventricular failure. Alphapress XR may be added to the therapeutic regimen in those patients who have not shown a satisfactory response or who have become refractory to conventional therapy with diuretics, with or without cardiac glycosides.Raynaud's Phenomenon And Raynaud's Disease: Alphapress XR indicated in the treatment of Raynaud's phenomenon and Raynaud's disease.Benign Prostatic Hyperplasia: Alphapress XR is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia. It is also of value in patients awaiting prostatic surgery.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Prazosin causes a decrease in total peripheral vascular resistance through selective inhibition of postsynaptic alpha-1-adrenoreceptors in vascular smooth muscle. In hypertensive patients, blood pressure is lowered in both the supine and standing positions; this effect is more pronounced on the diastolic blood pressure. Rebound elevation of blood pressure does not occur following abrupt cessation of Prazosin therapy. The therapeutic efficacy of Prazosin in patients with congestive heart failure is ascribed to a reduction in left ventricular filling pressure, reduction in cardiac impedance and an augmentation of cardiac output. The use of Prazosin in congestive heart failure does not provoke a reflex tachycardia and blood pressure reduction is minimal in normotensive patients. Prazosin reduce the severity of the signs, symptoms, frequency and duration of attacks, in patients with Raynaud's disease. In low dosage, antagonism of alpha-1-receptors on prostatic and urethral smooth muscle has been shown to improve the urinary pressure profile in men and to improve symptoms of benign prostatic hyperplasia. Clinical studies have shown that Prazosin therapy is not associated with adverse changes in the serum lipid profile.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alphapress XR XR has been administered without any adverse drug interaction in clinical experience to date with the following:",
        "items": [
          "Cardiac-glycosides-digitalis and digoxin;",
          "Hypoglycemic agents-insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide;",
          "tranquilizers and sedatives-chlordiazepoxide, diazepam and phenobarbital;",
          "antiarrhythmic agents-procainamide, propranolol and quinidine; and",
          "analgesic, antipyretic and anti-inflammatory agents-propxyphene, aspirin, indomethacin and phenylbutazone type."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Prazosin is contraindicated in patients with a known sensitivity to quinazolines.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common reactions associated with Alphapress XR therapy are dizziness, headache, drowsiness, lack of energy, weakness, palpitations and nausea. In most instances, side effects have disappeared with continued therapy or have been tolerated with no decrease in the dosage of the drug. In addition, the following reactions have been associated with Alphapress XR therapy; vomiting diarrhea, constipation, abdominal discomfort and/or pain, liver function abnormalities, pancreatitis, edema, orthostatic hypotension, dyspnea, faintness, tachycardia, nervousness, vertigo, hallucinations, depression, paresthesia, rash, pruritus alopecia, lichen planus, urinary frequency, impotence, incontinence, priapism, blurred vision, reddened solera, epistaxis, tinnitus, dry mouth, nasal congestion, diaphoresis, fever, positive ANA liter, and arthralgia. Some of these reactions have occurred rarely, and in many instances, the exact causal relationships have not been established. Literature reports exist associating Alphapress XR, therapy with a worsening of pre-existing narcolepsy. A causal relationship is uncertain in these cases. The following have been observed in parents being managed for left ventricular failure with Alphapress XR when used in conjunction with cardiac glycosides and diuretics; drowsiness, dizziness, postural hypotension, blurred vision, edema, dry mouth, palpitations, nausea, diarrhea, impotence, headache, and nasal congestion. In most instances, these occurrences have been mild to moderate in severity and have resolved with continued therapy or have been tolerated with no decrease in drug dosage. The most commonly although infrequently reported side effect in the treatment of Raynaud's Phenomenon/Disease was mild dizziness.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although no teratogenic effects were seen in animal testing; the safety of Prazosin use during. pregnancy has not yet been established. The use of prazosin and a beta-blocker for the control of sever hypertension of 44 pregnant women revealed no drug-related fetal adnormalities or adverse effects. Therapy with prazosin was continued for as long as 14 weeks. Prazosin has also been used alone or in combination with other hypotensive agents in severe hypertension or pregnancy. No fetal or neonatal abnormalities have been reported with the use of Prazosin. There are no adequate and well controlled studies that establish the safety of Prazosin in pregnant women. Prazosin should be used during pregnancy only if in the opinion of the physician the potential benefit justifies the potential risk to the mother and fetus. Prazosin has been shown to be excreted in small amounts in human milk. Caution shold be exercised when Prazosin is adminsitered to nursing mothers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Hypertension",
        "information": ": A very small percentage of patients have responded in an abrupt and exaggerated manner to the initial dose of Alphapress XR. Postural hypotension evidenced by dizziness and weakness, or rarely loss of consciousness, has been reported, particularly with the commencement of therapy, but this effect is readily avoided by initiating treatment with a low dose of Alphapress XR XR and with small increases in dosage during the first one to two weeks of therapy. The effect when observed is not related to the severity of hypertension is self-limiting and in most patients does not recur after the initial period of therapy or during subsequent dose titration steps. When instituting therapy with any effective antihypertensive agent, the patient should be advised how to avoid symptoms resulting from postural hypotension and what measures to take should they develop. The patient should be cautioned to avoid situations where injury could result should dizziness or weakness occur during the initiation of Alphapress XR therapy.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": When prazosin is initially administered to patients with left ventricular failure who have undergone vigorous diuretic or other vasodilator treatment, particularly in higher than the recommended starting dose, the resultant decrease in left ventricular filling pressure may be associated with a significant fall in cardiac output and systemic blood pressure. In such patients, observance of the recommended starting dose of prazosin followed by gradual titration is particularly important. (See dosage and administration). In occasional patients with left ventricular failure, the clinical efficacy of Alphapress XR has been reported to diminish after several months of treatment. In these patients, there is usually evidence of weight gain or peripheral edema indicating fluid retention. Since spontaneous deterioration may occur in such severely ill patients a causal relationship to prazosin therapy has not been established. Thus, as with all patients with left ventricular failure, careful adjustment of diuretic dosage according to the patient's clinical condition is required to prevent excessive fluid retention and consequent relief of symptoms. In those patients without evidence of fluid retention, when clinical improvement has diminished; an increase in the dosage, of Alphapress XR will usually restore clinical efficacy.",
        "items": []
      },
      {
        "title": "Raynaud's Phenomenon and Raynaud's Disease",
        "information": ": Because Alphapress XR decreases peripheral vascular resistance, careful monitoring of blood pressure during initial administration and titration of Alphapress XR is suggested. Close observation is especially recommended for patients already taking medication that are known the lower blood pressure.",
        "items": []
      },
      {
        "title": "Benign Prostatic Hyperplasia",
        "information": ": Alphapress XR decreases peripheral vasular resistance and since many patients with this disorder are elderly, careful monitoring of blood pressure during initial administration and during adjustment of the dose of Alphapress XR is suggested. Close observation is especially recommended for patients taking medications that are known to lower blood pressure.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children",
        "information": ": Alphapress XR is not recommended for the treatment of children under the age of 12 years since safe conditions for its use have not been established.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": Alphapress XR is not recommended in the treatment of left ventricular failure due to mechanical obstrcution such as aortic valve stenosis, mitral valve stenosis, pulmonary embolism and restrictive pericardial disease. Adequate data are not yet available to establish efficacy in patients with left ventricular failure due to a recent myocardial infarction.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Accidental ingestion of at least 50 mg of Alphapress XR in a two-year child resulted in profound drowsiness and depressed reflexes, No decrease in blood pressure was noted. Recovery was uneventful. Should overdosage lead to hypotension, support of the cardiovascular system is of first importance. Restoration of blood pressure and normalization of heart rate may be accomplished by keeping the patient in the supine position. If this measure is inadequate, shock should first be treated with volume expanders. If necessary, vasopressors should then be used. Renal function should be monitored and supported as needed. Laboratory data indicate Alphapress XR is not dialyzable because it is protein bound.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep away from light and moisture, store below 30°C. Keep away from reach out of the children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Alpha adrenoceptor blocking drugs",
    "dosage": [
      {
        "medication_type": "Prazosin Tablet",
        "information": ": There is evidence that toleration is best when therapy is initiated with a low starting dose. During the first week, the dosage of Prazosin should be adjusted according to the patient's individual toleration. Thereafter the daily dosage is to be adjusted on the basis of the patient's response. The response is usually seen within one to 14 days if it is to occur at any particular dose. When a response is seen, therapy should be continued at that dosage until the degree of response has reached optimum before the next dose increment is added.",
        "instructions": [
          "Hypertension: For maximum benefit, small increases should be continued until the desired effect is achieved or a total daily dosage of 20 mg is reached. A diuretic or adrenergic beta-blocking agent may be added to enhance efficacy. The maintenance dosage of Prazosin may be given as a twice or three times daily regimen.",
          "Patients Receiving No Antihypertensive Therapy. It is recommended that therapy be initiated with 0.5 mg given in the evening at bedtime then 0.5 mg b.i.d. or t.i.d for three to seven days. Unless poor toleration suggests the patient is unusually sensitive, this dosage should be increased to 1 mg given b.i.d. or t.i.d. for a further three to seven days. Thereafter, as determined by the patient's response to the blood pressure lowering effect, the dosage should be increased gradually to a total daily dosage of 20 mg given in divided doses.",
          "Patients Receiving Diuretic Therapy With inadequate Control of Blood Pressure. The diuretic should be reduced to a maintenance dosage level for the particular agent and Prazosin initiated with 0.5 mg h.s then proceeding to 0.5 mg b.i.d or t.i.d. After the initial period of observation, the dosage of Prazosin should be gradually increased as determined by the patient's response.",
          "Patients Receiving Other Antihypertensives But With Inadequate Control. Because some additive effect is anticipated, the other agent dosage level (e.g. beta-adrenergic blocking agents, methyldopa. reserpine, lsnidine etc.) should be reduced and Prazosin initiated at 0.5 mg h.s. then proceeding to 0.5 mg b.i.d, or t.i.d. Subsequent dosage increase should be made depending upon the patient's response. There is evidence that adding Prazosin to beta-adrenergic blocking agents, calcium antagonists or ACE inhibitors may bring about a substantial reduction in blood pressure. Thus, to low initial dosage regimen is strong, recommended.",
          "Patients With Moderate to Severe Grades of Renal Impairment Evidence to date shows that Prazosin does not further compromise renal function when used in patients with renal impairment. Because some patients in this category have responded to small doses of Prazosin , it is recommended that therapy be initiated at 0.5 mg daily and that dosage increases be instituted cautiously."
        ]
      },
      {
        "medication_type": "Left Ventricular Failure",
        "information": ": The recommended starting dose is 0.5 mg two, three or four times a day, Dosage should be titrated according to the patent's clinical response, based on careful monitoring of cardiopulmonary signs and symptoms, and when indicated, hemodynamic studies. Dosage titration steps may be performed as often as every two or three days in patients under close medical supervision. In severely ill, decompensated patients, rapid dosage titiration over one to two days may be indicated and is best done when hemodynamic- monitoring is available In dininai studies, the therapeutic dosages ranged from 4 mg to 20mg daily in divided doses. Adjustment of dosage may be required in the course of Prazosin therapy in some patients to maintain optimal clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5 mg b.i.d., t.i.d. or q.i.d. increasing to 4 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Use Daily Maintenance Dosage",
        "information": ": 4 mg once daily to 20 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Raynaud's Phenomenon And Raynaud's Disease",
        "information": ": The recommended starting dosage is 0.5 mg b.i.d. given for a period of three to seven days. Dosage should be adjusted according to the patient's clinical response.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5mg b.i.d.",
        "instructions": []
      },
      {
        "medication_type": "Usual Daily Maintenance Dosage",
        "information": ": 1mg or 2 mg b.i.d Doses up to 2 mg t.i.d. may be required for some patients.",
        "instructions": []
      },
      {
        "medication_type": "Benign Prostatic Hyperplasia",
        "information": ": The recommended starting dose is 0.5 mg twice daily given for a period of 3 to 7 days and should then be adjusted according to the patient's clinical responses. The usual maintenance dose is 2 mg twice daily. The safety and efficacy of a total daily dosage greater than 4 mg have not been established. Therefore, total daily dosages greater than 4mg should be used with caution.",
        "instructions": []
      },
      {
        "medication_type": "Prazosin XR Tablet",
        "information": ": Prazosin XR Extended-Release Tablets must be swallowed whole and should not be bitten or divided. Therapy for hypertension with Prazosin XR must be initiated at 2.5 mg once daily. The 5 mg dosage form of Prazosin XR is not for initial dosing. Dosage may be increased slowly, in general over a 7 to 14-day period, depending on the response to each dose level. Doses above 20 mg once daily have not been studied. Maintenance Dose: Dosage may be increased as clinically indicated to 20 mg given in once-daily doses. Hypertensive patients controlled on Prazosin Tablets alone or in combination with other antihypertensive medications may be switched to Prazosin XR Extended Release Tablets at the equivalent or nearest higher total daily dose, e.g. Prazosin Tablets 4 mg daily equivalent to Prazosin XR Extended Release Tablets 5 mg once daily. Blood pressure measurements should be taken at the end of the dosing interval to assure adequate blood pressure control is maintained throughout the 24-hour period. Further titration may be necessary in some patients. The addition of a diuretic or other antihypertensive agent to prazosin has been shown to cause an additive hypotensive effect.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:31.007Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e6f",
    "original_record": {
      "input_index": 910,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e6f"
        },
        "name": "Alphapress XR",
        "strength": "2.5 mg",
        "generic": "Prazosin Hydrochloride",
        "company": "Renata PLC",
        "medicine_type": "Tablet (Extended Release)",
        "source_url": "https://medex.com.bd/brands/29287/alphapress-xr-25-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/286/alphin-ds-400-mg-chewable-tablet",
    "name": "Alphin DS",
    "dosage_form": "Chewable Tablet",
    "generic": "Albendazole",
    "strength": "400 mg",
    "company": "Beximco Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5.00",
      "strip_price": "৳ 5.00",
      "pack_size_info": "(50 x 1: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.00",
          "pack_size_info": "(50 x 1: ৳ 250.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 5.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/16/albendazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alphin DS is indicated in single and mixed infestations of-",
        "items": [
          "Hookworm (Ancylostoma, Necator)",
          "Roundworm (Ascaris)",
          "Threadworm (Enterobius)",
          "Whipworm (Trichuris)",
          "Strongyloides",
          "Tapeworm",
          "Opisthorchi",
          "Hydatid."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Albendazole is a broad spectrum anthelmintic. Albendazole exhibits vermicidal, ovicidal and larvicidal activities. The drug is thought to exert its anthelmintic effect by blocking glucose uptake in the susceptible helminths, thereby depleting the energy level until it becomes inadequate for survival. Immobilization is followed by the parasite. These events may be a consequence of the binding and subsequent inhibition of parasite tubulin polymerization by Albendazole and its metabolites, although the drug also binds to human tubulin. Albendazole is extensively metabolized, probably in the liver. Albendazole is poorly absorbed from the gastrointestinal tract but rapidly undergoes extensive first-pass metabolism. The principal metabolite albendazole sulphoxide has anthelmintic activity and a plasma half-life of about 8.5 hrs. It is excreted in the urine together with other metabolites.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No interaction involving Alphin DS, either pharmacodynamic or pharmacokinetic, has been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": "Neonates",
        "information": ": Albendazole is not normally used in neonates.",
        "items": []
      },
      {
        "title": "Children",
        "information": ": Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.",
        "items": []
      },
      {
        "title": "Pregnant woman",
        "information": ": Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.",
        "items": []
      },
      {
        "title": "Concurrent disease",
        "information": ": There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal disturbances, headache, dizziness, changes in liver enzymes, rarely reversible alopecia; rash, fever, blood disorders including leucopenia and pancytopenia reported; allergic shock if cyst leakage; convulsion and meningism in cerebral disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy category of Albendazole is C. So, Albendazole should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Blood counts and liver function tests before treatment and twice during each cycle; breastfeeding; exclude pregnancy before starting treatment. Alphin DS should only be used in the treatment of Echinococcosis if there is constant medical supervision with regular monitoring of serum-transaminase concentrations and of leucocyte and platelet counts",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "Alphin DS is a benzimidazole anthelmintic, active against most nematodes and some cestodes. It is used in the treatment of intestinal nematode infections and in higher doses in the treatment of hydatid disease. Alphin DS exhibits vermicidal, ovicidal, and larvicidal activity. The principal mode of action of Alphin DS is its inhibitory effect on tubulin polymerization, which results in the loss of cytoplasmic microtubules.",
        "items": []
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anthelmintic",
    "dosage": [
      {
        "medication_type": "Adults & children over 2 years",
        "information": ":",
        "instructions": [
          "400 mg (1 tablet or 10 ml suspension) as a single dose in cases of Enterobius vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus.",
          "In cases of strongyloidiasis or taeniasis, 400 mg (1 tablet or 10 ml suspension) daily should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated."
        ]
      },
      {
        "medication_type": "Children of 1-2 years",
        "information": ": Recommended dose is a single dose of 200 mg (5 ml suspension).",
        "instructions": []
      },
      {
        "medication_type": "Children under 1 year",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In Hydatid disease (Echinococcosis)",
        "information": ":",
        "instructions": [
          "Albendazole is given by mouth with meals in a dose of 400 mg twice daily for 28 days for patients weighing over 60 kg.",
          "A dose of 15 mg/kg body weight daily in two divided doses (to a maximum total daily dose of 800 mg) is used for patients weighing less than 60 kg.",
          "For cystic echinococcosis, the 28 days course may be repeated after 14 days without treatment, to a total of 3 treatment cycles.",
          "For alveolar echinococcosis, cycles of 28 days of treatment followed by 14 days without treatment, may need to continue for months or years.",
          "In giardiasis, 400 mg (1 tablet or 10 ml suspension) once daily for five days is used."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:32.256Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e71",
    "original_record": {
      "input_index": 911,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e71"
        },
        "name": "Alphin DS",
        "strength": "400 mg",
        "generic": "Albendazole",
        "company": "Beximco Pharmaceuticals Ltd.",
        "medicine_type": "Chewable Tablet",
        "source_url": "https://medex.com.bd/brands/286/alphin-ds-400-mg-chewable-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/37748/alpk2-v500-manual-blood-bp-monitor-device",
    "name": "ALPK2 (V500)",
    "dosage_form": "BP Monitor Device",
    "generic": "BP monitoring device",
    "strength": "Manual blood pressure monitor",
    "company": "Tanaka Sangyo Co. Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 2,200.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "Each device",
          "price": "৳ 2,200.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/2390/bp-monitoring-device/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Blood pressure is a measure of the force of the blood against the wall of a blood vessel. Blood vessels are arteries and veins. They are tubes that carry blood throughout the body. When the heart beats, it pushes blood through these vessels. Blood pressure is a measure of the force on the walls of an ... Read moreBlood pressure is a measure of the force of the blood against the wall of a blood vessel. Blood vessels are arteries and veins. They are tubes that carry blood throughout the body. When the heart beats, it pushes blood through these vessels. Blood pressure is a measure of the force on the walls of an artery when the heart beats and when it relaxes between beats.",
        "items": [
          "Blood pressure is written as 2 numbers, for example, 110/60.",
          "The systolic blood pressure (suh-staa-luhk), the top number, is the pressure of the blood against the artery walls when the heart beats.",
          "The diastolic blood pressure (dai-uh-staa-luhk), the bottom number, is the pressure of the blood against the artery walls between heartbeats.",
          "Blood pressure can change during the day. It is often the lowest in the morning. Things that can affect blood pressure are: emotions, age, medicines, activity, body size, very hot or cold air temperature, and illness, injury, or pain.",
          "A normal ALPK2 (V500) for one child may not be normal for another. For children under age 18 years, a normal ALPK2 (V500) is based on their height. The doctor or health care provider will tell you what is normal for your child."
        ]
      }
    ],
    "mode_of_action": [],
    "interaction": [],
    "contraindications": [],
    "side_effects": [],
    "pregnancy_cat": [],
    "precautions": [],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [
      {
        "title": null,
        "information": "How to measure blood pressure using a manual monitor- How to measure blood pressure using an automatic monitor-",
        "items": [
          "Manual, or aneroid, equipment includes a cuff, an attached pump, a stethoscope and a gauge.",
          "This equipment requires coordination. It's difficult to use if you're hearing or visually impaired or if you're unable to perform the hand movements needed to squeeze the bulb and inflate the cuff.",
          "When you're ready to take your blood pressure, sit quietly for three to five minutes beforehand.",
          "To begin, place the cuff on your bare upper arm one inch above the bend of your elbow. Pull the end of the cuff so that it's evenly tight around your arm. You should place it tight enough so that you can only slip two fingertips under the top edge of the cuff. Make sure your skin doesn't pinch when the cuff inflates.",
          "Once the cuff is on, place the disk of the stethoscope facedown under the cuff, just to the inner side of your upper arm.",
          "Next, place the stethoscope earpieces in your ears, with the earpieces facing forward, pointing toward the tip of your nose. Rest the gauge in the open palm of the hand of your cuffed arm so that you can clearly see it.",
          "Then, squeeze the pump rapidly with your opposite hand until the gauge reads 30 points above your usual systolic pressure. (Be sure to inflate the cuff rapidly). Stop squeezing. Turn the knob on the pump toward you (counterclockwise) to let the air out slowly.",
          "Let the pressure fall 2 millimeters, or lines on the dial, per second while listening for your heart sounds. Note the reading when you first hear a heartbeat. This is your systolic pressure.",
          "Note when you no longer hear the beating sounds. This is your diastolic pressure.",
          "Rest quietly and wait about one to two minutes before taking another measurement. Record your numbers either by writing the information down or by entering the information into an electronic personal health record.",
          "To monitor your blood pressure using an automatic blood pressure monitor, find a comfortable place to sit with good back support at a table or desk.",
          "When you're ready to take your blood pressure, sit quietly for three to five minutes beforehand.",
          "Place your feet flat on the floor and rest your arm on a tabletop even with your heart. Lean against the back of the chair. Stretch out your arm, palm upward.",
          "Place the cuff on your bare upper arm one inch above the bend of your elbow. Make sure the tubing falls over the front center of your arm so that the sensor is correctly placed. Pull the end of the cuff so that it's evenly tight around your arm. You should place it tight enough so that you can only slip two fingertips under the top edge of the cuff. Make sure your skin doesn't pinch when the cuff inflates.",
          "To get started, wait a moment, then press start. Remain still and quiet as the machine begins measuring. The cuff will inflate, then slowly deflate so that the machine can take your measurement. When the reading is complete, the monitor displays your blood pressure and pulse on the digital panel. If the monitor doesn't record a reading, reposition the cuff and try again. Rest quietly and wait about one to two minutes before taking another measurement.",
          "Record your numbers, either by writing the information down or by entering the information into an electronic personal health record. Some monitors can upload your blood pressure readings automatically into a computer or mobile device."
        ]
      },
      {
        "title": "How to Take a Blood Pressure Reading-",
        "information": "Have your child rest their arm, palm facing up, where it will stay still. The ALPK2 (V500) cuff will need to be placed at about the same level as the heart. Put the cuff on a bare arm. Press the On/Off/Memory button to turn on the device. For a semi-automatic device: For an automatic device: Keeping a Record:",
        "items": [
          "The bottom edge of the cuff should be about 1 inch above the bend in your child’s elbow.",
          "Find the symbol or arrow on the edge of the cuff to know where to position the cuff over the artery.",
          "Wrap the cuff snugly. The tube(s) should hang freely toward your child’s body.",
          "Before putting on the cuff, make sure that there is no air in it. You may need to push an air release button near the bulb to let out the air.",
          "Put the cuff on and squeeze the bulb quickly to fill (inflate) it with air. The cuff should inflate to a number at least 30 higher than the expected systolic pressure. If your child is taking their own ALPK2 (V500), they should grasp the bulb with the hand opposite the arm the cuff is on.",
          "The cuff will become tight and hurt a little, but only for a few seconds.",
          "The machine will beep to let you know when the cuff is inflated enough. After you hear the beep, press the air release button, and lay down the bulb. Have your child relax and sit quietly. The device will do the rest of the work.",
          "As the device slowly lets air out (deflates), you will see numbers change and a flashing arrow pointing down. When the device senses a pulse, a heart symbol in the display starts to flash. You will hear a beep for each heartbeat.",
          "When done, the display will show the systolic and diastolic blood pressures and the",
          "heart rate.",
          "If the machine was not able to take the ALPK2 (V500), the display would show a flashing arrow pointing up. You will need to start over. This time, pump the bulb a little higher than",
          "30 above what you think the systolic pressure will be. Remind your child to sit still.",
          "After you press the START button, the cuff will fill with air. The device can sense how much to inflate the cuff. It will become tight and hurt a little, but only for a few seconds.",
          "As the device lets air out, you will see numbers and a tiny heart symbol flashing. The flashing heart is your child’s heartbeat.",
          "When done, the display will show the systolic and diastolic blood pressures and the heart rate.",
          "If your child moved or if the cuff was not put on right, the device may show an E or error message. When this happens, repeat steps 1 and 2.",
          "It is important to keep a record of your child's blood pressure. Use the Blood Pressure Record or write the readings down on a calendar. Take the record with you whenever your child sees their doctor or health care provider."
        ]
      }
    ],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": null,
    "dosage": [],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:33.841Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e73",
    "original_record": {
      "input_index": 912,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e73"
        },
        "name": "ALPK2 (V500)",
        "strength": "Manual blood pressure monitor",
        "generic": "BP monitoring device",
        "company": "Tanaka Sangyo Co. Ltd.",
        "medicine_type": "BP Monitor Device",
        "source_url": "https://medex.com.bd/brands/37748/alpk2-v500-manual-blood-bp-monitor-device",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/36373/alprazol-05-mg-tablet",
    "name": "Alprazol",
    "dosage_form": "Tablet",
    "generic": "Alprazolam",
    "strength": "0.5 mg",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.00",
      "strip_price": "৳ 20.00",
      "pack_size_info": "(3 x 10: ৳ 60.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.00",
          "pack_size_info": "(3 x 10: ৳ 60.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 20.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/36372/alprazol-025-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/18/alprazolam/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alprazol is indicated in-",
        "items": [
          "Anxiety disorder",
          "Short term relief of anxiety",
          "Anxiety associated with depression",
          "Panic disorder, with or without agoraphobia."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alprazolam is a triazole analog of the 1,4-benzodiazepine class of drugs. It is an anxiolytic with hypnotic and anticonvulsive properties. Alprazolam is presumed to produce its effects via interacting with the Gamma Aminobutyric Acid (GABA)- benzodiazepine receptor complex. Like all benzodiazepines, it causes a dose-related CNS depressant activity varying from mild impairment of task performance to hypnosis.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The CNS-depressant action of Alprazol may be aggravated by concomitant use of other psychotropic drugs, anticonvulsants, antihistaminics, alcohol and oral ontraceptives.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects, if occur, are generally observed at the beginning of therapy and usually disappear upon continued medication. The most frequent side effects are drowsiness and light-headedness. The other side effects, that may occur include depression, headache, confusion, dry mouth, constipation, etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Alprazolam has been categorized in pregnancy category D; that means, it should be avoided in pregnancy. Like other benzodiazepines, Alprazolam is assumed to be excreted in breast milk. Therefore, nursing should not be undertaken by mothers who must use Alprazolam.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Because Alprazol may produce psychological and physical dependence, the increment of dose or abrupt discontinuation of Alprazol therapy should not be done without the physician's advice. The duration of therapy must be determined by the physicians. Alprazol should be administered with caution to patients with hepatic or renal disease, chronic pulmonary insufficiency, or sleep apnea.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "The safety and effectiveness of Alprazol in individuals below 18 years of age have not been established.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Manifestations of Alprazol overdosage include somnolence, confusion, impaired coordination, diminished reflexes, and coma. In such cases of overdosage general supportive measures should be employed along with immediate gastric lavage.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Benzodiazepine sedatives",
    "dosage": [
      {
        "medication_type": null,
        "information": "Treatment should be initiated with a dose of 0.25 to 0.5 mg three times daily. Depending on the response, dose may be increased at intervals of 3 to 4 days in increments of no more than 1 mg/day. The maximum dose should not exceed 4 mg/day. Occasional patients with panic disorder may need as much as 10 mg a day to achieve a successful response and in these cases periodic reassessment and consideration of dosage adjustment is required. Dosage should be individualized for maximum beneficial effect with the lowest possible dose. If side-effects occur at starting dose, dose may be lowered. When discontinuing therapy, dosage should be reduced gradually by no more than 0.5 mg every three days. In elderly patients or in patients with advanced liver disease, the usual starting dose is 0.25 mg, two or three times daily and may be gradually increased if needed and tolerated. Alprazolam 1 mg should be administered once daily, preferably in the morning by patients who are on multiple dosage regimens of Alprazolam 0.25/0.5 mg. The tablets should be taken intact, they should not be chewed, crushed, or broken.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:34.980Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e79",
    "original_record": {
      "input_index": 913,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e79"
        },
        "name": "Alprazol",
        "strength": "0.5 mg",
        "generic": "Alprazolam",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/36373/alprazol-05-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/1982/alton-40-mg-tablet",
    "name": "Alton",
    "dosage_form": "Tablet (Enteric Coated)",
    "generic": "Esomeprazole",
    "strength": "40 mg",
    "company": "General Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 8.03",
      "strip_price": "৳ 80.30",
      "pack_size_info": "(3 x 10: ৳ 240.90)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.03",
          "pack_size_info": "(3 x 10: ৳ 240.90)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 80.30",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "20 mg (Tablet)",
        "href": "https://medex.com.bd/brands/1981/alton-20-mg-tablet?ref=1"
      },
      {
        "text": "40 mg/vial (Injection)",
        "href": "https://medex.com.bd/brands/26546/alton-40-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/433/esomeprazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alton is indicated:",
        "items": [
          "To relieve from chronic heartburn symptoms and other symptoms associated with GERD",
          "For the healing of erosive esophagitis",
          "For maintenance of healing of erosive esophagitis",
          "In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.",
          "Zollinger-Ellison Syndrome",
          "Acid related Dyspepsia",
          "Duodenal & Gastric ulcer"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole (S-isomer of omeprazole) is the first single optical isomer of proton pump inhibitor, provides better acid control than racemic proton pump inhibitors.Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma ... Read moreEsomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole (S-isomer of omeprazole) is the first single optical isomer of proton pump inhibitor, provides better acid control than racemic proton pump inhibitors.Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals. Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces. Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alton is extensively metabolized in the liver by CYP2C19 and CYP3A4. In vitro and in vivo studies have shown that Alton is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that Alton does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin. Alton may potentially interfere with CYP2C19, the major Alton metabolizing enzyme. Co-administration of Alton 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Alton inhibits gastric acid secretion. Therefore, Alton may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin). Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Alton. Combination Therapy with Clarithromycin: Co-administration of Alton, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of Alton and 14-hydroxyclarithromycin.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Esomeprazole is contraindicated in-patient with known hypersensitivity to any of the formulation.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most frequently occurring adverse events reported with Alton include headache, diarrhoea, nausea, flatulence, abdominal pain, constipation and dry mouth. There are no difference in types of related adverse events seen during maintenance treatment upto 12 months compared to short term treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies in pregnant women. Animal studies have revealed no teratogenic effects. The excretion of esomeprazole in milk has not been studied. Breast-feeding should be therefore be discontinued if the use of esomeprazole is considered essential.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "General",
        "information": ": Symptomatic response to therapy with Alton does not preclude the presence of gastric malignancy.",
        "items": []
      },
      {
        "title": "Information for patients",
        "information": ": Alton capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Alton capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking Alton.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Paediatric Use",
        "information": ": Safety and effectiveness in paediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety and efficacy have been observed between the elderly and younger individuals, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out",
        "items": []
      },
      {
        "title": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is recommended for patients with mild to moderate hepatic insufficiency. However, in patients with severe hepatic insufficiency, a dose of 20 mg once daily should not be exceeded.",
        "items": []
      },
      {
        "title": "Renal Insufficiency",
        "information": ": The Pharmacokinetics of Alton in patients with renal impairment are not expected to be altered relative to healthy volunteers as less than 1% of Alton is excreted unchanged in the urine.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "A single oral dose of Alton at 510 mg/kg (about 103 times the human dose on a body surface area basis), has been lethal to rats. The major signs of acute toxicity are reduced motor activity, changes in respiratory frequency, tremor, ataxia, and intermittent clonic convulsions. There have been no reports of overdose with Alton. No specific antidote for Alton is known. Since Alton is extensively protein bound, it is not expected to be removed by dialysis. In the event of overdosage, treatment should be symptomatic and supportive. As with the management of any overdose, the possibility of multiple drug ingestion should be considered.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": "Tablet or capsule",
        "information": ": should be swallowed whole and taken one hour before a meal.",
        "items": []
      },
      {
        "title": "Oral Suspension",
        "information": ": Whole contents of the packet should be taken into a small glass containing 15 ml. of water. The mixer should be stirred well and leave 2 to 3 minutes to thicken. Stir again and drink within 30 minutes. If any medicine remains after drinking, add more water, stir, and drink immediately. If the suspension is to be administered through a nasogastric or gastric tube, the volume of water in the syringe should be 15 ml. & immediately shake the syringe and leave 2 to 3 minutes to thicken. Shake the syringe and inject it through the nasogastric or gastric tube into the stomach within 30 minutes. An appropriately sized syringe should be used. Shake and flush any remaining contents from the nasogastric or gastric tube into the stomach.",
        "items": []
      },
      {
        "title": "IV Injection",
        "information": ": Solution for injection is prepared by adding 5 ml of 0.9% Sodium Chloride for intravenous injection into the vial containing the dry powder. The reconstituted solution for injection is clear and colorless to very slightly yellow. IV injection must be administrated intravenously over a period of at least 3 minutes. Prepared solution must be used within 12 hours of preparation and can be exposed to normal indoor lighting at a maximum of 30°C.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": "C17H19N3O3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-433-esomeprazole-chemical-structure-Tj2Jfp1VmPkRjNXznKqC.svg"
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Oral dosage form-",
        "instructions": []
      },
      {
        "medication_type": "Healing of Erosive Esophagitis",
        "information": ": 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive",
        "instructions": []
      },
      {
        "medication_type": "Esophagitis",
        "information": ": 20 mg Once Daily (Clinical studies did not extend 6 months).",
        "instructions": []
      },
      {
        "medication_type": "Symptomatic GERD",
        "information": ": 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.",
        "instructions": []
      },
      {
        "medication_type": "Helicobacter Pylori eradication",
        "information": ": Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.",
        "instructions": []
      },
      {
        "medication_type": "Zollinger-Ellison Syndrome",
        "information": ": The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.",
        "instructions": []
      },
      {
        "medication_type": "Acid-related Dyspepsia",
        "information": ": 20-40 mg once daily for 2-4 weeks according to the response.",
        "instructions": []
      },
      {
        "medication_type": "Duodenal ulcer",
        "information": ": 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "IV Injection or IV infusion:",
        "instructions": []
      },
      {
        "medication_type": "GERD with Erosive Esophagitis",
        "information": "- Adult Patients (≥18 years): Pediatric Patients (1 year to 17 years)",
        "instructions": [
          "20 mg or 40 mg once daily",
          "IV Injection: >3 Minutes, IV Infusion: 10-30 minutes",
          "Body weight <55 kg: 10 mg Once daily",
          "Body Weight ≥55 kg: 20 once daily",
          "1 month to <1 year: 0.5 mg/kg once daily",
          "IV Infusion: 10-30 minutes"
        ]
      },
      {
        "medication_type": "Risk reduction of rebleeding of Gastric or Duodenal Ulcers following therapeutic endoscopy in adults",
        "information": "- Adult Patients (≥18 years)",
        "instructions": [
          "80 mg",
          "IV Infusion: 30 minutes, followed by a continuous infusion of 8 mg/h for a total treatment duration of 72 hours."
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alton 40 mg Tablet?",
        "answer": [
          "Alton 40 mg Tablet is a proton pump inhibitor (PPI). PPIs work by reducing the amount of acid produced in the stomach. Alton 40 mg Tablet is used to treat gastroesophageal reflux disease (GERD), ulcers, and other conditions that involve too much stomach acid."
        ]
      },
      {
        "question": "What is Alton 40 mg Tablet used for?",
        "answer": [
          "Alton 40 mg Tablet has multiple uses. It eases heartburn and relieves GERD symptoms. It also aids in healing erosive esophagitis, a condition caused by stomach acid damaging the esophagus lining. Additionally, Alton 40 mg Tablet effectively prevents erosive esophagitis recurrence."
        ]
      },
      {
        "question": "What are the side effects of Alton 40 mg Tablet?",
        "answer": [
          "Alton 40 mg Tablet may cause common side effects like headaches, diarrhea, nausea, gas, stomach pain, constipation, and dry mouth. There aren't any differences in the types of side effects between long-term (up to 12 months) and short-term use."
        ]
      },
      {
        "question": "Can I take Alton 40 mg Tablet if I am pregnant or breastfeeding?",
        "answer": [
          "Alton 40 mg Tablet doesn't have any side-effects if you are pregnant or breastfeeding. You still should talk to your doctor about the risks and benefits of taking Alton 40 mg Tablet."
        ]
      },
      {
        "question": "How long does it take for Alton 40 mg Tablet to work?",
        "answer": [
          "Alton 40 mg Tablet usually starts to work within a few hours of taking it."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alton 40 mg Tablet is a well-tolerated medicine and provides relief for a long time.",
          "Avoid eating late at night or before bedtime.",
          "Inform your doctor if you get watery diarrhea, fever or stomach pain that does not go away.",
          "Long-term use of Alton 40 mg Tablet can cause weak bones and a deficiency of minerals such as magnesium. Take adequate dietary intake of calcium and magnesium or their supplements as prescribed by your doctor.",
          "Consult your doctor right away if you develop decreased urination, edema (swelling due to fluid retention), lower back pain, nausea, fatigue, and rash or fever. These could be signs of a kidney problem."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:28:36.262Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e80",
    "original_record": {
      "input_index": 914,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e80"
        },
        "name": "Alton",
        "strength": "40 mg",
        "generic": "Esomeprazole",
        "company": "General Pharmaceuticals Ltd.",
        "medicine_type": "Tablet (Enteric Coated)",
        "source_url": "https://medex.com.bd/brands/1982/alton-40-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/1981/alton-20-mg-tablet",
    "name": "Alton",
    "dosage_form": "Tablet (Enteric Coated)",
    "generic": "Esomeprazole",
    "strength": "20 mg",
    "company": "General Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 7.00",
      "strip_price": "৳ 70.00",
      "pack_size_info": "(3 x 10: ৳ 210.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 7.00",
          "pack_size_info": "(3 x 10: ৳ 210.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 70.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "40 mg (Tablet)",
        "href": "https://medex.com.bd/brands/1982/alton-40-mg-tablet?ref=1"
      },
      {
        "text": "40 mg/vial (Injection)",
        "href": "https://medex.com.bd/brands/26546/alton-40-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/433/esomeprazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alton is indicated:",
        "items": [
          "To relieve from chronic heartburn symptoms and other symptoms associated with GERD",
          "For the healing of erosive esophagitis",
          "For maintenance of healing of erosive esophagitis",
          "In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.",
          "Zollinger-Ellison Syndrome",
          "Acid related Dyspepsia",
          "Duodenal & Gastric ulcer"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole (S-isomer of omeprazole) is the first single optical isomer of proton pump inhibitor, provides better acid control than racemic proton pump inhibitors.Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma ... Read moreEsomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole (S-isomer of omeprazole) is the first single optical isomer of proton pump inhibitor, provides better acid control than racemic proton pump inhibitors.Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals. Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces. Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alton is extensively metabolized in the liver by CYP2C19 and CYP3A4. In vitro and in vivo studies have shown that Alton is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that Alton does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin. Alton may potentially interfere with CYP2C19, the major Alton metabolizing enzyme. Co-administration of Alton 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Alton inhibits gastric acid secretion. Therefore, Alton may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin). Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Alton. Combination Therapy with Clarithromycin: Co-administration of Alton, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of Alton and 14-hydroxyclarithromycin.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Esomeprazole is contraindicated in-patient with known hypersensitivity to any of the formulation.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most frequently occurring adverse events reported with Alton include headache, diarrhoea, nausea, flatulence, abdominal pain, constipation and dry mouth. There are no difference in types of related adverse events seen during maintenance treatment upto 12 months compared to short term treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate and well-controlled studies in pregnant women. Animal studies have revealed no teratogenic effects. The excretion of esomeprazole in milk has not been studied. Breast-feeding should be therefore be discontinued if the use of esomeprazole is considered essential.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "General",
        "information": ": Symptomatic response to therapy with Alton does not preclude the presence of gastric malignancy.",
        "items": []
      },
      {
        "title": "Information for patients",
        "information": ": Alton capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Alton capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking Alton.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Paediatric Use",
        "information": ": Safety and effectiveness in paediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": No overall differences in safety and efficacy have been observed between the elderly and younger individuals, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out",
        "items": []
      },
      {
        "title": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is recommended for patients with mild to moderate hepatic insufficiency. However, in patients with severe hepatic insufficiency, a dose of 20 mg once daily should not be exceeded.",
        "items": []
      },
      {
        "title": "Renal Insufficiency",
        "information": ": The Pharmacokinetics of Alton in patients with renal impairment are not expected to be altered relative to healthy volunteers as less than 1% of Alton is excreted unchanged in the urine.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "A single oral dose of Alton at 510 mg/kg (about 103 times the human dose on a body surface area basis), has been lethal to rats. The major signs of acute toxicity are reduced motor activity, changes in respiratory frequency, tremor, ataxia, and intermittent clonic convulsions. There have been no reports of overdose with Alton. No specific antidote for Alton is known. Since Alton is extensively protein bound, it is not expected to be removed by dialysis. In the event of overdosage, treatment should be symptomatic and supportive. As with the management of any overdose, the possibility of multiple drug ingestion should be considered.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": "Tablet or capsule",
        "information": ": should be swallowed whole and taken one hour before a meal.",
        "items": []
      },
      {
        "title": "Oral Suspension",
        "information": ": Whole contents of the packet should be taken into a small glass containing 15 ml. of water. The mixer should be stirred well and leave 2 to 3 minutes to thicken. Stir again and drink within 30 minutes. If any medicine remains after drinking, add more water, stir, and drink immediately. If the suspension is to be administered through a nasogastric or gastric tube, the volume of water in the syringe should be 15 ml. & immediately shake the syringe and leave 2 to 3 minutes to thicken. Shake the syringe and inject it through the nasogastric or gastric tube into the stomach within 30 minutes. An appropriately sized syringe should be used. Shake and flush any remaining contents from the nasogastric or gastric tube into the stomach.",
        "items": []
      },
      {
        "title": "IV Injection",
        "information": ": Solution for injection is prepared by adding 5 ml of 0.9% Sodium Chloride for intravenous injection into the vial containing the dry powder. The reconstituted solution for injection is clear and colorless to very slightly yellow. IV injection must be administrated intravenously over a period of at least 3 minutes. Prepared solution must be used within 12 hours of preparation and can be exposed to normal indoor lighting at a maximum of 30°C.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": "C17H19N3O3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-433-esomeprazole-chemical-structure-Tj2Jfp1VmPkRjNXznKqC.svg"
    },
    "therapeutic_class": null,
    "dosage": [
      {
        "medication_type": null,
        "information": "Oral dosage form-",
        "instructions": []
      },
      {
        "medication_type": "Healing of Erosive Esophagitis",
        "information": ": 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive",
        "instructions": []
      },
      {
        "medication_type": "Esophagitis",
        "information": ": 20 mg Once Daily (Clinical studies did not extend 6 months).",
        "instructions": []
      },
      {
        "medication_type": "Symptomatic GERD",
        "information": ": 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.",
        "instructions": []
      },
      {
        "medication_type": "Helicobacter Pylori eradication",
        "information": ": Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.",
        "instructions": []
      },
      {
        "medication_type": "Zollinger-Ellison Syndrome",
        "information": ": The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.",
        "instructions": []
      },
      {
        "medication_type": "Acid-related Dyspepsia",
        "information": ": 20-40 mg once daily for 2-4 weeks according to the response.",
        "instructions": []
      },
      {
        "medication_type": "Duodenal ulcer",
        "information": ": 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "IV Injection or IV infusion:",
        "instructions": []
      },
      {
        "medication_type": "GERD with Erosive Esophagitis",
        "information": "- Adult Patients (≥18 years): Pediatric Patients (1 year to 17 years)",
        "instructions": [
          "20 mg or 40 mg once daily",
          "IV Injection: >3 Minutes, IV Infusion: 10-30 minutes",
          "Body weight <55 kg: 10 mg Once daily",
          "Body Weight ≥55 kg: 20 once daily",
          "1 month to <1 year: 0.5 mg/kg once daily",
          "IV Infusion: 10-30 minutes"
        ]
      },
      {
        "medication_type": "Risk reduction of rebleeding of Gastric or Duodenal Ulcers following therapeutic endoscopy in adults",
        "information": "- Adult Patients (≥18 years)",
        "instructions": [
          "80 mg",
          "IV Infusion: 30 minutes, followed by a continuous infusion of 8 mg/h for a total treatment duration of 72 hours."
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alton 20 mg Tablet?",
        "answer": [
          "Alton 20 mg Tablet is a proton pump inhibitor (PPI). PPIs work by reducing the amount of acid produced in the stomach. Alton 20 mg Tablet is used to treat gastroesophageal reflux disease (GERD), ulcers, and other conditions that involve too much stomach acid."
        ]
      },
      {
        "question": "What is Alton 20 mg Tablet used for?",
        "answer": [
          "Alton 20 mg Tablet has multiple uses. It eases heartburn and relieves GERD symptoms. It also aids in healing erosive esophagitis, a condition caused by stomach acid damaging the esophagus lining. Additionally, Alton 20 mg Tablet effectively prevents erosive esophagitis recurrence."
        ]
      },
      {
        "question": "What are the side effects of Alton 20 mg Tablet?",
        "answer": [
          "Alton 20 mg Tablet may cause common side effects like headaches, diarrhea, nausea, gas, stomach pain, constipation, and dry mouth. There aren't any differences in the types of side effects between long-term (up to 12 months) and short-term use."
        ]
      },
      {
        "question": "Can I take Alton 20 mg Tablet if I am pregnant or breastfeeding?",
        "answer": [
          "Alton 20 mg Tablet doesn't have any side-effects if you are pregnant or breastfeeding. You still should talk to your doctor about the risks and benefits of taking Alton 20 mg Tablet."
        ]
      },
      {
        "question": "How long does it take for Alton 20 mg Tablet to work?",
        "answer": [
          "Alton 20 mg Tablet usually starts to work within a few hours of taking it."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alton 20 mg Tablet is a well-tolerated medicine and provides relief for a long time.",
          "Avoid eating late at night or before bedtime.",
          "Inform your doctor if you get watery diarrhea, fever or stomach pain that does not go away.",
          "Long-term use of Alton 20 mg Tablet can cause weak bones and a deficiency of minerals such as magnesium. Take adequate dietary intake of calcium and magnesium or their supplements as prescribed by your doctor.",
          "Consult your doctor right away if you develop decreased urination, edema (swelling due to fluid retention), lower back pain, nausea, fatigue, and rash or fever. These could be signs of a kidney problem."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:28:37.359Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e81",
    "original_record": {
      "input_index": 915,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e81"
        },
        "name": "Alton",
        "strength": "20 mg",
        "generic": "Esomeprazole",
        "company": "General Pharmaceuticals Ltd.",
        "medicine_type": "Tablet (Enteric Coated)",
        "source_url": "https://medex.com.bd/brands/1981/alton-20-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/4165/aluctin-30-mg-capsule",
    "name": "Aluctin",
    "dosage_form": "Capsule",
    "generic": "Flurazepam",
    "strength": "30 mg",
    "company": "Ambee Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 6.00",
      "strip_price": "৳ 60.00",
      "pack_size_info": "(10 x 10: ৳ 600.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 6.00",
          "pack_size_info": "(10 x 10: ৳ 600.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 60.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/488/flurazepam/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aluctin is indicated in the following conditions-",
        "items": [
          "Insomnia is characterized by difficulty in falling asleep, frequent nocturnal awakenings or early morning awakenings",
          "Recurring insomnia or poor sleeping habits",
          "In acute or chronic medical situations requiring restful sleep."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Flurazepam, a benzodiazepine derivative, is a hypnotic agent which does not appear to decrease dream time as measured by rapid eye movements (REM). Furthermore, it decreases sleep latency and number of awakenings for a consequent increase in total sleep time. Flurazepam binds to an allosteric site on GABA-A receptors. Binding potentiates the action of GABA on GABA-A receptors by opening the chloride channel within the receptor, causing chloride influx and hyperpolarization.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Aluctin potentiates other CNS depressants such as alcohol, barbiturates, sedative antidepressants, antihistamines and antipsychotic drugs. Cimetidine moderately prolongs the already long half-life of the active metabolite desalkyl Aluctin. Antacids may delay the absorption of benzodiazepines.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Patients with known hypersensitivity to benzodiazepines or any other ingredients of the capsule.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, light-headedness, staggering, ataxia have occurred, particularly in elderly or debilitated persons. Severe sedation, lethargy, disorientation and coma have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy category-C. Flurazepam is contraindicated in pregnant women. Lactating mothers should avoid it.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Since the risk of the development of oversedation, dizziness, confusion or ataxia increases substantially with larger doses in elderly and debilitated patients, it is recommended that in such patients the dosage should be limited to 15 mg. The usual precautions are indicated for severely depressed patients or those in whom there is any evidence of latent depression; particularly the recognition that suicidal tendencies may be present and protective measures may be necessary. The usual precautions should be observed in patients with chronic pulmonary insufficiency.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Aluctin overdosage includes somnolence, confusion and coma. Respiration, pulse and blood pressure should be monitored as in all cases of drug overdosage. General supportive measures should be employed, along with immediate gastric lavage.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Benzodiazepine hypnotics",
    "dosage": [
      {
        "medication_type": "Adult",
        "information": ": Usual dosage is 30 mg at bedtime. In some patients, 15 mg may sufficient.",
        "instructions": []
      },
      {
        "medication_type": "Elderly or debilitated",
        "information": ": 15 mg is usually sufficient for a therapeutic response.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": Not recommended.",
        "instructions": []
      },
      {
        "medication_type": "In hepatic and renal impairment",
        "information": ": Dosage may need to be reduced in patients with impaired hepatic or renal function.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:38.908Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e8b",
    "original_record": {
      "input_index": 916,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e8b"
        },
        "name": "Aluctin",
        "strength": "30 mg",
        "generic": "Flurazepam",
        "company": "Ambee Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/4165/aluctin-30-mg-capsule",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/517/alve-60-mg-tablet",
    "name": "Alve",
    "dosage_form": "Tablet",
    "generic": "Alverine Citrate",
    "strength": "60 mg",
    "company": "Orion Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5.01",
      "strip_price": "৳ 50.10",
      "pack_size_info": "(5 x 10: ৳ 250.50)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.01",
          "pack_size_info": "(5 x 10: ৳ 250.50)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 50.10",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/49/alverine-citrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alve is indicated in-",
        "items": [
          "Irritable Bowel Syndrome",
          "Bowel movement disturbances caused by small sacs or pouches in the wall of the gut (diverticular disease)",
          "Abdominal pain associated with menstrual periods (Primary dysmenorrhea)",
          "Relief of other conditions associated with spasm of involuntary muscle"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alverine Citrate is a smooth muscle relaxant. Smooth muscle is a type of muscle that is not under voluntary control; it is the muscle present in places such as the gut and uterus. Alverine Citrate acts directly on the muscle in the gut, causing it to relax. This prevents the muscle spasm which occur in the gut in conditions such as irritable bowel syndrome and diverticular disease. Alverine Citrate also relaxes the smooth muscle in the uterus. It is therefore also used to treat painful menstruation, which is caused by muscle spasm in the uterus (dysmenorrhea).",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "There are no drug interactions reported with this medicine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Paralytic ileus or known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Possible side effects may include nausea, headache, dizziness, itching, rash and allergic reactions.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although no teratogenic effects have been reported, use during pregnancy or lactation is not recommended as evidence of safety in preclinical studies are limited.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Avoid Alve in patients with intestinal obstruction or paralytic ileus.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Children under 12 years: Not recommended",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Can produce hypotension and atropine like-toxic effects. Management for overdose is as like as atropine poisoning with continuation of supportive therapy for hypotension.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, away from light. Keep all medicines out of the reach of children. Store below 25°C temperature.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anticholinergics",
    "dosage": [
      {
        "medication_type": "Adult",
        "information": ": Orally: 60-120 mg 1-3 times daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:40.097Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e8e",
    "original_record": {
      "input_index": 917,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e8e"
        },
        "name": "Alve",
        "strength": "60 mg",
        "generic": "Alverine Citrate",
        "company": "Orion Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/517/alve-60-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/22479/alvenor-450-mg-tablet",
    "name": "Alvenor",
    "dosage_form": "Tablet",
    "generic": "Diosmin + Hesperidin",
    "strength": "450 mg+50 mg",
    "company": "Beacon Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 13.00",
      "strip_price": "৳ 130.00",
      "pack_size_info": "(3 x 10: ৳ 390.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 13.00",
          "pack_size_info": "(3 x 10: ৳ 390.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 130.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "900 mg+100 mg (Tablet)",
        "href": "https://medex.com.bd/brands/27269/alvenor-900-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/369/diosmin-hesperidin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alvenor is indicated in the treatment of-",
        "items": [
          "Acute hemorrhoidal attacks.",
          "Chronic hemorrhoidal disease.",
          "Organic and functional chronic venous insufficiency of the lower limbs with the following symptoms: heavy legs, pain, nocturnal cramps."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Diosmin and Hesperidin is a phlebotonic drug and a vascular protecting agent. It reinforces venous tone by prolonging the activity of parietal noradrenaline. Thus Diosmin and Hesperidin decreases venous capacitance, venous distensibility, and venous emptying time. Diosmin and Hesperidin protects the microcirculation by fighting the microcirculation damaging process; It combats venous inflammation by decreasing leukocyte activation, and as a consequence, by inhibiting the release of inflammatory mediators, principally free radicals and prostaglandin. Thus Diosmin and Hesperidin normalizes capillary permeability and strengthens capillary resistance. Diosmin and Hesperidin acts on the lymphatic system, It improves lymphatic drainage by increasing lymph flow and lymph oncotic pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No evidence of drug incompatibility (drug interaction) has been reported in clinical trials.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Chronic venous insufficiency and its complications should be diagnosed and management monitored by a physician. It is contraindicated for anyone having a hypersensitivity to any ingredient in the product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Some cases of routine gastric disorders and neurovegetative disorders (feeling of discomfort) have been reported. In this cases discontinuation of treatment is not required.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Experimental studies have not shown any teratogenic effect in animals. In human beings, no harmful effect has so far been reported. In the absence of data concerning excretion into breast milk, breast feeding is not recommended during treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "If the hemorrhoidal symptoms do not disappear within 15 days, patient should ask doctor for advice. Diosmin (up to 900 mg/day) has been administered to a small number of breast cancer patients who were experiencing lymphedema following surgical and nodal irradiation treatment with resultant reduction of arm edema but no effect on the cancer. Animal studies and more than 20 years of clinical use in Europe have not found any evidence of carcinogenicity or mutagenicity when the components of Diosmin & Hesperidin are used as recommended. As a precaution, Diosmin & Hesperidin is not recommended for patients with a history of cancer since no specific studies have been performed in this population.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Tablet should be taken at meal times.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Phlebotonic & Vascular protecting preparation",
    "dosage": [
      {
        "medication_type": null,
        "information": "Diosmin 450 mg & Hesperidin 50 mg-",
        "instructions": []
      },
      {
        "medication_type": "Acute hemorrhoidal attacks",
        "information": ": 3 tablets twice daily for the first 4 days, then 2 tablets twice daily for three days and if required 1 tablet twice daily as a maintenance dosage.",
        "instructions": []
      },
      {
        "medication_type": "Chronic hemorrhoids",
        "information": ": 1 tablet twice daily.",
        "instructions": []
      },
      {
        "medication_type": "Chronic venous insufficiency",
        "information": ": 1 tablet twice daily initially for seven days. Duration may be increased depending on severity.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Diosmin 900 mg & Hesperidin 100 mg-",
        "instructions": []
      },
      {
        "medication_type": "Acute Hemorrhoid",
        "information": ": 1 tablet thrice daily for first 4 days, followed by 1 tablet twice daily for 3 days & then 1 tablet once daily as maintenance dose.",
        "instructions": []
      },
      {
        "medication_type": "Relapse of Internal Hemorrhoid & Chronic Hemorrhoid",
        "information": ": 1 tablet once daily for 3 months.",
        "instructions": []
      },
      {
        "medication_type": "Chronic venous insufficiency",
        "information": ": 1 tablet once daily for 2-6 months.",
        "instructions": []
      },
      {
        "medication_type": "Leg Wounds",
        "information": ": 1 tablet once daily for 2 months.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:41.375Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e90",
    "original_record": {
      "input_index": 918,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e90"
        },
        "name": "Alvenor",
        "strength": "450 mg+50 mg",
        "generic": "Diosmin + Hesperidin",
        "company": "Beacon Pharmaceuticals PLC",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/22479/alvenor-450-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/17575/alverate-60-mg-tablet",
    "name": "Alverate",
    "dosage_form": "Tablet",
    "generic": "Alverine Citrate",
    "strength": "60 mg",
    "company": "Ibn Sina Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5.00",
      "strip_price": "৳ 50.00",
      "pack_size_info": "(5 x 10: ৳ 250.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.00",
          "pack_size_info": "(5 x 10: ৳ 250.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 50.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/49/alverine-citrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alverate is indicated in-",
        "items": [
          "Irritable Bowel Syndrome",
          "Bowel movement disturbances caused by small sacs or pouches in the wall of the gut (diverticular disease)",
          "Abdominal pain associated with menstrual periods (Primary dysmenorrhea)",
          "Relief of other conditions associated with spasm of involuntary muscle"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alverine Citrate is a smooth muscle relaxant. Smooth muscle is a type of muscle that is not under voluntary control; it is the muscle present in places such as the gut and uterus. Alverine Citrate acts directly on the muscle in the gut, causing it to relax. This prevents the muscle spasm which occur in the gut in conditions such as irritable bowel syndrome and diverticular disease. Alverine Citrate also relaxes the smooth muscle in the uterus. It is therefore also used to treat painful menstruation, which is caused by muscle spasm in the uterus (dysmenorrhea).",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "There are no drug interactions reported with this medicine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Paralytic ileus or known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Possible side effects may include nausea, headache, dizziness, itching, rash and allergic reactions.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although no teratogenic effects have been reported, use during pregnancy or lactation is not recommended as evidence of safety in preclinical studies are limited.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Avoid Alverate in patients with intestinal obstruction or paralytic ileus.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Children under 12 years: Not recommended",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Can produce hypotension and atropine like-toxic effects. Management for overdose is as like as atropine poisoning with continuation of supportive therapy for hypotension.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool and dry place, away from light. Keep all medicines out of the reach of children. Store below 25°C temperature.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anticholinergics",
    "dosage": [
      {
        "medication_type": "Adult",
        "information": ": Orally: 60-120 mg 1-3 times daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:44.333Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e92",
    "original_record": {
      "input_index": 919,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e92"
        },
        "name": "Alverate",
        "strength": "60 mg",
        "generic": "Alverine Citrate",
        "company": "Ibn Sina Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/17575/alverate-60-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/36374/alvit-c-100-mg-syrup",
    "name": "Alvit C",
    "dosage_form": "Syrup",
    "generic": "Vitamin C [Ascorbic acid]",
    "strength": "100 mg/5 ml",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 40.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/1137/vitamin-c-ascorbic-acid/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ascorbic Acid (Alvit C) is indicated in- Ascorbic Acid (Alvit C) is indicated in-",
        "items": [
          "Prevents & treats scurvy",
          "Helps in healing wounds & broken bones",
          "Helps to form collagen in connective tissues",
          "Aids in iron absorption & helps to treat anemia",
          "Contributes in production of hemoglobin & red blood cell in bone marrow",
          "Prevents & treats scurvy",
          "Helps in healing wounds & broken bones",
          "Helps to form collagen in connective tissues",
          "Aids in iron absorption & helps to treat anemia",
          "Contributes in production of hemoglobin & red blood cell in bone marrow",
          "Aids in preventing many types of viral and bacterial infections and potentiates the immune system",
          "Aids in the treatment & prevention of the common cold",
          "Promotes healthy capillaries, gums & teeth"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a preparation of Ascorbic Acid (Vitamin C). Ascorbic Acid is an essential nutrient, which means it cannot be produced by the body and therefore must be obtained from diet or supplements. Ascorbic Acid has many important functions. It is required for tissue growth & repair, Adrenal gland function, enhanced immunity & healthy gums. As an antioxidant, it gives protection against harmful pollution, infection & reduces cellular damage. As a coenzyme, it is a necessary factor for wound healing, drug metabolism & metabolism of cholesterol & folic acid. As an essential nutrient, vitamin C supports healthy hair & skin, strengthens the immune system and maintain overall good health.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Potentially hazardous interactions",
        "information": ": Ascorbic acid is incompatible in solution with aminophylline, bleomycin, erythromycin, lactobionate, nafcillin, nitrofurantoin sodium, conjugated oestrogen, sodium bicarbonate, sulphafurazole diethanolamine, chloramphenicol sodium succinate, chlorthiazide sodium and hydrocortisone sodium succinate.",
        "items": []
      },
      {
        "title": "Useful interactions",
        "information": ": Ascorbic acid increases the apparent half-life of paracetamol and enhances iron absorption from the gastrointestinal tract.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Alvit C has little toxicity and only mega-doses of Alvit C may cause diarrhoea, abdominal bloating, iron over-absorption that is harmful in patients with thalassaemia, sideroblastic anemia, and haemochromatosis; hyperoxaluria, hyperuricosuria, and hemolysis in patients with glucose-6 phosphate dehydrogenase deficiency. A pregnant woman taking more than 5 gm/day may suffer fetal abortion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The drug is safe in normal doses in pregnant women, but a daily intake of 5 gm or more is reported to have caused abortion. The drug may be taken safely during lactation.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ingestion of megadose (more than 1000 mg daily) of Alvit C during pregnancy has resulted in scurvy in neonates. Alvit C in mega-doses has been contraindicated for patients with hyperoxaluria. Alvit C itself is a reactive substance in the redox system and can give rise to false positive reactions in certain analytical tests for glucose, uric acid, creatine and occult blood.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Should be stored in a dry place below 30˚C.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Vitamin-C Preparations",
    "dosage": [
      {
        "medication_type": "Oral tablet administration",
        "information": ":",
        "instructions": [
          "For the prevention of scurvy: 1 tablet daily",
          "For the treatment of scurvy: 1-2 tablets daily; but dose may be increased depending on the severity of the condition.",
          "For the reduction of risk of stroke in the elderly: 1-2 tablets daily.",
          "In other cases: 1 tablet daily or as directed by the physician.",
          "Maximum safe dose is 2000 mg daily in divided doses."
        ]
      },
      {
        "medication_type": "Oral sachet administration",
        "information": ": 1 sachet daily or as directed by registered physician. Maximum Dose: 2000 mg/day (4 sachets/day).",
        "instructions": []
      },
      {
        "medication_type": "Parenteral administration",
        "information": ":",
        "instructions": [
          "Vitamin C is usually administered orally. When oral administration is not feasible or when malabsorption is suspected, the drug may be administered IM, IV, or subcutaneously. When given parenterally, utilization of the vitamin reportedly is best after IM administration and that is the preferred parenteral route.",
          "For intravenous injection, dilution into a large volume parenteral such as Normal Saline, Water for Injection, or Glucose is recommended to minimize the adverse reactions associated with intravenous injection.",
          "The average protective dose of vitamin C for adults is 70 to 150 mg daily. In the presence of scurvy, doses of 300 mg to 1 g daily are recommended. However, as much as 6 g has been administered parenterally to normal adults without evidence of toxicity.",
          "To enhance wound healing, doses of 300 to 500 mg daily for a week or ten days both preoperatively and postoperatively are generally considered adequate, although considerably larger amounts have been recommended. In the treatment of burns, doses are governed by the extent of tissue injury. For severe burns, daily doses of 1 to 2 g are recommended. In other conditions in which the need for vitamin C is increased, three to five times the daily optimum allowances appear to be adequate.",
          "Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:45.532Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e94",
    "original_record": {
      "input_index": 920,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e94"
        },
        "name": "Alvit C",
        "strength": "100 mg/5 ml",
        "generic": "Vitamin C [Ascorbic acid]",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/36374/alvit-c-100-mg-syrup",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34172/alzacare-14-mg-capsule",
    "name": "Alzacare",
    "dosage_form": "Capsule (Extended Release)",
    "generic": "Memantine + Donepezil",
    "strength": "14 mg+10 mg",
    "company": "Renata PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 25.00",
      "strip_price": "৳ 150.00",
      "pack_size_info": "(3 x 6: ৳ 450.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 25.00",
          "pack_size_info": "(3 x 6: ৳ 450.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 150.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "21 mg+10 mg (Capsule)",
        "href": "https://medex.com.bd/brands/34169/alzacare-21-mg-capsule?ref=1"
      },
      {
        "text": "7 mg+10 mg (Capsule)",
        "href": "https://medex.com.bd/brands/34171/alzacare-7-mg-capsule?ref=1"
      },
      {
        "text": "28 mg+10 mg (Capsule)",
        "href": "https://medex.com.bd/brands/34173/alzacare-28-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1658/memantine-donepezil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Memantine and donepezil hydrochlorides extended-release capsules are a combination of memantine hydrochloride, an NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor, indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Memantine and donepezil hydrochlorides extended-release capsules contain two approved medications: memantine hydrochloride extended-release and donepezil hydrochloride. Each of those medications is postulated to have a different mechanism in Alzheimer’s disease.",
        "items": []
      },
      {
        "title": "Memantine",
        "information": ": Persistent activation of central nervous system NMDA receptors by the excitatory amino acid glutamate has been hypothesized to contribute to the symptomatology of Alzheimer’s disease. Memantine is postulated to exert its therapeutic effect through its action as a low to moderate affinity uncompetitive (open channel) NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels. There is no evidence that memantine prevents or slows neurodegeneration in patients with Alzheimer’s disease.",
        "items": []
      },
      {
        "title": "Donepezil",
        "information": ": Current theories on the pathogenesis of the cognitive signs and symptoms of Alzheimer’s disease attribute some of them to a deficiency of cholinergic neurotransmission. Donepezil is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine in the central nervous system through reversible inhibition of its hydrolysis by acetylcholinesterase. There is no evidence that donepezil prevents or slows neurodegeneration in patients with Alzheimer’s disease.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Combined use with NMDA antagonists: use with caution. Memantine and donepezil hydrochlorides extended-release may interfere with anticholinergic medications. Concomitant administration of succinylcholine, similar neuromuscular blocking agents, or cholinergic agonists may lead to synergistic effect.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Memantine and donepezil hydrochlorides extended-release capsules are contraindicated in patients with known hypersensitivity to memantine hydrochloride, donepezil hydrochloride, piperidine derivatives, or to any excipients used in the formulation.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse reactions, occurring at a frequency of at least 5% and greater than placebo with memantine hydrochloride extended-release 28 mg/day, were headache, diarrhea, and dizziness. The most common adverse reactions occurring at a frequency of at least 5% in patients receiving donepezil and at twice or more the placebo rate, include diarrhea, anorexia, vomiting, nausea, and ecchymosis.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data on the developmental risk associated with the use of memantine and donepezil hydrochlorides extended-release capsules or its active ingredients (memantine hydrochloride and donepezil hydrochloride) in pregnant women. There are no data on the presence of memantine or donepezil in human milk, the effects on the breastfed infant, or the effects of memantine and donepezil hydrochlorides extended-release capsules or its metabolites on milk production.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Memantine and donepezil hydrochlorides extended-release is likely to exaggerate succinylcholine-type muscle relaxation during anesthesia.",
          "Memantine and donepezil hydrochlorides extended-release may have vagotonic effects on the sinoatrial and atrioventricular nodes manifesting as bradycardia or heart block.",
          "Monitor patients for symptoms of active or occult gastrointestinal bleeding, especially those at increased risk for developing ulcers.",
          "Memantine and donepezil hydrochlorides extended-release can cause diarrhea, nausea, and vomiting.",
          "Memantine and donepezil hydrochlorides extended-release may cause bladder outflow obstructions.",
          "Conditions that raise urine pH may decrease the urinary elimination of memantine, resulting in increased plasma levels of memantine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Safety and effectiveness of memantine and donepezil hydrochlorides extended-release in pediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Renal Impairment",
        "information": ": No dosage adjustment is needed in patients with mild or moderate renal impairment.",
        "items": []
      },
      {
        "title": "Hepatic Impairment",
        "information": ": No dosage adjustment is needed in patients with mild or moderate hepatic impairment. Memantine and donepezil hydrochlorides extended-release has not been studied in patients with severe hepatic impairment",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-Alzheimer drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "For patients on donepezil hydrochloride 10 mg only, the recommended starting dose of memantine and donepezil hydrochlorides extended-release capsules is 7 mg/10 mg, taken once daily in the evening. The dose should be increased in 7 mg increments to the recommended maintenance dose of 28 mg/10 mg. The minimum recommended interval between dose increases is one week. Patients on memantine hydrochloride (10 mg twice daily or 28 mg extended-release once daily) and donepezil hydrochloride 10 mg once daily can be switched to memantine and donepezil hydrochlorides extended- release capsules 28 mg/10 mg, taken once daily in the evening. Memantine and donepezil hydrochlorides extended- release capsules can be taken with or without food, whole or sprinkled on applesauce; do not divide, chew, or crush. Severe renal impairment: the recommended maintenance dose for memantine and donepezil hydrochlorides extended-release capsules is 14 mg/10 mg once daily in the evening.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:46.626Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ea0",
    "original_record": {
      "input_index": 921,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ea0"
        },
        "name": "Alzacare",
        "strength": "14 mg+10 mg",
        "generic": "Memantine + Donepezil",
        "company": "Renata PLC",
        "medicine_type": "Capsule (Extended Release)",
        "source_url": "https://medex.com.bd/brands/34172/alzacare-14-mg-capsule",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/8544/am-500-mg-tablet",
    "name": "AM",
    "dosage_form": "Tablet",
    "generic": "Azithromycin Dihydrate",
    "strength": "500 mg",
    "company": "Reliance Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 30.00",
      "strip_price": null,
      "pack_size_info": "(10's pack: ৳ 300.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 30.00",
          "pack_size_info": "(10's pack: ৳ 300.00)"
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "200 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/8545/am-200-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/100/azithromycin-dihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "AM is indicated for infections (caused by susceptible organisms) in lower respiratory tract infections including bronchitis and pneumonia, in upper respiratory tract infections including sinusitis and pharyngitis/tonsillitis, in otitis media, and in skin and soft tissue infections. In sexually transmitted diseases in men and women, AM is indicated in the treatment of non-gonococcal urethritis and cervicitis due to Chlamydia trachomatis.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Azithromycin is acid-stable and can therefore be taken orally with no need of protection from gastric acids. It is readily absorbed; its absorption is greater on an empty stomach. Time to peak concentration in adults is 2.1 to 3.2 hours for oral dosage forms. Due to the high concentration in phagocytes, azithromycin is actively transported to the site of infection. During active phagocytosis, large concentrations of azithromycin are released. The concentration of azithromycin in the tissues can be over 50 times higher than in plasma. This is due to ion trapping and the high lipid solubility. Azithromycin's half-life allows a large single dose to be administered and yet maintain bacteriostatic levels in the infected tissue for several days. Following a single 500 mg dose, plasma concentrations of azithromycin declined in a polyphasic pattern with a mean apparent plasma clearance of 630 mL/min and a terminal elimination half life of 68 hours. The prolonged terminal half-life is thought to be due to extensive uptake and subsequent release of drug from tissues. Biliary excretion of azithromycin, predominantly unchanged, is a major route of elimination. Over the course of a week, approximately 6% of the administered dose appears as unchanged drug in urine. Microbiology: Azithromycin acts by binding to the 50S ribosomal subunit of susceptible microorganisms and, thus, interfering with microbial protein synthesis. Nucleic acid synthesis is not affected. Azithromycin has been shown to be active against most isolates of the following microorganisms, both in vitro and in clinical infections:",
        "items": [
          "Aerobic and facultative gram-positive microorganisms: Staphylococcus aureus, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes",
          "Aerobic and facultative gram-negative microorganisms: Haemophilus ducreyi, Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae",
          "Other microorganisms: Chlamydia pneumoniae, Chlamydia trachomatis , Mycoplasma pneumoniae , Betalactamase production should have no effect on azithromycin activity.",
          "Aerobic and facultative gram-positive microorganisms: Streptococci (Groups C,F,G), Viridans group streptococci",
          "Aerobic and facultative gram-negative microorganisms: Bordetella pertussis, Legionella pneumophila",
          "Anaerobic microorganisms: Peptostreptococcus species, Prevotella bivia"
        ]
      }
    ],
    "interaction": [
      {
        "title": "Antacid",
        "information": ": In patients receiving azithromycin and antacids, azithromycin should be taken at least 1 hour before or 2 hours after the antacid. Carbamazepine: In a pharmacokinetic interaction study in healthy volunteers, no significant effect was observed on the plasma levels of carbamazepine or its active metabolite.",
        "items": []
      },
      {
        "title": "Cyclosporin",
        "information": ": Some of the related macrolide antibiotics interfere with the metabolism of cyclosporin. In the absence of conclusive data from pharmacokinetic studies or clinical data investigating potential interactions between azithromycin and cyclosporine, caution should be exercised before co-administration of these two drugs. If coadministrations is necessary, cyclosporin levels should be monitored and the dose adjusted accordingly.",
        "items": []
      },
      {
        "title": "Digoxin",
        "information": ": Some of the macrolide antibiotics have been reported to impair the metabolism of digoxin (in the gut) in some patients. Therefore, in patients receiving concomitant azithromycin and digoxin the possibility of raised digoxin levels should be borne in mind and digoxin levels monitored.",
        "items": []
      },
      {
        "title": "Ergot derivatives",
        "information": ": Because of the theoretical possibility of ergotism, azithromycin and ergot derivatives should not be co-administered.",
        "items": []
      },
      {
        "title": "Methylprednisolone",
        "information": ": In a pharmacokinetic interaction study in healthy volunteers, azithromycin had no significant effect on the pharmacokinetics of methylprednisolone.",
        "items": []
      },
      {
        "title": "Theophylline",
        "information": ": There is no evidence of any pharmacokinetic interaction when azithromycin and theophylline are co-administered to healthy volunteers. In general, however, theophylline levels should be monitored.",
        "items": []
      },
      {
        "title": "Warfarin",
        "information": ": In a pharmacodynamic interaction study, azithromycin did not alter the anticoagulant effect of a single 15 mg dose of warfarin administered to healthy volunteers. AM and warfarin may be co-administered, but monitoring of the prothrombin time should be continued as routinely performed.",
        "items": []
      },
      {
        "title": "Terfenadine",
        "information": ": AM did not affect the pharmacokinetics of terfenadine administered at the recommended dose of 60 mg every 12 hours. Addition of azithromycin did not result in any significant changes in cardiac repolarisation (QTc interval) measured during the steady state dosing of terfenadine.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Azithromycin Dihydrate is contraindicated in patients hypersensitive to Azithromycin or any other macrolide antibiotic. Co-administration of ergot derivatives and Azithromycin is contraindicated. Azithromycin is contraindicated in patients with hepatic diseases.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "AM is well tolerated with a low incidence of side-effects. Most side-effects observed were mild to moderate in severity. The majority of side-effects were gastrointestinal in origin with nauseas, abdominal discomfort (pain/cramps), vomiting, flatulence, diarrhoea and loose stools being occasionally observed. Allergic reactions such as rash or photosensitivity have occurred and there have also been rare reports of serious hypersensitivity reactions. Reversible elevations in liver transaminases have been seen with a frequency similar to the comparative macrolides and penicillins used in clinical trials. Rarely, cases of cholestatic jaundice have been observed. Transient mild reductions in neutrofil counts have occasionally been observed in clinical trials, although a causal relationship to azithromycin has not been established. Hearing impairment: In investigational studies where higher doses were used for prolonged periods of time, reversible hearing impairment was seen in some patients.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category of Azithromycin Dihydrate is B. Animal reproduction studies have demonstrated that Azithromycin has no evidence of harm to the fetus. There are no adequate and well controlled studies in pregnant women. Since animal reproduction studies are not always predictive of human response, Azithromycin should be used during pregnancy only if adequate alternatives are not available. It is not known whether Azithromycin is secreted in breast milk. So, caution should be exercised when Azithromycin is administered to nursing women.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with erythromycin and other macrolides, rare serious allergic reactions, including angioneurotic oedema and anaphylaxis, has been reported. Some of these reactions with azithromycin have resulted in recurrent symptoms and required a long period of observation and treatment.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Use in renal impairment",
        "information": ": No dose adjustment is needed in patients with mild renal impairment (creatinine clearance >40 ml/min), but there are no data regarding azithromycin in patients with more severe renal impairment, thus caution should be exercised in using azithromycin in these patients.",
        "items": []
      },
      {
        "title": "Use in hepatic impairment",
        "information": ": As the liver is the principal route of excretion of azithromycin, it should not be used in patients with hepatic disease.",
        "items": []
      },
      {
        "title": "Effects on ability to drive and use machines",
        "information": ": There is no evidence to suggest that azithromycin may have an effect on a patient’s ability to drive or operate machinery.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "There is no data on overdosage with AM. Typical symptoms of overdosage with macrolide antibiotics include hearing loss, severe nausea, vomiting and diarrhoea. Gastric lavage and general supportive measures are indicated.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Reconstitution procedure of suspension-",
        "items": []
      },
      {
        "title": null,
        "information": "Azithromycin should be taken at least 1 hour before or 2 hours after meal.",
        "items": [
          "Step 01: Shake the bottle well to loosen the powder.",
          "Step 02: Add boiled and cooled water up to the water mark of the bottle label.",
          "Step 03: Shake until powder is completely mixed with water."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": "C38H72N2O12",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-100-azithromycin-dihydrate-chemical-structure-tFo4BQqfsRzQwcODCGo2.svg"
    },
    "therapeutic_class": "Macrolides",
    "dosage": [
      {
        "medication_type": "Oral",
        "information": "-",
        "instructions": []
      },
      {
        "medication_type": "Adult",
        "information": ": 500 mg once daily orally for 3 days or 500 mg once on day 1, then 250 mg once on days 2-5 for 4 days. For sexually transmitted diseases caused by Chlamydia trachomatis in adults, the dose is 1 gm given as a single dose or 500 mg once on day 1, followed by 250 mg once daily for next 2 days may also be given.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ":",
        "instructions": [
          "10 mg/kg body weight once daily for 3 days for child over 6 months",
          "200 mg (1 teaspoonful) for 3 days if body weight is 15-25 kg",
          "300 mg (1½ teaspoonfuls) for 3 days if body weight is 26-35 kg; 400 mg (2 teaspoonfuls) for 3 days if body weight is 36-45 kg.",
          "In typhoid fever, 500 mg (2½ teaspoonfuls) once daily for 7-10 days is given."
        ]
      },
      {
        "medication_type": "Azithromycin Injection (For IV Infusion only)",
        "information": ": The recommended dose of Azithromycin for injection for the treatment of adult patients with community-acquired pneumonia due to the indicated organisms is:",
        "instructions": [
          "500 mg as a single daily dose by the intravenous route for at least two days. Intravenous therapy should be followed by Azithromycin by the oral route at a single, daily dose of 500 mg, administered as two 250-mg tablets to complete a 7 to 10-day course of therapy. The timing of the switch to oral therapy should be done at the discretion of the physician and in accordance with clinical response.",
          "The recommended dose of Azithromycin for the treatment of adult patients with pelvic inflammatory disease due to the indicated organisms is: 500 mg as a single daily dose by the intravenous route for one or two days. Intravenous therapy should be followed by Azithromycin by the oral route at a single, daily dose of 250 mg to complete a 7-day course of therapy. The timing of the switch to oral therapy should be done at the discretion of the physician and in accordance with clinical response. If anaerobic microorganisms are suspected of contributing to the infection, an antimicrobial agent with anaerobic activity should be administered in combination with Azithromycin.",
          "Safety and effectiveness of azithromycin for injection in children or adolescents under 16 years have not been established."
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is AM 500 mg Tablet?",
        "answer": [
          "AM 500 mg Tablet performs its action by preventing the synthesis of essential proteins required by bacteria to carry out vital functions."
        ]
      },
      {
        "question": "What are the uses of AM 500 mg Tablet?",
        "answer": [
          "AM 500 mg Tablet is used for the treatment and prevention of community-acquired pneumonia, pharyngitis/tonsillitis, and skin and soft tissue infections."
        ]
      },
      {
        "question": "What are the Side Effects of AM 500 mg Tablet?",
        "answer": [
          "Side effects include diarrhea, dry or scaly skin, abdominal pain, difficult or painful urination, vomiting, fever, acid or sour stomach, aggression or anger, excessive air or gas in the stomach, and heartburn."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal AM 500 mg Tablet?",
        "answer": [
          "AM 500 mg Tablet should be kept in a cool dry place and its original packaging. Make sure this medication remains unreachable to children and pets. The patient should consult a doctor for its further uses."
        ]
      },
      {
        "question": "Can the use of AM 500 mg Tablet cause diarrhea?",
        "answer": [
          "Yes, the use of AM 500 mg Tablet can cause diarrhea. It is an antibiotic that kills harmful bacteria. However, it also affects the helpful bacteria in your stomach or intestine and causes diarrhea. If you are experiencing severe diarrhea, consult your doctor immediately."
        ]
      },
      {
        "question": "Is AM 500 mg Tablet safe?",
        "answer": [
          "AM 500 mg Tablet is safe if used at prescribed doses as advised by your doctor."
        ]
      },
      {
        "question": "Is AM 500 mg Tablet an antibiotic?",
        "answer": [
          "Yes, AM 500 mg Tablet is an antibiotic that belongs to a class of antibiotics known as macrolides."
        ]
      },
      {
        "question": "What if I don't get better even after taking AM 500 mg Tablet?",
        "answer": [
          "You should inform your doctor if you do not notice any improvement in your symptoms after 3 days of taking AM 500 mg Tablet and if your symptoms get worse."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Do not skip any doses of AM 500 mg Tablet and finish the full course of treatment even if you feel better. Stopping it early may make the infection to come back and harder to treat.",
          "Take AM 500 mg Tablet 1 hour before or two hours after food.",
          "Do not take antacids 2 hours before or after taking AM 500 mg Tablet.",
          "Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it doesn't stop or if you find blood in your stools.",
          "Stop taking AM 500 mg Tablet and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:28:47.801Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ea7",
    "original_record": {
      "input_index": 922,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ea7"
        },
        "name": "AM",
        "strength": "500 mg",
        "generic": "Azithromycin Dihydrate",
        "company": "Reliance Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/8544/am-500-mg-tablet",
        "_page": 30,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/26826/amaryl-m-1-mg-tablet",
    "name": "Amaryl M",
    "dosage_form": "Tablet (Prolonged Release)",
    "generic": "Glimepiride + Metformin",
    "strength": "1 mg+500 mg",
    "company": "Synovia Pharma PLC.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 12.00",
      "strip_price": "৳ 120.00",
      "pack_size_info": "(3 x 10: ৳ 360.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.00",
          "pack_size_info": "(3 x 10: ৳ 360.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "2 mg+500 mg (PR Tablet)",
        "href": "https://medex.com.bd/brands/26827/amaryl-m-2-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1471/glimepiride-metformin/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amaryl M tablet is indicated as an adjunct to diet and exercise in type 2 diabetes mellitus patients-",
        "items": [
          "In case that the monotherapy with glimepiride or metformin does not result in adequate glycemic control.",
          "Replacement of combination therapy of glimepiride and metformin."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. The primary mechanism of action of Glimepiride appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. In addition, extrapancreatic effects like reduction of basal hepatic glucose production, increased peripheral tissue sensitivity to insulin and glucose uptake may also play role in the activity of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic action of a single dose of Glimepiride persists for 24 hours. Metformin Hydrochloride is a biguanide type oral antihyperglycemic drug used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose. Its mechanism of action is different from those of sulfonylureas and it does not produce hypoglycemia. Metformin Hydrochloride decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by an increase in peripheral glucose uptake and utilization.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "For Glimepiride: For Metformin: Concomitant use not recommended: Organic cation transporters (OCT): Metformin is a substrate of both transporters OCT1 and OCT2. Co-administration of metformin with: Caution is therefore advised, especially in patients with renal impairment, when these drugs are coadministered with metformin, as metformin plasma concentration may increase. If needed, dose adjustment of metformin may be considered as OCT inhibitors/inducers may alter the efcacy of metformin.",
        "items": [
          "Glimepiride is metabolized by cytochrome P450 2C9 (CYP2C9). This should be taken into account when glimepiride is coadministered with inducers (e.g. rifampicin) or inhibitors (e.g. fuconazole) of CYP 2C9.",
          "Potentiation of the blood-glucose-lowering efect and, thus, in some instances hypoglycaemia may occur when one of the following drugs is taken, for example: insulin and other, oral antidiabetics; ACE inhibitors; anabolic steroids and male sex hormones; chloramphenicol; coumarin derivatives; cyclophosphamide; disopyramide; fenfuramine; fenyramidol; fbrates; fuoxetine; guanethidine; ifosfamide; MAO inhibitors; miconazole; fuconazole; para-aminosalicylic acid; pentoxifylline (high dose parenteral); phenylbutazone; azapropazone; oxyphenbutazone; probenecid; quinolones; salicylates; sulfnpyrazone; clarithromycin; sulfonamide antibiotics; tetracyclines; tritoqualine; trofosfamide.",
          "Weakening of the blood-glucose-lowering efect and, thus raised blood glucose levels may occur when one of the following drugs is taken, for example: acetazolamide; barbiturates; corticosteroids; diazoxide; diuretics; epinephrine (adrenaline) and other sympathomimetic agents; glucagon; laxatives (after protracted use); nicotinic acid (in high doses); oestrogens and progestogens; phenothiazines; phenytoin; rifampicin; thyroid hormones.",
          "H2 receptor antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of the blood-glucose-lowering efect. Under the infuence of sympatholytic drugs such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation to hypoglycaemia may be reduced or absent.",
          "Both acute and chronic alcohol intake may potentiate or weaken the blood-glucose-lowering action of glimepiride in an unpredictable fashion.",
          "The efect of coumarin derivatives may be potentiated or weakened.",
          "Bile acid sequestrant: Colesevelam binds to glimepiride and reduces glimepiride absorption from the gastrointestinal tract. Glimepiride should be administered at least 4 hours prior to colesevelam.",
          "Alcohol: Alcohol intoxication is associated with an increased risk of lactic acidosis, particularly in case of fasting, malnutrition or hepatic insufciency. Avoid consumption of alcohol and alcohol-containing medications",
          "Iodinated contrast agents: Metformin must be discontinued prior to, or at the time of the imaging procedure and not restarted until at least 48 hours after, provided that renal function has been re-evaluated and found to be stable.",
          "Combinations requiring precautions for use: Some medicinal products can adversely afect renal function which may increase the risk of lactic Acidosis. When starting or using such products in combination with metformin, close monitoring of renal function is necessary. Glucocorticoids, beta-2-agonists, and diuretics have intrinsic hyperglycemic activity. Inform the patient and perform more frequent blood glucose monitoring. ACE-inhibitors may decrease the blood glucose levels. Metformin may decrease the anticoagulant efect of phenprocoumon. Therefore, a close monitoring of the INR is recommended. Levothyroxine can reduce the hypoglycemic efect of metformin. Monitoring of blood glucose levels is recommended, especially when thyroid hormone therapy is initiated or stopped, and the dosage of metformin must be adjusted if necessary.",
          "Inhibitors of OCT1 (such as verapamil) may reduce efcacy of metformin.",
          "Inducers of OCT1 (such as rifampicin) may increase gastrointestinal absorption and efcacy of metformin.",
          "Inhibitors of OCT2 (such as cimetidine, dolutegravir, ranolazine, trimethoprime, vandetanib, isavuconazole) may decrease the renal elimination of metformin and thus lead to an increase in metformin plasma concentration.",
          "Inhibitors of both OCT1 and OCT2 (such as crizotinib, olaparib) may alter efcacy and renal elimination of metformin."
        ]
      }
    ],
    "contraindications": [
      {
        "title": "For Glimepiride",
        "information": "- No experience has been gained concerning the use of glimepiride in patients with severe impairment of liver function and in dialysis patients. In patients with severe impairment of hepatic function, change-over to insulin is indicated, not least to achieve optimal metabolic control.",
        "items": [
          "In patients hypersensitive to glimepiride, metformin, other sulfonylureas, other sulfonamides, or any of the excipients of Amaryl M.",
          "In pregnant women.",
          "In breastfeeding women."
        ]
      },
      {
        "title": "For Metformin",
        "information": "-",
        "items": [
          "Hypersensitivity to metformin or any of the excipients.",
          "Any type of acute metabolic acidosis such as lactic acidosis Diabetic ketoacidosis, diabetic pre-coma.",
          "Severe Renal failure or renal disfunction (e.g., serum creatine levels >135 μmol/L in males and >110 μmol/L in females), GFR < 30 mL/min.",
          "Acute conditions with the potential to alter renal function such as Dehydration, severe infection, intravascular administration of iodinated contrast agents etc.",
          "Acute or chronic disease which may cause tissue hypoxia such as cardiac or respiratory failure, recent myocardial infarction, shock",
          "Hepatic insufciency.",
          "Acute alcohol intoxication, alcoholism.",
          "Lactation."
        ]
      }
    ],
    "side_effects": [
      {
        "title": "For Glimepiride",
        "information": ": Metabolism and nutrition disorders- Eye disorders: Especially at the start of treatment, there may be temporary visual impairment due to the change in blood glucose levels. The cause is a temporary alteration in the turgidity and hence the refractive index of the lens, this being dependent on blood glucose level. Gastrointestinal disorders- Blood and lymphatic system disorders- Skin and subcutaneous tissue disorders: Alopecia (frequency not known) General disorders- Investigations: Glimepiride, like all sulfonylureas, can cause weight gain (frequency not known)",
        "items": [
          "As a result of the blood-glucose-lowering action of glimepiride, Hypoglycaemia which may also be prolonged.",
          "The clinical picture of a severe hypoglycaemic attack may resemble that of a stroke.",
          "Occasionally, Gastrointestinal symptoms such as nausea, vomiting, sensations of pressure or fulness in the epigastrium, abdominal pain and diarrhea may occur.",
          "In isolated cases, there may be hepatitis, elevation of liver enzyme levels and/or cholestasis and jaundice, which may progress to life-threatening liver failure.",
          "Dysgeusia (frequency not known)",
          "Changes in the blood picture may occur: Rarely, thrombocytopenia and, in isolated cases, leucopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis or pancytopenia may develop. Cases of severe thrombocytopenia with platelet count less than 10,000/μl and thrombocytopenic purpura have been reported in post-marketing experience (frequency not known).",
          "Occasionally, Allergic or pseudo allergic reactions may occur, e.g. in the form of itching, urticaria or rashes. Such mild reactions may develop into serious reactions with dyspnoea and a fall in blood pressure, sometimes progressing to shock.",
          "In isolated cases, a decrease in serum sodium concentration and allergic vasculitis or hypersensitivity of the skin to light may occur."
        ]
      },
      {
        "title": "For Metformin",
        "information": ":",
        "items": [
          "Gastrointestinal symptoms such as nausea, vomiting, diarrhoea, abdominal pain and loss of appetite (>10%) are very common. These occur most frequently during initiation of therapy and resolve spontaneously in most cases.",
          "Metallic taste (3%) is common",
          "Decrease of vitamin B12 absorption with decrease of serum levels has been observed in patients treated long-term with metformin and appears generally to be without clinical signifcance (<0.01%). However, Cases of peripheral neuropathy in patients with vitamin B12 defciency have been reported in post-marketing experience (frequency not known). (frequency unknown)",
          "Lactic acidosis (0.03 cases/1000 patient-years) is very rare",
          "Hemolytic anemia (frequency unknown)",
          "Reduction of thyrotropin level in patients with hypothyroidism (frequency unknown)",
          "Hypomagnesemia in the context of diarrhea (frequency unknown)",
          "Encephalopathy (frequency unknown)",
          "Photosensitivity (frequency unknown)",
          "Hepatobiliary disorders: Reports of liver function tests abnormalities and hepatitis resolving upon metformin discontinuation"
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy- Lactation-",
        "items": [
          "For Glimepiride: Glimepiride must not be taken during pregnancy. Otherwise, there is risk of harm to the child. The patient must change over to insulin during pregnancy. Patients planning a pregnancy must inform their physician. It is recommended that such patients change over to insulin.",
          "For Metformin: When the patient plans to become pregnant and during pregnancy, diabetes should not be treated with metformin but insulin should be used to maintain blood glucose levels as close to normal as possible in order to lower the risk of fetal malformations associated with abnormal blood glucose levels.",
          "For Glimepiride: To prevent possible ingestion with the breast milk and possible harm to the child, glimepiride must not be taken by breast-feeding women. If necessary the patient must change over to insulin, or must stop breastfeeding.",
          "For Metformin: Metformin is excreted into milk in lactating rats. Similar data is not available in humans and a decision should be made whether to discontinue nursing or to discontinue metformin, taking into account the importance of the compound to the mother."
        ]
      }
    ],
    "precautions": [
      {
        "title": "For Glimepiride",
        "information": ": In the initial weeks of treatment, the risk of hypoglycemia may be increased and necessitates especially careful monitoring. If risk factors for hypoglycemia are present, it may be necessary to adjust the dosage of glimepiride or the entire therapy. This also applies whenever illness occurs during therapy or the patient's life-style changes. It is known from other sulfonylureas that, despite initially successful countermeasures, hypoglycaemia may recur. Patients must, therefore, remain under close observation. Severe hypoglycaemia further requires immediate treatment and follow-up by a physician and, in some circumstances, in-patient hospital care. Treatment of patients with G6PD-defciency with sulfonylurea agents can lead to hemolytic anaemia. Since glimepiride belongs to the class of sulfonylurea agents, caution should be used in patients with G6PD-defciency and a non-sulfonylurea alternative should be considered.",
        "items": []
      },
      {
        "title": "For Metformin",
        "information": ": Regular monitoring of thyroid-stimulating hormone (TSH) levels is recommended in patients withhypothyroidism. Long-term treatment with metformin has been associated with a decrease in vitamin B12 serumlevels which may cause peripheral neuropathy. Monitoring of the vitamin B12 level is recommended.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children",
        "information": ": Data is insufficient to recommend pediatric use of this tablet.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": A GFR should be assessed before initiation of treatment with metformin-containing products and at least annually thereafter. In patients at increased risk of further progression of renal impairment and in the elderly, renal function should be assessed more frequently, e.g. every 3-6 months. The maximum daily dose of metformin should preferably be divided into 2-3 daily doses. Factors that may increase the risk of lactic acidosis should be reviewed before considering the initiation of metformin in patients with GFR<60 mL/min. If no adequate strength of this tablet is available, individual monocomponents should be used instead of the fixed dose combination. GFR 60-89 ml/min: GFR 45-59 ml/min: GFR 30-44 ml/min: GFR <30 ml/min:",
        "items": [
          "Metformin: Maximum daily dose is 3000 mg. Dose reduction may be considered in relation to declining renal function.",
          "Glimepiride: The highest recommended dose per day should be 8 mg of glimepiride.",
          "Metformin: Maximum daily dose is 2000 mg. The starting dose is at most half of the maximum dose.",
          "Metformin: Maximum daily dose is 1000 mg. The starting dose is at most half of the maximum dose.",
          "Metformin: Metformin is contraindicated",
          "Glimepiride: Change-over to insulin is indicated, not least to achieve optimal metabolic control."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": "For Glimepiride",
        "information": ": Acute overdosage, as well as long-term treatment with too high a dose of glimepiride, may lead to severe life-threatening hypoglycaemia. As soon as an overdose of glimepiride has been discovered, a physician must be notifed without delay. The patient must immediately take sugar, if possible in the form of glucose unless a physician has already undertaken responsibility for treating the overdose. Careful monitoring is essential until the physician is confdent that the patient is out of danger. It must be remembered that hypoglycaemia may recur after initial recovery. Admission to hospital may sometimes be necessary even as a precautionary measure. In particular, signifcant overdoses and severe reactions with signs such as loss of consciousness or other serious neurological disorders are medical emergencies and require immediate treatment and admission to hospital. If, for example, the patient is unconscious, an intravenous injection of concentrated glucose solution is indicated (for adults starting with 40 ml of 20% solution, for example). Alternatively in adults, administration of glucagon, e.g. in doses of 0.5 to 1 mg i.v., s.c. or i.m., may be considered. In particular when treating hypoglycaemia due to accidental intake of glimepiride in infants and young children, the dose of glucose given must be very carefully adjusted in view of the possibility of producing dangerous hyperglycaemia, and must be controlled by close monitoring of blood glucose. Patients who have ingested life-threatening amounts of glimepiride require detoxifcation (e.g. by gastric lavage and medicinal charcoal). After acute glucose replacement has been completed it is usually necessary to give an intravenous glucose infusion in lower concentration so as to ensure that the hypoglycaemia does not recur. The patient's blood glucose level should be carefully monitored for at least 24 hours. In severe cases with a protracted course, hypoglycaemia, or the danger of slipping back into hypoglycaemia, may persist for several days.",
        "items": []
      },
      {
        "title": "For Metformin",
        "information": ": Hypoglycaemia has not been seen with metformin doses of up to 85 g, although Lactic acidosis has occurred in such circumstances. High overdose or concomitant risks of metformin may lead to lactic acidosis Lactic acidosis is a medical emergency and must be treated in hospital. The most efective method to remove lactate and metformin is haemodialysis. Pancreatitis may occur in the context of a metformin overdose.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in a cool (not exceeding 25°C) and dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "This tablet must be swallowed whole and not crushed or chewed.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Combination Oral hypoglycemic preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": null,
        "instructions": [
          "The dosage of this tablet is governed by the desired blood glucose level. The dosage of this tablet must be the lowest which is sufficient to achieve the desired metabolic control. During treatment with this tablet glucose levels in blood and urine must be measured regularly.",
          "Mistakes, e.g. forgetting to take a dose, must never be corrected by subsequently taking a larger dose.",
          "As an improvement in control of diabetes is, in itself, associated with higher insulin sensitivity, glimepiride requirements may fall as treatment proceeds. To avoid hypoglycaemia timely dose reduction or cessation of this tablet therapy must therefore be considered.",
          "The highest recommended dose per day should be 8 mg of glimepiride and 2000 mg of metformin.",
          "In order to avoid hypoglycaemia the starting dose of this tablet should not exceed the daily doses of glimepiride or metformin already being taken.",
          "When switching from combination therapy of glimepiride plus metformin as separate tablets, this combination should be administered on the basis of dosage currently being taken."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:49.326Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eb1",
    "original_record": {
      "input_index": 923,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eb1"
        },
        "name": "Amaryl M",
        "strength": "1 mg+500 mg",
        "generic": "Glimepiride + Metformin",
        "company": "Synovia Pharma PLC.",
        "medicine_type": "Tablet (Prolonged Release)",
        "source_url": "https://medex.com.bd/brands/26826/amaryl-m-1-mg-tablet",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28015/ambeeclox-500-mg-capsule",
    "name": "Ambeeclox",
    "dosage_form": "Capsule",
    "generic": "Cloxacillin Sodium",
    "strength": "500 mg",
    "company": "Ambee Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 5.96",
      "strip_price": "৳ 59.60",
      "pack_size_info": "(10 x 10: ৳ 596.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.96",
          "pack_size_info": "(10 x 10: ৳ 596.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 59.60",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/292/cloxacillin-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "গ্রাম-পজিটিভ জীবাণু দ্বারা সৃষ্ট সংক্রমণের চিকিৎসায় ক্লক্সাসিলিন নির্দেশিত। পেনিসিলিনেজ উৎপাদনক্ষম স্টেফাইলোকক্কাই জনিত সংক্রমণের চিকিৎসায়ও এটি নির্দেশিত। এ জাতীয় সংক্রমণের মধ্যে রয়েছেঃ",
        "items": []
      },
      {
        "title": "স্কিন ও সফ্‌ট টিস্যু সংক্রমণ",
        "information": ": ফোঁড়া (boils), পূজাশয় (abscess), কার্বাংকল, ফারানকুলোসিস, সেলুলাইটিস, সংক্রমিত ক্ষত (infected wounds), সংক্রমিত পোড়া (infected burns), ত্বক প্রতিস্থাপন প্রতিরক্ষা (protection for skin grafts), ত্বকের বিভিন্ন সংক্রমণ যেমন আলসার, একজিমা ও একনি।",
        "items": []
      },
      {
        "title": "রেসপিরেটরী ট্র্যাক্ট, নাক, কান ও গলার সংক্রমণ",
        "information": ": নিউমোনিয়া, ফুসফুসের পূজাশয় (lung abscess), এমপায়েমা, সাইনোসাইটিস, ফ্যারিনজাইটিস, টনসিলাইটিস, কুইনসি, অটাইটিস মিডিয়া ও এক্সটারণা।",
        "items": []
      },
      {
        "title": "ক্লক্সাসিলিন-সংবেদনশীল (sensitive), জীবাণু জনিত অন্যান্য সংক্রমণ",
        "information": ": অসটিওমায়েলাইটিস, এনটেরাইটিস, এনডোকারডাইটিস, ইউরিনারী ট্র্যাক্ট সংক্রমণ ও সেপটিসেমিয়া।",
        "items": []
      }
    ],
    "mode_of_action": [],
    "interaction": [],
    "contraindications": [
      {
        "title": null,
        "information": "পেনিসিলিনে অতি-সংবেদনশীল (hypersensitive) রোগীদের ক্ষেত্রে ক্লক্সাসিলিন প্রয়োগ নিষিদ্ধ।",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "ক্লক্সাসিলিন এর পার্শ্ব-প্রতিক্রিয়া অন্যান্য পেনিসিলিনের মতই। এগুলো সাধারণতঃ মৃদু ও ক্ষণস্থায়ী হয়ে থাকে। এই সমস্ত পার্শ্ব-প্রতিক্রিয়ার মধ্যে রয়েছে জ্বর, ডায়রিয়া, অজীর্ণ (indigestion), র‍্যাশ-আরটিকারিয়েল অথবা ইরিথিমেটাস জাতীয়। যে কোন ধরণের র‍্যাশে রোগীকে এ ওষুধ দেয়া বন্ধ করতে হবে।",
        "items": []
      }
    ],
    "pregnancy_cat": [],
    "precautions": [
      {
        "title": null,
        "information": "যে সব রোগীর এলার্জির পূর্ব ইতিহাস আছে তাদের বেলায় ক্লক্সাসিলিন সতর্কতার সাথে ব্যবহার করতে হবে। ক্লক্সাসিলিন সাব-কনজাংটিভাল ইনজেকশন হিসেবে অথবা চোখের ড্রপস হিসেবে দেয়া যাবে না। ক্লক্সাসিলিন সিরাপ ও ড্রপস ব্যবহরের আগে তাৎক্ষনিকভাবে তৈরী করে ঠাণ্ডা স্থানে (সম্ভব হলে রেফ্রিজারেটরে) রাখতে হবে। সংমিশ্রিত সিরাপ ও ড্রপস সাধারণ তাপমাত্রায় রাখলে পাঁচ দিনের মধ্যে অথবা রেফ্রিজারেটরে রাখলে সাত দিনের মধ্যে ব্যবহার করতে হবে। মাংসপেশীতে বা শিরাপথে প্রয়োগের জন্য প্রস্তুতকৃত ক্লক্সাসিলিন দ্রবণ তৈরীর ৩০ মিনিটের মধ্যে ব্যবহার করতে হবে। অবশ্য ক্লক্সাসিলিন এর জলীয় দ্রবণ স্বাভাবিক তাপমাত্রায় (২৫° সেঃ) অনধিক ২৪ ঘন্টা পর্যন্ত কার্যকর থাকে। শিরাপথের প্রয়োগোপযোগী অধিকাংশ তরলের সাথেই ক্লক্সাসিলিন মেশানো যায়। তবে কখনোই আমিষ জাতীয় তরল (যেমন প্রোটিন হাইড্রোলাইসেটস) এর সাথে মেশানো যাবে না।",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "ক্লক্সাসিলিন এর সকল ডোসেজ ফরমকে ঠান্ডা ও শুকনো স্থানে রাখতে হবে। ক্লক্সাসিলিন ইনজেকশন ভায়ালকে অনধিক ২৫° সেঃ তাপমাত্রায় সংরক্ষণ করুন।",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Penicillinase-resistant penicillins",
    "dosage": [
      {
        "medication_type": "প্রাপ্তবয়স্কদের প্রচলিত মাত্রা",
        "information": "- খাওয়ার জন্য: ৫০০ মিগ্রা দিনে চার বার আহারের আধা থেকে এক ঘন্টা আগে। ইনজেকশন হিসেবে:",
        "instructions": []
      },
      {
        "medication_type": "মাংসপেশীতে ইনজেকশন হিসেবে",
        "information": ": ২৫০ মিগ্রা চার থেকে ছয় ঘন্টা পর পর।",
        "instructions": []
      },
      {
        "medication_type": "শিরাপথে ইনজেকশন হিসেবে",
        "information": ": ৫০০ মিগ্রা চার থেকে ছয় ঘন্টা পর পর। প্রয়োজনবোধে উপরোল্লিখিত মাত্রাকে দ্বিগুণ করা যেতে পারে।",
        "instructions": []
      },
      {
        "medication_type": "প্লুরাল কেভিটিতে ইনজেকশন হিসেবে",
        "information": ": ৫০০ মিগ্রা দিনে এক বার।",
        "instructions": []
      },
      {
        "medication_type": "জয়েন্ট কেভিটিতে ইনজেকশন হিসেবে",
        "information": ": ৫০০ মিগ্রা দিনে এক বার।",
        "instructions": []
      },
      {
        "medication_type": "শিশুদের প্রচলিত মাত্রা",
        "information": "- খাওয়ার জন্য: ২ থেকে ১০ বৎসর পর্যন্ত- প্রাপ্তবয়স্ক মাত্রার অর্ধেক। ২ বৎসরের নীচে- প্রাপ্তবয়স্ক মাত্রার এক-চতুর্থাংশ। ইনজেকশন হিসেবে:",
        "instructions": []
      },
      {
        "medication_type": "মাংসপেশীতে ইনজেকশন হিসেবে",
        "information": ": ২৫০ মিগ্রা এর সাথে ১.৫ মিলি কিংবা ৫০০ মিগ্রা এর সাথে ২ মিলি ওয়াটার ফর ইনজেকশন বিপি মিশিয়ে দ্রবীভূত করতে হবে।",
        "instructions": []
      },
      {
        "medication_type": "শিরাপথে ইনজকেশন হিসাবে",
        "information": ": ৫০০ মিগ্রা এর সাথে ৫-১০ মিলি ওয়াটার ফর ইনজকেশন বিপি মিশিয়ে দ্রবীভূত করতে হবে। এরপর এই দ্রবণকে তিন থেকে চার মিনিট ধরে ধীরে ধীরে শরীরে প্রয়োগ করতে হবে। ক্লক্সাসিলিন ইনজকেশনকে ইনফিউশন উপযোগী যে কোন তরলে মিশিয়ে দেয়া যায় অথবা যথাযথ ভাবে হালকা করে ড্রপি টউিবে তিন থেকে চার মিনিট ধরে ধীরে ধীরে প্রয়োগ করা যায়।",
        "instructions": []
      },
      {
        "medication_type": "প্লুরাল কেভেটিতে ইনজেকশন হিসেবে",
        "information": ": ৫০০ মিগ্রা এর সাথে ৫ থেকে ১০ মিলি ওয়াটার ফর ইনজকেশন বিপি মিশিয়ে দ্রবীভূত করে প্রয়োগ করতে হবে।",
        "instructions": []
      },
      {
        "medication_type": "জয়েন্টে কেভেটিতে ইনজেকশন হিসেবে",
        "information": ": ৫০০ মিগ্রা এর সাথে অনধকি ৫ মিলি ওয়াটার ফর ইনজকেশন বিপি অথবা ০.৫% লিগনোকেইন হাইড্রোক্লোরাইড দ্রবণ মিশিয়ে দ্রবীভূত করে প্রয়োগ করতে হবে।",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:50.389Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eb6",
    "original_record": {
      "input_index": 924,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eb6"
        },
        "name": "Ambeeclox",
        "strength": "500 mg",
        "generic": "Cloxacillin Sodium",
        "company": "Ambee Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/28015/ambeeclox-500-mg-capsule",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/28016/ambeexin-250-mg-capsule",
    "name": "Ambeexin",
    "dosage_form": "Capsule",
    "generic": "Amoxicillin Trihydrate",
    "strength": "250 mg",
    "company": "Ambee Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 3.55",
      "strip_price": "৳ 35.50",
      "pack_size_info": "(10 x 10: ৳ 355.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.55",
          "pack_size_info": "(10 x 10: ৳ 355.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 35.50",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/6422/ambeexin-125-mg-suspension?ref=1"
      },
      {
        "text": "125 mg/1.25 ml (Drops)",
        "href": "https://medex.com.bd/brands/28020/ambeexin-125-mg-pediatric-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/69/amoxicillin-trihydrate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambeexin is indicated in the treatment of infections due to susceptible ß-lactamase negative strains of microorganisms. These infections include Ambeexin is indicated in the treatment of infections due to susceptible ß-lactamase negative strains of microorganisms. These infections include",
        "items": [
          "Ear, nose and throat infections (i.e. otitis media, sinusitis, tonsillitis, pharyngitis, laryngitis)",
          "Lower respiratory tract infections (i.e. pneumonia, acute and chronic bronchitis lung abscess, empyema, bronchiectasis)",
          "Ear, nose and throat infections (i.e. otitis media, sinusitis, tonsillitis, pharyngitis, laryngitis)",
          "Lower respiratory tract infections (i.e. pneumonia, acute and chronic bronchitis lung abscess, empyema, bronchiectasis)",
          "Skin and soft tissue infections (i.e. cellulitis, carbuncles, furunculosis, infected wounds, abscess)",
          "Genito-urinary tract infections (i.e. pyelonephritis, cystitis and urethritis)",
          "Venereal disease (i.e. acute uncomplicated gonorrhoea)",
          "In dental abscess, it is used as short-term therapy.",
          "It is also indicated in combination with Clarithromycin and Lansoprazole (as triple therapy), for the treatment of patients with H. pylori infection and duodenal ulcer disease and to reduce the risk of duodenal ulcer recurrence."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Amoxicillin is a broad spectrum penicillin. It is effective against a wide range of Gram-positive and Gram-negative bacteria. It acts through the inhibition of biosynthesis of cell wall. Amoxicillin is stable in the presence of gastric acid and is rapidly absorbed after oral administration. After an oral dose, peak plasma concentration of Amoxicillin is reached within 1 to 2 hours. Amoxicillin is widely distributed at varying concentration in body tissues and fluids.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Concurrent use of Ambeexin and Probenecid may result in increased and prolonged blood levels of Ambeexin. Ambeexin may affect the gut flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral estrogen/progesterone contraceptives.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Amoxicillin is contraindicated in penicillin hypersensitive patients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects are mild and transient in nature. This may include diarrhoea, indigestion or occasionally rash. Pseudo-membranous colitis has been reported rarely.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA pregnancy category of Amoxicillin is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Amoxicillin has been shown to be excreted in human milk. So, caution should be exercised when Amoxicillin is administered to a lactating mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "The possibility of superinfections with mycotic or bacterial pathogens should be kept in mind during therapy. If superinfections occur, Ambeexin should be discontinued and appropriate therapy should be instituted.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Reconstituted suspension can be administered by adding the required amount of suspension to milk, fruit juice, water. These preparations should then be taken immediately.",
        "items": []
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Broad spectrum penicillins",
    "dosage": [
      {
        "medication_type": "Adult",
        "information": ": 250 mg three times daily, increasing up to 500 mg three times daily for severe infections.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": "(up to 10 years of age) : 125 mg three times daily, increasing up to 250 mg three times daily for severe infections.",
        "instructions": []
      },
      {
        "medication_type": "Severe or recurrent purulent respiratory infection",
        "information": ": 3 gm every 12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Otitis media",
        "information": ": Recommended dose is 1 g three times daily for adult and 40 mg/kg body weight daily in 3 divided doses for children (max. 3 g daily).",
        "instructions": []
      },
      {
        "medication_type": "Pneumonia",
        "information": ": Recommended dose is 500-1000 mg three times daily.",
        "instructions": []
      },
      {
        "medication_type": "Dental abscess",
        "information": ": Recommended dose is 3 gm, repeated after 10-12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Urinary tract infections",
        "information": ": Recommended dose is 3 gm, repeated after 10-12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Gonorrhoea",
        "information": ": Single dose of 2-3 gm with Probenecid 1 gm is recommended (Probenecid is contraindicated in children under 2 years).",
        "instructions": []
      },
      {
        "medication_type": "In renal impairment",
        "information": ": it may be necessary to reduce the total daily dosage.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:51.462Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ebb",
    "original_record": {
      "input_index": 925,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ebb"
        },
        "name": "Ambeexin",
        "strength": "250 mg",
        "generic": "Amoxicillin Trihydrate",
        "company": "Ambee Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/28016/ambeexin-250-mg-capsule",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/38333/ambfex-120-mg-tablet",
    "name": "Ambfex",
    "dosage_form": "Tablet",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "120 mg",
    "company": "Ambee Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 8.00",
      "strip_price": "৳ 80.00",
      "pack_size_info": "(3 x 10: ৳ 240.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.00",
          "pack_size_info": "(3 x 10: ৳ 240.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 80.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "180 mg (Tablet)",
        "href": "https://medex.com.bd/brands/38334/ambfex-180-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Ambfex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Ambfex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Ambfex improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Ambfex is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Ambfex significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Ambfex improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambfex does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Ambfex with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Ambfex caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Ambfex and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Ambfex should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Ambfex tablets will produce an effect on the ability to drive or use machines. In objective tests, Ambfex has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Ambfex. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Ambfex has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Ambfex from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Ambfex 120 mg Tablet?",
        "answer": [
          "Ambfex 120 mg Tablet is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Ambfex 120 mg Tablet?",
        "answer": [
          "Ambfex 120 mg Tablet is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Ambfex 120 mg Tablet?",
        "answer": [
          "Ambfex 120 mg Tablet has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Ambfex 120 mg Tablet?",
        "answer": [
          "Ambfex 120 mg Tablet should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Ambfex 120 mg Tablet make you sleepy?",
        "answer": [
          "Yes, Ambfex 120 mg Tablet can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Ambfex 120 mg Tablet?",
        "answer": [
          "Do not take an overdose of Ambfex 120 mg Tablet as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Ambfex 120 mg Tablet work?",
        "answer": [
          "Ambfex 120 mg Tablet starts working within 1 hour of consuming it. The peak benefit of Ambfex 120 mg Tablet is observed within 6 hours."
        ]
      },
      {
        "question": "Does Ambfex 120 mg Tablet relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Ambfex 120 mg Tablet can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Ambfex 120 mg Tablet?",
        "answer": [
          "Take some rest after taking Ambfex 120 mg Tablet if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Ambfex 120 mg Tablet?",
        "answer": [
          "Ambfex 120 mg Tablet should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Ambfex 120 mg Tablet."
        ]
      },
      {
        "question": "How should I take Ambfex 120 mg Tablet?",
        "answer": [
          "Ambfex 120 mg Tablet should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Ambfex 120 mg Tablet?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Ambfex 120 mg Tablet."
        ]
      },
      {
        "question": "Can Ambfex 120 mg Tablet cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Ambfex 120 mg Tablet is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Ambfex 120 mg Tablet is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Ambfex 120 mg Tablet with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Ambfex 120 mg Tablet may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Ambfex 120 mg Tablet. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:28:52.621Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ebf",
    "original_record": {
      "input_index": 926,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ebf"
        },
        "name": "Ambfex",
        "strength": "120 mg",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Ambee Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/38333/ambfex-120-mg-tablet",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/38332/ambkust-10-mg-tablet",
    "name": "Ambkust",
    "dosage_form": "Tablet",
    "generic": "Montelukast Sodium",
    "strength": "10 mg",
    "company": "Ambee Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 14.00",
      "strip_price": "৳ 140.00",
      "pack_size_info": "(3 x 10: ৳ 420.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 14.00",
          "pack_size_info": "(3 x 10: ৳ 420.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 140.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/768/montelukast-sodium/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambkust is indicated for:",
        "items": [
          "Prophylaxis and chronic treatment of asthma",
          "Acute prevention of Exercise-Induced Bronchoconstriction (EIB)",
          "Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis"
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT 1 ). The cysteinyl leukotrienes (LTC 4 , LTD 4 , LTE 4 ) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma & allergic rhinitis, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambkust has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions. In drug interaction studies, the recommended clinical dose of Ambkust did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1mg/ethinyl estradiol 35mcg), terfenadine, digoxin, and warfarin. Although additional specific interaction studies were not performed, Ambkust was used concomitantly with a wide range of commonly prescribed drugs in clinical studies without evidence of clinical adverse interactions. These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines and decongestants. Phenobarbital, which induces hepatic metabolism, decreased the AUC of Ambkust approximately 40% following a single 10mg dose of Ambkust. No dosage adjustment for Ambkust is recommended. It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with Ambkust.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Montelukast is contraindicated in patients who are hypersensitive to any component of this product.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": "Common",
        "information": ": Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.",
        "items": []
      },
      {
        "title": "Uncommon",
        "information": ": Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.",
        "items": []
      },
      {
        "title": "Rare",
        "information": ": Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Montelukast crosses the placenta following oral dosing in rats and rabbits. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Montelukast should be used during pregnancy only if clearly needed. Because many drugs are excreted in human milk, caution should be exercised when Montelukast is given to a nursing mother.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambkust is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus. Patients should be advised to have appropriate rescue medication available. Therapy with Ambkust can be continued during acute exacerbations of asthma. While the dose of inhaled corticosteroid may be reduced gradually under medical supervision, Ambkust should not be abruptly substituted for inhaled or oral corticosteroids. Ambkust should not be used as monotherapy for the treatment and management of exercise induced bronchospasm. Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents while taking Ambkust. Although Ambkust is effective in improving airway function in asthmatics with documented aspirin sensitivity, it has not been shown to truncate bronchoconstrictor response to aspirin and other non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Ambkust and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C35H36ClNO3S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg"
    },
    "therapeutic_class": "Leukotriene receptor antagonists",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adults and adolescents with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for adults and adolescents 15 years of age and older",
        "information": ": Montelukast 10 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Pediatric patients with asthma or seasonal allergic rhinitis:",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 to 14 years of age",
        "information": ": Montelukast 5 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 2 years to 5 years of age",
        "information": ": Montelukast 4 mg tablet once daily.",
        "instructions": []
      },
      {
        "medication_type": "The dosage for pediatric patients 6 months to 5 years of age",
        "information": ": Montelukast 4 mg oral granules once daily. This can be administered either directly in the mouth, or mixed with a spoonful of cold water or soft food at room temperature",
        "instructions": []
      },
      {
        "medication_type": "Use in the pediatric patient",
        "information": ": The safety and efficacy of Montelukast have been established in adequate and well-controlled studies in pediatric patients with asthma 6 months to 14 years of age. Safety and efficacy profiles in this age group are similar to those seen in adults.",
        "instructions": []
      },
      {
        "medication_type": "Hepatic Insufficiency",
        "information": ": No dosage adjustment is required in patients with mild-to-moderate hepatic insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Renal Insufficiency",
        "information": ": No dosage adjustment is recommended in patients with renal insufficiency.",
        "instructions": []
      },
      {
        "medication_type": "Elderly use",
        "information": ": The pharmacokinetic profile and the oral bioavailability of a single 10-mg oral dose of montelukast are similar in elderly and younger adults. The plasma half-life of montelukast is slightly longer in the elderly. No dosage adjustment in the elderly is required.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Ambkust 10 mg Tablet?",
        "answer": [
          "Ambkust 10 mg Tablet is a selective and orally active leukotriene receptor antagonist."
        ]
      },
      {
        "question": "What is Ambkust 10 mg Tablet used for?",
        "answer": [
          "Ambkust 10 mg Tablet is commonly used to treat asthma or allergic rhinitis. It helps keep airways open and easy breathing by blocking leukotrienes."
        ]
      },
      {
        "question": "How soon can the effect of Ambkust 10 mg Tablet be observed?",
        "answer": [
          "The effect of Ambkust 10 mg Tablet can be observed after 1-3 hours of administration. Ambkust 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks and needs to be taken daily to work properly."
        ]
      },
      {
        "question": "How long does the effect of Ambkust 10 mg Tablet last?",
        "answer": [
          "The effect of Ambkust 10 mg Tablet lasts for an average duration of 24 hours."
        ]
      },
      {
        "question": "Should I use Ambkust 10 mg Tablet empty stomach?",
        "answer": [
          "Ambkust 10 mg Tablet may be taken with or without food as prescribed by your doctor."
        ]
      },
      {
        "question": "What if I miss a dose of Ambkust 10 mg Tablet?",
        "answer": [
          "If you miss a dose, you may take it as soon as possible. But if it is almost time for your next dose, just skip that dose. Do not double up on doses."
        ]
      },
      {
        "question": "Are there any pregnancy warnings for Ambkust 10 mg Tablet?",
        "answer": [
          "Use of Ambkust 10 mg Tablet in pregnant women should be avoided unless clearly needed."
        ]
      },
      {
        "question": "General Instructions",
        "answer": [
          "Take Ambkust 10 mg Tablet exactly as prescribed by your doctor.",
          "Do not change your Ambkust 10 mg Tablet dose or stop using asthma medication without your doctor's advice.",
          "Ambkust 10 mg Tablet is not a fast-acting rescue medicine for asthma attacks. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working.",
          "Avoid situations or activities that may trigger an asthma attack.",
          "Talk to your doctor before using Ambkust 10 mg Tablet if you're pregnant or breastfeeding. They can help you decide if it's the right choice for you."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:28:54.039Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ec1",
    "original_record": {
      "input_index": 927,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ec1"
        },
        "name": "Ambkust",
        "strength": "10 mg",
        "generic": "Montelukast Sodium",
        "company": "Ambee Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/38332/ambkust-10-mg-tablet",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/25522/ambokof-6-mg-pediatric-drop",
    "name": "Ambokof",
    "dosage_form": "Pediatric Drops",
    "generic": "Ambroxol Hydrochloride",
    "strength": "6 mg/ml",
    "company": "Novelta Bestway Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 30.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "15 ml bottle",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "15 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/538/ambokof-15-mg-syrup?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambokof is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambokof should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambokof might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambokof should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:55.256Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ec4",
    "original_record": {
      "input_index": 928,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ec4"
        },
        "name": "Ambokof",
        "strength": "6 mg/ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Novelta Bestway Pharma Ltd.",
        "medicine_type": "Pediatric Drops",
        "source_url": "https://medex.com.bd/brands/25522/ambokof-6-mg-pediatric-drop",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/538/ambokof-15-mg-syrup",
    "name": "Ambokof",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Novelta Bestway Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 40.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "6 mg/ml (Drops)",
        "href": "https://medex.com.bd/brands/25522/ambokof-6-mg-pediatric-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambokof is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambokof should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambokof might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambokof should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:56.622Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ec5",
    "original_record": {
      "input_index": 929,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ec5"
        },
        "name": "Ambokof",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Novelta Bestway Pharma Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/538/ambokof-15-mg-syrup",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/541/ambolyt-15-mg-syrup",
    "name": "Ambolyt",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 50.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml botttle",
          "price": "৳ 50.00",
          "pack_size_info": null
        },
        {
          "label": "200 ml botttle",
          "price": "৳ 75.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "6 mg/ml (Drops)",
        "href": "https://medex.com.bd/brands/542/ambolyt-6-mg-pediatric-drop?ref=1"
      },
      {
        "text": "75 mg (SR Capsule)",
        "href": "https://medex.com.bd/brands/38220/ambolyt-sr-75-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambolyt is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambolyt should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambolyt might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambolyt should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:57.699Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eca",
    "original_record": {
      "input_index": 930,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eca"
        },
        "name": "Ambolyt",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/541/ambolyt-15-mg-syrup",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/38220/ambolyt-sr-75-mg-capsule",
    "name": "Ambolyt SR",
    "dosage_form": "Capsule (Sustained Release)",
    "generic": "Ambroxol Hydrochloride",
    "strength": "75 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 5.50",
      "strip_price": "৳ 55.00",
      "pack_size_info": "(3 x 10: ৳ 165.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.50",
          "pack_size_info": "(3 x 10: ৳ 165.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 55.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "15 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/541/ambolyt-15-mg-syrup?ref=1"
      },
      {
        "text": "6 mg/ml (Drops)",
        "href": "https://medex.com.bd/brands/542/ambolyt-6-mg-pediatric-drop?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambolyt SR is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambolyt SR should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambolyt SR might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambolyt SR should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:28:58.902Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ecb",
    "original_record": {
      "input_index": 931,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ecb"
        },
        "name": "Ambolyt SR",
        "strength": "75 mg",
        "generic": "Ambroxol Hydrochloride",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Capsule (Sustained Release)",
        "source_url": "https://medex.com.bd/brands/38220/ambolyt-sr-75-mg-capsule",
        "_page": 31,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/25498/ambrocod-15-mg-syrup",
    "name": "Ambrocod",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Amulet Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 40.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambrocod is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambrocod should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambrocod might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambrocod should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:00.061Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ed7",
    "original_record": {
      "input_index": 932,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ed7"
        },
        "name": "Ambrocod",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Amulet Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/25498/ambrocod-15-mg-syrup",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/35866/ambrogen-15-mg-syrup",
    "name": "Ambrogen",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Biogen Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 40.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambrogen is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambrogen should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambrogen might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambrogen should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:01.328Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ed9",
    "original_record": {
      "input_index": 933,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ed9"
        },
        "name": "Ambrogen",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Biogen Pharmaceuticals Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/35866/ambrogen-15-mg-syrup",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/554/ambronil-6-mg-pediatric-drop",
    "name": "Ambronil",
    "dosage_form": "Pediatric Drops",
    "generic": "Ambroxol Hydrochloride",
    "strength": "6 mg/ml",
    "company": "Orion Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 30.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "15 ml bottle",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "15 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/553/ambronil-15-mg-syrup?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambronil is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambronil should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambronil might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambronil should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:02.546Z",
    "medicine_id": "68c3c09aef5b8f2b163a8edd",
    "original_record": {
      "input_index": 934,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8edd"
        },
        "name": "Ambronil",
        "strength": "6 mg/ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Orion Pharma Ltd.",
        "medicine_type": "Pediatric Drops",
        "source_url": "https://medex.com.bd/brands/554/ambronil-6-mg-pediatric-drop",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/557/ambrotil-15-mg-syrup",
    "name": "Ambrotil",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Amico Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 35.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 35.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambrotil is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambrotil should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambrotil might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambrotil should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:03.653Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ee3",
    "original_record": {
      "input_index": 935,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ee3"
        },
        "name": "Ambrotil",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Amico Laboratories Ltd.",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/557/ambrotil-15-mg-syrup",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/559/ambrox-15-mg-syrup",
    "name": "Ambrox",
    "dosage_form": "Syrup",
    "generic": "Ambroxol Hydrochloride",
    "strength": "15 mg/5 ml",
    "company": "Square Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 50.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "100 ml bottle",
          "price": "৳ 50.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "6 mg/ml (Drops)",
        "href": "https://medex.com.bd/brands/560/ambrox-6-mg-pediatric-drop?ref=1"
      },
      {
        "text": "75 mg (SR Capsule)",
        "href": "https://medex.com.bd/brands/561/ambrox-sr-75-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambrox is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambrox should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambrox might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambrox should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:05.013Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ee6",
    "original_record": {
      "input_index": 936,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ee6"
        },
        "name": "Ambrox",
        "strength": "15 mg/5 ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Square Pharmaceuticals PLC",
        "medicine_type": "Syrup",
        "source_url": "https://medex.com.bd/brands/559/ambrox-15-mg-syrup",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/560/ambrox-6-mg-pediatric-drop",
    "name": "Ambrox",
    "dosage_form": "Pediatric Drops",
    "generic": "Ambroxol Hydrochloride",
    "strength": "6 mg/ml",
    "company": "Square Pharmaceuticals PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 40.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "15 ml bottle",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "15 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/559/ambrox-15-mg-syrup?ref=1"
      },
      {
        "text": "75 mg (SR Capsule)",
        "href": "https://medex.com.bd/brands/561/ambrox-sr-75-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambrox is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambrox should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambrox might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambrox should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:06.204Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ee7",
    "original_record": {
      "input_index": 937,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ee7"
        },
        "name": "Ambrox",
        "strength": "6 mg/ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Square Pharmaceuticals PLC",
        "medicine_type": "Pediatric Drops",
        "source_url": "https://medex.com.bd/brands/560/ambrox-6-mg-pediatric-drop",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/4030/ambryl-6-mg-pediatric-drop",
    "name": "Ambryl",
    "dosage_form": "Pediatric Drops",
    "generic": "Ambroxol Hydrochloride",
    "strength": "6 mg/ml",
    "company": "Jenphar Bangladesh Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 34.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "15 ml bottle",
          "price": "৳ 34.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [
      {
        "label": null,
        "note": null
      }
    ],
    "also_available": [
      {
        "text": "15 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/4029/ambryl-15-mg-syrup?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/53/ambroxol-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Ambryl is indicated in-",
        "items": [
          "Productive cough",
          "Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis",
          "Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus",
          "Asthmatic bronchitis bronchial asthma with thick expectoration",
          "Bronchiectasis",
          "Chronic pneumonia etc."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Ambroxol is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Ambroxol has anti inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Ambryl should not be taken simultaneously with antitussives (e.g.Codeine) because phlegm, which has been liquefied by Ambryl might not be expectorated.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema have been reported.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Teratogenic and fetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during the1st trimester. Safety during lactation has not been established yet.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Ambryl should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Protect from direct light exposure, Store in a dry place at a temperature not exceeding 30°C, Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Cough expectorants & mucolytics",
    "dosage": [
      {
        "medication_type": null,
        "information": "Average daily dose (preferably after meal): Pediatric Drops:",
        "instructions": []
      },
      {
        "medication_type": "0-6 months",
        "information": ": 0.5 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "6-12 months",
        "information": ": 1 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": "1-2 years",
        "information": ": 1.25 ml 2 times a day",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Syrup:",
        "instructions": []
      },
      {
        "medication_type": "2-5 years",
        "information": ": 2.5 ml (1/2 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "5-10 years",
        "information": ": 5 ml (1 teaspoonful) 2-3 times a day",
        "instructions": []
      },
      {
        "medication_type": "10 years and adults",
        "information": ": 10 ml (2 teaspoonful) 3 times a day.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Sustained release capsule: Adult and children over 12 years old: 1 capsule once daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:07.345Z",
    "medicine_id": "68c3c09aef5b8f2b163a8eeb",
    "original_record": {
      "input_index": 938,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8eeb"
        },
        "name": "Ambryl",
        "strength": "6 mg/ml",
        "generic": "Ambroxol Hydrochloride",
        "company": "Jenphar Bangladesh Ltd.",
        "medicine_type": "Pediatric Drops",
        "source_url": "https://medex.com.bd/brands/4030/ambryl-6-mg-pediatric-drop",
        "_page": 32,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/27840/amdin-10-mg-tablet",
    "name": "Amdin",
    "dosage_form": "Tablet",
    "generic": "Amlodipine Besilate",
    "strength": "10 mg",
    "company": "Alco Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 6.02",
      "strip_price": "৳ 60.20",
      "pack_size_info": "(3 x 10: ৳ 180.60)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 6.02",
          "pack_size_info": "(3 x 10: ৳ 180.60)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 60.20",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/636/amdin-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/62/amlodipine-besilate/brand-names",
    "indications": [
      {
        "title": "Essential hypertension",
        "information": ": Amdin is efficacious as monotherapy in the treatment of hypertension. It may be used in combination with other antihypertensive agents.",
        "items": []
      },
      {
        "title": "Angina pectoris",
        "information": ": Amdin is indicated for the treatment of chronic stable angina pectoris and is efficacious as monotherapy. It may be used in combination with other antianginal agents.",
        "items": []
      },
      {
        "title": "Vasospastic angina",
        "information": ": Amdin is indicated for the treatment of confirmed or suspected vasospastic angina. It may be used as monotherapy or in combination with other antianginal drugs.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Amlodipine is a dihydropyridine calcium-channel blocker, with a long duration of action, used for the treatment of hypertension and angina pectoris. Amlodipine influences the myocardial cells, the cells within the specialized conducting system of the heart, and the cells of vascular smooth muscle. Administration of Amlodipine results primarily in vasodilation, with reduced peripheral resistance, blood pressure and afterload, increased coronary blood flow and a reflex increase in coronary heart rate. This in turn results in an increase in myocardial oxygen supply and cardiac output.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Drug Interactions- Other Significant Interactions-",
        "items": [
          "Potentially hazardous interactions: Little or no data are available in patients with markedly impaired cardiac left ventricular function; however, as with other calcium antagonist drugs, the combination of Amdin and p-blockers should be avoided in such patients.",
          "Digoxin: Absence of any interaction between Amdin and Digoxin in healthy volunteers has been documented in a controlled clinical study.",
          "Cimetidine: An unpublished clinical study indicated no interaction between, Amdin and Cimetidine in healthy volunteers.",
          "Warfarin: An unpublished clinical study in healthy volunteers indicates that Amdin did not significantly alter the effect of Warfarin on prothrombin time.",
          "Food: Food does not alter the rate or extent of absorption of Amdin."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to dihydropyridine derivatives. Pregnant woman.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse effects of amlodipine are associated with vasodilatory action, such as dizziness, flushing, headache, hypotension and peripheral edema. Gastrointestinal disturbances, increased micturition frequency, lethargy, eye pain and mental depression may also occur. A paradoxical increase in ischaemic chest pain may occur at the start of the treatment and in a few patients excessive fall in blood pressure has led to cerebral or myocardial ischaemia or transient blindness. Rashes, fever and abnormalities in liver function due to hypersensitivity reaction of Amdin may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. There are no adequate and well-controlled studies of Amlodipine in pregnant women. Amlodipine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Amlodipine is excreted in human milk. In the absence of this information, it is recommended that nursing be discontinued while Amlodipine is administered.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Precaution should be taken in patients with hepatic impairment and during pregnancy and breast feeding.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children with hypertension from 6 years to 17 years of age",
        "information": ": 2.5 mg once daily as a starting dose, up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in pediatric patients.",
        "items": []
      },
      {
        "title": "Children under 6 years old",
        "information": ": The effect of amlodipine on blood pressure in patients less than 6 years of age is not known.",
        "items": []
      },
      {
        "title": "Elderly",
        "information": ": Amdin used at similar doses in elderly or younger patients is equally well tolerated. Normal dosage regimens are recommended in the elderly, but increase of the dosage should take place with care.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment, therefore the normal dosage is recommended. Amdin is not dialysable.",
        "items": []
      },
      {
        "title": "Hepatic impairment",
        "information": ": Dosage recommendations have not been established in patients with mild to moderate hepatic impairment; therefore dose selection should be cautions and should start at the lower end of the dosing range. The pharmacokinetics of Amdin have not been studied in severe hepatic impairment. Amdin should be initiated at the lowest dose (2.5 mg once daily) and titrated slowly in patients with severe hepatic impairment.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": "Symptoms",
        "information": ": Available data suggest that large overdosage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged systemic hypotension up to and including shock with fatal outcome have been reported.",
        "items": []
      },
      {
        "title": "Management",
        "information": ": Clinically significant hypotension due to amlodipine overdosage calls for active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities, and attention to circulating fluid volume and urine output. A vasoconstrictor may be helpful in restoring vascular tone and blood pressure, provided that there is no contraindication to its use. Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade. Gastric lavage may be worthwhile in some cases. In healthy volunteers the use of charcoal up to 2 hours after administration of amlodipine 10 mg has been shown to reduce the absorption rate of amlodipine. Since amlodipine is highly protein-bound, dialysis is not likely to be of benefit.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep all medicines out of reach of children. Store in a cool & dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Calcium-channel blockers",
    "dosage": [
      {
        "medication_type": "Hypertension",
        "information": ": Usual dose is 5 mg once daily. The maximum dose is 10 mg once daily. Elderly patients with hepatic insufficiency may be started on 2.5 mg once daily; this dose may also be used when adding Amlodipine to other antihypertensive therapy.",
        "instructions": []
      },
      {
        "medication_type": "Angina (Chronic stable or Vasospastic)",
        "information": ": 5 to 10 mg, using the lower dose for elderly and in patients with hepatic insufficiency. Most patients require 10 mg. Administrations: May be taken without regard to meals.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:08.376Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ef1",
    "original_record": {
      "input_index": 939,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ef1"
        },
        "name": "Amdin",
        "strength": "10 mg",
        "generic": "Amlodipine Besilate",
        "company": "Alco Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/27840/amdin-10-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/638/amdocal-5-mg-tablet",
    "name": "Amdocal",
    "dosage_form": "Tablet",
    "generic": "Amlodipine Besilate",
    "strength": "5 mg",
    "company": "Beximco Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 5.50",
      "strip_price": "৳ 82.43",
      "pack_size_info": "(7 x 15: ৳ 577.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.50",
          "pack_size_info": "(7 x 15: ৳ 577.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 82.43",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/637/amdocal-10-mg-tablet?ref=1"
      },
      {
        "text": "2.5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/34900/amdocal-25-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/62/amlodipine-besilate/brand-names",
    "indications": [
      {
        "title": "Essential hypertension",
        "information": ": Amdocal is efficacious as monotherapy in the treatment of hypertension. It may be used in combination with other antihypertensive agents.",
        "items": []
      },
      {
        "title": "Angina pectoris",
        "information": ": Amdocal is indicated for the treatment of chronic stable angina pectoris and is efficacious as monotherapy. It may be used in combination with other antianginal agents.",
        "items": []
      },
      {
        "title": "Vasospastic angina",
        "information": ": Amdocal is indicated for the treatment of confirmed or suspected vasospastic angina. It may be used as monotherapy or in combination with other antianginal drugs.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Amlodipine is a dihydropyridine calcium-channel blocker, with a long duration of action, used for the treatment of hypertension and angina pectoris. Amlodipine influences the myocardial cells, the cells within the specialized conducting system of the heart, and the cells of vascular smooth muscle. Administration of Amlodipine results primarily in vasodilation, with reduced peripheral resistance, blood pressure and afterload, increased coronary blood flow and a reflex increase in coronary heart rate. This in turn results in an increase in myocardial oxygen supply and cardiac output.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Drug Interactions- Other Significant Interactions-",
        "items": [
          "Potentially hazardous interactions: Little or no data are available in patients with markedly impaired cardiac left ventricular function; however, as with other calcium antagonist drugs, the combination of Amdocal and p-blockers should be avoided in such patients.",
          "Digoxin: Absence of any interaction between Amdocal and Digoxin in healthy volunteers has been documented in a controlled clinical study.",
          "Cimetidine: An unpublished clinical study indicated no interaction between, Amdocal and Cimetidine in healthy volunteers.",
          "Warfarin: An unpublished clinical study in healthy volunteers indicates that Amdocal did not significantly alter the effect of Warfarin on prothrombin time.",
          "Food: Food does not alter the rate or extent of absorption of Amdocal."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to dihydropyridine derivatives. Pregnant woman.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse effects of amlodipine are associated with vasodilatory action, such as dizziness, flushing, headache, hypotension and peripheral edema. Gastrointestinal disturbances, increased micturition frequency, lethargy, eye pain and mental depression may also occur. A paradoxical increase in ischaemic chest pain may occur at the start of the treatment and in a few patients excessive fall in blood pressure has led to cerebral or myocardial ischaemia or transient blindness. Rashes, fever and abnormalities in liver function due to hypersensitivity reaction of Amdocal may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. There are no adequate and well-controlled studies of Amlodipine in pregnant women. Amlodipine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Amlodipine is excreted in human milk. In the absence of this information, it is recommended that nursing be discontinued while Amlodipine is administered.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Precaution should be taken in patients with hepatic impairment and during pregnancy and breast feeding.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children with hypertension from 6 years to 17 years of age",
        "information": ": 2.5 mg once daily as a starting dose, up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in pediatric patients.",
        "items": []
      },
      {
        "title": "Children under 6 years old",
        "information": ": The effect of amlodipine on blood pressure in patients less than 6 years of age is not known.",
        "items": []
      },
      {
        "title": "Elderly",
        "information": ": Amdocal used at similar doses in elderly or younger patients is equally well tolerated. Normal dosage regimens are recommended in the elderly, but increase of the dosage should take place with care.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment, therefore the normal dosage is recommended. Amdocal is not dialysable.",
        "items": []
      },
      {
        "title": "Hepatic impairment",
        "information": ": Dosage recommendations have not been established in patients with mild to moderate hepatic impairment; therefore dose selection should be cautions and should start at the lower end of the dosing range. The pharmacokinetics of Amdocal have not been studied in severe hepatic impairment. Amdocal should be initiated at the lowest dose (2.5 mg once daily) and titrated slowly in patients with severe hepatic impairment.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": "Symptoms",
        "information": ": Available data suggest that large overdosage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged systemic hypotension up to and including shock with fatal outcome have been reported.",
        "items": []
      },
      {
        "title": "Management",
        "information": ": Clinically significant hypotension due to amlodipine overdosage calls for active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities, and attention to circulating fluid volume and urine output. A vasoconstrictor may be helpful in restoring vascular tone and blood pressure, provided that there is no contraindication to its use. Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade. Gastric lavage may be worthwhile in some cases. In healthy volunteers the use of charcoal up to 2 hours after administration of amlodipine 10 mg has been shown to reduce the absorption rate of amlodipine. Since amlodipine is highly protein-bound, dialysis is not likely to be of benefit.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep all medicines out of reach of children. Store in a cool & dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Calcium-channel blockers",
    "dosage": [
      {
        "medication_type": "Hypertension",
        "information": ": Usual dose is 5 mg once daily. The maximum dose is 10 mg once daily. Elderly patients with hepatic insufficiency may be started on 2.5 mg once daily; this dose may also be used when adding Amlodipine to other antihypertensive therapy.",
        "instructions": []
      },
      {
        "medication_type": "Angina (Chronic stable or Vasospastic)",
        "information": ": 5 to 10 mg, using the lower dose for elderly and in patients with hepatic insufficiency. Most patients require 10 mg. Administrations: May be taken without regard to meals.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:09.572Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ef3",
    "original_record": {
      "input_index": 940,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ef3"
        },
        "name": "Amdocal",
        "strength": "5 mg",
        "generic": "Amlodipine Besilate",
        "company": "Beximco Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/638/amdocal-5-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34900/amdocal-25-mg-tablet",
    "name": "Amdocal",
    "dosage_form": "Tablet",
    "generic": "Amlodipine Besilate",
    "strength": "2.5 mg",
    "company": "Beximco Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 3.00",
      "strip_price": "৳ 30.00",
      "pack_size_info": "(3 x 10: ৳ 90.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.00",
          "pack_size_info": "(3 x 10: ৳ 90.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "10 mg (Tablet)",
        "href": "https://medex.com.bd/brands/637/amdocal-10-mg-tablet?ref=1"
      },
      {
        "text": "5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/638/amdocal-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/62/amlodipine-besilate/brand-names",
    "indications": [
      {
        "title": "Essential hypertension",
        "information": ": Amdocal is efficacious as monotherapy in the treatment of hypertension. It may be used in combination with other antihypertensive agents.",
        "items": []
      },
      {
        "title": "Angina pectoris",
        "information": ": Amdocal is indicated for the treatment of chronic stable angina pectoris and is efficacious as monotherapy. It may be used in combination with other antianginal agents.",
        "items": []
      },
      {
        "title": "Vasospastic angina",
        "information": ": Amdocal is indicated for the treatment of confirmed or suspected vasospastic angina. It may be used as monotherapy or in combination with other antianginal drugs.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Amlodipine is a dihydropyridine calcium-channel blocker, with a long duration of action, used for the treatment of hypertension and angina pectoris. Amlodipine influences the myocardial cells, the cells within the specialized conducting system of the heart, and the cells of vascular smooth muscle. Administration of Amlodipine results primarily in vasodilation, with reduced peripheral resistance, blood pressure and afterload, increased coronary blood flow and a reflex increase in coronary heart rate. This in turn results in an increase in myocardial oxygen supply and cardiac output.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Drug Interactions- Other Significant Interactions-",
        "items": [
          "Potentially hazardous interactions: Little or no data are available in patients with markedly impaired cardiac left ventricular function; however, as with other calcium antagonist drugs, the combination of Amdocal and p-blockers should be avoided in such patients.",
          "Digoxin: Absence of any interaction between Amdocal and Digoxin in healthy volunteers has been documented in a controlled clinical study.",
          "Cimetidine: An unpublished clinical study indicated no interaction between, Amdocal and Cimetidine in healthy volunteers.",
          "Warfarin: An unpublished clinical study in healthy volunteers indicates that Amdocal did not significantly alter the effect of Warfarin on prothrombin time.",
          "Food: Food does not alter the rate or extent of absorption of Amdocal."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to dihydropyridine derivatives. Pregnant woman.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse effects of amlodipine are associated with vasodilatory action, such as dizziness, flushing, headache, hypotension and peripheral edema. Gastrointestinal disturbances, increased micturition frequency, lethargy, eye pain and mental depression may also occur. A paradoxical increase in ischaemic chest pain may occur at the start of the treatment and in a few patients excessive fall in blood pressure has led to cerebral or myocardial ischaemia or transient blindness. Rashes, fever and abnormalities in liver function due to hypersensitivity reaction of Amdocal may occur.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. There are no adequate and well-controlled studies of Amlodipine in pregnant women. Amlodipine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Amlodipine is excreted in human milk. In the absence of this information, it is recommended that nursing be discontinued while Amlodipine is administered.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Precaution should be taken in patients with hepatic impairment and during pregnancy and breast feeding.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children with hypertension from 6 years to 17 years of age",
        "information": ": 2.5 mg once daily as a starting dose, up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in pediatric patients.",
        "items": []
      },
      {
        "title": "Children under 6 years old",
        "information": ": The effect of amlodipine on blood pressure in patients less than 6 years of age is not known.",
        "items": []
      },
      {
        "title": "Elderly",
        "information": ": Amdocal used at similar doses in elderly or younger patients is equally well tolerated. Normal dosage regimens are recommended in the elderly, but increase of the dosage should take place with care.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment, therefore the normal dosage is recommended. Amdocal is not dialysable.",
        "items": []
      },
      {
        "title": "Hepatic impairment",
        "information": ": Dosage recommendations have not been established in patients with mild to moderate hepatic impairment; therefore dose selection should be cautions and should start at the lower end of the dosing range. The pharmacokinetics of Amdocal have not been studied in severe hepatic impairment. Amdocal should be initiated at the lowest dose (2.5 mg once daily) and titrated slowly in patients with severe hepatic impairment.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": "Symptoms",
        "information": ": Available data suggest that large overdosage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged systemic hypotension up to and including shock with fatal outcome have been reported.",
        "items": []
      },
      {
        "title": "Management",
        "information": ": Clinically significant hypotension due to amlodipine overdosage calls for active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities, and attention to circulating fluid volume and urine output. A vasoconstrictor may be helpful in restoring vascular tone and blood pressure, provided that there is no contraindication to its use. Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade. Gastric lavage may be worthwhile in some cases. In healthy volunteers the use of charcoal up to 2 hours after administration of amlodipine 10 mg has been shown to reduce the absorption rate of amlodipine. Since amlodipine is highly protein-bound, dialysis is not likely to be of benefit.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep all medicines out of reach of children. Store in a cool & dry place, protected from light.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Calcium-channel blockers",
    "dosage": [
      {
        "medication_type": "Hypertension",
        "information": ": Usual dose is 5 mg once daily. The maximum dose is 10 mg once daily. Elderly patients with hepatic insufficiency may be started on 2.5 mg once daily; this dose may also be used when adding Amlodipine to other antihypertensive therapy.",
        "instructions": []
      },
      {
        "medication_type": "Angina (Chronic stable or Vasospastic)",
        "information": ": 5 to 10 mg, using the lower dose for elderly and in patients with hepatic insufficiency. Most patients require 10 mg. Administrations: May be taken without regard to meals.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:10.750Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ef5",
    "original_record": {
      "input_index": 941,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ef5"
        },
        "name": "Amdocal",
        "strength": "2.5 mg",
        "generic": "Amlodipine Besilate",
        "company": "Beximco Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/34900/amdocal-25-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/788/amdocal-plus-5-mg-tablet",
    "name": "Amdocal Plus",
    "dosage_form": "Tablet",
    "generic": "Amlodipine Besilate + Atenolol",
    "strength": "5 mg+50 mg",
    "company": "Beximco Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 8.50",
      "strip_price": "৳ 85.00",
      "pack_size_info": "(6 x 10: ৳ 510.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 8.50",
          "pack_size_info": "(6 x 10: ৳ 510.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 85.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "5 mg+25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/787/amdocal-plus-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/63/amlodipine-besilate-atenolol/brand-names",
    "indications": [
      {
        "title": null,
        "information": "This is indicated in-",
        "items": [
          "Patients with essential hypertension",
          "Patients with angina pectoris & hypertension as co-existing diseases",
          "ln post Ml patients",
          "ln patients with refractory angina pectoris where nitrate therapy has failed."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a fixed-dose combination of Amlodipine and Atenolol. Amlodipine is a dihydropyridine calcium antagonist that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle; it has a greater effect on vascular smooth muscle than on cardiac muscle. Amlodipine is a peripheral vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure. Amlodipine reduces tone, decreases coronary vasoreactivity and lowers cardiac demand by reducing afterload. Atenolol is a cardioselective beta-blocker. The cardio-selectivity is dose-related. Atenolol causes a reduction in blood pressure by lowering cardiac output, decreasing the plasma renin activity and sympathetic outflow from CNS. Atenolol also causes a reduction in myocardial oxygen demand by virtue of its negative inotropic and negative chronotropic effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Disopyramide",
        "information": ": Atenolol reduces the clearance of disopyramide by 20%. Additive negative inotropic effects on the heart may be produced.",
        "items": []
      },
      {
        "title": "Ampicillin",
        "information": ": at doses of 1 gm and above may reduce Atenolol levels.",
        "items": []
      },
      {
        "title": "Oral antidiabetics and insulin",
        "information": ": Beta-blockers may decrease tissue sensitivity to insulin and inhibit insulin secretion e.g. in response to oral antidiabetics. Atenolol has less potential for these actions.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity to either component, sinus bradycardia, second and higher degrees of heart block, cardiogenic shock, hypotension, congestive heart failure, poor left ventricular function.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The combination of Amlodipine and Atenolol is well tolerated. Overall side-effects include fatigue, headache, edema, nausea, drowsiness, anxiety and depression.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The combination should be used during pregnancy only if the expected benefit outweighs the potential fetal risk. The combination should not be used by nursing mothers. If its use is considered necessary, breast-feeding should be stopped.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Bronchospasm",
        "information": ": The combination should be used with caution in patients with airway obstruction.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": The combination can be used in patients with renal impairment. However, caution may be necessary if the creatinine clearance is less than 30 ml/min because of possible reduction in the excretion of unchanged Atenolol.",
        "items": []
      },
      {
        "title": "Hepatic impairment",
        "information": ": Caution may be necessary in the use of the combination in patients with severe liver damage because of prolongation of the elimination half-life of Amlodipine.",
        "items": []
      },
      {
        "title": "Drug withdrawal",
        "information": ": Since coronary heart disease may exist without being recognized, patients should be warned against stopping the drug suddenly. Any discontinuation should be gradual and under observation.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Though not documented, hypotension and less frequently congestive cardiac failure may occur in cases of overdosage. Unabsorbed drugs may be removed by gastric lavage or administration of activated charcoal. Symptomatic treatment is suggested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Combined antihypertensive preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended dosage is Amlodipine and Atenolol 5/25 mg tablet once daily. If necessary, the dosage may be increased to 5/25 mg two tablets daily or as advised by the physicians. The dosage however should be individualized.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:11.897Z",
    "medicine_id": "68c3c09aef5b8f2b163a8ef6",
    "original_record": {
      "input_index": 942,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8ef6"
        },
        "name": "Amdocal Plus",
        "strength": "5 mg+50 mg",
        "generic": "Amlodipine Besilate + Atenolol",
        "company": "Beximco Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/788/amdocal-plus-5-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/34195/ameloss-m-7-mg-capsule",
    "name": "Ameloss M",
    "dosage_form": "Capsule (Extended Release)",
    "generic": "Memantine + Donepezil",
    "strength": "7 mg+10 mg",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 20.00",
      "strip_price": "৳ 200.00",
      "pack_size_info": "(2 x 10: ৳ 400.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 20.00",
          "pack_size_info": "(2 x 10: ৳ 400.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 200.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "14 mg+10 mg (Capsule)",
        "href": "https://medex.com.bd/brands/34196/ameloss-m-14-mg-capsule?ref=1"
      },
      {
        "text": "28 mg+10 mg (Capsule)",
        "href": "https://medex.com.bd/brands/34197/ameloss-m-28-mg-capsule?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1658/memantine-donepezil/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Memantine and donepezil hydrochlorides extended-release capsules are a combination of memantine hydrochloride, an NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor, indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Memantine and donepezil hydrochlorides extended-release capsules contain two approved medications: memantine hydrochloride extended-release and donepezil hydrochloride. Each of those medications is postulated to have a different mechanism in Alzheimer’s disease.",
        "items": []
      },
      {
        "title": "Memantine",
        "information": ": Persistent activation of central nervous system NMDA receptors by the excitatory amino acid glutamate has been hypothesized to contribute to the symptomatology of Alzheimer’s disease. Memantine is postulated to exert its therapeutic effect through its action as a low to moderate affinity uncompetitive (open channel) NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels. There is no evidence that memantine prevents or slows neurodegeneration in patients with Alzheimer’s disease.",
        "items": []
      },
      {
        "title": "Donepezil",
        "information": ": Current theories on the pathogenesis of the cognitive signs and symptoms of Alzheimer’s disease attribute some of them to a deficiency of cholinergic neurotransmission. Donepezil is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine in the central nervous system through reversible inhibition of its hydrolysis by acetylcholinesterase. There is no evidence that donepezil prevents or slows neurodegeneration in patients with Alzheimer’s disease.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Combined use with NMDA antagonists: use with caution. Memantine and donepezil hydrochlorides extended-release may interfere with anticholinergic medications. Concomitant administration of succinylcholine, similar neuromuscular blocking agents, or cholinergic agonists may lead to synergistic effect.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Memantine and donepezil hydrochlorides extended-release capsules are contraindicated in patients with known hypersensitivity to memantine hydrochloride, donepezil hydrochloride, piperidine derivatives, or to any excipients used in the formulation.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common adverse reactions, occurring at a frequency of at least 5% and greater than placebo with memantine hydrochloride extended-release 28 mg/day, were headache, diarrhea, and dizziness. The most common adverse reactions occurring at a frequency of at least 5% in patients receiving donepezil and at twice or more the placebo rate, include diarrhea, anorexia, vomiting, nausea, and ecchymosis.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data on the developmental risk associated with the use of memantine and donepezil hydrochlorides extended-release capsules or its active ingredients (memantine hydrochloride and donepezil hydrochloride) in pregnant women. There are no data on the presence of memantine or donepezil in human milk, the effects on the breastfed infant, or the effects of memantine and donepezil hydrochlorides extended-release capsules or its metabolites on milk production.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Memantine and donepezil hydrochlorides extended-release is likely to exaggerate succinylcholine-type muscle relaxation during anesthesia.",
          "Memantine and donepezil hydrochlorides extended-release may have vagotonic effects on the sinoatrial and atrioventricular nodes manifesting as bradycardia or heart block.",
          "Monitor patients for symptoms of active or occult gastrointestinal bleeding, especially those at increased risk for developing ulcers.",
          "Memantine and donepezil hydrochlorides extended-release can cause diarrhea, nausea, and vomiting.",
          "Memantine and donepezil hydrochlorides extended-release may cause bladder outflow obstructions.",
          "Conditions that raise urine pH may decrease the urinary elimination of memantine, resulting in increased plasma levels of memantine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Safety and effectiveness of memantine and donepezil hydrochlorides extended-release in pediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Renal Impairment",
        "information": ": No dosage adjustment is needed in patients with mild or moderate renal impairment.",
        "items": []
      },
      {
        "title": "Hepatic Impairment",
        "information": ": No dosage adjustment is needed in patients with mild or moderate hepatic impairment. Memantine and donepezil hydrochlorides extended-release has not been studied in patients with severe hepatic impairment",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Anti-Alzheimer drugs",
    "dosage": [
      {
        "medication_type": null,
        "information": "For patients on donepezil hydrochloride 10 mg only, the recommended starting dose of memantine and donepezil hydrochlorides extended-release capsules is 7 mg/10 mg, taken once daily in the evening. The dose should be increased in 7 mg increments to the recommended maintenance dose of 28 mg/10 mg. The minimum recommended interval between dose increases is one week. Patients on memantine hydrochloride (10 mg twice daily or 28 mg extended-release once daily) and donepezil hydrochloride 10 mg once daily can be switched to memantine and donepezil hydrochlorides extended- release capsules 28 mg/10 mg, taken once daily in the evening. Memantine and donepezil hydrochlorides extended- release capsules can be taken with or without food, whole or sprinkled on applesauce; do not divide, chew, or crush. Severe renal impairment: the recommended maintenance dose for memantine and donepezil hydrochlorides extended-release capsules is 14 mg/10 mg once daily in the evening.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:12.970Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f01",
    "original_record": {
      "input_index": 943,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f01"
        },
        "name": "Ameloss M",
        "strength": "7 mg+10 mg",
        "generic": "Memantine + Donepezil",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Capsule (Extended Release)",
        "source_url": "https://medex.com.bd/brands/34195/ameloss-m-7-mg-capsule",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/15677/ametrol-vt-100-mg-vaginal-tablet",
    "name": "Ametrol-VT",
    "dosage_form": "Vaginal Tablet",
    "generic": "Metronidazole + Miconazole Nitrate",
    "strength": "100 mg+100 mg",
    "company": "Ambee Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 11.04",
      "strip_price": "৳ 110.40",
      "pack_size_info": "(1 x 10: ৳ 110.40)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 11.04",
          "pack_size_info": "(1 x 10: ৳ 110.40)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 110.40",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": null,
    "indications": [
      {
        "title": null,
        "information": "Vaginal treatment of female urogenital trichomonas infection, prevention & local therapy of candidiasis.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Metronidazole is converted to reduction products that interact with DNA to cause destruction of helical DNA structure and strand leading to a protein synthesis inhibition and cell death in susceptible organisms. It is active against most anaerobic protozoa, some gm+ve, gm-ve and facultative anaerobes. Miconazole inhibits ergosterol synthesis thus damaging fungal cell wall membrane and increases its permeability, allowing leakage of nutrients.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": "Metronidazole:",
        "information": "Disulfiram-like reaction with alcohol. Increased oral anticoagulant effect, blood levels of phenytoin, lithium toxicity, plasma cone of astemizole & terfenadine; blood cone of carbamazepine. Decreased blood levels with phenobarb. Risk of CNS-related effects (eg psychotic reactions) with disulfiram. Increased blood levels & neurologic effects with cimetidine. May increase blood levels & toxicity of fluorouracil; toxicity of cyclosporine. Increased cardiotoxicity with amiodarone. Interference with blood levels of liver enzymes, glucose (hexokinase method), theophylline & procainamide. Decreased levels with phenytoin.",
        "items": []
      },
      {
        "title": "Miconazole:",
        "information": "Increased risk of bleeding with acenocoumarol, anisindione, dicumarol, phenindione, phenprocoumon, warfarin; plasma cone & exposure to oxybutinin. May increase risk of phenytoin, phosphenytoin, cyclosporine, trimetrexate toxicity & cardiotoxicity with pimozide. May inhibit metabolism of astemizole, cisapride & terfenadine. Reduced carbamazepine metabolism. Increased or prolonged effects of opioid (fentanyl). May cause hypoglycemia with glimepiride. Reduced clearance & increased plasma cone of oxycodone. May increase bioavailability of tolterodine (in patients with deficient CYP2D6 activity).",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Hypersensitivity; hepatic impairment (oral gel). Porphyria.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Nausea, vomiting, febrile reactions, rash, drowsiness, diarrhoea, anorexia and flushing, hepatitis. Local irritation and sensitisation, contact dermatitis.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "For external use only; discontinue if sensitization or irritation occurs. Pregnancy and lactation",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs used in Vaginal and Vulval condition",
    "dosage": [
      {
        "medication_type": null,
        "information": "In trichomoniasis, concurrently with oral metronidazole treatment and 1 vaginal tablet should be inserted high up into the vagina once a day (preferably before going to bed at night) for 10 days. Long-term recovery may be expected only is response to the simultaneous oral treatment of both partners. In candidiasis or other fungal infections, 1 vaginal tablet has to be inserted high up into the vagina for 10 days. The vaginal tablet should be slightly moistened before application.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:14.354Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f02",
    "original_record": {
      "input_index": 944,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f02"
        },
        "name": "Ametrol-VT",
        "strength": "100 mg+100 mg",
        "generic": "Metronidazole + Miconazole Nitrate",
        "company": "Ambee Pharmaceuticals Ltd.",
        "medicine_type": "Vaginal Tablet",
        "source_url": "https://medex.com.bd/brands/15677/ametrol-vt-100-mg-vaginal-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/10058/amezol-400-mg-tablet",
    "name": "Amezol",
    "dosage_form": "Tablet",
    "generic": "Metronidazole",
    "strength": "400 mg",
    "company": "Cosmic Pharma Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 1.25",
      "strip_price": null,
      "pack_size_info": "(100's pack: ৳ 125.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 1.25",
          "pack_size_info": "(100's pack: ৳ 125.00)"
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "200 mg/5 ml (Suspension)",
        "href": "https://medex.com.bd/brands/10059/amezol-200-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/751/metronidazole/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amezol is indicated in the treatment of following diseases: Amezol is indicated in the treatment of following diseases:",
        "items": [
          "The prevention of post-operative infections due to anaerobic bacteria (particularly species of bacteroides and anaerobic streptococci).",
          "The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, pelvic abscess, pelvic cellulitis and post-operative wound infections caused by anaerobes.",
          "The prevention of post-operative infections due to anaerobic bacteria (particularly species of bacteroides and anaerobic streptococci).",
          "The treatment of septicaemia, bacteraemia, peritonitis, brain abscess, pelvic abscess, pelvic cellulitis and post-operative wound infections caused by anaerobes.",
          "In the treatment of urogenital trichomoniasis.",
          "Bacterial vaginosis (also known as non-specific vaginitis).",
          "All forms of amoebiasis (intestinal, extra-intestinal disease and that of symptomless cyst passers).",
          "Giardiasis.",
          "Acute ulcerative gingivitis.",
          "Anaerobically infected leg ulcers and pressure sores.",
          "Acute dental infections due to anaerobic organisms.",
          "Antibiotic associated pseudomembranus colitis."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Metronidazole is a member of the imidazole class of antibacterial drug and is classified therapeutically as an antiprotozoal agent. The 5-nitro group of Metronidazole is reduced by anaerobes metabolically. Studies have demonstrated that the reduced form of this drug interacts with DNA and gives bactericidal action of Metronidazole.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": null,
        "items": [
          "Disulfiram: Psychotic reactions have been reported in patients who were using Amezol and disulfiram concurrently.",
          "Alcohol: Alcoholic beverages and drugs containing alcohol should not be consumed during therapy and for at least one day afterwards because of the possibility of a disulfiram-like (antabuse effect) reaction (flushing, vomiting, tachycardia). Oral anticoagulant therapy (warfarin type): Potentiation of the anticoagulant effect and increased hemorrhagic risk caused by decreased hepatic catabolism. In case of co-administration, prothrombin time should be more frequently monitored and anticoagulant therapy adjusted during treatment with Amezol.",
          "Lithium: Plasma levels of lithium may be increased by Amezol.",
          "Cyclosporin: Serum cyclosporin and serum creatinine should be closely monitored when co-administration is necessary.",
          "Phenytoin or phenobarbital: increased elimination of Amezol resulting in reduced plasma levels.",
          "5-Fluorouracil: Reduced clearance of 5-fluorouracil resulting in increased toxicity of 5-fluorouracil.",
          "Busulfan: Plasma levels of busulfan may be increased by Amezol, which may lead to severe busulfan toxicity."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Metronidazole is contraindicated in patients with a history of hypersensitivity to Metronidazole or other Nitroimidazole derivatives.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Metallic taste, nausea, vomiting, diarrhoea, drowsiness, rashes may be observed during treatment.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "US FDA Pregnancy Category of Metronidazole is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Metronidazole have been shown to be excreted in human milk. So, caution should be exercised when Metronidazole is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "If for compelling reasons, Amezol must be administered longer than the usually recommended duration, it is recommended that hematological tests, especially leucocyte count should be carried out regularly and that patients should be monitored for adverse reactions such as peripheral or central neuropathy (such as paresthesia, ataxia, dizziness, convulsive seizures).",
          "Amezol should be administered with caution to patients with hepatic encephalopathy.",
          "Patients should be warned that Amezol may darken urine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": "Hepatic impairment",
        "information": ": Amezol is mainly metabolised by hepatic oxidation. Substantial impairment of Amezol clearance may occur in the presence of advanced hepatic insufficiency. Significant cumulation may occur in patients with hepatic encephalopathy and the resulting high plasma concentrations of Amezol may contribute to the symptoms of the encephalopathy. Amezol should therefore, be administered with caution to patients with hepatic encephalopathy. The daily dosage should be reduced to one third and may be administered once daily. Patients should be warned that Amezol may darken urine.",
        "items": []
      },
      {
        "title": "Renal impairment",
        "information": ": The elimination half-life of Amezol remains unchanged in the presence of renal failure. The dosage of Amezol therefore needs no reduction. Such patients however retain the metabolites of Amezol. The clinical significance of this is not known at present. In patients undergoing haemodialysis Amezol and metabolites are efficiently removed during an eight hour period of dialysis. Amezol should therefore be re-administered immediately after haemodialysis. No routine adjustment in the dosage of Amezol need be made in patients with renal failure undergoing intermittent peritoneal dialysis (IDP) or continuous ambulatory peritoneal dialysis (CAPD).",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Single oral doses of Amezol, up to 12 g have been reported in suicide attempts and accidental overdoses. Symptoms were limited to vomiting, ataxia and slight disorientation. There is no specific antidote for Amezol overdosages. In case of suspected massive overdosages, a symptomatic and supportive treatment should be instituted.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store below 30°C. Keep protected from light. Keep medicines out of the reach of children. Do not use later than the date of expiry.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Amoebicides, Anti-diarrhoeal Antiprotozoal",
    "dosage": [
      {
        "medication_type": null,
        "information": "Tablet and Suspension: Trichomoniasis (Adults & Children over 10 yrs)- Trichomoniasis (Children)- Intestinal amoebiasis (Adults & Children over 10 yrs)- Intestinal amoebiasis (Children)- Extra-intestinal & Asymptomatic amoebiasis (Adults & Children over 10 yrs)- Extra-intestinal & Asymptomatic amoebiasis (Children)- Giardiasis (Adults & Children over 10 yrs)- Giardiasis (Children)- Acute ulcerative gingivitis (Adults & Children over 10 yrs)- Acute ulcerative gingivitis (Children)- Acute dental infections (Adults & Children over 10 yrs)- Bacterial Vaginosis (Adults & Children over 10 yrs)- Leg ulcers and pressure sores (Adults & Children over 10 yrs)- Anaerobic infections (Adults & Children over 10 yrs)- Anaerobic infections (Children)- Surgical prophylaxis (Adults & Children over 10 yrs)- Surgical prophylaxis (Children)- Vaginal Gel: The recommended dose is one applicator full of Metronidazole gel (approximately 5 grams containing approximately 37.5 mg of Metronidazole) intravaginally once or twice a day for 5 days. For once a day dosing, Metronidazole gel should be administered at bedtime. Suppository: Anaerobic Infections-",
        "instructions": [
          "200 mg tid or 400 mg bid for 7 days",
          "800 mg in the morning and 1-2 gm at night for 2 days",
          "2 gm as a single dose for 1 days",
          "Children 7-10 yrs: 100 mg tid",
          "Children 3-7 yrs: 100 mg bid",
          "Children 1-3 yrs: 50 mg tid",
          "800 mg tid for 5 days",
          "Children 7-10 yrs: 400 mg tid",
          "Children 3-7 yrs: 200 mg qid",
          "Children 1-3 yrs: 200 mg tid",
          "400-800 mg tid for 5-10 days",
          "Children 7-10 yrs: 200-400 mg tid",
          "Children 3-7 yrs: 100-200 mg qid",
          "Children 1-3 yrs: 100-200 mg tid",
          "2 gm once daily for 3 days",
          "Children 7-10 yrs: 1 gm once daily",
          "Children 3-7 yrs: 600-800 mg once daily",
          "Children 1-3 yrs: 500 mg once daily",
          "200 mg tid for 3 days",
          "Children 7-10 yrs: 100 mg tid",
          "Children 3-7 yrs: 100 mg bid",
          "Children 1-3 yrs: 50 mg tid",
          "200 mg tid for 3-7 days",
          "400 mg bid for 7 days",
          "2 gm as a single dose for 1 days",
          "400 mg tid for 7 days",
          "800 mg initially and then 400 mg tid for 7 days",
          "Children 1-10 yrs: 7.5 mg/kg tid",
          "400 mg tid started 24 hours before surgery for 1 days",
          "Children 1-10 yrs: 7.5 mg/kg tid"
        ]
      },
      {
        "medication_type": "Adults",
        "information": ": 1 g every 8 hours for 3 days, then 1 g every 12 hours.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 5-10 years: 500 mg every 8 hours for 3 days, then every 12 hours, Over 10 years adult dose.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Surgical Prophylaxis-",
        "instructions": []
      },
      {
        "medication_type": "Adults",
        "information": ": 1 g 2 hours before surgery; up to 3 further doses of 1 g may be given every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": "Children",
        "information": ": 5-10 years: 500 mg 2 hours before surgery; up to 3 further doses of 500 mg may be given every 8 hours for high risk procedures.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "IV Infusion: Metronidazole intravenous infusion requires no dilution and should not be mixed with any other drugs prior to administration.",
        "instructions": []
      },
      {
        "medication_type": "Adults and children over 12 years",
        "information": ": Infuse 500 mg 8 hourly at a rate of 5 ml/minute and a maximum of 4 g should not be exceeded during a 24-hour period. Treatment for 7 days is sufficient for most patients, but treatment can be extended, especially for cases where reinfection is likely. For surgical prophylaxis, administration shortly before surgery should be followed by 8-hourly doses for the next 24 hours.",
        "instructions": []
      },
      {
        "medication_type": "Children under 12 years",
        "information": ": 7.5 mg/kg body weight/day every 8 hours at a rate of 5 ml/minute.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is Amezol 400 mg Tablet?",
        "answer": [
          "Amezol 400 mg Tablet is an antibiotic medication that performs its action by preventing the growth of bacterias and parasites."
        ]
      },
      {
        "question": "What are the uses of Amezol 400 mg Tablet?",
        "answer": [
          "Amezol 400 mg Tablet is used for the treatment and prevention from viral and parasitic infections. It also prevents bacterial infections such as cold, cough, flu and vaginal infections. It also controls liver, skin, joints, brain and respiratory tract infections."
        ]
      },
      {
        "question": "What are the side effects of Amezol 400 mg Tablet?",
        "answer": [
          "Some side effects of Amezol 400 mg Tablet which are diarrhoea, headache, weakness, painful urination, trouble sleeping, numbness, muscle weakness and mouth ulcer."
        ]
      },
      {
        "question": "How long do I need to use Amezol 400 mg Tablet before I see improvement of my conditions?",
        "answer": [
          "Amezol 400 mg Tablet takes 1 or 2 days before you see an improvement in your health conditions."
        ]
      },
      {
        "question": "What are the contraindications to Amezol 400 mg Tablet?",
        "answer": [
          "Amezol 400 mg Tablet should not be used if you have the following conditions such as hives, flushing, nasal congestion, dryness of the mouth, fever, etc."
        ]
      },
      {
        "question": "Is Amezol 400 mg Tablet safe to use when pregnant?",
        "answer": [
          "Amezol 400 mg Tablet is not recommended for use in pregnant women unless absolutely necessary."
        ]
      },
      {
        "question": "Will Amezol 400 mg Tablet be more effective if taken in more than the recommended dose?",
        "answer": [
          "No, taking higher than the recommended dose of Amezol 400 mg Tablet lead to increased chances of side effects such as diarrhoea, excessive production of urine, headache, nausea, pain in the upper part of the stomach, painful and difficult urination, serious eating disorder (anorexia), etc."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Amezol 400 mg Tablet treats infections caused by bacteria and parasites.",
          "Amezol 400 mg Tablet may cause side effects like nausea, stomach upset, and a metallic taste in the mouth.",
          "Amezol 400 mg Tablet used in a high dose or for a prolonged time increases the risk of side effects such as nerve damage. Take it only as prescribed by your doctor.",
          "Do not drink alcohol during or for 2-3 days after treatment with this medicine. You may develop nausea, vomiting, flushing and headache.",
          "Inform your doctor if you have liver disease. Your dose may need to be adjusted in severe liver disease."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:29:15.618Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f03",
    "original_record": {
      "input_index": 945,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f03"
        },
        "name": "Amezol",
        "strength": "400 mg",
        "generic": "Metronidazole",
        "company": "Cosmic Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/10058/amezol-400-mg-tablet",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/25857/amfrad-500-mg-capsule",
    "name": "Amfrad",
    "dosage_form": "Capsule",
    "generic": "Cephradine",
    "strength": "500 mg",
    "company": "Amulet Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 12.54",
      "strip_price": null,
      "pack_size_info": "(24's pack: ৳ 300.96)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.54",
          "pack_size_info": "(24's pack: ৳ 300.96)"
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "250 mg (Capsule)",
        "href": "https://medex.com.bd/brands/25858/amfrad-250-mg-capsule?ref=1"
      },
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/25859/amfrad-125-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/232/cephradine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amfrad is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- Amfrad is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- The following microorganisms are susceptible, in vitro to Amfrad:",
        "items": [
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.",
          "Urinary tract infections: cystitis, urethritis and pyelonephritis.",
          "Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.",
          "Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.",
          "Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Amfrad which is unaffected by this enzyme."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.",
        "items": [
          "Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)",
          "Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis",
          "Psychiatric disorders- Unknown: Confusion, sleep disturbances",
          "Nervous system disorders- Unknown: hyperactivity, hypertonia, dizziness, nervousness; Rarely: Headache",
          "Hepatobiliary disorders- Frequency unknown: Liver, enzyme disturbances, transient hepatitis, cholestatic jaundice",
          "Renal and urinary disorders- Unknown: Reversible interstitial nephritis",
          "Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.",
          "Amfrad should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.",
          "Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.",
          "Amfrad may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).",
          "Dosage adjustment is necessary in renal impairment.",
          "Amfrad contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Renal Impairment: The following doses are recommended (based on 500 mg every 6 hours) for patients not on haemodialysis: Recommendations for patients on chronic, intermittent haemodialysis: Additional Information for all patients Regardless of patient age or weight, higher doses of up to 1 gm four times daily may be required for infections which are chronic or severe. Treatment should continue for at least 2 to 3 days after symptoms have resolved or bacteria have been eradicated. To reduce the possibility of rheumatic fever or glomerulonephritis resulting from infections with haemolytic streptococci, treatment should be continued for at least 10 days. Throughout treatment of chronic urinary tract infections and for several months thereafter, regular bacteriological and clinical monitoring is required. Doses below those recommended above should not be prescribed. Paediatric dosages should not exceed those specified for adults, regardless of severity of infection. It may be necessary to continue Amfrad therapy for several weeks in persistent infections. Patients may be transferred from intramuscular/intravenous Amfrad therapy to oral treatment at the same dosage level.",
        "items": [
          "CrCl: >20 ml/min: 500 mg every 6 hours",
          "CrCl: 5-20 ml/min: 250 mg every 6 hours",
          "CrCl: <5 ml/min: 250 mg every 50-70 hours.",
          "250 mg at the start of haemodialysis",
          "250 mg 6 to 12 hours after the start",
          "250 mg 36 to 48 hours after the start",
          "250 mg at the start of the next haemodialysis session if more than 30 hours have elapsed since the last dose."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Amfrad Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Amfrad Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "First generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "For oral administration",
        "information": "- Adults: Children: Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.",
        "instructions": [
          "Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.",
          "Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.",
          "Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.",
          "Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.",
          "Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.",
          "Maximum daily dosage: 4 gm"
        ]
      },
      {
        "medication_type": "For injectable administration",
        "information": "-",
        "instructions": [
          "Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.",
          "Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:16.681Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f05",
    "original_record": {
      "input_index": 946,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f05"
        },
        "name": "Amfrad",
        "strength": "500 mg",
        "generic": "Cephradine",
        "company": "Amulet Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/25857/amfrad-500-mg-capsule",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/25858/amfrad-250-mg-capsule",
    "name": "Amfrad",
    "dosage_form": "Capsule",
    "generic": "Cephradine",
    "strength": "250 mg",
    "company": "Amulet Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 6.25",
      "strip_price": null,
      "pack_size_info": "(30's pack: ৳ 187.50)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 6.25",
          "pack_size_info": "(30's pack: ৳ 187.50)"
        }
      ]
    },
    "flags": [
      {
        "label": "Antibiotic",
        "note": "Do not use without prescription of a registered physician"
      }
    ],
    "also_available": [
      {
        "text": "500 mg (Capsule)",
        "href": "https://medex.com.bd/brands/25857/amfrad-500-mg-capsule?ref=1"
      },
      {
        "text": "125 mg/5 ml (Syrup)",
        "href": "https://medex.com.bd/brands/25859/amfrad-125-mg-suspension?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/232/cephradine/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Amfrad is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- Amfrad is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include- The following microorganisms are susceptible, in vitro to Amfrad:",
        "items": [
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also",
          "Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.",
          "Urinary tract infections: cystitis, urethritis and pyelonephritis.",
          "Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.",
          "Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.",
          "Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Amfrad which is unaffected by this enzyme."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.",
        "items": [
          "Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)",
          "Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis",
          "Psychiatric disorders- Unknown: Confusion, sleep disturbances",
          "Nervous system disorders- Unknown: hyperactivity, hypertonia, dizziness, nervousness; Rarely: Headache",
          "Hepatobiliary disorders- Frequency unknown: Liver, enzyme disturbances, transient hepatitis, cholestatic jaundice",
          "Renal and urinary disorders- Unknown: Reversible interstitial nephritis",
          "Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase."
        ]
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.",
          "Amfrad should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.",
          "Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.",
          "Amfrad may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).",
          "Dosage adjustment is necessary in renal impairment.",
          "Amfrad contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine."
        ]
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "Renal Impairment: The following doses are recommended (based on 500 mg every 6 hours) for patients not on haemodialysis: Recommendations for patients on chronic, intermittent haemodialysis: Additional Information for all patients Regardless of patient age or weight, higher doses of up to 1 gm four times daily may be required for infections which are chronic or severe. Treatment should continue for at least 2 to 3 days after symptoms have resolved or bacteria have been eradicated. To reduce the possibility of rheumatic fever or glomerulonephritis resulting from infections with haemolytic streptococci, treatment should be continued for at least 10 days. Throughout treatment of chronic urinary tract infections and for several months thereafter, regular bacteriological and clinical monitoring is required. Doses below those recommended above should not be prescribed. Paediatric dosages should not exceed those specified for adults, regardless of severity of infection. It may be necessary to continue Amfrad therapy for several weeks in persistent infections. Patients may be transferred from intramuscular/intravenous Amfrad therapy to oral treatment at the same dosage level.",
        "items": [
          "CrCl: >20 ml/min: 500 mg every 6 hours",
          "CrCl: 5-20 ml/min: 250 mg every 6 hours",
          "CrCl: <5 ml/min: 250 mg every 50-70 hours.",
          "250 mg at the start of haemodialysis",
          "250 mg 6 to 12 hours after the start",
          "250 mg 36 to 48 hours after the start",
          "250 mg at the start of the next haemodialysis session if more than 30 hours have elapsed since the last dose."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Amfrad Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Amfrad Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "First generation Cephalosporins",
    "dosage": [
      {
        "medication_type": "For oral administration",
        "information": "- Adults: Children: Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.",
        "instructions": [
          "Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.",
          "Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.",
          "Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.",
          "Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.",
          "Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.",
          "Maximum daily dosage: 4 gm"
        ]
      },
      {
        "medication_type": "For injectable administration",
        "information": "-",
        "instructions": [
          "Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.",
          "Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection."
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:17.923Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f06",
    "original_record": {
      "input_index": 947,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f06"
        },
        "name": "Amfrad",
        "strength": "250 mg",
        "generic": "Cephradine",
        "company": "Amulet Pharmaceuticals Ltd.",
        "medicine_type": "Capsule",
        "source_url": "https://medex.com.bd/brands/25858/amfrad-250-mg-capsule",
        "_page": 33,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/20098/amicoxib-90-mg-tablet",
    "name": "AmiCoxib",
    "dosage_form": "Tablet",
    "generic": "Etoricoxib",
    "strength": "90 mg",
    "company": "Amico Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 12.00",
      "strip_price": "৳ 120.00",
      "pack_size_info": "(3 x 10: ৳ 360.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.00",
          "pack_size_info": "(3 x 10: ৳ 360.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "120 mg (Tablet)",
        "href": "https://medex.com.bd/brands/20099/amicoxib-120-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/446/etoricoxib/brand-names",
    "indications": [
      {
        "title": null,
        "information": "AmiCoxib tablet is indicated for the symptomatic relief of-",
        "items": [
          "Osteoarthritis (OA)",
          "Rheumatoid arthritis (RA)",
          "Ankylosing spondylitis, and",
          "The pain and signs of inflammation associated with acute gouty arthritis.",
          "For the short-term treatment of moderate pain associated with dental surgery."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Etoricoxib is a potent, orally active cyclooxygenase-2 (COX-2) specific inhibitor within, and significantly above, the clinical dose range. Two isoforms of cyclooxygenase have been identified: cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). COX-1 is responsible for prostaglandin-mediated normal physiologic functions such as gastric cytoprotection and platelet aggregation. Inhibition of COX-1 by nonselective NSAIDs has been associated with gastric damage and inhibition of platelet aggregation. COX-2 has been shown to be primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever. Selective inhibition of COX-2 by etoricoxib (within the clinical dose range) decreases these clinical signs and symptoms with decreased potential for Gl toxicity and effects on platelet aggregation. Etoricoxib produced dose-dependent inhibition of COX-2 without inhibition of COX-1 at doses up to 150 mg daily. Etoricoxib did not inhibit gastric prostaglandin synthesis.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "With medicine: With food & others: Take without regards to meals.",
        "items": [
          "Oral anticoagulants: In subjects stabilized on chronic warfarin therapy, the administration of AmiCoxib was associated with an increase in prothrombin time.",
          "Diuretics, ACE inhibitors and Angiotensin II Antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs.",
          "Acetylsalicylic Acid: AmiCoxib can be used concomitantly with acetylsalicylic acid at doses used for cardiovascular prophylaxis (low-dose acetylsalicylic acid).",
          "Ciclosporin and tacrolimus: Although this interaction has not been studied with AmiCoxib, coadministration of ciclosporin or tacrolimus with any NSAID may increase the nephrotoxic effect of ciclosporin or tacrolimus.",
          "Lithium: NSAIDs decrease lithium renal excretion and therefore increase lithium plasma levels."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": null,
        "items": [
          "Hypersensitivity to the active substance or to any of the excipients.",
          "Active peptic ulceration or active gastro-intestinai (Gl) bleeding.",
          "Patients who have experienced bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions after taking acetylsalicylic acid or NSAIDs including COX-2 (cyclooxygenase-2) inhibitors.",
          "Pregnancy and lactation.",
          "Severe hepatic dysfunction (serum albumin <25 g/l or Child-Pugh score 10).",
          "Estimated renal creatinine clearance <30 ml/min.",
          "Children and adolescents under 16 years of age.",
          "Inflammatory bowel disease.",
          "Congestive heart failure (NYHA ll-IV).",
          "Patients with hypertension whose blood pressure is persistently elevated above 140/90 mmHg and has not been adequately controlled.",
          "Established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease."
        ]
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Side-effects may include palpitation, fatigue, influenza-like symptoms, ecchymosis; less commonly dry mouth, taste disturbance, mouth ulcer, appetite and weight change, atrial fibrillation, transient ischaemic attack, chest pain, flushing, cough, dyspnoea, epistaxis, anxiety, mental acuity impaired, paraesthesia, electrolyte disturbance, myalgia and arthralgia; very rarely confusion and hallucinations.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The use of Etoricoxib, as with any drug substance known to inhibit COX-2, is not recommended in women attempting to conceive. It is not known whether Etoricoxib is excreted in human milk. Etoricoxib is excreted in the milk of lactating rats. Women who use Etoricoxib must not breastfeed.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": null,
        "items": [
          "Caution is advised with treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly or patients with a prior history of gastrointestinal disease, such as ulceration and Gl bleeding.",
          "Patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with AmiCoxib after careful consideration.",
          "Administration of AmiCoxib may cause a reduction in prostaglandin formation and, secondarily, in renal blood flow, and thereby impair renal function. Monitoring of renal function in such patients should be considered.",
          "Caution should be exercised in patients with a history of cardiac failure, left ventricular dysfunction, or hypertension and in patients with pre-existing edema from any other reason.",
          "Any patients with symptoms and/or signs suggesting liver dysfunction, or in whom an abnormalliver function test has occurred, should be monitored. If signs of hepatic insufficiency occur, or if persistently abnormal liver function tests (three times the upper limit of normal) are detected, AmiCoxib should be discontinued.",
          "AmiCoxib should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.",
          "AmiCoxib may mask fever and other signs of inflammation. Caution should be exercised when co-administering AmiCoxib with warfarin or other oral anticoagulants."
        ]
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Administration of single doses of AmiCoxib up to 500 mg and multiple doses up to 150 mg/day for 21 days did not result in significant toxicity. In the event of overdose, it is reasonable to employ the usual supportive measures, e.g., remove unabsorbed material from the Gl tract, employ clinical monitoring, and institute supportive therapy, if required.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store at a temperature of below 30°C, protect from light & moisture. Keep out of reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C18H15ClN2O2S",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-446-etoricoxib-chemical-structure-nEkDifKyFxQ9fjJEG7TQ.svg"
    },
    "therapeutic_class": "Non-steroidal Anti-inflammatory Drugs (NSAIDs)",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adult and adolescent over 16 years:",
        "instructions": []
      },
      {
        "medication_type": "Osteoarthritis",
        "information": ": The recommended dose is 30 mg once daily. In some patients with insufficient relief from symptoms, an increased dose of 60 mg once daily may increase efficacy.",
        "instructions": []
      },
      {
        "medication_type": "Rheumatoid arthritis",
        "information": ": The recommended dose is 90 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Ankylosing spondylitis",
        "information": ": The recommended dose is 90 mg once daily.",
        "instructions": []
      },
      {
        "medication_type": "Acute gouty arthritis",
        "information": ": The recommended dose is 120 mg once daily. In clinical trials for acute gouty arthritis, Etoricoxib was given for 8 days.",
        "instructions": []
      },
      {
        "medication_type": "Postoperative dental surgery pain",
        "information": ": The recommended dose is 90 mg once daily, limited to a maximum of 3 days.",
        "instructions": []
      },
      {
        "medication_type": null,
        "information": "Some patients may require additional postoperative analgesia. As the cardiovascular risks of Etoricoxib may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient's need for symptomatic relief and response to therapy should be re-evaluated periodically, especially in patients with osteoarthritis.",
        "instructions": []
      }
    ],
    "common_questions": [
      {
        "question": "What is AmiCoxib 90 mg Tablet?",
        "answer": [
          "AmiCoxib 90 mg Tablet is a selective COX-2 inhibitor. COX-2 has been shown to be primarily responsible for the synthesis of prostanoid mediators of pain, inflammation, and fever. AmiCoxib 90 mg Tablet produced dose-dependent inhibition of COX-2 without inhibition of COX-1 at doses up to 150 mg daily."
        ]
      },
      {
        "question": "What are the uses of AmiCoxib 90 mg Tablet?",
        "answer": [
          "AmiCoxib 90 mg Tablet is indicated for the symptomatic relief of Osteoarthritis (OA), Rheumatoid arthritis (RA), Ankylosing spondylitis."
        ]
      },
      {
        "question": "How long is the duration of effect of AmiCoxib 90 mg Tablet?",
        "answer": [
          "The effect of AmiCoxib 90 mg Tablet lasts for an average duration of 20-24 hours."
        ]
      },
      {
        "question": "What is the onset of action of AmiCoxib 90 mg Tablet?",
        "answer": [
          "The effect of AmiCoxib 90 mg Tablet can be observed within 1-2 hours of administration. The onset is faster if the medicine is taken without food."
        ]
      },
      {
        "question": "Are there any pregnancy warnings of AmiCoxib 90 mg Tablet?",
        "answer": [
          "Women who are pregnant should consult doctor before using AmiCoxib 90 mg Tablet."
        ]
      },
      {
        "question": "Is it habit forming of AmiCoxib 90 mg Tablet?",
        "answer": [
          "No habit forming tendencies were reported."
        ]
      },
      {
        "question": "Are there any breast-feeding warnings of AmiCoxib 90 mg Tablet?",
        "answer": [
          "AmiCoxib 90 mg Tablet is not recommended for use by mothers who are breastfeeding. It should be used only when the potential benefits outweigh the risks associated with usage. Consult your doctor before taking this medicine."
        ]
      },
      {
        "question": "Is AmiCoxib 90 mg Tablet safe with alcohol?",
        "answer": [
          "AmiCoxib 90 mg Tablet is found to be unsafe to consume this medicine with alcohol."
        ]
      },
      {
        "question": "Is AmiCoxib 90 mg Tablet safe to drive while on this medicine?",
        "answer": [
          "AmiCoxib 90 mg Tablet may affect alertness of the patient taking it. Thus patient must avoid driving."
        ]
      },
      {
        "question": "Does AmiCoxib 90 mg Tablet affect kidney function?",
        "answer": [
          "Caution must be taken in patient with kidney disease. Adjustment of dose might be needed. Consult your doctor before taking AmiCoxib 90 mg Tablet. use of this medicine is strictly not recommended in patients with severe kidney disease."
        ]
      },
      {
        "question": "Does AmiCoxib 90 mg Tablet affect liver function?",
        "answer": [
          "Caution must be taken in patient with liver disease. Adjustment of dose might be needed. Consult your doctor before taking AmiCoxib 90 mg Tablet. use of this medicine is strictly not recommended in patients with severe liver disease."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "AmiCoxib 90 mg Tablet helps relieve pain and inflammation.",
          "AmiCoxib 90 mg Tablet may cause fewer stomach problems as compared to other NSAIDs like Ibuprofen or Naproxen.",
          "AmiCoxib 90 mg Tablet may cause dizziness and fatigue. Do not drive or do anything requiring concentration until you know how it affects you.",
          "Do not consume alcohol while on treatment with AmiCoxib 90 mg Tablet as it may cause excessive drowsiness.",
          "Regularly monitor your blood pressure while taking this medicine, particularly in the first two weeks after starting treatment.",
          "Inform your doctor if you have a history of stomach ulcers, heart diseases, high blood pressure, and liver or kidney disease.",
          "During long-term treatment, your doctor may want to take regular blood tests to monitor your liver function.",
          "Do not take AmiCoxib 90 mg Tablet if you are pregnant, planning to conceive, or breastfeeding."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:29:19.012Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f0d",
    "original_record": {
      "input_index": 948,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f0d"
        },
        "name": "AmiCoxib",
        "strength": "90 mg",
        "generic": "Etoricoxib",
        "company": "Amico Laboratories Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/20098/amicoxib-90-mg-tablet",
        "_page": 34,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/21058/amidol-300-mg-injection",
    "name": "Amidol",
    "dosage_form": "Injection",
    "generic": "Iopamidol",
    "strength": "300 mg/50 ml",
    "company": "Incepta Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 1,203.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "50 ml vial",
          "price": "৳ 1,203.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "370 mg/50 ml (Injection)",
        "href": "https://medex.com.bd/brands/21057/amidol-370-mg-injection?ref=1"
      },
      {
        "text": "370 mg/100 ml (Injection)",
        "href": "https://medex.com.bd/brands/34198/amidol-370-mg-injection?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/623/iopamidol/brand-names",
    "indications": [
      {
        "title": "Neuroradiology:",
        "information": "Lumber myelography, thoraco-cervical myelography.",
        "items": []
      },
      {
        "title": "Angiography:",
        "information": "Cerebral angiography, selective coronary angiography, left ventriculography, aortography, angiocadiography, selective visceral arteriography, peripheral arteriography, digital subtraction angiography, venography, urography.",
        "items": []
      },
      {
        "title": "Other diagnostic procedures:",
        "information": "Contrast enhancement in CT scanning, arthrography, fistulography.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Iopamidol, an organic Iodine compound and used as a non-ionic water soluble radiographic contrast medium. Iopamidol blocks X-rays as they pass through the body, thereby allowing body structures not containing Iodine to be visualized. The degree of opacity produced by Iopamidol is directly proportional to the total amount of the iodinated contrast agent in the path of the X-rays. The visualization of body structures is dependent upon the distribution and elimination of Iopamidol.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Thyroid function test-use of Amidol 370/300 may interfere with tests or thyroid function. Biguanide oral anti-diabetic agents e.g. Metformin, are excreted unchanged through the kidneys. They therefore compete for excretion in the kidneys with contrast media and this could lead to reduction in kidney function. Patient with NIDDM who are taking Metformin or other biguanides should therefore be instructed not to take any doses of Metformin for 48 hours before or 48 hours after the x-ray examination.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "There are no definite or absolute contraindications to the use of Amidol, with the possible exception of waldenstrom's macroglobulinemia, multiple myeloma and severe liver and kidney disease.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The use of organic Iodine compounds may cause untoward side effects and manifestations of anaphylaxis. The symptoms include nausea, vomiting, widespread erythema, generalized heat sensation, headache, coryza, fever, sweating, asthenia, dizziness, pallor, dyspnea, and moderate hypotension. Skin reactions occur in the form of various types of rash or diffuse blister formation. More severe reactions involving the cardiovascular system such as peripheral vasodilation with pronounced hypotension, tachycardia, dyspnea, agitation, cyanosis and loss of consciousness, may require emergency treatment. During intracardiac and /or coronary arteriography, ventricular arrhythmia may infrequently occur. Hyperthyroidism may recur in patients previously treated for graves disease.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "In pregnant women, Iopamidol injection should be administered only if the procedure is considered essential by the physician. Fertility and mutagenicity studies have shown that Iopamidol has no influence on these parameters. Teratogenicity studies in rats and rabbits have shown no influence of Iopamidol up to 8.2 g/kg (rat) and 4.1 g/kg (rabbit).",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Amidol 370/300 should not be drawn into the syringe until immediately before use. The bottle, once opened, must be used immediately. In consideration of possible serious side effect the use of organoiodinate contrast media should be limited to cases for which there is a precise need for radiographic contrast examination. This should be evaluated according to clinical status of the patient, in particular in relation to pathologies of the cardiovascular, urinary or hepatobiliary system. In particular contrast media designed for cardioangiography should be used in hospitals or clinics equipped and staffed for intensive care in emergencies. For other diagnostic procedures requiring the use of iodinised contrast media, in the public or institutions where such procedures take place, resuscitation equipment and therapeutic measures should be immediately available. When examining small children or babies, do not limit fluid intake before administering a hypertonic contrast solution. Also correct any existing water and electrolyte imbalance. X-ray examination of woman should also, if possible be conducted during the pre-ovulation phage of menstrual cycle. In patients scheduled for thyroid examination with a radioactive Iodine tracer, one must take into consideration that Iodine uptake in the thyroid gland will be reduced for several days (up to two weeks) after dosing with an iodinised contrast medium that is eliminated through kidney. Biguanide oral anti diabetic agents e.g. Metformin, are excreted unchanged through the kidneys. They therefore compete for excretion in the kidneys with contrast media and this could lead to reduction in kidney function. Patient with NIDDM who are taking Metformin or other biguanides should therefore be instructed not to take any doses of Metformin for 48 hours before and 48 hours after the X-ray examination.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [
      {
        "title": null,
        "information": "Treatments of an overdose is directed toward the support of all vital functions and prompt institution of symptomatic therapy.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep Amidol away from light. Store below 30°C. Exceptionally crystallization of Amidol injections can occur. It has been shown that such a phenomenon is caused by a damaged container and therefore the product should not be used in this case. The bottle once opened, must be used immediately. Any residue of contrast medium must be discarded.",
        "items": []
      }
    ],
    "description": [],
    "administration": [
      {
        "title": null,
        "information": "Neuroradiology: Angiography: Urography:",
        "items": [
          "Lumber myelography: A slow sub-arachnoid injection is made through a fine lumber puncture needle into one of the lower interspinous spaces (L3-L4 or L4-L5). Optimum contrast appears immediately after injections and films should be obtained promptly.",
          "Thoraco-cervical myelography: Following a slow sub-arachnoid injection the patient should be turned on his/her side and tilted 10-20 degree head down under fluoroscopic control. In this manner it is possible to control movement of the contrast medium column into the dorsal region.",
          "If the cervical region is to be examined, the contrast medium should be run into the cervical region first, before the examination of the dorsal areas where it is progressively diluted. Iopamidol 300/370 may also be injected sub-occipitally or by lateral puncture technique. Care should be taken to ensure that the contrast medium does not move intracranially. It is generally recommended that in intrathecal use the patient should remain with a raised bed head and be kept well hydrated; following hydration it is preferable that the patient be allowed to be ambulatory.",
          "Cerebral angiography: Any current technique is suitable for radiological visualization of the cerebral vasculature with Iopamidol 370/300 injection. Carotid and vertebral angiography, performed by catheterization or percutaneous injection techniques, require rapid injection which, if necessary, may be repeated.",
          "Peripheral arteriography and venography: Percutaneous injection into the appropriate blood vessel is used for visualization of peripheral arteries and veins.",
          "Angiocardiography, left ventriculography, selective coronary arteriography: Iopamidol 370/300 injection may be administered by rapid injection through a catheter into a suitable peripheral artery or vein. It can also be introduced under pressure through a cardiac catheter in to any of the heart chambers, or injected into large vessel for immediate visualization. The contrast medium may also be administered during selective catheterization of the coronary arteries.",
          "Aortography: The contrast medium may be introduced directly or by intra-arterial injection for visualization of the aorta and its main branches.",
          "Selective visceral angiography: Visualization can be achieved by selective catheterization and injection into the hepatic, coeliac or mesenteric arteries.",
          "Digital subtraction angiography: For cardiac imaging, the contrast medium may be administered intra-arterially by selective catheterization to provide substrated images. Iopamidol 370/300 injected intravenously either centrally or peripherally is also recommended for use this modality."
        ]
      },
      {
        "title": null,
        "information": "Other diagnostic procedures:",
        "items": [
          "The contrast medium injected intravenously and rapidly eliminated through the kidneys. In patients with severe renal failure, high dose urography should be used.",
          "Arthrography: Visualization of joint cavities and articular surfaces can be achieved either single or double contrast examination.",
          "Contrast enhancement in CT scanning: Contrast enhancement for brain scans can be achieved between one and three minutes after i.v. injection. Iopamidol 370/300 are also be used for total body scanning examinations after i.v.administration as a bolus, as a drip infusion or by combination of the two methods."
        ]
      }
    ],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Contrast medium for diagnostic procedures",
    "dosage": [
      {
        "medication_type": null,
        "information": "Adult dosage: Children: Angiography: Cerebral angiography: Iopamidol 370, 6-13 ml Selective coronary arteriography: Iopamidol 370, 4-8 ml/artery Peripheral arteriography: Iopamidol 370, 20-50 ml Venography: Iopamidol 370, 24-60 ml Angiocardiography: Iopamidol 370, 30-80 ml Left ventriculography: Iopamidol 370, 30-80 ml Percutaneous transfemoral or renal arteriography: Iopamidol 370, 30 ml Selective renal arteriography: Iopamidol 370, 5-10 ml Hepatic angiography: Iopamidol 370, 70 ml Coeliac angiography: Iopamidol 370, 40-70 ml Superior mesenteric angiography: Iopamidol 370, 25-50 ml Inferior mesenteric angiography: Iopamidol 370, 5-30 ml Digital subtraction angiography: 30-50 ml (10-20 ml/sec) of Iopamidol 370, IV 25 ml (left ventricle), 2-5 ml (coronary arteries), 15 ml/sec. of Iopamidol 370 i.a for cardiac imaging",
        "instructions": [
          "Neurology: Lumber myelography: Iopamidol 370, 6-13 ml",
          "Thoraco-cervical myelography: Iopamidol 370, 6-13 ml",
          "Urography: Iopamidol 370, 40-80 ml IV up to 1.5 ml/kg in severe renal disease.",
          "Usual Dose: 1-2.5 ml/kg",
          "Other Diagnostic Procedure: Contrast enhancement in CT scanning: Iopamidol 370, 0.5-2.0 ml/kg"
        ]
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:20.333Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f0f",
    "original_record": {
      "input_index": 949,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f0f"
        },
        "name": "Amidol",
        "strength": "300 mg/50 ml",
        "generic": "Iopamidol",
        "company": "Incepta Pharmaceuticals Ltd.",
        "medicine_type": "Injection",
        "source_url": "https://medex.com.bd/brands/21058/amidol-300-mg-injection",
        "_page": 34,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/20330/amifex-60-mg-tablet",
    "name": "Amifex",
    "dosage_form": "Tablet",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "60 mg",
    "company": "Amico Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 3.50",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.50",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "120 mg (Tablet)",
        "href": "https://medex.com.bd/brands/20331/amifex-120-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Amifex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Amifex is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Amifex improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Amifex is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Amifex significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Amifex improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Amifex does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Amifex with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Amifex caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Amifex and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Amifex should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Amifex tablets will produce an effect on the ability to drive or use machines. In objective tests, Amifex has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Amifex. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Amifex has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Amifex from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Amifex 60 mg Tablet?",
        "answer": [
          "Amifex 60 mg Tablet is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Amifex 60 mg Tablet?",
        "answer": [
          "Amifex 60 mg Tablet is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Amifex 60 mg Tablet?",
        "answer": [
          "Amifex 60 mg Tablet has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Amifex 60 mg Tablet?",
        "answer": [
          "Amifex 60 mg Tablet should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Amifex 60 mg Tablet make you sleepy?",
        "answer": [
          "Yes, Amifex 60 mg Tablet can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Amifex 60 mg Tablet?",
        "answer": [
          "Do not take an overdose of Amifex 60 mg Tablet as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Amifex 60 mg Tablet work?",
        "answer": [
          "Amifex 60 mg Tablet starts working within 1 hour of consuming it. The peak benefit of Amifex 60 mg Tablet is observed within 6 hours."
        ]
      },
      {
        "question": "Does Amifex 60 mg Tablet relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Amifex 60 mg Tablet can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Amifex 60 mg Tablet?",
        "answer": [
          "Take some rest after taking Amifex 60 mg Tablet if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Amifex 60 mg Tablet?",
        "answer": [
          "Amifex 60 mg Tablet should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Amifex 60 mg Tablet."
        ]
      },
      {
        "question": "How should I take Amifex 60 mg Tablet?",
        "answer": [
          "Amifex 60 mg Tablet should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Amifex 60 mg Tablet?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Amifex 60 mg Tablet."
        ]
      },
      {
        "question": "Can Amifex 60 mg Tablet cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Amifex 60 mg Tablet is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Amifex 60 mg Tablet is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Amifex 60 mg Tablet with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Amifex 60 mg Tablet may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Amifex 60 mg Tablet. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:29:21.653Z",
    "medicine_id": "68c3c09aef5b8f2b163a8f14",
    "original_record": {
      "input_index": 950,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8f14"
        },
        "name": "Amifex",
        "strength": "60 mg",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Amico Laboratories Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/20330/amifex-60-mg-tablet",
        "_page": 34,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/17367/alofen-100-mg-tablet",
    "name": "Alofen",
    "dosage_form": "Tablet",
    "generic": "Aceclofenac",
    "strength": "100 mg",
    "company": "Avarox Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 5.00",
      "strip_price": "৳ 50.00",
      "pack_size_info": "(10 x 10: ৳ 500.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 5.00",
          "pack_size_info": "(10 x 10: ৳ 500.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 50.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/3/aceclofenac/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alofen is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, toothache, trauma and lumbago.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Aceclofenac is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No significant drug interactions has not been observed but close monitoring of patients is required when it is used with:",
        "items": [
          "Lithium and Digoxin: may increase plasma concentration of lithium and digoxin.",
          "Diuretics: may interact the activity of diuretics.",
          "Anticoagulants: may enhance the activity of anticoagulant.",
          "Methotrexate: may increase the plasma level of methotrexate."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Aceclofenac is contraindicated in patients with known hypersensitivity to it or in whom aspirin or NSAIDs precipitate attacks of asthma.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Alofen is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "The use of Aceclofenac should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Caution should be exercised to patients with active or suspected peptic ulcer or gastro-intestinal bleeding moderate to severe hepatic impairment and cardiac or renal impairment. Caution should also be exercised in patients suffering from dizziness or urticaria.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "There are no clinical data on the use of Alofen in children.",
        "items": []
      }
    ],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs)",
    "dosage": [
      {
        "medication_type": null,
        "information": "Extended release tablet: The recommended dose in adults is one 200 mg Aceclofenac tablet daily or as prescribed by the physician.Film coated tablet: The recommended dose in adults is 100 mg, twice daily.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:22.695Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e56",
    "original_record": {
      "input_index": 951,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e56"
        },
        "name": "Alofen",
        "strength": "100 mg",
        "generic": "Aceclofenac",
        "company": "Avarox Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/17367/alofen-100-mg-tablet",
        "_page": 27,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/30991/aloglip-125-mg-tablet",
    "name": "Aloglip",
    "dosage_form": "Tablet",
    "generic": "Alogliptin Benzoate",
    "strength": "12.5 mg",
    "company": "Navana Pharmaceuticals Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 12.00",
      "strip_price": "৳ 120.00",
      "pack_size_info": "(3 x 10: ৳ 360.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 12.00",
          "pack_size_info": "(3 x 10: ৳ 360.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 120.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/30977/aloglip-25-mg-tablet?ref=1"
      },
      {
        "text": "6.25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/30990/aloglip-625-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/1871/alogliptin-benzoate/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Aloglip is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type-2 diabetes mellitus.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alogliptin is a DPP-4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus. Increased concentrations of the incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are released into the bloodstream from the small intestine in response to meals. These hormones cause insulin release from the pancreatic beta cells in a glucose-dependent manner but are inactivated by the DPP-4 enzyme within minutes. GLP-1 also lowers glucagon secretion from pancreatic alpha cells, reducing hepatic glucose production. In patients with type 2 diabetes, concentrations of GLP-1 are reduced but the insulin response to GLP-1 is preserved.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Aloglip is primarily renally excreted. Cytochrome (CYP) P450-related metabolism is negligible. No significant drug-drug interactions are observed with the CYP-substrates or inhibitors tested or with renally excreted drugs.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "History of a serious hypersensitivity reaction to Alogliptin-containing products, such as anaphylaxis, angioedema or severe cutaneous adverse reactions.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Common side effects are nasopharyngitis, headache and upper respiratory tract infection.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category B. No adequate or well-controlled studies in pregnant women have been conducted with Alogliptin. Alogliptin tablets should be used during pregnancy only if clearly needed. It is not known whether Alogliptintin is excreted in human milk. caution should be exercised when Alogliptin is administered to a nursing woman.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Acute pancreatitis",
        "information": ": If pancreatitis is suspected, promptly Aloglip should be discontinued.",
        "items": []
      },
      {
        "title": "Hypersensitivity",
        "information": ": There have been postmarketing reports of serious hypersensitivity reactions in patients treated with Aloglip such as anaphylaxis, angioedema and severe cutaneous adverse reactions. In such cases, promptly Aloglip should be discontinued.",
        "items": []
      },
      {
        "title": "Hepatic effects",
        "information": ": Postmarketing reports of hepatic failure, sometimes fatal. Causality can not be excluded. If liver injury is detected, promptly interrupt Aloglip and assess patient for probable cause, then treat cause if possible, to resolution or stabilization. Do not restart Aloglip if liver injury is confirmed and no alternative etiology can be found.",
        "items": []
      },
      {
        "title": "Hypoglycemia",
        "information": ": When an insulin secretagogue (e.g. sulfonylurea) or insulin is used in combination with Aloglip, a lower dose of the insulin secretagogue or insulin may be required to minimize the risk of hypoglycaemia.",
        "items": []
      },
      {
        "title": "Macrovascular outcomes",
        "information": ": There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Aloglip or any other antidiabetic drug.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Pediatric Use",
        "information": ": Safety and effectiveness of Aloglip in pediatric patients have not been established.",
        "items": []
      },
      {
        "title": "Geriatric Use",
        "information": ": Of the total number of patients (N=8507) in clinical safety and efficacy studies treated with Aloglip, 2064 (24.3%) patients were 65 years and older and 341 (4%) patients were 75 years and older. No overall differences in safety or effectiveness were observed between patients 65 years and over and younger patients. While this clinical experience has not identified differences in responses between the elderly and younger patients, greater sensitivity of some older individuals cannot be ruled out.",
        "items": []
      },
      {
        "title": "Hepatic Impairment",
        "information": ": No dose adjustments are required in patients with mild to moderate hepatic impairment (Child-Pugh Grade A and B) based on insignificant change in systemic exposures (e.g., AUC) compared to subjects with normal hepatic function in a pharmacokinetic study. Aloglip has not been studied in patients with severe hepatic impairment (Child-Pugh Grade C). Use caution when administering Aloglip to patients with liver disease.",
        "items": []
      },
      {
        "title": "Patients with Renal Impairment",
        "information": ":",
        "items": [
          "No dose adjustment of Aloglip is necessary for patients with mild renal impairment (creatinine clearance ≥60 mL/min).",
          "The dose of Aloglip is 12.5 mg once daily for patients with moderate renal impairment (creatinine clearance ≥30 to <60 mL/min).",
          "The dose of Aloglip is 6.25 mg once daily for patients with severe renal impairment (creatinine clearance ≥15 to <30 mL/min) or with end-stage renal disease (ESRD) (creatinine clearance <15 mL/min or requiring hemodialysis).",
          "Patients requiring hemodialysis can receive their dose of alogliptin without regard to the timing of the dialysis."
        ]
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "The highest doses of Aloglip administered in clinical trials were single doses of 800 mg to healthy subjects and doses of 400 mg once daily for 14 days to patients with type 2 diabetes (equivalent to 32 times and 16 times the maximum recommended clinical dose of 25 mg, respectively). No serious adverse events were observed at these doses. In the event of an overdose, it is reasonable to institute the necessary clinical monitoring and supportive therapy as dictated by the patient's clinical status. Per clinical judgment, it may be reasonable to initiate removal of unabsorbed material from the gastrointestinal tract. Aloglip is minimally dialyzable; over a 3-hour hemodialysis session, approximately 7% of the drug was removed. Therefore, hemodialysis is unlikely to be beneficial in an overdose situation. It is not known if Aloglip is dialyzable by peritoneal dialysis.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Dipeptidyl Peptidase-4 (DPP-4) inhibitor",
    "dosage": [
      {
        "medication_type": null,
        "information": "The recommended dose in patients with normal renal function or mild renal impairment is 25 mg once daily or as directed by the physicians.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:23.747Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e57",
    "original_record": {
      "input_index": 952,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e57"
        },
        "name": "Aloglip",
        "strength": "12.5 mg",
        "generic": "Alogliptin Benzoate",
        "company": "Navana Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/30991/aloglip-125-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/32346/alovit-gold-tablet",
    "name": "Alovit Gold",
    "dosage_form": "Tablet",
    "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
    "strength": null,
    "company": "Al-Madina Pharmaceuticals Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 9.50",
      "strip_price": "৳ 95.00",
      "pack_size_info": "(3 x 10: ৳ 285.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 9.50",
          "pack_size_info": "(3 x 10: ৳ 285.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 95.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/781/multivitamin-multimineral-a-z-gold-preparation/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alovit Gold is indicated for the prevention and treatment of vitamins & minerals deficiencies. As a complete daily nutritional supplement, it is also indicated to meet the increased demand for vitamins and minerals in the conditions like physical and emotional stress, chronic diseases, infection illness, osteoporosis, injuries or wound, surgery, poor digestion, old age, pregnancy and lactation, poor appetite, excess dieting, exposure to environmental pollution, heavy exercise etc.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "This is a film coated tablet, which combines 32 high potency vitamins and minerals. This preparation maintains a healthy body and active life-style.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "No drug interactions have been reported.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "This product is contraindicated in patients with known hypersensitivity to any of the ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Generally, Alovit Gold is well tolerated. Diarrhoea may occasionally occur during treatment with beta carotene and the skin may assume a slightly yellow discoloration. Vitamin C and vitamin E may cause diarrhoea and other gastrointestinal disturbances.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Recommended by the consultation with physician.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Long term intake of high level of vitamin A (excluding that sourced from beta carotene) may increase the risk of osteoporosis in postmenopausal women.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place, away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Multi-vitamin & Multi-mineral combined preparations",
    "dosage": [
      {
        "medication_type": null,
        "information": "One tablet daily or as recommended by the physician.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:24.904Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e60",
    "original_record": {
      "input_index": 953,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e60"
        },
        "name": "Alovit Gold",
        "strength": null,
        "generic": "Multivitamin & Multimineral [A-Z gold preparation]",
        "company": "Al-Madina Pharmaceuticals Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/32346/alovit-gold-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/196/alpam-05-mg-tablet",
    "name": "Alpam",
    "dosage_form": "Tablet",
    "generic": "Alprazolam",
    "strength": "0.5 mg",
    "company": "Asiatic Laboratories Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 2.00",
      "strip_price": "৳ 20.00",
      "pack_size_info": "(5 x 10: ৳ 100.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 2.00",
          "pack_size_info": "(5 x 10: ৳ 100.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 20.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/195/alpam-025-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/18/alprazolam/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alpam is indicated in-",
        "items": [
          "Anxiety disorder",
          "Short term relief of anxiety",
          "Anxiety associated with depression",
          "Panic disorder, with or without agoraphobia."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alprazolam is a triazole analog of the 1,4-benzodiazepine class of drugs. It is an anxiolytic with hypnotic and anticonvulsive properties. Alprazolam is presumed to produce its effects via interacting with the Gamma Aminobutyric Acid (GABA)- benzodiazepine receptor complex. Like all benzodiazepines, it causes a dose-related CNS depressant activity varying from mild impairment of task performance to hypnosis.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The CNS-depressant action of Alpam may be aggravated by concomitant use of other psychotropic drugs, anticonvulsants, antihistaminics, alcohol and oral ontraceptives.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects, if occur, are generally observed at the beginning of therapy and usually disappear upon continued medication. The most frequent side effects are drowsiness and light-headedness. The other side effects, that may occur include depression, headache, confusion, dry mouth, constipation, etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Alprazolam has been categorized in pregnancy category D; that means, it should be avoided in pregnancy. Like other benzodiazepines, Alprazolam is assumed to be excreted in breast milk. Therefore, nursing should not be undertaken by mothers who must use Alprazolam.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Because Alpam may produce psychological and physical dependence, the increment of dose or abrupt discontinuation of Alpam therapy should not be done without the physician's advice. The duration of therapy must be determined by the physicians. Alpam should be administered with caution to patients with hepatic or renal disease, chronic pulmonary insufficiency, or sleep apnea.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "The safety and effectiveness of Alpam in individuals below 18 years of age have not been established.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Manifestations of Alpam overdosage include somnolence, confusion, impaired coordination, diminished reflexes, and coma. In such cases of overdosage general supportive measures should be employed along with immediate gastric lavage.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Benzodiazepine sedatives",
    "dosage": [
      {
        "medication_type": null,
        "information": "Treatment should be initiated with a dose of 0.25 to 0.5 mg three times daily. Depending on the response, dose may be increased at intervals of 3 to 4 days in increments of no more than 1 mg/day. The maximum dose should not exceed 4 mg/day. Occasional patients with panic disorder may need as much as 10 mg a day to achieve a successful response and in these cases periodic reassessment and consideration of dosage adjustment is required. Dosage should be individualized for maximum beneficial effect with the lowest possible dose. If side-effects occur at starting dose, dose may be lowered. When discontinuing therapy, dosage should be reduced gradually by no more than 0.5 mg every three days. In elderly patients or in patients with advanced liver disease, the usual starting dose is 0.25 mg, two or three times daily and may be gradually increased if needed and tolerated. Alprazolam 1 mg should be administered once daily, preferably in the morning by patients who are on multiple dosage regimens of Alprazolam 0.25/0.5 mg. The tablets should be taken intact, they should not be chewed, crushed, or broken.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:26.135Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e61",
    "original_record": {
      "input_index": 954,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e61"
        },
        "name": "Alpam",
        "strength": "0.5 mg",
        "generic": "Alprazolam",
        "company": "Asiatic Laboratories Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/196/alpam-05-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/982/alphanate-250-iu-injection",
    "name": "Alphanate",
    "dosage_form": "Injection",
    "generic": "Antihemophilic Factor [Factor VIII]",
    "strength": "250 IU/vial",
    "company": "Grifols Biologicals LLC",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 9,900.00",
      "strip_price": null,
      "pack_size_info": null,
      "packages": [
        {
          "label": "250 IU vial",
          "price": "৳ 9,900.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": null,
    "indications": [
      {
        "title": null,
        "information": "Treatment and prophylaxis of haemorrhagic episodes in patients with haemophilia A, Prophylaxis in severe haemophilia A",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Factor VIII is required for clot formation and maintenance of haemostasis. It activates factor X in conjunction with activated factor IX. Activated factor X then converts prothrombin to thrombin, which converts fibrinogen to fibrin, and forms a stable clot with factor XIII. Factor VIII is used for replacement therapy in patients with haemophilia A.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Allergic reactions e.g. chills, chest tightness, fever, headache, hyperfibrinogenaemia, jittery feeling, lethargy, nausea, vomiting, somnolence, stinging at infusion site, stomach discomfort, tingling, urticaria, vasomotor reactions with rapid infusion.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "In individuals who have had an anaphylactic or severe systemic reaction to antihemophilic factor or von Willebrand factor preparations.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "Allergic reactions e.g. chills, chest tightness, fever, headache, hyperfibrinogenaemia, jittery feeling, lethargy, nausea, vomiting, somnolence, stinging at infusion site, stomach discomfort, tingling, urticaria, vasomotor reactions with rapid infusion.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Pregnancy Category C. Either studies in animals have revealed adverse effects on the fetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the fetus.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Risk of intravascular haemolysis in patients with blood groups A, B, or AB receiving high doses or repeated doses of factor VIII preparations. Risk of transmission of some viral infections especially hepatitis B and C. Dose requirement may vary in patients with factor VIII inhibitors; thus optimal treatment should be based on clinical response. Monitor platelet counts regularly during treatment.",
        "items": []
      }
    ],
    "pediatric_uses": [],
    "overdose_effects": [],
    "storage_conditions": [
      {
        "title": null,
        "information": "Store between 2-8° C. Use within 3 hr of reconstitution; do not refrigerate after reconstitution due to risk of precipitation.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Antihaemophilic factor",
    "dosage": [
      {
        "medication_type": "Treatment and prophylaxis of haemorrhagic episodes in patients with haemophilia A",
        "information": ": Dosage is individualised based on coagulation tests performed before treatment and at regular intervals during treatment. Generally, 1 IU/kg will increase circulating factor VIII levels by about 2 IU/dL. Recommended doses vary according to the preparation used",
        "instructions": []
      },
      {
        "medication_type": "Suggested doses",
        "information": ": Mild-moderate haemorrhage (increase to 20-30% of normal): Usually with a single dose of 10-15 IU/kg",
        "instructions": []
      },
      {
        "medication_type": "More serious haemorrhage or minor surgery (increase to 30-50% of normal)",
        "information": ": Usual initial dose of 15-25 units/kg followed by 10-15 IU/kg every 8-12 hr if required",
        "instructions": []
      },
      {
        "medication_type": "Severe haemorrhage or major surgery (increase to 80-100% of normal)",
        "information": ": Usual initial dose of 40-50 IU/kg followed by 20-25 IU/kg every 8-12 hr. Refer to individual product information for further dosing details",
        "instructions": []
      },
      {
        "medication_type": "Prophylaxis in severe haemophilia A",
        "information": ": 10-50 IU/kg every 2-3 days, as needed",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:27.374Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e6a",
    "original_record": {
      "input_index": 955,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e6a"
        },
        "name": "Alphanate",
        "strength": "250 IU/vial",
        "generic": "Antihemophilic Factor [Factor VIII]",
        "company": "Grifols Biologicals LLC",
        "medicine_type": "Injection",
        "source_url": "https://medex.com.bd/brands/982/alphanate-250-iu-injection",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/2586/alphapress-1-mg-tablet",
    "name": "Alphapress",
    "dosage_form": "Tablet",
    "generic": "Prazosin Hydrochloride",
    "strength": "1 mg",
    "company": "Renata PLC",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 4.00",
      "strip_price": "৳ 40.00",
      "pack_size_info": "(10 x 10: ৳ 400.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 4.00",
          "pack_size_info": "(10 x 10: ৳ 400.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 40.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "2 mg (Tablet)",
        "href": "https://medex.com.bd/brands/2587/alphapress-2-mg-tablet?ref=1"
      },
      {
        "text": "2.5 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/29287/alphapress-xr-25-mg-tablet?ref=1"
      },
      {
        "text": "5 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/29288/alphapress-xr-5-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/913/prazosin-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Hypertension: Alphapress is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a ... Read moreHypertension: Alphapress is indicated in the treatment of all grades of essential (primary) hypertension and of all grades of secondary hypertension of variec etiology. It can be used as the initial and sole agent or it may be employed in a treatment program in combination with a diuretic and/or other antihypertensive drugs as needed for proper patient response. Renal blood flow and glomerular filtration rate are not impaired by long-term oral administration and thus Alphapress can be used with safety in hypertensive patients with impaired renal function.Left Ventricular Failure: Alphapress is indicated in the treatment of left ventricular failure. Alphapress may be added to the therapeutic regimen in those patients who have not shown a satisfactory response or who have become refractory to conventional therapy with diuretics, with or without cardiac glycosides.Raynaud's Phenomenon And Raynaud's Disease: Alphapress indicated in the treatment of Raynaud's phenomenon and Raynaud's disease.Benign Prostatic Hyperplasia: Alphapress is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia. It is also of value in patients awaiting prostatic surgery.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Prazosin causes a decrease in total peripheral vascular resistance through selective inhibition of postsynaptic alpha-1-adrenoreceptors in vascular smooth muscle. In hypertensive patients, blood pressure is lowered in both the supine and standing positions; this effect is more pronounced on the diastolic blood pressure. Rebound elevation of blood pressure does not occur following abrupt cessation of Prazosin therapy. The therapeutic efficacy of Prazosin in patients with congestive heart failure is ascribed to a reduction in left ventricular filling pressure, reduction in cardiac impedance and an augmentation of cardiac output. The use of Prazosin in congestive heart failure does not provoke a reflex tachycardia and blood pressure reduction is minimal in normotensive patients. Prazosin reduce the severity of the signs, symptoms, frequency and duration of attacks, in patients with Raynaud's disease. In low dosage, antagonism of alpha-1-receptors on prostatic and urethral smooth muscle has been shown to improve the urinary pressure profile in men and to improve symptoms of benign prostatic hyperplasia. Clinical studies have shown that Prazosin therapy is not associated with adverse changes in the serum lipid profile.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alphapress XR has been administered without any adverse drug interaction in clinical experience to date with the following:",
        "items": [
          "Cardiac-glycosides-digitalis and digoxin;",
          "Hypoglycemic agents-insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide;",
          "tranquilizers and sedatives-chlordiazepoxide, diazepam and phenobarbital;",
          "antiarrhythmic agents-procainamide, propranolol and quinidine; and",
          "analgesic, antipyretic and anti-inflammatory agents-propxyphene, aspirin, indomethacin and phenylbutazone type."
        ]
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Prazosin is contraindicated in patients with a known sensitivity to quinazolines.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The most common reactions associated with Alphapress therapy are dizziness, headache, drowsiness, lack of energy, weakness, palpitations and nausea. In most instances, side effects have disappeared with continued therapy or have been tolerated with no decrease in the dosage of the drug. In addition, the following reactions have been associated with Alphapress therapy; vomiting diarrhea, constipation, abdominal discomfort and/or pain, liver function abnormalities, pancreatitis, edema, orthostatic hypotension, dyspnea, faintness, tachycardia, nervousness, vertigo, hallucinations, depression, paresthesia, rash, pruritus alopecia, lichen planus, urinary frequency, impotence, incontinence, priapism, blurred vision, reddened solera, epistaxis, tinnitus, dry mouth, nasal congestion, diaphoresis, fever, positive ANA liter, and arthralgia. Some of these reactions have occurred rarely, and in many instances, the exact causal relationships have not been established. Literature reports exist associating Alphapress, therapy with a worsening of pre-existing narcolepsy. A causal relationship is uncertain in these cases. The following have been observed in parents being managed for left ventricular failure with Alphapress when used in conjunction with cardiac glycosides and diuretics; drowsiness, dizziness, postural hypotension, blurred vision, edema, dry mouth, palpitations, nausea, diarrhea, impotence, headache, and nasal congestion. In most instances, these occurrences have been mild to moderate in severity and have resolved with continued therapy or have been tolerated with no decrease in drug dosage. The most commonly although infrequently reported side effect in the treatment of Raynaud's Phenomenon/Disease was mild dizziness.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Although no teratogenic effects were seen in animal testing; the safety of Prazosin use during. pregnancy has not yet been established. The use of prazosin and a beta-blocker for the control of sever hypertension of 44 pregnant women revealed no drug-related fetal adnormalities or adverse effects. Therapy with prazosin was continued for as long as 14 weeks. Prazosin has also been used alone or in combination with other hypotensive agents in severe hypertension or pregnancy. No fetal or neonatal abnormalities have been reported with the use of Prazosin. There are no adequate and well controlled studies that establish the safety of Prazosin in pregnant women. Prazosin should be used during pregnancy only if in the opinion of the physician the potential benefit justifies the potential risk to the mother and fetus. Prazosin has been shown to be excreted in small amounts in human milk. Caution shold be exercised when Prazosin is adminsitered to nursing mothers.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": "Hypertension",
        "information": ": A very small percentage of patients have responded in an abrupt and exaggerated manner to the initial dose of Alphapress. Postural hypotension evidenced by dizziness and weakness, or rarely loss of consciousness, has been reported, particularly with the commencement of therapy, but this effect is readily avoided by initiating treatment with a low dose of Alphapress XR and with small increases in dosage during the first one to two weeks of therapy. The effect when observed is not related to the severity of hypertension is self-limiting and in most patients does not recur after the initial period of therapy or during subsequent dose titration steps. When instituting therapy with any effective antihypertensive agent, the patient should be advised how to avoid symptoms resulting from postural hypotension and what measures to take should they develop. The patient should be cautioned to avoid situations where injury could result should dizziness or weakness occur during the initiation of Alphapress therapy.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": When prazosin is initially administered to patients with left ventricular failure who have undergone vigorous diuretic or other vasodilator treatment, particularly in higher than the recommended starting dose, the resultant decrease in left ventricular filling pressure may be associated with a significant fall in cardiac output and systemic blood pressure. In such patients, observance of the recommended starting dose of prazosin followed by gradual titration is particularly important. (See dosage and administration). In occasional patients with left ventricular failure, the clinical efficacy of Alphapress has been reported to diminish after several months of treatment. In these patients, there is usually evidence of weight gain or peripheral edema indicating fluid retention. Since spontaneous deterioration may occur in such severely ill patients a causal relationship to prazosin therapy has not been established. Thus, as with all patients with left ventricular failure, careful adjustment of diuretic dosage according to the patient's clinical condition is required to prevent excessive fluid retention and consequent relief of symptoms. In those patients without evidence of fluid retention, when clinical improvement has diminished; an increase in the dosage, of Alphapress will usually restore clinical efficacy.",
        "items": []
      },
      {
        "title": "Raynaud's Phenomenon and Raynaud's Disease",
        "information": ": Because Alphapress decreases peripheral vascular resistance, careful monitoring of blood pressure during initial administration and titration of Alphapress is suggested. Close observation is especially recommended for patients already taking medication that are known the lower blood pressure.",
        "items": []
      },
      {
        "title": "Benign Prostatic Hyperplasia",
        "information": ": Alphapress decreases peripheral vasular resistance and since many patients with this disorder are elderly, careful monitoring of blood pressure during initial administration and during adjustment of the dose of Alphapress is suggested. Close observation is especially recommended for patients taking medications that are known to lower blood pressure.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Children",
        "information": ": Alphapress is not recommended for the treatment of children under the age of 12 years since safe conditions for its use have not been established.",
        "items": []
      },
      {
        "title": "Left Ventricular Failure",
        "information": ": Alphapress is not recommended in the treatment of left ventricular failure due to mechanical obstrcution such as aortic valve stenosis, mitral valve stenosis, pulmonary embolism and restrictive pericardial disease. Adequate data are not yet available to establish efficacy in patients with left ventricular failure due to a recent myocardial infarction.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Accidental ingestion of at least 50 mg of Alphapress in a two-year child resulted in profound drowsiness and depressed reflexes, No decrease in blood pressure was noted. Recovery was uneventful. Should overdosage lead to hypotension, support of the cardiovascular system is of first importance. Restoration of blood pressure and normalization of heart rate may be accomplished by keeping the patient in the supine position. If this measure is inadequate, shock should first be treated with volume expanders. If necessary, vasopressors should then be used. Renal function should be monitored and supported as needed. Laboratory data indicate Alphapress is not dialyzable because it is protein bound.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep away from light and moisture, store below 30°C. Keep away from reach out of the children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Alpha adrenoceptor blocking drugs",
    "dosage": [
      {
        "medication_type": "Prazosin Tablet",
        "information": ": There is evidence that toleration is best when therapy is initiated with a low starting dose. During the first week, the dosage of Prazosin should be adjusted according to the patient's individual toleration. Thereafter the daily dosage is to be adjusted on the basis of the patient's response. The response is usually seen within one to 14 days if it is to occur at any particular dose. When a response is seen, therapy should be continued at that dosage until the degree of response has reached optimum before the next dose increment is added.",
        "instructions": [
          "Hypertension: For maximum benefit, small increases should be continued until the desired effect is achieved or a total daily dosage of 20 mg is reached. A diuretic or adrenergic beta-blocking agent may be added to enhance efficacy. The maintenance dosage of Prazosin may be given as a twice or three times daily regimen.",
          "Patients Receiving No Antihypertensive Therapy. It is recommended that therapy be initiated with 0.5 mg given in the evening at bedtime then 0.5 mg b.i.d. or t.i.d for three to seven days. Unless poor toleration suggests the patient is unusually sensitive, this dosage should be increased to 1 mg given b.i.d. or t.i.d. for a further three to seven days. Thereafter, as determined by the patient's response to the blood pressure lowering effect, the dosage should be increased gradually to a total daily dosage of 20 mg given in divided doses.",
          "Patients Receiving Diuretic Therapy With inadequate Control of Blood Pressure. The diuretic should be reduced to a maintenance dosage level for the particular agent and Prazosin initiated with 0.5 mg h.s then proceeding to 0.5 mg b.i.d or t.i.d. After the initial period of observation, the dosage of Prazosin should be gradually increased as determined by the patient's response.",
          "Patients Receiving Other Antihypertensives But With Inadequate Control. Because some additive effect is anticipated, the other agent dosage level (e.g. beta-adrenergic blocking agents, methyldopa. reserpine, lsnidine etc.) should be reduced and Prazosin initiated at 0.5 mg h.s. then proceeding to 0.5 mg b.i.d, or t.i.d. Subsequent dosage increase should be made depending upon the patient's response. There is evidence that adding Prazosin to beta-adrenergic blocking agents, calcium antagonists or ACE inhibitors may bring about a substantial reduction in blood pressure. Thus, to low initial dosage regimen is strong, recommended.",
          "Patients With Moderate to Severe Grades of Renal Impairment Evidence to date shows that Prazosin does not further compromise renal function when used in patients with renal impairment. Because some patients in this category have responded to small doses of Prazosin , it is recommended that therapy be initiated at 0.5 mg daily and that dosage increases be instituted cautiously."
        ]
      },
      {
        "medication_type": "Left Ventricular Failure",
        "information": ": The recommended starting dose is 0.5 mg two, three or four times a day, Dosage should be titrated according to the patent's clinical response, based on careful monitoring of cardiopulmonary signs and symptoms, and when indicated, hemodynamic studies. Dosage titration steps may be performed as often as every two or three days in patients under close medical supervision. In severely ill, decompensated patients, rapid dosage titiration over one to two days may be indicated and is best done when hemodynamic- monitoring is available In dininai studies, the therapeutic dosages ranged from 4 mg to 20mg daily in divided doses. Adjustment of dosage may be required in the course of Prazosin therapy in some patients to maintain optimal clinical improvement.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5 mg b.i.d., t.i.d. or q.i.d. increasing to 4 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Use Daily Maintenance Dosage",
        "information": ": 4 mg once daily to 20 mg in divided doses.",
        "instructions": []
      },
      {
        "medication_type": "Raynaud's Phenomenon And Raynaud's Disease",
        "information": ": The recommended starting dosage is 0.5 mg b.i.d. given for a period of three to seven days. Dosage should be adjusted according to the patient's clinical response.",
        "instructions": []
      },
      {
        "medication_type": "Suggested Starting Dosage",
        "information": ": 0.5mg b.i.d.",
        "instructions": []
      },
      {
        "medication_type": "Usual Daily Maintenance Dosage",
        "information": ": 1mg or 2 mg b.i.d Doses up to 2 mg t.i.d. may be required for some patients.",
        "instructions": []
      },
      {
        "medication_type": "Benign Prostatic Hyperplasia",
        "information": ": The recommended starting dose is 0.5 mg twice daily given for a period of 3 to 7 days and should then be adjusted according to the patient's clinical responses. The usual maintenance dose is 2 mg twice daily. The safety and efficacy of a total daily dosage greater than 4 mg have not been established. Therefore, total daily dosages greater than 4mg should be used with caution.",
        "instructions": []
      },
      {
        "medication_type": "Prazosin XR Tablet",
        "information": ": Prazosin XR Extended-Release Tablets must be swallowed whole and should not be bitten or divided. Therapy for hypertension with Prazosin XR must be initiated at 2.5 mg once daily. The 5 mg dosage form of Prazosin XR is not for initial dosing. Dosage may be increased slowly, in general over a 7 to 14-day period, depending on the response to each dose level. Doses above 20 mg once daily have not been studied. Maintenance Dose: Dosage may be increased as clinically indicated to 20 mg given in once-daily doses. Hypertensive patients controlled on Prazosin Tablets alone or in combination with other antihypertensive medications may be switched to Prazosin XR Extended Release Tablets at the equivalent or nearest higher total daily dose, e.g. Prazosin Tablets 4 mg daily equivalent to Prazosin XR Extended Release Tablets 5 mg once daily. Blood pressure measurements should be taken at the end of the dosing interval to assure adequate blood pressure control is maintained throughout the 24-hour period. Further titration may be necessary in some patients. The addition of a diuretic or other antihypertensive agent to prazosin has been shown to cause an additive hypotensive effect.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:28.743Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e6c",
    "original_record": {
      "input_index": 956,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e6c"
        },
        "name": "Alphapress",
        "strength": "1 mg",
        "generic": "Prazosin Hydrochloride",
        "company": "Renata PLC",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/2586/alphapress-1-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/6220/alphedin-120-mg-tablet",
    "name": "Alphedin",
    "dosage_form": "Tablet",
    "generic": "Fexofenadine Hydrochloride",
    "strength": "120 mg",
    "company": "Doctor’s Chemical Works Ltd.",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 7.00",
      "strip_price": "৳ 70.00",
      "pack_size_info": "(5 x 10: ৳ 350.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 7.00",
          "pack_size_info": "(5 x 10: ৳ 350.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 70.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [],
    "alternate_brands_url": "https://medex.com.bd/generics/468/fexofenadine-hydrochloride/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Allergic rhinitis: Alphedin is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat ... Read moreAllergic rhinitis: Alphedin is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, in adults and children 12 years of age and over. Symptoms treated effectively include sneezing, rhinorrhea, lacrimation, itchy, red eyes and itchy nose/palate/throat. Alphedin improves health-related quality of life and work/activity productivity. Chronic idiopathic urticaria: Alphedin is indicated for the relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years of age and older. Alphedin significantly reduces the signs and symptoms of chronic idiopathic urticaria, the number of wheals, and pruritus. Alphedin improves health-related quality of life and work/activity productivity.",
        "items": []
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "The H1 histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to allergen results in the degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H1 receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes. Fexofenadine is considered an \"inverse agonist\" of the H1 receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects. It has a potent and selective affinity for H1 receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity. Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "Alphedin does not undergo hepatic biotransformation and therefore will not interact with other medicinal products through hepatic mechanisms. Coadministration of Alphedin with erythromycin or ketoconazole has been found to result in a 2-3 times increase in the level of fexofenadine in plasma. The changes were not accompanied by any effects on the QT interval and were not associated with any increase in adverse reactions compared to the medicinal products given singly. No interaction between fexofenadine and omeprazole was observed. However, the administration of an antacid containing aluminium and magnesium hydroxide gels 15 minutes prior to Alphedin caused a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. It is advisable to leave 2 hours between administration of Alphedin and aluminium and magnesium hydroxide containing antacids.",
        "items": []
      }
    ],
    "contraindications": [
      {
        "title": null,
        "information": "Contraindicated in patients with known hypersensitivity to Fexofenadine Hydrochloride or any of its ingredients.",
        "items": []
      }
    ],
    "side_effects": [
      {
        "title": null,
        "information": "The following frequency rating has been used, when applicable: Very common ≥1/10; Common ≥1/100 and <1/10; Uncommon ≥1/1,000 and <1/100; Rare ≥1/10,000 and <1/1,000; Very rare <1/10,000 and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials, with an incidence similar to that observed with placebo: Nervous system disorders- Common: headache, drowsiness, dizziness; Gastrointestinal disorders- Common: nausea; General disorders and administration site conditions- Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from available data): Immune system disorders- hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, flushing and systemic anaphylaxis; Psychiatric disorders- insomnia, nervousness, sleep disorders or nightmares/excessive dreaming (paroniria); Cardiac disorders- tachycardia, palpitations; Gastrointestinal disorders- diarrhea; Skin and subcutaneous tissue disorders- rash, urticaria, pruritus",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "There are no adequate data from the use of Fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to effects on pregnancy, embryonal/foetal development, parturition or postnatal development. Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. There are no data on the content of human milk after administering Fexofenadine hydrochloride. However, when Terfenadine was administered to nursing mothers Fexofenadine was found to cross into human breast milk. Therefore, Fexofenadine hydrochloride is not recommended for mothers breast-feeding their babies. No human data on the effect of Fexofenadine hydrochloride on fertility are available. In mice, there was no effect on fertility with Fexofenadine hydrochloride treatment.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "As with most new medicinal products there is only limited data in the older people and renally or hepatically impaired patients. Alphedin should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a medicine class, have been associated with the adverse reactions, tachycardia and palpitations. Effects on ability to drive and use machines: On the basis of the pharmacodynamic profile and reported adverse reactions it is unlikely that Alphedin tablets will produce an effect on the ability to drive or use machines. In objective tests, Alphedin has been shown to have no significant effects on central nervous system function. This means that patients may drive or perform tasks that require concentration. However, in order to identify sensitive people who have an unusual reaction to medicinal products, it is advisable to check the individual response before driving or performing complicated tasks.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": "Renal and hepatic impaired patient",
        "information": ": The pharmacokinetics of fexofenadine are altered in individuals with renal impairment. Based on increases in bioavailability and half-life, a dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Moderate to severe hepatic disease does not affect the pharmacokinetics of fexofenadine substantially.",
        "items": []
      },
      {
        "title": "Elderly patient",
        "information": ": Adverse events were similar in this group compared to patients under 65 years of age. Nevertheless, the pharmacokinetics of fexofenadine is altered (increased bioavailability) in individuals over 65 years of age.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Dizziness, drowsiness, fatigue and dry mouth have been reported with overdose of Alphedin. Single doses up to 800 mg and doses up to 690 mg twice daily for 1 month or 240 mg once daily for 1 year have been administered to healthy subjects without the development of clinically significant adverse reactions as compared with placebo. The maximum tolerated dose of Alphedin has not been established. Standard measures should be considered to remove any unabsorbed medicinal product. Symptomatic and supportive treatment is recommended. Haemodialysis does not effectively remove Alphedin from blood.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep in a dry place away from light and heat. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": "C32H39NO4",
      "chemical_structure": "https://medex.com.bd/storage/res/g-res-468-fexofenadine-hydrochloride-chemical-structure-HrM3XW8ofnGVhLdcBRox.svg"
    },
    "therapeutic_class": "Non-sedating antihistamines",
    "dosage": [
      {
        "medication_type": "Allergic Rhinitis-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 2 to 11 years",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 30 mg or 5 ml twice daily",
          "In case of impaired renal function: 30 mg or 5 ml once daily"
        ]
      },
      {
        "medication_type": "Chronic Idiopathic Urticaria-",
        "information": "Adults and children 12 years and older: Children from 6 to 11 years: Children from 6 months to less than 2 years: Children from 2 to 11 years:",
        "instructions": [
          "Tablet: 60 mg twice daily or 120 mg once daily or 180 mg once daily",
          "In case of impaired renal function: 60 mg once daily",
          "Tablet: 30 mg twice daily or 60 mg once daily",
          "In case of impaired renal function: 30 mg once daily",
          "Suspension: 15 mg or 2.5 ml (1/2 tsp) twice daily",
          "In case of impaired renal function: 15 mg or 2.5 ml (1/2 tsp) once daily",
          "Suspension: 30 mg or 5 ml (1 tsp) twice daily",
          "In case of impaired renal function: 30 mg or 5 ml (1 tsp) once daily"
        ]
      }
    ],
    "common_questions": [
      {
        "question": "What is Alphedin 120 mg Tablet?",
        "answer": [
          "Alphedin 120 mg Tablet is an antihistamine. It works by blocking histamine that the body makes during an allergic reaction."
        ]
      },
      {
        "question": "What are the uses of Alphedin 120 mg Tablet?",
        "answer": [
          "Alphedin 120 mg Tablet is used for the treatment of allergic rhinitis and urticaria. It relieves allergy symptoms such as runny nose, itching eyes/nose, sneezing, hives, and itching."
        ]
      },
      {
        "question": "What are the Side Effects of Alphedin 120 mg Tablet?",
        "answer": [
          "Alphedin 120 mg Tablet has some reported side effects such as Vomiting, Headache, Coughing, Diarrhea, Painful menstruation, Pain in the arms and legs, Hives and redness of skin, Swelling of face, lips, eyelids, tongue, hands and feet."
        ]
      },
      {
        "question": "What are the instructions for storage and disposal Alphedin 120 mg Tablet?",
        "answer": [
          "Alphedin 120 mg Tablet should be kept in a cool dry place and in its original pack. Make sure this medication remains unreachable to children and pets."
        ]
      },
      {
        "question": "Can Alphedin 120 mg Tablet make you sleepy?",
        "answer": [
          "Yes, Alphedin 120 mg Tablet can make you feel sleepy, infect sleepiness is a common side effect of this medicine."
        ]
      },
      {
        "question": "Can you overdose on Alphedin 120 mg Tablet?",
        "answer": [
          "Do not take an overdose of Alphedin 120 mg Tablet as this can cause adverse reactions and may increase the risk of side effects like dizziness, drowsiness, fatigue, and dry mouth."
        ]
      },
      {
        "question": "How quickly does Alphedin 120 mg Tablet work?",
        "answer": [
          "Alphedin 120 mg Tablet starts working within 1 hour of consuming it. The peak benefit of Alphedin 120 mg Tablet is observed within 6 hours."
        ]
      },
      {
        "question": "Does Alphedin 120 mg Tablet relieve symptoms of outdoor and indoor allergies?",
        "answer": [
          "Yes, Alphedin 120 mg Tablet can help relieve symptoms that may be caused by outdoor and indoor allergens such as upper respiratory allergies, hay fever, watery eyes, runny nose, and sneezing, or itching of the nose or throat."
        ]
      },
      {
        "question": "How to cope with dizziness caused by Alphedin 120 mg Tablet?",
        "answer": [
          "Take some rest after taking Alphedin 120 mg Tablet if you feel dizzy or sleep. Do not use heavy machinery or drive and move very slowly. Exercise caution and if there is extreme dizziness, then consult a doctor as soon as possible."
        ]
      },
      {
        "question": "Can I take antacids while taking Alphedin 120 mg Tablet?",
        "answer": [
          "Alphedin 120 mg Tablet should not be used in combination with antacids as the interaction between them can result in a decreased absorption of Alphedin 120 mg Tablet."
        ]
      },
      {
        "question": "How should I take Alphedin 120 mg Tablet?",
        "answer": [
          "Alphedin 120 mg Tablet should be taken in dose and duration as recommended by the doctor. Do not take an overdose as this can affect your health adversely."
        ]
      },
      {
        "question": "Is there any food or drink that I need to avoid while taking Alphedin 120 mg Tablet?",
        "answer": [
          "Do not consume juices like grapefruit juice, orange juice and apple juice if you are on the course of medication with Alphedin 120 mg Tablet."
        ]
      },
      {
        "question": "Can Alphedin 120 mg Tablet cause heart problems?",
        "answer": [
          "Those who suffer from heart disorders should exercise caution and must look out for some other alternative of this medicine."
        ]
      },
      {
        "question": "Quick Tips",
        "answer": [
          "Alphedin 120 mg Tablet is an antihistaminic medication. It treats allergy symptoms such as itching, swelling, and rashes by blocking the effects of a chemical messenger (histamine) in the body.",
          "Alphedin 120 mg Tablet is less likely to make you feel sleepy than some other similar medicines.",
          "Do not take Alphedin 120 mg Tablet with any fruit juices (such as apple, orange, or grapefruit) as they might make the drug less effective.",
          "Alphedin 120 mg Tablet may cause nausea. Stick to simple meals, and do not eat rich or spicy food.",
          "Avoid using antacids 30 minutes before or after taking Alphedin 120 mg Tablet. It can make it harder for your body to absorb this medication."
        ]
      }
    ],
    "fetched_at": "2025-09-19T05:29:30.128Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e70",
    "original_record": {
      "input_index": 957,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e70"
        },
        "name": "Alphedin",
        "strength": "120 mg",
        "generic": "Fexofenadine Hydrochloride",
        "company": "Doctor’s Chemical Works Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/6220/alphedin-120-mg-tablet",
        "_page": 28,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/198/alprax-05-mg-tablet",
    "name": "Alprax",
    "dosage_form": "Tablet",
    "generic": "Alprazolam",
    "strength": "0.5 mg",
    "company": "Opsonin Pharma Ltd.",
    "pack_image": "https://medex.com.bd/data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNzUiIGhlaWdodD0iMTE1Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBmaWxsPSJ0cmFuc3BhcmVudCIvPjwvc3ZnPg==",
    "pricing": {
      "unit_price": "৳ 3.00",
      "strip_price": "৳ 30.00",
      "pack_size_info": "(5 x 10: ৳ 150.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 3.00",
          "pack_size_info": "(5 x 10: ৳ 150.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 30.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.25 mg (Tablet)",
        "href": "https://medex.com.bd/brands/197/alprax-025-mg-tablet?ref=1"
      },
      {
        "text": "2 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/199/alprax-xr-2-mg-tablet?ref=1"
      },
      {
        "text": "1 mg (ER Tablet)",
        "href": "https://medex.com.bd/brands/200/alprax-xr-1-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/18/alprazolam/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alprax is indicated in-",
        "items": [
          "Anxiety disorder",
          "Short term relief of anxiety",
          "Anxiety associated with depression",
          "Panic disorder, with or without agoraphobia."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alprazolam is a triazole analog of the 1,4-benzodiazepine class of drugs. It is an anxiolytic with hypnotic and anticonvulsive properties. Alprazolam is presumed to produce its effects via interacting with the Gamma Aminobutyric Acid (GABA)- benzodiazepine receptor complex. Like all benzodiazepines, it causes a dose-related CNS depressant activity varying from mild impairment of task performance to hypnosis.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The CNS-depressant action of Alprax may be aggravated by concomitant use of other psychotropic drugs, anticonvulsants, antihistaminics, alcohol and oral ontraceptives.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects, if occur, are generally observed at the beginning of therapy and usually disappear upon continued medication. The most frequent side effects are drowsiness and light-headedness. The other side effects, that may occur include depression, headache, confusion, dry mouth, constipation, etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Alprazolam has been categorized in pregnancy category D; that means, it should be avoided in pregnancy. Like other benzodiazepines, Alprazolam is assumed to be excreted in breast milk. Therefore, nursing should not be undertaken by mothers who must use Alprazolam.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Because Alprax may produce psychological and physical dependence, the increment of dose or abrupt discontinuation of Alprax therapy should not be done without the physician's advice. The duration of therapy must be determined by the physicians. Alprax should be administered with caution to patients with hepatic or renal disease, chronic pulmonary insufficiency, or sleep apnea.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "The safety and effectiveness of Alprax in individuals below 18 years of age have not been established.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Manifestations of Alprax overdosage include somnolence, confusion, impaired coordination, diminished reflexes, and coma. In such cases of overdosage general supportive measures should be employed along with immediate gastric lavage.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Benzodiazepine sedatives",
    "dosage": [
      {
        "medication_type": null,
        "information": "Treatment should be initiated with a dose of 0.25 to 0.5 mg three times daily. Depending on the response, dose may be increased at intervals of 3 to 4 days in increments of no more than 1 mg/day. The maximum dose should not exceed 4 mg/day. Occasional patients with panic disorder may need as much as 10 mg a day to achieve a successful response and in these cases periodic reassessment and consideration of dosage adjustment is required. Dosage should be individualized for maximum beneficial effect with the lowest possible dose. If side-effects occur at starting dose, dose may be lowered. When discontinuing therapy, dosage should be reduced gradually by no more than 0.5 mg every three days. In elderly patients or in patients with advanced liver disease, the usual starting dose is 0.25 mg, two or three times daily and may be gradually increased if needed and tolerated. Alprazolam 1 mg should be administered once daily, preferably in the morning by patients who are on multiple dosage regimens of Alprazolam 0.25/0.5 mg. The tablets should be taken intact, they should not be chewed, crushed, or broken.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:31.778Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e75",
    "original_record": {
      "input_index": 958,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e75"
        },
        "name": "Alprax",
        "strength": "0.5 mg",
        "generic": "Alprazolam",
        "company": "Opsonin Pharma Ltd.",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/198/alprax-05-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  },
  {
    "source_url": "https://medex.com.bd/brands/36372/alprazol-025-mg-tablet",
    "name": "Alprazol",
    "dosage_form": "Tablet",
    "generic": "Alprazolam",
    "strength": "0.25 mg",
    "company": "Albion Laboratories Limited",
    "pack_image": null,
    "pricing": {
      "unit_price": "৳ 1.50",
      "strip_price": "৳ 15.00",
      "pack_size_info": "(3 x 10: ৳ 45.00)",
      "packages": [
        {
          "label": "Unit Price",
          "price": "৳ 1.50",
          "pack_size_info": "(3 x 10: ৳ 45.00)"
        },
        {
          "label": "Strip Price",
          "price": "৳ 15.00",
          "pack_size_info": null
        }
      ]
    },
    "flags": [],
    "also_available": [
      {
        "text": "0.5 mg (Tablet)",
        "href": "https://medex.com.bd/brands/36373/alprazol-05-mg-tablet?ref=1"
      }
    ],
    "alternate_brands_url": "https://medex.com.bd/generics/18/alprazolam/brand-names",
    "indications": [
      {
        "title": null,
        "information": "Alprazol is indicated in-",
        "items": [
          "Anxiety disorder",
          "Short term relief of anxiety",
          "Anxiety associated with depression",
          "Panic disorder, with or without agoraphobia."
        ]
      }
    ],
    "mode_of_action": [
      {
        "title": null,
        "information": "Alprazolam is a triazole analog of the 1,4-benzodiazepine class of drugs. It is an anxiolytic with hypnotic and anticonvulsive properties. Alprazolam is presumed to produce its effects via interacting with the Gamma Aminobutyric Acid (GABA)- benzodiazepine receptor complex. Like all benzodiazepines, it causes a dose-related CNS depressant activity varying from mild impairment of task performance to hypnosis.",
        "items": []
      }
    ],
    "interaction": [
      {
        "title": null,
        "information": "The CNS-depressant action of Alprazol may be aggravated by concomitant use of other psychotropic drugs, anticonvulsants, antihistaminics, alcohol and oral ontraceptives.",
        "items": []
      }
    ],
    "contraindications": [],
    "side_effects": [
      {
        "title": null,
        "information": "Side effects, if occur, are generally observed at the beginning of therapy and usually disappear upon continued medication. The most frequent side effects are drowsiness and light-headedness. The other side effects, that may occur include depression, headache, confusion, dry mouth, constipation, etc.",
        "items": []
      }
    ],
    "pregnancy_cat": [
      {
        "title": null,
        "information": "Alprazolam has been categorized in pregnancy category D; that means, it should be avoided in pregnancy. Like other benzodiazepines, Alprazolam is assumed to be excreted in breast milk. Therefore, nursing should not be undertaken by mothers who must use Alprazolam.",
        "items": []
      }
    ],
    "precautions": [
      {
        "title": null,
        "information": "Because Alprazol may produce psychological and physical dependence, the increment of dose or abrupt discontinuation of Alprazol therapy should not be done without the physician's advice. The duration of therapy must be determined by the physicians. Alprazol should be administered with caution to patients with hepatic or renal disease, chronic pulmonary insufficiency, or sleep apnea.",
        "items": []
      }
    ],
    "pediatric_uses": [
      {
        "title": null,
        "information": "The safety and effectiveness of Alprazol in individuals below 18 years of age have not been established.",
        "items": []
      }
    ],
    "overdose_effects": [
      {
        "title": null,
        "information": "Manifestations of Alprazol overdosage include somnolence, confusion, impaired coordination, diminished reflexes, and coma. In such cases of overdosage general supportive measures should be employed along with immediate gastric lavage.",
        "items": []
      }
    ],
    "storage_conditions": [
      {
        "title": null,
        "information": "Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.",
        "items": []
      }
    ],
    "description": [],
    "administration": [],
    "compound_summary": {
      "molecular_formula": null,
      "chemical_structure": null
    },
    "therapeutic_class": "Benzodiazepine sedatives",
    "dosage": [
      {
        "medication_type": null,
        "information": "Treatment should be initiated with a dose of 0.25 to 0.5 mg three times daily. Depending on the response, dose may be increased at intervals of 3 to 4 days in increments of no more than 1 mg/day. The maximum dose should not exceed 4 mg/day. Occasional patients with panic disorder may need as much as 10 mg a day to achieve a successful response and in these cases periodic reassessment and consideration of dosage adjustment is required. Dosage should be individualized for maximum beneficial effect with the lowest possible dose. If side-effects occur at starting dose, dose may be lowered. When discontinuing therapy, dosage should be reduced gradually by no more than 0.5 mg every three days. In elderly patients or in patients with advanced liver disease, the usual starting dose is 0.25 mg, two or three times daily and may be gradually increased if needed and tolerated. Alprazolam 1 mg should be administered once daily, preferably in the morning by patients who are on multiple dosage regimens of Alprazolam 0.25/0.5 mg. The tablets should be taken intact, they should not be chewed, crushed, or broken.",
        "instructions": []
      }
    ],
    "common_questions": [],
    "fetched_at": "2025-09-19T05:29:33.796Z",
    "medicine_id": "68c3c09aef5b8f2b163a8e78",
    "original_record": {
      "input_index": 959,
      "brand_record": {
        "_id": {
          "$oid": "68c3c09aef5b8f2b163a8e78"
        },
        "name": "Alprazol",
        "strength": "0.25 mg",
        "generic": "Alprazolam",
        "company": "Albion Laboratories Limited",
        "medicine_type": "Tablet",
        "source_url": "https://medex.com.bd/brands/36372/alprazol-025-mg-tablet",
        "_page": 29,
        "image_uri": null,
        "createdAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        },
        "updatedAt": {
          "$date": "2025-09-12T06:45:33.175Z"
        }
      }
    }
  }
]